PT J
AU Finsterer, J
   Zarrouk, S
AF Finsterer, Josef
   Zarrouk, Sinda
TI Fatigue and Exercise Intolerance as Initial Manifestations of a Nonsyndromic Mitochondrial Disorder Due to the Variant m.3243A&gt;G
SO CASE REPORTS IN NEUROLOGICAL MEDICINE
LA English
DT Article
ID a3243g mutation
AB Objectives. Fatigue and exercise intolerance have been only rarely reported as initial- and sole-onset manifestations of a mitochondrial disorder (MID). We present a patient with nonsyndromic MID with fatigue and exercise intolerance as its initial manifestations of the disease. Case Report. A 39 yo female experienced fatigue since age 18 and exercise intolerance since age 21. Later on, she developed Hashimoto thyroiditis, recurrent diffuse headache, and double vision upon exercise. Clinical exam revealed short stature, bilateral ptosis, partially reduced tendon reflexes, and hypertrophic calves. Serum lactate was elevated, and the lactate stress test was abnormal. Workup for suspected MID revealed ragged-red fibers and NADH-deficient muscle fibers, and biochemical investigations revealed a mild complex-I defect. mtDNA sequencing revealed the variant m.3243A>G with a heteroplasmy rate of 70% in the muscle. Conclusions. This case shows that the initial manifestation of a MID can be fatigue and exercise intolerance. MIDs due to the m.3243A>G variant may have a slowly progressive course and only delayed multisystem involvement. The variant m.3243A>G may not only manifest as syndromic MID, particularly MELAS but also as nonsyndromic phenotype. MIDs should be considered as differentials of chronic fatigue even if no other phenotypic manifestation of a MID is present.
C1 [Finsterer, Josef] Neurol & Neurophysiol Ctr, Vienna, Austria.
   [Zarrouk, Sinda] Univ Tunis El Manar, Tunis, Tunisia.
C3 Universite de Tunis-El-Manar
RP Finsterer, J (corresponding author), Neurol & Neurophysiol Ctr, Vienna, Austria.
EM fipaps@yahoo.de
CR Blum S, 2011, INTERN MED J, V41, P200, DOI 10.1111/j.1445-5994.2010.02379.x
   Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Gal Aniko, 2008, ORVOSI HETILAP, V149, P1593, DOI 10.1556/OH.2008.28398
   Kanungo S, 2018, ANN TRANSL MED, V6, P0, DOI 10.21037/atm.2018.12.13
   Komlósi K, 2005, PATHOL ONCOL RES, V11, P82, DOI 10.1007/BF02893371
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Parikh S, 2019, NEUROMUSCULAR DISORD, V29, P895, DOI 10.1016/j.nmd.2019.09.012
   Verhaak C, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0403-5
NR 10
TC 0
Z9 0
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-6668
EI 2090-6676
J9 CASE REP NEUROL MED
JI Case Rep. Neurol. Med.
PD MAR 23
PY 2022
VL 2022
IS 
BP 
EP 
DI 10.1155/2022/7846852
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA 3I7FD
UT WOS:000832876800001
PM 35369674
DA 2024-11-01
ER

PT J
AU Ulger, O
   Kubat, GB
AF Ulger, Oner
   Kubat, Gokhan Burcin
TI Therapeutic applications of mitochondrial transplantation
SO BIOCHIMIE
LA English
DT Review
DE Mitochondria dysfunction; Mitochondrial transplantation; Mitochondrial dynamics; Mitochondrial isolation
ID ischemia-reperfusion injury; permeability transition; extracellular vesicles; skeletal-muscle; dna mutations; polar body; intercellular communication; membrane permeabilization; photothermal nanoblade; replacement therapy
AB This review aims to make a framework of exogenous healthy mitochondrial transplantation and to assemble present information for improving new therapeutic applications in a variety of diseases. Recently, the significance of mitochondrial transplantation has been emphasized in a variety of mitochondrial dysfunction-related diseases such as neurodegenerative diseases, toxic injury, ischemia, cardiovascular diseases. We describe the natural mitochondrial transfer mechanisms (ie. TNT, EVs, mitochondrial dynamics), mitochondrial isolation process for transplantation (ie. source of mitochondria, requirements for successful isolation), mitochondrial transplantation methods (in vivo, in vitro), the effects and limitations of mitochondrial transplantation. Since mitochondrial transplantation is seen as an innovative potential treatment for diseases that can not be treated at the desired level, we expect to represent how the mitochondrial transplantation methods can be used in different diseases. (c) 2022 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.
C1 [Ulger, Oner] Gulhane Training & Res Hosp, Dept Educ, Ankara, Turkey.
   [Kubat, Gokhan Burcin] Hacettepe Univ, Dept Exercise & Sports Physiol, Ankara, Turkey.
   [Kubat, Gokhan Burcin] Gulhane Training & Res Hosp, Dept Pathol, Ankara, Turkey.
C3 Gulhane Training & Research Hospital; Hacettepe University; Gulhane Training & Research Hospital
RP Ulger, O (corresponding author), Gulhane Training & Res Hosp, Dept Educ, Ankara, Turkey.; Kubat, GB (corresponding author), Hacettepe Univ, Dept Exercise & Sports Physiol, Ankara, Turkey.
EM oner.ulger@saglik.gov.tr; gokhankubat@hacettepe.edu.ti
CR Abounit S, 2012, J CELL SCI, V125, P1089, DOI 10.1242/jcs.083279
   Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011
   Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030
   Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   Anderson GR, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04033-x
   ARDUINI A, 1988, BIOCHIM BIOPHYS ACTA, V970, P113, DOI 10.1016/0167-4889(88)90169-3
   Babenko VA, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23030687
   Betancourt AM, 2014, BIOCHEM J, V461, P223, DOI 10.1042/BJ20131433
   Bonora M, 2014, FRONT ONCOL, V4, P0, DOI 10.3389/fonc.2014.00302
   Boyapati Ray K, 2017, F1000RES, V6, P169, DOI 10.12688/f1000research.10397.1
   Caicedo A, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09073
   Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876
   CAPECCHI MR, 1980, CELL, V22, P479, DOI 10.1016/0092-8674(80)90358-X
   Carraro M, 2016, CELL CALCIUM, V60, P102, DOI 10.1016/j.ceca.2016.03.005
   Casares D, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20092167
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chan PH, 2005, ANN NY ACAD SCI, V1042, P203, DOI 10.1196/annals.1338.022
   Chang CY, 2019, TRANSL NEURODEGENER, V8, P0, DOI 10.1186/s40035-019-0158-8
   Chang JC, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-10870-5
   Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003
   Chang JC, 2013, NEUROSIGNALS, V21, P160, DOI 10.1159/000341981
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen X, 2017, ONCOL REP, V38, P522, DOI 10.3892/or.2017.5697
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chiou EPY, 2013, PHOTOTHERMAL NANOBLA, V0, P0
   Chung KP, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-11327-1
   Chung Susan, 2007, NAT CLIN PRACT CARDIOVASC MED, V4 Suppl 1, PS60, DOI 10.1038/ncpcardio0766
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   CLARK MA, 1982, NATURE, V295, P605, DOI 10.1038/295605a0
   Cloonan SM, 2020, EUR RESPIR REV, V29, P0, DOI 10.1183/16000617.0165-2020
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Costa-Borges N, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.48591
   Costa-Borges N, 2019, FERTIL STERIL, V112, PE5, DOI 10.1016/j.fertnstert.2019.07.1329
   Cowan DB, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-17813-0
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233
   Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR
   Dai W, 2007, J MOL CELL CARDIOL, V43, P504, DOI 10.1016/j.yjmcc.2007.07.001
   Dalfó E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a
   Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111
   Dawson ER, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-71199-0
   DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021
   Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC
   Domhan S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021283
   EBERT K M, 1989, MOLECULAR REPRODUCTION AND DEVELOPMENT, V1, P156, DOI 10.1002/mrd.1080010303
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Ellinger J, 2008, BJU INT, V102, P628, DOI 10.1111/j.1464-410X.2008.07613.x
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Fang SY, 2021, J THORAC CARDIOV SUR, V161, PE337, DOI 10.1016/j.jtcvs.2019.10.151
   Février B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003
   Filadi R, 2015, P NATL ACAD SCI USA, V112, PE2174, DOI 10.1073/pnas.1504880112
   FLOOD JT, 1990, FERTIL STERIL, V53, P1049
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Giorgio V, 2018, CELL CALCIUM, V70, P56, DOI 10.1016/j.ceca.2017.05.004
   Gollihue JL, 2017, J NEUROSCI METH, V287, P1, DOI 10.1016/j.jneumeth.2017.05.023
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Greenfield A, 2017, NAT BIOTECHNOL, V35, P1059, DOI 10.1038/nbt.3997
   Greenwalt TJ, 2006, TRANSFUSION, V46, P143, DOI 10.1111/j.1537-2995.2006.00692.x
   Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200
   Guariento A, 2021, J THORAC CARDIOV SUR, V162, P992, DOI 10.1016/j.jtcvs.2020.10.151
   Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8
   Guo J, 2020, EXP CELL RES, V389, P0, DOI 10.1016/j.yexcr.2020.111880
   Gupta N, 2016, HEPATIC MED-EVID RES, V8, P115, DOI 10.2147/HMER.S116852
   Häberle H, 2021, J INTENSIVE CARE MED, V36, P681, DOI 10.1177/0885066621997365
   Hagège AA, 2003, LANCET, V361, P491, DOI 10.1016/S0140-6736(03)12458-0
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   He KM, 2011, CARDIOVASC RES, V92, P39, DOI 10.1093/cvr/cvr189
   Heineman Bd LX, 2021, J CLIN TRANSL HEPATO, V0, P0
   Huang PJ, 2016, CELL TRANSPLANT, V25, P913, DOI 10.3727/096368915X689785
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Iraci N, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17020171
   Irwin MH, 1999, TRANSGENIC RES, V8, P119, DOI 10.1023/A:1008925419758
   JAESCHKE H, 1989, BIOCHEM BIOPH RES CO, V160, P140, DOI 10.1016/0006-291X(89)91632-X
   Jassem W, 2002, TRANSPLANTATION, V73, P493, DOI 10.1097/00007890-200202270-00001
   Jiang DA, 2016, CELL DEATH DIS, V7, P0, DOI 10.1038/cddis.2016.358
   Jiang WW, 2005, CLIN CANCER RES, V11, P2486, DOI 10.1158/1078-0432.CCR-04-2147
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Katrangi E, 2007, REJUV RES, V10, P561, DOI 10.1089/rej.2007.0575
   Kaza AK, 2017, J THORAC CARDIOV SUR, V153, P934, DOI 10.1016/j.jtcvs.2016.10.077
   KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0
   Kitani T, 2014, J CELL MOL MED, V18, P1694, DOI 10.1111/jcmm.12316
   Kofidis T, 2005, EUR J CARDIO-THORAC, V28, P461, DOI 10.1016/j.ejcts.2005.03.049
   Kolbe T, 2021, METHODS MOL BIOL, V2277, P91, DOI 10.1007/978-1-0716-1270-5_6
   Kowaltowski AJ, 1996, J BIOL CHEM, V271, P2929, DOI 10.1074/jbc.271.6.2929
   KOYAMA I, 1985, TRANSPLANTATION, V40, P590, DOI 10.1097/00007890-198512000-00003
   Kubat GB, 2021, J BIOCHEM MOL TOXIC, V35, P0, DOI 10.1002/jbt.22898
   Kubat GB, 2021, J BIOCHEM MOL TOXIC, V35, P0, DOI 10.1002/jbt.22612
   Kühlbrandt W, 2015, BMC BIOL, V13, P0, DOI 10.1186/s12915-015-0201-x
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kurokawa T, 1996, J SURG RES, V66, P1, DOI 10.1006/jsre.1996.0363
   Kuznetsov AV, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8100454
   Lazo S, 2021, AGING CELL, V20, P0, DOI 10.1111/acel.13283
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Lee JM, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10050696
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Li XX, 2015, J HISTOCHEM CYTOCHEM, V63, P301, DOI 10.1369/0022155415574818
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Lima AR, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9020115
   Lin HC, 2013, SHOCK, V39, P304, DOI 10.1097/SHK.0b013e318283035f
   Lin HC, 2012, TRANSPLANTATION, V93, P265, DOI 10.1097/TP.0b013e31823ef335
   Liu DL, 2021, SIGNAL TRANSDUCT TAR, V6, P0, DOI 10.1038/s41392-020-00440-z
   Liu F, 2018, AGING DIS, V9, P924, DOI 10.14336/AD.2017.1126
   Liu KM, 2014, MICROVASC RES, V92, P10, DOI 10.1016/j.mvr.2014.01.008
   Liu LP, 2017, MIL MED, V182, P175, DOI 10.7205/MILMED-D-16-00096
   Liu XC, 2020, J GASTROEN HEPATOL, V35, P2241, DOI 10.1111/jgh.15091
   Lodi R, 2011, ARCH NEUROL-CHICAGO, V68, P67, DOI 10.1001/archneurol.2010.228
   Ma H, 2017, CELL STEM CELL, V20, P112, DOI 10.1016/j.stem.2016.10.001
   Macheiner T, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep35571
   Maeda A, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.277
   Marin WW, 2021, INT J MOL MED, V47, P485, DOI 10.3892/ijmm.2020.4823
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, PH966, DOI 10.1152/ajpheart.00883.2012
   McCully JD, 2009, AM J PHYSIOL-HEART C, V296, PH94, DOI 10.1152/ajpheart.00567.2008
   Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704
   Mistry JJ, 2019, P NATL ACAD SCI USA, V116, P24610, DOI 10.1073/pnas.1913278116
   Moon HE, 2015, EXP NEUROBIOL, V24, P103, DOI 10.5607/en.2015.24.2.103
   Morán M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009
   Morrison TJ, 2017, AM J RESP CRIT CARE, V196, P1275, DOI 10.1164/rccm.201701-0170OC
   Moskowitzova K, 2019, J HEART LUNG TRANSPL, V38, P92, DOI 10.1016/j.healun.2018.09.025
   Mottie S, 2018, J CELL BIOL, V217, P507, DOI 10.1083/jcb.201611194
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Munoz-Morris MA, 2007, BIOCHEM BIOPH RES CO, V355, P877, DOI 10.1016/j.bbrc.2007.02.046
   Nakahira K, 2015, ANTIOXID REDOX SIGN, V23, P1329, DOI 10.1089/ars.2015.6407
   Nasoni MG, 2021, J PINEAL RES, V71, P0, DOI 10.1111/jpi.12747
   Nicoletti V, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.636506
   Nunes MDS, 2013, MOL ECOL, V22, P2106, DOI 10.1111/mec.12256
   Orfany A, 2020, J VASC SURG, V71, P1014, DOI 10.1016/j.jvs.2019.03.079
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Pacak CA, 2015, BIOL OPEN, V4, P622, DOI 10.1242/bio.201511478
   Paliwal S, 2018, J BIOMED SCI, V25, P0, DOI 10.1186/s12929-018-0429-1
   Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4
   Paradies G, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8070728
   Parakatselaki ME, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11070633
   Patel D, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-13227-0
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pell VR, 2016, CARDIOVASC RES, V111, P134, DOI 10.1093/cvr/cvw100
   Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050
   Picard M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0018317
   Pitt JM, 2016, J CLIN INVEST, V126, P1139, DOI 10.1172/JCI87316
   Politi Y, 2014, DEV CELL, V29, P305, DOI 10.1016/j.devcel.2014.04.005
   Pour PA, 2021, AM J PHYSIOL-CELL PH, V321, PC489, DOI 10.1152/ajpcell.00152.2021
   Pour PA, 2020, J AM HEART ASSOC, V9, P0, DOI 10.1161/JAHA.119.014501
   Puhm F, 2019, CIRC RES, V125, P43, DOI 10.1161/CIRCRESAHA.118.314601
   Qin YM, 2021, FRONT ONCOL, V11, P0, DOI 10.3389/fonc.2021.672781
   Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006
   Ramos ES, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008085
   Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012
   Ren L, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.580070
   Renault TT, 2015, MOL CELL, V57, P69, DOI 10.1016/j.molcel.2014.10.028
   Reubold TF, 2012, CELL SIGNAL, V24, P1420, DOI 10.1016/j.cellsig.2012.03.007
   Reznichenko AS, 2016, APPL TRANSL GENOM, V11, P40, DOI 10.1016/j.atg.2016.10.001
   Roche S, 2013, INT J PHARMACEUT, V440, P72, DOI 10.1016/j.ijpharm.2011.12.041
   Roger AJ, 2017, CURR BIOL, V27, PR1177, DOI 10.1016/j.cub.2017.09.015
   Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROUSLIN W, 1983, AM J PHYSIOL, V244, PH743, DOI 10.1152/ajpheart.1983.244.6.H743
   Roy SS, 2009, METHODS MOL BIOL, V559, P173, DOI 10.1007/978-1-60327-017-5_13
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Sansone P, 2017, P NATL ACAD SCI USA, V114, PE9066, DOI 10.1073/pnas.1704862114
   Sastre B, 2017, FRONT IMMUNOL, V8, P0, DOI 10.3389/fimmu.2017.00826
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sercel AJ, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.63102
   Shanmughapriya S, 2020, AGEING RES REV, V62, P0, DOI 10.1016/j.arr.2020.101128
   Shi XX, 2018, TRANSL RES, V196, P31, DOI 10.1016/j.trsl.2018.02.003
   Shi XX, 2017, MITOCHONDRION, V34, P91, DOI 10.1016/j.mito.2017.02.005
   Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242
   Sun CK, 2015, J PINEAL RES, V58, P137, DOI 10.1111/jpi.12199
   Sun CK, 2012, CRIT CARE MED, V40, P1279, DOI 10.1097/CCM.0b013e31823dae23
   SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0
   Tachibana M, 2018, REPROD MED BIOL, V17, P421, DOI 10.1002/rmb2.12230
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Ulger O, 2021, LIFE SCI, V279, P0, DOI 10.1016/j.lfs.2021.119669
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125
   VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5
   Wakayama T, 1998, BIOL REPROD, V59, P100, DOI 10.1095/biolreprod59.1.100
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042
   Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208
   Wang Y, 2011, CELL DEATH DIFFER, V18, P732, DOI 10.1038/cdd.2010.147
   Wang Y, 2019, PROG NEURO-PSYCHOPH, V93, P240, DOI 10.1016/j.pnpbp.2019.04.010
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042
   Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wilkins HM, 2014, REDOX BIOL, V2, P619, DOI 10.1016/j.redox.2014.03.006
   Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001
   Wu KL, 2017, CELL RES, V27, P1069, DOI 10.1038/cr.2017.67
   Wu MJ, 2019, CELL METAB, V29, P993, DOI 10.1016/j.cmet.2018.11.004
   Wu T, 2011, 16 INT C OPTICAL MEM, V0, P0
   Wu TH, 2016, CELL METAB, V23, P921, DOI 10.1016/j.cmet.2016.04.007
   Wu TH, 2011, ANAL CHEM, V83, P1321, DOI 10.1021/ac102532w
   Wu TH, 2010, OPT EXPRESS, V18, P23153, DOI 10.1364/OE.18.023153
   Wu YC, 2015, NAT METHODS, V12, P439, DOI 10.1038/NMETH.3357
   Xia MF, 2019, CELL BIOSCI, V9, P0, DOI 10.1186/s13578-019-0289-8
   Yamada M, 2021, REPROD MED BIOL, V20, P53, DOI 10.1002/rmb2.12356
   Yamada M, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21165880
   Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001
   Yao Y, 2018, STEM CELL REP, V11, P1120, DOI 10.1016/j.stemcr.2018.09.012
   Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108
   Zappulli V, 2016, J CLIN INVEST, V126, P1198, DOI 10.1172/JCI81134
   Zhang LZ, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-2429-9
   Zhang ZQ, 2019, BEHAV BRAIN RES, V356, P322, DOI 10.1016/j.bbr.2018.09.005
NR 217
TC 31
Z9 32
U1 16
U2 58
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD APR 15
PY 2022
VL 195
IS 
BP 1
EP 15
DI 10.1016/j.biochi.2022.01.002
EA JAN 2022
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 8P0UV
UT WOS:000926247100001
PM 35026361
DA 2024-11-01
ER

PT J
AU Domínguez-González, C
   Hernández-Voth, A
   De la Hoz, CPDF
   Guerrero, LB
   Morís, G
   García-García, J
   Muelas, N
   Hernández, JCL
   Rabasa, M
   Lora, D
   Blázquez, A
   Arenas, J
   Martin, MA
AF Dominguez-Gonzalez, Cristina
   Hernandez-Voth, Ana
   De Fuenmayor-Fernandez De la Hoz, Carlos Pablo
   Guerrero, Laura Bermejo
   Moris, German
   Garcia-Garcia, Jorge
   Muelas, Nuria
   Leon Hernandez, Juan Carlos
   Rabasa, Maria
   Lora, David
   Blazquez, Alberto
   Arenas, Joaquin
   Martin, Miguel Angel
TI Metrics of progression and prognosis in untreated adults with thymidine kinase 2 deficiency: An observational study
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Thymidine kinase 2 deficiency; Creatinine; Mitochondrial disease; Clinical trials (observational study)
ID mitochondrial-dna depletion; differentiation factor 15; natural-history; mutations; biomarker; growth; mechanisms; defect
AB This historical cohort study evaluated clinical characteristics of progression and prognosis in adults with thymidine kinase 2 deficiency (TK2d). Records were available for 17 untreated adults with TK2d (mean age of onset, 32 years), including longitudinal data from 6 patients (mean follow-up duration, 26.5 months). Pearson's correlation assessed associations between standard motor and respiratory assessments, clinical characteristics, and laboratory values. Longitudinal data were assessed by linear regression mixed models. Respiratory involvement progressed at an annual rate of 8.16% decrement in forced vital capacity (FVC). Most patients under noninvasive ventilation (NIV) remained ambulant (12/14, 86%), reduced FVC was not associated with concomitant decline in 6-minute walk test (6MWT), and 6MWT results were not correlated with FVC. Disease severity, assessed by age at NIV onset, correlated most strongly at diagnosis with: creatinine levels ( r = 0.8036; P = 0.0 0 09), followed by FVC ( r = 0.7265; P = 0.0033), mtDNA levels in muscle ( r = 0.7933; P = 0.0188), and age at disease onset ( r = 0.7128; P = 0.0042). This population of adults with TK2d demonstrates rapid deterioration of respiratory muscles, which progresses independently of motor impairment. The results support FVC at diagnosis, mtDNA levels in muscle, and age at disease onset as prognostic indicators. Creatinine levels may also be potentially prognostic, as previously reported in other neuromuscular disorders.(c) 2022 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
C1 [Dominguez-Gonzalez, Cristina; De Fuenmayor-Fernandez De la Hoz, Carlos Pablo; Guerrero, Laura Bermejo] Hosp 12 Octubre, Neuromuscular Disorders Unit, Neurol Dept, Madrid 28041, Spain.
   [Dominguez-Gonzalez, Cristina; Muelas, Nuria; Blazquez, Alberto; Martin, Miguel Angel] Inst Salud Carlos III, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.
   [Hernandez-Voth, Ana] Hosp 12 Octubre, Mech Ventilat Unit, Pneumol Dept, Madrid, Spain.
   [Moris, German] Hosp Univ Cent Asturias, Neurol Dept, Neuromuscular Disorders Unit, Asturias, Spain.
   [Garcia-Garcia, Jorge] Hosp Univ Albacete, Dept Neurol, Albacete, Spain.
   [Muelas, Nuria] Hosp Univ & Politecn La Fe, Inst Invest Sanitaria La Fe, Neurol Dept, Neuromuscular Dis Unit,Neuromuscular & Ataxias Re, Valencia, Spain.
   [Leon Hernandez, Juan Carlos] Hosp Univ Nuestra Senora Candelaria, Neurol Dept, Tenerife, Spain.
   [Rabasa, Maria] Hosp Fuenlabrada, Neurol Dept, Madrid, Spain.
   [Lora, David] Hosp 12 Octubre Res Inst Imas12, Clin Res Unit, Madrid 28041, Spain.
   [Blazquez, Alberto; Arenas, Joaquin; Martin, Miguel Angel] Hosp Univ 12 Octubre, Res Inst Imas12, Clin Biochem Dept, Mitochondrial Disorders Lab, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina] Hosp 12 Octubre, Inst Invest Imas12, Madrid, Spain.
   [Lora, David] Univ Complutense Madrid, Fac Estudios Estadist, Dept Estadist & Ciencia Datos, Madrid 28040, Spain.
   [Lora, David] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain.
C3 Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre; Central University Hospital Asturias; Hospital Universitari i Politecnic La Fe; Hospital Universitario Fuenlabrada; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP
RP Domínguez-González, C (corresponding author), Hosp 12 Octubre, Neuromuscular Disorders Unit, Neurol Dept, Madrid 28041, Spain.
EM cdgonzalez@salud.madrid.org
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alves CRR, 2020, NEUROLOGY, V94, PE921, DOI 10.1212/WNL.0000000000008762
   Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Annane D, 1999, EUR RESPIR J, V13, P157, DOI 10.1183/09031936.99.13115799
   Annane D, 2014, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001941.pub3
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Boenzi S, 2018, ESSAYS BIOCHEM, V62, P443, DOI 10.1042/EBC20170111
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   de la Hoz CPDF, 2021, MOL GENET METAB REP, V26, P0, DOI 10.1016/j.ymgmr.2020.100701
   Desler C, 2006, NUCLEOS NUCLEOT NUCL, V25, P1171, DOI 10.1080/15257770600894501
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Eriksson S, 2008, NUCLEOS NUCLEOT NUCL, V27, P800, DOI 10.1080/15257770802146197
   Esterhuizen K, 2019, MITOCHONDRION, V45, P38, DOI 10.1016/j.mito.2018.02.003
   Garone C, 2014, J NEUROMUSCUL DIS, V1, P0
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Guo QF, 2021, ANN CLIN TRANSL NEUR, V8, P448, DOI 10.1002/acn3.51299
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Hamon SM, 2019, CLIN CHEM LAB MED, V57, P510, DOI 10.1515/cclm-2018-0534
   Hijikata Y, 2018, NEUROLOGY, V90, PE1501, DOI 10.1212/WNL.0000000000005360
   Hijikata Y, 2016, ANN CLIN TRANSL NEUR, V3, P537, DOI 10.1002/acn3.324
   Holdom CJ, 2021, EUR J NEUROL, V28, P3615, DOI 10.1111/ene.15003
   Ji XB, 2017, MOL NEUROBIOL, V54, P8110, DOI 10.1007/s12035-016-0283-7
   Knierim E, 2015, MITOCHONDRION, V20, P1, DOI 10.1016/j.mito.2014.10.007
   Laine-Menéndez S, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22115598
   Leshinsky-Silver E, 2008, EUR J PAEDIATR NEURO, V12, P309, DOI 10.1016/j.ejpn.2007.09.005
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Lopez-Gomez C, 2021, ANN NEUROL, V90, P640, DOI 10.1002/ana.26185
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Martín-Hernández E, 2017, PEDIATR DEVEL PATHOL, V20, P416, DOI 10.1177/1093526616686439
   Mayhew AG, 2013, DEV MED CHILD NEUROL, V55, P1046, DOI 10.1111/dmcn.12220
   Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Poulsen NS, 2020, MITOCHONDRION, V50, P35, DOI 10.1016/j.mito.2019.10.005
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Wang J, 2019, TK2 RELATED MITOCHON, V0, P0
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wang L, 2017, FRONT NEUROL, V8, P0, DOI 10.3389/fneur.2017.00196
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Zhang HL, 2015, DIS MARKERS, V2015, P0, DOI 10.1155/2015/141856
NR 50
TC 3
Z9 3
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD SEP 15
PY 2022
VL 32
IS 9
BP 728
EP 735
DI 10.1016/j.nmd.2022.07.399
EA SEP 2022
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 5H1WB
UT WOS:000867474800003
PM 35907766
DA 2024-11-01
ER

PT J
AU Manini, A
   Caporali, L
   Meneri, M
   Zanotti, S
   Piga, D
   Arena, IG
   Corti, S
   Toscano, A
   Comi, GP
   Musumeci, O
   Carelli, V
   Ronchi, D
AF Manini, Arianna
   Caporali, Leonardo
   Meneri, Megi
   Zanotti, Simona
   Piga, Daniela
   Arena, Ignazio Giuseppe
   Corti, Stefania
   Toscano, Antonio
   Comi, Giacomo Pietro
   Musumeci, Olimpia
   Carelli, Valerio
   Ronchi, Dario
TI Case Report: Rare Homozygous <i>RNASEH1</i> Mutations Associated With Adult-Onset Mitochondrial Encephalomyopathy and Multiple Mitochondrial DNA Deletions
SO FRONTIERS IN GENETICS
LA English
DT Article
DE RNASEH1; ribonuclease H1; mitochondrial DNA; mtDNA maintenance disorders; myopathy; CPEO
ID impair mtdna replication
AB Mitochondrial DNA (mtDNA) maintenance disorders embrace a broad range of clinical syndromes distinguished by the evidence of mtDNA depletion and/or deletions in affected tissues. Among the nuclear genes associated with mtDNA maintenance disorders, RNASEH1 mutations produce a homogeneous phenotype, with progressive external ophthalmoplegia (PEO), ptosis, limb weakness, cerebellar ataxia, and dysphagia. The encoded enzyme, ribonuclease H1, is involved in mtDNA replication, whose impairment leads to an increase in replication intermediates resulting from mtDNA replication slowdown. Here, we describe two unrelated Italian probands (Patient 1 and Patient 2) affected by chronic PEO, ptosis, and muscle weakness. Cerebellar features and severe dysphagia requiring enteral feeding were observed in one patient. In both cases, muscle biopsy revealed diffuse mitochondrial abnormalities and multiple mtDNA deletions. A targeted next-generation sequencing analysis revealed the homozygous RNASEH1 mutations c.129-3C>G and c.424G>A in patients 1 and 2, respectively. The c.129-3C>G substitution has never been described as disease-related and resulted in the loss of exon 2 in Patient 1 muscle RNASEH1 transcript. Overall, we recommend implementing the use of high-throughput sequencing approaches in the clinical setting to reach genetic diagnosis in case of suspected presentations with impaired mtDNA homeostasis.
C1 [Manini, Arianna; Meneri, Megi; Corti, Stefania; Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Caporali, Leonardo; Carelli, Valerio] Ist Sci Neurolog Bologna, Programma Neurogenet, Bologna, Italy.
   [Meneri, Megi; Piga, Daniela; Corti, Stefania; Ronchi, Dario] Fdn IRCCS CaGranda Osped Maggiore Policlin, Dept Neurosci, Neurol Unit, Milan, Italy.
   [Zanotti, Simona; Comi, Giacomo Pietro] Fdn IRCCS CaGranda Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Arena, Ignazio Giuseppe; Toscano, Antonio; Musumeci, Olimpia] Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular disorders, Messina, Italy.
   [Carelli, Valerio] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DIBINEM, Bologna, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Messina; University of Bologna
RP Ronchi, D (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.; Carelli, V (corresponding author), Ist Sci Neurolog Bologna, Programma Neurogenet, Bologna, Italy.; Ronchi, D (corresponding author), Fdn IRCCS CaGranda Osped Maggiore Policlin, Dept Neurosci, Neurol Unit, Milan, Italy.; Musumeci, O (corresponding author), Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular disorders, Messina, Italy.; Carelli, V (corresponding author), Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DIBINEM, Bologna, Italy.
EM dario.ronchi@unimi.it; valerio.carelli@unibo.it; olimpia.musumeci@unime.it
FU Italian Ministry of Health (Ministero della Salute); Foundation IRCCS Ca Granda Ospedale Maggiore Policlinico Grant Ricerca Corrente 2020; IRCCS Istituto delle Scienze Neurologiche di Bologna Grant Ricerca Corrente 2020
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Bugiardini E, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000149
   Carreño-Gago L, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00576
   Cerritelli SM, 1998, GENOMICS, V53, P300, DOI 10.1006/geno.1998.5497
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Holt IJ, 2019, DNA REPAIR, V84, P0, DOI 10.1016/j.dnarep.2019.06.001
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Lima WF, 2016, NUCLEIC ACIDS RES, V44, P5299, DOI 10.1093/nar/gkw350
   Manini A, 2022, AGEING RES REV, V76, P0, DOI 10.1016/j.arr.2022.101578
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Sachdev A, 2018, CAN J OPHTHALMOL, V53, PE203, DOI 10.1016/j.jcjo.2018.01.005
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
NR 15
TC 3
Z9 3
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD MAY 31
PY 2022
VL 13
IS 
BP 
EP 
DI 10.3389/fgene.2022.906667
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 2C6BH
UT WOS:000810951000001
PM 35711919
DA 2024-11-01
ER

PT J
AU Keraite, I
   Becker, P
   Canevazzi, D
   Frias-López, C
   Dabad, M
   Tonda-Hernandez, R
   Paramonov, I
   Ingham, MJ
   Brun-Heath, I
   Leno, J
   Abulí, A
   Garcia-Arumí, E
   Heath, SC
   Gut, M
   Gut, IG
AF Keraite, Ieva
   Becker, Philipp
   Canevazzi, Davide
   Frias-Lopez, Cristina
   Dabad, Marc
   Tonda-Hernandez, Raul
   Paramonov, Ida
   Ingham, Matthew John
   Brun-Heath, Isabelle
   Leno, Jordi
   Abuli, Anna
   Garcia-Arumi, Elena
   Heath, Simon Charles
   Gut, Marta
   Gut, Ivo Glynne
TI A method for multiplexed full-length single-molecule sequencing of the human mitochondrial genome
SO NATURE COMMUNICATIONS
LA English
DT Article
ID drosophila-melanogaster; myoclonic epilepsy; dna mutations; heteroplasmy; nuclear; organization; program; muscle
AB Accurate analysis of mitochondrial DNA is important for mitochondrial disease clinical research and diagnostics. Here, authors present a method using Cas9 cleavage, nanopore sequencing and a custom pipeline to identify pathogenic variants, deletions and accurately quantify heteroplasmy to below 1%. Methods to reconstruct the mitochondrial DNA (mtDNA) sequence using short-read sequencing come with an inherent bias due to amplification and mapping. They can fail to determine the phase of variants, to capture multiple deletions and to cover the mitochondrial genome evenly. Here we describe a method to target, multiplex and sequence at high coverage full-length human mitochondrial genomes as native single-molecules, utilizing the RNA-guided DNA endonuclease Cas9. Combining Cas9 induced breaks, that define the mtDNA beginning and end of the sequencing reads, as barcodes, we achieve high demultiplexing specificity and delineation of the full-length of the mtDNA, regardless of the structural variant pattern. The long-read sequencing data is analysed with a pipeline where our custom-developed software, baldur, efficiently detects single nucleotide heteroplasmy to below 1%, physically determines phase and can accurately disentangle complex deletions. Our workflow is a tool for studying mtDNA variation and will accelerate mitochondrial research.
C1 [Keraite, Ieva; Becker, Philipp; Canevazzi, Davide; Frias-Lopez, Cristina; Dabad, Marc; Tonda-Hernandez, Raul; Paramonov, Ida; Ingham, Matthew John; Heath, Simon Charles; Gut, Marta; Gut, Ivo Glynne] Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, CNAG CRG, Barcelona, Spain.
   [Brun-Heath, Isabelle] Barcelona Inst Sci & Technol BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain.
   [Brun-Heath, Isabelle] Joint IRB BSC Program Computat Biol, Barcelona, Spain.
   [Leno, Jordi; Abuli, Anna; Garcia-Arumi, Elena] Hosp Univ Vall Hebron, Dept Clin & Mol Genet & Rare Dis, Barcelona, Spain.
   [Leno, Jordi; Abuli, Anna] Hosp Univ Vall Hebron, Med Genet Grp, VHIR, Barcelona, Spain.
   [Garcia-Arumi, Elena] Hosp Univ Vall Hebron, Res Grp Neuromuscular & Mitochondrial Disorders, VHIR, Barcelona, Spain.
   [Garcia-Arumi, Elena] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain.
   [Heath, Simon Charles; Gut, Marta; Gut, Ivo Glynne] Univ Pompeu Fabra, Barcelona, Spain.
   [Becker, Philipp] Qiagen, Hilden, Germany.
C3 Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Pompeu Fabra University; QIAGEN GmbH
RP Gut, M; Gut, IG (corresponding author), Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, CNAG CRG, Barcelona, Spain.; Gut, M; Gut, IG (corresponding author), Univ Pompeu Fabra, Barcelona, Spain.
EM marta.gut@cnag.crg.eu; ivo.gut@cnag.crg.eu
FU European Union [824110]; ERC Synergy project BCLL@las [810287]; Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias; ERDF funds [PI19/01772]; Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III; European Regional Development Fund (MINECO/FEDER) [BIO2015-71792-P]; Centro de Excelencia Severo Ochoa; Generalitat de Catalunya through the Departament de Salut, Departament d'Empresa i Coneixement; CERCA Programme; European Research Council (ERC) [810287] Funding Source: European Research Council (ERC)
CR Albayrak L, 2016, BMC GENOMICS, V17, P0, DOI 10.1186/s12864-016-3375-x
   Alkanaq AN, 2019, J HUM GENET, V64, P1107, DOI 10.1038/s10038-019-0654-9
   Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   Alsemari A, 2016, CLIN CASE REP, V4, P111, DOI 10.1002/ccr3.435
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Auton A, 2015, NATURE, V526, P68
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1821-7
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Cingolani Pablo, 2012, FRONTIERS IN GENETICS, V3, P35, DOI 10.3389/fgene.2012.00035
   CORMIERDAIRE V, 1994, J PEDIATR-US, V124, P63, DOI 10.1016/S0022-3476(94)70255-1
   Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038
   Duan MQ, 2019, GENE, V699, P145, DOI 10.1016/j.gene.2019.03.016
   Duan MQ, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23020323
   Dunn T, 2019, BIOINFORMATICS, V35, P1579, DOI 10.1093/bioinformatics/bty849
   Georgieva D, 2020, NUCLEIC ACIDS RES, V48, P0, DOI 10.1093/nar/gkaa517
   Gilpatrick T, 2020, NAT BIOTECHNOL, V38, P433, DOI 10.1038/s41587-020-0407-5
   Goenka SD, 2022, NAT BIOTECHNOL, V40, P1035, DOI 10.1038/s41587-022-01221-5
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hafford-Tear NJ, 2019, GENET MED, V21, P2092, DOI 10.1038/s41436-019-0453-x
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Heath SC, 2022, GITHUB, V0, P0, DOI DOI 10.5281/zenodo.6961084
   Heath SC, 2022, GITHUB, V0, P0, DOI DOI 10.5281/zenodo.6961078
   Heath SC, 2022, METHOD MULTIPLEXED F, V0, P0, DOI DOI 10.5281/zenodo.6959216
   HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Kenneth L, 1997, STAT BIOL HLTH, V0, P0
   Kloss-Brandstätter A, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0135643
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Lanfear R, 2019, BIOINFORMATICS, V35, P523, DOI 10.1093/bioinformatics/bty654
   Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6
   Laricchia KM, 2022, GENOME RES, V32, P569, DOI 10.1101/gr.276013.121
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li MK, 2012, NUCLEIC ACIDS RES, V40, P0, DOI 10.1093/nar/gks499
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Macken WL, 2021, NAT REV NEUROL, V17, P215, DOI 10.1038/s41582-021-00455-2
   Maeda R, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-67686-z
   Maude H, 2019, FRONT CELL DEV BIOL, V7, P0, DOI 10.3389/fcell.2019.00201
   Molder Felix, 2021, F1000RES, V10, P33, DOI 10.12688/f1000research.29032.1
   Palculict ME, 2016, METHODS MOL BIOL, V1351, P3, DOI 10.1007/978-1-4939-3040-1_1
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   POULTON J, 1989, LANCET, V1, P236
   Rong EG, 2018, BIOMED RES INT, V2018, P0, DOI 10.1155/2018/1286480
   Salas A, 2020, FORENSIC SCI INT-GEN, V47, P0, DOI 10.1016/j.fsigen.2020.102274
   Santibanez-Koref M, 2019, MITOCHONDRION, V46, P302, DOI 10.1016/j.mito.2018.08.003
   Shafin K, 2021, NAT METHODS, V18, P1322, DOI 10.1038/s41592-021-01299-w
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Stewart JB, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005333
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Trifunov S, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30143-z
   Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996
   Van der Verren SE, 2020, NAT BIOTECHNOL, V38, P0, DOI 10.1038/s41587-020-0570-8
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Weissensteiner H, 2021, GENOME RES, V31, P309, DOI 10.1101/gr.256545.119
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zhou KX, 2020, J MOL DIAGN, V22, P1408, DOI 10.1016/j.jmoldx.2020.09.005
NR 64
TC 10
Z9 10
U1 0
U2 22
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD OCT 6
PY 2022
VL 13
IS 1
BP 
EP 
DI 10.1038/s41467-022-33530-3
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 5D0IC
UT WOS:000864633700005
PM 36202811
DA 2024-11-01
ER

PT J
AU Wolfe, R
   Heiman, P
   D'Annibale, O
   Karunanidhi, A
   Powers, A
   Mcguire, M
   Seminotti, B
   Dobrowolski, SF
   Reyes-Múgica, M
   Torok, KS
   Mohsen, AW
   Vockley, J
   Ghaloul-Gonzalez, L
AF Wolfe, Rachel
   Heiman, Paige
   D'Annibale, Olivia
   Karunanidhi, Anuradha
   Powers, Alyssa
   Mcguire, Marianne
   Seminotti, Bianca
   Dobrowolski, Steven F.
   Reyes-Mugica, Miguel
   Torok, Kathryn S.
   Mohsen, Al-Walid
   Vockley, Jerry
   Ghaloul-Gonzalez, Lina
TI ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE ITCH; Autoimmune disease; Ubiquitination; Apoptosis; E3 ligase; Mitochondrial dysfunction
ID ubiquitin-proteasome system; protein-degradation; fbxl4; ubiquitylation; thioredoxin; mutations
AB Autoimmune Disease, Multisystem, with Facial Dysmorphism (ADMFD) is an autosomal recessive disorder due to pathogenic variants in the ITCH gene. It is characterized by failure to thrive, dysmorphic facial features, developmental delay, and systemic autoimmunity that can manifest variably with autoimmune hepatitis, thyroiditis, and enteropathy, among other organ manifestations. It was originally described in 10 consanguineous Old Order Amish patients, and more recently in two patients of White British and Black German ethnicities. While the role of ITCH protein in apoptosis and inflammation has previously been characterized, a defect in cellular bioenergetics has not yet been reported in ITCH deficiency. Here we present a Caucasian female originally evaluated for possible mitochondrial respiratory chain deficiency, who ultimately was found to have two novel variants in ITCH with absence of ITCH protein in patient derived fibroblasts. Clinical studies of patient muscle showed mitochondrial DNA copy number of 57% compared to controls. Functional studies in skin fibroblasts revealed decreased activity of mitochondrial fatty acid oxidation and oxidative phosphorylation, and decreased overall ATP production. Our findings confirm mitochondrial energy dysfunction in a patient with ITCH deficiency offering the opportunity to assess alternative therapeutic options.
C1 [Wolfe, Rachel; Heiman, Paige; D'Annibale, Olivia; Karunanidhi, Anuradha; Powers, Alyssa; Seminotti, Bianca; Mohsen, Al-Walid; Vockley, Jerry; Ghaloul-Gonzalez, Lina] Univ Pittsburgh, Dept Pediat, Div Genet & Genom Med, Pittsburgh, PA 15224 USA.
   [Wolfe, Rachel] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA.
   [D'Annibale, Olivia; Powers, Alyssa; Mohsen, Al-Walid; Vockley, Jerry; Ghaloul-Gonzalez, Lina] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15224 USA.
   [Mcguire, Marianne] UPMC Magee Womens Hosp, UPMC Clin Genom Lab, Pittsburgh, PA USA.
   [Dobrowolski, Steven F.; Reyes-Mugica, Miguel] Univ Pittsburgh, Dept Pathol, Div Clin Chem, Pittsburgh, PA 15224 USA.
   [Torok, Kathryn S.] Univ Pittsburgh, Dept Pediat, Div Rheumatol, Pittsburgh, PA 15224 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh
RP Ghaloul-Gonzalez, L (corresponding author), UPMC Childrens Hosp Pittsburgh, Dept Pediat, Div Genet & Genom Med, Rangos Res Bldg, Pittsburgh, PA 15224 USA.
EM lina.gonzalez@chp.edu
FU National Human Genome Research Institute (NHGRI) [K08 HG010490]; National Institutes of Health (NIH)
CR Azakir BA, 2010, FEBS J, V277, P1319, DOI 10.1111/j.1742-4658.2010.07562.x
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Brittain HK, 2019, AM J MED GENET A, V179, P1346, DOI 10.1002/ajmg.a.61169
   Choi YB, 2017, MOL CELL BIOL, V37, P0, DOI 10.1128/MCB.00422-16
   Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692
   de Moura MB, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0106028
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Gehrke S, 2015, CELL METAB, V21, P95, DOI 10.1016/j.cmet.2014.12.007
   Goetzman ES, 2014, J BIOL CHEM, V289, P10668, DOI 10.1074/jbc.M113.540260
   Gold VAM, 2017, EMBO REP, V18, P1786, DOI 10.15252/embr.201744261
   Heiman P, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-07076-9
   Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   HUSTAD CM, 1995, GENETICS, V140, P255
   Jiang LF, 2020, MOL MED REP, V22, P4307, DOI 10.3892/mmr.2020.11499
   Kaimul AM, 2007, FREE RADICAL BIO MED, V43, P861, DOI 10.1016/j.freeradbiomed.2007.05.032
   Kleine-Eggebrecht N, 2019, PEDIATRICS, V143, P0, DOI 10.1542/peds.2018-1554
   Lavie J, 2018, CELL REP, V23, P2852, DOI 10.1016/j.celrep.2018.05.013
   Lehmann G, 2016, BIOCHEM BIOPH RES CO, V473, P80, DOI 10.1016/j.bbrc.2016.03.055
   Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028
   Matesic LE, 2008, CURR TOP MICROBIOL, V321, P185
   Mentrup HL, 2018, DIFFERENTIATION, V99, P51, DOI 10.1016/j.diff.2017.12.003
   Otaki Y, 2016, J AM HEART ASSOC, V5, P0, DOI 10.1161/JAHA.115.002485
   Parravicini V, 2008, BLOOD, V111, P4273, DOI 10.1182/blood-2007-10-115667
   Patel T, 2021, J ALLER CL IMM-PRACT, V9, P2885, DOI 10.1016/j.jaip.2021.04.010
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Roberts JZ, 2022, CELL DEATH DIFFER, V29, P272, DOI 10.1038/s41418-021-00922-9
   Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103
   Schiff M, 2013, MOL GENET METAB, V109, P21, DOI 10.1016/j.ymgme.2013.02.002
   Seminotti B, 2019, HUM MOL GENET, V28, P928, DOI 10.1093/hmg/ddy403
   Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094
   Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905
   Wagner SA, 2011, MOL CELL PROTEOMICS, V10, P0, DOI 10.1074/mcp.M111.013284
   Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249
   Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321
   Ziviani E, 2010, AUTOPHAGY, V6, P660, DOI 10.4161/auto.6.5.12242
NR 36
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 
EI 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD DEC 15
PY 2022
VL 33
IS 
BP 
EP 
DI 10.1016/j.ymgmr.2022.100932
EA OCT 2022
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 7H4OE
UT WOS:000903182600013
PM 36338154
DA 2024-11-01
ER

PT J
AU Gremminger, VL
   Omosule, CL
   Crawford, TK
   Cunningham, R
   Rector, RS
   Phillips, CL
AF Gremminger, Victoria L.
   Omosule, Catherine L.
   Crawford, Tara K.
   Cunningham, Rory
   Rector, R. Scott
   Phillips, Charlotte L.
TI Skeletal muscle mitochondrial function and whole-body metabolic energetics in the<i> +/G610C</i> mouse model of osteogenesis imperfecta
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Genetic mouse models; Mitochondrial function; Osteogenesis imperfecta; Skeletal muscle; Respiratory quotient
ID energy-metabolism; physical-activity; protein; p62; dna
AB Osteogenesis imperfecta (OI) is rare heritable connective tissue disorder that most often arises from mutations in the type I collagen genes, COL1A1 and COL1A2, displaying a range of symptoms including skeletal fragility, short stature, blue-gray sclera, and muscle weakness. Recent investigations into the intrinsic muscle weakness have demonstrated reduced contractile generating force in some murine models consistent with patient population studies, as well as alterations in whole body bioenergetics. Muscle weakness is found in approximately 80% of pa-tients and has been equivocal in OI mouse models. Understanding the mechanism responsible for OI muscle weakness is crucial in building our knowledge of muscle bone cross-talk via mechanotransduction and biochem-ical signaling, and for potential novel therapeutic approaches. In this study we evaluated skeletal muscle mito-chondrial function and whole-body bioenergetics in the heterozygous +/G610C (Amish) mouse modeling mild/moderate human type I/VI OI and minimal skeletal muscle weakness. Our analyses revealed several changes in the +/G610C mouse relative to their wildtype littermates including reduced state 3 mitochondrial respiration, increased mitochondrial citrate synthase activity, increased Parkin and p62 protein content, and an increased re-spiratory quotient. These changes may represent the ability of the +/G610C mouse to compensate for mitochon-drial and metabolic changes that may arise due to type I collagen mutations and may also account for the lack of muscle weakness observed in the +/G610C model relative to the more severe OI models.(c) 2022 Elsevier Inc. All rights reserved.
C1 [Gremminger, Victoria L.; Omosule, Catherine L.; Crawford, Tara K.; Phillips, Charlotte L.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.
   [Cunningham, Rory; Rector, R. Scott] Univ Missouri, Harry S Truman Mem VA Hosp, Dept Nutr & Exercise Physiol, Res Serv, Columbia, MO 65201 USA.
   [Cunningham, Rory; Rector, R. Scott] Univ Missouri, Harry S Truman Mem VA Hosp, Dept Med GI, Res Serv, Columbia, MO 65201 USA.
   [Phillips, Charlotte L.] Univ Missouri, Dept Child Hlth, Columbia, MO 65212 USA.
   [Phillips, Charlotte L.] Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.
C3 University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia
RP Phillips, CL (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.
EM phillipscl@missouri.edu
FU Washington University Institute of Clinical and Translational Sciences (ICTS) , Clinical and Translational Research Funding Program Pilot Grant; NIH/National Center for Advancing Translational Sciences (NCATS) [L1TR002345]; NIH/NIAMS [R21 (1R21AR077813-01)]; Kansas City Musculoskeletal Diseases (KCMD) Consortium; Collaborative Research for Neuromuscular/Musculoskeletal Disorders pilot grant, University of Missouri; Child Health Research Institute-Leda J. Sears Research Project Awards; NIH/NIGMS [University of Missouri Post-baccalaureate Research Education Program [PREP: R25GM064120]; Initiative for Maximizing Student Development (IMSD) [T32GM135744]; Ryan Foundation; Wayne L. Ryan Graduate Fellowship; VA -Merit Grant [101BX003271-04]; Harry S. Truman Memorial Veterans Hospital in Columbia, MO; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR077813] Funding Source: NIH RePORTER
CR Abdelaziz DM, 2015, BONE, V81, P400, DOI 10.1016/j.bone.2015.08.001
   Baglole CJ, 2018, PEDIATR RES, V83, P1165, DOI 10.1038/pr.2018.36
   Boraschi-Diaz I, 2017, J ENDOCRINOL, V234, P279, DOI 10.1530/JOE-17-0335
   Carter HN, 2018, J PHYSIOL-LONDON, V596, P3567, DOI 10.1113/JP275998
   CROPP GJA, 1972, PEDIATRICS, V49, P375
   Daley E, 2010, J BONE MINER RES, V25, P247, DOI 10.1359/jbmr.090720
   de Paula FJA, 2013, BONE RES, V1, P0, DOI 10.4248/BR201301005
   Díaz-Vegasa A, 2019, ARCH BIOCHEM BIOPHYS, V664, P89, DOI 10.1016/j.abb.2019.01.037
   Durán A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9
   Etich J, 2020, CELL SIGNAL, V76, P0, DOI 10.1016/j.cellsig.2020.109789
   Etich Julia, 2020, MOL CELL PEDIATR, V7, P9, DOI 10.1186/s40348-020-00101-9
   Folkestad L, 2017, J BONE MINER RES, V32, P125, DOI 10.1002/jbmr.2920
   Gentry BA, 2010, MATRIX BIOL, V29, P638, DOI 10.1016/j.matbio.2010.06.006
   Gremminger VL, 2021, MOL GENET METAB, V132, P244, DOI 10.1016/j.ymgme.2021.02.004
   Gremminger VL, 2019, J BONE MINER RES, V34, P1646, DOI 10.1002/jbmr.3732
   GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x
   Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933
   Heymsfield SB, 2019, EUR J CLIN NUTR, V73, P166, DOI 10.1038/s41430-018-0319-3
   Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310
   Hood DA, 2016, BIOCHEM J, V473, P2295, DOI 10.1042/BCJ20160009
   Jeong Y, 2018, MUSCLE NERVE, V57, P294, DOI 10.1002/mus.25706
   Jeong Y, 2015, J BONE MINER RES, V30, P1874, DOI 10.1002/jbmr.2518
   JEQUIER E, 1987, ANNU REV NUTR, V7, P187, DOI 10.1146/annurev.nu.07.070187.001155
   Kilkenny C, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000412
   Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Lee WC, 2017, ENDOCR REV, V38, P255, DOI 10.1210/er.2017-00064
   Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z
   Liu WJ, 2016, CELL MOL BIOL LETT, V21, P0, DOI 10.1186/s11658-016-0031-z
   Long M, 2017, TRENDS ENDOCRIN MET, V28, P818, DOI 10.1016/j.tem.2017.09.001
   Lundby C, 2016, EXP PHYSIOL, V101, P17, DOI 10.1113/EP085319
   Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003
   Marini JC, 2017, NAT REV DIS PRIMERS, V3, P0, DOI 10.1038/nrdp.2017.52
   Marom R, 2020, EUR J ENDOCRINOL, V183, PR95, DOI 10.1530/EJE-20-0299
   Mirigian LS, 2016, J BONE MINER RES, V31, P1608, DOI 10.1002/jbmr.2824
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   Omari S, 2018, P NATL ACAD SCI USA, V115, PE10099, DOI 10.1073/pnas.1814552115
   Phillips CL, 2018, CURR OSTEOPOROS REP, V16, P478, DOI 10.1007/s11914-018-0456-6
   Pouliot-Laforte A, 2015, J MUSCULOSKEL NEURON, V15, P171
   Rahman FA, 2021, CELL MOL LIFE SCI, V78, P4653, DOI 10.1007/s00018-021-03807-9
   Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, PG619, DOI 10.1152/ajpgi.00428.2007
   Rosa-Caldwell ME, 2019, BIOL SEX DIFFER, V10, P0, DOI 10.1186/s13293-019-0257-3
   Sabbieti MG, 2015, ONCOTARGET, V6, P3590, DOI 10.18632/oncotarget.2884
   Seirafi M, 2015, FEBS J, V282, P2076, DOI 10.1111/febs.13249
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   Shin J, 1998, ARCH PHARM RES, V21, P629, DOI 10.1007/BF02976748
   Soto JE, 2019, OBESITY, V27, P793, DOI 10.1002/oby.22441
   Speakman JR, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00034
   Srere PA, 1969, METHODS IN ENZYMOLOGY, V13, P3
   Toledo FGS, 2006, J CLIN ENDOCR METAB, V91, P3224, DOI 10.1210/jc.2006-0002
   Veilleux LN, 2017, J MUSCULOSKEL NEURON, V17, P1
   Veilleux LN, 2017, CURR OSTEOPOROS REP, V15, P425, DOI 10.1007/s11914-017-0396-6
   Veilleux LN, 2017, CALCIFIED TISSUE INT, V101, P362, DOI 10.1007/s00223-017-0287-y
   Veilleux LN, 2015, BONE, V79, P52, DOI 10.1016/j.bone.2015.05.019
   Veilleux LN, 2014, J CLIN ENDOCR METAB, V99, PE356, DOI 10.1210/jc.2013-3209
   Ventura-Clapier R, 2017, CLIN SCI, V131, P803, DOI 10.1042/CS20160485
   Vieira-Potter VJ, 2015, AM J PHYSIOL-REG I, V308, PR530, DOI 10.1152/ajpregu.00401.2014
   WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97
   ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857
NR 59
TC 2
Z9 2
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD AUG 15
PY 2022
VL 136
IS 4
BP 315
EP 323
DI 10.1016/j.ymgme.2022.06.004
EA JUL 2022
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 4E7ED
UT WOS:000847984100003
PM 35725939
DA 2024-11-01
ER

PT J
AU Huisman, TAGM
   Kralik, SF
   Desai, NK
   Serrallach, BL
   Orman, G
AF Huisman, Thierry A. G. M.
   Kralik, Stephen F.
   Desai, Nilesh K.
   Serrallach, Bettina L.
   Orman, Gunes
TI Neuroimaging of primary mitochondrial disorders in children: A review
SO JOURNAL OF NEUROIMAGING
LA English
DT Review
DE energy production; heteroplasmy; mitochondrial disorder; mitochondrial DNA; MRI; MRS; neuroimaging; nuclear DNA
ID mutations; mtfmt
AB Mitochondrial disorders represent a diverse and complex group of entities typified by defective energy metabolism. The mitochondrial oxidative phosphorylation system is typically impaired, which is the predominant source of energy production. Because mitochondria are present in nearly all organs, multiple systems may be affected including the central nervous system, skeletal muscles, kidneys, and liver. In particular, those organs that are metabolically active with high energy demands are explicitly vulnerable. Initial diagnostic work up relies on a detailed evaluation of clinical symptoms including physical examination as well as a comprehensive review of the evolution of symptoms over time, relation to possible "triggering" events (eg, fever, infection), blood workup, and family history. High-end neuroimaging plays a pivotal role in establishing diagnosis, narrowing differential diagnosis, monitoring disease progression, and predicting prognosis. The pattern and characteristics of the neuroimaging findings are often highly suggestive of a mitochondrial disorder; unfortunately, in many cases the wide variability of involved metabolic processes prevents a more specific subclassification. Consequently, additional diagnostic steps including muscle biopsy, metabolic workup, and genetic tests are necessary. In the current manuscript, basic concepts of energy production, genetics, and inheritance patterns are reviewed. In addition, the imaging findings of several illustrative mitochondrial disorders are presented to familiarize the involved physicians with pediatric mitochondrial disorders. In addition, the significance of spinal cord imaging and the value of "reversed image-based discovery" for the recognition and correct (re-)classification of mitochondrial disorders is discussed.
C1 [Orman, Gunes] Texas Childrens Hosp, Edward B Singleton Dept Radiol, 6701 Fannin St,Suite 470, Houston, TX 77030 USA.
   [Orman, Gunes] Baylor Coll Med, 6701 Fannin St,Suite 470, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine
RP Orman, G (corresponding author), Texas Childrens Hosp, Edward B Singleton Dept Radiol, 6701 Fannin St,Suite 470, Houston, TX 77030 USA.; Orman, G (corresponding author), Baylor Coll Med, 6701 Fannin St,Suite 470, Houston, TX 77030 USA.
EM gxorman@texaschildrens.org
CR Alves Cesar Augusto Pinheiro Ferreira, 2018, TOP MAGN RESON IMAGING, V27, P219, DOI 10.1097/RMR.0000000000000173
   Baertling F, 2016, CHILD NERV SYST, V32, P2077, DOI 10.1007/s00381-016-3190-3
   Biswas A, 2021, TRANSL PEDIATR, V10, P1201, DOI 10.21037/tp-20-335
   Brunetti D, 2021, STEM CELLS, V39, P1289, DOI 10.1002/stem.3425
   Delonlay P, 2013, HAND CLINIC, V113, P1651, DOI 10.1016/B978-0-444-59565-2.00033-2
   Gonçalves FG, 2020, RADIOGRAPHICS, V40, P2042, DOI 10.1148/rg.2020200052
   Hayhurst H, 2019, ANN CLIN TRANSL NEUR, V6, P515, DOI 10.1002/acn3.725
   Kevelam SH, 2013, NEUROLOGY, V80, P1577, DOI 10.1212/WNL.0b013e31828f1914
   Longo N, 2003, NEUROL CLIN, V21, P817, DOI 10.1016/S0733-8619(03)00015-X
   Mankad Kshitij, 2018, TOP MAGN RESON IMAGING, V27, P179, DOI 10.1097/RMR.0000000000000176
   Morava E, 2005, MAGNETIC RESONANCE M, V0, P195
   Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 13
TC 4
Z9 4
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1051-2284
EI 1552-6569
J9 J NEUROIMAGING
JI J. Neuroimaging
PD MAR 15
PY 2022
VL 32
IS 2
BP 191
EP 200
DI 10.1111/jon.12976
EA FEB 2022
PG 10
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA ZP1UM
UT WOS:000749571500001
PM 35107193
DA 2024-11-01
ER

PT J
AU Jou, C
   Nascimento, A
   Codina, A
   Montoya, J
   López-Gallardo, E
   Emperador, S
   Ruiz-Pesini, E
   Montero, R
   Natera-de Benito, D
   Ortez, CI
   Marquez, J
   Zelaya, MV
   Gutierrez-Mata, A
   Badosa, C
   Carrera-García, L
   Expósito-Escudero, J
   Roldán, M
   Camara, Y
   Marti, R
   Ferrer, I
   Jimenez-Mallebrera, C
   Artuch, R
AF Jou, Cristina
   Nascimento, Andres
   Codina, Anna
   Montoya, Julio
   Lopez-Gallardo, Ester
   Emperador, Sonia
   Ruiz-Pesini, Eduardo
   Montero, Raquel
   Natera-de Benito, Daniel
   Ortez, Carlos, I
   Marquez, Jesus
   Zelaya, Maria, V
   Gutierrez-Mata, Alfonso
   Badosa, Carmen
   Carrera-Garcia, Laura
   Exposito-Escudero, Jesica
   Roldan, Monica
   Camara, Yolanda
   Marti, Ramon
   Ferrer, Isidre
   Jimenez-Mallebrera, Cecilia
   Artuch, Rafael
TI Pathological Features in Paediatric Patients with TK2 Deficiency
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE TK2 deficiency; paediatric patients; ultrastructural studies; muscle biopsy; mitochondrial myopathies; ragged red fibres
ID mitochondrial-dna depletion; thymidine kinase; skeletal-muscle; myopathic form
AB Thymidine kinase (TK2) deficiency causes mitochondrial DNA depletion syndrome. We aimed to report the clinical, biochemical, genetic, histopathological, and ultrastructural features of a cohort of paediatric patients with TK2 deficiency. Mitochondrial DNA was isolated from muscle biopsies to assess depletions and deletions. The TK2 genes were sequenced using Sanger sequencing from genomic DNA. All muscle biopsies presented ragged red fibres (RRFs), and the prevalence was greater in younger ages, along with an increase in succinate dehydrogenase (SDH) activity and cytochrome c oxidase (COX)-negative fibres. An endomysial inflammatory infiltrate was observed in younger patients and was accompanied by an overexpression of major histocompatibility complex type I (MHC I). The immunofluorescence study for complex I and IV showed a greater number of fibres than those that were visualized by COX staining. In the ultrastructural analysis, we found three major types of mitochondrial alterations, consisting of concentrically arranged lamellar cristae, electrodense granules, and intramitochondrial vacuoles. The pathological features in the muscle showed substantial differences in the youngest patients when compared with those that had a later onset of the disease. Additional ultrastructural features are described in the muscle biopsy, such as sarcomeric de-structuration in the youngest patients with a more severe phenotype.
C1 [Jou, Cristina; Nascimento, Andres; Codina, Anna; Montero, Raquel; Natera-de Benito, Daniel; Ortez, Carlos, I; Marquez, Jesus; Badosa, Carmen; Carrera-Garcia, Laura; Exposito-Escudero, Jesica; Jimenez-Mallebrera, Cecilia; Artuch, Rafael] Hosp St Joan Deu, Pathol Biobank Pediat Neurol Neuromuscular Unit, Barcelona 08950, Spain.
   [Jou, Cristina; Nascimento, Andres; Codina, Anna; Montero, Raquel; Natera-de Benito, Daniel; Ortez, Carlos, I; Marquez, Jesus; Badosa, Carmen; Carrera-Garcia, Laura; Exposito-Escudero, Jesica; Jimenez-Mallebrera, Cecilia; Artuch, Rafael] Hosp St Joan Deu, Clin Biochem Dept, Barcelona 08950, Spain.
   [Jou, Cristina; Nascimento, Andres; Codina, Anna; Montero, Raquel; Natera-de Benito, Daniel; Ortez, Carlos, I; Marquez, Jesus; Badosa, Carmen; Carrera-Garcia, Laura; Exposito-Escudero, Jesica; Jimenez-Mallebrera, Cecilia; Artuch, Rafael] Inst Recerca St Joan Deu, Barcelona 08950, Spain.
   [Jou, Cristina; Nascimento, Andres; Montoya, Julio; Lopez-Gallardo, Ester; Emperador, Sonia; Ruiz-Pesini, Eduardo; Camara, Yolanda; Marti, Ramon; Jimenez-Mallebrera, Cecilia; Artuch, Rafael] Biomed Ctr Res Rare Dis CIBERER ISCIII, Madrid 28029, Spain.
   [Montoya, Julio; Lopez-Gallardo, Ester; Emperador, Sonia; Ruiz-Pesini, Eduardo] Univ Zaragoza, Inst Invest Sanitaria Aragon IISA, Zaragoza 50011, Spain.
   [Zelaya, Maria, V] Navarra Inst Hlth Res, Complejo Hosp Navarra IdiSNA, Dept Pathol, Pamplona 31008, Spain.
   [Gutierrez-Mata, Alfonso] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Pediat Neurol Dept, San Jose 2671005, Costa Rica.
   [Roldan, Monica] Hosp St Joan Deu, Inst Pediat Malaties Rares IPER, Serv Med Genet & Mol, Unitat Microscopia Confocal & Imatge Cellular, Barcelona 08950, Spain.
   [Camara, Yolanda; Marti, Ramon] Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Res Grp Neuromuscular & Mitochondrial Disorders, Barcelona 08193, Spain.
   [Ferrer, Isidre] Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona 08007, Spain.
   [Ferrer, Isidre] Bellvitge Inst Biomed Res IDI BELL, Biomed Ctr Res Neurodegenerat Dis CIBERNED, Barcelona 08007, Spain.
   [Ferrer, Isidre; Jimenez-Mallebrera, Cecilia] Univ Barcelona, Dept Genet Microbiol & Stat, Barcelona 08007, Spain.
C3 University of Barcelona; University of Barcelona; University of Zaragoza; Servicio Navarro de Salud - Osasunbidea; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Barcelona; University of Barcelona
RP Jimenez-Mallebrera, C; Artuch, R (corresponding author), Hosp St Joan Deu, Pathol Biobank Pediat Neurol Neuromuscular Unit, Barcelona 08950, Spain.; Jimenez-Mallebrera, C; Artuch, R (corresponding author), Hosp St Joan Deu, Clin Biochem Dept, Barcelona 08950, Spain.; Jimenez-Mallebrera, C; Artuch, R (corresponding author), Inst Recerca St Joan Deu, Barcelona 08950, Spain.; Jimenez-Mallebrera, C; Artuch, R (corresponding author), Biomed Ctr Res Rare Dis CIBERER ISCIII, Madrid 28029, Spain.; Jimenez-Mallebrera, C (corresponding author), Univ Barcelona, Dept Genet Microbiol & Stat, Barcelona 08007, Spain.
EM cecilia.jimenez@sjd.es; rafael.artuch@sjd.es
FU Instituto de Salud Carlos III [FIS-PI17-00021, PI17-00166, PI20-00340]; European Regional Development Fund [PR194]; Gobierno de Aragon [B33_20R]; FEDER; Asociacion de Enfermos de Patologia Mitocondrial (AEPMI)
CR Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Casado M, 2018, METABOLOMICS, V14, P0, DOI 10.1007/s11306-018-1374-4
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   De Paepe B, 2009, J CLIN PATHOL, V62, P172, DOI 10.1136/jcp.2008.061267
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Dubowitz V, 2020, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   Finsterer J, 2018, MOL GENET METAB REP, V16, P13, DOI 10.1016/j.ymgmr.2018.06.003
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Marcuello A, 2005, J APPL PHYSIOL, V99, P1372, DOI 10.1152/japplphysiol.00289.2005
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Phadke R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6070064
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Romero NB, 2013, HAND CLINIC, V113, P1321, DOI 10.1016/B978-0-444-59565-2.00004-6
   Roos S, 2014, NEUROMUSCULAR DISORD, V24, P713, DOI 10.1016/j.nmd.2014.05.009
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sabouny R, 2021, J CELL SCI, V134, P0, DOI 10.1242/jcs.258944
   Sewry CA, 2010, ACTA NEUROPATHOL, V120, P343, DOI 10.1007/s00401-010-0727-5
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Vincent AE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30610
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   Zeviani M, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11040637
NR 30
TC 1
Z9 1
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT 15
PY 2022
VL 23
IS 19
BP 
EP 
DI 10.3390/ijms231911002
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 5H5TL
UT WOS:000867741500001
PM 36232299
DA 2024-11-01
ER

PT J
AU Mensah, EA
   Sarfo, B
   Yawson, AE
   Arthur, J
   Ocloo, A
AF Mensah, Eric A.
   Sarfo, Bismark
   Yawson, Alfred E.
   Arthur, Joshua
   Ocloo, Augustine
TI Knowledge and awareness of mitochondrial diseases among physicians in the tertiary hospitals in Ghana
SO PLOS ONE
LA English
DT Article
ID respiratory-chain disorders; diagnostic-criteria; metabolomics; management; cohort
AB Background Mitochondrial diseases/disorders (MDs), for decades, have been identified as a key underlying condition for many chronic diseases globally. However, data on the knowledge and prevalence of MDs in many countries in sub-Saharan Africa are lacking. This study assessed the knowledge, and awareness, of MDs among senior medical doctors in the five tertiary hospitals in Ghana. Method Data were collected from one hundred and twenty-eight (128) medical doctors in the five Tertiary Hospitals in Ghana using both closed and open-ended questionnaires and analysed using descriptive statistics. Results Of the 128 respondents, 70.32% were senior medical officers and above, 87% of them indicated that they were aware of MDs and over 90% said physicians do not often diagnose MDs in Ghana. About 81% indicated that MDs are associated with chronic illnesses whilst 72% said the disease is diagnosed in both males and females. About 45% of the respondents alluded to the fact that MDs are difficult to diagnose, are associated with mutations in both the mitochondrial and the nuclear DNA, and are non-infectious diseases. Approximately 85% said nervous system dysfunction and muscle weakness are some of the symptoms associated with MDs whilst 77% said fatigue is also one of the symptoms. About 38% of the respondents specified that they encounter myopathies. A majority (70%) did not know about the availability of any consensus or standard diagnostic procedure and/or drugs for MDs. Conclusion There is a high level of knowledge and awareness of MDs among the respondents. However, there is a low disease encounter, which could be due to a lack of diagnostic protocols or a low disease prevalence. It is, therefore recommend that a patient perspective study, which looks at clinical records and laboratory data be conducted to fully ascertain the prevalence of MDs in Ghana and that appropriate educational strategies and interventions aimed at improving the diagnosis of mitochondrial diseases in Ghana be put in place.
C1 [Mensah, Eric A.; Ocloo, Augustine] Univ Ghana, Coll Basic & Appl Sci, Sch Biol Sci, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana.
   [Mensah, Eric A.] Univ Ghana, West African Ctr Cell Biol Infect Pathogens, Legon, Accra, Ghana.
   [Sarfo, Bismark] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Dis Control, Legon, Accra, Ghana.
   [Yawson, Alfred E.] Univ Ghana, Dept Community Hlth, Med Sch, Coll Hlth Sci,Univ Ghana Korle Bu, Accra, Ghana.
   [Arthur, Joshua] Komfo Anokye Teaching Hosp, Publ Hlth Unit, Kumasi, Ghana.
C3 University of Ghana; University of Ghana; University of Ghana; University of Ghana; Kwame Nkrumah University Science & Technology
RP Ocloo, A (corresponding author), Univ Ghana, Coll Basic & Appl Sci, Sch Biol Sci, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana.
EM aocloo@ug.edu.gh
FU West African Centre for the Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Legon
CR Afrifa J, 2019, MITOCHONDRION, V47, P238, DOI 10.1016/j.mito.2018.12.003
   Bajgain KT, 2021, AM J INFECT CONTROL, V49, P238, DOI 10.1016/j.ajic.2020.06.213
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Breton CV, 2019, MITOCHONDRION, V46, P22, DOI 10.1016/j.mito.2019.04.001
   Davison J, 2019, PAED CHILD HEALT-CAN, V29, P116
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Forbes-Hernández TY, 2014, FOOD CHEM TOXICOL, V68, P154, DOI 10.1016/j.fct.2014.03.017
   Grier J, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000230
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hettiarachchi D, 2022, MITOCHONDRION, V62, P24, DOI 10.1016/j.mito.2021.10.007
   Houston BA, 2017, J CARD FAIL, V23, P652, DOI 10.1016/j.cardfail.2017.06.001
   Karaa A, 2019, MOL GENET METAB, V127, P122, DOI 10.1016/j.ymgme.2019.05.012
   Karaa A, 2019, MITOCHONDRION, V46, P214, DOI 10.1016/j.mito.2018.06.007
   Koene S, 2016, J INHERIT METAB DIS, V39, P705, DOI 10.1007/s10545-016-9948-7
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Meldau S, 2018, CLIN GENET, V93, P1093, DOI 10.1111/cge.13208
   Menezes MJ, 2014, BBA-GEN SUBJECTS, V1840, P1368, DOI 10.1016/j.bbagen.2013.12.025
   Miller RL, 2003, AZ SOCIAL RES DICT K, V0, P0
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Pal A, 2018, INDIAN J ANIM SCI, V88, P637
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Pulkes T, 2001, ADV DRUG DELIVER REV, V49, P27, DOI 10.1016/S0169-409X(01)00124-7
   Reinecke CJ, 2012, METABOLOMICS, V8, P264, DOI 10.1007/s11306-011-0309-0
   Saleh J, 2020, MITOCHONDRION, V54, P1, DOI 10.1016/j.mito.2020.06.008
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Singh KK, 2015, MITOCHONDRION, V24, P0
   Smeitink JAM, 2003, J INHERIT METAB DIS, V26, P199, DOI 10.1023/A:1024489218004
   Smuts I, 2010, J INHERIT METAB DIS, V33, PS95, DOI 10.1007/s10545-009-9031-8
   Taivassalo T, 2012, BRAIN, V135, P53, DOI 10.1093/brain/awr293
   van der Walt EM, 2012, EUR J HUM GENET, V20, P650, DOI 10.1038/ejhg.2011.262
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
NR 34
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD OCT 20
PY 2022
VL 17
IS 10
BP 
EP 
DI 10.1371/journal.pone.0276549
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 8N3QK
UT WOS:000925064400104
PM 36264964
DA 2024-11-01
ER

PT J
AU Masingue, M
   Rucheton, B
   Bris, C
   Romero, NB
   Procaccio, V
   Eymard, B
AF Masingue, M.
   Rucheton, B.
   Bris, C.
   Romero, N. B.
   Procaccio, V.
   Eymard, B.
TI Highly asymmetrical distribution of muscle wasting correlates to the heteroplasmy in a patient carrying a large-scale mitochondrial DNA deletion: a novel pathophysiological mechanism for explaining asymmetry in mitochondrial myopathies
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA deletion; Asymmetrical genetic myopathy; eKLIPse
ID progressive external ophthalmoplegia; duchenne muscular-dystrophy; carriers; mtdna; phenotypes; mutations; spectrum; weakness; disease
AB Mitochondrial diseases are a heterogeneous group of pathologies, caused by missense mutations, sporadic large-scale deletions of mitochondrial DNA (mtDNA) or mutations of nuclear maintenance genes. We report the case of a patient in whom extended muscle pathology, biochemical and genetic mtDNA analyses have proven to be essential to elucidate a unique asymmetrical myopathic presentation. From the age of 34 years on, the patient has presented with oculomotor disorders, right facial peripheral palsy and predominantly left upper limb muscle weakness and atrophy. By contrast, he displayed no motor weakness on the right hemi-body, and no sensory symptoms, cerebellar syndrome, hypoacusis, or parkinsonism. Cardiac function was normal. CK levels were elevated (671 UI/L). Electroneuromyography (ENMG) and muscle MRI showed diffuse myogenic alterations, more pronounced on the left side muscles. Biopsy of the left deltoid muscle showed multiple mitochondrial defects, whereas in the right deltoid, mitochondrial defects were much less marked. Extended mitochondrial biochemical and molecular workup revealed a unique mtDNA deletion, with a 63.4% heteroplasmy load in the left deltoid, versus 8.1% in the right one. This case demonstrates that, in mitochondrial myopathies, heteroplasmy levels may drastically vary for the same type of muscle, rising the hypothesis of a new pathophysiological mechanism explaining asymmetry in hereditary myopathies.(c) 2022 Elsevier B.V. All rights reserved.
C1 [Masingue, M.; Eymard, B.] CHU Pitie Salpetriere, Inst Myol, Reference Ctr Neuromuscular Disorders Nord Est Ile, Neuromuscular Morphol Unit, Paris, France.
   [Rucheton, B.] Serv Biochim Metab, UF Biochim Malad neuromet abol neurodegenerat t, AP HP, Paris, France.
   [Bris, C.; Procaccio, V.] Angers Hosp, Dept Genet, Angers, France.
   [Bris, C.; Procaccio, V.] Univ Angers, Inst MitoVasc, MitoLab Team, UMR CNRS 6015 INSERM U1083, Angers, France.
   [Romero, N. B.] Univ Sorbonne, Ctr Res Myol, INSERM UMRS974, CNRS FRE3617,UPMC Paris 06, Paris, France.
   [Masingue, M.; Eymard, B.] CHU Pitie Salpetriere, APHP, Ctr Reference Pathol Neuromusculaire, F-75013 Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Sorbonne Universite
RP Masingue, M; Eymard, B (corresponding author), CHU Pitie Salpetriere, APHP, Ctr Reference Pathol Neuromusculaire, F-75013 Paris, France.
EM marion.masingue@aphp.fr; brunoeymard@aphp.fr
CR [Anonymous], 1985, N ENGL J MED, V312, P171
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Bevilacqua JA, 2009, ACTA NEUROPATHOL, V117, P283, DOI 10.1007/s00401-008-0472-1
   Biancalana V, 2017, ACTA NEUROPATHOL, V134, P889, DOI 10.1007/s00401-017-1748-0
   Boucret L, 2017, HUM REPROD, V32, P2101, DOI 10.1093/humrep/dex268
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Cocanougher BT, 2019, NEUROLOGY, V93, PE1535, DOI 10.1212/WNL.0000000000008316
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Goldstein A, 2003, MITOCHONDRIAL DNA DE, V0, P0
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Guglieri M, 2008, HUM MUTAT, V29, P258, DOI 10.1002/humu.20642
   Helderman-van den Enden ATJM, 2003, NEUROMUSCULAR DISORD, V13, P317, DOI 10.1016/S0960-8966(02)00285-7
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Hoogerwaard EM, 1999, LANCET, V353, P2116, DOI 10.1016/S0140-6736(98)10028-4
   Kim Y, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/3165396
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   MATTHEWS PM, 1995, NEUROMUSCULAR DISORD, V5, P209, DOI 10.1016/0960-8966(94)00057-G
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Mercier S, 2013, EUR J HUM GENET, V21, P855, DOI 10.1038/ejhg.2012.269
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Paradas C, 2010, NEUROLOGY, V75, P316, DOI 10.1212/WNL.0b013e3181ea1564
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Rijken NHM, 2014, NEUROMUSCULAR DISORD, V24, P1087, DOI 10.1016/j.nmd.2014.05.012
   Sarkozy A, 2012, NEUROMUSCULAR DISORD, V22, PS122, DOI 10.1016/j.nmd.2012.05.012
   Savarese M, 2016, NEUROMUSCULAR DISORD, V26, P292, DOI 10.1016/j.nmd.2016.02.004
   Sharma NK, 2002, J NEUROL NEUROSUR PS, V73, P95, DOI 10.1136/jnnp.73.1.95
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Vissing J, 2016, CURR OPIN NEUROL, V29, P635, DOI 10.1097/WCO.0000000000000375
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang LH, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0667-0
   Wei W, 2020, J INTERN MED, V287, P634, DOI 10.1111/joim.13047
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 35
TC 1
Z9 1
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD DEC 15
PY 2022
VL 32
IS 11-12
BP 923
EP 930
DI 10.1016/j.nmd.2022.10.006
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 7K0FU
UT WOS:000904962000001
PM 36428163
DA 2024-11-01
ER

PT J
AU Long, HS
   Wen, C
   Zhao, J
   Wang, JW
   Li, Y
   Fu, XX
   Huang, LH
AF Long, Haishan
   Wen, Cheng
   Zhao, Juan
   Wang, Jiawei
   Li, Yang
   Fu, Xinxing
   Huang, Lihui
TI ENT characteristics and therapeutic results in multisystemic disorders of mitochondrial encephalomyopathy
SO EUROPEAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Article
DE Hearing loss; Dysphagia; Facial weakness; Ptosis; Exercise intolerance; Mitochondrial
ID hereditary optic neuropathy; mutation; management; dysphagia
AB Here we report the evaluation of the frequency of subjective and objective otolaryngologic findings and therapeutic results in 32 patients with mitochondrial encephalomyopathy (MEM) from September 2001 to June 2021. Our analysis included studying the patients' family histories, the clinical manifestations of MEM, and the therapeutic effects of treatments. The patients' ages ranged from 2 to 77 years, with a median age of 12.3 years. We found that MEM ENT symptoms were characterized by hearing loss, dysphagia, and facial weakness. Most cases of sensorineural hearing loss were bilateral symmetrical progressive or sudden deafness since adolescence, which were often underestimated. Associated neuromuscular symptoms required mtDNA testing. Dysphagia and facial weakness occurred preferentially in middle-aged patients, and muscle biopsies were advised. Distortion product otoacoustic emissions and auditory brainstem responsetesting were more sensitive and reliable than pure tone averages for objective monitoring of pathogenesis. Administration of the mitochondrial synthase complex benefited patients with acute episodes. If patients did not fully recover and exhibitedresidual language deficits, hearing aids or cochlear implants were recommended. Counsel was given regarding synthetical treatments for facial weakness, endoscopic circopharyngealmyotomy for dysphagia, and surgical correction of ptosis. This study demonstrates that increased awareness of these symptoms is important to address appropriate interventions and avoid complications such as ablepsia, aphasia, social isolation, malnutrition, aspiration pneumonia, and heart failure in the setting of MEM.
C1 [Long, Haishan; Wen, Cheng; Fu, Xinxing; Huang, Lihui] Capital Med Univ, Dept Otolaryngol Head & Neck Surg, Beijing Tongren Hosp, Key Lab Otolaryngol Head & Neck Surg,Minist Educ, Beijing 100730, Peoples R China.
   [Wen, Cheng; Fu, Xinxing; Huang, Lihui] Beijing Inst Otolaryngol, Beijing 100005, Peoples R China.
   [Zhao, Juan; Wang, Jiawei] Capital Med Univ, Beijing Tongren Hosp, Dept Neurol, Cent Lab, Beijing 100730, Peoples R China.
   [Li, Yang] Capital Med Univ, Dept Ophthalmol, Beijing Inst Ophthalmol,Beijing Tongren Hosp, Key Lab Ophthalmol & Visual Sci,Minist Educ,Beiji, Beijing 100730, Peoples R China.
C3 Capital Medical University; Capital Medical University; Capital Medical University
RP Huang, LH (corresponding author), Capital Med Univ, Dept Otolaryngol Head & Neck Surg, Beijing Tongren Hosp, Key Lab Otolaryngol Head & Neck Surg,Minist Educ, Beijing 100730, Peoples R China.; Huang, LH (corresponding author), Beijing Inst Otolaryngol, Beijing 100005, Peoples R China.
EM huanglihui@ccmu.edu.cn
CR Amore G, 2021, DRUGS, V81, P57, DOI 10.1007/s40265-020-01428-3
   Balali M, 2016, THER CLIN RISK MANAG, V12, P117, DOI 10.2147/TCRM.S90581
   Bindu PS, 2018, CLIN NEUROL NEUROSUR, V164, P182, DOI 10.1016/j.clineuro.2017.12.010
   Bottani E, 2020, PHARMACEUTICS, V12, P0, DOI 10.3390/pharmaceutics12111083
   Burgin HJ, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21062139
   Cai T, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0183394
   Carlot S, 2021, ACTA OPHTHALMOL, V99, P0, DOI 10.1111/j.1755-3768.2020.0177
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chandra S, 2019, J NEUROL SCI, V405, P0, DOI 10.1016/j.jns.2019.10.1295
   Custers JAE, 2018, ORPHANET J RARE DIS, V13, P0, DOI 10.1186/s13023-018-0951-y
   Davison JE, 2017, ARCH DIS CHILD, V102, P1082, DOI 10.1136/archdischild-2016-311370
   Doerfer KW, 2020, LARYNGOSCOPE INVEST, V5, P497, DOI 10.1002/lio2.379
   Fang F, 2018, SCI CHINA LIFE SCI, V61, P1606, DOI 10.1007/s11427-017-9130-4
   Finsterer J, 2016, CLIN OPHTHALMOL, V10, P2187, DOI 10.2147/OPTH.S120197
   Ghaoui R, 2018, J NEUROL, V265, P1230, DOI 10.1007/s00415-017-8722-6
   Habbane M, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11091007
   Hedermann G, 2017, MITOCHONDRION, V32, P27, DOI 10.1016/j.mito.2016.11.007
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Humes LE, 2019, INT J AUDIOL, V58, P12, DOI 10.1080/14992027.2018.1518598
   Ichikawa Hiroo, 2016, BRAIN NERVE, V68, P151, DOI 10.11477/mf.1416200366
   Jiang ZC, 2016, MITOCHONDRIAL DNA A, V27, P1564, DOI 10.3109/19401736.2014.953137
   Jiang ZX, 2019, J DIABETES RES, V2019, P0, DOI 10.1155/2019/5184647
   Kisilevsley E, 2020, SURV OPHTHALMOL, V65, P294, DOI 10.1016/j.survophthal.2019.11.001
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131
   Kousaki H, 2018, PRACT OTOL KYOTO, V152, P8, DOI 10.5631/jibirinsuppl.152.8
   Kozak Igor, 2018, RETIN CASES BRIEF REP, V12, P349, DOI 10.1097/ICB.0000000000000503
   Kullar P, 2016, HEARING BALANC COMMU, V14, P101, DOI 10.3109/21695717.2016.1151124
   Liu GL, 2020, J NEUROL SCI, V408, P0, DOI 10.1016/j.jns.2019.116562
   Masingue M, 2019, J NEUROL SCI, V396, P112, DOI 10.1016/j.jns.2018.11.014
   Mohannak N, 2019, INT J GEN MED, V12, P465, DOI 10.2147/IJGM.S198031
   Morlet T, 2018, J NEUROL, V265, P1580, DOI 10.1007/s00415-018-8884-x
   Mutsumi O, 2015, J PLAST RECONSTR AES, V68, PE113, DOI 10.1016/j.bjps.2015.02.013
   Niu FN, 2017, CNS NEUROSCI THER, V23, P686, DOI 10.1111/cns.12714
   Orsini M, 2018, NEUROL INT, V10, P3, DOI 10.4081/ni.2018.7473
   Ost M, 2018, CURR OPIN CLIN NUTR, V21, P336, DOI 10.1097/MCO.0000000000000486
   Peedikayil Musthafa Chalikandy, 2015, HEMATOL ONCOL STEM CELL THER, V8, P85, DOI 10.1016/j.hemonc.2014.12.001
   Poulton J, 2017, MOL DIAGN THER, V21, P419, DOI 10.1007/s40291-017-0279-7
   [北京医学会罕见病分会 Rare Diseases Branch of Beijing Medical Association], 2020, 中华神经科杂志 CHINESE JOURNAL OF NEUROLOGY, V53, P171
   Ricardo CP, 2018, HEART, V104, PA8, DOI 10.1136/heartjnl-2018-BSCR.24
   Rinninella E, 2018, EUR REV MED PHARMACO, V22, P4288, DOI 10.26355/eurrev_201807_15425
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Saldaña-Martínez A, 2019, GENE, V688, P171, DOI 10.1016/j.gene.2018.11.085
   Silver G, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21155519
   Sudakov NP, 2017, EUR J MED RES, V22, P0, DOI 10.1186/s40001-016-0241-x
   The Neuro-Ophthalmology Group of the Ophthalmology Branch of the Chinese Medical Association. The Leber hereditary optic neuropathy Collaboration Group, 2019, OPHTHALMOLOGY, V28, P328, DOI 10.13281/j.cnki.issn.1004-4469.2019.05.003
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P163, DOI 10.1007/978-3-319-95046-4_31
   Wang CA, 2020, EUR J MED RES, V25, P0, DOI 10.1186/s40001-020-00431-4
   Wang R, 2021, J MAGN RESON IMAGING, V53, P427, DOI 10.1002/jmri.27353
   Wong RCB, 2017, AGING-US, V9, P1341, DOI 10.18632/aging.101231
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
   Yamamoto N, 2015, OTOL NEUROTOL, V36, PE129, DOI 10.1097/MAO.0000000000000817
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   [袁云 Yuan Yun], 2019, 中华神经科杂志 CHINESE JOURNAL OF NEUROLOGY, V52, P327
   [张哲 Zhang Zhe], 2016, 中华神经科杂志 CHINESE JOURNAL OF NEUROLOGY, V49, P237
   [张志坚 Zhang Zhijian], 2017, 听力学及言语疾病杂志 JOURNAL OF AUDIOLOGY AND SPEECH PATHOLOGY, V25, P571
NR 57
TC 2
Z9 2
U1 1
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0949-2321
EI 2047-783X
J9 EUR J MED RES
JI Eur. J. Med. Res.
PD OCT 29
PY 2022
VL 27
IS 1
BP 
EP 
DI 10.1186/s40001-022-00832-7
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 5U1KT
UT WOS:000876312700003
PM 36309717
DA 2024-11-01
ER

PT J
AU Davis, RL
   Kumar, KR
   Puttick, C
   Liang, C
   Ahmad, KE
   Edema-Hildebrand, F
   Park, JS
   Minoche, AE
   Gayevskiy, V
   Mallawaarachchi, AC
   Christodoulou, J
   Schofield, D
   Dinger, ME
   Cowley, MJ
   Sue, CM
AF Davis, Ryan L.
   Kumar, Kishore R.
   Puttick, Clare
   Liang, Christina
   Ahmad, Kate E.
   Edema-Hildebrand, Fabienne
   Park, Jin-Sung
   Minoche, Andre E.
   Gayevskiy, Velimir
   Mallawaarachchi, Amali C.
   Christodoulou, John
   Schofield, Deborah
   Dinger, Marcel E.
   Cowley, Mark J.
   Sue, Carolyn M.
TI Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
SO NEUROLOGY
LA English
DT Article
ID dna mutations; prevalence; genetics; muscle
AB Background and Objectives Mitochondrial diseases (MDs) are the commonest group of heritable metabolic disorders. Phenotypic diversity can make molecular diagnosis challenging, and causative genetic variants may reside in either mitochondrial or nuclear DNA. A single comprehensive genetic diagnostic test would be highly useful and transform the field. We applied whole-genome sequencing (WGS) to evaluate the variant detection rate and diagnostic capacity of this technology with a view to simplifying and improving the MD diagnostic pathway. Methods Adult patients presenting to a specialist MD clinic in Sydney, Australia, were recruited to the study if they satisfied clinical MD (Nijmegen) criteria. WGS was performed on blood DNA, followed by clinical genetic analysis for known pathogenic MD-associated variants and MD mimics. Results Of the 242 consecutive patients recruited, 62 participants had "definite," 108 had "probable," and 72 had "possible" MD classification by the Nijmegen criteria. Disease-causing variants were identified for 130 participants, regardless of the location of the causative genetic variants, giving an overall diagnostic rate of 53.7% (130 of 242). Identification of causative genetic variants informed precise treatment, restored reproductive confidence, and optimized clinical management of MD. Discussion Comprehensive bigenomic sequencing accurately detects causative genetic variants in affected MD patients, simplifying diagnosis, enabling early treatment, and informing the risk of genetic transmission.
C1 [Davis, Ryan L.; Kumar, Kishore R.; Ahmad, Kate E.; Park, Jin-Sung; Sue, Carolyn M.] Univ Sydney, Kolling Inst, Fac Med & Hlth, Dept Neurogenet, Sydney, NSW, Australia.
   [Davis, Ryan L.; Kumar, Kishore R.; Ahmad, Kate E.; Park, Jin-Sung; Sue, Carolyn M.] Royal North Shore Hosp, Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia.
   [Davis, Ryan L.; Kumar, Kishore R.; Puttick, Clare; Minoche, Andre E.; Gayevskiy, Velimir; Mallawaarachchi, Amali C.; Dinger, Marcel E.; Cowley, Mark J.; Sue, Carolyn M.] Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Darlinghurst, NSW, Australia.
   [Kumar, Kishore R.; Liang, Christina; Edema-Hildebrand, Fabienne; Sue, Carolyn M.] Royal North Shore Hosp, Northern Sydney Local Hlth Dist, Dept Neurol, St Leonards, NSW, Australia.
   [Kumar, Kishore R.] Concord Hosp, Mol Med Lab, Concord, NSW, Australia.
   [Park, Jin-Sung] Cenyx Biotech, Seoul, South Korea.
   [Christodoulou, John] Murdoch Childrens Res Inst, Brain & Mitochondrial Res Grp, Parkville, Vic, Australia.
   [Christodoulou, John] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Schofield, Deborah] GenIMPACT, Macquarie Pk, NSW, Australia.
   [Schofield, Deborah] Macquarie Univ, Ctr Econ Impacts Genom Med, Macquarie Pk, NSW, Australia.
   [Dinger, Marcel E.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Randwick, NSW, Australia.
   [Cowley, Mark J.] Univ New South Wales, Childrens Canc Inst, Computat Biol Grp, Randwick, NSW, Australia.
C3 University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; Northern Sydney Local Health District; Garvan Institute of Medical Research; Royal North Shore Hospital; Northern Sydney Local Health District; Concord Repatriation General Hospital; Murdoch Children's Research Institute; University of Melbourne; Macquarie University; University of New South Wales Sydney; Children's Cancer Institute; University of New South Wales Sydney
RP Sue, CM (corresponding author), Univ Sydney, Kolling Inst, Fac Med & Hlth, Dept Neurogenet, Sydney, NSW, Australia.; Sue, CM (corresponding author), Royal North Shore Hosp, Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia.
EM carolyn.sue@sydney.edu.au
FU New South Wales Ministry of Health Collaborative Genomics Grant
CR Baldwin EJ, 2010, J NEUROL NEUROSUR PS, V81, P954, DOI 10.1136/jnnp.2008.161059
   Cabrera-Pérez R, 2019, HUM GENE THER, V30, P985, DOI 10.1089/hum.2018.217
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Carelli V, 2017, J NEURO-OPHTHALMOL, V37, P371, DOI 10.1097/WNO.0000000000000570
   Caspar SM, 2018, CLIN GENET, V93, P508, DOI 10.1111/cge.13190
   Clark MM, 2018, NPJ GENOM MED, V3, P0, DOI 10.1038/s41525-018-0053-8
   Craven L, 2017, HUM REPROD UPDATE, V23, P501, DOI 10.1093/humupd/dmx018
   Davis Ryan L, 2018, HANDB CLIN NEUROL, V147, P125, DOI 10.1016/B978-0-444-63233-3.00010-5
   Davis RL, 2011, SEMIN NEUROL, V31, P519, DOI 10.1055/s-0031-1299790
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Finsterer J, 2010, DRUG CHEM TOXICOL, V33, P138, DOI 10.3109/01480540903207076
   Garret P, 2019, HUM MUTAT, V40, P2430, DOI 10.1002/humu.23885
   Garvan Institute, 2018, AB US, V0, P0
   Gayevskiy V, 2019, BIOINFORMATICS, V35, P122, DOI 10.1093/bioinformatics/bty540
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grier J, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000230
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Karaarslan C, 2019, ADV THER, V36, P3299, DOI 10.1007/s12325-019-01113-2
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Kumar KR, 2019, SEMIN THROMB HEMOST, V45, P661, DOI 10.1055/s-0039-1688446
   Liang C, 2011, AUSTR DOCTOR, V25, P27
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Manwaring N, 2008, ANN NEUROL, V64, P471, DOI 10.1002/ana.21469
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mattick JS, 2018, MED J AUSTRALIA, V209, P197, DOI 10.5694/mja17.01176
   Minoche AE, 2019, GENET MED, V21, P650, DOI 10.1038/s41436-018-0084-7
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Pickett SJ, 2019, NEW ENGL J MED, V380, P1971, DOI 10.1056/NEJMc1808565
   Pinese M, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-14079-0
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Pronicka E, 2011, MED SCI MONITOR, V17, PCR203, DOI 10.12659/MSM.881716
   Puttick C, 2019, BIORXIV, V0, P0, DOI DOI 10.1101/852210
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Cruz PMR, 2015, NEUROLOGY, V85, P1043, DOI 10.1212/WNL.0000000000001952
   Rudaks LI, 2022, AM J MED GENET A, V188, P2226, DOI 10.1002/ajmg.a.62755
   Schofield D, 2017, NPJ GENOM MED, V2, P0, DOI 10.1038/s41525-017-0006-7
   Smith EH, 2010, J INHERIT METAB DIS, V33, PS349, DOI 10.1007/s10545-010-9183-6
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Sue CM, 2010, MED J AUSTRALIA, V193, P195, DOI 10.5694/j.1326-5377.2010.tb03864.x
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188
   Stormo Gary D, 2013, CURR PROTOC BIOINFORMATICS, V43, P0, DOI 10.1002/0471250953.bi1110s43
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   Watson E, 2020, J. TRANSL. GENET. GENOMICS, V4, P188, DOI 10.20517/JTGG.2020.31
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 54
TC 27
Z9 26
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD AUG 16
PY 2022
VL 99
IS 7
BP E730
EP E742
DI 10.1212/WNL.0000000000200745
PG 13
WC Clinical Neurology
SC Neurosciences & Neurology
GA 3U3NP
UT WOS:000840881900022
PM 35641312
DA 2024-11-01
ER

PT J
AU Roy, A
   Kandettu, A
   Ray, S
   Chakrabarty, S
AF Roy, Abhipsa
   Kandettu, Amoolya
   Ray, Swagat
   Chakrabarty, Sanjiban
TI Mitochondrial DNA replication and repair defects: Clinical phenotypes and therapeutic interventions
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Review
DE mtDNA replication; POLG; Base-excision repair; LIG3; CPEO
ID base-excision-repair; progressive external ophthalmoplegia; strand break repair; nucleotide translocator-1 gene; messenger-rna localization; impair mtdna replication; dominant optic atrophy; mouse l-cells; polymerase-gamma; autosomal-dominant
AB Mitochondria is a unique cellular organelle involved in multiple cellular processes and is critical for maintaining cellular homeostasis. This semi-autonomous organelle contains its circular genome - mtDNA (mitochondrial DNA), that undergoes continuous cycles of replication and repair to maintain the mitochondrial genome integrity. The majority of the mitochondrial genes, including mitochondrial replisome and repair genes, are nuclear-encoded. Although the repair machinery of mitochondria is quite efficient, the mitochondrial genome is highly susceptible to oxidative damage and other types of exogenous and endogenous agent-induced DNA damage, due to the absence of protective histones and their proximity to the main ROS production sites. Mutations in replication and repair genes of mitochondria can result in mtDNA depletion and deletions subsequently leading to mitochondrial genome instability. The combined action of mutations and deletions can result in compromised mitochondrial genome maintenance and lead to various mitochondrial disorders. Here, we review the mechanism of mitochondrial DNA replication and repair process, key proteins involved, and their altered function in mitochondrial disorders. The focus of this review will be on the key genes of mitochondrial DNA replication and repair machinery and the clinical phenotypes associated with mutations in these genes.
C1 [Roy, Abhipsa; Kandettu, Amoolya; Chakrabarty, Sanjiban] Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal 576104, Karnataka, India.
   [Ray, Swagat] Univ Lincoln, Sch Life & Environm Sci, Dept Life Sci, Lincoln LN6 7TS, England.
C3 Manipal Academy of Higher Education (MAHE); University of Lincoln
RP Chakrabarty, S (corresponding author), Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal 576104, Karnataka, India.
EM sanjiban.c@manipal.edu
FU Science and Engineering Research Board (SERB) , Department of Science and Technology, Government of India [YSS/2015/001051, CRG/2020/004681]
CR Aamann MD, 2010, FASEB J, V24, P2334, DOI 10.1096/fj.09-147991
   Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   Al-Behadili A, 2018, NUCLEIC ACIDS RES, V46, P9471, DOI 10.1093/nar/gky708
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012641
   Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDERSON CTM, 1980, NUCLEIC ACIDS RES, V8, P875
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Balkenhol T, 2020, FRONT NEUROSCI-SWITZ, V14, P0, DOI 10.3389/fnins.2020.586119
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   Bermúdez-Guzmán L, 2019, TRANSL NEURODEGENER, V8, P0, DOI 10.1186/s40035-019-0156-x
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Bonda E, 2016, ONCOTARGET, V7, P73323, DOI 10.18632/oncotarget.12331
   Bonnefoy Nathalie, 2007, METHODS MOL BIOL, V372, P153, DOI 10.1007/978-1-59745-365-3_11
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bonnet C, 2008, BBA-MOL CELL RES, V1783, P1707, DOI 10.1016/j.bbamcr.2008.04.018
   Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Bouaita A, 2012, BRAIN, V135, P35, DOI 10.1093/brain/awr290
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BRESOLIN N, 1990, J NEUROL SCI, V100, P70, DOI 10.1016/0022-510X(90)90015-F
   Broskey NT, 2014, J CLIN ENDOCR METAB, V99, P1852, DOI 10.1210/jc.2013-3983
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Brunyanszki A, 2016, FREE RADICAL BIO MED, V100, P257, DOI 10.1016/j.freeradbiomed.2016.02.024
   Cai SB, 2005, CANCER RES, V65, P3319, DOI 10.1158/0008-5472.CAN-04-3335
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Camp KM, 2016, MOL GENET METAB, V119, P187, DOI 10.1016/j.ymgme.2016.09.002
   Caradonna S, 1996, EXP CELL RES, V222, P345, DOI 10.1006/excr.1996.0044
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chiang SC, 2017, SCI ADV, V3, P0, DOI 10.1126/sciadv.1602506
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895
   Coffey G, 2000, NUCLEIC ACIDS RES, V28, P3793, DOI 10.1093/nar/28.19.3793
   Cohen BH, 1993, GENEREVIEWS((R)), V0, P0
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006
   Das BB, 2021, MITOCHONDRION, V60, P234, DOI 10.1016/j.mito.2021.08.017
   Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107
   Dassa EP, 2009, EMBO MOL MED, V1, P30, DOI 10.1002/emmm.200900001
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Davies DR, 2003, CHEM BIOL, V10, P139, DOI 10.1016/S1074-5521(03)00021-8
   Davies DR, 2002, STRUCTURE, V10, P237, DOI 10.1016/S0969-2126(02)00707-4
   De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Deepha S, 2021, J MOL NEUROSCI, V71, P2219, DOI 10.1007/s12031-020-01765-8
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   DiMauro S, 2006, MITOCHONDRIAL MED, V0, P0, DOI DOI 10.1201/9780367800154
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Dodson ML, 2002, FREE RADICAL BIO MED, V32, P678, DOI 10.1016/S0891-5849(02)00767-0
   Dörner A, 2007, TRENDS CARDIOVAS MED, V17, P284, DOI 10.1016/j.tcm.2007.10.001
   Douarre C, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0041094
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   Duncan GE, 2004, J CLIN ENDOCR METAB, V89, P1733, DOI 10.1210/jc.2003-031684
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Edmonds JL, 2004, MITOCHONDRION, V4, P543, DOI 10.1016/j.mito.2004.07.012
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Farge G, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20112770
   Farge G, 2014, CELL REP, V8, P66, DOI 10.1016/j.celrep.2014.05.046
   Farge G, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms2001
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Flierl A, 2005, GENE THER, V12, P570, DOI 10.1038/sj.gt.3302443
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185
   Fusté JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   Ghosh A, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aax9778
   Gimenes AC, 2015, BRAZ J MED BIOL RES, V48, P354, DOI 10.1590/1414-431X20143467
   Goffart S, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20082041
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213
   Gredilla Ricardo, 2010, J AGING RES, V2011, P257093, DOI 10.4061/2011/257093
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hämäläinen RH, 2019, NAT METAB, V1, P958, DOI 10.1038/s42255-019-0120-1
   Han DD, 2019, ELIFE, V8, P0, DOI 10.7554/eLife.49044
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hangas A, 2018, NUCLEIC ACIDS RES, V46, P9625, DOI 10.1093/nar/gky793
   Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359
   Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799
   Herrmann GK, 2021, J BIOL CHEM, V296, P0, DOI 10.1016/j.jbc.2021.100309
   Hirano M, 1993, GENEREVIEWS®, V0, P0
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hu BW, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00581
   Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Ide H, 2004, BIOL PHARM BULL, V27, P480, DOI 10.1248/bpb.27.480
   Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694
   Jackson CB, 2020, TRENDS MOL MED, V26, P698, DOI 10.1016/j.molmed.2020.02.006
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jang Y, 2018, LIFE SCI, V209, P455, DOI 10.1016/j.lfs.2018.08.045
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaltimbacher V, 2006, RNA, V12, P1408, DOI 10.1261/rna.18206
   Kanabus M, 2016, J INHERIT METAB DIS, V39, P415, DOI 10.1007/s10545-016-9930-4
   Karahalil B, 2003, J BIOL CHEM, V278, P33701, DOI 10.1074/jbc.M301617200
   Kasiviswanathan R, 2012, J BIOL CHEM, V287, P9222, DOI 10.1074/jbc.M111.306852
   Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kentab AY, 2019, JNSK, V9, P0, DOI 10.15406/jnsk.2019.09.00342
   Kesäniemi J, 2020, EVOL ECOL, V34, P163, DOI 10.1007/s10682-019-10028-x
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kornblum C, 2005, EUR J NEUROL, V12, P300, DOI 10.1111/j.1468-1331.2004.00970.x
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Krokan HE, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012583
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Kumar P, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-31122-0
   Kuszak AJ, 2018, ANNU REV PATHOL-MECH, V13, P163, DOI 10.1146/annurev-pathol-020117-043644
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880
   Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198
   Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LeDoux SP, 1999, MUTAT RES-DNA REPAIR, V434, P149, DOI 10.1016/S0921-8777(99)00026-9
   LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967
   Lee SR, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/8060949
   Lee YK, 2013, MOL CELLS, V35, P489, DOI 10.1007/s10059-013-2343-4
   Leon J, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep22086
   Liet JM, 2003, J PEDIATR-US, V142, P62, DOI 10.1067/mpd.2003.mpd0333
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Louro P, 2016, J INHERIT METAB DIS, V39, P743, DOI 10.1007/s10545-016-9951-z
   Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Mancuso M, 2010, J NEUROL, V257, P774, DOI 10.1007/s00415-009-5409-7
   Mandal SM, 2012, J BIOL CHEM, V287, P2819, DOI 10.1074/jbc.M111.272179
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Marín-García J, 2016, HEART FAIL REV, V21, P475, DOI 10.1007/s10741-016-9543-x
   MARTENS PA, 1979, J MOL BIOL, V135, P327, DOI 10.1016/0022-2836(79)90440-6
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Matic S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03552-x
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIGNOTTE B, 1985, NUCLEIC ACIDS RES, V13, P1703, DOI 10.1093/nar/13.5.1703
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Millhouse-Flourie TJ, 2004, MITOCHONDRION, V4, P549, DOI 10.1016/j.mito.2004.07.013
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Mishra A, 2018, MOL CELL BIOL, V38, P0, DOI 10.1128/MCB.00489-17
   Moretton A, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0176795
   Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618
   Murrey DA, 2014, HUM GENE THER CL DEV, V25, P72, DOI 10.1089/humc.2013.208
   MYERS KA, 1988, CARCINOGENESIS, V9, P285, DOI 10.1093/carcin/9.2.285
   Nakamura J, 1999, CANCER RES, V59, P2522
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Ngo HB, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4077
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nicolson GL, 2007, J CELL BIOCHEM, V100, P1352, DOI 10.1002/jcb.21247
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750
   Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637
   Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355
   Omar Garcia-Lepe U, 2019, DNA REPAIR- AN UPDATE, V0, P0, DOI DOI 10.5772/INTECHOPEN.84627
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Osenbroch PO, 2009, FEBS J, V276, P2811, DOI 10.1111/j.1742-4658.2009.07004.x
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Pannunzio NR, 2018, J BIOL CHEM, V293, P10512, DOI 10.1074/jbc.TM117.000374
   Paramasiyam A, 2019, MITOCHONDRION, V48, P78, DOI 10.1016/j.mito.2019.08.003
   Perales-Clemente E, 2008, P NATL ACAD SCI USA, V105, P18735, DOI 10.1073/pnas.0810518105
   Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005
   Pohjoismäki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   Pohjoismäki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020
   Posse V, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1007781
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Ragg S, 2000, CANCER RES, V60, P5187
   Ranieri M, 2013, NEUROL RES INT, V2013, P0, DOI 10.1155/2013/293893
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Saki M, 2017, FREE RADICAL BIO MED, V107, P216, DOI 10.1016/j.freeradbiomed.2016.11.050
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Santos J, 2014, COLLOID SURFACE B, V121, P129, DOI 10.1016/j.colsurfb.2014.06.003
   Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schnepp BC, 2003, J VIROL, V77, P3495, DOI 10.1128/JVI.77.6.3495-3504.2003
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Sharma H, 2005, CANCER CELL INT, V5, P0, DOI 10.1186/1475-2867-5-34
   Sharma NK, 2014, DNA REPAIR, V13, P22, DOI 10.1016/j.dnarep.2013.11.002
   Sharma P, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8020100
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Sobek S, 2014, EXP GERONTOL, V56, P135, DOI 10.1016/j.exger.2014.01.009
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegelman Bruce M, 2007, NOVARTIS FOUND SYMP, V287, P60
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226
   Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382
   Stein A, 2017, FRONT BIOSCI-LANDMRK, V22, P920, DOI 10.2741/4525
   Stierum RH, 1999, NUCLEIC ACIDS RES, V27, P3712, DOI 10.1093/nar/27.18.3712
   Stierum RH, 1999, J BIOL CHEM, V274, P7128, DOI 10.1074/jbc.274.11.7128
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Subedi S, 2015, ROLE HUMAN POLYNUCLE, V0, P0, DOI DOI 10.7939/R3JM23W6K
   Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466
   Sykora P, 2012, MECH AGEING DEV, V133, P169, DOI 10.1016/j.mad.2011.11.003
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tahbaz N, 2012, NUCLEIC ACIDS RES, V40, P3484, DOI 10.1093/nar/gkr1245
   Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917
   Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703
   Tigchelaar W, 2015, AM J PHYSIOL-CELL PH, V308, PC155, DOI 10.1152/ajpcell.00227.2014
   TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I
   Tomkinson AE, 2013, GENE, V531, P150, DOI 10.1016/j.gene.2013.08.061
   Torregrosa-Muñumer R, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-45244-6
   TSURUMI T, 1990, J VIROL, V64, P450, DOI 10.1128/JVI.64.1.450-452.1990
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Vaisman A, 1999, BIOCHEMISTRY-US, V38, P11026, DOI 10.1021/bi9909187
   Van Houten B, 2016, FRONT BIOSCI-LANDMRK, V21, P42, DOI 10.2741/4375
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499
   Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Wright WD, 2018, J BIOL CHEM, V293, P10524, DOI 10.1074/jbc.TM118.000372
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yao NNY, 2016, CRIT REV BIOCHEM MOL, V51, P135, DOI 10.3109/10409238.2015.1125845
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Yasuzaki Y, 2015, MOL PHARMACEUT, V12, P4311, DOI 10.1021/acs.molpharmaceut.5b00511
   Youn CK, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep45290
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2016, MITOCHONDRIAL CASE S, V0, PP159, DOI 10.1016/B978-0-12-800877-5.00018-8
   Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002
   Zeviani M, 2008, BRAIN, V131, P2809, DOI 10.1093/brain/awn264
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhang HL, 2014, NUCLEIC ACIDS RES, V42, P7259, DOI 10.1093/nar/gku384
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zinovkina LA, 2019, BIOCHEMISTRY-MOSCOW+, V84, P884, DOI 10.1134/S0006297919080042
   Zinovkina LA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P233, DOI 10.1134/S0006297918030045
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 340
TC 12
Z9 15
U1 3
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD JUN 1
PY 2022
VL 1863
IS 5
BP 
EP 
DI 10.1016/j.bbabio.2022.148554
EA MAR 2022
PG 21
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 1K8LQ
UT WOS:000798847800006
PM 35341749
DA 2024-11-01
ER

PT J
AU Edgar, JA
   Molyneux, RJ
   Colegate, SM
AF Edgar, John A.
   Molyneux, Russell J.
   Colegate, Steven M.
TI 1,2-Dehydropyrrolizidine Alkaloids: Their Potential as a Dietary Cause of Sporadic Motor Neuron Diseases
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID amyotrophic-lateral-sclerosis; central-nervous-system; decreased glutathione levels; exogenous risk-factor; pyrrolizidine alkaloids; pulmonary-hypertension; venoocclusive disease; superoxide-dismutase; crotalaria-retusa; cytochrome-p450 enzymes
AB Sporadic motor neuron diseases (MNDs), such as amyotrophic lateral sclerosis (ALS), can be caused by spontaneous genetic mutations. However, many sporadic cases of ALS and other debilitating neurodegenerative diseases (NDDs) are believed to be caused by environmental factors, subject to considerable debate and requiring intensive research. A common pathology associated with MND development involves progressive mitochondrial dysfunction and oxidative stress in motor neurons and glial cells of the central nervous system (CNS), leading to apoptosis. Consequent degeneration of skeletal and respiratory muscle cells can lead to death from respiratory failure. A significant number of MND cases present with cancers and liver and lung pathology. This Perspective explores the possibility that MNDs could be caused by intermittent, low-level dietary exposure to 1,2-dehydropyrrolizidine alkaloids (1,2-dehydroPAs) that are increasingly recognized as contaminants of many foods consumed throughout the world. Nontoxic, per se, 1,2-dehydroPAs are metabolized, by particular cytochrome P450 (CYP450) isoforms, to 6,7-dihydropyrrolizines that react with nucleophilic groups (-NH, -SH, -OH) on DNA, proteins, and other vital biochemicals, such as glutathione. Many factors, including aging, gender, smoking, and alcohol consumption, influence CYP450 isoform activity in a range of tissues, including glial cells and neurons of the CNS. Activation of 1,2-dehydroPAs in CNS cells can be expected to cause gene mutations and oxidative stress, potentially leading to the development of MNDs and other NDDs. While relatively high dietary exposure to 1,2-dehydroPAs causes hepatic sinusoidal obstruction syndrome, pulmonary venoocclusive disease, neurotoxicity, and diverse cancers, this Perspective suggests that, at current intermittent, low levels of dietary exposure, neurotoxicity could become the primary pathology that develops over time in susceptible individuals, along with a tendency for some of them to also display liver and lung pathology and diverse cancers co-occurring with some MND/NDD cases. Targeted research is recommended to investigate this proposal.
C1 [Molyneux, Russell J.] Univ Hawaii Hilo, Daniel K Inouye Coll Pharm, Hilo, HI 96720 USA.
   [Colegate, Steven M.] ARS USDA, Poisonous Plant Res Lab, Logan, UT 84341 USA.
   [Edgar, John A.] CSIRO Agr & Food, N Ryde, NSW 2113, Australia.
C3 University of Hawaii System; University Hawaii Hilo; United States Department of Agriculture (USDA); Commonwealth Scientific & Industrial Research Organisation (CSIRO)
RP Edgar, JA (corresponding author), CSIRO Agr & Food, N Ryde, NSW 2113, Australia.
EM john.a.edgar@hotmail.com
CR Abass K, 2012, TOXICOLOGY, V294, P17, DOI 10.1016/j.tox.2012.01.010
   Acevedo K, 2019, J BIOL INORG CHEM, V24, P1141, DOI 10.1007/s00775-019-01731-9
   Agarwal AN, 2019, ARCH PATHOL LAB MED, V143, P1256, DOI 10.5858/arpa.2018-0455-OA
   Ahuja A, 2015, J TRACE ELEM MED BIO, V29, P11, DOI 10.1016/j.jtemb.2014.05.003
   AI-Chalabi A, 2014, LANCET NEUROL, V13, P1108, DOI 10.1016/S1474-4422(14)70219-4
   Akan O, 2021, ACTA NEUROL BELG, V121, P1123, DOI 10.1007/s13760-020-01337-y
   ALLEN JR, 1972, EXP MOL PATHOL, V17, P220, DOI 10.1016/0014-4800(72)90071-8
   ALLEN JR, 1975, CANCER RES, V35, P997
   Allgaier C, 2015, REGUL TOXICOL PHARM, V73, P494, DOI 10.1016/j.yrtph.2015.09.024
   Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150
   [Anonymous], 2011, EFSA J, V9, P0, DOI 10.2903/j.efsa.2011.2406
   [Anonymous], 1957, AUST VET J, V0, P0
   [Anonymous], 1988, PYRROLIZIDINE ALKALOIDS. ENVIRONMENTAL HEALTH CRITERIA 80, V0, P0
   Armon C, 2018, J NEUROL SCI, V391, P134, DOI 10.1016/j.jns.2018.05.016
   Babu GN, 2008, NEUROCHEM INT, V52, P1284, DOI 10.1016/j.neuint.2008.01.009
   Bjorklund G, 2021, NEUROSCI BIOBEHAV R, V120, P470, DOI 10.1016/j.neubiorev.2020.10.004
   Boppré M, 2005, J AGR FOOD CHEM, V53, P594, DOI 10.1021/jf0484531
   Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660
   BRAIN, 1965, BRAIN, V88, P479, DOI 10.1093/brain/88.3.479
   Brasil AA, 2013, FEMS YEAST RES, V13, P433, DOI 10.1111/1567-1364.12045
   Braun AT, 2018, CLIN CHEST MED, V39, P391, DOI 10.1016/j.ccm.2018.01.003
   Bull LB, 1968, THE PYRROLIZIDINE ALKALOIDS, V0, P0
   BURNS J, 1972, J PATHOL, V106, P187, DOI 10.1002/path.1711060306
   BUTLER WH, 1970, J PATHOL, V100, P169, DOI 10.1002/path.1711000305
   Cantó-Santos J, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9100964
   Carrì MT, 2015, FRONT CELL NEUROSCI, V9, P0, DOI 10.3389/fncel.2015.00041
   Caudle WM, 2012, NEUROTOXICOLOGY, V33, P178, DOI 10.1016/j.neuro.2012.01.010
   Chen T, 2010, J APPL TOXICOL, V30, P183, DOI 10.1002/jat.1504
   Chen Y, 2020, TOXICOL LETT, V323, P41, DOI 10.1016/j.toxlet.2020.01.021
   CHESNEY CF, 1973, CARDIOVASC RES, V7, P508, DOI 10.1093/cvr/7.4.508
   CHESNEY CF, 1973, AM J PATHOL, V70, P489
   Chi L, 2007, NEUROSCIENCE, V144, P991, DOI 10.1016/j.neuroscience.2006.09.064
   Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005
   Ciecko-Michalska I, 2012, GASTROENT RES PRACT, V2012, P0, DOI 10.1155/2012/642108
   CIRIOLO MR, 1990, J BIOL CHEM, V265, P11030
   Cooper RA, 1996, TOXICON, V34, P604, DOI 10.1016/0041-0101(95)00169-7
   Corcia P, 2015, AMYOTROPH LAT SCL FR, V16, P252, DOI 10.3109/21678421.2014.965178
   Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469
   Dau SL, 2019, ACTA SCI VET, V47, P0, DOI 10.22456/1679-9216.91989
   DeLeve LD, 2003, GASTROENTEROLOGY, V125, P882, DOI 10.1016/S0016-5085(03)01056-4
   DeLeve LD, 2003, AM J PHYSIOL-GASTR L, V284, PG1045, DOI 10.1152/ajpgi.00526.2002
   DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204
   Santa-Cruz LD, 2016, ACS CHEM NEUROSCI, V7, P886, DOI 10.1021/acschemneuro.6b00032
   dos Santos AB, 2009, TOXICON, V54, P16, DOI 10.1016/j.toxicon.2009.03.004
   Dumitrascu R, 2011, EUR RESPIR J, V37, P1104, DOI 10.1183/09031936.00126010
   Dunlop RA, 2019, NEUROTOX RES, V36, P602, DOI 10.1007/s12640-019-00089-9
   Dunlop RA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075376
   Dutheil F, 2008, BIOCHIMIE, V90, P426, DOI 10.1016/j.biochi.2007.10.007
   Dutheil F, 2010, EXPERT OPIN DRUG MET, V6, P1161, DOI 10.1517/17425255.2010.510832
   Edgar JA, 2011, FOOD ADDIT CONTAM A, V28, P308, DOI 10.1080/19440049.2010.547520
   Edgar JA, 2015, CHEM RES TOXICOL, V28, P4, DOI 10.1021/tx500403t
   EFSA, 2016, EFSA J, V14, P0, DOI 10.2903/j.efsa.2016.4572
   Ferguson CS, 2011, TRENDS PHARMACOL SCI, V32, P708, DOI 10.1016/j.tips.2011.08.005
   Filipi T, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9010261
   FISHMAN AP, 1974, CIRC RES, V35, P657, DOI 10.1161/01.RES.35.5.657
   FISMAN M, 1987, ARCH NEUROL-CHICAGO, V44, P997, DOI 10.1001/archneur.1987.00520220007005
   Forsyth PA, 1997, ANN NEUROL, V41, P722, DOI 10.1002/ana.410410608
   Freedman DM, 2013, CANCER CAUSE CONTROL, V24, P55, DOI 10.1007/s10552-012-0089-5
   Fu PP, 2004, DRUG METAB REV, V36, P1, DOI 10.1081/DMR-120028426
   Furukawa Y, 2020, TRANSL NEURODEGENER, V9, P0, DOI 10.1186/s40035-020-00209-y
   Gao AF, 2017, INT J PATHOL CLIN RE, V3, P0
   Gao H, 2012, J DIGEST DIS, V13, P33, DOI 10.1111/j.1751-2980.2011.00552.x
   Garbuzova-Davis S, 2020, CELL TRANSPLANT, V29, P0, DOI 10.1177/0963689720913494
   García ML, 2013, J NEUROL SCI, V330, P18, DOI 10.1016/j.jns.2013.03.019
   Ghasemi M, 2018, CSH PERSPECT MED, V8, P0, DOI 10.1101/cshperspect.a024125
   Ghosh C, 2016, DRUG DISCOV TODAY, V21, P1609, DOI 10.1016/j.drudis.2016.06.004
   Giampietro R, 2018, MOL PHARMACEUT, V15, P808, DOI 10.1021/acs.molpharmaceut.7b00841
   Gil-Bea FJ, 2017, EXPERT REV MOL MED, V19, P0, DOI 10.1017/erm.2017.9
   Golden TR, 2009, ANTIOXID REDOX SIGN, V11, P555, DOI 10.1089/ars.2008.2256
   Goodfellow J, 2019, NEUROL SCI, V40, P1461, DOI 10.1007/s10072-019-03784-9
   Gromadzka G, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21239259
   GUBBAY SS, 1985, J NEUROL, V232, P295, DOI 10.1007/BF00313868
   Günthardt BF, 2021, ENVIRON SCI TECHNOL, V55, P1036, DOI 10.1021/acs.est.0c06411
   Guo LY, 2019, DRUG DES DEV THER, V13, P2799, DOI 10.2147/DDDT.S213817
   Hadjihambi A, 2018, HEPATOL INT, V12, PS135, DOI 10.1007/s12072-017-9812-3
   Hama JR, 2021, SCI TOTAL ENVIRON, V755, P0, DOI 10.1016/j.scitotenv.2020.142822
   Hanumegowda UM, 2003, TOXICOL SCI, V76, P237, DOI 10.1093/toxsci/kfg222
   Hartmann T, 1995, ALKALOIDS: CHEMICAL AND BIOLOGICAL PERSPECTIVES, V0, P155
   Harwood CA, 2016, AMYOTROPH LAT SCL FR, V17, P377, DOI 10.3109/21678421.2016.1154575
   Harwood CA, 2009, AMYOTROPH LATERAL SC, V10, P191, DOI 10.1080/17482960802549739
   He YS, 2021, ARCH TOXICOL, V95, P103, DOI 10.1007/s00204-020-02921-0
   HEATH D, 1975, THORAX, V30, P399, DOI 10.1136/thx.30.4.399
   Henden L, 2020, NPJ GENOM MED, V5, P0, DOI 10.1038/s41525-020-00139-8
   Houssaini A, 2013, AM J RESP CELL MOL, V48, P568, DOI 10.1165/rcmb.2012-0429OC
   HSU IC, 1975, RES COMMUN CHEM PATH, V11, P99
   HSU IC, 1976, CHEM-BIOL INTERACT, V12, P19, DOI 10.1016/0009-2797(76)90063-6
   Huxtable RJ, 1999, NATURAL SELECTED SYN, V0, P100
   Huxtable RJ, 1996, NEUROCHEM RES, V21, P141, DOI 10.1007/BF02529131
   Ingre C, 2015, CLIN EPIDEMIOL, V7, P181, DOI 10.2147/CLEP.S37505
   Ismailov NI, 1970, KLIN DIAGNOSTIKA LEC, V0, P85
   Jayakumar AR, 2018, J CLIN EXP HEPATOL, V8, P272, DOI 10.1016/j.jceh.2018.06.007
   Ji LL, 2010, HUM EXP TOXICOL, V29, P303, DOI 10.1177/0960327110361757
   Jiang Z, 2015, TRANSL NEURODEGENER, V4, P0, DOI 10.1186/s40035-015-0037-x
   Kakar F, 2010, J TOXICOL-US, V2010, P0, DOI 10.1155/2010/313280
   KAY JM, 1966, J PATHOL BACTERIOL, V92, P385, DOI 10.1002/path.1700920216
   KAY JM, 1967, THORAX, V22, P176, DOI 10.1136/thx.22.2.176
   Killoy KM, 2018, EXP NEUROL, V302, P129, DOI 10.1016/j.expneurol.2018.01.004
   Kisielius V, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-76586-1
   Knottenbelt DC, 1996, EQUINE VETERINARY EDUCATION, V8, P196, DOI 10.1111/j.2042-3292.1996.tb01701.x
   Kok JR, 2021, CELL MOL LIFE SCI, V78, P5707, DOI 10.1007/s00018-021-03872-0
   Kreuzer M, 2020, J BIOPHOTONICS, V13, P0, DOI 10.1002/jbio.202000069
   Lagrange E, 2021, J NEUROL SCI, V427, P0, DOI 10.1016/j.jns.2021.117558
   Le Gall L, 2020, J PERS MED, V10, P0, DOI 10.3390/jpm10030101
   Leal PV, 2019, ACTA SCI VET, V47, P0, DOI 10.22456/1679-9216.89439
   Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997
   Lee SH, 2018, NEURODEGENER DIS, V18, P200, DOI 10.1159/000491392
   Leong ZP, 2019, VASC PHARMACOL, V122, P0, DOI 10.1016/j.vph.2019.106599
   Liu D, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0080779
   Logroscino G, 2018, LANCET NEUROL, V17, P1083, DOI 10.1016/S1474-4422(18)30404-6
   Lohse JC, 2018, AUSTRAL J VET SCI, V50, P107, DOI 10.4067/S0719-81322018000200107
   Longinetti E, 2019, CURR OPIN NEUROL, V32, P771, DOI 10.1097/WCO.0000000000000730
   Lu Y, 2018, ARCH TOXICOL, V92, P3403, DOI 10.1007/s00204-018-2309-6
   Lu Y, 2014, J NEUROL SCI, V343, P15, DOI 10.1016/j.jns.2014.05.033
   Ma J, 2021, ARCH TOXICOL, V95, P759, DOI 10.1007/s00204-020-02947-4
   Manjaly ZR, 2010, AMYOTROPH LATERAL SC, V11, P439, DOI 10.3109/17482961003610853
   Mann A, 2008, NEUROPHARMACOLOGY, V55, P1147, DOI 10.1016/j.neuropharm.2008.07.017
   Marangi G, 2015, BRAIN RES, V1607, P75, DOI 10.1016/j.brainres.2014.10.009
   Maryon EB, 2013, AM J PHYSIOL-CELL PH, V304, PC768, DOI 10.1152/ajpcell.00417.2012
   MASUI Y, 1985, J NEUROL, V232, P15, DOI 10.1007/BF00314034
   MATTOCKS AR, 1973, CHEM-BIOL INTERACT, V6, P297, DOI 10.1016/0009-2797(73)90044-6
   Mattocks AR, 1986, CHEM TOXICOLOGY PYRR, V0, P0
   McCombe PA, 2010, GENDER MED, V7, P557, DOI 10.1016/j.genm.2010.11.010
   Mejzini R, 2019, FRONT NEUROSCI-SWITZ, V13, P0, DOI 10.3389/fnins.2019.01310
   Mellick GD, 2006, J NEURAL TRANSM-SUPP, V0, P159
   Miksys S, 2003, NEUROPHARMACOLOGY, V45, P122, DOI 10.1016/S0028-3908(03)00136-9
   Miksys S, 2002, J NEUROCHEM, V82, P1376, DOI 10.1046/j.1471-4159.2002.01069.x
   Mitchell JD, 1998, J NEUROL NEUROSUR PS, V65, P842, DOI 10.1136/jnnp.65.6.842
   Mohajer A, 2019, COMPARATIVE CLINICAL PATHOLOGY, V28, P397, DOI 10.1007/s00580-019-02913-2
   Mora JS, 2020, AMYOTROPH LAT SCL FR, V21, P5, DOI 10.1080/21678421.2019.1632346
   Moreira R, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19061668
   Nakamura K, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20235885
   NAKANO Y, 1987, ARCH NEUROL-CHICAGO, V44, P103, DOI 10.1001/archneur.1987.00520130079022
   Nascimento RP, 2017, TOXICON, V134, P41, DOI 10.1016/j.toxicon.2017.04.005
   Navarro-Mabarak C, 2018, DRUG METAB REV, V50, P95, DOI 10.1080/03602532.2018.1439502
   Ninan J, 2017, J HOSP MED, V12, P659, DOI 10.12788/jhm.2794
   Nobre VMD, 2004, PESQUI VET BRASIL, V24, P132, DOI 10.1590/S0100-736X2004000300004
   Nowicka N, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20112616
   OCallaghan A, 2018, J PARKINSONISM RESTL, V8, P13, DOI 10.2147/JPRLS.S114309
   OBENOUR WH, 1972, AM REV RESPIR DIS, V105, P382
   Obrador E, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9090901
   PAN LC, 1993, TOXICOL APPL PHARM, V118, P87, DOI 10.1006/taap.1993.1013
   Pan-Montojo F, 2014, TRANSL NEURODEGENER, V3, P0, DOI 10.1186/2047-9158-3-10
   Pansarasa O, 2014, MOL NEUROBIOL, V49, P984, DOI 10.1007/s12035-013-8578-4
   Panziera W, 2017, PESQUI VET BRASIL, V37, P313, DOI 10.1590/S0100-736X2017000400003
   Paré B, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-31773-z
   Patten SA, 2014, DIS MODEL MECH, V7, P799, DOI 10.1242/dmm.015719
   PEARSON EG, 1991, J AM VET MED ASSOC, V198, P1651
   Pehar M, 2016, MOL CELL PROTEOMICS, V15, P493, DOI 10.1074/mcp.M115.049288
   Peng B, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21072316
   Peters S, 2020, J NEUROL NEUROSUR PS, V91, P33, DOI 10.1136/jnnp-2019-320986
   Peters TL, 2017, OCCUP ENVIRON MED, V74, P87, DOI 10.1136/oemed-2016-103700
   Picron JF, 2021, FOOD ADDIT CONTAM A, V38, P962, DOI 10.1080/19440049.2021.1889043
   Pitanga BPS, 2011, NEUROTOXICOLOGY, V32, P776, DOI 10.1016/j.neuro.2011.07.002
   Pokusa M, 2020, PHYSIOL RES, V69, PS69, DOI 10.33549/physiolres.934405
   Polkey MI, 2017, AM J RESP CRIT CARE, V195, P86, DOI 10.1164/rccm.201604-0848OC
   Prakash AS, 1999, MUTAT RES-GEN TOX EN, V443, P53, DOI 10.1016/S1383-5742(99)00010-1
   Rakhit R, 2006, BBA-MOL BASIS DIS, V1762, P1025, DOI 10.1016/j.bbadis.2006.05.004
   Ramachandran Anup, 2018, J CLIN TRANSL RES, V4, P75
   Rasenack R, 2003, FETAL DIAGN THER, V18, P223, DOI 10.1159/000070799
   Ravindranath V, 2013, EXPERT OPIN DRUG MET, V9, P551, DOI 10.1517/17425255.2013.759208
   Honorio JER, 2012, OXID MED CELL LONGEV, V2012, P0, DOI 10.1155/2012/697541
   Rickman OJ, 2020, BRAIN, V143, P1073, DOI 10.1093/brain/awz382
   RIDKER PM, 1985, GASTROENTEROLOGY, V88, P1050, DOI 10.1016/S0016-5085(85)80027-5
   Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430
   Rollason V, 2016, EUR J CLIN PHARMACOL, V72, P507, DOI 10.1007/s00228-015-1986-9
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, P0, DOI 10.3389/fncel.2013.00253
   Sabate M, 1996, J NEUROL SCI, V138, P114, DOI 10.1016/0022-510X(96)00003-2
   Salehi B, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.01300
   Sauzéat L, 2018, ISCIENCE, V6, P264, DOI 10.1016/j.isci.2018.07.023
   SCHOENTAL R, 1975, CANCER RES, V35, P2020
   Pitanga BPS, 2012, FRONT PHARMACOL, V3, P0, DOI 10.3389/fphar.2012.00144
   Segura-Ibarra V, 2017, INT J PHARMACEUT, V524, P257, DOI 10.1016/j.ijpharm.2017.03.069
   Selmar D, 2019, ENVIRON POLLUT, V248, P456, DOI 10.1016/j.envpol.2019.02.026
   Shao O, 2021, MOL MED REP, V23, P0, DOI 10.3892/mmr.2021.11977
   SHUMAKER RC, 1976, JNCI-J NATL CANCER I, V56, P787, DOI 10.1093/jnci/56.4.787
   Silva-Neto JP, 2010, TOXICON, V55, P105, DOI 10.1016/j.toxicon.2009.07.007
   Siracusa R, 2019, FRONT PHARMACOL, V10, P0, DOI 10.3389/fphar.2019.01114
   Skopp A, 2019, BIOMETALS, V32, P695, DOI 10.1007/s10534-019-00206-3
   Smith EF, 2019, NEUROSCI LETT, V710, P0, DOI 10.1016/j.neulet.2017.06.052
   SMITH LW, 1981, J NAT PROD, V44, P129, DOI 10.1021/np50014a001
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Song ZH, 2018, J CHIN MED ASSOC, V81, P1077, DOI 10.1016/j.jcma.2018.03.013
   Song ZJ, 2020, J ENV SCI HEAL C-TOX, V38, P124, DOI 10.1080/26896583.2020.1743608
   Soo SK, 2020, MECH AGEING DEV, V190, P0, DOI 10.1016/j.mad.2020.111297
   Spencer PS, 2021, CHEM RES TOXICOL, V34, P1953, DOI 10.1021/acs.chemrestox.1c00150
   Spencer PS, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00754
   Spencer PS, 2018, TOXICON, V155, P49, DOI 10.1016/j.toxicon.2018.10.005
   Spencer PS, 2018, J NEUROL SCI, V391, P141, DOI 10.1016/j.jns.2018.05.017
   STILLMAN AE, 1977, GASTROENTEROLOGY, V73, P349
   SVOBODA DJ, 1972, CANCER RES, V32, P908
   SWICK RA, 1982, J TOXICOL ENV HEALTH, V10, P757, DOI 10.1080/15287398209530293
   Swinnen B, 2014, NAT REV NEUROL, V10, P661, DOI 10.1038/nrneurol.2014.184
   Taguchi YH, 2017, GENES-BASEL, V8, P0, DOI 10.3390/genes8100243
   Tang BL, 2020, TOXICS, V8, P0, DOI 10.3390/toxics8020021
   Tokuda E, 2013, NEUROBIOL DIS, V54, P308, DOI 10.1016/j.nbd.2013.01.001
   Tokuda E, 2009, J NEUROCHEM, V111, P181, DOI 10.1111/j.1471-4159.2009.06310.x
   Trias Emiliano, 2018, CLIN EXP NEUROIMMUNOL, V9, P225, DOI 10.1111/cen3.12476
   Trinh D, 2021, J NEUROCHEM, V156, P715, DOI 10.1111/jnc.15154
   Trist BG, 2021, ANGEW CHEM INT EDIT, V60, P9215, DOI 10.1002/anie.202000451
   Trist BG, 2018, CELL CHEM BIOL, V25, P807, DOI 10.1016/j.chembiol.2018.05.004
   VALK J, 1992, AM J NEURORADIOL, V13, P747
   Vargas MR, 2011, NEUROBIOL DIS, V43, P543, DOI 10.1016/j.nbd.2011.04.025
   Vigliani MC, 2000, J NEUROL, V247, P778, DOI 10.1007/s004150070092
   VINCKEN WG, 1984, NEW ENGL J MED, V311, P438, DOI 10.1056/NEJM198408163110704
   Violi F, 2020, METALLOMICS, V12, P668, DOI 10.1039/d0mt00051e
   Visser AE, 2018, J NEUROL NEUROSUR PS, V89, P797, DOI 10.1136/jnnp-2017-317724
   Wang H, 2011, ARCH NEUROL-CHICAGO, V68, P207, DOI 10.1001/archneurol.2010.367
   Wang WQ, 2020, J APPL TOXICOL, V40, P1534, DOI 10.1002/jat.4004
   Wang XD, 2000, HEPATOLOGY, V31, P428, DOI 10.1002/hep.510310224
   Watkins J, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-76070-w
   Wiedenfeld H, 2011, FOOD ADDIT CONTAM A, V28, P282, DOI 10.1080/19440049.2010.541288
   Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, P0, DOI 10.1186/1750-1172-4-3
   Xia QS, 2020, J FOOD DRUG ANAL, V28, P167, DOI 10.1016/j.jfda.2019.12.001
   Xia QS, 2015, CHEM RES TOXICOL, V28, P615, DOI 10.1021/tx500417q
   Xia QS, 2013, CHEM RES TOXICOL, V26, P1384, DOI 10.1021/tx400241c
   Xiong AZ, 2016, PHYTOMEDICINE, V23, P931, DOI 10.1016/j.phymed.2016.06.006
   Xue YC, 2018, FRONT MOL NEUROSCI, V11, P0, DOI 10.3389/fnmol.2018.00063
   Yang XQ, 2019, WORLD J GASTROENTERO, V25, P3753, DOI 10.3748/wjg.v25.i28.3753
   Yoshida T, 2020, EXP THER MED, V20, P0, DOI 10.3892/etm.2020.9278
   Yu XH, 2020, ANN NEUROL, V88, P195, DOI 10.1002/ana.25721
   Zhan YQ, 2019, ANN NEUROL, V85, P482, DOI 10.1002/ana.25443
   Zhang CF, 2019, J CELL PHYSIOL, V234, P16755, DOI 10.1002/jcp.28531
   Zhang JL, 2019, EUR J PHARMACOL, V858, P0, DOI 10.1016/j.ejphar.2019.172500
NR 225
TC 0
Z9 0
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD MAR 21
PY 2022
VL 35
IS 3
BP 340
EP 354
DI 10.1021/acs.chemrestox.1c00384
PG 15
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA 0O9IM
UT WOS:000783836900001
PM 35238548
DA 2024-11-01
ER

PT J
AU Ertuglu, L
   Yildiz, A
   Gamboa, J
   Ikizler, TA
AF Ertuglu, Lale
   Yildiz, Abdulmecit
   Gamboa, Jorge
   Ikizler, T. Alp
TI Skeletal muscle energetics in patients with moderate to advanced kidney disease
SO KIDNEY RESEARCH AND CLINICAL PRACTICE
LA English
DT Review
DE Chronic renal insufficiency; Mitochondria; Muscles; Sarcopenia
ID mitochondrial-function; oxidative capacity; tnf-alpha; exercise; protein; injury; damage
AB Sarcopenia, defined as decrease in muscle function and mass, is common in patients with moderate to advanced chronic kidney disease (CKD) and is associated with poor clinical outcomes. Muscle mitochondrial dysfunction is proposed as one of the mechanisms underlying sarcopenia. Patients with moderate to advanced CKD have decreased muscle mitochondrial content and oxidative capacity along with suppressed activity of various mitochondrial enzymes such as mitochondrial electron transport chain complexes and pyruvate dehydrogenase, leading to impaired energy production. Other mitochondrial abnormalities found in this population include defective beta-oxidation of fatty acids and mitochondrial DNA mutations. These changes are noticeable from the early stages of CKD and correlate with severity of the disease. Damage induced by uremic toxins, oxidative stress, and systemic inflammation has been implicated in the development of mitochondrial dysfunction in CKD patients. Given that mitochondrial function is an important determinant of physical activity and performance, its modulation is a potential therapeutic target for sarcopenia in patients with kidney disease. Coenzyme Q, nicotinamide, and cardiolipin-targeted peptides have been tested as therapeutic interventions in early studies. Aerobic exercise, a well-established strategy to improve muscle function and mass in healthy adults, is not as effective in patients with advanced kidney disease. This might be due to reduced expression or impaired activation of peroxisome proliferator-activated receptor-gamma coactivator 1 alpha, the master regulator of mitochondrial biogenesis. Further studies are needed to broaden our understanding of the pathogenesis of mitochondrial dysfunction and to develop mitochondrial-targeted therapies for prevention and treatment of sarcopenia in patients with CKD.
C1 [Ertuglu, Lale; Ikizler, T. Alp] Vanderbilt Univ, Dept Med, Div Nephrol & Hypertens, Med Ctr, Nashville, TN 37232 USA.
   [Yildiz, Abdulmecit] Uludag Univ, Dept Med, Div Nephrol, Bursa, Turkey.
   [Gamboa, Jorge] Vanderbilt Univ, Dept Med, Div Clin Pharmacol, Med Ctr, Nashville, TN 37232 USA.
   [Ikizler, T. Alp] Vanderbilt Univ, Vanderbilt Ctr Kidney Dis, Med Ctr, Nashville, TN 37232 USA.
   [Ikizler, T. Alp] Tennessee Valley Healthcare Syst, Vet Hlth Affairs, Nashville, TN USA.
C3 Vanderbilt University; Uludag University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System
RP Ikizler, TA (corresponding author), Vanderbilt Univ, Div Nephrol, Med Ctr, 1161 21st Ave South,S-3223 Med Ctr North, Nashville, TN 37232 USA.
EM alp.ikizler@vanderbilt.edu
CR Adey D, 2000, AM J PHYSIOL-ENDOC M, V278, PE219, DOI 10.1152/ajpendo.2000.278.2.E219
   Amara CE, 2008, METHODS, V46, P312, DOI 10.1016/j.ymeth.2008.10.001
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Bakhshayeshkaram M, 2018, CURR PHARM DESIGN, V24, P3710, DOI 10.2174/1381612824666181112112857
   Ben-Shoshan J, 2012, J CLIN EXPT CARDIOL, V3, P184
   Bigelman E, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0198196
   Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Campbell MD, 2019, FREE RADICAL BIO MED, V134, P268, DOI 10.1016/j.freeradbiomed.2018.12.031
   Cantarin MPM, 2017, NEPHROL DIAL TRANSPL, V32, P943, DOI 10.1093/ndt/gfx050
   Chen L, 2020, BRIT J OPHTHALMOL, V104, P748, DOI 10.1136/bjophthalmol-2020-316304
   Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049
   Daenen K, 2019, PEDIATR NEPHROL, V34, P975, DOI 10.1007/s00467-018-4005-4
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a
   Eirin A, 2016, J AM HEART ASSOC, V5, P0, DOI 10.1161/JAHA.115.003118
   Fazakerley DJ, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.32111
   Gamboa JL, 2020, CLIN J AM SOC NEPHRO, V15, P926, DOI 10.2215/CJN.10320819
   Gamboa JL, 2016, PHYSIOL REP, V4, P0, DOI 10.14814/phy2.12780
   Garone C, 2018, BIOCHEM SOC T, V46, P1247, DOI 10.1042/BST20180134
   Groennebaek T, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00713
   Miranda-Díaz AG, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/3836186
   Kaltsatou A, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00102
   Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762
   Kestenbaum B, 2020, JCI INSIGHT, V5, P0, DOI 10.1172/jci.insight.133289
   Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083
   Lewis MI, 2012, J APPL PHYSIOL, V112, P72, DOI 10.1152/japplphysiol.00556.2011
   Lim PS, 2002, J BIOMED SCI, V9, P549, DOI 10.1159/000064728
   Liu SY, 2014, AM J PHYSIOL-RENAL, V306, PF970, DOI 10.1152/ajprenal.00697.2013
   Mayrhofer C, 2009, AM J PATHOL, V174, P1191, DOI 10.2353/ajpath.2009.080654
   Mazumder MK, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-018-37935-3
   Migliavacca E, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-13694-1
   Min K, 2011, J APPL PHYSIOL, V111, P1459, DOI 10.1152/japplphysiol.00591.2011
   Murray AM, 2008, ADV CHRONIC KIDNEY D, V15, P123, DOI 10.1053/j.ackd.2008.01.010
   Nosadini R, 2011, NUTR METAB CARDIOVAS, V21, P79, DOI 10.1016/j.numecd.2010.10.002
   Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007
   Patel HJ, 2017, LIFE SCI, V170, P56, DOI 10.1016/j.lfs.2016.11.033
   Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031
   Roshanravan B, 2018, JCI INSIGHT, V3, P0, DOI 10.1172/jci.insight.122219
   Roshanravan B, 2016, AM J KIDNEY DIS, V68, P658, DOI 10.1053/j.ajkd.2016.05.011
   Schijvens AM, 2020, KIDNEY INT REP, V5, P2146, DOI 10.1016/j.ekir.2020.09.044
   Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412
   Shah VO, 2009, GENET MED, V11, P147, DOI 10.1097/GIM.0b013e31819307a2
   Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102
   Sietsema KE, 2004, KIDNEY INT, V65, P719, DOI 10.1111/j.1523-1755.2004.00411.x
   Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x
   Sun CY, 2017, ONCOTARGET, V8, P77722, DOI 10.18632/oncotarget.20773
   Szeto HH, 2017, J AM SOC NEPHROL, V28, P2856, DOI 10.1681/ASN.2017030247
   Tamaki M, 2014, KIDNEY INT, V85, P1330, DOI 10.1038/ki.2013.473
   Thome T, 2019, AM J PHYSIOL-CELL PH, V317, PC701, DOI 10.1152/ajpcell.00098.2019
   Watson EL, 2020, FASEB J, V34, P1755, DOI 10.1096/fj.201901936RR
   Webb M, 2019, BIOORG MED CHEM LETT, V29, P1270, DOI 10.1016/j.bmcl.2019.03.041
   Webster JM, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.597675
   Zhang YY, 2019, EUR J CLIN NUTR, V73, P950, DOI 10.1038/s41430-018-0381-x
NR 54
TC 7
Z9 7
U1 1
U2 2
PU KOREAN SOC NEPHROLOGY
PI SEOCHO-GU
PA 1401 HYUNDAI KIRIM BLDG, 1330-18 SEOCHO 2-DONG, SEOCHO-GU, SEOUL 137-858, SOUTH KOREA
SN 2211-9132
EI 2211-9140
J9 KIDNEY RES CLIN PRAC
JI Kidney Res. Clin. Pract.
PD JAN 15
PY 2022
VL 41
IS 1
BP 14
EP 21
DI 10.23876/j.krcp.21.175
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA ZR8KV
UT WOS:000768027600003
PM 35108768
DA 2024-11-01
ER

PT J
AU Yin, YY
   Shen, HT
AF Yin, Yiyuan
   Shen, Haitao
TI Common methods in mitochondrial research (Review)
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Review
DE mitochondria; mitochondrial morphology; mitochondrial dysfunction; mitochondrial DNA; mitochondrial diseases
ID respiratory-chain supercomplexes; sayre syndrome still; oxygen-consumption; atomic-force; alzheimers-disease; high-resolution; peptide ss31; biallelic variants; arrhythmic risk; redox imbalance
AB Mitochondrial abnormalities are primarily seen in morphology, structure and function. They can cause damage to organs, including the heart, brain and muscle, by various mechanisms, such as oxidative stress, abnormal energy metabolism, or genetic mutations. Identifying and detecting pathophysiological alterations in mitochondria is the principal means of studying mitochondrial abnormalities. The present study reviewed methods in mitochondrial research and focused on three aspects: Mitochondrial extraction and purification, morphology and structure and function. In addition to classical methods, such as electron microscopy and mitochondrial membrane potential monitoring, newly developed methods, such as mitochondrial ultrastructural determination, mtDNA mutation assays, metabolomics and analyses of regulatory mechanisms, have also been utilized in recent years. These approaches enable the accurate detection of mitochondrial abnormalities and provide guidance for the diagnosis and treatment of related diseases.
C1 [Yin, Yiyuan; Shen, Haitao] Shengjing Hosp China Med Univ, Dept Emergency Med, Shenyang 110004, Liaoning, Peoples R China.
   [Shen, Haitao] China Med Univ, Shengjing Hosp, Dept Emergency Med, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China.
C3 China Medical University
RP Shen, HT (corresponding author), China Med Univ, Shengjing Hosp, Dept Emergency Med, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China.
EM shenht@sj-hospital.org
FU Foundation of Liaoning Education Department
CR Acetoze G, 2018, J ANIM PHYSIOL AN N, V102, PE787, DOI 10.1111/jpn.12836
   Adam N, 2021, AGEING RES REV, V68, P0, DOI 10.1016/j.arr.2021.101320
   Akbari M, 2019, AGEING RES REV, V54, P0, DOI 10.1016/j.arr.2019.100940
   Alexander JF, 2021, THERANOSTICS, V11, P3109, DOI 10.7150/thno.53474
   Algieri C, 2021, ARCH BIOCHEM BIOPHYS, V712, P0, DOI 10.1016/j.abb.2021.109027
   Allouche J, 2021, CELL, V184, P4268, DOI 10.1016/j.cell.2021.06.022
   Alpert NM, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0190968
   Alyasin A, 2020, ANDROLOGIA, V52, P0, DOI 10.1111/and.13588
   Amore G, 2021, DRUGS, V81, P57, DOI 10.1007/s40265-020-01428-3
   Andersen JV, 2019, J NEUROSCI RES, V97, P961, DOI 10.1002/jnr.24371
   Andrieux P, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222111338
   Angelova PR, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10071021
   Angelova PR, 2021, MED RES REV, V41, P770, DOI 10.1002/med.21712
   Ansó E, 2017, NAT CELL BIOL, V19, P614, DOI 10.1038/ncb3529
   Aqawi M, 2021, FRONT MICROBIOL, V12, P0, DOI 10.3389/fmicb.2021.656471
   Arai S, 2018, ANGEW CHEM INT EDIT, V57, P10873, DOI 10.1002/anie.201804304
   Asfaram S, 2022, ACTA PARASITOL, V67, P842, DOI 10.1007/s11686-022-00528-2
   Ashton TM, 2018, CLIN CANCER RES, V24, P2482, DOI 10.1158/1078-0432.CCR-17-3070
   Asperti M, 2021, FREE RADICAL BIO MED, V169, P294, DOI 10.1016/j.freeradbiomed.2021.04.024
   Bagge EK, 2020, BMC BIOL, V18, P0, DOI 10.1186/s12915-020-00890-5
   Baines CP, 2018, CELL CALCIUM, V73, P121, DOI 10.1016/j.ceca.2018.05.003
   Ballarò R, 2021, CANCERS, V13, P0, DOI 10.3390/cancers13040850
   Balsa E, 2019, MOL CELL, V74, P877, DOI 10.1016/j.molcel.2019.03.031
   Banh RS, 2016, NAT CELL BIOL, V18, P803, DOI 10.1038/ncb3376
   Bartolák-Suki E, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-019-57301-1
   Bastian C, 2019, NEUROMOL MED, V21, P484, DOI 10.1007/s12017-019-08550-w
   Baumann K, 2019, NAT REV MOL CELL BIO, V20, P663, DOI 10.1038/s41580-019-0182-7
   Beamer E, 2019, BRAIN RES BULL, V151, P65, DOI 10.1016/j.brainresbull.2018.12.021
   Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107
   Bhatti JS, 2021, MITOCHONDRION, V58, P49, DOI 10.1016/j.mito.2021.02.007
   Bhatti JS, 2021, MOL NEUROBIOL, V58, P795, DOI 10.1007/s12035-020-02142-7
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bikas A, 2019, INT J ONCOL, V55, P7, DOI 10.3892/ijo.2019.4802
   Billingham LK, 2022, NAT IMMUNOL, V23, P692, DOI 10.1038/s41590-022-01185-3
   Bjorklund G, 2020, FREE RADICAL BIO MED, V160, P149, DOI 10.1016/j.freeradbiomed.2020.07.017
   Blanco FJ, 2018, NAT REV RHEUMATOL, V14, P327, DOI 10.1038/s41584-018-0001-0
   Blotto BL, 2021, CLADISTICS, V37, P36, DOI 10.1111/cla.12409
   Bock FJ, 2020, NAT REV MOL CELL BIO, V21, P85, DOI 10.1038/s41580-019-0173-8
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Bonora M, 2019, NAT REV CARDIOL, V16, P33, DOI 10.1038/s41569-018-0074-0
   Borsche M, 2020, BRAIN, V143, P3041, DOI 10.1093/brain/awaa246
   Boussardon Clement, 2022, METHODS MOL BIOL, V2363, P13, DOI 10.1007/978-1-0716-1653-6_2
   Boyman L, 2020, TRENDS MOL MED, V26, P21, DOI 10.1016/j.molmed.2019.10.007
   Bozi LHM, 2020, MOL ASPECTS MED, V71, P0, DOI 10.1016/j.mam.2019.100836
   Bravo-Sagua R, 2017, COMPR PHYSIOL, V7, P623, DOI 10.1002/cphy.c160013
   Briston T, 2019, TRENDS PHARMACOL SCI, V40, P50, DOI 10.1016/j.tips.2018.11.004
   Buckel W, 2004, CURR OPIN CHEM BIOL, V8, P462, DOI 10.1016/j.cbpa.2004.07.001
   Burke PJ, 2017, TRENDS CANCER, V3, P857, DOI 10.1016/j.trecan.2017.10.006
   Calvo-Rodriguez M, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-16074-2
   Campos JC, 2017, AUTOPHAGY, V13, P1304, DOI 10.1080/15548627.2017.1325062
   Cano M, 2021, AGING CELL, V20, P0, DOI 10.1111/acel.13444
   Cartuche L, 2019, MAR DRUGS, V17, P0, DOI 10.3390/md17100588
   Castellana S, 2021, NUCLEIC ACIDS RES, V49, PD1282, DOI 10.1093/nar/gkaa1032
   Chakrabarty RP, 2021, CELL STEM CELL, V28, P394, DOI 10.1016/j.stem.2021.02.011
   Chandhok G, 2018, BIOL REV, V93, P933, DOI 10.1111/brv.12378
   Chandra K, 2017, ACS OMEGA, V2, P4878, DOI 10.1021/acsomega.7b00871
   Chen BY, 2019, CLIN CHIM ACTA, V493, P14, DOI 10.1016/j.cca.2019.02.021
   Chen HG, 2021, CRIT REV BIOTECHNOL, V41, P16, DOI 10.1080/07388551.2020.1826403
   Chen JJ, 2021, OPHTHALMOLOGY, V128, P661, DOI 10.1016/j.ophtha.2021.01.023
   Chen JZ, 2022, J COLLOID INTERF SCI, V605, P263, DOI 10.1016/j.jcis.2021.07.080
   Chen M, 2020, ACS CHEM NEUROSCI, V11, P1283, DOI 10.1021/acschemneuro.0c00041
   Chen WW, 2017, NAT PROTOC, V12, P2215, DOI 10.1038/nprot.2017.104
   Chiang JL, 2020, AGEING RES REV, V63, P0, DOI 10.1016/j.arr.2020.101168
   Chinopoulos C, 2020, EXP NEUROL, V327, P0, DOI 10.1016/j.expneurol.2020.113218
   Chinopoulos C, 2018, NEUROCHEM INT, V117, P49, DOI 10.1016/j.neuint.2017.06.010
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Cho H, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165808
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   Cieluch A, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21082852
   Cogliati S, 2018, J MOL BIOL, V430, P4849, DOI 10.1016/j.jmb.2018.09.016
   Colaço HG, 2021, IMMUNITY, V54, P53, DOI 10.1016/j.immuni.2020.09.011
   Cornman RS, 2021, PEERJ, V9, P0, DOI 10.7717/peerj.10539
   Correia-Alvarez E, 2020, NICOTINE TOB RES, V22, PS4, DOI 10.1093/ntr/ntaa177
   Costa R, 2019, CELL REP, V28, P1949, DOI 10.1016/j.celrep.2019.07.050
   Country MW, 2021, J EXP BIOL, V224, P0, DOI 10.1242/jeb.242634
   Csordás G, 2018, TRENDS CELL BIOL, V28, P523, DOI 10.1016/j.tcb.2018.02.009
   Cui YX, 2021, ACTA BIOMATER, V131, P544, DOI 10.1016/j.actbio.2021.07.018
   Cui YT, 2021, MOL CELL BIOCHEM, V476, P493, DOI 10.1007/s11010-020-03926-0
   DAngelo R, 2020, J NEUROL, V267, P3702, DOI 10.1007/s00415-020-10051-x
   Dabravolski SA, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23031323
   Dalecká M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22157805
   Daniyal M, 2021, PHYTOTHER RES, V35, P3977, DOI 10.1002/ptr.7114
   Darr CR, 2016, THERIOGENOLOGY, V86, P1382, DOI 10.1016/j.theriogenology.2016.04.082
   Datki Z, 2021, ECOTOX ENVIRON SAFE, V208, P0, DOI 10.1016/j.ecoenv.2020.111666
   Davidson SM, 2021, CARDIOVASC RES, V117, P2161, DOI 10.1093/cvr/cvab200
   Del Monte F, 2021, EUROPACE, V23, P980, DOI 10.1093/europace/euab104
   Deng HF, 2021, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.624529
   Deng XH, 2020, INT J BIOL SCI, V16, P1403, DOI 10.7150/ijbs.41768
   Deng YY, 2020, SMALL, V16, P0, DOI 10.1002/smll.202001747
   Dennerlein S, 2017, TRENDS CELL BIOL, V27, P712, DOI 10.1016/j.tcb.2017.05.004
   Depaoli MR, 2018, CELL REP, V25, P501, DOI 10.1016/j.celrep.2018.09.027
   Di Mambro C, 2021, EUROPACE, V23, P981, DOI 10.1093/europace/euab105
   Di Nora C, 2019, TRANSPLANTATION, V103, PE393, DOI 10.1097/TP.0000000000002860
   Diebold LP, 2019, NAT METAB, V1, P158, DOI 10.1038/s42255-018-0011-x
   Ding XW, 2021, PHARMACOL RES, V171, P0, DOI 10.1016/j.phrs.2021.105783
   Dominkus PP, 2018, BBA-BIOMEMBRANES, V1860, P1350, DOI 10.1016/j.bbamem.2018.03.013
   Dorr BM, 2018, CURR OPIN CHEM BIOL, V43, P127, DOI 10.1016/j.cbpa.2018.01.008
   Dreier DA, 2019, J CHEM INF MODEL, V59, P702, DOI 10.1021/acs.jcim.8b00433
   Du RL, 2020, J PHARMACOL TOX MET, V101, P0, DOI 10.1016/j.vascn.2019.106664
   Dumitru AC, 2021, NANO LETT, V21, P4950, DOI 10.1021/acs.nanolett.1c00599
   Durand MJ, 2019, CARDIOVASC RES, V115, P1546, DOI 10.1093/cvr/cvy294
   Eagleson KL, 2020, NEUROBIOL STRESS, V13, P0, DOI 10.1016/j.ynstr.2020.100251
   Écija-Arenas A, 2021, TALANTA, V222, P0, DOI 10.1016/j.talanta.2020.121532
   El Manaa W, 2021, AUTOPHAGY, V17, P4363, DOI 10.1080/15548627.2021.1917129
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   Elekofehinti OO, 2019, J ETHNOPHARMACOL, V242, P0, DOI 10.1016/j.jep.2019.112026
   Elgamal S, 2021, JCI INSIGHT, V6, P0, DOI 10.1172/jci.insight.137937
   Emoto MC, 2021, FREE RADICAL BIO MED, V172, P9, DOI 10.1016/j.freeradbiomed.2021.05.035
   Erard M, 2018, AM J PHYSIOL-REG I, V314, PR667, DOI 10.1152/ajpregu.00140.2017
   Espinosa JA, 2021, CURR PROTOC, V1, P0, DOI 10.1002/cpz1.75
   Fan YX, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8091071
   Fang HB, 2019, ACS NANO, V13, P14426, DOI 10.1021/acsnano.9b08011
   Feng BD, 2019, ANAL CHEM, V91, P13962, DOI 10.1021/acs.analchem.9b03494
   Feng RQ, 2019, ANAL CHEM, V91, P3704, DOI 10.1021/acs.analchem.8b05822
   Fernandez-Vizarra E, 2021, FEBS LETT, V595, P1062, DOI 10.1002/1873-3468.13995
   Fernström J, 2021, TRANSL PSYCHIAT, V11, P0, DOI 10.1038/s41398-021-01723-x
   Fernström J, 2021, PLOS ONE, V16, P0, DOI 10.1371/journal.pone.0259591
   Finley D, 2020, CSH PERSPECT BIOL, V12, P0, DOI 10.1101/cshperspect.a033985
   Fisher JJ, 2021, J PHYSIOL-LONDON, V599, P1291, DOI 10.1113/JP280593
   Flones IH, 2020, ACTA NEUROPATHOL COM, V8, P0, DOI 10.1186/s40478-020-00915-8
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Formosa LE, 2018, SEMIN CELL DEV BIOL, V76, P154, DOI 10.1016/j.semcdb.2017.08.011
   Franco-Iborra S, 2021, AUTOPHAGY, V17, P672, DOI 10.1080/15548627.2020.1728096
   Fu Y, 2020, NEURO-ONCOLOGY, V22, P240, DOI 10.1093/neuonc/noz183
   Fuhrmann DC, 2017, REDOX BIOL, V12, P208, DOI 10.1016/j.redox.2017.02.012
   Gabandé-Rodríguez E, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9010082
   Gäbelein CG, 2022, PLOS BIOL, V20, P0, DOI 10.1371/journal.pbio.3001576
   Galla L, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22189945
   Galvan DL, 2017, KIDNEY INT, V92, P1051, DOI 10.1016/j.kint.2017.05.034
   Ganta KK, 2017, CELL BIOL TOXICOL, V33, P69, DOI 10.1007/s10565-016-9362-9
   Gao CH, 2020, ACTA BIOMATER, V108, P285, DOI 10.1016/j.actbio.2020.03.029
   Gao FL, 2019, ANAL CHEM, V91, P3336, DOI 10.1021/acs.analchem.8b04418
   Gao G, 2017, BIOMED PHARMACOTHER, V96, P1380, DOI 10.1016/j.biopha.2017.11.057
   Gao J, 2020, ADV MATER, V32, P0, DOI 10.1002/adma.201805798
   Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042
   Ge YQ, 2021, LANGMUIR, V37, P11657, DOI 10.1021/acs.langmuir.1c01376
   Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI 10.1038/nchembio.2287
   Ghosh P, 2018, J CELL PHYSIOL, V233, P1041, DOI 10.1002/jcp.25958
   Gloria A, 2018, ANIM REPROD SCI, V189, P51, DOI 10.1016/j.anireprosci.2017.12.007
   Gonçalves VF, 2021, J PSYCHIATR RES, V139, P25, DOI 10.1016/j.jpsychires.2021.05.015
   Gong Xiaodi, 2021, INT J NANOMEDICINE, V16, P6661, DOI 10.2147/IJN.S329341
   Gonzalez LF, 2021, PHARMACEUTICS, V13, P0, DOI 10.3390/pharmaceutics13122055
   Gotham JP, 2020, FREE RADICAL BIO MED, V154, P84, DOI 10.1016/j.freeradbiomed.2020.04.020
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y
   Grist TM, 2022, RADIOLOGY, V304, P289, DOI 10.1148/radiol.221183
   Grosser JA, 2021, BMC RES NOTES, V14, P0, DOI 10.1186/s13104-021-05613-9
   Grünewald A, 2019, PROG NEUROBIOL, V177, P73, DOI 10.1016/j.pneurobio.2018.09.003
   Gu X, 2021, STAR PROTOC, V2, P0, DOI 10.1016/j.xpro.2020.100245
   Gu XG, 2017, BIOMATERIALS, V146, P115, DOI 10.1016/j.biomaterials.2017.09.004
   Guntur AR, 2018, J BONE MINER RES, V33, P1052, DOI 10.1002/jbmr.3390
   Guo QL, 2021, EMERG MICROBES INFEC, V10, P19, DOI 10.1080/22221751.2020.1861913
   Guo RL, 2021, BIOMED OPT EXPRESS, V12, P1869, DOI 10.1364/BOE.419598
   Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050
   Haider SZ, 2021, EXP EYE RES, V202, P0, DOI 10.1016/j.exer.2020.108318
   Hamel Y, 2021, CELL REP MED, V2, P0, DOI 10.1016/j.xcrm.2021.100370
   Hamilton K, 2021, J CYST FIBROS, V20, P664, DOI 10.1016/j.jcf.2020.10.006
   Hammler D, 2018, CHEM-EUR J, V24, P15329, DOI 10.1002/chem.201803234
   Hammond K, 2021, BBA-BIOMEMBRANES, V1863, P0, DOI 10.1016/j.bbamem.2020.183447
   Hampl V, 2019, TRENDS MICROBIOL, V27, P96, DOI 10.1016/j.tim.2018.10.005
   Han Y, 2020, DRUG DELIV, V27, P502, DOI 10.1080/10717544.2020.1745328
   Hassani M, 2020, J LEUKOCYTE BIOL, V107, P809, DOI 10.1002/JLB.5HR0120-459R
   He AQ, 2020, PLAST RECONSTR SURG, V145, P712, DOI 10.1097/PRS.0000000000006607
   He CY, 2019, NANOMED-NANOTECHNOL, V15, P59, DOI 10.1016/j.nano.2018.09.003
   He GP, 2020, ACS APPL MATER INTER, V12, P48296, DOI 10.1021/acsami.0c12139
   He L, 2021, J HAZARD MATER, V417, P0, DOI 10.1016/j.jhazmat.2021.126113
   He Y, 2022, BIOMED RES INT, V2022, P0, DOI 10.1155/2022/6180349
   He Y, 2021, J BIOMED NANOTECHNOL, V17, P1679, DOI 10.1166/jbn.2021.3141
   He Y, 2021, BIOMED RES INT, V2021, P0, DOI 10.1155/2021/9915699
   Heath GR, 2021, NATURE, V594, P385, DOI 10.1038/s41586-021-03551-x
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   Hernansanz-Agustín P, 2020, NATURE, V586, P287, DOI 10.1038/s41586-020-2551-y
   Heyman E, 2020, DIABETES CARE, V43, P209, DOI 10.2337/dc19-1125
   Hinoshita M, 2021, J APPL TOXICOL, V41, P247, DOI 10.1002/jat.4040
   Hirano M, 2021, J INHERIT METAB DIS, V44, P376, DOI 10.1002/jimd.12300
   Hong HTK, 2019, PROTEIN EXPRES PURIF, V155, P86, DOI 10.1016/j.pep.2018.11.010
   Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310
   Hu P, 2017, MOL CELL, V68, P1006, DOI 10.1016/j.molcel.2017.11.017
   Huang LZ, 2021, LIGHT-SCI APPL, V10, P0, DOI 10.1038/s41377-021-00506-9
   Hubbard WB, 2019, J NEUROTRAUM, V36, P1252, DOI 10.1089/neu.2018.5990
   Ignatenko O, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-017-01859-9
   Inoue T, 2021, J HEPATOL, V75, P302, DOI 10.1016/j.jhep.2021.02.017
   Ishida A, 2008, ANAL BIOANAL CHEM, V392, P987, DOI 10.1007/s00216-008-2334-z
   Isshiki M, 2013, CELL CALCIUM, V54, P395, DOI 10.1016/j.ceca.2013.09.002
   Jackson CB, 2020, TRENDS MOL MED, V26, P698, DOI 10.1016/j.molmed.2020.02.006
   Jelenik T, 2013, ANTIOXID REDOX SIGN, V19, P258, DOI 10.1089/ars.2012.4910
   Jerri HA, 2010, LANGMUIR, V26, P4725, DOI 10.1021/la903616p
   Jian CS, 2017, J CELL SCI, V130, P2620, DOI 10.1242/jcs.198523
   Jiang H, 2019, SMALL, V15, P0, DOI 10.1002/smll.201901787
   Jiang Q, 2021, THERANOSTICS, V11, P1814, DOI 10.7150/thno.51550
   Jiang SQ, 2021, MAR DRUGS, V19, P0, DOI 10.3390/md19110599
   Jiang SG, 2011, PLANTA MED, V77, P1005, DOI 10.1055/s-0030-1270732
   Jiang XQ, 2018, ANTIOXID REDOX SIGN, V29, P518, DOI 10.1089/ars.2017.7491
   Jiang YY, 2019, FRONT PHARMACOL, V10, P0, DOI 10.3389/fphar.2019.01167
   Jiang ZX, 2022, REPROD SCI, V29, P711, DOI 10.1007/s43032-021-00523-4
   Jing XM, 2019, MOL CANCER, V18, P0, DOI 10.1186/s12943-019-1089-9
   Johnson ME, 2016, ANAL BIOANAL CHEM, V408, P7629, DOI 10.1007/s00216-016-9844-x
   Pérez MJ, 2018, REDOX BIOL, V19, P290, DOI 10.1016/j.redox.2018.09.001
   Jung HS, 2017, J AM CHEM SOC, V139, P9972, DOI 10.1021/jacs.7b04263
   Kalani K, 2018, DRUG DISCOV TODAY, V23, P1983, DOI 10.1016/j.drudis.2018.08.001
   Kalyanaraman B, 2018, REDOX BIOL, V14, P316, DOI 10.1016/j.redox.2017.09.020
   Kambe Y, 2021, ACTA BIOMATER, V130, P199, DOI 10.1016/j.actbio.2021.05.030
   Kaplan P, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21207698
   Karshovska E, 2020, ARTERIOSCL THROM VAS, V40, P583, DOI 10.1161/ATVBAHA.119.313290
   Kasahara T, 2018, BIOL PSYCHIAT, V83, P731, DOI 10.1016/j.biopsych.2017.09.010
   Kazak L, 2017, P NATL ACAD SCI USA, V114, P7981, DOI 10.1073/pnas.1705406114
   Ke HJ, 2018, J BIOL CHEM, V293, P8128, DOI 10.1074/jbc.RA118.002552
   Kelly B, 2020, CELL METAB, V32, P154, DOI 10.1016/j.cmet.2020.06.010
   Kim HK, 2017, SEMIN CANCER BIOL, V47, P154, DOI 10.1016/j.semcancer.2017.06.006
   Kim HJ, 2017, SEMIN CANCER BIOL, V47, P67, DOI 10.1016/j.semcancer.2017.04.004
   Kirk NM, 2021, FRONT VET SCI, V8, P0, DOI 10.3389/fvets.2021.621732
   Kleih M, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-2081-4
   Klier PEZ, 2021, J AM CHEM SOC, V143, P4095, DOI 10.1021/jacs.0c13110
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Kobayashi A, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21186683
   Koch RE, 2017, BIOL REV, V92, P1459, DOI 10.1111/brv.12291
   Kolossov VL, 2018, MICROSC RES TECHNIQ, V81, P115, DOI 10.1002/jemt.22968
   Kowaltowski AJ, 2019, FASEB J, V33, P13176, DOI 10.1096/fj.201901136R
   Kozlov AV, 2017, REDOX BIOL, V13, P170, DOI 10.1016/j.redox.2017.05.017
   Kripps KA, 2020, MOL GENET METAB, V130, P58, DOI 10.1016/j.ymgme.2020.03.001
   Kurhaluk N, 2019, CAN J PHYSIOL PHARM, V97, P392, DOI 10.1139/cjpp-2018-0642
   Kuwahara Y, 2016, INT J RADIAT ONCOL, V96, P556, DOI 10.1016/j.ijrobp.2016.07.002
   Labarta E, 2019, FERTIL STERIL, V111, P219, DOI 10.1016/j.fertnstert.2018.10.036
   Lamers MM, 2021, EMBO J, V40, P0, DOI 10.15252/embj.2020105912
   Lan HY, 2021, J ETHNOPHARMACOL, V274, P0, DOI 10.1016/j.jep.2021.114073
   Langton AK, 2021, J EUR ACAD DERMATOL, V35, P762, DOI 10.1111/jdv.17063
   Larsson NG, 2020, J INTERN MED, V287, P589, DOI 10.1111/joim.13088
   Laskaratou D, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-22816-7
   Lazo S, 2021, AGING CELL, V20, P0, DOI 10.1111/acel.13283
   Le Gal K, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10020163
   Leduc-Gaudet JP, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22158179
   Lee D, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25071708
   Lee H, 2020, ACS SENSORS, V5, P655, DOI 10.1021/acssensors.9b01456
   Lee JH, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20194924
   Lee JH, 2020, REDOX BIOL, V32, P0, DOI 10.1016/j.redox.2020.101511
   Lee JY, 2019, PESTIC BIOCHEM PHYS, V159, P144, DOI 10.1016/j.pestbp.2019.06.009
   Lee P, 2020, NAT REV MOL CELL BIO, V21, P268, DOI 10.1038/s41580-020-0227-y
   Léger JL, 2021, METHODS MOL BIOL, V2276, P57, DOI 10.1007/978-1-0716-1266-8_4
   Léger JL, 2020, PLATELETS, V31, P258, DOI 10.1080/09537104.2019.1609666
   Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460
   Li CN, 2020, ACS APPL MATER INTER, V12, P30077, DOI 10.1021/acsami.0c06144
   Li C, 2021, PHARMACOL RES, V174, P0, DOI 10.1016/j.phrs.2021.105933
   Li DY, 2017, J EXP CLIN CANC RES, V36, P0, DOI 10.1186/s13046-017-0638-6
   Li HZ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8060608
   Li KL, 2019, J ORG CHEM, V84, P12626, DOI 10.1021/acs.joc.9b01270
   Li L, 2021, NAT METAB, V3, P1242, DOI 10.1038/s42255-021-00443-2
   Li S, 2021, BASIC RES CARDIOL, V116, P0, DOI 10.1007/s00395-021-00905-4
   Li WQ, 2017, ACS APPL MATER INTER, V9, P16794, DOI 10.1021/acsami.7b01540
   Liang SZ, 2022, IEEE T ULTRASON FERR, V69, P98, DOI 10.1109/TUFFC.2021.3108163
   Liao PC, 2020, METHOD CELL BIOL, V155, P3, DOI 10.1016/bs.mcb.2019.10.002
   Lin KH, 2019, CELL METAB, V29, P1217, DOI 10.1016/j.cmet.2019.01.011
   Lin YX, 2020, ACS NANO, V14, P11846, DOI 10.1021/acsnano.0c04727
   Lin YT, 2019, LAB CHIP, V19, P3862, DOI 10.1039/c9lc00633h
   Liu C, 2020, ANGEW CHEM INT EDIT, V59, P2634, DOI 10.1002/anie.201911508
   Liu KM, 2021, CNS NEUROSCI THER, V27, P733, DOI 10.1111/cns.13618
   Liu L, 2022, BIOSENS BIOELECTRON, V212, P0, DOI 10.1016/j.bios.2022.114389
   Liu LY, 2019, FRONT PHARMACOL, V10, P0, DOI 10.3389/fphar.2019.01042
   Liu XT, 2021, SPECTROCHIM ACTA A, V250, P0, DOI 10.1016/j.saa.2020.119363
   Liu Y, 2021, MOL THER-NUCL ACIDS, V23, P657, DOI 10.1016/j.omtn.2020.12.017
   Lleonart ME, 2017, MED RES REV, V37, P1275, DOI 10.1002/med.21459
   Lobo-Jarne T, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2019103912
   Lobo-Jarne T, 2018, SEMIN CELL DEV BIOL, V76, P179, DOI 10.1016/j.semcdb.2017.07.021
   Long QQ, 2019, METHODS MOL BIOL, V1966, P237, DOI 10.1007/978-1-4939-9195-2_19
   Lu MR, 2020, ANGEW CHEM INT EDIT, V59, P8698, DOI 10.1002/anie.202002576
   Luo XJ, 2021, ANGEW CHEM INT EDIT, V60, P1403, DOI 10.1002/anie.202012237
   Luo ZL, 2021, FOOD FUNCT, V12, P5658, DOI 10.1039/d1fo01154e
   Ma ZJ, 2018, EUR J PHARMACOL, V821, P1, DOI 10.1016/j.ejphar.2017.12.027
   Macdonald R, 2018, BIOCHEM SOC T, V46, P891, DOI 10.1042/BST20170501
   Maclean AE, 2018, CURR BIOL, V28, P1614, DOI 10.1016/j.cub.2018.03.036
   Madreiter-Sokolowski CT, 2020, REDOX BIOL, V36, P0, DOI 10.1016/j.redox.2020.101678
   Maksimovic JD, 2021, PHYSIOL PLANTARUM, V173, P818, DOI 10.1111/ppl.13476
   Manczak M, 2019, HUM MOL GENET, V28, P177, DOI 10.1093/hmg/ddy335
   Marchi S, 2018, CELL CALCIUM, V69, P62, DOI 10.1016/j.ceca.2017.05.003
   Marcondes NA, 2019, CYTOM PART A, V95A, P214, DOI 10.1002/cyto.a.23567
   Maremanda KP, 2021, REDOX BIOL, V45, P0, DOI 10.1016/j.redox.2021.102055
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Sabogal-Guáqueta AM, 2019, BIOMED PHARMACOTHER, V118, P0, DOI 10.1016/j.biopha.2019.109295
   Markevich NI, 2020, REDOX BIOL, V37, P0, DOI 10.1016/j.redox.2020.101630
   Martínez-Reyes I, 2020, NATURE, V585, P288, DOI 10.1038/s41586-020-2475-6
   Martínez-Reyes I, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13668-3
   Martins WK, 2019, AUTOPHAGY, V15, P259, DOI 10.1080/15548627.2018.1515609
   Mata-Martínez E, 2021, ANDROLOGY-US, V9, P1227, DOI 10.1111/andr.12989
   Matsui H, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-23452-x
   Matsumoto K, 2021, FREE RADICAL RES, V55, P450, DOI 10.1080/10715762.2021.1899171
   Mazat JP, 2020, CELL MOL LIFE SCI, V77, P455, DOI 10.1007/s00018-019-03381-1
   McAlpin BR, 2022, THERANOSTICS, V12, P603, DOI 10.7150/thno.67410
   Medeiros TC, 2019, AUTOPHAGY, V15, P178, DOI 10.1080/15548627.2018.1532263
   Mejia-Vergara AJ, 2020, CURR NEUROL NEUROSCI, V20, P0, DOI 10.1007/s11910-020-01032-8
   Mendoza C, 2021, ENVIRON SCI POLLUT R, V28, P25124, DOI 10.1007/s11356-019-04763-5
   Messal HA, 2021, NAT PROTOC, V16, P239, DOI 10.1038/s41596-020-00414-z
   MIDELFORT CF, 1976, J BIOL CHEM, V251, P5881
   Mirali S, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.aaz8264
   Mita M, 2022, CELL CHEM BIOL, V29, P98, DOI 10.1016/j.chembiol.2021.06.002
   Miyashita L, 2021, ENVIRON SCI POLLUT R, V28, P30384, DOI 10.1007/s11356-021-14025-y
   Mohammadinejad R, 2019, AUTOPHAGY, V15, P4, DOI 10.1080/15548627.2018.1509171
   Mohanraj K, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201809561
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Mollazadeh H, 2021, J CACHEXIA SARCOPENI, V12, P237, DOI 10.1002/jcsm.12654
   Morimoto N, 2020, J ASSIST REPROD GEN, V37, P1815, DOI 10.1007/s10815-020-01869-5
   Moriyama M, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12632-5
   Müller DJ, 2021, CHEM REV, V121, P11701, DOI 10.1021/acs.chemrev.0c00617
   Müller ME, 2019, ENVIRON TOXICOL CHEM, V38, P1000, DOI 10.1002/etc.4396
   Mukherjee R, 2016, GUT, V65, P1333, DOI 10.1136/gutjnl-2014-308553
   Mulhern JG, 2022, SEMIN NUCL MED, V52, P453, DOI 10.1053/j.semnuclmed.2021.12.005
   Murata O, 2020, ANAL CHEM, V92, P966, DOI 10.1021/acs.analchem.9b03872
   Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87
   Nagao T, 2020, FASEB J, V34, P1859, DOI 10.1096/fj.201800389R
   Nakamura T, 2021, EMBO REP, V22, P0, DOI 10.15252/embr.202051532
   Nam HY, 2018, BIOCONJUGATE CHEM, V29, P1669, DOI 10.1021/acs.bioconjchem.8b00148
   Naryzhnaya NV, 2019, DRUG DEVELOP RES, V80, P1013, DOI 10.1002/ddr.21593
   Nash GT, 2021, J AM CHEM SOC, V143, P2194, DOI 10.1021/jacs.0c12330
   Ndi M, 2018, J MOL BIOL, V430, P3892, DOI 10.1016/j.jmb.2018.04.036
   Nesci S, 2020, CRIT REV BIOCHEM MOL, V55, P309, DOI 10.1080/10409238.2020.1784084
   Nesci S, 2018, BIOCHIMIE, V152, P85, DOI 10.1016/j.biochi.2018.06.022
   Newman NJ, 2021, OPHTHALMOLOGY, V128, P649, DOI 10.1016/j.ophtha.2020.12.012
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nguyen MTB, 2019, NEUROLOGY, V92, PE519, DOI 10.1212/WNL.0000000000006861
   Ni KY, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06655-7
   Nie S, 2020, IUBMB LIFE, V72, P1879, DOI 10.1002/iub.2339
   Nishida M, 2021, J IMMUNOTHER CANCER, V9, P0, DOI 10.1136/jitc-2021-002954
   Nishida Y, 2020, J CACHEXIA SARCOPENI, V11, P241, DOI 10.1002/jcsm.12530
   Nissanka N, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201949612
   Okazaki Y, 2021, ARCH BIOCHEM BIOPHYS, V700, P0, DOI 10.1016/j.abb.2021.108762
   Olgar Y, 2020, EXP GERONTOL, V136, P0, DOI 10.1016/j.exger.2020.110961
   Ooi K, 2021, MOL NEUROBIOL, V58, P6625, DOI 10.1007/s12035-021-02488-6
   Ortega-Villasante C, 2018, FREE RADICAL BIO MED, V122, P202, DOI 10.1016/j.freeradbiomed.2018.04.005
   Ortega-Villasante C, 2016, METHODS, V109, P92, DOI 10.1016/j.ymeth.2016.07.009
   Panel M, 2019, GASTROENTEROLOGY, V157, P1368, DOI 10.1053/j.gastro.2019.07.026
   Parés M, 2021, HUM GENE THER, V32, P1210, DOI 10.1089/hum.2021.152
   Porporato PE, 2018, CELL RES, V28, P265, DOI 10.1038/cr.2017.155
   Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094
   Poznanski RR, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0183677
   Prasad A, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22189963
   Priesnitz C, 2018, GENE DEV, V32, P1285, DOI 10.1101/gad.316547.118
   Qattan AT, 2010, J PROTEOME RES, V9, P495, DOI 10.1021/pr9008332
   Qi T, 2019, BIOMATERIALS, V213, P0, DOI 10.1016/j.biomaterials.2019.05.030
   Rabinovich-Nikitin I, 2021, AUTOPHAGY, V17, P3794, DOI 10.1080/15548627.2021.1938913
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rahman MH, 2021, MOL BIOL+, V343, P355, DOI 10.1007/978-1-0716-1266-8_26
   Ramachandra CJA, 2020, EBIOMEDICINE, V57, P0, DOI 10.1016/j.ebiom.2020.102884
   Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006
   Ramezani Maral, 2021, ASIAN PAC J CANCER PREV, V22, P2295, DOI 10.31557/APJCP.2021.22.7.2295
   Rao M, 2018, CURR OPIN NEPHROL HY, V27, P113, DOI 10.1097/MNH.0000000000000393
   Raut S, 2021, FLUIDS BARRIERS CNS, V18, P0, DOI 10.1186/s12987-020-00235-y
   Rawat PS, 2021, BIOMED PHARMACOTHER, V139, P0, DOI 10.1016/j.biopha.2021.111708
   Rebelo AP, 2021, BRAIN, V144, P1467, DOI 10.1093/brain/awab071
   Restall BS, 2021, J BIOMED OPT, V26, P0, DOI 10.1117/1.JBO.26.9.096501
   Rhie A, 2021, NATURE, V592, P737, DOI 10.1038/s41586-021-03451-0
   Rocha EM, 2018, NEUROBIOL DIS, V109, P249, DOI 10.1016/j.nbd.2017.04.004
   Rodriguez-Gallardo S, 2021, PLOS ONE, V16, P0, DOI 10.1371/journal.pone.0258111
   Roger AJ, 2017, CURR BIOL, V27, PR1177, DOI 10.1016/j.cub.2017.09.015
   Rossmann MP, 2021, SCIENCE, V372, P716, DOI 10.1126/science.aaz2740
   Rossow HA, 2018, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/58387
   Roth KG, 2020, TRENDS MOL MED, V26, P119, DOI 10.1016/j.molmed.2019.06.009
   Rottenberg H, 2017, AGING CELL, V16, P943, DOI 10.1111/acel.12650
   Rovini A, 2021, FASEB J, V35, P0, DOI 10.1096/fj.202001693R
   Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Ruzzenente B, 2021, METHODS MOL BIOL, V2224, P47, DOI 10.1007/978-1-0716-1008-4_3
   Saeb-Parsy K, 2021, TRENDS MOL MED, V27, P185, DOI 10.1016/j.molmed.2020.08.001
   Sakthivel R, 2018, BIOMED PHARMACOTHER, V105, P742, DOI 10.1016/j.biopha.2018.06.035
   Samuvel DJ, 2022, AUTOPHAGY, V18, P2671, DOI 10.1080/15548627.2022.2046457
   Saraf KK, 2017, ANIM REPROD SCI, V180, P30, DOI 10.1016/j.anireprosci.2017.02.010
   Schönfeld P, 2016, J LIPID RES, V57, P943, DOI 10.1194/jlr.R067629
   Semerikov VL, 2022, PLANTS-BASEL, V11, P0, DOI 10.3390/plants11060762
   Senkler J, 2018, CURR BIOL, V28, P1606, DOI 10.1016/j.cub.2018.03.050
   Shah SS, 2019, J AM SOC NEPHROL, V30, P2355, DOI 10.1681/ASN.2019020114
   Shetty T, 2021, STAR PROTOC, V2, P0, DOI 10.1016/j.xpro.2021.100533
   Shi W, 2020, INT IMMUNOPHARMACOL, V85, P0, DOI 10.1016/j.intimp.2020.106632
   Shoshan-Barmatz V, 2018, PHARMACOL RES, V131, P87, DOI 10.1016/j.phrs.2018.03.010
   Sidlauskaite E, 2018, REDOX BIOL, V16, P344, DOI 10.1016/j.redox.2018.03.012
   Signes A, 2018, ESSAYS BIOCHEM, V62, P255, DOI 10.1042/EBC20170098
   Smith GM, 2018, DEV NEUROBIOL, V78, P221, DOI 10.1002/dneu.22546
   Soukas AA, 2019, TRENDS ENDOCRIN MET, V30, P745, DOI 10.1016/j.tem.2019.07.015
   Spinelli JB, 2021, SCIENCE, V374, P1227, DOI 10.1126/science.abi7495
   Stenton SL, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI138267
   Strobbe D, 2018, TRENDS PHARMACOL SCI, V39, P437, DOI 10.1016/j.tips.2018.02.008
   Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023
   Sun C, 2019, THERANOSTICS, V9, P3595, DOI 10.7150/thno.33100
   Sun J, 2019, J AM SOC NEPHROL, V30, P1151, DOI 10.1681/ASN.2018111126
   Sun JY, 2021, TRANSL STROKE RES, V12, P1067, DOI 10.1007/s12975-021-00906-4
   Sun Min, 2021, ZHONGHUA WEI ZHONG BING JI JIU YI XUE, V33, P1418, DOI 10.3760/cma.j.cn121430-20210719-01063
   Suo L, 2022, THERANOSTICS, V12, P277, DOI 10.7150/thno.63441
   Szymanski J, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18071576
   Tabish TA, 2021, ACTA BIOMATER, V129, P43, DOI 10.1016/j.actbio.2021.04.054
   Tan DX, 2013, J PINEAL RES, V54, P127, DOI 10.1111/jpi.12026
   Tan KY, 2017, ANAL CHEM, V89, P1749, DOI 10.1021/acs.analchem.6b04020
   Tao L, 2020, NEUROL RES, V42, P597, DOI 10.1080/01616412.2020.1773610
   Tay E, 2022, J FUNGI, V8, P0, DOI 10.3390/jof8050462
   Thiele JC, 2020, ACS NANO, V14, P14190, DOI 10.1021/acsnano.0c07322
   Thomas LW, 2019, CELL MOL LIFE SCI, V76, P1759, DOI 10.1007/s00018-019-03039-y
   Tian J, 2021, ACTA BIOMATER, V130, P447, DOI 10.1016/j.actbio.2021.05.048
   Tian T, 2019, J CELL BIOCHEM, V120, P3621, DOI 10.1002/jcb.27639
   Timón-Gómez A, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107607
   Tóth EA, 2021, J EXTRACELL VESICLES, V10, P0, DOI 10.1002/jev2.12140
   Tricaud N, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10061447
   Tsai YL, 2020, GENE DEV, V34, P785, DOI 10.1101/gad.335836.119
   Tuncer S, 2021, N-S ARCH PHARMACOL, V394, P545, DOI 10.1007/s00210-020-02039-1
   Ucar H, 2021, NATURE, V600, P686, DOI 10.1038/s41586-021-04125-7
   Urbani A, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12331-1
   Usaj M, 2021, COMMUN BIOL, V4, P0, DOI 10.1038/s42003-020-01574-0
   Valenti D, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22158312
   van der Reest J, 2021, AGEING RES REV, V70, P0, DOI 10.1016/j.arr.2021.101378
   Vankayala R, 2018, ADV MATER, V30, P0, DOI 10.1002/adma.201706320
   Vasta JD, 2018, CELL CHEM BIOL, V25, P206, DOI 10.1016/j.chembiol.2017.10.010
   Veerman RE, 2021, J EXTRACELL VESICLES, V10, P0, DOI 10.1002/jev2.12128
   Vercellino I, 2022, NAT REV MOL CELL BIO, V23, P141, DOI 10.1038/s41580-021-00415-0
   Vincent AE, 2017, TRENDS CELL BIOL, V27, P797, DOI 10.1016/j.tcb.2017.08.009
   Vogt N, 2021, NAT METHODS, V18, P859, DOI 10.1038/s41592-021-01246-9
   Vrijsen S, 2020, P NATL ACAD SCI USA, V117, P31198, DOI 10.1073/pnas.1922342117
   Wacquier B, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-60177-1
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wang CX, 2017, ANAL CHEM, V89, P11514, DOI 10.1021/acs.analchem.7b02781
   Wang H, 2021, J NANOBIOTECHNOL, V19, P0, DOI 10.1186/s12951-021-00895-4
   Wang HW, 2020, CHEMOSPHERE, V238, P0, DOI 10.1016/j.chemosphere.2019.124607
   Wang J, 2016, J HEPATOL, V65, P700, DOI 10.1016/j.jhep.2016.05.029
   Wang J, 2022, MOL GENET METAB, V135, P93, DOI 10.1016/j.ymgme.2021.12.006
   Wang L, 2021, EUR J NEUROL, V28, P2871, DOI 10.1111/ene.14995
   Wang M, 2020, MOL PLANT PATHOL, V21, P1529, DOI 10.1111/mpp.12993
   Wang QC, 2021, J OVARIAN RES, V14, P0, DOI 10.1186/s13048-021-00817-w
   Wang SH, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-021-03821-6
   Wang S, 2021, ACTA BIOMATER, V130, P138, DOI 10.1016/j.actbio.2021.05.027
   Wang XQ, 2018, NANO LETT, V18, P6804, DOI 10.1021/acs.nanolett.8b02670
   Wang Y, 2021, FRONT IMMUNOL, V12, P0, DOI 10.3389/fimmu.2021.652782
   Wanrooij PH, 2020, P NATL ACAD SCI USA, V117, P14306, DOI 10.1073/pnas.1916851117
   Wei W, 2020, J INTERN MED, V287, P634, DOI 10.1111/joim.13047
   Weiland D, 2018, J INVEST DERMATOL, V138, P132, DOI 10.1016/j.jid.2017.08.019
   Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   Wiemerslage L, 2016, J NEUROSCI METH, V262, P56, DOI 10.1016/j.jneumeth.2016.01.008
   Wiessner M, 2021, BRAIN, V144, P1422, DOI 10.1093/brain/awab041
   Winquist RJ, 2020, BIOCHEM PHARMACOL, V177, P0, DOI 10.1016/j.bcp.2020.113995
   Wong HH, 2021, AM J HUM GENET, V108, P1301, DOI 10.1016/j.ajhg.2021.05.003
   Wu HC, 2021, CANCER DISCOV, V11, P3198, DOI 10.1158/2159-8290.CD-21-0177
   Wu M, 2020, PROTEIN CELL, V11, P318, DOI 10.1007/s13238-019-00681-x
   Wu SN, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21144987
   Wu TS, 2020, PART FIBRE TOXICOL, V17, P0, DOI 10.1186/s12989-020-00363-1
   Wu YC, 2021, NATURE, V600, P279, DOI 10.1038/s41586-021-04110-0
   Wu Y, 2019, CHINESE MED J-PEKING, V132, P1202, DOI 10.1097/CM9.0000000000000262
   Xie LL, 2018, CANCER SCI, V109, P3686, DOI 10.1111/cas.13830
   Xiong B, 2011, J CHROMATOGR A, V1218, P3823, DOI 10.1016/j.chroma.2011.04.038
   Yamada S, 2020, PLANT CELL PHYSIOL, V61, P283, DOI 10.1093/pcp/pcz193
   Yamaguchi M, 2021, LANGMUIR, V37, P9883, DOI 10.1021/acs.langmuir.1c01578
   Yamashita K, 2019, ANTIMICROB AGENTS CH, V63, P0, DOI 10.1128/AAC.00374-19
   Yang GL, 2019, ACS APPL MATER INTER, V11, P44961, DOI 10.1021/acsami.9b15996
   Yang JQ, 2021, DRUG DES DEV THER, V15, P233, DOI 10.2147/DDDT.S278975
   Yang J, 2018, REDOX BIOL, V19, P158, DOI 10.1016/j.redox.2018.08.016
   Yang ZY, 2022, CURR PROTOC, V2, P0, DOI 10.1002/cpz1.412
   Yazdankhah M, 2021, AUTOPHAGY, V17, P3140, DOI 10.1080/15548627.2020.1871204
   Ying ZF, 2018, CELL METAB, V28, P935, DOI 10.1016/j.cmet.2018.08.001
   Yoon S, 2020, SENSORS-BASEL, V20, P0, DOI 10.3390/s20174998
   Yordanov S, 2021, BIOMED OPT EXPRESS, V12, P3372, DOI 10.1364/BOE.420788
   Young VC, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2019317118
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.aaz7423
   Yuan P, 2021, ADV HEALTHC MATER, V10, P0, DOI 10.1002/adhm.202100198
   Zeng WN, 2021, J NANOBIOTECHNOL, V19, P0, DOI 10.1186/s12951-021-00831-6
   Zhan Y, 2021, ANGEW CHEM INT EDIT, V60, P2637, DOI 10.1002/anie.202011903
   Zhang CX, 2019, J NANOBIOTECHNOL, V17, P0, DOI 10.1186/s12951-019-0451-9
   Zhang DG, 2021, FOOD CHEM, V360, P0, DOI 10.1016/j.foodchem.2021.129814
   Zhang GW, 2019, HUM REPROD, V34, P3, DOI 10.1093/humrep/dey335
   Zhang KX, 2018, J AM CHEM SOC, V140, P11293, DOI 10.1021/jacs.8b05309
   Zhang LX, 2019, REDOX BIOL, V26, P0, DOI 10.1016/j.redox.2019.101284
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang S, 2019, CELL METAB, V29, P443, DOI 10.1016/j.cmet.2018.12.004
   Zhang Y, 2021, J AM CHEM SOC, V143, P11490, DOI 10.1021/jacs.1c03642
   Zhao HX, 2019, NAT CELL BIOL, V21, P476, DOI 10.1038/s41556-019-0296-3
   Zhao M, 2021, ACS NANO, V15, P1519, DOI 10.1021/acsnano.0c08947
   Zhao YY, 2021, IEEE T PATTERN ANAL, V43, P2206, DOI 10.1109/TPAMI.2021.3075366
   Zheng X, 2020, J EXTRACELL VESICLES, V9, P0, DOI 10.1080/20013078.2020.1750202
   Zhong XY, 2022, J CLIN LAB ANAL, V36, P0, DOI 10.1002/jcla.24558
   Zhou B, 2019, CELL, V177, P299, DOI 10.1016/j.cell.2019.02.013
   Zhou GL, 2021, FRONT GENET, V12, P0, DOI 10.3389/fgene.2021.719451
   Zhou YS, 2020, AUTOPHAGY, V16, P562, DOI 10.1080/15548627.2019.1634944
   Zhu JM, 2019, THERANOSTICS, V9, P6901, DOI 10.7150/thno.37357
   Zhu SC, 2020, PFLUG ARCH EUR J PHY, V472, P367, DOI 10.1007/s00424-020-02355-8
   Zhu XJ, 2020, ANAL CHEM, V92, P10815, DOI 10.1021/acs.analchem.0c02298
   Zhu YX, 2022, OXID MED CELL LONGEV, V2022, P0, DOI 10.1155/2022/1295509
NR 478
TC 16
Z9 16
U1 5
U2 54
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD OCT 15
PY 2022
VL 50
IS 4
BP 
EP 
DI 10.3892/ijmm.2022.5182
PG 29
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 6E0FZ
UT WOS:000883061400001
PM 36004457
DA 2024-11-01
ER

PT J
AU Cheng, WQ
   Zhang, YT
   He, L
AF Cheng, Weiqin
   Zhang, Yuting
   He, Ling
TI MRI Features of Stroke-Like Episodes in Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-Like Episodes
SO FRONTIERS IN NEUROLOGY
LA English
DT Review
DE mitochondrial myopathy; encephalopathy; lactic acidosis and stroke-like episodes (MELAS); stroke-like episodes; MRI; neuroimaging; application
ID magnetic-resonance-spectroscopy; melas syndrome; ischemic-stroke; diffusion; encephalopathy; myopathy; lesions; hyperperfusion; pathogenesis; mutation
AB Mitochondrial myopathy encephalopathy lactic acidosis and stroke-like episodes (MELAS) is an important cause of stroke-mimicking diseases that predominantly affect patients before 40 years of age. MELAS results from gene mutations in either mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) responsible for the wide spectrum of clinical symptoms and imaging findings. Neurological manifestations can present with stroke-like episodes (the cardinal features of MELAS), epilepsy, cognitive and mental disorders, or recurrent headaches. Magnetic resonance imaging (MRI) is an important tool for detecting stroke-like lesions, accurate recognition of imaging findings is important in guiding clinical decision making in MELAS patients. With the development of neuroimaging technologies, MRI plays an increasingly important role in course monitoring and efficacy assessment of the disease. In this article, we provide an overview of the neuroimaging features and the application of novel MRI techniques in MELAS syndrome.
C1 [Cheng, Weiqin; Zhang, Yuting; He, Ling] Chongqing Med Univ, Childrens Hosp,China Int Sci & Technol Cooperat B, Dept Radiol,Natl Clin Res Ctr Child Hlth & Diorde, Minist Educ,Key Lab Child Dev & Disorders,Chongqi, Chongqing, Peoples R China.
C3 Chongqing Medical University
RP Zhang, YT; He, L (corresponding author), Chongqing Med Univ, Childrens Hosp,China Int Sci & Technol Cooperat B, Dept Radiol,Natl Clin Res Ctr Child Hlth & Diorde, Minist Educ,Key Lab Child Dev & Disorders,Chongqi, Chongqing, Peoples R China.
EM zhangyuting@cqmu.edu.cn; doctorheling@yeah.net
FU joint Chongqing Health Commission; Chongqing Science and Technology Bureau Medical Research Project [2020FYYX128]; Chongqing Science and Technology Bureau, Technology Foresight and System Innovation Project [cstc2021jsyj-yzysbAX0019]
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bhatia KD, 2020, AM J NEURORADIOL, V41, P167, DOI 10.3174/ajnr.A6325
   Casimiro C, 2012, ACTA MEDICA PORT, V25, P59
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   Chen CN, 2012, NEUROL INDIA, V60, P86, DOI 10.4103/0028-3886.93609
   Chen H, 2020, SOMATOSENS MOT RES, V37, P45, DOI 10.1080/08990220.2020.1720636
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Gieraerts C, 2013, J COMPUT ASSIST TOMO, V37, P279, DOI 10.1097/RCT.0b013e3182811170
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   Gramegna LL, 2021, J NEURORADIOLOGY, V48, P359, DOI 10.1016/j.neurad.2021.02.002
   Hovsepian DA, 2019, ACTA NEUROL SCAND, V139, P82, DOI 10.1111/ane.13027
   Hsu YHR, 2016, HEART FAIL REV, V21, P103, DOI 10.1007/s10741-015-9524-5
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Ikawa M, 2013, MITOCHONDRION, V13, P676, DOI 10.1016/j.mito.2013.09.007
   Ishigaki H, 2021, BRAIN DEV-JPN, V43, P931, DOI 10.1016/j.braindev.2021.05.002
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Kolb SJ, 2003, J NEUROL SCI, V216, P11, DOI 10.1016/S0022-510X(03)00218-1
   Li C, 2021, MITOCHONDRION, V58, P131, DOI 10.1016/j.mito.2021.02.015
   Li R, 2017, J MAGN RESON IMAGING, V45, P199, DOI 10.1002/jmri.25354
   Li YX, 2019, CLIN NEURORADIOL, V29, P321, DOI 10.1007/s00062-018-0662-8
   Li YX, 2017, J MAGN RESON IMAGING, V46, P915, DOI 10.1002/jmri.25592
   Malhotra K, 2016, CURR PAIN HEADACHE R, V20, P0, DOI 10.1007/s11916-016-0583-7
   Minobe S, 2015, J CLIN NEUROSCI, V22, P407, DOI 10.1016/j.jocn.2014.05.021
   Möller HE, 2005, J NEUROL SCI, V229, P131, DOI 10.1016/j.jns.2004.11.014
   Ohshita T, 2000, NEURORADIOLOGY, V42, P651, DOI 10.1007/s002340000335
   Pittet MP, 2016, J INHERIT METAB DIS, V39, P465, DOI 10.1007/s10545-016-9929-x
   Pizzamiglio C, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12101643
   [北京医学会罕见病分会 Rare Diseases Branch of Beijing Medical Association], 2020, 中华神经科杂志 CHINESE JOURNAL OF NEUROLOGY, V53, P171
   Renard D, 2020, ACTA NEUROL BELG, V120, P455, DOI 10.1007/s13760-017-0867-7
   Renard D, 2014, J NEUROL NEUROSUR PS, V85, P1055, DOI 10.1136/jnnp-2013-306933
   Rodan LH, 2015, MITOCHONDRION, V22, P66, DOI 10.1016/j.mito.2015.03.002
   Rodan LH, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0238224
   Stoquart-ElSankari S, 2008, J NEUROL, V255, P1593, DOI 10.1007/s00415-008-0968-6
   Sun XR, 2018, MEDICINE, V97, P0, DOI 10.1097/MD.0000000000013866
   Takasu Miyuki, 2002, MAGN RESON MED SCI, V1, P50, DOI 10.2463/mrms.1.50
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tsujikawa T, 2010, BRAIN DEV-JPN, V32, P143, DOI 10.1016/j.braindev.2008.12.003
   Tzoulis C, 2009, STROKE, V40, PE15, DOI 10.1161/STROKEAHA.108.523118
   Virtanen SM, 2011, AM J NEURORADIOL, V32, P522, DOI 10.3174/ajnr.A2309
   Wang R, 2020, NEUROIMAGE-CLIN, V28, P0, DOI 10.1016/j.nicl.2020.102480
   Wang R, 2021, J MAGN RESON IMAGING, V53, P427, DOI 10.1002/jmri.27353
   Wang YX, 2015, CHINESE MED J-PEKING, V128, P1820, DOI 10.4103/0366-6999.159360
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Whitehead MT, 2017, PEDIATR NEUROL, V75, P61, DOI 10.1016/j.pediatrneurol.2017.06.017
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Xu WXZ, 2018, J COMPUT ASSIST TOMO, V42, P510, DOI 10.1097/RCT.0000000000000712
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yonemura K, 2001, AM J NEURORADIOL, V22, P269
   Yoshida T, 2013, INTERNAL MED, V52, P1389, DOI 10.2169/internalmedicine.52.0188
   Yu HO, 2019, J NEUROL, V266, P1459, DOI 10.1007/s00415-019-09283-3
NR 55
TC 18
Z9 20
U1 0
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD FEB 9
PY 2022
VL 13
IS 
BP 
EP 
DI 10.3389/fneur.2022.843386
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ZH1UG
UT WOS:000760730800001
PM 35222261
DA 2024-11-01
ER

PT J
AU Bullock, G
   Johnson, GS
   Mhlanga-Mutangadura, T
   Petesch, SC
   Thompson, S
   Goebbels, S
   Katz, ML
AF Bullock, Garrett
   Johnson, Gary S.
   Mhlanga-Mutangadura, Tendai
   Petesch, Scott C.
   Thompson, Samantha
   Goebbels, Sandra
   Katz, Martin L.
TI Lysosomal storage disease associated with a CNP sequence variant in Dalmatian dogs
SO GENE
LA English
DT Article
ID 2',3'-cyclic nucleotide 3'-phosphodiesterase; neuronal ceroid-lipofuscinosis; mitochondrial atp synthase; enzyme replacement therapy; subunit-c; cardiac telocytes; membrane anchor; deficiency; gene; mutation
AB A progressive neurological disorder was identified in purebred Dalmatian dogs. The disease is characterized by anxiety, pacing and circling, hypersensitivity, cognitive decline, sleep disturbance, loss of coordination, loss of control over urination and defecation, and visual impairment. Neurological signs first became apparent when the dogs were approximately 18 months of age and progressed slowly. Two affected littermates were euthanized at approximately 7 years, 5 months and 8 years, 2 months of age due to the severity of neurological impairment. The mother of the affected dogs and four other relatives exhibited milder, later-onset neurological signs. Pronounced accumulations of autofluorescent intracellular inclusions were found in cerebral cortex, cerebellum, optic nerve, and cardiac muscle of the affected dogs. These inclusions co-localized with immunolabeling of the lysosomal marker protein LAMP2 and bound antibodies to mitochondrial ATPase subunit c, indicating that the dogs suffered from a lysosomal storage disease with similarities to the neuronal ceroid lipofuscinoses. Ultrastructural analysis indicated that the storage bodies were surrounded by a single-layer membrane, but the storage granules were distinct from those reported for other lysosomal storage diseases. Whole genome sequences, generated with DNA from the two euthanized Dalmatians, both contained a rare, homozygous single-base deletion and reading-frame shift in CNP which encodes the enzyme CNPase (EC 3.1.4.37). The late-onset disease was exhibited by five of seven related Dalmatians that were heterozygous for the deletion allele and over 8 years of age, whereas none of 16 age-matched reference-allele homozygotes developed neurologic signs. No CNPase antigen could be detected with immunohistochemical labeling in tissues from the dogs with the earlier-onset disorder. Similar to the later-onset Dalmatians, autofluorescent storage granules were apparent in brain and cardiac tissue from transgenic mice that were nullizygous for Cnp. Based on the clinical signs, the histopathological, immu-nohistochemical, ultrastructural, and molecular-genetic findings, and the finding that nullizygous Cnp mice accumulate autofluorescent storage granules, we propose that the earlier-onset Dalmatian disorder is a novel lysosomal storage disease that results from a loss-of-function mutation in CNP and that shares features char-acteristic of the neuronal ceroid lipofuscinoses. That the later-onset disorder occurred only in dogs heterozygous for the CNP deletion variant suggests that this disorder is a result of the variant allele's presence.
C1 [Bullock, Garrett; Johnson, Gary S.; Mhlanga-Mutangadura, Tendai] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO USA.
   [Petesch, Scott C.] Univ Penn, Sch Vet Med, Philadelphia, PA USA.
   [Thompson, Samantha] Pocono Peak Vet Ctr, Stroudsburg, PA USA.
   [Goebbels, Sandra] Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.
   [Katz, Martin L.] Univ Missouri, Neurodegenerat Dis Res Lab, Sch Med, Columbia, MO USA.
C3 University of Missouri System; University of Missouri Columbia; University of Pennsylvania; Max Planck Society; University of Missouri System; University of Missouri Columbia
RP Katz, ML (corresponding author), Univ Missouri, Neurodegenerat Dis Res Lab, Sch Med, Columbia, MO USA.
EM katzm@health.missouri.edu
FU American Kennel Club Canine Health Foundation [02604]
CR Abitbol M, 2010, P NATL ACAD SCI USA, V107, P14775, DOI 10.1073/pnas.0914206107
   Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915
   Al-Abdi L, 2020, HUM GENET, V139, P615, DOI 10.1007/s00439-020-02144-4
   Anitei M, 2012, NAT CELL BIOL, V14, P11, DOI 10.1038/ncb2409
   Awano T, 2006, MOL GENET METAB, V87, P341, DOI 10.1016/j.ymgme.2005.11.005
   Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, PC1428, DOI 10.1152/ajpcell.00006.2009
   Beck-Wödl S, 2018, ACTA NEUROPATHOL COM, V6, P0, DOI 10.1186/s40478-018-0646-6
   Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799
   BRAUN PE, 1991, J NEUROSCI RES, V30, P540, DOI 10.1002/jnr.490300311
   Butz ES, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2019.165571
   Cannon DM, 2012, TRANSL PSYCHIAT, V2, P0, DOI 10.1038/tp.2012.82
   Cao Y, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0017118
   Che RL, 2009, BMC MED GENET, V10, P0, DOI 10.1186/1471-2350-10-31
   COOPER A, 1988, J INHERIT METAB DIS, V11, P17, DOI 10.1007/BF01800054
   Damme M, 2011, J NEUROPATH EXP NEUR, V70, P83, DOI 10.1097/NEN.0b013e31820428fa
   DeAngelis DA, 1996, J NEUROCHEM, V67, P943
   DWORZAK F, 1994, NEUROMUSCULAR DISORD, V4, P243, DOI 10.1016/0960-8966(94)90025-6
   Edgar JM, 2009, GLIA, V57, P1815, DOI 10.1002/glia.20893
   El Haddad S, 2012, ELECTROPHORESIS, V33, P3798, DOI 10.1002/elps.201200472
   Esposito C, 2008, BIOCHEMISTRY-US, V47, P308, DOI 10.1021/bi701474t
   EVANS A, 1992, EXP BRAIN RES, V91, P79
   Farias FHG, 2011, NEUROBIOL DIS, V42, P468, DOI 10.1016/j.nbd.2011.02.009
   Gherghiceanu M, 2012, CELL TISSUE RES, V348, P265, DOI 10.1007/s00441-012-1333-8
   Gravel M, 2009, J NEUROSCI RES, V87, P1069, DOI 10.1002/jnr.21939
   Gupta P, 2003, P NATL ACAD SCI USA, V100, P12325, DOI 10.1073/pnas.2033229100
   Hagemeyer N, 2012, EMBO MOL MED, V4, P528, DOI 10.1002/emmm.201200230
   HOSAIN S, 1995, AM J MED GENET, V57, P239, DOI 10.1002/ajmg.1320570226
   Iwamoto K, 2008, PSYCHIAT CLIN NEUROS, V62, P103, DOI 10.1111/j.1440-1819.2007.01786.x
   Janova H, 2018, J CLIN INVEST, V128, P734, DOI 10.1172/JCI97032
   JONES MZ, 1981, J BIOL CHEM, V256, P5185
   Katz ML, 2005, BIOCHEM BIOPH RES CO, V327, P541, DOI 10.1016/j.bbrc.2004.12.038
   KATZ ML, 1995, BIOCHEM J, V310, P887, DOI 10.1042/bj3100887
   KATZ ML, 1982, EXP EYE RES, V34, P339, DOI 10.1016/0014-4835(82)90082-3
   Kolicheski A, 2017, J VET INTERN MED, V31, P1520, DOI 10.1111/jvim.14794
   KOMINAMI E, 1992, J BIOCHEM, V111, P278, DOI 10.1093/oxfordjournals.jbchem.a123749
   Kostin S, 2016, SEMIN CELL DEV BIOL, V55, P22, DOI 10.1016/j.semcdb.2016.02.023
   Kowalewski B, 2012, P NATL ACAD SCI USA, V109, P10310, DOI 10.1073/pnas.1202071109
   Kowalewski B, 2021, BIOCHEM J, V478, P3221, DOI 10.1042/BCJ20210415
   KURIHARA T, 1990, BIOCHEM BIOPH RES CO, V170, P1074, DOI 10.1016/0006-291X(90)90502-E
   Laezza C, 1997, FEBS LETT, V413, P260, DOI 10.1016/S0014-5793(97)00924-1
   Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095
   Lee J, 2006, MOL CELL NEUROSCI, V31, P446, DOI 10.1016/j.mcn.2005.10.017
   Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047
   LOWDEN JA, 1981, NEUROLOGY, V31, P719, DOI 10.1212/WNL.31.6.719
   Mitkus SN, 2008, SCHIZOPHR RES, V98, P129, DOI 10.1016/j.schres.2007.09.032
   Morgan BR, 2013, J NEUROSCI RES, V91, P1639, DOI 10.1002/jnr.23287
   Naseri N, 2021, CLIN GENET, V99, P111, DOI 10.1111/cge.13829
   OLDFORS A, 1981, ACTA NEUROPATHOL, V54, P287, DOI 10.1007/BF00697002
   Olga K, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21093217
   Pastores GM, 2013, NEUROL CLIN, V31, P1051, DOI 10.1016/j.ncl.2013.04.007
   Peirce TR, 2006, ARCH GEN PSYCHIAT, V63, P18, DOI 10.1001/archpsyc.63.1.18
   Platt FM, 2018, NAT REV DIS PRIMERS, V4, P0, DOI 10.1038/s41572-018-0025-4
   Poët M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103
   Rasband MN, 2005, GLIA, V50, P86, DOI 10.1002/glia.20165
   ROWAN SA, 1995, AM J MED GENET, V57, P172, DOI 10.1002/ajmg.1320570213
   Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107
   Smith KR, 2013, HUM MOL GENET, V22, P1417, DOI 10.1093/hmg/dds558
   Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021
   Snaidero N, 2017, CELL REP, V18, P314, DOI 10.1016/j.celrep.2016.12.053
   Stypmann J, 2002, P NATL ACAD SCI USA, V99, P6234, DOI 10.1073/pnas.092637699
   Tang CH, 2006, MOL CELL BIOL, V26, P2309, DOI 10.1128/MCB.26.6.2309-2316.2006
   Tang FL, 2007, NEUROSCI LETT, V416, P113, DOI 10.1016/j.neulet.2007.01.054
   Trabszo C, 2020, BIOCHEM J, V477, P3433, DOI 10.1042/BCJ20200546
   Tyynelä J, 2000, EMBO J, V19, P2786, DOI 10.1093/emboj/19.12.2786
   Usui H, 2006, SCHIZOPHR RES, V88, P245, DOI 10.1016/j.schres.2006.07.019
   Verrier JD, 2013, GLIA, V61, P1595, DOI 10.1002/glia.22523
   Vesa J, 2002, CURRENT MOLECULAR MEDICINE (HILVERSUM), V2, P439, DOI 10.2174/1566524023362311
   Villani NA, 2019, MOL GENET METAB, V127, P107, DOI 10.1016/j.ymgme.2019.04.003
   Vizovisek M, 2019, MATRIX BIOL, V75-76, P141, DOI 10.1016/j.matbio.2018.01.024
   Voineskos AN, 2008, PSYCHIAT GENET, V18, P143, DOI 10.1097/YPG.0b013e3282fa1874
   Wang RY, 2011, GENET MED, V13, P457, DOI 10.1097/GIM.0b013e318211a7e1
   WENGER DA, 1986, NEW ENGL J MED, V315, P1201, DOI 10.1056/NEJM198611063151906
   Whiting REH, 2020, EXP EYE RES, V197, P0, DOI 10.1016/j.exer.2020.108130
   Whiting REH, 2014, EXP EYE RES, V125, P164, DOI 10.1016/j.exer.2014.06.008
   WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531
   WISNIEWSKI K, 1985, NEUROPEDIATRICS, V16, P98, DOI 10.1055/s-2008-1052551
   Yanagawa M, 2007, J BIOL CHEM, V282, P1851, DOI 10.1074/jbc.M604143200
NR 77
TC 7
Z9 7
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD JUL 1
PY 2022
VL 830
IS 
BP 
EP 
DI 10.1016/j.gene.2022.146513
EA APR 2022
PG 17
WC Genetics & Heredity
SC Genetics & Heredity
GA 1L1WE
UT WOS:000799082700001
PM 35447247
DA 2024-11-01
ER

PT J
AU Zhu, Q
   Chen, CW
   Yao, JY
AF Zhu, Qin
   Chen, Chunwen
   Yao, Jingyan
TI Kearns-Sayre syndrome with a novel large-scale deletion: a case report
SO BMC OPHTHALMOLOGY
LA English
DT Article
DE Kearns-Sayre syndrome; Large-scale deletion; OCTA
ID mitochondrial; disease; adults
AB Background Kearns-Sayre syndrome (KSS) is a rare, multisystem mitochondrial encephalomyopathy. We report a case of KSS with a novel 7.6-kb deletion as assessed through a long-range polymerase chain reaction (PCR) study in the blood. In addition, optical coherence tomography angiography (OCTA) confirmed deep retinal capillary atrophy for the first time. Case presentation A 13-year-old patient presented with progressive vision loss and difficulty with eye opening and was diagnosed with progressive external ophthalmoplegia and retinitis pigmentosa (RP). The patient also experienced heart block, vestibular dysfunction, growth retardation and multiple demyelinating lesions. A long-range PCR study in the blood revealed a large-scale Chrm: 6341-13,993 deletion, which was first reported and broadened the genetic spectrum of this disease. The patient underwent complete ophthalmic examination, medical history review and gene detection, resulting in a confirmation of the diagnosis of KSS. The patient was given a pair of applicable glasses to wear and was followed up every 3 months. An implantable pacemaker was also installed based on the advice of the physician. Conclusions We reported a novel large-scale deletion in the mitochondrial DNA of KSS, and OCTA was used for the first time to confirm deep retinal capillary atrophy. Furthermore, because ophthalmic symptoms are often the primary manifestation of KSS, the relationship between ophthalmology and mitochondrial diseases should be emphasised.
C1 [Zhu, Qin; Chen, Chunwen; Yao, Jingyan] Soochow Univ, Dept Ophthalmol, Affiliated Hosp 1, 188 Shizi Sreet, Suzhou 215006, Peoples R China.
C3 Soochow University - China
RP Yao, JY (corresponding author), Soochow Univ, Dept Ophthalmol, Affiliated Hosp 1, 188 Shizi Sreet, Suzhou 215006, Peoples R China.
EM yjy00547@163.com
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Falavarjani KG, 2018, J OPHTHAL VIS RES, V13, P260, DOI 10.4103/jovr.jovr_173_17
   Finsterer J, 2018, CAN J CARDIOL, V34, P0, DOI 10.1016/j.cjca.2018.05.027
   Goldstein A, 2012, SEMIN PEDIATR NEUROL, V19, P181, DOI 10.1016/j.spen.2012.09.005
   Grönlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Guo L, 2020, DNA CELL BIOL, V39, P1449, DOI 10.1089/dna.2019.5010
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Kamel K, 2017, MITOCHONDRION, V35, P44, DOI 10.1016/j.mito.2017.05.004
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Latorre-Pellicer Ana, 2017, NATURE, V542, P124, DOI 10.1038/nature20773
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   MCKECHNIE NM, 1985, BRIT J OPHTHALMOL, V69, P63, DOI 10.1136/bjo.69.1.63
   Mehndiratta MM, 2002, NEUROL INDIA, V50, P162
   Min Chan Hong, 2020, KOREAN J OPHTHALMOL, V34, P106, DOI 10.3341/kjo.2019.0113
   Ortiz Alvaro, 2017, INT J RETINA VITREOUS, V3, P24, DOI 10.1186/s40942-017-0077-8
   Ozcelik H, 2012, J MOL DIAGN, V14, P467, DOI 10.1016/j.jmoldx.2012.03.006
   Sabella-Jiménez V, 2020, MOL GENET GENOM MED, V8, P0, DOI 10.1002/mgg3.1509
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100
   Shen C, 2020, BMC OPHTHALMOL, V20, P0, DOI 10.1186/s12886-020-01640-5
   Spector Reynold, 2010, CEREBROSPINAL FLUID RES, V7, P14, DOI 10.1186/1743-8454-7-14
   Xiong F, 2020, J OPHTHALMOL, V2020, P0, DOI 10.1155/2020/5896016
   Yu J, 2015, INVEST OPHTH VIS SCI, V56, P3212, DOI 10.1167/iovs.14-16270
NR 26
TC 5
Z9 5
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2415
J9 BMC OPHTHALMOL
JI BMC Ophthalmol.
PD JAN 24
PY 2022
VL 22
IS 1
BP 
EP 
DI 10.1186/s12886-021-02224-7
PG 8
WC Ophthalmology
SC Ophthalmology
GA YM5LD
UT WOS:000746615200003
PM 35073857
DA 2024-11-01
ER

PT J
AU Tanaka, M
   Szabó, A
   Spekker, E
   Polyák, H
   Tóth, F
   Vécsei, L
AF Tanaka, Masaru
   Szabo, Agnes
   Spekker, Eleonora
   Polyak, Helga
   Toth, Fanni
   Vecsei, Laszlo
TI Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan-Kynurenine Metabolic System
SO CELLS
LA English
DT Review
DE mitochondria; stress resilience; plasticity; stress; kynurenine; Alzheimer's disease; neurodegenerative; depression; anxiety; psychiatric
ID amyotrophic-lateral-sclerosis; magnetic-resonance-spectroscopy; noninvasive brain-stimulation; generalized anxiety disorder; glutamic-acid decarboxylase; muscle energy-metabolism; alzheimers-disease; mouse model; multiple-sclerosis; mutant huntingtin
AB Nearly half a century has passed since the discovery of cytoplasmic inheritance of human chloramphenicol resistance. The inheritance was then revealed to take place maternally by mitochondrial DNA (mtDNA). Later, a number of mutations in mtDNA were identified as a cause of severe inheritable metabolic diseases with neurological manifestation, and the impairment of mitochondrial functions has been probed in the pathogenesis of a wide range of illnesses including neurodegenerative diseases. Recently, a growing number of preclinical studies have revealed that animal behaviors are influenced by the impairment of mitochondrial functions and possibly by the loss of mitochondrial stress resilience. Indeed, as high as 54% of patients with one of the most common primary mitochondrial diseases, mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome, present psychiatric symptoms including cognitive impairment, mood disorder, anxiety, and psychosis. Mitochondria are multifunctional organelles which produce cellular energy and play a major role in other cellular functions including homeostasis, cellular signaling, and gene expression, among others. Mitochondrial functions are observed to be compromised and to become less resilient under continuous stress. Meanwhile, stress and inflammation have been linked to the activation of the tryptophan (Trp)-kynurenine (KYN) metabolic system, which observably contributes to the development of pathological conditions including neurological and psychiatric disorders. This review discusses the functions of mitochondria and the Trp-KYN system, the interaction of the Trp-KYN system with mitochondria, and the current understanding of the involvement of mitochondria and the Trp-KYN system in preclinical and clinical studies of major neurological and psychiatric diseases.
C1 [Tanaka, Masaru; Spekker, Eleonora; Toth, Fanni; Vecsei, Laszlo] Univ Szeged ELKH SZTE, Danube Neurosci Res Lab, Eotvos Lorand Res Network, ELKH SZTE Neurosci Res Grp, Tisza Lajos Krt 113, H-6725 Szeged, Hungary.
   [Szabo, Agnes; Polyak, Helga; Vecsei, Laszlo] Univ Szeged, Albert Szent Gyorgyi Med Sch, Dept Neurol, Semmelweis U 6, H-6725 Szeged, Hungary.
   [Szabo, Agnes; Polyak, Helga] Univ Szeged, Doctoral Sch Clin Med, Koranyi Fasor 6, H-6720 Szeged, Hungary.
C3 Hungarian Research Network; Office for Supported Research Groups (ELKH); Szeged University; Szeged University
RP Vécsei, L (corresponding author), Univ Szeged ELKH SZTE, Danube Neurosci Res Lab, Eotvos Lorand Res Network, ELKH SZTE Neurosci Res Grp, Tisza Lajos Krt 113, H-6725 Szeged, Hungary.; Vécsei, L (corresponding author), Univ Szeged, Albert Szent Gyorgyi Med Sch, Dept Neurol, Semmelweis U 6, H-6725 Szeged, Hungary.
EM vecsei.laszlo@med.u-szeged.hu
FU National Research, Development and Innovation Office [NKFIH 138125, MTA-JSP-050609]; New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research Development and Innovation Fund [UNKP-21-3, EFOP-3.6.3-VEKOP-16-2017-00009]; ELKH-SZTE
CR Aarsland TIM, 2015, BEHAV BRAIN FUNCT, V11, P0, DOI 10.1186/s12993-015-0080-x
   Abuaish S, 2021, BRAIN SCI, V11, P0, DOI 10.3390/brainsci11081038
   Adeel M, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23126850
   Aeinehband S, 2016, BRAIN BEHAV IMMUN, V51, P47, DOI 10.1016/j.bbi.2015.07.016
   Agarwal S, 2016, J BIOL CHEM, V291, P15923, DOI 10.1074/jbc.M115.709493
   Agarwala S, 2021, EGYPTIAN J MED HUMAN, V22, P0, DOI 10.1186/s43042-021-00138-z
   Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003
   Ahmad M, 2022, STATPEARLS, V0, P0
   Almannai M, 2020, MOL GENET METAB, V131, P1, DOI 10.1016/j.ymgme.2020.10.002
   Almulla AF, 2022, J ALZHEIMERS DIS, V88, P1325, DOI 10.3233/JAD-220295
   Altmaier E, 2013, PSYCHONEUROENDOCRINO, V38, P1299, DOI 10.1016/j.psyneuen.2012.11.014
   [Anonymous], 1904, BEITR CHEM PHYSIOL PATHOL, V0, P0
   Arnone D, 2018, NEUROSCI BIOBEHAV R, V92, P477, DOI 10.1016/j.neubiorev.2018.05.031
   Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998
   Avan R, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11121365
   Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, P0, DOI 10.1177/1178646917691938
   Bala S, 2013, J CHEM-NY, V2013, P0, DOI 10.1155/2013/412053
   Balogh L, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9040340
   Bandelow B, 2017, DIALOGUES CLIN NEURO, V19, P93
   Barahona AJ, 2022, TOXICS, V10, P0, DOI 10.3390/toxics10040191
   BARBIROLI B, 1992, NEUROLOGY, V42, P1209, DOI 10.1212/WNL.42.6.1209
   Barik S, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21228776
   Bartlett RD, 1998, NEUROPHARMACOLOGY, V37, P839, DOI 10.1016/S0028-3908(98)00080-X
   Battaglia S, 2022, FRONT BEHAV NEUROSCI, V16, P0, DOI 10.3389/fnbeh.2022.946263
   Battaglia S, 2022, PSYCHOPHYSIOLOGY, V59, P0, DOI 10.1111/psyp.14122
   Battaglia S, 2022, TRENDS NEUROSCI, V45, P504, DOI 10.1016/j.tins.2022.04.003
   Battaglia S, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10030627
   Battaglia S, 2022, MOL PSYCHIATR, V27, P784, DOI 10.1038/s41380-021-01326-4
   Battaglia S, 2021, BEHAV RES THER, V146, P0, DOI 10.1016/j.brat.2021.103963
   Battaglia S, 2020, J NEUROSCI, V40, P8491, DOI 10.1523/JNEUROSCI.0304-20.2020
   Battaglia S, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-31000-9
   BEAL MF, 1990, J NEUROCHEM, V55, P1327, DOI 10.1111/j.1471-4159.1990.tb03143.x
   Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105
   Bedard-Gilligan M, 2017, CLIN PSYCHOL SCI, V5, P212, DOI 10.1177/2167702616676581
   Beekman M, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0440
   Belitser VATET, 1939, BIOKHIMIYA, V4, P516
   Bergado-Acosta JR, 2008, LEARN MEMORY, V15, P163, DOI 10.1101/lm.705408
   Beyer DKE, 2017, INT J BIPOLAR DISORD, V5, P0, DOI 10.1186/s40345-017-0104-6
   Birner A, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0172699
   Blankfield A, 2012, INT J TRYPTOPHAN RES, V5, P27, DOI 10.4137/IJTR.S10085
   Blesa J, 2014, FRONT NEUROANAT, V8, P0, DOI 10.3389/fnana.2014.00155
   Boes AD, 2018, J NEUROPSYCH CLIN N, V30, P173, DOI 10.1176/appi.neuropsych.17110262
   Boeschoten RE, 2017, J NEUROL SCI, V372, P331, DOI 10.1016/j.jns.2016.11.067
   Bonda DJ, 2010, REDOX REP, V15, P161, DOI 10.1179/174329210X12650506623645
   Borgomaneri S, 2021, BRAIN SCI, V11, P0, DOI 10.3390/brainsci11091203
   Borgomaneri S, 2021, NEUROSCI BIOBEHAV R, V127, P334, DOI 10.1016/j.neubiorev.2021.04.036
   Borgomaneri S, 2021, J AFFECT DISORDERS, V286, P78, DOI 10.1016/j.jad.2021.02.076
   Borgomaneri S, 2020, CORTEX, V132, P404, DOI 10.1016/j.cortex.2020.09.002
   Borgomaneri S, 2020, CURR BIOL, V30, P3672, DOI 10.1016/j.cub.2020.06.091
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Brady RO, 2013, BIPOLAR DISORD, V15, P434, DOI 10.1111/bdi.12074
   Bryn V, 2018, NEUROPSYCHOBIOLOGY, V76, P82, DOI 10.1159/000488157
   Burtscher J, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21155412
   Calarco CA, 2021, FRONT PSYCHIATRY, V12, P0, DOI 10.3389/fpsyt.2021.737389
   Candini M, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-82223-2
   Cao B, 2017, MOL PSYCHIATR, V22, P1352, DOI 10.1038/mp.2016.262
   Carafoli E, 2012, CELL CALCIUM, V52, P1, DOI 10.1016/j.ceca.2012.02.007
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Carrillo-Mora P, 2020, NEUROREHAB NEURAL RE, V34, P936, DOI 10.1177/1545968320953671
   Castillo-Mariqueo L, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10050973
   Cenini G, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/1270256
   Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018
   Chen APF, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9060647
   Chen C, 2022, ADV CLIN EXP MED, V31, P355, DOI 10.17219/acem/147441
   Chen YQ, 2010, NEUROTOX RES, V18, P132, DOI 10.1007/s12640-009-9129-7
   Chia SJ, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21072464
   Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162
   Ciapala K, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222011055
   Comings DE, 2001, ANN NY ACAD SCI, V931, P50
   Copeland CS, 2013, NEUROPHARMACOLOGY, V66, P133, DOI 10.1016/j.neuropharm.2012.03.009
   Correia BSB, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9030235
   Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766
   Curto M, 2016, J HEADACHE PAIN, V17, P0, DOI 10.1186/s10194-016-0638-5
   Curto M, 2016, J HEADACHE PAIN, V17, P0, DOI 10.1186/s10194-016-0620-2
   Cutler JA, 2012, J PSYCHOPHARMACOL, V26, P360, DOI 10.1177/0269881111434622
   Dias FLD, 2013, REV ASSOC MED BRAS, V59, P435, DOI 10.1016/j.ramb.2013.04.004
   Dafinca R, 2016, STEM CELLS, V34, P2063, DOI 10.1002/stem.2388
   Dahoun T, 2017, TRANSL PSYCHIAT, V7, P0, DOI 10.1038/tp.2016.282
   Dai M-H, 2018, ONCOTARGET, V9, P15132, DOI 10.18632/ONCOTARGET.23738
   Daniels TE, 2020, ANNU REV CLIN PSYCHO, V16, P165, DOI 10.1146/annurev-clinpsy-082719-104030
   de Barcelos IP, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020037
   de Pablo GS, 2021, BRAIN SCI, V11, P0, DOI 10.3390/brainsci11111544
   De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226
   Carrera-González MD, 2022, ADV CLIN EXP MED, V31, P469, DOI 10.17219/acem/149897
   Delgado PL, 2000, J CLIN PSYCHIAT, V61, P7
   Demarquoy Jean, 2015, WORLD J BIOL CHEM, V6, P301, DOI 10.4331/wjbc.v6.i4.301
   DeTure MA, 2019, MOL NEURODEGENER, V14, P0, DOI 10.1186/s13024-019-0333-5
   Diogo CV, 2018, BIOCHEM BIOPH RES CO, V500, P87, DOI 10.1016/j.bbrc.2017.04.124
   Dixit S, 2017, FREE RADICAL BIO MED, V112, P515, DOI 10.1016/j.freeradbiomed.2017.08.021
   Dong X, 2017, NEUROSCI LETT, V636, P127, DOI 10.1016/j.neulet.2016.10.054
   Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x
   Dugger BN, 2017, CSH PERSPECT BIOL, V9, P0, DOI 10.1101/cshperspect.a028035
   Ehret Megan, 2019, MENT HEALTH CLIN, V9, P373, DOI 10.9740/mhc.2019.11.373
   Ellena G, 2020, EXP BRAIN RES, V238, P2009, DOI 10.1007/s00221-020-05829-4
   Erabi H, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-73918-z
   Erhardt S, 2017, BIOL PSYCHIAT, V82, P756, DOI 10.1016/j.biopsych.2016.12.011
   ERNSTER L, 1959, NATURE, V184, P1851, DOI 10.1038/1841851a0
   Falk MJ, 2010, CURR OPIN PEDIATR, V22, P711, DOI 10.1097/MOP.0b013e3283402e21
   Fan HC, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11111111
   Faras H, 2010, ANN SAUDI MED, V30, P295, DOI 10.4103/0256-4947.65261
   Farooq RK, 2017, BIOMED REP, V6, P15, DOI 10.3892/br.2016.807
   Fazio F, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep17799
   Fila M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms221810134
   Finkel T, 2015, CIRC RES, V116, P1810, DOI 10.1161/CIRCRESAHA.116.305484
   Fiske CH, 1929, SCIENCE, V70, P381, DOI 10.1126/science.70.1816.381-a
   FLATMARK T, 1980, EUR J CELL BIOL, V23, P141
   Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017
   Fonseca F, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9124103
   Forrest CM, 2010, J NEUROCHEM, V112, P112, DOI 10.1111/j.1471-4159.2009.06442.x
   Fride E, 2005, BEHAV PHARMACOL, V16, P431, DOI 10.1097/00008877-200509000-00016
   Fried NT, 2014, AM J PHYSIOL-CELL PH, V307, PC1017, DOI 10.1152/ajpcell.00332.2013
   FRIEDKIN M, 1949, J BIOL CHEM, V178, P611
   Frye RE, 2020, SEMIN PEDIATR NEUROL, V35, P0, DOI 10.1016/j.spen.2020.100829
   Frye RE, 2020, TRANSL PSYCHIAT, V10, P0, DOI 10.1038/s41398-020-00905-3
   Gaebler AJ, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10051096
   Gamaro GD, 2003, NEUROCHEM RES, V28, P1339, DOI 10.1023/A:1024988113978
   Gamboa OL, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10071555
   Gano LB, 2014, J LIPID RES, V55, P2211, DOI 10.1194/jlr.R048975
   Garofalo S, 2017, J COGNITIVE NEUROSCI, V29, P718, DOI 10.1162/jocn_a_01074
   Gebara E, 2021, BIOL PSYCHIAT, V89, P1033, DOI 10.1016/j.biopsych.2020.12.003
   Gecse K, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11142258
   Giménez-Gómez P, 2021, NEUROPHARMACOLOGY, V197, P0, DOI 10.1016/j.neuropharm.2021.108753
   Giménez-Palomo A, 2021, FRONT PSYCHIATRY, V12, P0, DOI 10.3389/fpsyt.2021.546801
   Giorgi C, 2018, INT REV CEL MOL BIO, V340, P209, DOI 10.1016/bs.ircmb.2018.05.006
   Giorgini F, 2013, J BIOL CHEM, V288, P36554, DOI 10.1074/jbc.M113.503813
   Gladka A, 2022, ADV CLIN EXP MED, V31, P1139, DOI 10.17219/acem/149988
   Gong Y, 2011, NEUROSCI LETT, V488, P76, DOI 10.1016/j.neulet.2010.11.006
   Gonzalez-Escamilla G, 2022, FRONT BEHAV NEUROSCI, V16, P0, DOI 10.3389/fnbeh.2022.924305
   Gonzalez-Rodríguez P, 2021, NATURE, V599, P650, DOI 10.1038/s41586-021-04059-0
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008
   Gross EC, 2019, NAT REV NEUROL, V15, P627, DOI 10.1038/s41582-019-0255-4
   GUBBAY SS, 1985, J NEUROL, V232, P295, DOI 10.1007/BF00313868
   Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006
   Guillemin GJ, 2005, NEUROPATH APPL NEURO, V31, P395, DOI 10.1111/j.1365-2990.2005.00655.x
   Gulaj E, 2010, ADV MED SCI-POLAND, V55, P204, DOI 10.2478/v10039-010-0023-6
   Gusev A, 2020, COMMUNICATION, V0, P0
   Gutiérrez-Rojas L, 2020, BRAZ J PSYCHIAT, V42, P657
   Gutknecht L, 2015, PSYCHOPHARMACOLOGY, V232, P2429, DOI 10.1007/s00213-015-3879-0
   Hales KG, 2010, NAT. EDUC, V3, P12
   Han Q, 2008, BIOSCIENCE REP, V28, P205, DOI 10.1042/BSR20080085
   Hartai Z, 2005, J NEUROL SCI, V239, P31, DOI 10.1016/j.jns.2005.07.006
   Hartai Z, 2005, ACTA NEUROL SCAND, V112, P93, DOI 10.1111/j.1600-0404.2005.00442.x
   Hattori Satoko, 2018, NEUROPSYCHOPHARMACOLOGY REPORTS, V38, P52, DOI 10.1002/npr2.12006
   Hepsomali P, 2022, ADV CLIN EXP MED, V31, P821, DOI 10.17219/acem/152350
   Heredi J, 2017, BRAIN STRUCT FUNCT, V222, P1663, DOI 10.1007/s00429-016-1299-5
   Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001
   Hill JL, 2016, TRANSL PSYCHIAT, V6, P0, DOI 10.1038/tp.2016.153
   Hirata Nao, 2018, NEUROPSYCHOPHARMACOLOGY REPORTS, V38, P133, DOI 10.1002/npr2.12019
   Hollis F, 2015, P NATL ACAD SCI USA, V112, P15486, DOI 10.1073/pnas.1512653112
   Holper L, 2019, NEUROPSYCHOPHARMACOL, V44, P837, DOI 10.1038/s41386-018-0090-0
   Holt DJ, 2009, BIOL PSYCHIAT, V65, P455, DOI 10.1016/j.biopsych.2008.09.017
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holtze M, 2012, J PSYCHIATR NEUROSCI, V37, P53, DOI 10.1503/jpn.100175
   Huang WJ, 2017, EXP THER MED, V13, P3163, DOI 10.3892/etm.2017.4410
   Hunt C, 2020, NEUROSCI BIOBEHAV R, V118, P514, DOI 10.1016/j.neubiorev.2020.08.010
   Ilzecka J, 2003, ACTA NEUROL SCAND, V107, P412, DOI 10.1034/j.1600-0404.2003.00076.x
   ISSA F, 1994, PSYCHIAT RES, V52, P251, DOI 10.1016/0165-1781(94)90070-1
   Jacobs KR, 2019, NEUROBIOL AGING, V80, P11, DOI 10.1016/j.neurobiolaging.2019.03.015
   Jamshed L, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23116300
   Jhelum P, 2020, J NEUROSCI, V40, P9327, DOI 10.1523/JNEUROSCI.1749-20.2020
   Jia YB, 2018, PSYCHONEUROENDOCRINO, V95, P97, DOI 10.1016/j.psyneuen.2018.05.015
   Jiang S, 2019, FRONT PSYCHIATRY, V10, P0, DOI 10.3389/fpsyt.2019.00808
   Jopowicz A, 2022, BRAIN SCI, V12, P0, DOI 10.3390/brainsci12030345
   Jovanovic F, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21176045
   Kanai M, 2009, MOL BRAIN, V2, P0, DOI 10.1186/1756-6606-2-8
   Kanungo S, 2018, ANN TRANSL MED, V6, P0, DOI 10.21037/atm.2018.12.13
   Kasahara T, 2016, MOL PSYCHIATR, V21, P39, DOI 10.1038/mp.2015.156
   Kato T, 2017, SCHIZOPHR RES, V187, P62, DOI 10.1016/j.schres.2016.10.037
   Kaye J, 2021, FACULTY REV, V10, P77, DOI 10.12703/r/10-77
   Kee TR, 2021, FRONT AGING NEUROSCI, V13, P0, DOI 10.3389/fnagi.2021.660843
   Khajuria K, 2021, INT J PHARM PHARM SCI, V13, P14, DOI 10.22159/IJPPS.2021V13I3.40335
   Khan NA, 2015, INDIAN J MED RES, V141, P13
   Kim H, 2012, J CLIN INVEST, V122, P2940, DOI 10.1172/JCI61884
   Kim HW, 2015, NEUROBIOL AGING, V36, P2617, DOI 10.1016/j.neurobiolaging.2015.05.008
   Kim JI, 2019, FRONT PSYCHIATRY, V10, P0, DOI 10.3389/fpsyt.2019.00506
   Kim TD, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9020107
   King SB, 2017, NEUROPSYCHOPHARMACOL, V42, P1679, DOI 10.1038/npp.2017.16
   Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   KLINGMAN JD, 1958, J BIOL CHEM, V232, P369
   Klivenyi P, 2001, J NEUROL NEUROSUR PS, V70, P359, DOI 10.1136/jnnp.70.3.359
   Koene S, 2013, MITOCHONDRION, V13, P15, DOI 10.1016/j.mito.2012.11.002
   Kozin M, 2020, GENE, V758, P0, DOI 10.1016/j.gene.2020.144962
   Krebs HS, 1987, KREBS CITRIC ACID CY, V0, P25
   Krebs HA, 1937, BIOCHEM J, V31, P645, DOI 10.1042/bj0310645
   Krebs HA, 1940, BIOCHEM J, V34, P775, DOI 10.1042/bj0340775
   Kristensen M, 2018, MOL PSYCHIATR, V23, P70, DOI 10.1038/mp.2017.192
   Kvajo M, 2011, P NATL ACAD SCI USA, V108, PE1349, DOI 10.1073/pnas.1114113108
   Kyaga S, 2013, J PSYCHIATR RES, V47, P83, DOI 10.1016/j.jpsychires.2012.09.010
   Latchoumycandane C, 2011, TOXICOL APPL PHARM, V256, P314, DOI 10.1016/j.taap.2011.07.021
   Lee A, 2018, CURR OPIN PHYSIOL, V3, P82, DOI 10.1016/j.cophys.2018.03.009
   Lee GA, 2021, BRAIN SCI, V11, P0, DOI 10.3390/brainsci11081085
   Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054
   Lesiewska N, 2022, FRONT BIOSCI-LANDMRK, V27, P0, DOI 10.31083/j.fbl2703076
   LeWitt PA, 2013, MOVEMENT DISORD, V28, P1653, DOI 10.1002/mds.25555
   Li RX, 2016, MED SCI MONITOR, V22, P3229, DOI 10.12659/MSM.900185
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Lim CK, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep41473
   Lim CK, 2016, AUTISM RES, V9, P621, DOI 10.1002/aur.1565
   Lin CC, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23105494
   LIPMANN F, 1946, J BIOL CHEM, V162, P743
   LIPMANN F, 1954, SCIENCE, V120, P855, DOI 10.1126/science.120.3126.855
   LITTLEWOOD J, 1984, J NEUROL NEUROSUR PS, V47, P338, DOI 10.1136/jnnp.47.4.338
   Liu DL, 2021, SIGNAL TRANSDUCT TAR, V6, P0, DOI 10.1038/s41392-020-00440-z
   Liu Y, 2017, J NEUROSCI, V37, P871, DOI 10.1523/JNEUROSCI.2235-16.2016
   Lohmann K, 1929, NATURWISSENSCHAFTEN, V17, P624
   Lugo-Huitrón R, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/104024
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Magrané J, 2014, HUM MOL GENET, V23, P1413, DOI 10.1093/hmg/ddt528
   Mahone EM, 2017, J INT NEUROPSYCH SOC, V23, P916, DOI 10.1017/S1355617717000807
   Majláth Z, 2014, J NEURAL TRANSM, V121, P881, DOI 10.1007/s00702-013-1135-5
   Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0
   Martin EI, 2009, PSYCHIAT CLIN N AM, V32, P549, DOI 10.1016/j.psc.2009.05.004
   Martos D, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10040849
   MARUYAMA K, 1991, J HIST BIOL, V24, P145
   Marx W, 2021, MOL PSYCHIATR, V26, P4158, DOI 10.1038/s41380-020-00951-9
   McCormick EM, 2018, CURR OPIN PEDIATR, V30, P714, DOI 10.1097/MOP.0000000000000686
   Mehla J, 2019, NEUROBIOL AGING, V75, P25, DOI 10.1016/j.neurobiolaging.2018.10.026
   Menalled Liliana B, 2005, NEURORX, V2, P465, DOI 10.1602/neurorx.2.3.465
   Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12
   Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026
   Mirchandani-Duque M, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10061297
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Moisoi N, 2014, NEUROPHARMACOLOGY, V77, P350, DOI 10.1016/j.neuropharm.2013.10.009
   MONTAGNA P, 1988, HEADACHE, V28, P477, DOI 10.1111/j.1526-4610.1988.hed2807477.x
   Montano V, 2021, ARCH BIOCHEM BIOPHYS, V697, P0, DOI 10.1016/j.abb.2020.108689
   Mor A, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10071603
   Morales-Puerto N, 2021, PHARMACOL THERAPEUT, V223, P0, DOI 10.1016/j.pharmthera.2021.107807
   Morrice JR, 2018, NEURAL REGEN RES, V13, P2050, DOI 10.4103/1673-5374.241445
   Mosienko V, 2012, TRANSL PSYCHIAT, V2, P0, DOI 10.1038/tp.2012.44
   Murakami Y, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-49781-y
   Nabi R, 2004, AM J MED GENET B, V125B, P63, DOI 10.1002/ajmg.b.20147
   Nagy-Grócz G, 2016, CEPHALALGIA, V36, P849, DOI 10.1177/0333102415613766
   Naito M, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10020454
   Niigaki ST, 2019, PROG NEURO-PSYCHOPH, V90, P169, DOI 10.1016/j.pnpbp.2018.11.020
   Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Noguchi M, 2018, BIOCHEM BIOPH RES CO, V500, P59, DOI 10.1016/j.bbrc.2017.06.094
   Norkett R, 2016, J BIOL CHEM, V291, P613, DOI 10.1074/jbc.M115.699447
   Nyatega CO, 2021, APPL SCI-BASEL, V11, P0, DOI 10.3390/app112311392
   OConnor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722
   OTuathaigh CMP, 2012, INT J NEUROPSYCHOPH, V15, P1331, DOI 10.1017/S1461145711001581
   Ogawa S, 2014, J CLIN PSYCHIAT, V75, PE906, DOI 10.4088/JCP.13r08908
   Ogyu K, 2018, NEUROSCI BIOBEHAV R, V90, P16, DOI 10.1016/j.neubiorev.2018.03.023
   Okada H, 1998, HEADACHE, V38, P39, DOI 10.1046/j.1526-4610.1998.3801039.x
   Okada K, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0040307
   Okusaga O, 2016, PSYCHOSOM MED, V78, P931, DOI 10.1097/PSY.0000000000000352
   ORLIKOV AB, 1994, BIOL PSYCHIAT, V36, P97, DOI 10.1016/0006-3223(94)91189-4
   Orso B, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10030544
   Otto C, 2001, MOL BRAIN RES, V92, P78, DOI 10.1016/S0169-328X(01)00153-X
   Palego Lionella, 2016, J AMINO ACIDS, V2016, P8952520, DOI 10.1155/2016/8952520
   Palotai M, 2014, BEHAV BRAIN RES, V274, P264, DOI 10.1016/j.bbr.2014.08.007
   Panov A, 2010, J MEMBRANE BIOL, V237, P71, DOI 10.1007/s00232-010-9307-9
   Panov G, 2022, FRONT PSYCHIATRY, V13, P0, DOI 10.3389/fpsyt.2022.845493
   Park A, 2009, J NEUROL, V256, PS293, DOI 10.1007/s00415-009-5240-1
   Park C, 2012, MOL CELLS, V33, P105, DOI 10.1007/s10059-012-2284-3
   PEARSON SJ, 1992, NEUROSCI LETT, V144, P199, DOI 10.1016/0304-3940(92)90749-W
   Picard M, 2018, PSYCHOSOM MED, V80, P141, DOI 10.1097/PSY.0000000000000545
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Polyák H, 2021, HELIYON, V7, P0, DOI 10.1016/j.heliyon.2021.e06124
   Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39
   Praet J, 2014, NEUROSCI BIOBEHAV R, V47, P485, DOI 10.1016/j.neubiorev.2014.10.004
   Prescott C, 2006, NEUROSCI LETT, V402, P108, DOI 10.1016/j.neulet.2006.03.051
   Preston G, 2020, BRAIN BEHAV IMMUN-HL, V6, P0, DOI 10.1016/j.bbih.2020.100104
   Procaccini C, 2015, EUR J PHARMACOL, V759, P182, DOI 10.1016/j.ejphar.2015.03.042
   Pukoli D, 2021, FRONT NEUROSCI-SWITZ, V15, P0, DOI 10.3389/fnins.2021.658202
   Qi XP, 2006, J BIOL CHEM, V281, P31950, DOI 10.1074/jbc.M603717200
   Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499
   Rajasekaran A, 2015, NEUROSCI BIOBEHAV R, V48, P10, DOI 10.1016/j.neubiorev.2014.11.005
   Rajda C, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21082665
   Ortega DR, 2022, ANTIOXIDANTS-BASEL, V11, P0, DOI 10.3390/antiox11010031
   Refolo G, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00008
   Reiner A, 2011, INT REV NEUROBIOL, V98, P325, DOI 10.1016/B978-0-12-381328-2.00014-6
   Reyngoudt H, 2012, CEPHALALGIA, V32, P845, DOI 10.1177/0333102412452048
   Reyngoudt H, 2011, CEPHALALGIA, V31, P1243, DOI 10.1177/0333102410394675
   Richter-Levin G, 2019, MOL PSYCHIATR, V24, P1135, DOI 10.1038/s41380-018-0272-5
   Rigotto G, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/7210892
   Rog J, 2020, BIOMEDICINES, V8, P0, DOI 10.3390/biomedicines8080243
   Romero-Garcia S, 2019, INT J ONCOL, V54, P1155, DOI 10.3892/ijo.2019.4696
   Rönnbäck A, 2016, J NEUROCHEM, V136, P497, DOI 10.1111/jnc.13410
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Rózsa E, 2008, J NEURAL TRANSM, V115, P1087, DOI 10.1007/s00702-008-0052-5
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   Ruscio AM, 2017, JAMA PSYCHIAT, V74, P465, DOI 10.1001/jamapsychiatry.2017.0056
   Sabbagh JJ, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0107241
   Saccaro LF, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9101313
   Sadeghian M, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep33249
   Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   Santuy A, 2018, CEREB CORTEX, V28, P3673, DOI 10.1093/cercor/bhy159
   Sareen J, 1900, PATHOPHYSIOLOGY, V0, P0
   Scaglia F, 2010, DEV DISABIL RES REV, V16, P136, DOI 10.1002/ddrr.115
   Schlieben LD, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.600079
   Schuck PF, 2007, NEUROSCI RES, V57, P277, DOI 10.1016/j.neures.2006.10.013
   Schulz UG, 2007, BRAIN, V130, P3102, DOI 10.1093/brain/awm165
   Schwarz MJ, 2013, EUR ARCH PSY CLIN N, V263, P345, DOI 10.1007/s00406-012-0384-x
   Sellitto M, 2022, BRAIN SCI, V12, P0, DOI 10.3390/brainsci12050582
   Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732
   Sheng ZH, 2017, TRENDS CELL BIOL, V27, P403, DOI 10.1016/j.tcb.2017.01.005
   Shi HJ, 2017, NEW ENGL J MED, V377, P544, DOI 10.1056/NEJMoa1616361
   Simon C, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23095193
   SKINHOJ E, 1973, ARCH NEUROL-CHICAGO, V29, P95, DOI 10.1001/archneur.1973.00490260039007
   Smith AK, 2012, MOL PSYCHIATR, V17, P781, DOI 10.1038/mp.2011.67
   Smith EF, 2019, NEUROSCI LETT, V710, P0, DOI 10.1016/j.neulet.2017.06.052
   Soledad RB, 2019, ARCH BIOCHEM BIOPHYS, V666, P52, DOI 10.1016/j.abb.2019.03.019
   Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886
   Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x
   Spekker E, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10010076
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Stenton Sarah L, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI138267
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Stone TW, 2020, J NEUROCHEM, V152, P627, DOI 10.1111/jnc.14907
   Strawn JR, 2018, EXPERT OPIN PHARMACO, V19, P1057, DOI 10.1080/14656566.2018.1491966
   Stryer L, 1995, BIOCHEMISTRY-US, V0, P603
   Sundaramurthy S, 2021, GRAEF ARCH CLIN EXP, V259, P2461, DOI 10.1007/s00417-020-04993-1
   Taliaz D, 2021, TRANSL PSYCHIAT, V11, P0, DOI 10.1038/s41398-021-01488-3
   Tanaka M, 2012, BEHAV BRAIN RES, V228, P388, DOI 10.1016/j.bbr.2011.12.022
   Tanaka M, 2011, BRAIN RES BULL, V84, P414, DOI 10.1016/j.brainresbull.2011.01.016
   Tanaka M, 2022, P 1 INT EL C BIOM BA, V0, PP10301, DOI 10.3390/ECB2021-10301
   Tanaka M, 2021, NEUROPSYCHOPHARMACOTHERAPY, V0, PP1, DOI 10.1007/978-3-319-56015-1_444-1
   Tanaka M, 2022, CASE SERIES, V0, P1
   Tanaka M, 2020, ARXIV, V0, P0
   Tanaka M, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23136991
   Tanaka M, 2022, J NEURAL TRANSM, V129, P627, DOI 10.1007/s00702-022-02513-5
   Tanaka M, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9080897
   Tanaka M, 2021, ADV CLIN EXP MED, V30, P775, DOI 10.17219/acem/139572
   Tanaka M, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9070734
   Tanaka M, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9050517
   Tanaka M, 2021, EXPERT OPIN PHARMACO, V22, P1221, DOI 10.1080/14656566.2021.1910235
   Tanaka M, 2020, BIOMEDICINES, V8, P0, DOI 10.3390/biomedicines8100406
   Tanaka M, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21072431
   Tanaka M, 2020, PHARMACOL REP, V72, P449, DOI 10.1007/s43440-020-00067-5
   Tanaka M, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25030564
   Tanaka M, 2014, BEHAV BRAIN RES, V259, P196, DOI 10.1016/j.bbr.2013.11.005
   Telegdy G, 2011, BEHAV BRAIN RES, V224, P155, DOI 10.1016/j.bbr.2011.05.036
   Telegdy G, 2009, NEUROPEPTIDES, V43, P229, DOI 10.1016/j.npep.2009.03.001
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Thabault M, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23042294
   Thomas RL, 2013, CIRC J, V77, P2449, DOI 10.1253/circj.CJ-13-0835
   Todkar K, 2017, FRONT CELL DEV BIOL, V5, P0, DOI 10.3389/fcell.2017.00106
   Too LK, 2016, DATA BRIEF, V9, P275, DOI 10.1016/j.dib.2016.08.071
   Too LK, 2016, BEHAV BRAIN RES, V312, P102, DOI 10.1016/j.bbr.2016.06.018
   Török N, 2021, PREPRINTS, V0, P0, DOI DOI 10.20944/preprints202010.0172.v2
   Török N, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21249338
   Trowbridge S, 2011, ANAT REC, V294, P1615, DOI 10.1002/ar.21248
   Tuka B, 2021, J HEADACHE PAIN, V22, P0, DOI 10.1186/s10194-021-01239-1
   U.S. Department of Health and Human Services (HHS) Office of the Surgeon General, 2016, FACING ADDICTION IN AMERICA: THE SURGEON GENERALS REPORT ON ALCOHOL, V0, P0
   Uhl GR, 2019, ANN NY ACAD SCI, V1451, P5, DOI 10.1111/nyas.13989
   Ulivieri M, 2020, SCHIZOPHRENIA BULL, V46, P1471, DOI 10.1093/schbul/sbaa074
   UNCINI A, 1995, J NEUROL SCI, V129, P214, DOI 10.1016/0022-510X(94)00283-T
   van Donkelaar EL, 2011, MOL PSYCHIATR, V16, P695, DOI 10.1038/mp.2011.9
   van Enkhuizen J, 2013, BEHAV BRAIN RES, V249, P44, DOI 10.1016/j.bbr.2013.04.023
   Vringer E, 2019, FRONT CELL DEV BIOL, V7, P0, DOI 10.3389/fcell.2019.00100
   WAKABAYASHI T, 1975, ACTA PATHOL JAPON, V25, P39
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang AK, 2018, SCHIZOPHRENIA BULL, V44, P75, DOI 10.1093/schbul/sbx035
   Wang BY, 2021, FRONT AGING NEUROSCI, V13, P0, DOI 10.3389/fnagi.2021.650038
   Wang QZ, 2017, PROG NEURO-PSYCHOPH, V77, P99, DOI 10.1016/j.pnpbp.2017.04.008
   Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319
   Wang YC, 2022, EXP NEUROL, V349, P0, DOI 10.1016/j.expneurol.2021.113964
   Wang Y, 2019, CNS NEUROSCI THER, V25, P816, DOI 10.1111/cns.13116
   Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007
   Wen L, 2014, PHYSIOL BEHAV, V132, P57, DOI 10.1016/j.physbeh.2014.04.050
   Widner B, 1999, ADV EXP MED BIOL, V467, P133
   Wohleb ES, 2016, NAT REV NEUROSCI, V17, P497, DOI 10.1038/nrn.2016.69
   Womer FY, 2009, ACTA NEUROPSYCHIATR, V21, P228, DOI 10.1111/j.1601-5215.2009.00414.x
   Wonodi I, 2014, SCHIZOPHR RES, V160, P80, DOI 10.1016/j.schres.2014.10.026
   Xia MF, 2019, CELL BIOSCI, V9, P0, DOI 10.1186/s13578-019-0289-8
   Xu ZL, 2016, CURR GENOMICS, V17, P215, DOI 10.2174/1389202917666160202215748
   Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106
   Yardeni T, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2021429118
   Yeo AJ, 2021, ISCIENCE, V24, P0, DOI 10.1016/j.isci.2020.101972
   Yu P, 2004, MOL CELL BIOL, V24, P6919, DOI 10.1128/MCB.24.16.6919-6930.2004
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhang W, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20133210
   Zhang Y, 2011, CIRC-CARDIOVASC GENE, V4, P687, DOI 10.1161/CIRCGENETICS.110.959064
NR 390
TC 117
Z9 116
U1 15
U2 83
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD AUG 15
PY 2022
VL 11
IS 16
BP 
EP 
DI 10.3390/cells11162607
PG 42
WC Cell Biology
SC Cell Biology
GA 4B8UZ
UT WOS:000846046200001
PM 36010683
DA 2024-11-01
ER

PT J
AU Curtis, WM
   Seeds, WA
   Mattson, MP
   Bradshaw, PC
AF Curtis, William M.
   Seeds, William A.
   Mattson, Mark P.
   Bradshaw, Patrick C.
TI NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson's Disease
SO CELLS
LA English
DT Review
DE Parkinson's disease; mitochondrial quality control; NADPH; DJ-1; PINK1; Parkin; IDH1; metabolic therapy; fasting; exercise; NAD; mitophagy; mitochondrial biogenesis; circadian; nicotinamide adenine dinucleotide; nicotinamide adenine dinucleotide phosphate; coffee
ID nicotinamide-adenine-dinucleotide; permeability transition pore; transcription factor-4 atf4; extends life-span; skeletal-muscle; redox state; oxidative stress; dna deletions; beta-hydroxybutyrate; dietary restriction
AB Dysfunctional mitochondrial quality control (MQC) is implicated in the pathogenesis of Parkinson's disease (PD). The improper selection of mitochondria for mitophagy increases reactive oxygen species (ROS) levels and lowers ATP levels. The downstream effects include oxidative damage, failure to maintain proteostasis and ion gradients, and decreased NAD(+) and NADPH levels, resulting in insufficient energy metabolism and neurotransmitter synthesis. A ketosis-based metabolic therapy that increases the levels of (R)-3-hydroxybutyrate (BHB) may reverse the dysfunctional MQC by partially replacing glucose as an energy source, by stimulating mitophagy, and by decreasing inflammation. Fasting can potentially raise cytoplasmic NADPH levels by increasing the mitochondrial export and cytoplasmic metabolism of ketone body-derived citrate that increases flux through isocitrate dehydrogenase 1 (IDH1). NADPH is an essential cofactor for nitric oxide synthase, and the nitric oxide synthesized can diffuse into the mitochondrial matrix and react with electron transport chain-synthesized superoxide to form peroxynitrite. Excessive superoxide and peroxynitrite production can cause the opening of the mitochondrial permeability transition pore (mPTP) to depolarize the mitochondria and activate PINK1-dependent mitophagy. Both fasting and exercise increase ketogenesis and increase the cellular NAD(+)/NADH ratio, both of which are beneficial for neuronal metabolism. In addition, both fasting and exercise engage the adaptive cellular stress response signaling pathways that protect neurons against the oxidative and proteotoxic stress implicated in PD. Here, we discuss how intermittent fasting from the evening meal through to the next-day lunch together with morning exercise, when circadian NAD(+)/NADH is most oxidized, circadian NADP(+)/NADPH is most reduced, and circadian mitophagy gene expression is high, may slow the progression of PD.
C1 [Curtis, William M.; Bradshaw, Patrick C.] East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA.
   [Seeds, William A.] Spire Inst, Seeds Sci Performance Res, Geneva, OH 44041 USA.
   [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.
C3 East Tennessee State University; Johns Hopkins University
RP Bradshaw, PC (corresponding author), East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA.
EM bradshawp@etsu.edu
FU NIH [AG059096]
CR Abdrakhmanova A, 2006, BBA-BIOENERGETICS, V1757, P1676, DOI 10.1016/j.bbabio.2006.09.003
   Abraham MA, 2016, DIABETOLOGIA, V59, P1367, DOI 10.1007/s00125-016-3950-3
   Acosta-Rodríguez V, 2022, SCIENCE, V376, P1192, DOI 10.1126/science.abk0297
   ADAMS JD, 1993, FREE RADICAL BIO MED, V15, P181, DOI 10.1016/0891-5849(93)90057-2
   Almasalmeh A, 2014, FEBS J, V281, P647, DOI 10.1111/febs.12653
   Almeida LM, 2022, BIOL REV, V97, P1737, DOI 10.1111/brv.12860
   Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200
   Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054
   Barber CN, 2019, FRONT CELL NEUROSCI, V13, P0, DOI 10.3389/fncel.2019.00212
   BEATTIE DS, 1967, J BIOL CHEM, V242, P4584
   Beg M, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.26896
   Bell SM, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21238924
   Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200
   Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Blacker TS, 2016, FREE RADICAL BIO MED, V100, P53, DOI 10.1016/j.freeradbiomed.2016.08.010
   Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bomba-Warczak E, 2021, J CELL BIOL, V220, P0, DOI 10.1083/jcb.202005193
   Borst P, 2020, IUBMB LIFE, V72, P2241, DOI 10.1002/iub.2367
   Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   Brakedal B, 2022, CELL METAB, V34, P396, DOI 10.1016/j.cmet.2022.02.001
   Breen DP, 2014, JAMA NEUROL, V71, P589, DOI 10.1001/jamaneurol.2014.65
   Brekk OR, 2020, P NATL ACAD SCI USA, V117, P27646, DOI 10.1073/pnas.2003021117
   Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0
   Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223
   Butkovich LM, 2020, J NEUROSCI, V40, P7559, DOI 10.1523/JNEUROSCI.1468-19.2020
   Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258
   Cai R, 2019, J CLIN INVEST, V129, P4539, DOI 10.1172/JCI129987
   Cai Y, 2010, EUR J NEUROL, V17, P550, DOI 10.1111/j.1468-1331.2009.02848.x
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0
   Chen L, 2019, NAT METAB, V1, P404, DOI 10.1038/s42255-019-0043-x
   Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49
   Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264
   Chinta SJ, 2018, CELL REP, V22, P930, DOI 10.1016/j.celrep.2017.12.092
   Choi A, 2021, NEUROTHERAPEUTICS, V18, P1637, DOI 10.1007/s13311-021-01067-w
   Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837
   Colman RJ, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4557
   Conlon N, 2022, BIOCHEM PHARMACOL, V198, P0, DOI 10.1016/j.bcp.2022.114946
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   da Fonseca TL, 2015, BIOMOLECULES, V5, P435, DOI 10.3390/biom5020435
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Daneshmandi S, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.67476
   de Abreu RM, 2019, BRAZ J PHYS THER, V23, P279, DOI 10.1016/j.bjpt.2018.09.010
   de Goede P, 2022, FASEB J, V36, P0, DOI 10.1096/fj.202100707R
   de Goede P, 2018, J MOL ENDOCRINOL, V60, PR115, DOI 10.1530/JME-17-0196
   Dedkova EN, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00260
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Di Benedetto S, 2017, NEUROSCI BIOBEHAV R, V75, P114, DOI 10.1016/j.neubiorev.2017.01.044
   Dolgacheva LP, 2019, J BIOENERG BIOMEMBR, V51, P175, DOI 10.1007/s10863-019-09798-4
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Dorninger F, 2020, NEUROBIOL DIS, V145, P0, DOI 10.1016/j.nbd.2020.105061
   Du J, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2200923119
   Edwards C, 2014, AGING-US, V6, P621, DOI 10.18632/aging.100683
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Elamin M, 2017, FRONT MOL NEUROSCI, V10, P0, DOI 10.3389/fnmol.2017.00377
   Eldeeb MA, 2022, PHYSIOL REV, V102, P1721, DOI 10.1152/physrev.00041.2021
   Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607
   Erlich AT, 2018, AM J PHYSIOL-CELL PH, V314, PC62, DOI 10.1152/ajpcell.00162.2017
   Estrada NM, 2009, FRONT SYST NEUROSCI, V3, P0, DOI 10.3389/neuro.06.005.2009
   Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109
   ForsmarkAndree P, 1996, ARCH BIOCHEM BIOPHYS, V336, P113, DOI 10.1006/abbi.1996.0538
   Francisco A, 2020, NEUROSCIENCE, V440, P210, DOI 10.1016/j.neuroscience.2020.05.042
   Gala MGF, 2021, FEBS LETT, V595, P1205, DOI 10.1002/1873-3468.14039
   Galmozzi A, 2013, DIABETES, V62, P732, DOI 10.2337/db12-0548
   Gannon MC, 1996, METABOLISM, V45, P492, DOI 10.1016/S0026-0495(96)90225-5
   García N, 2005, LIFE SCI, V76, P2873, DOI 10.1016/j.lfs.2004.12.012
   Gendi F, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23084235
   Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI 10.1038/nchembio.2287
   Ghosh D, 2014, AGING CELL, V13, P631, DOI 10.1111/acel.12216
   Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012
   Gialluisi A, 2021, MOL NEURODEGENER, V16, P0, DOI 10.1186/s13024-021-00455-2
   Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725
   Goodman RP, 2020, NATURE, V583, P122, DOI 10.1038/s41586-020-2337-2
   Goodman RP, 2018, J BIOL CHEM, V293, P7508, DOI 10.1074/jbc.TM117.000258
   Grammatikopoulou MG, 2022, MATURITAS, V163, P46, DOI 10.1016/j.maturitas.2022.06.001
   Green CL, 2022, NAT REV MOL CELL BIO, V23, P56, DOI 10.1038/s41580-021-00411-4
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536
   Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057
   Hao ZK, 2022, BRAIN SCI, V12, P0, DOI 10.3390/brainsci12060698
   Harper C, 2021, J TRANSL MED, V19, P0, DOI 10.1186/s12967-021-02737-1
   Harrison AP, 2008, J PHYSIOL PHARMACOL, V59, P91
   Harvey M, 2019, CLIN REHABIL, V33, P428, DOI 10.1177/0269215518815221
   He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200
   Heck DE, 2005, TOXICOLOGY, V208, P259, DOI 10.1016/j.tox.2004.11.027
   Hill CM, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-29499-8
   Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048
   Hoehne MN, 2022, EMBO J, V41, P0, DOI 10.15252/embj.2021109169
   Hoffman-Kuczynski B, 2005, NEUROCHEM RES, V30, P47, DOI 10.1007/s11064-004-9685-4
   Holmstrom Kira M, 2016, CURRENT OPINION IN TOXICOLOGY, V1, P80, DOI 10.1016/j.cotox.2016.10.002
   Hood DA, 2016, BIOCHEM J, V473, P2295, DOI 10.1042/BCJ20160009
   Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010
   Hou YJ, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2011226118
   Hoxhaj G, 2019, SCIENCE, V363, P1088, DOI 10.1126/science.aau3903
   Hsu YH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059267
   Huang S, 2021, CELL COMMUN SIGNAL, V19, P0, DOI 10.1186/s12964-020-00681-z
   Hunt J, 2022, MOL NEURODEGENER, V17, P0, DOI 10.1186/s13024-021-00504-w
   Hvingelby VS, 2022, J NEUROL, V269, P4068, DOI 10.1007/s00415-022-11091-1
   Imbesi M, 2009, NEUROSCIENCE, V158, P537, DOI 10.1016/j.neuroscience.2008.10.044
   Ioannou MS, 2019, CELL, V177, P1522, DOI 10.1016/j.cell.2019.04.001
   Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001
   Izuta Y, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12699
   Jacobi D, 2015, CELL METAB, V22, P709, DOI 10.1016/j.cmet.2015.08.006
   Jayashankar V, 2021, EMBO MOL MED, V13, P0, DOI 10.15252/emmm.202013086
   Jenkins CM, 2018, J BIOL CHEM, V293, P8693, DOI 10.1074/jbc.RA117.001629
   Jiménez-Jiménez FJ, 2020, EUR J NEUROL, V27, P2336, DOI 10.1111/ene.14470
   Jo DS, 2019, ARCH PHARM RES, V42, P393, DOI 10.1007/s12272-019-01131-2
   Marchissio MJ, 2012, TOXICOL APPL PHARM, V264, P246, DOI 10.1016/j.taap.2012.08.005
   Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727
   Kasai S, 2019, J CLIN BIOCHEM NUTR, V64, P1, DOI 10.3164/jcbn.18-37
   Kim J, 2018, MOL CELLS, V41, P742, DOI 10.14348/molcells.2018.0201
   Kim J, 2022, ANTIOXIDANTS-BASEL, V11, P0, DOI 10.3390/antiox11020192
   Kim KH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0063517
   Kimura T, 2019, LIFE SCI ALLIANCE, V2, P0, DOI 10.26508/lsa.201900348
   KLAIDMAN LK, 1993, FREE RADICAL BIO MED, V15, P169, DOI 10.1016/0891-5849(93)90056-Z
   Klaus S, 2021, CELL MOL LIFE SCI, V78, P3369, DOI 10.1007/s00018-020-03748-9
   Kluever V, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abn4437
   Kobilo T, 2014, LEARN MEMORY, V21, P119, DOI 10.1101/lm.033332.113
   Koronowski KB, 2021, CELL REP, V36, P0, DOI 10.1016/j.celrep.2021.109487
   Korshunov KS, 2017, FRONT CELL NEUROSCI, V11, P0, DOI 10.3389/fncel.2017.00091
   Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishna S, 2021, DEV CELL, V56, P2952, DOI 10.1016/j.devcel.2021.10.008
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   KURZ GM, 1993, J NEUROCHEM, V60, P1467, DOI 10.1111/j.1471-4159.1993.tb03309.x
   Kwon JH, 2020, HEALTHCARE-BASEL, V8, P0, DOI 10.3390/healthcare8040378
   Lamb DA, 2020, AGING-US, V12, P9447, DOI 10.18632/aging.103218
   Lamberts JT, 2015, NEUROBIOL DIS, V77, P276, DOI 10.1016/j.nbd.2014.07.002
   Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460
   Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x
   Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1
   Li H, 2019, NEUROTOX RES, V35, P421, DOI 10.1007/s12640-018-9968-1
   Li SY, 2017, CHINESE MED J-PEKING, V130, P1085, DOI 10.4103/0366-6999.204920
   Li W, 2021, NAT METAB, V3, P75, DOI 10.1038/s42255-020-00330-2
   Li WQ, 2014, AGING CELL, V13, P1012, DOI 10.1111/acel.12264
   Lin AL, 2015, NEUROBIOL AGING, V36, P2296, DOI 10.1016/j.neurobiolaging.2015.03.012
   Liu C, 2020, NEUROCHEM INT, V138, P0, DOI 10.1016/j.neuint.2020.104754
   Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018
   Liu Q, 2022, NAT METAB, V4, P559, DOI 10.1038/s42255-022-00575-z
   Liu WW, 2020, FASEB J, V34, P6570, DOI 10.1096/fj.201901565RR
   Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008
   Luna A, 2015, PLOS COMPUT BIOL, V11, P0, DOI 10.1371/journal.pcbi.1004144
   Ma J K, 2013, OPEN J MOL INTEGR PHYSIOL, V3, P0, DOI 10.4236/ojmip.2013.34027
   MacMillan-Crow LA, 1999, ARCH BIOCHEM BIOPHYS, V366, P82, DOI 10.1006/abbi.1999.1202
   Magni G, 2006, MINI-REV MED CHEM, V6, P739, DOI 10.2174/138955706777698688
   Mahajan M, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2023079118
   MAKINO K, 1991, RADIAT PHYS CHEM, V37, P657
   Mancuso DJ, 2009, J BIOL CHEM, V284, P35632, DOI 10.1074/jbc.M109.055194
   Manini A, 2022, AGEING RES REV, V76, P0, DOI 10.1016/j.arr.2022.101578
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Marosi K, 2016, J NEUROCHEM, V139, P769, DOI 10.1111/jnc.13868
   Marosi K, 2014, TRENDS ENDOCRIN MET, V25, P89, DOI 10.1016/j.tem.2013.10.006
   Martini H, 2023, FEBS J, V290, P1186, DOI 10.1111/febs.16361
   Mary C, 2022, MOL CELL, V82, P3299, DOI 10.1016/j.molcel.2022.06.026
   Mattson MP, 2018, NAT REV NEUROSCI, V19, P81, DOI 10.1038/nrn.2017.156
   Mawatari S, 2020, PARKINSONS DIS-US, V2020, P0, DOI 10.1155/2020/2671070
   McCarthy CG, 2022, AM J PHYSIOL-HEART C, V322, PH466, DOI 10.1152/ajpheart.00486.2021
   McCarty MF, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21103624
   McKiernan SH, 2012, EXP GERONTOL, V47, P229, DOI 10.1016/j.exger.2011.12.009
   McReynolds MR, 2021, CELL SYST, V12, P1160, DOI 10.1016/j.cels.2021.09.001
   Mendoza J, 2014, NEUROSCIENCE, V282, P230, DOI 10.1016/j.neuroscience.2014.07.081
   MENZIES RA, 1972, J NEUROCHEM, V19, P1671, DOI 10.1111/j.1471-4159.1972.tb06212.x
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   MERRILL DK, 1981, BRAIN RES, V221, P307, DOI 10.1016/0006-8993(81)90780-0
   Mesquita PHC, 2020, PHYSIOL REP, V8, P0, DOI 10.14814/phy2.14526
   Minich T, 2003, J NEUROCHEM, V86, P605, DOI 10.1046/j.1471-4159.2003.01871.x
   Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055
   Mitchell SJ, 2019, CELL METAB, V29, P221, DOI 10.1016/j.cmet.2018.08.011
   Moebus S, 2011, EUR J EPIDEMIOL, V26, P719, DOI 10.1007/s10654-011-9608-z
   Monteiro-Cardoso VF, 2015, J ALZHEIMERS DIS, V43, P1375, DOI 10.3233/JAD-141002
   Murari A, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abl8716
   Murata K, 2021, P JPN ACAD B-PHYS, V97, P479, DOI 10.2183/pjab.97.024
   NAGHIZADEH F, 1977, CLIN CHIM ACTA, V81, P277, DOI 10.1016/0009-8981(77)90060-2
   Nalls MA, 2015, LANCET NEUROL, V14, P1002, DOI 10.1016/S1474-4422(15)00178-7
   Newman JC, 2017, ANNU REV NUTR, V37, P51, DOI 10.1146/annurev-nutr-071816-064916
   Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5
   OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016
   Palacios-Callender M, 2004, P NATL ACAD SCI USA, V101, P7630, DOI 10.1073/pnas.0401723101
   Palma JA, 2018, MOVEMENT DISORD, V33, P372, DOI 10.1002/mds.27344
   Panicker N, 2021, J CELL BIOL, V220, P0, DOI 10.1083/jcb.202012095
   Panov A, 2014, BIOMED RES INT-UK, V2014, P0, DOI 10.1155/2014/472459
   Parekh PK, 2015, ALCOHOL, V49, P341, DOI 10.1016/j.alcohol.2014.09.034
   Parihar MS, 2008, J NEUROSCI RES, V86, P2339, DOI 10.1002/jnr.21679
   Park J, 2021, FRONT PHYSIOL, V12, P0, DOI 10.3389/fphys.2021.736905
   Pathak SS, 2019, NEURON, V104, P724, DOI 10.1016/j.neuron.2019.08.007
   Patrushev M, 2004, CELL MOL LIFE SCI, V61, P3100, DOI 10.1007/s00018-004-4424-1
   Pawlosky RJ, 2017, J NEUROCHEM, V141, P195, DOI 10.1111/jnc.13958
   Peluso A, 2022, NUTRIENTS, V14, P0, DOI 10.3390/nu14010101
   Peng IC, 2012, AM J PHYSIOL-ENDOC M, V302, PE1560, DOI 10.1152/ajpendo.00504.2011
   Perez MA, 2020, DEV CELL, V54, P447, DOI 10.1016/j.devcel.2020.06.019
   Perrin L, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.34114
   Peth A, 2013, J BIOL CHEM, V288, P29215, DOI 10.1074/jbc.M113.482570
   Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002
   Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007
   Pfeiffer RF, 2020, NEUROTHERAPEUTICS, V17, P1464, DOI 10.1007/s13311-020-00897-4
   Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200
   Prudon B, 2014, MOVEMENT DISORD, V29, P259, DOI 10.1002/mds.25730
   Qiu Z, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-020-03295-y
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Rabinovich-Nikitin I, 2021, AUTOPHAGY, V17, P3794, DOI 10.1080/15548627.2021.1938913
   RADI R, 1991, J BIOL CHEM, V266, P22028
   Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5
   Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200
   Ramamurthy S, 2014, NEUROSCIENCE, V259, P13, DOI 10.1016/j.neuroscience.2013.11.048
   RAMSAY RR, 1986, LIFE SCI, V39, P581, DOI 10.1016/0024-3205(86)90037-8
   Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641
   Rauckhorst AJ, 2015, FEBS LETT, V589, P2367, DOI 10.1016/j.febslet.2015.07.016
   Reiten OK, 2021, MECH AGEING DEV, V199, P0, DOI 10.1016/j.mad.2021.111567
   Ren XP, 2020, FRONT NEUROSCI-SWITZ, V14, P0, DOI 10.3389/fnins.2020.602697
   Renz PF, 2020, EXP CELL RES, V396, P0, DOI 10.1016/j.yexcr.2020.112229
   Rhea EM, 2021, PHARM RES-DORDR, V38, P1469, DOI 10.1007/s11095-021-03098-6
   Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009
   Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049
   Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6
   Salnikov V, 2007, BIOPHYS J, V92, P1058, DOI 10.1529/biophysj.106.094318
   Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200
   Santiago JA, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23116223
   Sato S, 2022, CELL METAB, V34, P329, DOI 10.1016/j.cmet.2021.12.016
   Satpute R, 2013, HUM EXP TOXICOL, V32, P747, DOI 10.1177/0960327112468172
   Schmitt K, 2018, CELL METAB, V27, P657, DOI 10.1016/j.cmet.2018.01.011
   Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211
   Senanayake V, 2019, ALZH DEMENT-TRCI, V5, P524, DOI 10.1016/j.trci.2019.08.003
   Sengupta S, 2016, FREE RADICAL BIO MED, V93, P177, DOI 10.1016/j.freeradbiomed.2016.02.004
   Shahmirzadi AA, 2020, CELL METAB, V32, P447, DOI 10.1016/j.cmet.2020.08.004
   Shats I, 2020, CELL METAB, V31, P564, DOI 10.1016/j.cmet.2020.02.001
   Shaw E, 2020, MOL CELL BIOL, V40, P0, DOI 10.1128/MCB.00212-19
   SHEN RS, 1985, FEBS LETT, V189, P225, DOI 10.1016/0014-5793(85)81028-0
   Shimokawa I, 2015, AGING CELL, V14, P707, DOI 10.1111/acel.12340
   Shkodina AD, 2022, AGEING RES REV, V74, P0, DOI 10.1016/j.arr.2021.101554
   Shrimali NM, 2021, EBIOMEDICINE, V73, P0, DOI 10.1016/j.ebiom.2021.103672
   Simeone TA, 2017, NEUROCHEM RES, V42, P2011, DOI 10.1007/s11064-017-2253-5
   Singh F, 2021, BIOCHEM SOC T, V49, P551, DOI 10.1042/BST20190236
   Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004
   Sleiman SF, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.15092
   Someya S, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0171159
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017
   Stillman CM, 2016, FRONT HUM NEUROSCI, V10, P0, DOI 10.3389/fnhum.2016.00626
   Stotland A, 2015, BBA-MOL CELL RES, V1853, P2802, DOI 10.1016/j.bbamcr.2014.12.041
   Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577
   Stromland O, 2021, MECH AGEING DEV, V199, P0, DOI 10.1016/j.mad.2021.111569
   Su Y, 2019, AGING-US, V11, P4183, DOI 10.18632/aging.102045
   Subrahmanian N, 2021, BRAIN RES, V1767, P0, DOI 10.1016/j.brainres.2021.147434
   Sun XY, 2017, ONCOTARGET, V8, P75232, DOI 10.18632/oncotarget.20744
   Teresak P, 2022, AUTOPHAGY, V18, P24, DOI 10.1080/15548627.2021.1888244
   Terranova CJ, 2021, CELL REP, V37, P0, DOI 10.1016/j.celrep.2021.110044
   Thomas MH, 2020, BIORXIV, V0, P0, DOI DOI 10.1101/2020.11.30.404293
   Torrence ME, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.63326
   Torres S, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.01168
   Tripathi A, 2022, BIOMOLECULES, V12, P0, DOI 10.3390/biom12010040
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Uhrbrand A, 2015, J NEUROL SCI, V353, P9, DOI 10.1016/j.jns.2015.04.004
   Vallée A, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9020314
   van Moorsel D, 2016, MOL METAB, V5, P635, DOI 10.1016/j.molmet.2016.06.012
   Veech RL, 2019, IUBMB LIFE, V71, P565, DOI 10.1002/iub.1997
   VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a
   Verma DK, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10071694
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vivar C, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms2101
   Vogelauer M, 2012, J BIOL CHEM, V287, P32006, DOI 10.1074/jbc.M112.362467
   Wahl P, 2022, INT J SPORTS MED, V43, P195, DOI 10.1055/a-1551-9294
   Wan XS, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/807874
   Wang HQ, 2021, NEUROPEPTIDES, V87, P0, DOI 10.1016/j.npep.2021.102134
   Wang L, 2011, J APPL PHYSIOL, V111, P1335, DOI 10.1152/japplphysiol.00086.2011
   Wang XD, 2022, CIRC RES, V131, P91, DOI 10.1161/CIRCRESAHA.122.321050
   Wang Y, 2021, NATURE, V599, P136, DOI 10.1038/s41586-021-04025-w
   Wang Y, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-19360-1
   Wasselin T, 2014, PROTEOMICS, V14, P1905, DOI 10.1002/pmic.201400051
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006
   WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514
   Wood PL, 2011, LIPIDS HEALTH DIS, V10, P0, DOI 10.1186/1476-511X-10-227
   Xian HX, 2022, IMMUNITY, V55, P1370, DOI 10.1016/j.immuni.2022.06.007
   Xiao B, 2017, CELL DEATH DIS, V8, P0, DOI 10.1038/cddis.2017.463
   Xu SQ, 2018, J NEUROCHEM, V145, P312, DOI 10.1111/jnc.14297
   Yamada N, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-2334-2
   Yanagi S, 2018, CELL METAB, V27, P786, DOI 10.1016/j.cmet.2018.02.008
   Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x
   Yang YR, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.602748
   Yao W, 2021, TRANSL PSYCHIAT, V11, P0, DOI 10.1038/s41398-021-01261-6
   Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804
   Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103
   Zago EB, 2000, FEBS LETT, V478, P29, DOI 10.1016/S0014-5793(00)01815-9
   Zeidler JD, 2022, AM J PHYSIOL-CELL PH, V322, PC521, DOI 10.1152/ajpcell.00451.2021
   Zhang J, 2018, FREE RADICAL BIO MED, V129, P268, DOI 10.1016/j.freeradbiomed.2018.09.032
   Zhang Q, 2012, NEUROSCIENCE, V205, P10, DOI 10.1016/j.neuroscience.2011.12.053
   Zhang Y, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abo0404
   Zhang Y, 2012, ELIFE, V1, P0, DOI 10.7554/eLife.00065
   Zhang ZY, 2021, NAT METAB, V3, P1608, DOI 10.1038/s42255-021-00487-4
   Zhao YX, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10121917
   Zhu JJ, 2021, SCIENCE, V372, P968, DOI 10.1126/science.abd5491
   Zong ZH, 2012, BBA-MOL CELL RES, V1823, P1395, DOI 10.1016/j.bbamcr.2012.06.001
NR 298
TC 25
Z9 25
U1 2
U2 29
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD AUG 15
PY 2022
VL 11
IS 15
BP 
EP 
DI 10.3390/cells11152416
PG 38
WC Cell Biology
SC Cell Biology
GA 3R9XT
UT WOS:000839258300001
PM 35954260
DA 2024-11-01
ER

PT J
AU Na, JH
   Lee, YM
AF Na, Ji-Hoon
   Lee, Young-Mock
TI Genotype-phenotype analysis of <i>MT-ATP6</i>-associated Leigh syndrome
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Article
DE heteroplasmic mutant load; Leigh syndrome; mitochondrial disease; MT-ATP6; mtDNA
ID mitochondrial; children; diagnosis; insights; disease
AB Objectives Mitochondrial DNA (mtDNA)-associated Leigh syndrome (LS) is characterized by maternal inheritance, and the heteroplasmic mutant load of mtDNA pathogenic variants is known to affect clinical phenotypes. Among mtDNA pathogenic variants, variants of the MT-ATP6 gene account for most of reported cases. In this report, we aimed to describe the clinical and genetic findings of MT-ATP6-associated LS patients diagnosed at a single tertiary institution in Korea. Methods Thirteen patients with genetically confirmed MT-ATP6-associated LS were selected. We reviewed each patient's clinical findings, including general characteristics, biochemical parameters, brain MR images, muscle biopsy results, and heteroplasmic mutant load over a long-term follow-up period. Results MT-ATP6-associated LS was of predominantly early onset (age <2 years), although we identified 2 late-onset (>60 months) LS patients. The heteroplasmic mutant load estimated by next-generation sequencing was 96%-100% in all nucleotide change groups. Compared with other forms of MT-ATP6-associated LS, the m.8993T>G point mutation elicited a significantly higher rate of symptom onset before 2 years of age. Brain MRI showed bilateral basal ganglia involvement in all patients, followed by cerebral atrophy, brainstem and thalamus involvement, and cerebellar atrophy. After follow-up (median 7.2 years, range 1.4 to 11.5 years), LS with m.8993T>G point mutations had a slightly more severe clinical progression compared with other forms of MT-ATP6-associated LS. Conclusions MT-ATP6-associated LS patients presented with a broad spectrum of clinical diagnoses and had a very high heteroplasmic mutant load. This study provides valuable data on MT-ATP6-associated LS that will inform subsequent studies on LS.
C1 [Na, Ji-Hoon; Lee, Young-Mock] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea.
   [Lee, Young-Mock] Yonsei Univ, Coll Med, Epilepsy Res Inst, Seoul, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System
RP Lee, YM (corresponding author), Yonsei Univ, Coll Med, Dept Pediat, Gangnam Severance Hosp, 211 Eonju Ro, Seoul 135720, South Korea.
EM ymleemd@yuhs.ac
FU Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [2018-31-0425/HI18C1166020018, 2018-31-1061/HI18C1166020019, 2019-31-1183/HI18C1166020020]
CR Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Craig DW, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep24607
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Eom S, 2017, FRONT NEUROL, V8, P0, DOI 10.3389/fneur.2017.00208
   Eom S, 2017, PEDIATR NEUROL, V66, P82, DOI 10.1016/j.pediatrneurol.2016.10.006
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Gould MP, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0139253
   Huptas Christopher, 2016, BMC RES NOTES, V9, P269, DOI 10.1186/s13104-016-2072-9
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Larson AA, 2019, MITOCHONDRION, V44, P58, DOI 10.1016/j.mito.2018.01.001
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   López-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034
   Ma YY, 2013, MITOCHONDR DNA, V24, P297, DOI 10.3109/19401736.2012.760071
   Na JH, 2020, THER ADV NEUROL DISO, V13, P0, DOI 10.1177/1756286419897813
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   Ogawa E, 2020, J INHERIT METAB DIS, V43, P819, DOI 10.1002/jimd.12218
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Palculict ME, 2016, METHODS MOL BIOL, V1351, P3, DOI 10.1007/978-1-4939-3040-1_1
   Preston JL, 2016, BMC GENOMICS, V17, P0, DOI 10.1186/s12864-016-2669-3
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Sofou K, 2018, J MED GENET, V55, P21, DOI 10.1136/jmedgenet-2017-104891
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Takada R, 2020, BRAIN DEV-JPN, V42, P69, DOI 10.1016/j.braindev.2019.08.006
   Thorburn DR, 1993, GENEREVIEWS, V0, P0
   Uittenbogaard M, 2018, MOL GENET METAB, V124, P71, DOI 10.1016/j.ymgme.2018.03.011
   Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001
NR 28
TC 7
Z9 8
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 1600-0404
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD APR 15
PY 2022
VL 145
IS 4
BP 414
EP 422
DI 10.1111/ane.13566
EA DEC 2021
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA ZL9EK
UT WOS:000727791500001
PM 34877647
DA 2024-11-01
ER

PT J
AU Arbeithuber, B
   Cremona, MA
   Hester, J
   Barrett, A
   Higgins, B
   Anthony, K
   Chiaromonte, F
   Diaz, FJ
   Makova, KD
AF Arbeithuber, Barbara
   Cremona, Marzia A.
   Hester, James
   Barrett, Alison
   Higgins, Bonnie
   Anthony, Kate
   Chiaromonte, Francesca
   Diaz, Francisco J.
   Makova, Kateryna D.
TI Advanced age increases frequencies of de novo mitochondrial mutations in macaque oocytes and somatic tissues
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE mitochondria; oocytes; mutations; duplex sequencing; heteroplasmy
ID rna-polymerase; in-vivo; dna; generation; turnover; cells; mtdna; reproduction; liver
AB Mutations in mitochondrial DNA (mtDNA) contribute to multiple diseases. However, how new mtDNA mutations arise and accumulate with age remains understudied because of the high error rates of current sequencing technologies. Duplex sequencing reduces error rates by several orders of magnitude via independently tagging and analyzing each of the two template DNA strands. Here, using duplex sequencing, we obtained high-quality mtDNA sequences for somatic tissues (liver and skeletal muscle) and single oocytes of 30 unrelated rhesus macaques, from 1 to 23 y of age. Sequencing single oocytes minimized effects of natural selection on germline mutations. In total, we identified 17,637 tissue-specific de novo mutations. Their frequency increased similar to 3.5-fold in liver and similar to 2.8-fold in muscle over the similar to 20 y assessed. Mutation frequency in oocytes increased similar to 2.5-fold until the age of 9 y, but did not increase after that, suggesting that oocytes of older animals maintain the quality of their mtDNA. We found the lightstrand origin of replication (OriL) to be a hotspot for mutation accumulation with aging in liver. Indeed, the 33-nucleotide-long OriL harbored 12 variant hotspots, 10 of which likely disrupt its hairpin structure and affect replication efficiency. Moreover, in somatic tissues, protein-coding variants were subject to positive selection (potentially mitigating toxic effects of mitochondrial activity), the strength of which increased with the number of macaques harboring variants. Our work illuminates the origins and accumulation of somatic and germline mtDNA mutations with aging in primates and has implications for delayed reproduction in modern human societies.
C1 [Arbeithuber, Barbara; Barrett, Alison; Higgins, Bonnie; Anthony, Kate; Makova, Kateryna D.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA.
   [Arbeithuber, Barbara] Johannes Kepler Univ Linz, Kepler Univ Hosp Linz, Expt Gynaecol Obstet & Gynaecol Endocrinol, A-4020 Linz, Austria.
   [Cremona, Marzia A.] Univ Laval, Dept Operat & Decis Syst, Quebec City, PQ G1V 0A6, Canada.
   [Cremona, Marzia A.] Univ Laval, CHU Quebec, Populat Hlth & Optimal Hlth Practices, Res Ctr, Quebec City, PQ G1V 4G2, Canada.
   [Cremona, Marzia A.; Chiaromonte, Francesca; Makova, Kateryna D.] Penn State Univ, Ctr Med Genom, University Pk, PA 16802 USA.
   [Hester, James; Diaz, Francisco J.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.
   [Chiaromonte, Francesca] Penn State Univ, Dept Stat, University Pk, PA 16802 USA.
   [Chiaromonte, Francesca] St Anna Sch Adv Studies, Inst Econ, I-56127 Pisa, Italy.
   [Chiaromonte, Francesca] St Anna Sch Adv Studies, EMbeDS, I-56127 Pisa, Italy.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Johannes Kepler University Linz; Kepler University Hospital; Laval University; Laval University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Scuola Superiore Sant'Anna; Scuola Superiore Sant'Anna
RP Makova, KD (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.; Makova, KD (corresponding author), Penn State Univ, Ctr Med Genom, University Pk, PA 16802 USA.
EM kdm16@psu.edu
FU NIH [R01GM116044]; Schrodinger Fellowship from the Austrian Science Fund (FWF) [J-4096]; Office of Science Engagement; Huck Institute of Life Sciences; Institute for Computational and Data Sciences at Penn State; National Institutes of Health [P51OD011092]; Eberly College of Sciences
CR Ancora M, 2017, MITOCHONDRIAL DNA A, V28, P180, DOI 10.3109/19401736.2015.1115499
   Arbeithuber B, 2020, PLOS BIOL, V18, P0, DOI 10.1371/journal.pbio.3000745
   Barrett A, 2020, PHILOS T R SOC B, V375, P0, DOI 10.1098/rstb.2019.0175
   Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026
   Boucret L, 2017, HUM REPROD, V32, P2101, DOI 10.1093/humrep/dex268
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Degtyareva NP, 2019, PLOS BIOL, V17, P0, DOI 10.1371/journal.pbio.3000263
   Erwin JA, 2016, NAT NEUROSCI, V19, P1583, DOI 10.1038/nn.4388
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Fan LH, 2019, BIOCHEM BIOPH RES CO, V513, P912, DOI 10.1016/j.bbrc.2019.04.100
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gigarel N, 2011, AM J HUM GENET, V88, P494, DOI 10.1016/j.ajhg.2011.03.010
   Gorelick AN, 2021, NAT METAB, V3, P558, DOI 10.1038/s42255-021-00378-8
   Guiblet WM, 2021, NUCLEIC ACIDS RES, V49, P1497, DOI 10.1093/nar/gkaa1269
   Hendy MD, 2009, BIOL LETTERS, V5, P397, DOI 10.1098/rsbl.2009.0104
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Iismaa SE, 2018, NPJ REGEN MED, V3, P0, DOI 10.1038/s41536-018-0044-5
   Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kirillova A, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10092484
   Kopp JL, 2016, NAT CELL BIOL, V18, P238, DOI 10.1038/ncb3309
   Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lindsay SJ, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12023-w
   Liu BJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep23421
   May-Panloup P, 2016, HUM REPROD UPDATE, V22, P725, DOI 10.1093/humupd/dmw028
   Mechta M, 2017, FRONT GENET, V8, P0, DOI 10.3389/fgene.2017.00166
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   Millar CD, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000209
   Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x
   Moorjani P, 2016, P NATL ACAD SCI USA, V113, P10607, DOI 10.1073/pnas.1600374113
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Patil V, 2019, NUCLEIC ACIDS RES, V47, P10072, DOI 10.1093/nar/gkz762
   Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0
   Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469
   RAWLINS RG, 1985, AM J PRIMATOL, V9, P87, DOI 10.1002/ajp.1350090203
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109
   Shen QZ, 2021, BIOL REPROD, V104, P294, DOI 10.1093/biolre/ioaa194
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028
   Stoler N, 2020, BMC BIOINFORMATICS, V21, P0, DOI 10.1186/s12859-020-3419-8
   Suspène R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Tardif S, 2012, AM COLL LAB, V0, PP197, DOI 10.1016/B978-0-12-381365-7.00008-X
   Walker ErnestP, 1983, WALKERS MAMMALS OF THE WORLD, V0, P0
   Wang RJ, 2020, GENOME RES, V30, P826, DOI 10.1101/gr.255174.119
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Williams SL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003990
   Wilton PR, 2018, GENETICS, V208, P1261, DOI 10.1534/genetics.118.300711
   Xue C, 2016, GENOME RES, V26, P1651, DOI 10.1101/gr.204255.116
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 60
TC 18
Z9 19
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 12
PY 2022
VL 119
IS 15
BP 
EP 
DI 10.1073/pnas.2118740119
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 2P6SA
UT WOS:000819867000014
PM 35394879
DA 2024-11-01
ER

PT J
AU Mposhi, A
   Liang, L
   Mennega, KP
   Yildiz, D
   Kampert, C
   Hof, IH
   Jellema, PG
   de Koning, TJ
   Faber, KN
   Ruiters, MHJ
   Niezen-Koning, KE
   Rots, MG
AF Mposhi, Archibold
   Liang, Lin
   Mennega, Kevin P.
   Yildiz, Dilemin
   Kampert, Crista
   Hof, Ingrid H.
   Jellema, Pytrick G.
   de Koning, Tom J.
   Faber, Klaas Nico
   Ruiters, Marcel H. J.
   Niezen-Koning, Klary E.
   Rots, Marianne G.
TI The Mitochondrial Epigenome: An Unexplored Avenue to Explain Unexplained Myopathies?
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE mitochondrial epigenome; myopathies; mitochondrial DNA methylation; cytochrome B
ID displacement loop; gene-expression; dna; methylation; mtdna; number; mass; diagnosis; features; genome
AB Mutations in either mitochondrial DNA (mtDNA) or nuclear genes that encode mitochondrial proteins may lead to dysfunctional mitochondria, giving rise to mitochondrial diseases. Some mitochondrial myopathies, however, present without a known underlying cause. Interestingly, methylation of mtDNA has been associated with various clinical pathologies. The present study set out to assess whether mtDNA methylation could explain impaired mitochondrial function in patients diagnosed with myopathy without known underlying genetic mutations. Enhanced mtDNA methylation was indicated by pyrosequencing for muscle biopsies of 14 myopathy patients compared to four healthy controls, at selected cytosines in the Cytochrome B (CYTB) gene, but not within the displacement loop (D-loop) region. The mtDNA methylation patterns of the four healthy muscle biopsies were highly consistent and showed intriguing tissue-specific differences at particular cytosines with control skin fibroblasts cultured in vitro. Within individual myopathy patients, the overall mtDNA methylation pattern correlated well between muscle and skin fibroblasts. Despite this correlation, a pilot analysis of four myopathy and five healthy fibroblast samples did not reveal a disease-associated difference in mtDNA methylation. We did, however, detect increased expression of solute carrier family 25A26 (SLC25A26), encoding the importer of S-adenosylmethionine, together with enhanced mtDNA copy numbers in myopathy fibroblasts compared to healthy controls. To confirm that pyrosequencing indeed reflected DNA methylation and not bisulfite accessibility, mass spectrometry was employed. Although no myopathy-related differences in total amount of methylated cytosines were detected at this stage, a significant contribution of contaminating nuclear DNA (nDNA) was revealed, and steps to improve enrichment for mtDNA are reported. In conclusion, in this explorative study we show that analyzing the mitochondrial genome beyond its sequence opens novel avenues to identify potential molecular biomarkers assisting in the diagnosis of unexplained myopathies.
C1 [Mposhi, Archibold; Liang, Lin; Mennega, Kevin P.; Jellema, Pytrick G.; Ruiters, Marcel H. J.; Rots, Marianne G.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
   [Mposhi, Archibold; Faber, Klaas Nico] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
   [Mennega, Kevin P.; Yildiz, Dilemin; Kampert, Crista; Hof, Ingrid H.; Niezen-Koning, Klary E.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Lab Metab Dis, NL-9713 GZ Groningen, Netherlands.
   [de Koning, Tom J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
   [de Koning, Tom J.] Lund Univ, Dept Clin Sci, Lasarettgatan 40, S-22185 Lund, Sweden.
C3 University of Groningen; University of Groningen; University of Groningen; University of Groningen; Lund University
RP Rots, MG (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
EM mposhiarchibold@gmail.com; l.liang@umcg.nl; k.p.mennega@umcg.nl; dileminyildiz@gmail.com; crista.kampert@gmail.com; i.h.hof@umcg.nl; p.g.jellema@umcg.nl; t.j.de.koning@umcg.nl; k.n.faber@umcg.nl; m.h.j.ruiters@umcg.nl; k.e.niezen-koning@umcg.nl; m.g.rots@umcg.nl
FU University Medical Center Groningen; China Scholarship Council (CSC); EU H2020 [CM1406]; COST (European Cooperation in Science and Technology)
CR Ahuja AS, 2018, PEERJ, V6, P0, DOI 10.7717/peerj.4790
   Baccarelli AA, 2015, CLIN EPIGENETICS, V7, P0, DOI 10.1186/s13148-015-0078-0
   Bachmann C, 2019, HUM MUTAT, V40, P962, DOI 10.1002/humu.23745
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bai YD, 2004, ANN NY ACAD SCI, V1011, P272, DOI 10.1196/annals.1293.026
   Barchiesi A, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20092221
   Barrès R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011
   Basu U, 2020, J BIOL CHEM, V295, P18406, DOI 10.1074/jbc.REV120.011202
   Bicci I, 2021, NUCLEIC ACIDS RES, V49, P12757, DOI 10.1093/nar/gkab1179
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Devall M, 2017, CLIN EPIGENETICS, V9, P0, DOI 10.1186/s13148-017-0337-3
   Dorman Charles J, 2016, BIOPHYS REV, V8, P209, DOI 10.1007/s12551-016-0205-y
   Dostal V, 2019, BBA-GENE REGUL MECH, V1862, P598, DOI 10.1016/j.bbagrm.2019.01.006
   Dou XY, 2019, GENOME RES, V29, P1622, DOI 10.1101/gr.234021.117
   Emmanuele V, 2013, J CHILD NEUROL, V28, P236, DOI 10.1177/0883073812445787
   Feng S, 2012, MOL MED REP, V6, P125, DOI 10.3892/mmr.2012.870
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gao JH, 2015, MOL MED REP, V12, P7033, DOI 10.3892/mmr.2015.4256
   Goldsmith C, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-87457-8
   Gu F, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2013.68
   Hao ZY, 2020, MOL CELL, V78, P382, DOI 10.1016/j.molcel.2020.02.018
   Infantino V, 2011, MOL GENET METAB, V102, P378, DOI 10.1016/j.ymgme.2010.11.166
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Jin CJ, 2007, J NUTR, V137, P339, DOI 10.1093/jn/137.2.339
   Pirola CJ, 2013, GUT, V62, P1356, DOI 10.1136/gutjnl-2012-302962
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   Lin XC, 2016, ANAL CHEM, V88, P1083, DOI 10.1021/acs.analchem.5b04247
   Liu BJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep23421
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lueth T, 2021, FRONT AGING NEUROSCI, V13, P0, DOI 10.3389/fnagi.2021.713084
   Lunnon K, 2017, NEUROBIOL AGING, V53, P36, DOI 10.1016/j.neurobiolaging.2016.12.029
   Massie R, 2010, MUSCLE NERVE, V42, P136, DOI 10.1002/mus.21649
   Matsuda S, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-24251-z
   Mechta M, 2017, FRONT GENET, V8, P0, DOI 10.3389/fgene.2017.00166
   Menga A, 2017, FEBS J, V284, P967, DOI 10.1111/febs.14028
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Mposhi A, 2017, FRONT BIOSCI-LANDMRK, V22, P1099, DOI 10.2741/4535
   Nakamura M, 2021, NAT CELL BIOL, V23, P11, DOI 10.1038/s41556-020-00620-7
   Ngo HB, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4077
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Owa C, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0192722
   Patil V, 2019, NUCLEIC ACIDS RES, V47, P10072, DOI 10.1093/nar/gkz762
   Powell CA, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00079
   Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111
   Rebelo AP, 2009, NUCLEIC ACIDS RES, V37, P6701, DOI 10.1093/nar/gkp727
   REIS RJS, 1983, J BIOL CHEM, V258, P9078
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Stoccoro A, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22094594
   Stoccoro A, 2018, EPIGENOMICS-UK, V10, P1431, DOI 10.2217/epi-2018-0072
   van der Wijst MGP, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-00263-z
   van der Wijst MGP, 2015, TRENDS GENET, V31, P353, DOI 10.1016/j.tig.2015.03.009
   Vattemi G, 2014, AUTOIMMUN HIGHLIGHTS, V5, P77, DOI 10.1007/s13317-014-0062-2
   Veeranki S, 2015, INT J MOL SCI, V16, P1252, DOI 10.3390/ijms16011252
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Yahata N, 2021, MOL THER-METH CLIN D, V20, P54, DOI 10.1016/j.omtm.2020.10.017
   Zheng LD, 2015, CLIN EPIGENETICS, V7, P0, DOI 10.1186/s13148-015-0093-1
   Zhou GS, 2014, FOOD CHEM, V150, P260, DOI 10.1016/j.foodchem.2013.10.143
NR 60
TC 8
Z9 8
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB 15
PY 2022
VL 23
IS 4
BP 
EP 
DI 10.3390/ijms23042197
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA ZN0GP
UT WOS:000764724100001
PM 35216315
DA 2024-11-01
ER

PT J
AU Willis, JCW
   Silva-Pinheiro, P
   Widdup, L
   Minczuk, M
   Liu, DR
AF Willis, Julian C. W.
   Silva-Pinheiro, Pedro
   Widdup, Lily
   Minczuk, Michal
   Liu, David R.
TI Compact zinc finger base editors that edit mitochondrial or nuclear DNA in vitro and in vivo
SO NATURE COMMUNICATIONS
LA English
DT Article
ID proteins; genm; mutations; residues
AB DddA-derived cytosine base editors (DdCBEs) use programmable DNA-binding TALE repeat arrays, rather than CRISPR proteins, a split double-stranded DNA cytidine deaminase (DddA), and a uracil glycosylase inhibitor to mediate C center dot G-to-T center dot A editing in nuclear and organelle DNA. Here we report the development of zinc finger DdCBEs (ZF-DdCBEs) and the improvement of their editing performance through engineering their architectures, defining improved ZF scaffolds, and installing DddA activity-enhancing mutations. We engineer variants with improved DNA specificity by integrating four strategies to reduce off-target editing. We use optimized ZF-DdCBEs to install or correct disease-associated mutations in mitochondria and in the nucleus. Leveraging their small size, we use a single AAV9 to deliver into heart, liver, and skeletal muscle in post-natal mice ZF-DdCBEs that efficiently install disease-associated mutations. While off-target editing of ZF-DdCBEs is likely too high for therapeutic applications, these findings demonstrate a compact, all-protein base editing research tool for precise editing of organelle or nuclear DNA without double-strand DNA breaks. Zinc finger (ZF) arrays are programmable DNA-binding proteins. Here the authors report ZF-DddA-derived cytosine base editors (DdCBEs) and optimise their architectures to improve targeting; they apply these variants in vitro and in vivo to mitochondrial base editing and show higher editing than ZF deaminases.
C1 [Willis, Julian C. W.; Widdup, Lily; Liu, David R.] Broad Inst MIT & Harvard, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA.
   [Willis, Julian C. W.; Widdup, Lily; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.
   [Willis, Julian C. W.; Widdup, Lily; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.
   [Silva-Pinheiro, Pedro; Minczuk, Michal] Univ Cambridge, MRC Mitochondria Biol Unit, Cambridge, England.
C3 Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; University of Cambridge
RP Liu, DR (corresponding author), Broad Inst MIT & Harvard, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA.; Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Liu, DR (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.
EM drliu@fas.harvard.edu
FU Merkin Institute of Transformative Technologies in Healthcare; US National Institutes of Health (NIH) [RM1HG009490, R01EB027793, R01EB031172, R35GM118062, U01AI142756]; HHMI; Human Frontiers Science Program longterm fellowship; National Science Foundation Graduate Research Fellowship Program; Champ Foundation; Medical Research Council UK [MC_UU_00015/4, MC_UU_00028/3]; MRC [MC_UU_00028/3] Funding Source: UKRI; National Institute of General Medical Sciences [R35GM118062] Funding Source: NIH RePORTER
CR Achilli A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042242
   Agustín-Pavón C, 2016, MOL NEURODEGENER, V11, P0, DOI 10.1186/s13024-016-0128-x
   Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Banskota S, 2022, CELL, V185, P250, DOI 10.1016/j.cell.2021.12.021
   Becker S, 2021, GENE GENOME EDITING, V2, P100007, DOI 10.1016/j.ggedit.2021.100007
   Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112
   Bhakta MS, 2010, METHODS MOL BIOL, V649, P3, DOI 10.1007/978-1-60761-753-2_1
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3
   Cradick TJ, 2011, BMC BIOINFORMATICS, V12, P0, DOI 10.1186/1471-2105-12-152
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   de Castro E, 2006, NUCLEIC ACIDS RES, V34, PW362, DOI 10.1093/nar/gkl124
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gehrke JM, 2018, NAT BIOTECHNOL, V36, P977, DOI 10.1038/nbt.4199
   Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w
   Giardine B, 2021, NUCLEIC ACIDS RES, V49, PD1192, DOI 10.1093/nar/gkaa959
   Gill JS, 2017, BRIT J OPHTHALMOL, V101, P1298, DOI 10.1136/bjophthalmol-2017-310370
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Huang TP, 2021, NAT PROTOC, V16, P0, DOI 10.1038/s41596-020-00450-9
   Ibraheim R, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-26518-y
   Isalan M, 1997, P NATL ACAD SCI USA, V94, P5617, DOI 10.1073/pnas.94.11.5617
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   Kang BC, 2021, NAT PLANTS, V7, P899, DOI 10.1038/s41477-021-00943-9
   Kim JS, 1998, P NATL ACAD SCI USA, V95, P2812, DOI 10.1073/pnas.95.6.2812
   Leach KM, 2003, NUCLEIC ACIDS RES, V31, P1292, DOI 10.1093/nar/gkg209
   Li A, 2019, MOL THER-METH CLIN D, V12, P111, DOI 10.1016/j.omtm.2018.11.009
   Li JZ, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0079910
   Li Q, 2021, MOL THER-METH CLIN D, V20, P652, DOI 10.1016/j.omtm.2021.02.005
   Lim K, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-27962-0
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016
   Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98
   Mak ANS, 2013, CURR OPIN STRUC BIOL, V23, P93, DOI 10.1016/j.sbi.2012.11.001
   Manickam AH, 2017, INDIAN J OPHTHALMOL, V65, P1087, DOI 10.4103/ijo.IJO_358_17
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Mok BY, 2022, NAT BIOTECHNOL, V40, P1378, DOI 10.1038/s41587-022-01256-8
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Moore M, 2001, P NATL ACAD SCI USA, V98, P1437, DOI 10.1073/pnas.98.4.1437
   Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104
   Nagaoka M, 2001, BIOCHEMISTRY-US, V40, P2932, DOI 10.1021/bi001762+
   Nissanka N, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04895-1
   ORKIN SH, 1983, NUCLEIC ACIDS RES, V11, P4727, DOI 10.1093/nar/11.14.4727
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200
   Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011
   Peeva V, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04131-w
   Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374
   Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1
   Rees HA, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15790
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Richter U, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06471-z
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542
   Silva-Pinheiro P, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-28358-w
   Silva-Pinheiro P, 2022, NAT REV GENET, V23, P199, DOI 10.1038/s41576-021-00432-x
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tarnopolsky MA, 2019, MITOCHONDRION, V46, P69, DOI 10.1016/j.mito.2018.02.008
   Vassalli G, 2003, INT J CARDIOL, V90, P229, DOI 10.1016/S0167-5273(02)00554-5
   Waryah CB, 2018, METHODS MOL BIOL, V1767, P19, DOI 10.1007/978-1-4939-7774-1_2
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102
   Yang LH, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13330
   Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081
NR 68
TC 26
Z9 31
U1 2
U2 14
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 23
PY 2022
VL 13
IS 1
BP 
EP 
DI 10.1038/s41467-022-34784-7
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 6L1RO
UT WOS:000887967800021
PM 36418298
DA 2024-11-01
ER

PT J
AU Guo, J
   Chiang, WC
AF Guo, Jing
   Chiang, Wei-Chung
TI Mitophagy in aging and longevity
SO IUBMB LIFE
LA English
DT Article
DE aging; longevity; mitophagy
ID life-span extension; mitochondrial-dna mutations; autophagic cell-death; tumor-suppressor gene; paternal mitochondria; selective autophagy; oxidative stress; skeletal-muscle; molecular-mechanisms; neurodegenerative diseases
AB The clearance of damaged or unwanted mitochondria by autophagy (also known as mitophagy) is a mitochondrial quality control mechanism postulated to play an essential role in cellular homeostasis, metabolism, and development and confers protection against a wide range of diseases. Proper removal of damaged or unwanted mitochondria is essential for organismal health. Defects in mitophagy are associated with Parkinson's, Alzheimer's disease, cancer, and other degenerative disorders. Mitochondria regulate organismal fitness and longevity via multiple pathways, including cellular senescence, stem cell function, inflammation, mitochondrial unfolded protein response (mtUPR), and bioenergetics. Thus, mitophagy is postulated to be pivotal for maintaining organismal healthspan and lifespan and the protection against aged-related degeneration. In this review, we will summarize recent understanding of the mechanism of mitophagy and aspects of mitochondrial functions. We will focus on mitochondria-related cellular processes that are linked to aging and examine current genetic evidence that supports the hypothesis that mitophagy is a pro-longevity mechanism.
C1 [Guo, Jing; Chiang, Wei-Chung] Natl Yang Ming Chiao Tung Univ, Inst Biochem & Mol Biol, Taipei, Taiwan.
C3 National Yang Ming Chiao Tung University
RP Chiang, WC (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Biochem & Mol Biol, Taipei, Taiwan.
EM wchiang@nycu.edu.tw
FU Ministry of Science and Technology, Taiwan [MOST 110-2628-B-010-009, MOST 110-2628-BA49A-513]; National Health Research Institutes [NHRIEX110-11009SC]; Yen Tjing Ling Medical Foundation [CI110-31]
CR Agnihotri S, 2016, CANCER RES, V76, P4708, DOI 10.1158/0008-5472.CAN-15-3079
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Akada M, 2005, CLIN CANCER RES, V11, P3094, DOI 10.1158/1078-0432.CCR-04-1785
   Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   Amartuvshin O, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13191
   An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803
   Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Aparicio R, 2019, CELL REP, V28, P1029, DOI 10.1016/j.celrep.2019.06.070
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466
   Bonifati V, 2002, NEUROL SCI, V23, PS59, DOI 10.1007/s100720200069
   Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457
   Cavey JR, 2005, J BONE MINER RES, V20, P619, DOI 10.1359/JBMR.041205
   Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012
   Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100
   Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Chaudhari SN, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00274-4
   Chen G, 2014, MOL CELL, V54, P362, DOI 10.1016/j.molcel.2014.02.034
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Chen M, 2016, AUTOPHAGY, V12, P689, DOI 10.1080/15548627.2016.1151580
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   Chiu FL, 2008, FEBS LETT, V582, P2407, DOI 10.1016/j.febslet.2008.05.049
   Chourasia AH, 2015, EMBO REP, V16, P1145, DOI 10.15252/embr.201540759
   Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   Cianfanelli V, 2015, MOL CELL ONCOL, V2, P0, DOI 10.4161/23723548.2014.970059
   Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2
   Compagnoni GM, 2020, MOL NEUROBIOL, V57, P2959, DOI 10.1007/s12035-020-01926-1
   Cooper JF, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-16637-2
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002
   Cummins J M, 2000, HUM REPROD, V15 Suppl 2, P92
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084
   Dalle Pezze Piero, 2014, PLOS COMPUT BIOL, V10, Pe1003728, DOI 10.1371/journal.pcbi.1003728
   de la Cruz-Ruiz P, 2021, AGING CELL, V20, P0, DOI 10.1111/acel.13359
   Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Di Rita A, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-05722-3
   Di Rita A, 2018, FRONT CELL NEUROSCI, V12, P0, DOI 10.3389/fncel.2018.00092
   Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537
   Drummond MJ, 2014, J GERONTOL A-BIOL, V69, P1040, DOI 10.1093/gerona/glu004
   Duicu OM, 2013, CAN J PHYSIOL PHARM, V91, P593, DOI 10.1139/cjpp-2012-0422
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Dutta D, 2018, MOL NEUROBIOL, V55, P804, DOI 10.1007/s12035-016-0328-y
   Dyle MC, 2014, J BIOL CHEM, V289, P14913, DOI 10.1074/jbc.M114.556241
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9
   Fang EF, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep46208
   Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fernandez Alvaro F, 2018, NATURE, V558, P136, DOI 10.1038/s41586-018-0162-7
   Ferrer I, 2007, NEUROSCI LETT, V415, P205, DOI 10.1016/j.neulet.2007.01.026
   Franco-Iborra S, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00342
   Fu M, 2013, MOL BIOL CELL, V24, P1153, DOI 10.1091/mbc.E12-08-0607
   Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199
   Fujiwara Y, 2012, J AGR FOOD CHEM, V60, P2472, DOI 10.1021/jf204197r
   Gao F, 2015, HUM MOL GENET, V24, P2528, DOI 10.1093/hmg/ddv017
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gatsi R, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0107671
   Gelino Sara, 2012, J CLIN EXP PATHOL, VSuppl 4, P0
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564
   Grazioli S, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.00832
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Grumati P, 2018, J CELL SCI, V131, P0, DOI 10.1242/jcs.217364
   Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936
   Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119
   Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   Hoshino A, 2014, P NATL ACAD SCI USA, V111, P3116, DOI 10.1073/pnas.1318951111
   Hoshino A, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3308
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Humpton TJ, 2019, CANCER DISCOV, V9, P1268, DOI 10.1158/2159-8290.CD-18-1409
   Hwang S, 2010, MOL CELLS, V29, P575, DOI 10.1007/s10059-010-0068-1
   Ikeda Y, 2015, J MOL CELL CARDIOL, V78, P116, DOI 10.1016/j.yjmcc.2014.09.019
   Ishihara-Paul L, 2008, NEUROLOGY, V71, P896, DOI 10.1212/01.wnl.0000323812.40708.1f
   Ising C, 2015, EMBO MOL MED, V7, P275, DOI 10.15252/emmm.201404916
   Iwadate R, 2015, AM J PATHOL, V185, P2523, DOI 10.1016/j.ajpath.2015.05.008
   Jiang HC, 2015, P NATL ACAD SCI USA, V112, P8768, DOI 10.1073/pnas.1501831112
   Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095
   Kawajiri S, 2011, TRENDS PHARMACOL SCI, V32, P573, DOI 10.1016/j.tips.2011.06.001
   Kerr JS, 2017, TRENDS NEUROSCI, V40, P151, DOI 10.1016/j.tins.2017.01.002
   Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Knuppertz L, 2016, MECH AGEING DEV, V153, P30, DOI 10.1016/j.mad.2016.01.003
   Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917
   Koop EA, 2009, BMC CANCER, V9, P0, DOI 10.1186/1471-2407-9-175
   Korwitz A, 2016, J CELL BIOL, V212, P157, DOI 10.1083/jcb.201507022
   Koushyar S, 2015, CANCER LETT, V369, P316, DOI 10.1016/j.canlet.2015.09.012
   Krüger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumsta C, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-13540-4
   Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14
   Lee TT, 2021, AGING CELL, V20, P0, DOI 10.1111/acel.13379
   Lee Y, 2011, AM J PHYSIOL-HEART C, V301, PH1924, DOI 10.1152/ajpheart.00368.2011
   Lei C, 2020, MEDICINE, V99, P0, DOI 10.1097/MD.0000000000018791
   Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1
   Levine B, 2011, SCIENCE, V334, P1069, DOI 10.1126/science.1215480
   Lewis KN, 2015, P NATL ACAD SCI USA, V112, P3722, DOI 10.1073/pnas.1417566112
   Li CF, 2018, DEV CELL, V46, P441, DOI 10.1016/j.devcel.2018.07.012
   Liau WS, 2007, BMC GENET, V8, P0, DOI 10.1186/1471-2156-8-8
   Lim Y, 2019, DEV BIOL, V454, P15, DOI 10.1016/j.ydbio.2019.06.016
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lionaki E, 2015, BBA-BIOENERGETICS, V1847, P1412, DOI 10.1016/j.bbabio.2015.04.010
   Lionaki E, 2013, AGEING RES REV, V12, P413, DOI 10.1016/j.arr.2012.05.001
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   Liu PY, 2017, CELL CYCLE, V16, P776, DOI 10.1080/15384101.2017.1295193
   Liu YQ, 2009, HYPERTENSION, V53, P1083, DOI 10.1161/HYPERTENSIONAHA.109.128702
   Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lou GF, 2020, TRENDS MOL MED, V26, P8, DOI 10.1016/j.molmed.2019.07.002
   Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404
   Manka D, 2005, CANCER RES, V65, P11689, DOI 10.1158/0008-5472.CAN-05-3091
   Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024
   Marder KS, 2010, ARCH NEUROL-CHICAGO, V67, P731, DOI 10.1001/archneurol.2010.95
   Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3
   Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   Meléndez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Merkwirth C, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003021
   Mizushima N, 2020, NEW ENGL J MED, V383, P1564, DOI 10.1056/NEJMra2022774
   Mookherjee D, 2021, AUTOPHAGY, V17, P1729, DOI 10.1080/15548627.2020.1783118
   Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161
   Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107
   Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145
   Moscat J, 2016, CELL, V167, P606, DOI 10.1016/j.cell.2016.09.030
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Müller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036
   Muñoz-Carvajal F, 2020, FRONT AGING NEUROSCI, V12, P0, DOI 10.3389/fnagi.2020.581849
   Murai M, 2005, BRIT J CANCER, V92, P1165, DOI 10.1038/sj.bjc.6602422
   Murai M, 2005, CLIN CANCER RES, V11, P1021
   Murakawa T, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8527
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Ogrodnik M, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15691
   Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089
   Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013
   Oliveira SA, 2003, ANN NEUROL, V53, P624, DOI 10.1002/ana.10524
   Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546
   Otsu K, 2015, AUTOPHAGY, V11, P1932, DOI 10.1080/15548627.2015.1084459
   Palikaras K, 2015, CELL DEATH DIFFER, V22, P1399, DOI 10.1038/cdd.2015.86
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Palikaras K, 2015, AUTOPHAGY, V11, P1428, DOI 10.1080/15548627.2015.1061172
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Papa L, 2019, STEM CELLS INT, V2019, P0, DOI 10.1155/2019/4067162
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Piper PW, 2002, MECH AGEING DEV, V123, P287, DOI 10.1016/S0047-6374(01)00326-8
   Piper PW, 2002, AGING CELL, V1, P149, DOI 10.1046/j.1474-9728.2002.00018.x
   Pircs K, 2018, CELL REP, V24, P1397, DOI 10.1016/j.celrep.2018.07.017
   Politi Y, 2014, DEV CELL, V29, P305, DOI 10.1016/j.devcel.2014.04.005
   Poole AC, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010054
   Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010
   Pryde KR, 2016, J CELL BIOL, V213, P163, DOI 10.1083/jcb.201509003
   Pyo JO, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3300
   Rakovic A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016746
   Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9
   Rana A, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00525-4
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Rauthan M, 2015, G3-GENES GENOM GENET, V5, P1639, DOI 10.1534/g3.115.018598
   Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901
   Redmann M, 2014, INT J BIOCHEM CELL B, V53, P127, DOI 10.1016/j.biocel.2014.05.010
   Ren Y, 2009, J BIOL CHEM, V284, P4009, DOI 10.1074/jbc.M806245200
   Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013
   Rivera-Torres J, 2013, J PROTEOMICS, V91, P466, DOI 10.1016/j.jprot.2013.08.008
   Rogov VV, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-01258-6
   Rojansky R, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.17896
   Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Rui YN, 2015, AUTOPHAGY, V11, P858, DOI 10.1080/15548627.2015.1039219
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Salminen A, 2012, PROG NEUROBIOL, V96, P87, DOI 10.1016/j.pneurobio.2011.11.005
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Sato M, 2018, NAT CELL BIOL, V20, P81, DOI 10.1038/s41556-017-0008-9
   Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333
   Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059
   Schleit J, 2013, AGING CELL, V12, P1050, DOI 10.1111/acel.12130
   Schroeder S, 2021, CELL REP, V35, P0, DOI 10.1016/j.celrep.2021.108985
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Sebastián D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shirakabe A, 2016, CIRC RES, V118, P1563, DOI 10.1161/CIRCRESAHA.116.307474
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Si HB, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0225214
   Smith EF, 2019, NEUROSCI LETT, V710, P0, DOI 10.1016/j.neulet.2017.06.052
   Stefanis L, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a009399
   STOCCO DM, 1977, J CELL PHYSIOL, V90, P295, DOI 10.1002/jcp.1040900215
   STOCCO DM, 1978, J GERONTOL, V33, P802, DOI 10.1093/geronj/33.6.802
   Strappazzon F, 2015, CELL DEATH DIFFER, V22, P419, DOI 10.1038/cdd.2014.139
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152
   Szargel R, 2016, HUM MOL GENET, V25, P3476, DOI 10.1093/hmg/ddw189
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Todd AM, 2012, GENET MOL RES, V11, P1497, DOI 10.4238/2012.May.21.6
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003
   Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256
   Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011
   Vartiainen S, 2006, EXP GERONTOL, V41, P871, DOI 10.1016/j.exger.2006.05.005
   Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491
   Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Vizioli MG, 2020, GENE DEV, V34, P428, DOI 10.1101/gad.331272.119
   Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang Y, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12569
   Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042
   Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024
   Wenz Tina, 2011, J AGING RES, V2011, P810619, DOI 10.4061/2011/810619
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wu YB, 2019, MITOCHONDRION, V49, P35, DOI 10.1016/j.mito.2019.07.003
   Wu ZY, 2018, BMC BIOL, V16, P0, DOI 10.1186/s12915-018-0615-3
   Yaku K, 2018, AGEING RES REV, V47, P1, DOI 10.1016/j.arr.2018.05.006
   Yan XY, 2020, CANCER CELL INT, V20, P0, DOI 10.1186/s12935-020-01196-w
   Yang CC, 2011, AGING CELL, V10, P724, DOI 10.1111/j.1474-9726.2011.00711.x
   Yang X, 2020, AGING-US, V12, P16852, DOI 10.18632/aging.103578
   Yang Y, 2014, J ALZHEIMERS DIS, V40, P929, DOI 10.3233/JAD-132270
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yun JN, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.01958
   Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108
   Zhang F, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-2238-1
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200
   Zhang TM, 2016, J BIOL CHEM, V291, P21616, DOI 10.1074/jbc.M116.733410
   Zhang Y, 2019, ELIFE, V8, P0, DOI 10.7554/eLife.49158
   Zhao YH, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.34701
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
   Zhou QH, 2011, CELL RES, V21, P1662, DOI 10.1038/cr.2011.182
   Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345
   Ziada AS, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.13018
NR 260
TC 25
Z9 26
U1 2
U2 41
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD APR 15
PY 2022
VL 74
IS 4
BP 296
EP 316
DI 10.1002/iub.2585
EA DEC 2021
PG 21
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA ZV4BN
UT WOS:000728695400001
PM 34889504
DA 2024-11-01
ER

PT J
AU Cater, M
   Bombek, LK
AF Cater, Masa
   Bombek, Lidija Krizancic
TI Protective Role of Mitochondrial Uncoupling Proteins against Age-Related Oxidative Stress in Type 2 Diabetes Mellitus
SO ANTIOXIDANTS
LA English
DT Review
DE uncoupling proteins; reactive oxygen species; aging; age-related diseases; diabetes
ID beta-cell dysfunction; brown adipose-tissue; stimulated insulin-secretion; dna deletion levels; skeletal-muscle; high glucose; endothelial-cells; superoxide-production; advanced glycation; nitric-oxide
AB The accumulation of oxidative damage to DNA and other biomolecules plays an important role in the etiology of aging and age-related diseases such as type 2 diabetes mellitus (T2D), atherosclerosis, and neurodegenerative disorders. Mitochondrial DNA (mtDNA) is especially sensitive to oxidative stress. Mitochondrial dysfunction resulting from the accumulation of mtDNA damage impairs normal cellular function and leads to a bioenergetic crisis that accelerates aging and associated diseases. Age-related mitochondrial dysfunction decreases ATP production, which directly affects insulin secretion by pancreatic beta cells and triggers the gradual development of the chronic metabolic dysfunction that characterizes T2D. At the same time, decreased glucose oxidation in skeletal muscle due to mitochondrial damage leads to prolonged postprandial blood glucose rise, which further worsens glucose homeostasis. ROS are not only highly reactive by-products of mitochondrial respiration capable of oxidizing DNA, proteins, and lipids but can also function as signaling and effector molecules in cell membranes mediating signal transduction and inflammation. Mitochondrial uncoupling proteins (UCPs) located in the inner mitochondrial membrane of various tissues can be activated by ROS to protect cells from mitochondrial damage. Mitochondrial UCPs facilitate the reflux of protons from the mitochondrial intermembrane space into the matrix, thereby dissipating the proton gradient required for oxidative phosphorylation. There are five known isoforms (UCP1-UCP5) of mitochondrial UCPs. UCP1 can indirectly reduce ROS formation by increasing glutathione levels, thermogenesis, and energy expenditure. In contrast, UCP2 and UCP3 regulate fatty acid metabolism and insulin secretion by beta cells and modulate insulin sensitivity. Understanding the functions of UCPs may play a critical role in developing pharmacological strategies to combat T2D. This review summarizes the current knowledge on the protective role of various UCP homologs against age-related oxidative stress in T2D.
C1 [Cater, Masa; Bombek, Lidija Krizancic] Univ Maribor, Fac Med, Inst Physiol, Taborska Ulica 8, Maribor 2000, Slovenia.
C3 University of Maribor
RP Cater, M; Bombek, LK (corresponding author), Univ Maribor, Fac Med, Inst Physiol, Taborska Ulica 8, Maribor 2000, Slovenia.
EM masa.cater@um.si; lidija.bombek@um.si
FU Slovenian Research Agency [J3-9289, N3-0133, P3-0396]
CR Abd Eldaim MA, 2016, J ANIM SCI, V94, P5097, DOI 10.2527/jas.2016-0726
   Adjeitey CNK, 2013, AM J PHYSIOL-ENDOC M, V305, PE405, DOI 10.1152/ajpendo.00057.2013
   Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954
   Aguer C, 2013, FASEB J, V27, P4213, DOI 10.1096/fj.13-234302
   Armstrong Donald, 1992, JOURNAL OF DIABETES AND ITS COMPLICATIONS, V6, P116, DOI 10.1016/1056-8727(92)90022-D
   ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0
   Astaneie F, 2005, ARCH MED RES, V36, P376, DOI 10.1016/j.arcmed.2005.03.007
   Atari-Hajipirloo S, 2016, INT J ENDOCRINOL MET, V14, P0, DOI 10.5812/ijem.33273
   Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035
   Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   BERGSTEN P, 1994, J BIOL CHEM, V269, P8749
   Berthiaume JM, 2019, ANTIOXID REDOX SIGN, V30, P375, DOI 10.1089/ars.2017.7415
   Bogdanov P, 2015, ACTA DIABETOL, V52, P113, DOI 10.1007/s00592-014-0610-2
   Bogdanov P, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0097302
   Bombek LK, 2022, METABOLITES, V12, P0, DOI 10.3390/metabo12030259
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Bravard A, 2011, AM J PHYSIOL-ENDOC M, V300, PE581, DOI 10.1152/ajpendo.00455.2010
   Brondani LA, 2012, INVEST OPHTH VIS SCI, V53, P7449, DOI 10.1167/iovs.12-10660
   BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Bugger H, 2014, DIABETOLOGIA, V57, P660, DOI 10.1007/s00125-014-3171-6
   Busiello RA, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00036
   Cadenas S, 2018, BBA-BIOENERGETICS, V1859, P940, DOI 10.1016/j.bbabio.2018.05.019
   Cadet J, 2008, ACCOUNTS CHEM RES, V41, P1075, DOI 10.1021/ar700245e
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Cardoso S, 2013, J BIOENERG BIOMEMBR, V45, P397, DOI 10.1007/s10863-013-9503-2
   Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589
   Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302
   Chan CB, 1999, DIABETES, V48, P1482, DOI 10.2337/diabetes.48.7.1482
   Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, PE7, DOI 10.1152/ajpendo.00366.2002
   Choudhuri S, 2013, DIABETES RES CLIN PR, V100, P376, DOI 10.1016/j.diabres.2013.03.031
   Chung SSM, 2003, J AM SOC NEPHROL, V14, PS233, DOI 10.1097/01.ASN.0000077408.15865.06
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Costford SR, 2008, AM J PHYSIOL-ENDOC M, V295, PE1018, DOI 10.1152/ajpendo.00779.2007
   CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526
   Cui Y, 2006, EXP EYE RES, V83, P807, DOI 10.1016/j.exer.2006.03.024
   DAdamo M, 2004, DIABETES, V53, P1905, DOI 10.2337/diabetes.53.7.1905
   Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014
   De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com
   Del Prato S, 2003, DIABETOLOGIA, V46, PM2, DOI 10.1007/s00125-002-0930-6
   Dröse S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6
   EDRIS W, 1994, MUTAT RES-DNAGING G, V316, P69, DOI 10.1016/0921-8734(94)90009-4
   Erlanson-Albertsson C, 2003, ACTA PHYSIOL SCAND, V178, P405, DOI 10.1046/j.1365-201X.2003.01159.x
   Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1
   Figueroa-Romero C, 2008, REV ENDOCR METAB DIS, V9, P301, DOI 10.1007/s11154-008-9104-2
   Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095
   Fortuño A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098
   Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010
   Gewaltig MT, 2002, CARDIOVASC RES, V55, P250, DOI 10.1016/S0008-6363(02)00327-9
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Giardino I, 1996, J CLIN INVEST, V97, P1422, DOI 10.1172/JCI118563
   Görlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010
   Goldberg IJ, 2001, J CLIN ENDOCR METAB, V86, P965, DOI 10.1210/jc.86.3.965
   GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393
   Grubelnik V, 2020, LIFE-BASEL, V10, P0, DOI 10.3390/life10120348
   Grubelnik V, 2020, ROY SOC OPEN SCI, V7, P0, DOI 10.1098/rsos.191171
   Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028
   Han D, 2009, ANTIOXID REDOX SIGN, V11, P2245, DOI 10.1089/ars.2009.2611
   Hansen ME, 2014, J DIABETES RES, V2014, P0, DOI 10.1155/2014/765784
   HARDING JJ, 1988, BIOCHEM J, V249, P617, DOI 10.1042/bj2490617
   Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730
   Hass DT, 2021, PROG RETIN EYE RES, V83, P0, DOI 10.1016/j.preteyeres.2021.100941
   He Y, 2014, INT J MOL MED, V33, P1275, DOI 10.3892/ijmm.2014.1676
   He Y, 2019, INT J OPHTHALMOL-CHI, V12, P375, DOI 10.18240/ijo.2019.03.04
   Henquin JC, 2006, DIABETES, V55, P441, DOI 10.2337/diabetes.55.02.06.db05-1051
   Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027
   Hilse KE, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.00747
   Hilse KE, 2016, BBA-BIOENERGETICS, V1857, P72, DOI 10.1016/j.bbabio.2015.10.011
   Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204
   Hink U, 2001, CIRC RES, V88, P0
   Hirschenson J, 2022, ANTIOXIDANTS-BASEL, V11, P0, DOI 10.3390/antiox11020322
   Horimoto M, 2004, HEPATOLOGY, V39, P386, DOI 10.1002/hep.20047
   HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879
   Huang JD, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/2758262
   Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999
   International Diabetes Federation, 2021, IDF DIABETES ATLAS, V0, P0
   Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179
   Jaffredo M, 2021, DIABETES, V70, P878, DOI 10.2337/db20-0214
   Jezek P, 2018, ANTIOXID REDOX SIGN, V29, P667, DOI 10.1089/ars.2017.7225
   Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586
   Juan CA, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22094642
   Kahancová A, 2018, FEBS LETT, V592, P999, DOI 10.1002/1873-3468.12991
   Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Kalil GZ, 2012, HYPERTENS RES, V35, P4, DOI 10.1038/hr.2011.173
   Kaludercic N, 2020, FRONT CARDIOVASC MED, V7, P0, DOI 10.3389/fcvm.2020.00012
   Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041
   Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200
   Kaneto H, 2001, J BIOL CHEM, V276, P31099, DOI 10.1074/jbc.M104115200
   Kang D, 2002, CURR GENET, V41, P311, DOI 10.1007/s00294-002-0312-0
   Kang DC, 2005, CURR MED CHEM, V12, P429, DOI 10.2174/0929867053363081
   Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581
   Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Kjobsted R, 2018, FASEB J, V32, P1741, DOI 10.1096/fj.201700442R
   Kopecky J, 2001, BIOCHEM SOC T, V29, P791, DOI 10.1042/bst0290791
   Kowluru RA, 2004, DIABETES, V53, P3233, DOI 10.2337/diabetes.53.12.3233
   Kowluru RA, 2001, EXPERT OPIN INV DRUG, V10, P1665, DOI 10.1517/13543784.10.9.1665
   Kowluru RA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1266, DOI 10.1001/archopht.126.9.1266
   Kowluru RA, 2007, EXP DIABETES RES, V0, P0, DOI DOI 10.1155/2007/43603
   Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859
   Koziel A, 2015, AM J PHYSIOL-HEART C, V309, PH147, DOI 10.1152/ajpheart.00759.2014
   Koziel A, 2012, PFLUG ARCH EUR J PHY, V464, P657, DOI 10.1007/s00424-012-1156-1
   Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774
   Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592
   LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780
   LEE CM, 1993, J GERONTOL, V48, PB201, DOI 10.1093/geronj/48.6.B201
   Lee KU, 2005, CIRC RES, V96, P1200, DOI 10.1161/01.RES.0000170075.73039.5b
   Li YF, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001397
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Liu J, 2013, J DIABETES RES, V2013, P0, DOI 10.1155/2013/585897
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Lo YYC, 1996, J BIOL CHEM, V271, P15703, DOI 10.1074/jbc.271.26.15703
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longo M, 2019, FRONT ENDOCRINOL, V10, P0, DOI 10.3389/fendo.2019.00045
   Lowe J, 2017, IUBMB LIFE, V69, P255, DOI 10.1002/iub.1614
   Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076
   Mailloux RJ, 2015, REDOX BIOL, V4, P381, DOI 10.1016/j.redox.2015.02.001
   Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004
   Mailloux RJ, 2012, FASEB J, V26, P363, DOI 10.1096/fj.11-189639
   Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022
   Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242
   Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X
   Maurer SF, 2020, AM J PHYSIOL-ENDOC M, V318, PE198, DOI 10.1152/ajpendo.00121.2019
   Mehta JL, 2006, INT J BIOCHEM CELL B, V38, P794, DOI 10.1016/j.biocel.2005.12.008
   Meirhaeghe A, 2000, DIABETOLOGIA, V43, P1424, DOI 10.1007/s001250051549
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102
   Miki A, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0196570
   Moschinger M, 2019, BIOL SEX DIFFER, V10, P0, DOI 10.1186/s13293-019-0267-1
   Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nabben M, 2008, PHYSIOL BEHAV, V94, P259, DOI 10.1016/j.physbeh.2007.11.039
   Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459
   NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366
   Newsholme P, 2012, ADV EXP MED BIOL, V942, P235, DOI 10.1007/978-94-007-2869-1_10
   Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200
   Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015
   Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Pedersen SB, 2001, BIOCHEM BIOPH RES CO, V288, P191, DOI 10.1006/bbrc.2001.5763
   Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0
   Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642
   Pitocco D, 2013, INT J MOL SCI, V14, P21525, DOI 10.3390/ijms141121525
   Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063
   Pop-Busui R, 2006, DIABETES-METAB RES, V22, P257, DOI 10.1002/dmrr.625
   Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x
   Ramsden DB, 2012, BRAIN BEHAV, V2, P468, DOI 10.1002/brb3.55
   Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103
   Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345
   Ricquier D, 2000, J PHYSIOL-LONDON, V529, P3, DOI 10.1111/j.1469-7793.2000.00003.x
   Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581
   Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72
   Rorsman P, 2018, PHYSIOL REV, V98, P117, DOI 10.1152/physrev.00008.2017
   Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, PF420, DOI 10.1152/ajprenal.00415.2004
   Rose G, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0029650
   Ross MF, 2006, BIOCHEM J, V400, P199, DOI 10.1042/BJ20060919
   Rousset S, 2004, DIABETES, V53, PS130, DOI 10.2337/diabetes.53.2007.S130
   Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com
   Sack MN, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a013102
   SAKUMI K, 1993, J BIOL CHEM, V268, P23524
   Sale Michele M, 2007, BMC ENDOCR DISORD, V7, P1, DOI 10.1186/1472-6823-7-1
   Saleh MC, 2002, DIABETOLOGIA, V45, P174, DOI 10.1007/s00125-001-0737-x
   Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200
   Sanchis D, 1998, J BIOL CHEM, V273, P34611, DOI 10.1074/jbc.273.51.34611
   Sasso FC, 2005, J AM COLL CARDIOL, V46, P827, DOI 10.1016/j.jacc.2005.06.007
   Schieber M, 2014, CURR BIOL, V24, PR453, DOI 10.1016/j.cub.2014.03.034
   Schleicher ED, 2000, KIDNEY INT, V58, PS13, DOI 10.1046/j.1523-1755.2000.07703.x
   Schoonbroodt S, 2000, BIOCHEM PHARMACOL, V60, P1075, DOI 10.1016/S0006-2952(00)00371-3
   Schrauwen P, 2006, J CLIN ENDOCR METAB, V91, P1520, DOI 10.1210/jc.2005-1572
   Schrauwen P, 2004, P NUTR SOC, V63, P287, DOI 10.1079/PNS2003336
   Schrauwen P, 2001, FASEB J, V15, P2497, DOI 10.1096/fj.01-0400hyp
   Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3
   Serpillon S, 2009, AM J PHYSIOL-HEART C, V297, PH153, DOI 10.1152/ajpheart.01142.2008
   Sesti G, 2003, DIABETES, V52, P1280, DOI 10.2337/diabetes.52.5.1280
   Sharma Yashodhara, 2012, J OCUL BIOL DIS INFOR, V5, P63, DOI 10.1007/s12177-013-9104-7
   Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039
   Albert-Garay JS, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-05284-x
   SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F
   Singh A, 2022, MOLECULES, V27, P0, DOI 10.3390/molecules27030950
   Singh VP, 2014, KOREAN J PHYSIOL PHA, V18, P1, DOI 10.4196/kjpp.2014.18.1.1
   Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795
   Sloan G, 2021, NAT REV ENDOCRINOL, V17, P400, DOI 10.1038/s41574-021-00496-z
   Stozer A, 2021, AM J PHYSIOL-ENDOC M, V321, PE305, DOI 10.1152/ajpendo.00043.2021
   Stozer A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054638
   Sun H, 2022, DIABETES RES CLIN PR, V183, P0, DOI 10.1016/j.diabres.2021.109119
   SUTTORP N, 1986, AM J PHYSIOL, V251, PC671, DOI 10.1152/ajpcell.1986.251.5.C671
   Szoke E, 2008, DIABETES CARE, V31, P539, DOI 10.2337/dc07-1443
   Takahashi T, 2014, J DIABETES RES, V2014, P0, DOI 10.1155/2014/590541
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D
   Thallas-Bonke V, 2008, DIABETES, V57, P460, DOI 10.2337/db07-1119
   THOMAS SM, 1989, BIOCHIM BIOPHYS ACTA, V1002, P189, DOI 10.1016/0005-2760(89)90286-5
   Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733
   Tiwari Brahm Kumar, 2013, J BIOMARK, V2013, P378790, DOI 10.1155/2013/378790
   Tokarz VL, 2018, J CELL BIOL, V217, P2273, DOI 10.1083/jcb.201802095
   Ullah A, 2016, SAUDI PHARM J, V24, P547, DOI 10.1016/j.jsps.2015.03.013
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   van den Berg SAA, 2011, CURR OPIN CLIN NUTR, V14, P243, DOI 10.1097/MCO.0b013e3283455d7a
   Vankoningsloo S, 2005, J LIPID RES, V46, P1133, DOI 10.1194/jlr.M400464-JLR200
   VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740
   Vimaleswaran KS, 2011, DIABETES TECHNOL THE, V13, P19, DOI 10.1089/dia.2010.0091
   Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243
   Woods SC, 2006, PHILOS T R SOC B, V361, P1219, DOI 10.1098/rstb.2006.1858
   Wu JZ, 2016, DIABET METAB SYND OB, V9, P145, DOI 10.2147/DMSO.S106087
   Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610
   Xu K, 2011, DIABETOLOGIA, V54, P2315, DOI 10.1007/s00125-011-2245-y
   Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336
   YkiJarvinen H, 1996, DIABETES, V45, P302, DOI 10.2337/diabetes.45.3.302
   Yoon MS, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00788
   Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010
   Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6
   Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151
   Zhuang TF, 2014, NUTRIENTS, V6, P3968, DOI 10.3390/nu6093968
NR 227
TC 24
Z9 25
U1 3
U2 20
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD AUG 15
PY 2022
VL 11
IS 8
BP 
EP 
DI 10.3390/antiox11081473
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology
GA 4C2VW
UT WOS:000846318900001
PM 36009191
DA 2024-11-01
ER

PT J
AU Oudbier, SJ
   Goh, J
   Looijaard, SMLM
   Reijnierse, EM
   Meskers, CGM
   Maier, AB
AF Oudbier, Susanne Janette
   Goh, Jorming
   Looijaard, Stephanie Marcella Leonie Maria
   Reijnierse, Esmee Marielle
   Meskers, Carolus Gerardus Maria
   Maier, Andrea Britta
TI Pathophysiological Mechanisms Explaining the Association Between Low Skeletal Muscle Mass and Cognitive Function
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
LA English
DT Review
DE Dementia; Inflammation; Insulin; Myokines
ID alzheimers-disease; insulin-resistance; mitochondrial dysfunction; neurotrophic factor; adipose-tissue; older-adults; brain; protein; interleukin-6; sarcopenia
AB Low skeletal muscle mass is associated with cognitive impairment and dementia in older adults. This review describes the possible underlying pathophysiological mechanisms: systemic inflammation, insulin metabolism, protein metabolism, and mitochondrial function. We hypothesize that the central tenet in this pathophysiology is the dysfunctional myokine secretion consequent to minimal physical activity. Myokines, such as fibronectin type III domain containing 5/irisin and cathepsin B, are released by physically active muscle and cross the blood-brain barrier. These myokines upregulate local neurotrophin expression such as brain-derived neurotrophic factor (BDNF) in the brain microenvironment. BDNF exerts anti-inflammatory effects that may be responsible for neuroprotection. Altered myokine secretion due to physical inactivity exacerbates inflammation and impairs muscle glucose metabolism, potentially affecting the transport of insulin across the blood-brain barrier. Our working model also suggests other underlying mechanisms. A negative systemic protein balance, commonly observed in older adults, contributes to low skeletal muscle mass and may also reflect deficient protein metabolism in brain tissues. As a result of age-related loss in skeletal muscle mass, decrease in the abundance of mitochondria and detriments in their function lead to a decrease in tissue oxidative capacity. Dysfunctional mitochondria in skeletal muscle and brain result in the excessive production of reactive oxygen species, which drives tissue oxidative stress and further perpetuates the dysfunction in mitochondria. Both oxidative stress and accumulation of mitochondrial DNA mutations due to aging drive cellular senescence. A targeted approach in the pathophysiology of low muscle mass and cognition could be to restore myokine balance by physical activity.
C1 [Oudbier, Susanne Janette] Vrije Univ Amsterdam, Amsterdam UMC Locat, Amsterdam Publ Hlth Res Inst, Dept Outpatient Clin, Amsterdam, Netherlands.
   [Goh, Jorming; Maier, Andrea Britta] Natl Univ Singapore, Yong Loo Lin Sch Med, Hlth Longev Translat Res Program, Singapore, Singapore.
   [Goh, Jorming; Maier, Andrea Britta] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore.
   [Goh, Jorming; Maier, Andrea Britta] Natl Univ Hlth Syst, AgeSingapore, Ctr Hlth Longev, 28 Med Dr, Singapore 117456, Singapore.
   [Looijaard, Stephanie Marcella Leonie Maria] Alrijne Hosp, Dept Internal Med, Leiderdorp, Netherlands.
   [Reijnierse, Esmee Marielle; Meskers, Carolus Gerardus Maria] Vrije Univ Amsterdam, Amsterdam UMC Locat, Rehabil Med, Amsterdam, Netherlands.
   [Reijnierse, Esmee Marielle; Meskers, Carolus Gerardus Maria] Amsterdam Movement Sci Ageing & Vital, Amsterdam, Netherlands.
   [Reijnierse, Esmee Marielle; Maier, Andrea Britta] Univ Melbourne, Royal Melbourne Hosp, AgeMelbourne, Dept Med & Aged Care, Parkville, Vic, Australia.
   [Maier, Andrea Britta] Vrije Univ Amsterdam, Amsterdam Movement Sci, Fac Behav & Movement Sci, Dept Human Movement Sci,AgeAmsterdam, Amsterdam, Netherlands.
C3 Vrije Universiteit Amsterdam; National University of Singapore; National University of Singapore; National University of Singapore; Vrije Universiteit Amsterdam; Melbourne Health; Royal Melbourne Hospital; University of Melbourne; Vrije Universiteit Amsterdam
RP Maier, AB (corresponding author), Natl Univ Hlth Syst, AgeSingapore, Ctr Hlth Longev, 28 Med Dr, Singapore 117456, Singapore.
EM a.maier@nus.edu.sg
CR Akbari M, 2018, INFLAMMOPHARMACOLOGY, V26, P685, DOI 10.1007/s10787-018-0458-0
   Al Mamun A, 2020, NEUROTOX RES, V38, P8, DOI 10.1007/s12640-020-00185-1
   Allen MD, 2021, EXP GERONTOL, V152, P0, DOI 10.1016/j.exger.2021.111465
   Anisimova AS, 2018, AGING-US, V10, P4269, DOI 10.18632/aging.101721
   Barclay RD, 2019, FRONT NUTR, V6, P0, DOI 10.3389/fnut.2019.00146
   Beeri MS, 2021, J AM GERIATR SOC, V69, P1826, DOI 10.1111/jgs.17206
   Bian AL, 2020, BMC MUSCULOSKEL DIS, V21, P0, DOI 10.1186/s12891-020-03236-y
   Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019
   Blasko I, 2003, DRUG AGING, V20, P101, DOI 10.2165/00002512-200320020-00002
   Brandt C, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/520258
   Burd NA, 2013, EXERC SPORT SCI REV, V41, P169, DOI 10.1097/JES.0b013e318292f3d5
   Burton MD, 2011, J NEUROINFLAMM, V8, P0, DOI 10.1186/1742-2094-8-54
   Burtscher J, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22126479
   Cipolli GC, 2019, J NUTR HEALTH AGING, V23, P525, DOI 10.1007/s12603-019-1188-8
   Calabrese F, 2014, FRONT CELL NEUROSCI, V8, P0, DOI 10.3389/fncel.2014.00430
   Campbell IL, 2014, J NEUROSCI, V34, P2503, DOI 10.1523/JNEUROSCI.2830-13.2014
   Cao Q, 2020, J ALZHEIMERS DIS, V73, P1157, DOI 10.3233/JAD-191092
   Chakrabarti S, 2011, AGING DIS, V2, P242
   Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, PE7, DOI 10.1152/ajpendo.00366.2002
   Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498
   Chen WT, 2021, J CELL PHYSIOL, V236, P2393, DOI 10.1002/jcp.30033
   Cheng AW, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms2238
   Cholerton B, 2013, EUR J PHARMACOL, V719, P170, DOI 10.1016/j.ejphar.2013.08.008
   Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y
   Cleasby ME, 2016, J ENDOCRINOL, V229, PR67, DOI 10.1530/JOE-15-0533
   Correia JC, 2021, CELL METAB, V33, P2215, DOI 10.1016/j.cmet.2021.09.003
   Côté S, 2012, ALZHEIMERS DEMENT, V8, P219, DOI 10.1016/j.jalz.2011.03.012
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
   Darweesh SKL, 2018, ALZHEIMERS DEMENT, V14, P1450, DOI 10.1016/j.jalz.2018.02.014
   de Freitas GB, 2020, J NEUROCHEM, V155, P602, DOI 10.1111/jnc.15039
   Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108
   Domínguez M, 2016, FREE RADICAL BIO MED, V95, P1, DOI 10.1016/j.freeradbiomed.2016.02.034
   Du Z, 2018, CLIN INTERV AGING, V13, P1593, DOI 10.2147/CIA.S169565
   Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253
   Ekblad LL, 2017, DIABETES CARE, V40, P751, DOI 10.2337/dc16-2001
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, PS76, DOI 10.1016/j.jalz.2013.12.010
   Ferri E, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21155236
   Fulop T, 2023, CLIN REV ALLERG IMMU, V64, P109, DOI 10.1007/s12016-021-08899-6
   Funk JA, 2011, BRAIN BEHAV IMMUN, V25, P1063, DOI 10.1016/j.bbi.2011.03.012
   Gan ZJ, 2018, CELL RES, V28, P969, DOI 10.1038/s41422-018-0078-7
   Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45
   Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420
   Ismail R, 2020, J NEUROINFLAMM, V17, P0, DOI 10.1186/s12974-020-01820-6
   Jarmusch S, 2021, BMC MUSCULOSKEL DIS, V22, P0, DOI 10.1186/s12891-021-04699-3
   Karssemeijer EGA, 2017, AGEING RES REV, V40, P75, DOI 10.1016/j.arr.2017.09.003
   Khacho M, 2019, NAT REV NEUROSCI, V20, P34, DOI 10.1038/s41583-018-0091-3
   Kim IY, 2020, ANN GERIATR MED RES, V24, P157
   Kim KH, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-23254-0
   KOMAKI G, 1992, AM J PHYSIOL, V262, PE246, DOI 10.1152/ajpendo.1992.262.2.E246
   Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014
   Koyama A, 2013, J GERONTOL A-BIOL, V68, P433, DOI 10.1093/gerona/gls187
   Kraakman MJ, 2015, CELL METAB, V21, P403, DOI 10.1016/j.cmet.2015.02.006
   Krabbe KS, 2009, J AM GERIATR SOC, V57, P1447, DOI 10.1111/j.1532-5415.2009.02345.x
   Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009
   Kullmann S, 2016, PHYSIOL REV, V96, P1169, DOI 10.1152/physrev.00032.2015
   Kwan Ping, 2013, J AGING RES, V2013, P791679, DOI 10.1155/2013/791679
   Leuner K, 2012, ANTIOXID REDOX SIGN, V16, P1421, DOI 10.1089/ars.2011.4173
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Limoge M, 2017, ONCOTARGET, V8, P35592, DOI 10.18632/oncotarget.16022
   Liu PZ, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00052
   Lourenco MV, 2020, ALZH DEMENT-DADM, V12, P0, DOI 10.1002/dad2.12034
   Lourenco MV, 2019, NAT MED, V25, P165, DOI 10.1038/s41591-018-0275-4
   Lovestone S, 2002, J NEUROL NEUROSUR PS, V72, P152, DOI 10.1136/jnnp.72.2.152
   Ma LN, 2015, CLIN CHIM ACTA, V444, P18, DOI 10.1016/j.cca.2015.01.027
   Maher FO, 2005, NEUROBIOL AGING, V26, P717, DOI 10.1016/j.neurobiolaging.2004.07.002
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001
   Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025
   Murman Daniel L, 2015, SEMINARS IN HEARING, V36, P111, DOI 10.1055/s-0035-1555115
   Nguyen TT, 2020, NEUROCHEM RES, V45, P1481, DOI 10.1007/s11064-020-03031-0
   Nishikawa H, 2021, INT J MOL MED, V48, P0, DOI 10.3892/ijmm.2021.4989
   Ogawa Y, 2018, FRONT NEUROL, V9, P0, DOI 10.3389/fneur.2018.00710
   Pacifico J, 2020, EXP GERONTOL, V131, P0, DOI 10.1016/j.exger.2019.110801
   Pannese E, 2011, BRAIN STRUCT FUNCT, V216, P85, DOI 10.1007/s00429-011-0308-y
   Papadopoli David, 2019, F1000RES, V8, P0, DOI 10.12688/f1000research.17196.1
   Pedersen BK, 2011, BRAIN BEHAV IMMUN, V25, P811, DOI 10.1016/j.bbi.2011.02.010
   Pedersen BK, 2011, J EXP BIOL, V214, P337, DOI 10.1242/jeb.048074
   Pedersen BK, 2019, NAT REV ENDOCRINOL, V15, P383, DOI 10.1038/s41574-019-0174-x
   Pedersen BK, 2005, BRAIN BEHAV IMMUN, V19, P371, DOI 10.1016/j.bbi.2005.04.008
   Perluigi M, 2015, NEUROBIOL DIS, V84, P39, DOI 10.1016/j.nbd.2015.03.014
   Peterson Courtney M, 2012, J AGING RES, V2012, P194821, DOI 10.1155/2012/194821
   Picca A, 2018, BIOL CHEM, V399, P421, DOI 10.1515/hsz-2017-0331
   Poddar J, 2019, J CHEM NEUROANAT, V95, P70, DOI 10.1016/j.jchemneu.2018.04.002
   Ramsey KA, 2021, AGEING RES REV, V67, P0, DOI 10.1016/j.arr.2021.101266
   Rezus E, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21020592
   Rhea EM, 2021, J NEUROENDOCRINOL, V33, P0, DOI 10.1111/jne.12929
   Rocha M, 2010, CURR PHARM DESIGN, V16, P3124, DOI 10.2174/138161210793292519
   Roh E, 2016, EXP MOL MED, V48, P0, DOI 10.1038/emm.2016.4
   Rose-John S, 2021, CYTOKINE, V144, P0, DOI 10.1016/j.cyto.2021.155577
   Sadeghabadi ZA, 2019, J DIABETES METAB DIS, V18, P437, DOI 10.1007/s40200-019-00437-8
   Sakuma K, 2018, PFLUG ARCH EUR J PHY, V470, P449, DOI 10.1007/s00424-017-2077-9
   Schumertl T, 2022, BBA-MOL CELL RES, V1869, P0, DOI 10.1016/j.bbamcr.2021.119143
   Severinsen MCK, 2020, ENDOCR REV, V41, P0, DOI 10.1210/endrev/bnaa016
   Shen XN, 2019, J NEUROL NEUROSUR PS, V90, P590, DOI 10.1136/jnnp-2018-319148
   Singh-Manoux A, 2014, NEUROLOGY, V83, P486, DOI 10.1212/WNL.0000000000000665
   Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585
   Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010
   Sylow L, 2021, CELL METAB, V33, P758, DOI 10.1016/j.cmet.2021.03.020
   Szekely CA, 2004, NEUROEPIDEMIOLOGY, V23, P159, DOI 10.1159/000078501
   Taekema DG, 2012, AGE AGEING, V41, P506, DOI 10.1093/ageing/afs013
   Thambisetty M, 2013, NEUROBIOL AGING, V34, P2271, DOI 10.1016/j.neurobiolaging.2013.03.025
   Tobore TO, 2019, NEUROL SCI, V40, P1527, DOI 10.1007/s10072-019-03863-x
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Tuttle CSL, 2020, AGEING RES REV, V64, P0, DOI 10.1016/j.arr.2020.101185
   Tuttle CSL, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13083
   van Dam R, 2018, DEMENT GERIATR COGN, V45, P243, DOI 10.1159/000486711
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Volpi E, 2004, CURR OPIN CLIN NUTR, V7, P405, DOI 10.1097/01.mco.0000134362.76653.b2
   Wang DXM, 2020, J CACHEXIA SARCOPENI, V11, P3, DOI 10.1002/jcsm.12502
   Wennberg AMV, 2018, NEUROBIOL AGING, V66, P68, DOI 10.1016/j.neurobiolaging.2017.11.017
   White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200
   Wong KY, 2020, AGING DIS, V11, P1291, DOI 10.14336/AD.2019.1125
   Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008
   Wu HX, 2020, PHYSIOL REP, V8, P0, DOI 10.14814/phy2.14575
   Xie B, 2020, INT J NEUROSCI, V130, P218, DOI 10.1080/00207454.2019.1667794
   Yakabe M, 2015, RNA TRANSCR, V1, P10, DOI 10.11648/J.BS.20150102.11
   Yeung SSY, 2019, J CACHEXIA SARCOPENI, V10, P485, DOI 10.1002/jcsm.12411
NR 120
TC 37
Z9 39
U1 1
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD OCT 6
PY 2022
VL 77
IS 10
BP 1959
EP 1968
DI 10.1093/gerona/glac121
EA JUN 2022
PG 10
WC Geriatrics & Gerontology; Gerontology
SC Geriatrics & Gerontology
GA 5C6JY
UT WOS:000820943600001
PM 35661882
DA 2024-11-01
ER

PT J
AU Bohra, SK
   Achar, RR
   Chidambaram, SB
   Pellegrino, C
   Laurin, J
   Masoodi, M
   Srinivasan, A
AF Bohra, Shraman Kumar
   Achar, Raghu Ram
   Chidambaram, Saravana Babu
   Pellegrino, Christophe
   Laurin, Jerome
   Masoodi, Mojgan
   Srinivasan, Asha
TI Current perspectives on mitochondrial dysfunction in migraine
SO EUROPEAN JOURNAL OF NEUROSCIENCE
LA English
DT Review
DE impairment; metabolism; migraine; mitochondrial dysfunction; mitochondrial genetics
ID magnetic-resonance-spectroscopy; cyclic vomiting syndrome; high-dose riboflavin; familial hemiplegic migraine; transfer rnaleu(uur) gene; monoamine-oxidase-a; low brain magnesium; alpha-lipoic acid; oxidative stress; lactic-acidosis
AB Mitochondria are an autonomous organelle that plays a crucial role in the metabolic aspects of a cell. Cortical spreading depression (CSD) and fluctuations in the cerebral blood flow have for long been mechanisms underlying migraine. It is a neurovascular disorder with a unilateral manifestation of disturbing, throbbing and pulsating head pain. Migraine affects 2.6% and 21.7% of the general population and is the major cause of partial disability in the age group 15-49. Higher mutation rates, imbalance in concentration of physiologically relevant molecules and oxidative stress biomarkers have been the main themes of discussion in determining the role of mitochondrial disability in migraine. The correlation of migraine with other disorders like hemiplegic migraine; mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes [MELAS]; tension-type headache (TTH); cyclic vomiting syndrome (CVS), ischaemic stroke; and hypertension has helped in the assessment of the physiological and morphogenetic basis of migraine. Here, we have reviewed the different nuances of mitochondrial dysfunction and migraine. The different mtDNA polymorphisms that can affect the generation and transmission of nerve impulse has been highlighted and supported with research findings. In addition to this, the genetic basis of migraine pathogenesis as a consequence of mutations in nuclear DNA that can, in turn, affect the synthesis of defective mitochondrial proteins is discussed along with a brief overview of epigenetic profile. This review gives an overview of the pathophysiology of migraine and explores mitochondrial dysfunction as a potential underlying mechanism. Also, therapeutic supplements for managing migraine have been discussed at different junctures in this paper.
C1 [Bohra, Shraman Kumar] Pooja Bhagavat Mem Mahajana Educ Ctr, Dept Life Sci, Mysore, Karnataka, India.
   [Achar, Raghu Ram] JSS Acad Higher Educ & Res, Sch Life Sci, Div Biochem, Mysore, Karnataka, India.
   [Chidambaram, Saravana Babu] JSS Acad Higher Educ & Res, JSS Coll Pharm, Dept Pharmacol, Mysore, Karnataka, India.
   [Pellegrino, Christophe] Aix Marseille Univ, INSERM, Inst Mediterranean Neurobiol, Marseille, France.
   [Laurin, Jerome] Aix Marseille Univ, Sport Sci Fac, Inst Neurobiol Mediterranee, INMED INSERM AMU, Marseille, France.
   [Masoodi, Mojgan] Univ Hosp Bern, Inst Clin Chem, Bern, Switzerland.
   [Srinivasan, Asha] JSS Acad Higher Educ & Res, JSS Med Coll, Sch Life Sci, Div Nanosci & Technol, Mysore 570015, Karnataka, India.
   [Srinivasan, Asha] JSS Acad Higher Educ & Res, JSS Med Coll, Ctr Excellence Mol Biol & Regenerat Med, Mysore 570015, Karnataka, India.
C3 JSS Academy of Higher Education & Research; JSS Academy of Higher Education & Research; JSS College of Pharmacy, Mysuru; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Aix-Marseille Universite; University of Bern; University Hospital of Bern; JSS Academy of Higher Education & Research; JSS Medical College, Mysuru; JSS Academy of Higher Education & Research; JSS Medical College, Mysuru
RP Srinivasan, A (corresponding author), JSS Acad Higher Educ & Res, JSS Med Coll, Sch Life Sci, Div Nanosci & Technol, Mysore 570015, Karnataka, India.; Srinivasan, A (corresponding author), JSS Acad Higher Educ & Res, JSS Med Coll, Ctr Excellence Mol Biol & Regenerat Med, Mysore 570015, Karnataka, India.
EM asha.srinivasan@jssuni.edu.in
CR Aggarwal M, 2012, ANN NEUROSCI, V19, P88, DOI 10.5214/ans.0972.7531.12190210
   Al Khalili Y, 2019, STATPEARLS, V0, P0
   Albrecht DS, 2019, NEUROLOGY, V92, PE2038, DOI 10.1212/WNL.0000000000007371
   Alloush R, 2019, NEUROSCIENCE MED, V10, P339, DOI 10.4236/nm.2019.104025
   Amin FM, 2014, BRAIN, V137, P779, DOI 10.1093/brain/awt369
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Ashoori M, 2014, BRIT J NUTR, V111, P1985, DOI 10.1017/S0007114514000178
   Atlante A, 2001, FEBS LETT, V497, P1, DOI 10.1016/S0014-5793(01)02437-1
   Bandiera S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0020746
   Banne AF, 2003, J ANTI-AGING MED, V6, P327, DOI 10.1089/109454503323028920
   BARBIROLI B, 1990, CEPHALALGIA, V10, P263, DOI 10.1046/j.1468-2982.1990.1005263.x
   Borte S, 2020, CEPHALALGIA, V40, P625, DOI 10.1177/0333102420906835
   Bron C, 2021, NEUROPSYCH DIS TREAT, V17, P1183, DOI 10.2147/NDT.S282562
   Brown GC, 2007, FRONT BIOSCI-LANDMRK, V12, P1024, DOI 10.2741/2122
   Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482
   Burow P, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10092471
   Burstein R, 2015, J NEUROSCI, V35, P6619, DOI 10.1523/JNEUROSCI.0373-15.2015
   Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004
   Charbit AR, 2010, CURR OPIN NEUROL, V23, P275, DOI 10.1097/WCO.0b013e3283378d5c
   Cheng J, 2011, EUR J PHARMACOL, V650, P184, DOI 10.1016/j.ejphar.2010.09.033
   Chial H, 2008, NATURE EDUC, V1, P217
   Condò M, 2009, J HEADACHE PAIN, V10, P361, DOI 10.1007/s10194-009-0142-2
   Daniel O, 2016, CURR TREAT OPTION NE, V18, P0, DOI 10.1007/s11940-016-0398-1
   Davis Ryan L, 2018, HANDB CLIN NEUROL, V147, P125, DOI 10.1016/B978-0-444-63233-3.00010-5
   De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081
   Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dong YR, 2017, EPIGENET CHROMATIN, V10, P0, DOI 10.1186/s13072-017-0149-x
   Durham PL, 2006, HEADACHE, V46, PS3, DOI 10.1111/j.1526-4610.2006.00483.x
   ERECINSKA M, 1990, J GEN PHYSIOL, V95, P591, DOI 10.1085/jgp.95.4.591
   Eren Y, 2015, ACTA NEUROL BELG, V115, P643, DOI 10.1007/s13760-015-0427-y
   Fanibunda SE, 2019, P NATL ACAD SCI USA, V116, P11028, DOI 10.1073/pnas.1821332116
   Farré AL, 2001, HYPERTENSION, V38, P1400, DOI 10.1161/hy1201.099612
   Fazzini F, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-33684-5
   Ferrari MD, 2015, LANCET NEUROL, V14, P65, DOI 10.1016/S1474-4422(14)70220-0
   Fila M, 2019, ARCH MED SCI, V15, P944, DOI 10.5114/aoms.2019.86061
   Filic V, 2005, J NEUROL SCI, V228, P149, DOI 10.1016/j.jns.2004.11.045
   Geyik S, 2016, J HEADACHE PAIN, V17, P0, DOI 10.1186/s10194-016-0623-z
   Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Green MW, 2021, CURR OPIN NEUROL, V34, P329, DOI 10.1097/WCO.0000000000000939
   Gross EC, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-84102-2
   Gross EC, 2019, NAT REV NEUROL, V15, P627, DOI 10.1038/s41582-019-0255-4
   Guo S, 2016, EUR J NEUROL, V23, P175, DOI 10.1111/ene.12832
   Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127
   Holland P, 2007, HEADACHE, V47, P951, DOI 10.1111/j.1526-4610.2007.00842.x
   Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c
   Ikeda K, 2003, J NEUROSCI, V23, P4667
   Jimenez L, 2014, J CELL SCI, V127, P719, DOI 10.1242/jcs.137141
   Kagan R, 2013, NEUROSCIENCE, V248, P359, DOI 10.1016/j.neuroscience.2013.06.014
   Kataria S, 2020, CUREUS J MED SCIENCE, V12, P0, DOI 10.7759/cureus.9226
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kausar S, 2018, CELLS-BASEL, V7, P0, DOI 10.3390/cells7120274
   Kelishadi MR, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-021-04397-z
   KEMP GJ, 1993, NMR BIOMED, V6, P302, DOI 10.1002/nbm.1940060504
   Kim HK, 2015, NEURAL PLAST, V2015, P0, DOI 10.1155/2015/408136
   KOBARI M, 1989, HEADACHE, V29, P282, DOI 10.1111/j.1526-4610.1989.hed2905282.x
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Köseoglu E, 2008, MAGNESIUM RES, V21, P101
   Kraya T, 2018, HEADACHE, V58, P45, DOI 10.1111/head.13219
   Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007
   Lemos C, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050626
   Li BUK, 2003, GASTROENTEROL CLIN N, V32, P997, DOI 10.1016/S0889-8553(03)00045-1
   Li BUK, 1999, J PEDIATR-US, V134, P567, DOI 10.1016/S0022-3476(99)70242-8
   Lin KH, 2016, CEPHALALGIA, V36, P1218, DOI 10.1177/0333102415623069
   Liu F, 2018, AGING DIS, V9, P924, DOI 10.14336/AD.2017.1126
   Lodi R, 1997, PEDIATR RES, V42, P866, DOI 10.1203/00006450-199712000-00024
   Loggia ML, 2015, BRAIN, V138, P604, DOI 10.1093/brain/awu377
   MacGregor EA, 2004, LANCET NEUROL, V3, P354, DOI 10.1016/S1474-4422(04)00768-9
   MacLennan SC, 2008, J CHILD NEUROL, V23, P1300, DOI 10.1177/0883073808318053
   Maizels M, 2012, HEADACHE, V52, P1553, DOI 10.1111/j.1526-4610.2012.02209.x
   Majamaa K, 1998, LANCET, V352, P455, DOI 10.1016/S0140-6736(05)79190-X
   Maleki N, 2011, MOL PAIN, V7, P0, DOI 10.1186/1744-8069-7-71
   Marrocco I, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/6501046
   Marziniak M, 2005, NEUROLOGY, V64, P157, DOI 10.1212/01.WNL.0000148597.52312.9E
   Marziniak M, 2004, J NEURAL TRANSM, V111, P603, DOI 10.1007/s00702-004-0108-0
   MATALON R, 1984, J PEDIATR-US, V104, P65, DOI 10.1016/S0022-3476(84)80591-0
   Mathew NT, 1999, CEPHALALGIA, V19, P17, DOI 10.1177/0333102499019S2504
   Matilainen O, 2017, TRENDS CELL BIOL, V27, P453, DOI 10.1016/j.tcb.2017.02.004
   Matsuda M, 2019, J ANESTH, V33, P131, DOI 10.1007/s00540-018-2579-4
   May A, 2006, J NEUROSCI, V26, P3589, DOI 10.1523/JNEUROSCI.4609-05.2006
   Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006
   Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6
   Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055
   Montagna LP, 2003, J HEADACHE PAIN, V4, P47, DOI 10.1007/s10194-003-0030-0
   Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109
   Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052
   Nicolson GL, 2014, ALTERN THER HEALTH M, V20, P18
   Nyholt DR, 1998, HUM MOL GENET, V7, P459, DOI 10.1093/hmg/7.3.459
   Okada H, 1998, HEADACHE, V38, P39, DOI 10.1046/j.1526-4610.1998.3801039.x
   Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202
   Ong JJY, 2018, NEUROTHERAPEUTICS, V15, P274, DOI 10.1007/s13311-017-0592-1
   Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2
   Ouyang JP, 2019, PAIN RES MANAG, V2019, P0, DOI 10.1155/2019/3173149
   Paprocka J, 2020, BRAIN SCI, V10, P0, DOI 10.3390/brainsci10110849
   Passaro D, 2010, BRAIN RES, V1329, P1, DOI 10.1016/j.brainres.2010.03.001
   Pescador Ruschel MA, 2021, STATPEARLS, V0, P0
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Pomes LM, 2019, J HEADACHE PAIN, V20, P0, DOI 10.1186/s10194-019-1010-3
   Ramachandran R, 2014, CEPHALALGIA, V34, P136, DOI 10.1177/0333102413502735
   RAMADAN NM, 1989, HEADACHE, V29, P590, DOI 10.1111/j.1526-4610.1989.hed2909590.x
   Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003
   Rosen N, 2008, HEADACHE, V48, P733, DOI 10.1111/j.1526-4610.2008.01118.x
   Rudkin TM, 1999, ARCH NEUROL-CHICAGO, V56, P919, DOI 10.1001/archneur.56.8.919
   RUSSELL MB, 1993, CEPHALALGIA, V13, P245, DOI 10.1046/j.1468-2982.1993.1304245.x
   Russell MB, 1997, ACTA NEUROL SCAND, V96, P171
   Sacco S, 2012, J HEADACHE PAIN, V13, P177, DOI 10.1007/s10194-012-0424-y
   Sándor PS, 2005, CEPHALALGIA, V25, P507, DOI 10.1111/j.1468-2982.2005.00900.x
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   Sanoobar M, 2015, NUTR NEUROSCI, V18, P169, DOI 10.1179/1476830513Y.0000000106
   Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005
   Scarrone S, 2007, CEPHALALGIA, V27, P128, DOI 10.1111/j.1468-2982.2007.01267.x
   Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49
   SCHOENEN J, 1994, CEPHALALGIA, V14, P328, DOI 10.1046/j.1468-2982.1994.1405328.x
   Schoenen J, 1998, NEUROLOGY, V50, P466, DOI 10.1212/WNL.50.2.466
   Schulte LH, 2017, NEUROLOGY, V88, P2011, DOI 10.1212/WNL.0000000000003963
   Shatillo A, 2013, NEUROSCIENCE, V253, P341, DOI 10.1016/j.neuroscience.2013.09.002
   Shay KP, 2008, IUBMB LIFE, V60, P362, DOI 10.1002/iub.40
   Shoeibi A, 2017, ACTA NEUROL BELG, V117, P103, DOI 10.1007/s13760-016-0697-z
   SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535
   Smeitink Jan, 2019, JIMD REP, V46, P52, DOI 10.1002/jmd2.12017
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x
   Stuart S, 2012, MOL GENET GENOMICS, V287, P837, DOI 10.1007/s00438-012-0723-7
   Sun-Edelstein C, 2009, EXPERT REV NEUROTHER, V9, P369, DOI 10.1586/14737175.9.3.369
   Symon DNK, 1995, J PEDIATR GASTR NUTR, V21, PS42, DOI 10.1097/00005176-199501001-00012
   Takeshima T, 2001, CEPHALALGIA, V21, P987, DOI 10.1046/j.1468-2982.2001.00305.x
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Togha M, 2019, BMC NEUROL, V19, P0, DOI 10.1186/s12883-019-1555-4
   Tottene A, 2011, CHANNELS, V5, P110, DOI 10.4161/chan.5.2.14149
   Tripathi GM, 2018, INT J NEUROSCI, V128, P318, DOI 10.1080/00207454.2017.1374959
   UNCINI A, 1995, J NEUROL SCI, V129, P214, DOI 10.1016/0022-510X(94)00283-T
   van der Wijst MGP, 2015, TRENDS GENET, V31, P353, DOI 10.1016/j.tig.2015.03.009
   VEECH RL, 1979, J BIOL CHEM, V254, P6538
   Veitia RA, 2018, HUM MOL GENET, V27, P1565, DOI 10.1093/hmg/ddy063
   Vernieri F, 2010, BMC NEUROL, V10, P0, DOI 10.1186/1471-2377-10-18
   Vuralli D, 2021, EXPERT REV NEUROTHER, V21, P1069, DOI 10.1080/14737175.2021.1947797
   Wang QX, 2004, AM J MED GENET A, V131A, P50, DOI 10.1002/ajmg.a.30323
   Wang Shuu-Jiun, 2003, CURR NEUROL NEUROSCI REP, V3, P104, DOI 10.1007/s11910-003-0060-7
   Warfvinge K, 2013, CEPHALALGIA, V33, P593, DOI 10.1177/0333102412472072
   Wei PH, 2019, FRONT CELL NEUROSCI, V13, P0, DOI 10.3389/fncel.2019.00073
   WEYLER W, 1990, PHARMACOL THERAPEUT, V47, P391, DOI 10.1016/0163-7258(90)90064-9
   Wieser T, 2010, HEADACHE, V50, P420, DOI 10.1111/j.1526-4610.2009.01428.x
   WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505
   Wouters J, 1998, CURR MED CHEM, V5, P137
   Yablon L A, 2011, MAGNESIUM IN THE CENTRAL NERVOUS SYSTEM INTERNET, V0, P0
   Yetkin E, 2007, HEADACHE, V47, P104, DOI 10.1111/j.1526-4610.2007.00657.x
   Yorns WR, 2013, SEMIN PEDIATR NEUROL, V20, P188, DOI 10.1016/j.spen.2013.09.002
   Zaki E A, 2009, CEPHALALGIA, V29, P719, DOI 10.1111/j.1468-2982.2008.01793.x
   Zamorano-León JJ, 2010, CELL PHYSIOL BIOCHEM, V25, P347, DOI 10.1159/000276567
NR 151
TC 7
Z9 8
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0953-816X
EI 1460-9568
J9 EUR J NEUROSCI
JI Eur. J. Neurosci.
PD JUL 15
PY 2022
VL 56
IS 1
BP 3738
EP 3754
DI 10.1111/ejn.15676
EA MAY 2022
PG 17
WC Neurosciences
SC Neurosciences & Neurology
GA 2R0AB
UT WOS:000794045600001
PM 35478208
DA 2024-11-01
ER

PT J
AU Chu, X
   Dai, J
   Cui, HX
   Shen, HL
   Wu, Q
   Zhu, XY
   Zhu, BF
AF Chu, Xin
   Dai, Jie
   Cui, Hengxiang
   Shen, Hailin
   Wu, Qi
   Zhu, Xiangyang
   Zhu, Baofeng
TI A Patient with MELAS Syndrome Carried an M.3243A>G Mutation in Mitochondrial DNA and Multiple Nuclear Genetic Variants: A Case Report
SO IRANIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Mitochondrial DNA mutation; MELAS Syndrome; Epilepsy; Myelinloss; Case report
ID neuregulin-1; disease; epilepsy
AB We discuss the involvement of nuclear genetic variants correlating to observed phenotype in this case study. In January 2020, the 19-year-old boy from Nantong, Jiangsu Province, China with epilepsy symptom was identified to have myelin loss in the motor and sensory nerves in the electromyogram examination. Brain magnetic resonance imaging (MRI) demonstrated high-intensity areas of small multifocal gray matter regions in the bilateral temporal, parietal, and occipital lobes. In the serum of the patient, the levels of lactate dehydrogenase (LDH) and lactic acid were higher than the normal range values in multiple tests. By subsequent whole exome sequencing (WES) including analysis of the mitochondrial genome, the patient was revealed to carry an m.3243A>G mutation in mitochondria MTTL1 gene which was confirmed by direct Sanger sequencing analysis. Thus, disease of the patient was diagnosed as mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. According to WES analysis, the patient also carried multiple homozygous variants, which correlating to myelinloss and epilepsy in nuclear genes. The peripheral neuropathy of the patient carrying single mitochondrial m.3243A>G mutation could be caused by multiple nuclear DNA defect.
C1 [Chu, Xin; Wu, Qi; Zhu, Baofeng] Nantong Univ, Affiliated Hosp 2, Emergency Dept, Nantong, Jiangsu, Peoples R China.
   [Dai, Jie; Shen, Hailin; Zhu, Xiangyang] Nantong Univ, Affiliated Hosp 2, Neurol Dept, Nantong, Jiangsu, Peoples R China.
   [Cui, Hengxiang] Nantong Univ, Affiliated Hosp 2, Clin Med Res Ctr, Nantong, Jiangsu, Peoples R China.
C3 Nantong University; Nantong University; Nantong University
RP Zhu, BF (corresponding author), Nantong Univ, Affiliated Hosp 2, Emergency Dept, Nantong, Jiangsu, Peoples R China.
EM Baofengdr123@oudook.com
FU Science Fund for Research Initiation for Doctor of Second Affiliated Hospital of Nantong University [SFRI-2020-4218]; general project of Jiangsu Provincial Health Committee [H2019057]
CR Aridon P, 2006, AM J HUM GENET, V79, P342, DOI 10.1086/506459
   Conrad K, 2007, ANN NY ACAD SCI, V1109, P256, DOI 10.1196/annals.1398.031
   de Laat P, 2013, JIMD REP, V8, P47, DOI 10.1007/8904_2012_159
   Geng X, 2019, DIABETIC MED, V36, P776, DOI 10.1111/dme.13874
   Haast RAM, 2018, NEUROIMAGE-CLIN, V18, P231, DOI 10.1016/j.nicl.2018.01.017
   Hong LE, 2008, BIOL PSYCHIAT, V63, P17, DOI 10.1016/j.biopsych.2007.05.011
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kuijf M, 2009, J PERIPHER NERV SYST, V2009, P0
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392
   Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007
   Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Park J, 2013, J CLIN NEUROL, V9, P283, DOI 10.3988/jcn.2013.9.4.283
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
NR 16
TC 0
Z9 0
U1 3
U2 4
PU IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY
PI TEHRAN
PA SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN
SN 2251-6085
EI 2251-6093
J9 IRAN J PUBLIC HEALTH
JI Iran J. Public Health
PD DEC 15
PY 2022
VL 51
IS 12
BP 2817
EP 2825
DI 
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 9Q2KN
UT WOS:000944799600019
PM 36742238
DA 2024-11-01
ER

PT J
AU Dohrn, MF
   Heller, C
   Zengeler, D
   Obermaier, CD
   Biskup, S
   Weis, J
   Nikolin, S
   Claeys, KG
   Schöne, U
   Beijer, D
   Winter, N
   Achenbach, P
   Gess, B
   Schulz, JB
   Mulahasanovic, L
AF Dohrn, Maike F.
   Heller, Corina
   Zengeler, Diana
   Obermaier, Carolin D.
   Biskup, Saskia
   Weis, Joachim
   Nikolin, Stefan
   Claeys, Kristl G.
   Schone, Ulrike
   Beijer, Danique
   Winter, Natalie
   Achenbach, Pascal
   Gess, Burkhard
   Schulz, Jorg B.
   Mulahasanovic, Lejla
TI Heterozygous POLG variant Ser1181Asn co-segregating in a family with autosomal dominant axonal neuropathy, proximal muscle fatigability, ptosis, and ragged red fibers
SO NEUROLOGICAL RESEARCH AND PRACTICE
LA English
DT Article
DE Polymerase gamma; Autosomal dominant; Axonal neuropathy; Myo-neuropathy; Mitochondrial myopathy
ID dna-polymerase-gamma; progressive external ophthalmoplegia; mutations
AB By whole-exome sequencing, we found the heterozygous POLG variant c.3542G>A; p.Ser1181Asn in a family of four affected individuals, presenting with a mixed neuro-myopathic phenotype. The variant is located within the active site of polymerase gamma, in a cluster region associated with an autosomal dominant inheritance. In adolescence, the index developed distal atrophies and weakness, sensory loss, afferent ataxia, double vision, and bilateral ptosis. One older sister presented with Charcot-Marie-Tooth-like symptoms, while the youngest sister and father reported exercise-induced muscle pain and proximal weakness. In none of the individuals, we observed any involvement of the central nervous system. Muscle biopsies obtained from the father and the older sister showed ragged-red fibers, and electron microscopy confirmed mitochondrial damage. We conclude that this novel POLG variant explains this family's phenotype.
C1 [Dohrn, Maike F.; Schone, Ulrike; Achenbach, Pascal; Gess, Burkhard; Schulz, Jorg B.] Rhein Westfal TH Aachen, Med Fac, Dept Neurol, Aachen, Germany.
   [Dohrn, Maike F.; Beijer, Danique] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL USA.
   [Dohrn, Maike F.; Beijer, Danique] Univ Miami, John P Hussman Inst Human Genom, Miller Sch Med, Miami, FL USA.
   [Heller, Corina; Zengeler, Diana; Obermaier, Carolin D.; Mulahasanovic, Lejla] Praxis Humangenetik Tubingen, Tubingen, Germany.
   [Heller, Corina; Zengeler, Diana; Obermaier, Carolin D.; Biskup, Saskia; Mulahasanovic, Lejla] CeGaT GmbH, Tubingen, Germany.
   [Weis, Joachim; Nikolin, Stefan; Achenbach, Pascal] Rhein Westfal TH Aachen, Inst Neuropathol, Med Fac, Aachen, Germany.
   [Nikolin, Stefan] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium.
   [Claeys, Kristl G.] Katholieke Univ Leuven, Lab Muscle Dis & Neuropathies, Leuven, Belgium.
   [Winter, Natalie] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany.
   [Schulz, Jorg B.] Forschungszentrum Julich GmbH, JARA BRAIN Inst Mol Neuroscience & Neuroimaging, Aachen, Germany.
   [Schulz, Jorg B.] Rhein Westfal TH Aachen, Aachen, Germany.
C3 RWTH Aachen University; University of Miami; University of Miami; CeGaT; RWTH Aachen University; KU Leuven; University Hospital Leuven; KU Leuven; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; Research Center Julich; RWTH Aachen University
RP Dohrn, MF (corresponding author), Rhein Westfal TH Aachen, Med Fac, Dept Neurol, Aachen, Germany.; Dohrn, MF (corresponding author), Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL USA.; Dohrn, MF (corresponding author), Univ Miami, John P Hussman Inst Human Genom, Miller Sch Med, Miami, FL USA.
EM mdohrn@ukaachen.de
CR Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lehmann H, 2020, NEUE Z MUSIK, V0, PP20, DOI 10.1186/s42466-020-00064-2
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395
   Tchikviladze M, 2015, J NEUROL NEUROSUR PS, V86, P646, DOI 10.1136/jnnp-2013-306799
NR 12
TC 2
Z9 2
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 
EI 2524-3489
J9 NEUROL RES PRACT
JI Neurol. Res. Pract.
PD JUN 15
PY 2022
VL 4
IS 1
BP 
EP 
DI 10.1186/s42466-022-00169-w
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA IM5Z7
UT WOS:001166769500005
PM 35101151
DA 2024-11-01
ER

PT J
AU Xu, P
   Jia, ML
   Yan, JM
   Yuan, XS
   Yu, WD
   Zhou, ZH
   Fang, HZ
   Gao, F
   Shen, LJ
AF Xu, Pu
   Jia, Manli
   Yan, Jimei
   Yuan, Xiangshu
   Yu, Weidong
   Zhou, Zhuohua
   Fang, Hezhi
   Gao, Feng
   Shen, Lijun
TI Determining Mitochondrial 3243A>G Heteroplasmy Using an ARMS-ddPCR Strategy
SO AMERICAN JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
DE ARMS-qPCR; ddPCR; Heteroplasmy; mtDNA copy number; Mitochondrial disease
ID lactic-acidosis; copy number; mutation; dna; quantification; encephalopathy; accurate; myopathy; common; pcr
AB Objectives Determining mitochondrial DNA (mtDNA) A-to-G substitution at nucleotide 3243 (m.3243A>G) heteroplasmy is essential for both precision diagnosis of m.3243A>G-associated mitochondrial disease and genetic counseling. Precise determination of m.3243A>G heteroplasmy is challenging, however, without appropriate strategies to accommodate heteroplasmic levels ranging from 1% to 100% in samples carrying thousands to millions of mtDNA copies. Methods We used a combined strategy of amplification-refractory mutation system-quantitative polymerase chain reaction (ARMS-qPCR) and droplet digital PCR (ddPCR) to determine m.3243A>G heteroplasmy. Primers were specifically designed and screened for both ARMS-qPCR and ddPCR to determine m.3243A>G heteroplasmy. An optimized ARMS-qPCR-ddPCR-based strategy was established using artificial standards, with different mixtures of m.3243A-containing and m.3243G-containing plasmids and further tested using clinical samples containing the m.3243A>G mutation. Results One of 20 primer pairs designed in the study was omitted for ARMS-qPCR-ddPCR strategy application according to criteria of 85% to 110%, R-2 > 0.98 amplification efficiency, melt curve with a single clear peak, and specificity for m.3243A and m.3243G artificial standards (|Ct(Wt)-Ct(Mut)|(max)). Using plasmid standards with various m.3243A>G heteroplasmy (1%-100%) at low, mid, and high copy numbers (3,000, 10(4), and 10(5)-10(7), respectively) and DNA from the blood of 20 patients carrying m.3243A>G with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes, we found that ARMS-qPCR was reliable for determining m.3243A>G at 3% to 100% for low copy number and 1% to 100% for mid to high copy number samples. Meanwhile, ddPCR was reliable for determining m.3243A>G at 1% to 100% at low to mid copy number samples. Conclusions An ARMS-qPCR-ddPCR-based strategy was successfully established for precise determination of m.3243A>G heteroplasmy in complex clinical samples.
C1 [Xu, Pu] Xian Med Univ, Affiliated Hosp 1, Lab Med, Xian, Peoples R China.
   [Xu, Pu; Jia, Manli; Yan, Jimei; Yuan, Xiangshu; Yu, Weidong; Zhou, Zhuohua; Fang, Hezhi; Shen, Lijun] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Peoples R China.
   [Gao, Feng] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Hangzhou, Peoples R China.
C3 Xi'an Medical University; Wenzhou Medical University; Hangzhou Medical College; Zhejiang Provincial People's Hospital
RP Fang, HZ; Shen, LJ (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Peoples R China.; Gao, F (corresponding author), Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Hangzhou, Peoples R China.
EM fangh@wmu.edu.cn; chinapeakcool10000@163.com; ysslj23@163.com
FU Zhejiang Provincial Natural Science Foundation of China [LR20H200001]; National Natural Science Foundation of China [81830071]; Wenzhou Science and Technology Bureau Project [Y20170029]
CR Annesley SJ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8070680
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Christodoulou C, 2017, FERTIL STERIL, V107, P212, DOI 10.1016/j.fertnstert.2016.09.045
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Green Michael R, 2018, COLD SPRING HARB PROTOC, V2018, P0, DOI 10.1101/pdb.prot095026
   Hardinge P, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-57473-1
   Hartman P, 2019, MOL GENET METAB REP, V19, P0, DOI 10.1016/j.ymgmr.2019.100464
   Hashimoto S, 2017, J ASSIST REPROD GEN, V34, P573, DOI 10.1007/s10815-017-0886-6
   Kisiel MA, 2019, METHODS MOL BIOL, V1993, P71, DOI 10.1007/978-1-4939-9473-1_6
   Liu J, 2012, PLANT METHODS, V8, P0, DOI 10.1186/1746-4811-8-34
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Lou YY, 2020, J MOL DIAGN, V22, P699, DOI 10.1016/j.jmoldx.2020.02.007
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503
   OHara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Sallevelt SCEH, 2017, HUM REPROD, V32, P698, DOI 10.1093/humrep/dew356
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Shen SX, 2012, DIAGN PATHOL, V7, P0, DOI 10.1186/1746-1596-7-56
   Sofronova JK, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1031, DOI 10.1134/S0006297916100011
   Tabebi M, 2015, BIOCHEM BIOPH RES CO, V459, P353, DOI 10.1016/j.bbrc.2015.01.151
   Tatuch Yuriy, 1994, EUROPEAN JOURNAL OF HUMAN GENETICS, V2, P35
   Tranah GJ, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30255-6
   Uittenbogaard M, 2018, MOL GENET METAB, V124, P71, DOI 10.1016/j.ymgme.2018.03.011
   Wang Jing, 2011, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1906s68
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   Xia CY, 2017, CHINESE MED J-PEKING, V130, P2435, DOI 10.4103/0366-6999.216395
   Yan JB, 2014, J MOL DIAGN, V16, P431, DOI 10.1016/j.jmoldx.2014.03.005
   Ye J, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-134
   You FM, 2008, BMC BIOINFORMATICS, V9, P0, DOI 10.1186/1471-2105-9-253
NR 37
TC 1
Z9 1
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9173
EI 1943-7722
J9 AM J CLIN PATHOL
JI Am. J. Clin. Pathol.
PD MAY 4
PY 2022
VL 157
IS 5
BP 664
EP 677
DI 10.1093/ajcp/aqab174
EA OCT 2021
PG 14
WC Pathology
SC Pathology
GA 1A1GC
UT WOS:000789176500001
PM 34698344
DA 2024-11-01
ER

PT J
AU Hintze, S
   Baber, L
   Hofmeister, F
   Jarmusch, S
   Todorow, V
   Mehaffey, S
   Tanganelli, F
   Ferrari, U
   Neuerburg, C
   Teupser, D
   Bidlingmaier, M
   Marques, JG
   Koletzko, B
   Schoser, B
   Drey, M
   Meinke, P
AF Hintze, Stefan
   Baber, Lisa
   Hofmeister, Fabian
   Jarmusch, Stefanie
   Todorow, Vanessa
   Mehaffey, Stefan
   Tanganelli, Fabiana
   Ferrari, Uta
   Neuerburg, Carl
   Teupser, Daniel
   Bidlingmaier, Martin
   Marques, Jair Gonzalez
   Koletzko, Berthold
   Schoser, Benedikt
   Drey, Michael
   Meinke, Peter
TI Exploration of mitochondrial defects in sarcopenic hip fracture patients
SO HELIYON
LA English
DT Article
DE Sarcopenia; Tricarboxylic acid cycle; TCA; Mitochondria; Metabolism; Myoblast culture
ID skeletal-muscle mass; dna deletion; prevalence; consensus; falls; risk; men; age
AB Severe cases of age-related loss of muscle function and mass are clinically unique to sarcopenia. Mitochondrial dysfunction has been associated with aging and sarcopenia, but the causal connection in this context is not well eluded. Here we investigated different aspects of mitochondrial respiration in sarcopenia. Open muscle biopsies were taken from a total of 31 hip fracture patients, older than 70 years. Patients were assigned a sarcopenia Z -score based on EWGSOP2 criteria. Primary myoblast cultures were generated from the muscle tissue samples and used for real time metabolic measurement. Muscle and serum samples showed correlation of high Z-scores with reduced mitochondrial complex I activity, increased tricarboxylic acid cycle (TCA) metabolites, reduced vitamin D3 levels, and signs of an altered iron metabolism. Primary myoblast cultures gained from the same muscle bi-opsies did not show significant mitochondrial defects. We hypothesize that a sum of external consequences, including vitamin D3 deficiency and iron deficiency caused by disturbances in the iron metabolism, result in complex I deficiency, which in turn affects the TCA and contributes to muscle weakness and loss.
C1 [Hintze, Stefan; Todorow, Vanessa; Schoser, Benedikt; Meinke, Peter] Ludwig Maximilians Univ Munchen, Dept Neurol, LMU Klinikum, Munich, Germany.
   [Baber, Lisa; Hofmeister, Fabian; Jarmusch, Stefanie; Tanganelli, Fabiana; Ferrari, Uta; Drey, Michael] Ludwig Maximilians Univ Munchen, Dept Med 4, LMU Klinikum, Munich, Germany.
   [Mehaffey, Stefan; Neuerburg, Carl] Ludwig Maximilians Univ Munchen, Dept Gen Trauma and Reconstruct Surg, LMU Klinikum, Munich, Germany.
   [Teupser, Daniel] Ludwig Maximilians Univ Munchen, Inst Lab Med, LMU Klinikum, Munich, Germany.
   [Bidlingmaier, Martin] Ludwig Maximilians Univ Munchen, Dept Med 4, LMU Klinikum, Endocrinol, Munich, Germany.
   [Marques, Jair Gonzalez; Koletzko, Berthold] Ludwig Maximilians Univ Munchen, Dr Von Hauner Childrens Hosp, Dept Pediat, LMU Klinikum, Munich, Germany.
C3 University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; University of Munich
RP Meinke, P (corresponding author), Ludwig Maximilians Univ Munchen, Dept Neurol, LMU Klinikum, Munich, Germany.
EM peter.meinke@med.uni-muenchen.de
FU EU project Keep Control; European Union's Horizon 2020 research and innovation programmed under the Marie Sklodowska-Curie [721577]; European Commission H2020 Programme Lifecycle [733206]; European Joint Programming Initiative Projects NutriPRO-GRAM; German Research Council DFG [INST 409/224-1 FUGG]; Else Kroner-Fresenius-Foundation; LMU University Hospitals; Deutsche For-schungsgemeinschaft (DFG, German Research Foundation) - Pro-jektnummer [470092532]
CR Bastian TW, 2020, NEUROSCI INSIGHTS, V15, P0, DOI 10.1177/2633105520935104
   Beaudart C, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0169548
   Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539
   Brunetti D, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.01171
   Cawthon PM, 2015, J AM GERIATR SOC, V63, P2247, DOI 10.1111/jgs.13788
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Ferri E, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21155236
   Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003
   Fischer JC, 1986, EUR J PEDIATR, V0, P0
   Han DS, 2021, FRONT MED-LAUSANNE, V8, P0, DOI 10.3389/fmed.2021.630009
   Hida T, 2013, GERIATR GERONTOL INT, V13, P413, DOI 10.1111/j.1447-0594.2012.00918.x
   Hipkiss AR, 2010, ADV CLIN CHEM, V50, P123, DOI 10.1016/S0065-2423(10)50007-6
   Huo YR, 2015, J NUTR HEALTH AGING, V19, P474, DOI 10.1007/s12603-014-0543-z
   Janssen I, 2000, J APPL PHYSIOL, V89, P81
   Kemmler W, 2016, OSTEOPOROSIS INT, V27, P3261, DOI 10.1007/s00198-016-3662-z
   Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378
   Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007
   Lee CM, 1997, FREE RADICAL BIO MED, V22, P1259, DOI 10.1016/S0891-5849(96)00546-1
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Marchioro L, 2020, CLIN NUTR, V39, P2129, DOI 10.1016/j.clnu.2019.08.030
   Martínez-Reyes I, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13668-3
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Migliavacca E, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-13694-1
   Montenegro KR, 2019, NUTR RES REV, V32, P192, DOI 10.1017/S0954422419000064
   Oliveira A, 2015, CLIN RHEUMATOL, V34, P1673, DOI 10.1007/s10067-015-2943-9
   Rezus E, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21020592
   Rineau E, 2018, INT J CARDIOL, V266, P206, DOI 10.1016/j.ijcard.2018.02.021
   Romanello V, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22010091
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Sergi G, 2015, CLIN NUTR, V34, P667, DOI 10.1016/j.clnu.2014.07.010
   Shah VO, 2009, GENET MED, V11, P147, DOI 10.1097/GIM.0b013e31819307a2
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09
   Silva AM, 2010, AM J HUM BIOL, V22, P76, DOI 10.1002/ajhb.20956
   Stangl MK, 2019, EXP CLIN ENDOCR DIAB, V127, P8, DOI 10.1055/a-0672-1007
   Tanganelli F, 2021, EXP GERONTOL, V144, P0, DOI 10.1016/j.exger.2020.111171
   Urrutia PJ, 2017, BBA-MOL BASIS DIS, V1863, P2202, DOI 10.1016/j.bbadis.2017.05.015
   von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P129, DOI 10.1007/s13539-010-0014-2
   Wu WT, 2021, J CLIN MED, V10, P0
   Yeung SSY, 2019, J CACHEXIA SARCOPENI, V10, P485, DOI 10.1002/jcsm.12411
NR 43
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 
EI 2405-8440
J9 HELIYON
JI Heliyon
PD OCT 15
PY 2022
VL 8
IS 10
BP 
EP 
DI 10.1016/j.heliyon.2022.e11143
EA OCT 2022
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA C3OL9
UT WOS:000961048700018
PM 36303924
DA 2024-11-01
ER

PT J
AU Birtel, J
   von Landenberg, C
   Gliem, M
   Gliem, C
   Reimann, J
   Kunz, WS
   Herrmann, P
   Betz, C
   Caswell, R
   Nesbitt, V
   Kornblum, C
   Issa, PC
AF Birtel, Johannes
   von Landenberg, Christina
   Gliem, Martin
   Gliem, Carla
   Reimann, Jens
   Kunz, Wolfram S.
   Herrmann, Philipp
   Betz, Christian
   Caswell, Richard
   Nesbitt, Victoria
   Kornblum, Cornelia
   Issa, Peter Charbel
TI Mitochondrial Retinopathy
SO OPHTHALMOLOGY RETINA
LA English
DT Article
DE Autofluorescence; Genetics; Mitochondrial disease; OCT; Retinal imaging
ID near-infrared autofluorescence; kearns-sayre syndrome; macular dystrophy; retinal dystrophy; external ophthalmoplegia; dna mutation; deletions; features; gene; manifestations
AB Purpose: To report the retinal phenotype and the associated genetic and systemic findings in patients with mitochondrial disease. Design: Retrospective case series. Participants: Twenty-three patients with retinopathy and mitochondrial disease, including chronic progressive external ophthalmoplegia (CPEO), maternally inherited diabetes and deafness (MIDD), mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), Kearns-Sayre syndrome, neuropathy, ataxia, and retinitis pigmentosa (NARP) syndrome, and other systemic manifestations. Methods: Review of case notes, retinal imaging, electrophysiologic assessment, molecular genetic testing including protein modeling, and histologic analysis of muscle biopsy. Main Outcome Measures: Phenotypic characteristics of mitochondrial retinopathy. Results: Genetic testing identified sporadic large-scale mitochondrial DNA deletions and variants in MT-TL1, MT-ATP6, MT-TK, MT-RNR1, or RRM2B. Based on retinal imaging, 3 phenotypes could be differentiated: type 1 with mild, focal pigmentary abnormalities; type 2 characterized by multifocal white-yellowish subretinal deposits and pigment changes limited to the posterior pole; and type 3 with widespread granular pigment alterations. Advanced type 2 and 3 retinopathy presented with chorioretinal atrophy that typically started in the peripapillary and paracentral areas with foveal sparing. Two patients exhibited a different phenotype: 1 revealed an occult retinopathy, and the patient with RRM2B-associated retinopathy showed no foveal sparing, no severe peripapillary involvement, and substantial photoreceptor atrophy before loss of the retinal pigment epithelium. Two patients with type 1 disease showed additional characteristics of mild macular telangiectasia type 2. Patients with type 1 and mild type 2 or 3 disease demonstrated good visual acuity and no symptoms associated with the retinopathy. In contrast, patients with advanced type 2 or 3 disease often reported vision problems in dim light conditions, reduced visual acuity, or both. Short-wavelength autofluorescence usually revealed a distinct pattern, and near-infrared autofluorescence may be severely reduced in type 3 disease. The retinal phenotype was key to suspecting mitochondrial disease in 11 patients, whereas 12 patients were diagnosed before retinal examination. Conclusions: Different types of mitochondrial retinopathy show characteristic features. Even in absence of visual symptoms, their recognition may facilitate the often challenging and delayed diagnosis of mitochondrial disease, in particular in patients with mild or nebulous multisystem disease. (C) 2021 by the American Academy of Ophthalmology.
C1 [Birtel, Johannes; Gliem, Martin; Issa, Peter Charbel] Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England.
   [Birtel, Johannes; Gliem, Martin; Issa, Peter Charbel] Univ Oxford, Nuffield Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford, England.
   [Birtel, Johannes; Herrmann, Philipp] Univ Hosp Bonn, Dept Ophthalmol, Bonn, Germany.
   [Birtel, Johannes; von Landenberg, Christina; Herrmann, Philipp; Kornblum, Cornelia] Univ Hosp Bonn, Ctr Rare Dis Bonn ZSEB, Bonn, Germany.
   [von Landenberg, Christina; Gliem, Carla; Reimann, Jens; Kornblum, Cornelia] Univ Hosp Bonn, Dept Neurol, Sect Neuromuscular Dis, Bonn, Germany.
   [Kunz, Wolfram S.] Univ Hosp Bonn, Life & Brain Ctr, Dept Epileptol, Bonn, Germany.
   [Betz, Christian] Bioscientia Ctr Human Genet, Ingelheim, Germany.
   [Caswell, Richard] Royal Devon & Exeter NHS Fdn Trust, Genom Lab, Exeter, Devon, England.
   [Caswell, Richard] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England.
   [Nesbitt, Victoria] Churchill Hosp, Nuffield Dept Womens & Reprod Hlth, NHS Highly Specialised Serv Rare Mitochondrial Di, Oxford, England.
C3 Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Exeter; University of Exeter; University of Oxford
RP Issa, PC (corresponding author), Oxford Eye Hosp, John Radcliffe Hosp, Oxford OX3 9DU, England.
EM study-enquiry@outlook.com
FU Dr. Werner Jackstadt Foundation, Wuppertal, Germany [S0134-10.22]; Bayer Global Ophthalmology Awards Program; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC); Chiesi Farmaceutici, Parma, Italy; German Federal Ministry of Education and Research [01GM1906E]
CR Alecu I, 2017, J LIPID RES, V58, P42, DOI 10.1194/jlr.M068676
   Ascaso FJ, 2010, CLIN EXP OPHTHALMOL, V38, P812, DOI 10.1111/j.1442-9071.2010.02335.x
   Birtel J, 2018, OPHTHALMOLOGE, V115, P1021, DOI 10.1007/s00347-018-0779-9
   Birtel J, 2021, KLIN MONATSBL AUGENH, V238, P249, DOI 10.1055/a-1388-7236
   Birtel J, 2019, AM J OPHTHALMOL, V199, P19, DOI 10.1016/j.ajo.2018.10.021
   Birtel J, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-22096-0
   CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028
   Coppieters F, 2016, AM J HUM GENET, V99, P470, DOI 10.1016/j.ajhg.2016.06.017
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V0, P0
   EAGLE RC, 1982, OPHTHALMOLOGY, V89, P1433
   Flynn J T, 1985, TRANS AM OPHTHALMOL SOC, V83, P131
   Gantner ML, 2019, NEW ENGL J MED, V381, P1422, DOI 10.1056/NEJMoa1815111
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grier J, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000230
   Grönlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Heeren TFC, 2020, OPHTHALMOLOGY, V127, P1539, DOI 10.1016/j.ophtha.2020.03.040
   Hirano M, 1993, GENEREVIEWS, V0, P0
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Issa PC, 2008, INVEST OPHTH VIS SCI, V49, P1172, DOI 10.1167/iovs.07-0636
   Issa PC, 2016, RETINA-J RET VIT DIS, V36, P524, DOI 10.1097/IAE.0000000000000863
   Issa PC, 2013, PROG RETIN EYE RES, V34, P49, DOI 10.1016/j.preteyeres.2012.11.002
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Keilhauer CN, 2006, INVEST OPHTH VIS SCI, V47, P3556, DOI 10.1167/iovs.06-0122
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kozak Igor, 2018, RETIN CASES BRIEF REP, V12, P349, DOI 10.1097/ICB.0000000000000503
   Latkany P, 1999, AM J OPHTHALMOL, V128, P112, DOI 10.1016/S0002-9394(99)00057-4
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   MCKECHNIE NM, 1985, BRIT J OPHTHALMOL, V69, P63, DOI 10.1136/bjo.69.1.63
   Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Mucciolo DP, 2019, OPHTHALMOLOGICA, V242, P195, DOI 10.1159/000501282
   Müller PL, 2020, AM J OPHTHALMOL, V218, P136, DOI 10.1016/j.ajo.2020.05.023
   Müller PL, 2020, AM J OPHTHALMOL, V213, P134, DOI 10.1016/j.ajo.2020.01.013
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Nguyen MTB, 2019, NEUROLOGY, V92, PE519, DOI 10.1212/WNL.0000000000006861
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Ortiz Alvaro, 2017, INT J RETINA VITREOUS, V3, P24, DOI 10.1186/s40942-017-0077-8
   Padhy SK, 2018, BMJ CASE REP, V2018, P0, DOI 10.1136/BCR-2018-227394
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Rath PP, 2008, BRIT J OPHTHALMOL, V92, P623, DOI 10.1136/bjo.2007.131177
   RUNGE P, 1986, BRIT J OPHTHALMOL, V70, P782, DOI 10.1136/bjo.70.10.782
   Scerri TS, 2017, NAT GENET, V49, P559, DOI 10.1038/ng.3799
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Taubitz T, 2019, EBIOMEDICINE, V48, P592, DOI 10.1016/j.ebiom.2019.09.048
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Viscomi C, 2016, BIOCHEM SOC T, V44, P1483, DOI 10.1042/BST20160085
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Yusuf IH, 2020, JAMA OPHTHALMOL, V138, P900, DOI 10.1001/jamaophthalmol.2020.2364
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang T, 2018, MOL NEUROBIOL, V55, P7025, DOI 10.1007/s12035-017-0840-8
   Zucker CL, 2020, P NATL ACAD SCI USA, V117, P18780, DOI 10.1073/pnas.2011532117
NR 58
TC 24
Z9 25
U1 0
U2 5
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2468-6530
EI 
J9 OPHTHALMOL RETINA
JI Ophthalmol. Retina
PD JAN 15
PY 2022
VL 6
IS 1
BP 65
EP 79
DI 10.1016/j.oret.2021.02.017
EA JAN 2022
PG 15
WC Ophthalmology
SC Ophthalmology
GA YE0WV
UT WOS:000740853700010
PM 34257060
DA 2024-11-01
ER

PT J
AU Yang, JJ
   Chen, SX
   Duan, FY
   Wang, XX
   Zhang, XX
   Lian, BX
   Kou, M
   Chiang, ZX
   Li, ZY
   Lian, QZ
AF Yang, Jinjuan
   Chen, Shaoxiang
   Duan, Fuyu
   Wang, Xiuxiu
   Zhang, Xiaoxian
   Lian, Boonxuan
   Kou, Meng
   Chiang, Zhixin
   Li, Ziyue
   Lian, Qizhou
TI Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic Management
SO CELLS
LA English
DT Review
DE mitochondrial cardiomyopathy; molecular epidemiology; diagnosis; animal model; cellular model; gene therapy; pharmacological approach; mitochondrial transfer; transplantation
ID pluripotent stem-cell; permeability transition; heart; disease; patient; transplantation; dysfunction; deficiency; cardiomyocytes; involvement
AB Mitochondrial cardiomyopathy (MCM) is characterized by abnormal heart-muscle structure and function, caused by mutations in the nuclear genome or mitochondrial DNA. The heterogeneity of gene mutations and various clinical presentations in patients with cardiomyopathy make its diagnosis, molecular mechanism, and therapeutics great challenges. This review describes the molecular epidemiology of MCM and its clinical features, reviews the promising diagnostic tests applied for mitochondrial diseases and cardiomyopathies, and details the animal and cellular models used for modeling cardiomyopathy and to investigate disease pathogenesis in a controlled in vitro environment. It also discusses the emerging therapeutics tested in pre-clinical and clinical studies of cardiac regeneration.
C1 [Yang, Jinjuan; Chen, Shaoxiang; Duan, Fuyu; Zhang, Xiaoxian; Kou, Meng; Li, Ziyue; Lian, Qizhou] Guangzhou Med Univ, Cord Blood Bank Ctr, Guangzhou Women & Childrens Med Ctr, Guangzhou 510180, Peoples R China.
   [Wang, Xiuxiu] Wenzhou Med Univ, Dept Lab Med, Pingyang Peoples Hosp, Wenzhou 325499, Peoples R China.
   [Lian, Boonxuan] Univ Adelaide, Adelaide Med Sch, 30 Frome Rd, Adelaide, SA 5000, Australia.
   [Chiang, Zhixin] Tunku Abdul Rahman Univ, Dept Allied Hlth Sci, Fac Sci, Ipoh 31900, Malaysia.
   [Lian, Qizhou] Shenzhen Hong Kong Univ Hosp, Dept Surg, Shenzhen 518053, Peoples R China.
   [Lian, Qizhou] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong 999077, Peoples R China.
C3 Guangzhou Medical University; Guangzhou Women & Children's Medical Center; Wenzhou Medical University; University of Adelaide; University of Hong Kong
RP Lian, QZ (corresponding author), Guangzhou Med Univ, Cord Blood Bank Ctr, Guangzhou Women & Childrens Med Ctr, Guangzhou 510180, Peoples R China.; Lian, QZ (corresponding author), Shenzhen Hong Kong Univ Hosp, Dept Surg, Shenzhen 518053, Peoples R China.; Lian, QZ (corresponding author), Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong 999077, Peoples R China.
EM qzlian@hku.hk
FU Shenzhen Science and Technology Program [5001-4001010, JCYJ20210324114606019]
CR Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Nguyen BY, 2019, BRIT J PHARMACOL, V176, P4302, DOI 10.1111/bph.14431
   Blitzer D, 2020, ANN THORAC SURG, V109, P711, DOI 10.1016/j.athoracsur.2019.06.075
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Brunel-Guitton C, 2015, CAN J CARDIOL, V31, P1360, DOI 10.1016/j.cjca.2015.08.017
   Cha MJ, 2022, KOREAN J RADIOL, V23, P581, DOI 10.3348/kjr.2021.0815
   Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003
   Chuang YC, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/5691215
   Dambrot C, 2014, J CELL MOL MED, V18, P1509, DOI 10.1111/jcmm.12356
   Davis RP, 2011, TRENDS MOL MED, V17, P475, DOI 10.1016/j.molmed.2011.05.001
   Diguet N, 2018, CIRCULATION, V137, P2256, DOI 10.1161/CIRCULATIONAHA.116.026099
   Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601
   Doulamis IP, 2020, EUR J CARDIO-THORAC, V57, P836, DOI 10.1093/ejcts/ezz326
   Duran AG, 2018, THORAC CARDIOV SURG, V66, P53, DOI 10.1055/s-0037-1608761
   El-Hattab AW, 2016, FRONT CARDIOVASC MED, V3, P0, DOI 10.3389/fcvm.2016.00025
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Fu AL, 2017, FRONT PHARMACOL, V8, P0, DOI 10.3389/fphar.2017.00241
   Goldenthal MJ, 2016, HEART FAIL REV, V21, P137, DOI 10.1007/s10741-016-9531-1
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Hick A, 2013, DIS MODEL MECH, V6, P608, DOI 10.1242/dmm.010900
   Himori K, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0169146
   Hu YT, 2021, HEART LUNG CIRC, V30, P1449, DOI 10.1016/j.hlc.2021.05.074
   Huang PJ, 2016, CELL TRANSPLANT, V25, P913, DOI 10.3727/096368915X689785
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Imai-Okazaki A, 2021, INT J CARDIOL, V341, P48, DOI 10.1016/j.ijcard.2021.06.042
   Imai-Okazaki A, 2019, INT J CARDIOL, V279, P115, DOI 10.1016/j.ijcard.2019.01.017
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Javadov S, 2015, ONCOTARGET, V6, P39469, DOI 10.18632/oncotarget.5783
   Jiang D, 2020, THERANOSTICS, V10, P7260, DOI 10.7150/thno.46332
   Jiang D, 2019, THERANOSTICS, V9, P2395, DOI 10.7150/thno.29422
   Jimenez-Tellez N, 2019, WORLD J CARDIOL, V11, P221, DOI 10.4330/wjc.v11.i10.221
   Jose T, 2011, INT J CARDIOL, V149, PE24, DOI 10.1016/j.ijcard.2009.03.057
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   Ke BX, 2012, P NATL ACAD SCI USA, V109, P6165, DOI 10.1073/pnas.1113987109
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Krebs P, 2011, P NATL ACAD SCI USA, V108, P19678, DOI 10.1073/pnas.1117835108
   Lee KH, 2014, CIRCULATION, V130, P1832, DOI 10.1161/CIRCULATIONAHA.114.010779
   Lee YK, 2014, PFLUG ARCH EUR J PHY, V466, P1831, DOI 10.1007/s00424-013-1414-x
   Li C, 2019, BIOSCIENCE REP, V39, P0, DOI 10.1042/BSR20182417
   Li SS, 2018, STEM CELL REP, V10, P808, DOI 10.1016/j.stemcr.2018.01.013
   Li X, 2014, AM J RESP CELL MOL, V51, P455, DOI 10.1165/rcmb.2013-0529OC
   Limongelli G, 2012, FUTUR CARDIOL, V8, P71, DOI 10.2217/fca.11.79
   Ling YH, 2021, ANIM MODEL EXP MED, V4, P381, DOI 10.1002/ame2.12193
   Liu W, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00664-8
   Liu YT, 2020, HUM MOL GENET, V29, P1547, DOI 10.1093/hmg/ddaa077
   Liu ZH, 2022, CELL BIOSCI, V12, P0, DOI 10.1186/s13578-022-00805-7
   Lou WJ, 2018, BBA-MOL CELL BIOL L, V1863, P857, DOI 10.1016/j.bbalip.2018.04.015
   Louwagie EJ, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22052382
   Machiraju P, 2019, FRONT CARDIOVASC MED, V6, P0, DOI 10.3389/fcvm.2019.00167
   Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014
   Meurs KM, 2019, GENES-BASEL, V10, P0, DOI 10.3390/genes10020168
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679
   Nakamura Y, 2020, EXP NEUROL, V324, P0, DOI 10.1016/j.expneurol.2019.113114
   Narula N, 2011, JACC-CARDIOVASC IMAG, V4, P1, DOI 10.1016/j.jcmg.2010.06.018
   Orfany A, 2020, J VASC SURG, V71, P1014, DOI 10.1016/j.jvs.2019.03.079
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Partington SL, 2011, CIRCULATION, V123, PE227, DOI 10.1161/CIRCULATIONAHA.110.973305
   Pavez-Giani MG, 2022, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.800529
   Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510
   Pour PA, 2021, AM J PHYSIOL-CELL PH, V321, PC489, DOI 10.1152/ajpcell.00152.2021
   Pour PA, 2020, J AM HEART ASSOC, V9, P0, DOI 10.1161/JAHA.119.014501
   Qin YM, 2021, FRONT ONCOL, V11, P0, DOI 10.3389/fonc.2021.672781
   Rai PK, 2018, ESSAYS BIOCHEM, V62, P455, DOI 10.1042/EBC20170113
   Rajendran J, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201809456
   Ramachandra CJA, 2021, CARDIOVASC RES, V117, P694, DOI 10.1093/cvr/cvaa125
   Ribeiro RF, 2018, FREE RADICAL BIO MED, V117, P18, DOI 10.1016/j.freeradbiomed.2018.01.012
   Richman TR, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005089
   Rohani L, 2020, CAN J CARDIOL, V36, P554, DOI 10.1016/j.cjca.2019.09.021
   Rossman MJ, 2018, HYPERTENSION, V71, P1056, DOI 10.1161/HYPERTENSIONAHA.117.10787
   Ruzzenente B, 2016, HUM MOL GENET, V25, PR115, DOI 10.1093/hmg/ddw176
   Saito T, 2017, CARDIOVASC RES, V113, P1173, DOI 10.1093/cvr/cvx095
   Sayles NM, 2022, CELL REP, V38, P0, DOI 10.1016/j.celrep.2022.110475
   Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015
   Shao KF, 2013, MOL THER, V21, P240, DOI 10.1038/mt.2012.207
   Sharma P, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8020100
   Sharov VG, 2007, J MOL CELL CARDIOL, V42, P150, DOI 10.1016/j.yjmcc.2006.09.013
   Shi XJ, 2020, J CELL MOL MED, V24, P13151, DOI 10.1111/jcmm.15921
   Shin J, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053577
   St-Pierre G, 2019, CAN J CARDIOL, V35, P221, DOI 10.1016/j.cjca.2018.11.018
   Steven S, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/7092151
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Takeda A, 2021, J CLIN PATHOL, V74, P365, DOI 10.1136/jclinpath-2020-206801
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545
   Wu HD, 2019, EUR HEART J, V40, P3685, DOI 10.1093/eurheartj/ehz326
   Wu TH, 2016, CELL METAB, V23, P921, DOI 10.1016/j.cmet.2016.04.007
   Yang T, 2002, J LAB CLIN MED, V140, P263, DOI 10.1067/mlc.2002.127725
   Yao Y, 2018, STEM CELL REP, V11, P1120, DOI 10.1016/j.stemcr.2018.09.012
   Yokota M, 2017, CELL DEATH DIS, V8, P0, DOI 10.1038/cddis.2016.484
   Zhang DH, 2018, CIRC RES, V122, P74, DOI 10.1161/CIRCRESAHA.117.311349
   Zhang YM, 2020, STEM CELL RES, V47, P0, DOI 10.1016/j.scr.2020.101912
   Zhang YL, 2016, STEM CELL REP, V7, P749, DOI 10.1016/j.stemcr.2016.08.009
   Zhou J, 2016, ONCOTARGET, V7, P31284, DOI 10.18632/oncotarget.8893
   Zhu ST, 2021, CIRC-HEART FAIL, V14, P0, DOI 10.1161/CIRCHEARTFAILURE.121.008289
NR 99
TC 9
Z9 9
U1 2
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD NOV 15
PY 2022
VL 11
IS 21
BP 
EP 
DI 10.3390/cells11213511
PG 19
WC Cell Biology
SC Cell Biology
GA 6F2CI
UT WOS:000883875400001
PM 36359908
DA 2024-11-01
ER

PT J
AU Gwaltney, C
   Stokes, J
   Aiudi, A
   Mazar, I
   Ollis, S
   Love, E
   Karaa, A
   Houts, CR
   Wirth, RJ
   Shields, AL
AF Gwaltney, Chad
   Stokes, Jonathan
   Aiudi, Anthony
   Mazar, Iyar
   Ollis, Sarah
   Love, Emily
   Karaa, Amel
   Houts, Carrie R.
   Wirth, R. J.
   Shields, Alan L.
TI Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease
SO JOURNAL OF PATIENT-REPORTED OUTCOMES
LA English
DT Article
DE Psychometric evaluation; Patient-reported outcomes; Mitochondrial disease; Primary Mitochondrial Myopathy; Primary Mitochondrial Myopathy Symptom Assessment
ID patient-reported outcm; quality-of-life; task-force; pro instruments; dna mutations; prevalence; scale; time
AB Background: The Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) is a 10-item patient-reported outcome (PRO) measure designed to assess the severity of mitochondrial disease symptoms. Analyses of data from a clinical trial with PMM patients were conducted to evaluate the psychometric properties of the PMMSA and to provide score interpretation guidelines for the measure.Methods: The PMMSA was completed as a daily diary for approximately 14 weeks by individuals in a Phase 2 randomized, placebo-controlled crossover trial evaluating the safety, tolerability, and efficacy of subcutaneous injections of elamipretide in patents with mitochondrial disease. In addition to the PMMSA, performance-based assessments, clinician ratings, and other PRO measures were also completed. Descriptive statistics, psychometric analyses, and score interpretation guidelines were evaluated for the PMMSA.Results: Participants (N = 30) had a mean age of 45.3 years, with the majority of the sample being female (n = 25, 83.3%) and non-Hispanic white (n = 29, 96.6%). The 10 PMMSA items assessing a diverse symptomology were not found to form a single underlying construct. However, four items assessing tiredness and muscle weakness were grouped into a "general fatigue " domain score. The PMMSA Fatigue 4 summary score (4FS) demonstrated stable test-retest scores, internal consistency, correlations with the scores produced by reference measures, and the ability to differentiate between different global health levels. Changes on the PMMSA 4FS were also related to change scores produced by the reference measures. PMMSA severity scores were higher for the symptom rated as "most bothersome " by each subject relative to the remaining nine PMMSA items (most bothersome symptom mean = 2.88 vs. 2.18 for other items). Distribution- and anchor-based evaluations suggested that reduction in weekly scores between 0.79 and 2.14 (scale range: 4-16) may represent a meaningful change on the PMMSA 4FS and reduction in weekly scores between 0.03 and 0.61 may represent a responder for each of the remaining six non-fatigue items, scored independently.Conclusions: Upon evaluation of its psychometric properties, the PMMSA, specifically the 4FS domain, demonstrated strong reliability and construct-related validity. The PMMSA can be used to evaluate treatment benefit in clinical trials with individuals with PMM.
C1 [Gwaltney, Chad] Gwaltney Consulting Grp, 1 Bucks Trail, Westerly, RI 02891 USA.
   [Stokes, Jonathan; Mazar, Iyar; Ollis, Sarah; Love, Emily; Shields, Alan L.] Adelphi Values, Boston, MA USA.
   [Aiudi, Anthony] Stealth BioTherapeut Inc, Newton, MA USA.
   [Karaa, Amel] Massachusetts Gen Hosp, Boston, MA USA.
   [Houts, Carrie R.; Wirth, R. J.] Vector Psychometr Grp LLC, Chapel Hill, NC USA.
C3 Harvard University; Massachusetts General Hospital
RP Gwaltney, C (corresponding author), Gwaltney Consulting Grp, 1 Bucks Trail, Westerly, RI 02891 USA.
EM cgwaltney@gwaltneyconsulting.com
FU Stealth Bio Therapeutics Inc.
CR Béhin A, 2015, REV NEUROL-FRANCE, V171, P715, DOI 10.1016/j.neurol.2015.06.002
   Benjamin K, 2017, VALUE HEALTH, V20, P838, DOI 10.1016/j.jval.2017.05.015
   Brown TA, 2006, CONFIRMATORY FACTOR, V0, P0
   Cappelleri JC, 2014, CH CRC BIOSTAT SER, V0, P1
   Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744
   Chinnery PF, 1993, MITOCHONDRIAL DISORD, V0, P0
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Cohen J, 1988, STATISTICAL POWER ANALYSIS FOR THE BEHAVIORAL SCIENCES, V2nd ed, P0
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89
   Elson JL, 2013, NEUROMUSCULAR DISORD, V23, P324, DOI 10.1016/j.nmd.2012.12.012
   Enright Paul L, 2003, RESPIR CARE, V48, P783
   Goldstein A, 2021, J INHERIT METAB DIS, V44, P343, DOI 10.1002/jimd.12320
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gwaltney Chad, 2020, J CLIN NEUROMUSCUL DIS, V22, P65, DOI 10.1097/CND.0000000000000303
   Husted JA, 2001, ARTHRIT RHEUM-ARTHR, V45, P151
   Karaa A, 2020, J CACHEXIA SARCOPENI, V11, P909, DOI 10.1002/jcsm.12559
   Karaa A, 2018, NEUROLOGY, V90, PE1212, DOI 10.1212/WNL.0000000000005255
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   National Institutes of Health, 2017, US, V0, P0
   Orsucci D, 2012, NEUROEPIDEMIOLOGY, V38, P195, DOI 10.1159/000337161
   Parikh S, 2019, J MED GENET, V56, P123, DOI 10.1136/jmedgenet-2018-105800
   Patrick DL, 2011, VALUE HEALTH, V14, P978, DOI 10.1016/j.jval.2011.06.013
   Patrick DL, 2011, VALUE HEALTH, V14, P967, DOI 10.1016/j.jval.2011.06.014
   Peipert JD, 2023, QUAL LIFE RES, V32, P1341, DOI 10.1007/s11136-022-03200-4
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x
   Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schmitz-Hübsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92
   Shields A, 2015, EXPERT REV PHARM OUT, V15, P951, DOI 10.1586/14737167.2015.1115348
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   USDepartment of Health and Human Services Food and Drug Administration, 2009, GUID IND PAT REP OUT, V0, P0
   United Mitochondrial Disease Foundation, 2018, VOIC PAT REP MIT DIS, V0, P1
   Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x
   Wirth RJ, 2007, PSYCHOL METHODS, V12, P58, DOI 10.1037/1082-989X.12.1.58
   Wyrwich KW, 2013, QUAL LIFE RES, V22, P475, DOI 10.1007/s11136-012-0175-x
   Zolkipli-Cunningham Z, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0197513
NR 41
TC 2
Z9 2
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 
EI 2509-8020
J9 J PATIENT-REP OUTCOM
JI J. Patient-Rep. Outcomes
PD DEC 23
PY 2022
VL 6
IS 1
BP 
EP 
DI 10.1186/s41687-022-00534-y
PG 17
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA 7H9FU
UT WOS:000903502500001
PM 36562873
DA 2024-11-01
ER

PT J
AU Wang, PL
   Castellani, CA
   Yao, J
   Huan, TX
   Bielak, LF
   Zhao, W
   Haessler, J
   Joehanes, R
   Sun, XB
   Guo, XQ
   Longchamps, RJ
   Manson, JE
   Grove, ML
   Bressler, J
   Taylor, KD
   Lappalainen, T
   Kasela, S
   Van den Berg, DJ
   Hou, LF
   Reiner, A
   Liu, YM
   Boerwinkle, E
   Smith, JA
   Peyser, PA
   Fornage, M
   Rich, SS
   Rotter, JI
   Kooperberg, C
   Arking, DE
   Levy, D
   Liu, CY
AF Wang, Penglong
   Castellani, Christina A.
   Yao, Jie
   Huan, Tianxiao
   Bielak, Lawrence F.
   Zhao, Wei
   Haessler, Jeffrey
   Joehanes, Roby
   Sun, Xianbang
   Guo, Xiuqing
   Longchamps, Ryan J.
   Manson, JoAnn E.
   Grove, Megan L.
   Bressler, Jan
   Taylor, Kent D.
   Lappalainen, Tuuli
   Kasela, Silva
   Van den Berg, David J.
   Hou, Lifang
   Reiner, Alexander
   Liu, Yongmei
   Boerwinkle, Eric
   Smith, Jennifer A.
   Peyser, Patricia A.
   Fornage, Myriam
   Rich, Stephen S.
   Rotter, Jerome, I
   Kooperberg, Charles
   Arking, Dan E.
   Levy, Daniel
   Liu, Chunyu
TI Epigenome-wide association study of mitochondrial genome copy number
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID dna methylation; gene-expression; atherosclerosis risk; peripheral-blood; skeletal-muscle; design; health; transcription; interface; discovery
AB We conducted cohort- and race-specific epigenome-wide association analyses of mitochondrial deoxyribonucleic acid (mtDNA) copy number (mtDNA CN) measured in whole blood from participants of African and European origins in five cohorts (n = 6182, mean age = 57-67 years, 65% women). In the meta-analysis of all the participants, we discovered 21 mtDNA CN-associated DNA methylation sites (CpG) (P < 1 x 10(-7)), with a 0.7-3.0 standard deviation increase (3 CpGs) or decrease (18 CpGs) in mtDNA CN corresponding to a 1% increase in DNA methylation. Several significant CpGs have been reported to be associated with at least two risk factors (e.g. chronological age or smoking) for cardiovascular disease (CVD). Five genes [PR/SET domain 16, nuclear receptor subfamily 1 group H member 3 (NR1H3), DNA repair protein, DNA polymerase kappa and decaprenyl-diphosphate synthase subunit 2], which harbor nine significant CpGs, are known to be involved in mitochondrial biosynthesis and functions. For example, NR1H3 encodes a transcription factor that is differentially expressed during an adipose tissue transition. The methylation level of cg09548275 in NR1H3 was negatively associated with mtDNA CN (effect size = -1.71, P = 4 x 10(-8)) and was positively associated with the NR1H3 expression level (effect size = 0.43, P = 0.0003), which indicates that the methylation level in NR1H3 may underlie the relationship between mtDNA CN, the NR1H3 transcription factor and energy expenditure. In summary, the study results suggest that mtDNA CN variation in whole blood is associated with DNA methylation levels in genes that are involved in a wide range of mitochondrial activities. These findings will help reveal molecular mechanisms between mtDNA CN and CVD.
C1 [Wang, Penglong; Huan, Tianxiao; Joehanes, Roby; Levy, Daniel] NHLBI, Populat Sci Branch, NIH, Bethesda, MD 20892 USA.
   [Castellani, Christina A.; Longchamps, Ryan J.; Arking, Dan E.] Johns Hopkins Univ, McKusick Nathans Dept Genet Med, Sch Med, Baltimore, MD 21287 USA.
   [Castellani, Christina A.; Taylor, Kent D.] Western Univ, Dept Pathol & Lab Med, London, ON N6A 5C1, Canada.
   [Yao, Jie; Guo, Xiuqing; Rotter, Jerome, I] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Dept Pediat, Lundquist Inst Biomed Innovat, Torrance, CA 90502 USA.
   [Bielak, Lawrence F.; Zhao, Wei; Smith, Jennifer A.; Peyser, Patricia A.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Haessler, Jeffrey; Reiner, Alexander; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.
   [Sun, Xianbang; Liu, Chunyu] Boston Univ, Dept Biostat, Boston, MA 02118 USA.
   [Manson, JoAnn E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Grove, Megan L.; Bressler, Jan; Boerwinkle, Eric; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.
   [Lappalainen, Tuuli; Kasela, Silva] New York Genome Ctr, New York, NY 10013 USA.
   [Lappalainen, Tuuli; Kasela, Silva] Columbia Univ, Dept Syst Biol, New York, NY 10034 USA.
   [Van den Berg, David J.] Univ Southern Calif, Ctr Genet Epidemiol, Keck Sch Med USC, Dept Populat & Publ Hlth Sci, Los Angeles, CA 90033 USA.
   [Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Liu, Yongmei] Duke Univ, Dept Med, Div Cardiol, Med Ctr, Durham, NC 27704 USA.
   [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
   [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, McGovern Med Sch, Houston, TX 77030 USA.
   [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA.
   [Levy, Daniel; Liu, Chunyu] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Western University (University of Western Ontario); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Michigan System; University of Michigan; Fred Hutchinson Cancer Center; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Columbia University; University of Southern California; Northwestern University; Feinberg School of Medicine; Duke University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study
RP Liu, CY (corresponding author), Boston Univ, Dept Biostat, Sch Publ Hlth, 801 Massachusetts Ave,3rd Floor, Boston, MA 02118 USA.
EM liuc@bu.edu
FU National Heart, Lung, and Blood Institute [R01HL105756, R01HL155569]
CR Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
   [Anonymous], 2007, LINEAR NONLINEAR MIX, V0, P0
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bartolomé MA, 2002, OBES SURG, V12, P324, DOI 10.1381/096089202321088084
   Basse AL, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/s12864-015-1405-8
   Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008
   Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887
   Battram T, 2021, OSF PREPR, V0, P0, DOI DOI 10.31219/osf.io/837wn
   Bellizzi D, 2012, EPIGENOMICS-UK, V4, P17, DOI 10.2217/EPI.11.109
   Benton MC, 2015, GENOME BIOL, V16, P0, DOI 10.1186/s13059-014-0569-x
   Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518
   Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045
   Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007
   Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14
   Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113
   Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1
   Breeze CE, 2019, BIOINFORMATICS, V35, P4767, DOI 10.1093/bioinformatics/btz456
   Castellani CA, 2020, GENOME MED, V12, P0, DOI 10.1186/s13073-020-00778-7
   Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470
   DAgostino Sabrina, 2018, ONCOTARGET, V9, P23334, DOI 10.18632/oncotarget.25101
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Daniels PR, 2004, AM J MED, V116, P676, DOI 10.1016/j.amjmed.2003.12.032
   Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7
   Hemani G, 2020, MENDELIAN RANDOMIZAT, V0, P0
   HONDA H, 1994, BLOOD, V84, P4186, DOI 10.1182/blood.V84.12.4186.bloodjournal84124186
   Houseman EA, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-86
   Huan TX, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12228-z
   Joehanes R, 2017, GENOME BIOL, V18, P0, DOI 10.1186/s13059-016-1142-6
   Joehanes R, 2013, ARTERIOSCL THROM VAS, V33, P1418, DOI 10.1161/ATVBAHA.112.301169
   Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005
   Kuan PF, 2010, BIOINFORMATICS, V26, P2849, DOI 10.1093/bioinformatics/btq553
   Lee W, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.34
   Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161
   Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li Y, 2018, CANCER RES, V78, P4471, DOI 10.1158/0008-5472.CAN-17-2172
   Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533
   Longchamps RJ, 2021, GENOME WIDE ANAL MIT, V0, P0, DOI DOI 10.1101/2021.01.25.428086
   Longchamps RJ, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0228166
   Martens JHA, 2013, HAEMATOLOGICA, V98, P1487, DOI 10.3324/haematol.2013.094243
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mi HY, 2019, NUCLEIC ACIDS RES, V47, PD419, DOI 10.1093/nar/gky1038
   Mishra A, 2018, MOL CELL BIOL, V38, P0, DOI 10.1128/MCB.00489-17
   Monickaraj F, 2012, MOL CELL BIOCHEM, V365, P343, DOI 10.1007/s11010-012-1276-0
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112
   Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113
   Peng M, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000061
   Permuth-Wey J, 2011, CANCER EPIDEM BIOMAR, V20, P1131, DOI 10.1158/1055-9965.EPI-10-1224
   Petersen MH, 2014, MITOCHONDRION, V17, P14, DOI 10.1016/j.mito.2014.05.001
   Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685
   Price EM, 2013, EPIGENET CHROMATIN, V6, P0, DOI 10.1186/1756-8935-6-4
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Rajao MA, 2009, MOL MICROBIOL, V71, P185, DOI 10.1111/j.1365-2958.2008.06521.x
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Schwarze G, 2015, GEN PACKAGE METAANAL, V0, P0
   Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001
   SHERRATT HSA, 1991, REV NEUROL, V147, P417
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021
   Sun X, 2018, EPIGENET CHROMATIN, V11, P0, DOI 10.1186/s13072-018-0223-z
   Taguchi Y, 2005, BIOINFORMATICS, V21, P730, DOI 10.1093/bioinformatics/bti067
   Taliun D, 2021, NATURE, V590, P0, DOI 10.1038/s41586-021-03205-y
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661
   Vivian CJ, 2017, CANCER RES, V77, P6202, DOI 10.1158/0008-5472.CAN-17-1473
   WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184
   Yang SY, 2021, GENOME RES, V31, P349, DOI 10.1101/gr.269381.120
   Yao J, 2020, ASS MITOCHONDRIAL DN, V0, P0, DOI DOI 10.1101/2020.04.20.20016337
   Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613
NR 79
TC 5
Z9 5
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 15
PY 2022
VL 31
IS 2
BP 309
EP 319
DI 10.1093/hmg/ddab240
EA AUG 2021
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA YI5XZ
UT WOS:000743922000013
PM 34415308
DA 2024-11-01
ER

PT J
AU Cai, MC
   Yu, Q
   Bao, JF
AF Cai, Minchao
   Yu, Qing
   Bao, Jinfang
TI A case report of mitochondrial myopathy with membranous nephropathy
SO BMC NEPHROLOGY
LA English
DT Article
DE Mitochondrial myopathy; Membranous nephropathy; mtDNA mutation
ID disease; dna
AB Background MtDNA 3243 A > G mutation leads to mitochondrial myopathies with predominant hyperlactatemia. Given the ubiquitous nature of mitochondria, cellular dysfunction can also appear in tissues with high metabolic turnover; thus, there can be cardiac, digestive, ophthalmologic, and kidney complications. MtDNA 3243 A > G mutation has been shown to be with renal involvement in the previous cases of which are FSGS and tubularinterstitial nephritis. Case presentation We report a case of patient who had the mitochondrial myopathy with mitochondrial DNA (mtDNA) 3243 A > G mutation diagnosed membranous nephropathy by kidney biopsy, which was never reported before. Our patient was found to have chest tightness and shortness of breath with hyperlactatemia and was diagnosed mitochondrial myopathy with mtDNA 3243 A > G mutation 11 months ago. Acute kidney injury occurred with hyperuricemia (urid acid 1011umol/L) which may be associated with mtDNA mutation. Since then, persistent proteinuria was also found and the 24-h urine protein quantitative was around 2 g. Kidney biopsy was performed and the result was consistent with membranous nephropathy, with abnormal mitochondria seen in renal tubules by electron microscopy. Conclusions Patients with mitochondrial myopathy could also have renal presentation of membranous nephropathy. Patients with mtDNA mutation may have various renal manifestations so that more attention should be paid on their kidneys.
C1 [Cai, Minchao; Yu, Qing; Bao, Jinfang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Nephrol, 100 Haining Rd, Shanghai 200080, Peoples R China.
C3 Shanghai Jiao Tong University
RP Bao, JF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Nephrol, 100 Haining Rd, Shanghai 200080, Peoples R China.
EM bamboobao@163.com
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   DICKMAN K G, 1990, AMERICAN JOURNAL OF PHYSIOLOGY, V258, P0
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Hirano M, 2002, INTERNAL MED, V41, P113, DOI 10.2169/internalmedicine.41.113
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Kawamoto T, 2011, LIPIDS HEALTH DIS, V10, P0, DOI 10.1186/1476-511X-10-105
   Rudnicki M, 2016, AM J KIDNEY DIS, V68, P949, DOI 10.1053/j.ajkd.2016.06.027
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
NR 13
TC 2
Z9 4
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2369
J9 BMC NEPHROL
JI BMC Nephrol.
PD MAR 4
PY 2022
VL 23
IS 1
BP 
EP 
DI 10.1186/s12882-022-02710-0
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA ZN0OM
UT WOS:000764744700004
PM 35246049
DA 2024-11-01
ER

PT J
AU Evangelisti, S
   Gramegna, LL
   La Morgia, C
   Di Vito, L
   Maresca, A
   Talozzi, L
   Bianchini, C
   Mitolo, M
   Manners, DN
   Caporali, L
   Valentino, ML
   Liguori, R
   Carelli, V
   Lodi, R
   Testa, C
   Tonon, C
AF Evangelisti, Stefania
   Gramegna, Laura Ludovica
   La Morgia, Chiara
   Di Vito, Lidia
   Maresca, Alessandra
   Talozzi, Lia
   Bianchini, Claudio
   Mitolo, Micaela
   Manners, David Neil
   Caporali, Leonardo
   Valentino, Maria Lucia
   Liguori, Rocco
   Carelli, Valerio
   Lodi, Raffaele
   Testa, Claudia
   Tonon, Caterina
TI Molecular biomarkers correlate with brain grey and white matter changes in patients with mitochondrial m.3243A &gt; G mutation
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE M.3243A > G mutation; Molecular biomarkers; MR neuroimaging; Brain gray matter atrophy; Brain white matter microstructure
ID nitric-oxide; melas; responses
AB Introduction: The mitochondrial DNA (mtDNA) m.3243A > G mutation in the MT-TL1 gene results in a multi systemic disease, that is commonly associated with neurodegenerative changes in the brain. Methods: Seventeen patients harboring the m3243A > G mutation were enrolled (age 43.1 +/- 11.4 years, 10 M/7F). A panel of plasma biomarkers including lactate acid, alanine, L-arginine, fibroblast growth factor 21 (FGF-21), growth/differentiation factor 15 (GDF-15) and circulating cell free-mtDNA (ccf-mtDNA), as well as blood, urine and muscle mtDNA heteroplasmy were evaluated. Patients also underwent a brain standardized MR protocol that included volumetric T1-weighted images and diffusion-weighted MRI. Twenty sex-and age-matched healthy controls were included. Voxel-wise analysis was performed on T1-weighted and diffusion imaging, respectively with VBM (voxel-based morphometry) and TBSS (Tract-based Spatial Statistics). Ventricular lactate was also evaluated by H-1-MR spectroscopy. Results: A widespread cortical gray matter (GM) loss was observed, more severe (p < 0.001) in the bilateral calcarine, insular, frontal and parietal cortex, along with infratentorial cerebellar cortex. High urine mtDNA mutation load, high levels of plasma lactate and alanine, low levels of plasma arginine, high levels of serum FGF-21 and ventricular lactate accumulation significantly (p < 0.05) correlated with the reduced brain GM density. Widespread microstructural alterations were highlighted in the white matter, significantly (p < 0.05) correlated with plasma alanine and arginine levels, with mtDNA mutation load in urine, with high level of serum GDF-15 and with high content of plasma ccf-mtDNA. Conclusions: Our results suggest that the synergy of two pathogenic mechanisms, mtDNA-related mitochondrial respiratory deficiency and defective nitric oxide metabolism, contributes to the brain neurodegeneration in m.3243A > G patients. (c) 2021 Elsevier Inc. All rights reserved.
C1 [Evangelisti, Stefania; Gramegna, Laura Ludovica; Talozzi, Lia; Bianchini, Claudio; Manners, David Neil; Valentino, Maria Lucia; Liguori, Rocco; Carelli, Valerio; Lodi, Raffaele; Tonon, Caterina] Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy.
   [Gramegna, Laura Ludovica; Mitolo, Micaela; Lodi, Raffaele; Testa, Claudia; Tonon, Caterina] IRCCS Ist Sci Neurol Bologna, Funct & Mol Neuroimaging Unit, Via Altura 3, I-40139 Bologna, Italy.
   [La Morgia, Chiara; Di Vito, Lidia; Caporali, Leonardo; Valentino, Maria Lucia; Liguori, Rocco] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Bologna, Italy.
   [La Morgia, Chiara; Maresca, Alessandra; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Bologna, Italy.
   [Testa, Claudia] Univ Bologna, Dept Phys & Astron, Bologna, Italy.
C3 University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna
RP Tonon, C (corresponding author), IRCCS Ist Sci Neurol Bologna, Funct & Mol Neuroimaging Unit, Via Altura 3, I-40139 Bologna, Italy.
EM caterina.tonon@unibo.it
CR Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007
   Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344
   Benarroch EE, 2011, NEUROLOGY, V77, P1568, DOI 10.1212/WNL.0b013e318233b3e4
   Carelli V, 2018, ESSAYS BIOCHEM, V62, P235, DOI 10.1042/EBC20170097
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Ceccarelli A, 2012, AM J NEURORADIOL, V33, P1579, DOI 10.3174/ajnr.A3083
   Chinnery PF, 2018, CLIN MITOCHONDRIAL M, V0, P0
   Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045
   Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056
   El-Hattab Ayman W, 2017, J. INBORN ERRORS METAB. SCREEN., V5, Pe160051, DOI 10.1177/2326409817697399
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   Formichi P, 2020, NEUROL SCI, V41, P3653, DOI 10.1007/s10072-020-04422-5
   Gambardella S, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.01064
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Gramegna LL, 2021, J NEURORADIOLOGY, V0, P0
   Gramegna LL, 2021, ANN CLIN TRANSL NEUR, V8, P1200, DOI 10.1002/acn3.51329
   Gramegna LL, 2018, NEUROMUSCULAR DISORD, V28, P144, DOI 10.1016/j.nmd.2017.10.007
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Gunnewiek TMK, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107538
   Haast RAM, 2018, NEUROIMAGE-CLIN, V18, P231, DOI 10.1016/j.nicl.2018.01.017
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Lax N, 2012, MITOCHONDRIAL DYSFUNCTION IN NEURODEGENERATIVE DISORDERS, V0, P21
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lindroos MM, 2009, BRAIN, V132, P3274, DOI 10.1093/brain/awp259
   Lodi R, 2004, BBA-BIOENERGETICS, V1657, P146, DOI 10.1016/j.bbabio.2004.05.003
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Montano V, 2021, NEUROL SCI, V42, P383, DOI 10.1007/s10072-020-04638-5
   Ridgway GR, 2008, NEUROIMAGE, V40, P1429, DOI 10.1016/j.neuroimage.2008.01.003
   Rodan LH, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0238224
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Schreglmann SR, 2018, MOVEMENT DISORD, V33, P146, DOI 10.1002/mds.27174
   Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Testa C, 2019, PARKINSONISM RELAT D, V62, P226, DOI 10.1016/j.parkreldis.2018.11.018
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tsujikawa K, 2016, MITOCHONDRION, V30, P229, DOI 10.1016/j.mito.2016.08.011
   Tsygankova PG, 2019, J INHERIT METAB DIS, V42, P918, DOI 10.1002/jimd.12142
   Virtanen SM, 2011, AM J NEURORADIOL, V32, P522, DOI 10.3174/ajnr.A2309
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yokoyama T, 2010, NEUROPATHOLOGY, V30, P56, DOI 10.1111/j.1440-1789.2009.01026.x
   Zanigni S, 2017, PARKINSONISM RELAT D, V39, P44, DOI 10.1016/j.parkreldis.2017.03.001
   Zanigni S, 2016, NEUROIMAGE-CLIN, V11, P678, DOI 10.1016/j.nicl.2016.04.012
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
NR 52
TC 4
Z9 4
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JAN 15
PY 2022
VL 135
IS 1
BP 72
EP 81
DI 10.1016/j.ymgme.2021.11.012
EA JAN 2022
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA YV2MV
UT WOS:000752566300011
PM 34916127
DA 2024-11-01
ER

PT J
AU Kim, DS
   Wheeler, MT
   Ashley, EA
AF Kim, Daniel Seung
   Wheeler, Matthew T.
   Ashley, Euan A.
TI The genetics of human performance
SO NATURE REVIEWS GENETICS
LA English
DT Review
ID genome-wide association; human skeletal-muscle; exercise heart-rate; blood-pressure; mitochondrial biogenesis; familial aggregation; energy-expenditure; alcohol dependence; cardiac structure; actn3 genotype
AB Human physiology is likely to have been selected for endurance physical activity. However, modern humans have become largely sedentary, with physical activity becoming a leisure-time pursuit for most. Whereas inactivity is a strong risk factor for disease, regular physical activity reduces the risk of chronic disease and mortality. Although substantial epidemiological evidence supports the beneficial effects of exercise, comparatively little is known about the molecular mechanisms through which these effects operate. Genetic and genomic analyses have identified genetic variation associated with human performance and, together with recent proteomic, metabolomic and multi-omic analyses, are beginning to elucidate the molecular genetic mechanisms underlying the beneficial effects of physical activity on human health. Regular physical activity reduces the risk of chronic disease and mortality, but the mechanisms underpinning this protective effect are poorly understood. Here, Kim et al. review candidate genes and pathways implicated in human performance by genetic, genomic and multi-omic studies.
C1 [Kim, Daniel Seung; Wheeler, Matthew T.; Ashley, Euan A.] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.
   [Wheeler, Matthew T.; Ashley, Euan A.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.
   [Ashley, Euan A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.
   [Ashley, Euan A.] Stanford Univ, Dept Biomed Data Sci, Sch Med, Stanford, CA 94305 USA.
C3 Stanford University; Stanford University; Stanford University; Stanford University
RP Ashley, EA (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.; Ashley, EA (corresponding author), Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.; Ashley, EA (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Ashley, EA (corresponding author), Stanford Univ, Dept Biomed Data Sci, Sch Med, Stanford, CA 94305 USA.
EM euan@stanford.edu
CR Ahmetov II, 2015, BIOL SPORT, V32, P3, DOI 10.5604/20831862.1124568
   AIello L, 2002, INTRO HUMAN EVOLUTIO, V15, P0, DOI 10.1016/b978-0-08-057100-3.50019-5
   Al-Khelaifi F, 2020, FRONT GENET, V11, P0, DOI 10.3389/fgene.2020.00595
   Amar D, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-23579-x
   An P, 2003, INT J SPORTS MED, V24, P57, DOI 10.1055/s-2003-37200
   Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Aung N, 2019, CIRCULATION, V140, P1318, DOI 10.1161/CIRCULATIONAHA.119.041161
   BACCAREDDABOY A, 1964, ANGIOLOGICA, V1, P209
   Barrès R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001
   Benton ML, 2021, NAT REV GENET, V22, P269, DOI 10.1038/s41576-020-00305-9
   Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9
   Bohannon RW, 2017, J FRALITY AGING, V6, P83, DOI 10.14283/jfa.2017.8
   Booth FW, 2017, PHYSIOL REV, V97, P1351, DOI 10.1152/physrev.00019.2016
   BOUCHARD C, 1995, MED SCI SPORT EXER, V27, P721
   Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003
   Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013
   Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010
   Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052
   Brodde OE, 1999, PHARMACOL REV, V51, P651
   Bye A, 2020, PROG CARDIOVASC DIS, V63, P341, DOI 10.1016/j.pcad.2020.02.001
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165
   Chan JPL, 2015, AGE, V37, P0, DOI 10.1007/s11357-015-9745-5
   Chapman MA, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107808
   Chen MH, 2020, CELL, V182, P1198, DOI 10.1016/j.cell.2020.06.045
   Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771
   Choquet H, 2020, CIRC-GENOM PRECIS ME, V13, P0, DOI 10.1161/CIRCGEN.119.002804
   CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605
   Contrepois K, 2020, CELL, V181, P1112, DOI 10.1016/j.cell.2020.04.043
   Crittenden AN, 2013, ATTACHMENT RECONSIDE, V0, P0
   Del Coso J, 2019, EUR J APPL PHYSIOL, V119, P49, DOI 10.1007/s00421-018-4010-0
   DELACHAPELLE A, 1993, P NATL ACAD SCI USA, V90, P4495, DOI 10.1073/pnas.90.10.4495
   Dikilitas O, 2020, AM J HUM GENET, V106, P707, DOI 10.1016/j.ajhg.2020.04.002
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809
   Eppinga RN, 2016, NAT GENET, V48, P1557, DOI 10.1038/ng.3708
   Eynon N, 2011, PHYSIOL GENOMICS, V43, P789, DOI 10.1152/physiolgenomics.00029.2011
   Eynon N, 2011, MITOCHONDRION, V11, P64, DOI 10.1016/j.mito.2010.07.004
   Fan WW, 2017, CELL METAB, V25, P242, DOI 10.1016/j.cmet.2016.10.022
   Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629
   Fox ER, 2013, CIRC-CARDIOVASC GENE, V6, P37, DOI 10.1161/CIRCGENETICS.111.962365
   Frampton J, 2020, NAT METAB, V2, P840, DOI 10.1038/s42255-020-0188-7
   Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466
   Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637
   Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815
   Ghosh S, 2013, J APPL PHYSIOL, V115, P1343, DOI 10.1152/japplphysiol.01487.2012
   Hall D, 2003, AM J HUM GENET, V73, P370, DOI 10.1086/377003
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Harvey NR, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-67870-1
   Harvey NR, 2020, MOL GENET GENOMICS, V295, P515, DOI 10.1007/s00438-019-01639-8
   Hautala AJ, 2009, ANN MED, V41, P197, DOI 10.1080/07853890802477866
   Heinicke K, 2001, INT J SPORTS MED, V22, P504, DOI 10.1055/s-2001-17613
   HIGGINBOTHAM MB, 1986, CIRC RES, V58, P281, DOI 10.1161/01.RES.58.2.281
   Illig T, 2004, J CLIN ENDOCR METAB, V89, P5053, DOI 10.1210/jc.2004-0355
   Ingelsson E, 2007, CIRCULATION, V115, P2917, DOI 10.1161/CIRCULATIONAHA.106.683821
   Jacques M, 2019, EPIGENETICS-US, V14, P633, DOI 10.1080/15592294.2019.1614416
   Kamberov YG, 2018, J HUM EVOL, V125, P99, DOI 10.1016/j.jhevol.2018.10.008
   Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100
   Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6
   Kim DS, 2021, J AM COLL CARDIOL, V78, P496, DOI 10.1016/j.jacc.2021.03.346
   Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049
   KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0
   La Rovere MT, 1998, LANCET, V351, P478
   Landen S, 2019, EPIGENETICS-US, V14, P523, DOI 10.1080/15592294.2019.1603961
   Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449
   Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6
   Liebenberg L, 2006, CURR ANTHROPOL, V47, P1017, DOI 10.1086/508695
   Lieberman DE, 2015, CURR SPORT MED REP, V14, P313, DOI 10.1249/JSR.0000000000000168
   Lieberman DE, 2015, COMPR PHYSIOL, V5, P99, DOI 10.1002/cphy.c140011
   Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lindholm ME, 2014, AM J PHYSIOL-REG I, V307, PR248, DOI 10.1152/ajpregu.00036.2013
   Lindholm ME, 2016, EXP PHYSIOL, V101, P28, DOI 10.1113/EP085318
   Lindholm ME, 2014, EPIGENETICS-US, V9, P1557, DOI 10.4161/15592294.2014.982445
   Liu XJ, 2017, CSH PERSPECT MED, V7, P0, DOI 10.1101/cshperspect.a029850
   Lorenzo FR, 2014, NAT GENET, V46, P951, DOI 10.1038/ng.3067
   Lundby C, 2006, EUR J APPL PHYSIOL, V96, P363, DOI 10.1007/s00421-005-0085-5
   Luo XG, 2005, HUM MOL GENET, V14, P2421, DOI 10.1093/hmg/ddi244
   Ma PC, 2014, MOL CELL BIOL, V34, P4355, DOI 10.1128/MCB.00731-14
   MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122
   MACDOUGALL JD, 1985, J APPL PHYSIOL, V58, P785, DOI 10.1152/jappl.1985.58.3.785
   MALCZEWSKALENCZJ, 2020, J STRENGTH COND RES, V0, P0
   Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288
   Matteini AM, 2016, AGING CELL, V15, P792, DOI 10.1111/acel.12468
   McGee SL, 2019, TRENDS ENDOCRIN MET, V30, P636, DOI 10.1016/j.tem.2019.06.002
   McGee SL, 2009, J PHYSIOL-LONDON, V587, P5951, DOI 10.1113/jphysiol.2009.181065
   Medrano JL, 2017, J BIOL CHEM, V292, P20975, DOI 10.1074/jbc.M117.806422
   Meyer HV, 2020, NATURE, V584, P589, DOI 10.1038/s41586-020-2635-8
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Minetti AE, 2003, NATURE, V426, P785, DOI 10.1038/426785a
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Nezhad FY, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00262
   Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653
   North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675
   Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016
   Papadimitriou ID, 2018, BMC GENOMICS, V19, P0, DOI 10.1186/s12864-017-4412-0
   Paré G, 2007, AM J HUM GENET, V80, P673, DOI 10.1086/513286
   Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040
   Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103
   Persson HC, 2015, BMC NEUROL, V15, P0, DOI 10.1186/s12883-015-0436-8
   Pettersen IKN, 2019, MITOCHONDRION, V49, P97, DOI 10.1016/j.mito.2019.07.009
   Pillon NJ, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13869-w
   Pirruccello JP, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15823-7
   Pitsiladis YP, 2016, PHYSIOL GENOMICS, V48, P183, DOI 10.1152/physiolgenomics.00105.2015
   Rabinowitz JD, 2020, NAT METAB, V2, P566, DOI 10.1038/s42255-020-0243-4
   Ramírez J, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04148-1
   Rankinen T, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0147330
   Rankinen T, 2012, J APPL PHYSIOL, V112, P892, DOI 10.1152/japplphysiol.01287.2011
   REED T, 2009, ANN HUM BIOL, V18, P0
   Rice T, 2002, MED SCI SPORT EXER, V34, P972, DOI 10.1097/00005768-200206000-00011
   ROBERTSHAW D, 1985, J HUM EVOL, V14, P63, DOI 10.1016/S0047-2484(85)80096-8
   SALE DG, 1988, MED SCI SPORT EXER, V20, PS135, DOI 10.1249/00005768-198810001-00009
   Sanford JA, 2020, CELL, V181, P1464, DOI 10.1016/j.cell.2020.06.004
   Sarzynski MA, 2020, NAT METAB, V2, P796, DOI 10.1038/s42255-020-0233-6
   Sarzynski MA, 2017, J PHYSIOL-LONDON, V595, P2931, DOI 10.1113/JP272559
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Scheiman J, 2019, NAT MED, V25, P1104, DOI 10.1038/s41591-019-0485-4
   SCHMIDTNIELSEN K, 1970, SCIENCE, V169, P1102, DOI 10.1126/science.169.3950.1102
   Schnohr P, 2015, J AM COLL CARDIOL, V65, P411, DOI 10.1016/j.jacc.2014.11.023
   Semenova EA, 2020, EUR J APPL PHYSIOL, V120, P665, DOI 10.1007/s00421-020-04306-8
   Semenova EA, 2019, SPORTS, V0, P0
   Seto JT, 2013, J CLIN INVEST, V123, P4255, DOI 10.1172/JCI67691
   Shave RE, 2019, P NATL ACAD SCI USA, V116, P19905, DOI 10.1073/pnas.1906902116
   Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886
   Song DS, 2020, P NATL ACAD SCI USA, V117, P12230, DOI 10.1073/pnas.1920546117
   Stefano E, 2019, MITOCHONDRION, V47, P125, DOI 10.1016/j.mito.2019.06.004
   Surendran P, 2020, NAT GENET, V52, P1314, DOI 10.1038/s41588-020-00713-x
   Tadros R, 2021, NAT GENET, V53, P128, DOI 10.1038/s41588-020-00762-2
   Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986
   TAYLOR CR, 1973, AM J PHYSIOL, V224, P848, DOI 10.1152/ajplegacy.1973.224.4.848
   Theilen NT, 2017, J CELL PHYSIOL, V232, P2348, DOI 10.1002/jcp.25737
   Tikkanen E, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-24735-y
   Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009
   Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003
   Turner DC, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-72730-z
   van de Vegte YJ, 2019, CELL MOL LIFE SCI, V76, P2391, DOI 10.1007/s00018-019-03079-4
   Vasan RS, 2007, BMC MED GENET, V8, P0, DOI 10.1186/1471-2350-8-S1-S2
   Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a
   Verweij N, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03395-6
   Vuckovic D, 2020, CELL, V182, P1214, DOI 10.1016/j.cell.2020.08.008
   Vujkovic M, 2020, NAT GENET, V52, P680, DOI 10.1038/s41588-020-0637-y
   Wang JC, 2004, HUM MOL GENET, V13, P1903, DOI 10.1093/hmg/ddh194
   Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17
   Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294
   WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434
   Wild PS, 2017, J CLIN INVEST, V127, P1798, DOI 10.1172/JCI84840
   Willems SM, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms16015
   Wilmore JH, 2001, MED SCI SPORT EXER, V33, P107
   Wone BWM, 2019, MITOCHONDRION, V46, P134, DOI 10.1016/j.mito.2018.04.002
   Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590
   Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4
NR 154
TC 24
Z9 24
U1 3
U2 38
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD JAN 15
PY 2022
VL 23
IS 1
BP 40
EP 54
DI 10.1038/s41576-021-00400-5
EA SEP 2021
PG 15
WC Genetics & Heredity
SC Genetics & Heredity
GA XO5FF
UT WOS:000695804900002
PM 34522035
DA 2024-11-01
ER

PT J
AU Zhao, XT
   Yu, M
   Zhao, YW
   Zheng, YM
   Meng, LC
   Du, K
   Xie, ZY
   Lv, H
   Zhang, W
   Liu, J
   Wang, QQ
   Yuan, Y
   Wang, ZX
   Deng, JW
AF Zhao, Xutong
   Yu, Meng
   Zhao, Yawen
   Zheng, Yiming
   Meng, Lingchao
   Du, Kang
   Xie, Zhiying
   Lv, He
   Zhang, Wei
   Liu, Jing
   Wang, Qingqing
   Yuan, Yun
   Wang, Zhaoxia
   Deng, Jianwen
TI Circulating cell-free mtDNA release is associated with the activation of cGAS-STING pathway and inflammation in mitochondrial diseases
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Mitochondrial diseases; Ccf-mtDNA; cGAS-STING pathway; Inflammation
ID cerebrospinal-fluid; dna; infection; biomarker; responses
AB Background There is increasing evidence for the role of inflammation in the pathogenesis of mitochondrial diseases (MDs). However, the mechanisms underlying mutation-induced inflammation in MD remain elusive. Our previous study suggested that mitophagy is impaired in the skeletal muscle of those with MD, likely causing mitochondrial DNA (mtDNA) release and thereby triggering inflammation. We here aimed to decipher the role of the cGAS-STING pathway in inflammatory process in MDs. Methods We investigated the levels of circulating cell-free mtDNA (ccf-mtDNA) in the serum of 104 patients with MDs. Immunofluorescence was performed in skeletal muscles in MDs and control. Biochemical analysis of muscle biopsies was conducted with western blot to detect cGAS, STING, TBK1, IRF3 and phosphorylated IRF3 (p-IRF3). RT-qPCR was performed to detect the downstream genes of type I interferon in skeletal muscles. Furthermore, a protein microarray was used to examine the cytokine levels in the serum of patients with MDs. Results We found that ccf-mtDNA levels were significantly increased in those with MDs compared to the controls. Consistently, the immunofluorescent results showed that cytosolic dsDNA levels were increased in the muscle samples of MD patients. Biochemical analysis of muscle biopsies showed that cGAS, IRF3, and TBK1 protein levels were significantly increased in those with MDs, indicating that there was activation of the cGAS-STING pathway. RT-qPCR showed that downstream genes of type I interferon were upregulated in muscle samples of MDs. Protein microarray results showed that a total of six cytokines associated with the cGAS-STING pathway were significantly increased in MD patients (fold change > 1.2, p value < 0.05). Conclusions These findings suggest that increases in ccf-mtDNA levels is associated with the activation of the cGAS-STING pathway, thereby triggering inflammation in MDs.
C1 [Zhao, Xutong; Yu, Meng; Zhao, Yawen; Zheng, Yiming; Meng, Lingchao; Du, Kang; Xie, Zhiying; Lv, He; Zhang, Wei; Liu, Jing; Wang, Qingqing; Yuan, Yun; Wang, Zhaoxia; Deng, Jianwen] Peking Univ First Hosp, Dept Neurol, 8 Xishiku St, Beijing 100034, Peoples R China.
   [Wang, Zhaoxia; Deng, Jianwen] Beijing Key Lab Neurovasc Dis Discovery, Beijing 100034, Peoples R China.
C3 Peking University
RP Wang, ZX; Deng, JW (corresponding author), Peking Univ First Hosp, Dept Neurol, 8 Xishiku St, Beijing 100034, Peoples R China.; Wang, ZX; Deng, JW (corresponding author), Beijing Key Lab Neurovasc Dis Discovery, Beijing 100034, Peoples R China.
EM drwangzx@163.com; jianwendeng@pkufh.com
FU National Natural Science Foundation of China [81571219, 82071409, 82171846, U20A20356]; Capital's Funds for Health Improvement and Research [2022-4-40716]
CR Arshad O, 2018, JAIDS-J ACQ IMM DEF, V78, P111, DOI 10.1097/QAI.0000000000001650
   Bai JL, 2017, P NATL ACAD SCI USA, V114, P12196, DOI 10.1073/pnas.1708744114
   Balsa E, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-16423-1
   Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921
   Barichello T, 2010, BRAIN RES BULL, V82, P302, DOI 10.1016/j.brainresbull.2010.05.012
   Blot M, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30226-x
   Borsche M, 2020, BRAIN, V143, P3041, DOI 10.1093/brain/awaa246
   Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Deng JW, 2020, BIOCHEM BIOPH RES CO, V523, P91, DOI 10.1016/j.bbrc.2019.12.005
   Denton AE, 2019, J EXP MED, V216, P621, DOI 10.1084/jem.20181216
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fang CJ, 2016, PROTEIN CELL, V7, P11, DOI 10.1007/s13238-015-0222-9
   Gambardella S, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.01064
   Gopinathan U, 2017, BMC IMMUNOL, V18, P0, DOI 10.1186/s12865-017-0229-5
   Grabosch S, 2019, ONCOGENE, V38, P2380, DOI 10.1038/s41388-018-0581-9
   Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, PD480, DOI 10.1093/nar/gkm882
   Koti M, 2019, BLADDER CANCER, V5, P225, DOI 10.3233/BLC-190228
   Lepelley A, 2021, J EXP MED, V218, P0, DOI 10.1084/jem.20201560
   Li Q, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20040895
   Liu PY, 2021, NAT CELL BIOL, V23, P355, DOI 10.1038/s41556-021-00656-3
   Mancuso M, 2013, NEUROMUSCULAR DISORD, V23, P907, DOI 10.1016/j.nmd.2013.07.011
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Mehta SR, 2017, J NEUROINFLAMM, V14, P0, DOI 10.1186/s12974-017-0848-z
   Perry EA, 2021, NAT METAB, V3, P33, DOI 10.1038/s42255-020-00334-y
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   Soustek MS, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-018-0696-5
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Trifunov S, 2021, CLIN CHEM, V67, P1113, DOI 10.1093/clinchem/hvab091
   Tsai CH, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-021-04136-2
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao HK, 2021, SIGNAL TRANSDUCT TAR, V6, P0, DOI 10.1038/s41392-021-00658-5
   Zhao J, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0128629
NR 41
TC 13
Z9 13
U1 2
U2 23
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD SEP 15
PY 2022
VL 269
IS 9
BP 4985
EP 4996
DI 10.1007/s00415-022-11146-3
EA APR 2022
PG 12
WC Clinical Neurology
SC Neurosciences & Neurology
GA 3Q4FB
UT WOS:000788980700001
PM 35486214
DA 2024-11-01
ER

PT J
AU Lamb, JA
AF Lamb, Janine A.
TI The Genetics of Autoimmune Myositis
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE myositis; idiopathic inflammatory myopathies; genetics; genetic risk factors; gene expression; pathogenesis; human leukocyte antigen
ID idiopathic inflammatory myopathy; risk; association; dermatomyositis; classification; mitochondrial; antibody; adult; men
AB The idiopathic inflammatory myopathies (IIM) are rare, heterogeneous systemic autoimmune disorders, characterized by inflammation of skeletal muscle and multi-organ involvement. Studies to identify genetic risk factors and dysregulated gene expression in IIM aim to increase our understanding of disease pathogenesis. Genome-wide association studies have confirmed the HLA region as the most strongly associated region in IIM, with different associations between clinically-defined subgroups. Associated genes are involved in both the innate and adaptive immune response, while identification of variants reported in other autoimmune disorders suggests shared biological pathways. Targeted imputation analysis has identified key associated amino acid residues within HLA molecules that may influence antigen recognition. These amino acids increase risk for specific clinical phenotypes and autoantibody subgroups, and suggest that serology-defined subgroups may be more homogeneous. Recent data support the contribution of rare genetic variation to disease susceptibility in IIM, including mitochondrial DNA variation in sporadic inclusion body myositis and somatic mutations and loss of heterozygosity in cancer-associated myositis. Gene expression studies in skeletal muscle, blood and skin from individuals with IIM has confirmed the role of interferon signalling and other dysregulated pathways, and identified cell-type specific signatures. These dysregulated genes differentiate IIM subgroups and identify potential biomarkers. Here, we review recent genetic studies in IIM, and how these inform our understanding of disease pathogenesis and provide mechanistic insights into biological pathways.
C1 [Lamb, Janine A.] Univ Manchester, Sch Hlth Sci, Epidemiol & Publ Hlth Grp, Manchester, Lancs, England.
C3 University of Manchester
RP Lamb, JA (corresponding author), Univ Manchester, Sch Hlth Sci, Epidemiol & Publ Hlth Grp, Manchester, Lancs, England.
EM Janine.Lamb@manchester.ac.uk
CR Acosta-Herrera M, 2018, ANN RHEUM DIS, V78, P0, DOI 10.1136/annrheumdis-2018-214127
   Allenbach Y, 2018, NEUROMUSCULAR DISORD, V28, P87, DOI 10.1016/j.nmd.2017.09.016
   Amici DR, 2021, ACTA NEUROPATHOL, V142, P887, DOI 10.1007/s00401-021-02365-5
   Barturen G, 2021, ARTHRITIS RHEUMATOL, V73, P1073, DOI 10.1002/art.41610
   Bianchi M, 2022, ARTHRITIS RHEUMATOL, V74, P342, DOI 10.1002/art.41929
   Burren OS, 2020, GENOME MED, V12, P0, DOI 10.1186/s13073-020-00797-4
   Che WI, 2021, ANN RHEUM DIS, V80, P1461, DOI 10.1136/annrheumdis-2021-219914
   Chen ZY, 2017, J RHEUMATOL, V44, P1389, DOI 10.3899/jrheum.170165
   Chinoy H, 2012, ANN RHEUM DIS, V71, P961, DOI 10.1136/annrheumdis-2011-200182
   Deakin CT, 2022, HUM MOL GENET, V31, P2471, DOI 10.1093/hmg/ddac019
   Dillon SP, 2012, J AUTOIMMUN, V38, PJ129, DOI 10.1016/j.jaut.2011.10.004
   Gang Q, 2016, NEUROBIOL AGING, V47, P0, DOI 10.1016/j.neurobiolaging.2016.07.024
   González-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, PD784, DOI 10.1093/nar/gku1166
   Greenberg SA, 2019, BRAIN, V142, P2590, DOI 10.1093/brain/awz207
   Güttsches AK, 2017, ANN NEUROL, V81, P227, DOI 10.1002/ana.24847
   Harris VM, 2016, CLIN IMMUNOL, V168, P25, DOI 10.1016/j.clim.2016.04.002
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, P0, DOI 10.1111/bpa.12931
   Hou C, 2021, ARTHRITIS RHEUMATOL, V73, P1044, DOI 10.1002/art.41625
   Jia XM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064683
   Joseph CG, 2014, SCIENCE, V343, P152, DOI 10.1126/science.1246886
   Kang EH, 2019, SEMIN ARTHRITIS RHEU, V49, P283, DOI 10.1016/j.semarthrit.2019.03.005
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Kim H, 2020, ARTHRITIS RES THER, V22, P0, DOI 10.1186/s13075-020-02160-9
   Kishi T, 2017, ARTHRIT CARE RES, V69, P1088, DOI 10.1002/acr.23113
   Kochi Y, 2018, ANN RHEUM DIS, V77, P602, DOI 10.1136/annrheumdis-2017-212149
   Lee-Kirsch MA, 2017, ANNU REV MED, V68, P297, DOI 10.1146/annurev-med-050715-104506
   Lenz TL, 2015, NAT GENET, V47, P1085, DOI 10.1038/ng.3379
   Liang L, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.628128
   Lintner KE, 2016, ANN RHEUM DIS, V75, P1599, DOI 10.1136/annrheumdis-2015-207762
   Lundberg IE, 2017, ANN RHEUM DIS, V76, P1955, DOI 10.1136/annrheumdis-2017-211468
   Mammen AL, 2012, ARTHRIT CARE RES, V64, P1233, DOI 10.1002/acr.21671
   Melki I, 2020, RHEUMATOLOGY, V59, P1927, DOI 10.1093/rheumatology/kez525
   Menconi F, 2010, P NATL ACAD SCI USA, V107, P16899, DOI 10.1073/pnas.1009511107
   Miller FW, 2013, ARTHRITIS RHEUM-US, V65, P3239, DOI 10.1002/art.38137
   Nishina N, 2020, RMD OPEN, V6, P0, DOI 10.1136/rmdopen-2020-001202
   Pinal-Fernandez I, 2020, ANN RHEUM DIS, V79, P1234, DOI 10.1136/annrheumdis-2019-216599
   Pinal-Fernandez I, 2019, NEUROLOGY, V93, PE1193, DOI 10.1212/WNL.0000000000008128
   Pinal-Fernandez I, 2019, ARTHRITIS RHEUMATOL, V71, P1371, DOI 10.1002/art.40883
   Pinal-Fernandez I, 2018, RHEUMATOLOGY, V57, P388, DOI 10.1093/rheumatology/kex413
   Preusse C, 2021, BRAIN PATHOL, V31, P0, DOI 10.1111/bpa.12957
   Rothwell S, 2022, MYOSITIS GENETICS CO, V0, P0
   Rothwell S, 2019, ANN RHEUM DIS, V78, P996, DOI 10.1136/annrheumdis-2019-215046
   Rothwell S, 2017, ARTHRITIS RHEUMATOL, V69, P1090, DOI 10.1002/art.40045
   Rothwell S, 2016, CURR OPIN RHEUMATOL, V28, P651, DOI 10.1097/BOR.0000000000000328
   Rothwell S, 2016, ANN RHEUM DIS, V75, P1558, DOI 10.1136/annrheumdis-2015-208119
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Schiffenbauer A, 2018, SEMIN ARTHRITIS RHEU, V48, P504, DOI 10.1016/j.semarthrit.2018.02.003
   Scofield RH, 2022, ACR OPEN RHEUMATOL, V4, P528, DOI 10.1002/acr2.11413
   Shah AA, 2015, ARTHRITIS RHEUMATOL, V67, P317, DOI 10.1002/art.38928
   Tasa T, 2019, EUR J HUM GENET, V27, P442, DOI 10.1038/s41431-018-0300-6
   Thomsen H, 2020, RHEUMATOL ADV PRACT, V4, P0, DOI 10.1093/rap/rkaa048
   Phuong TNT, 2019, RHEUMATOLOGY, V58, P361, DOI 10.1093/rheumatology/key313
   Tsoi LC, 2020, JCI INSIGHT, V5, P0, DOI 10.1172/jci.insight.139558
   Weihl CC, 2015, NEUROMUSCULAR DISORD, V25, P289, DOI 10.1016/j.nmd.2014.12.009
   Wienke J, 2020, ARTHRITIS RHEUMATOL, V72, P1214, DOI 10.1002/art.41236
   Zhang CE, 2016, J DERMATOL, V43, P1307, DOI 10.1111/1346-8138.13397
NR 57
TC 7
Z9 7
U1 1
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
EI 
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAY 26
PY 2022
VL 13
IS 
BP 
EP 
DI 10.3389/fimmu.2022.886290
PG 9
WC Immunology
SC Immunology
GA 1Y6KJ
UT WOS:000808251000001
PM 35693792
DA 2024-11-01
ER

PT J
AU Kowald, A
   Kemeth, FP
   Kirkwood, TBL
AF Kowald, Axel
   Kemeth, Felix P.
   Kirkwood, Tom B. L.
TI An explanation of how mutant and wild-type mitochondria might stably co-exist in inherited mitochondrial diseases
SO PNAS NEXUS
LA English
DT Article
DE mitochondrial disease; mathematical model; aging
ID dna deletion mutations; aged muscle-fibers; quality-control; accumulation; replication; turnover; fusion; segregation; mitophagy; fission
AB Mitochondria are cellular organelles of crucial relevance for the survival of metazoan organisms. Damage to the mitochondrial DNA can give rise to a variety of mitochondrial diseases and is thought also to be involved in the aging process. The fate of mtDNA mutants is controlled by their synthesis as well as degradation and mathematical models can help to better understand this complex interplay. We present here a model that combines a replicative advantage for mtDNA mutants with selective degradation enabled by mitochondrial fission and fusion processes. The model not only shows that the cell has efficient means to deal with (many) types of mutants but, surprisingly, also predicts that under certain conditions a stable co-existence of mutant and wild-type mtDNAs is possible. We discuss how this new finding might explain how mitochondria can be at the heart of processes with such different phenotypes as mitochondrial diseases and aging.
C1 [Kowald, Axel; Kirkwood, Tom B. L.] Newcastle Univ, UK Natl Innovat Ctr Ageing, Catalyst,3 Sci Sq, Newcastle Upon Tyne NE4 5TG, Tyne & Wear, England.
   [Kowald, Axel] Rostock Univ, Inst Biostat & Informat Med & Aging Res IBIMA, Med Ctr, D-18057 Rostock, Germany.
   [Kirkwood, Tom B. L.] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Hlthy Aging, DK-2200 Copenhagen N, Denmark.
   [Kemeth, Felix P.] Tech Univ Munich, Phys Dept, Nonequilibrium Chem Phys, James Franck Str 1, D-85748 Garching, Germany.
C3 Newcastle University - UK; University of Rostock; University of Copenhagen; Technical University of Munich
RP Kowald, A (corresponding author), Newcastle Univ, UK Natl Innovat Ctr Ageing, Catalyst,3 Sci Sq, Newcastle Upon Tyne NE4 5TG, Tyne & Wear, England.; Kowald, A (corresponding author), Rostock Univ, Inst Biostat & Informat Med & Aging Res IBIMA, Med Ctr, D-18057 Rostock, Germany.
EM Axel.Kowald@ncl.ac.uk
FU Federal Ministry of Education and Research (BMBF) of Germany [FKZ 01ZX103A]; NORDEA Foundation [02-2013-0220]; Novo Nordisk Foundation [NNF17OC00278]
CR Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Aryaman J, 2019, GENETICS, V212, P1429, DOI 10.1534/genetics.119.302423
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   Blackstone NW, 2003, GENETIC AND CULTURAL EVOLUTION OF COOPERATION, V0, P0
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Gottlieb RA, 2021, CELL MOL LIFE SCI, V78, P3791, DOI 10.1007/s00018-021-03772-3
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   HUEMER RP, 1971, EXP GERONTOL, V6, P327, DOI 10.1016/0531-5565(71)90001-5
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kowald A, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9030126
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Lawless C, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200061
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   Shi RY, 2018, TRENDS CARDIOVAS MED, V28, P246, DOI 10.1016/j.tcm.2017.11.008
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, P0, DOI 10.1371/journal.pcbi.1004183
   Tam ZY, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0076230
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
NR 39
TC 1
Z9 1
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 
EI 2752-6542
J9 PNAS NEXUS
JI PNAS Nexus
PD SEP 15
PY 2022
VL 1
IS 4
BP 
EP 
DI 10.1093/pnasnexus/pgac192
EA OCT 2022
PG 11
WC Multidisciplinary Sciences; Social Sciences, Interdisciplinary
SC Science & Technology - Other Topics; Social Sciences - Other Topics
GA R3LF2
UT WOS:001063393200057
PM 36714863
DA 2024-11-01
ER

PT J
AU Takeda, Y
   Suzuki, H
   Hosono, K
   Hikoya, A
   Komori, M
   Inagaki, R
   Haseoka, T
   Arai, S
   Takagi, Y
   Hotta, Y
   Sato, M
AF Takeda, Yu
   Suzuki, Hiroko
   Hosono, Katsuhiro
   Hikoya, Akiko
   Komori, Miwa
   Inagaki, Risako
   Haseoka, Takashi
   Arai, Shinji
   Takagi, Yuri
   Hotta, Yoshihiro
   Sato, Miho
TI Exophthalmos associated with chronic progressive external ophthalmoplegia
SO JAPANESE JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
DE Exophthalmos; Chronic progressive external ophthalmoplegia; Strabismus; Ptosis
ID extraocular-muscles; values
AB Purpose Chronic progressive external ophthalmoplegia (CPEO) is a mitochondrial disease characterized by slowly progressive ptosis and limitations in ocular motility. Although exophthalmos is not considered to be a common feature of CPEO, this study focused on the incidence of exophthalmos in patients with CPEO. Study design Retrospective observational case series Methods We reviewed the clinical charts of patients who received a diagnosis of CPEO sometime during the period between January 2010 and December 2018. CPEO was diagnosed on the basis of detection of a deletion of mitochondrial DNA (mtDNA) from saliva, buccal mucosa, or extraocular muscle specimens obtained during strabismus surgery. Horizontal MRI/CT images or Hertel ophthalmometry was used in determining exophthalmos. Results Seven patients (4 males) were identified. The mean age at diagnosis was 32.6 years (range 13-53 years). mtDNA deletion mutations were detected in the buccal mucous membrane DNA in 5 patients and in the saliva and extraocular muscle DNA in 2 patients. MRI/CT was recorded in 6 patients, four of whom showed exophthalmos (cases 1-4), and case 5 was determined as exophthalmos on the basis of a Hertel ophthalmometer reading. Exophthalmos was bilateral in 4 of the patients (cases 1, 2, 4, and 5) and unilateral in 1 patient (case 3). Exophthalmos was the chief concern of 2 of the patients; however, it was not clinically significant in the other patients. Conclusions Although exophthalmos may not be recognized by either the patient or the clinician, it may be one of the common features of CPEO. A large multiethnic study should be performed.
C1 [Takeda, Yu; Suzuki, Hiroko; Hosono, Katsuhiro; Hikoya, Akiko; Komori, Miwa; Inagaki, Risako; Haseoka, Takashi; Arai, Shinji; Takagi, Yuri; Hotta, Yoshihiro; Sato, Miho] Hamamatsu Univ, Dept Ophthalmol, Sch Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.
C3 Hamamatsu University School of Medicine
RP Sato, M (corresponding author), Hamamatsu Univ, Dept Ophthalmol, Sch Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.
EM mihosato@hama-med.ac.jp
FU Japan Society for the Promotion of Science [JP17K11479, JP16K11284, JP20K09825]
CR Brodsky MC, 2016, PEDIAT NEUROOPHTHALM, V0, P0
   Carlow TJ, 1998, AM J NEURORADIOL, V19, P95
   Chehade LK, 2017, CLIN EXP OPHTHALMOL, V45, P929, DOI 10.1111/ceo.12987
   Cohen J M, 1997, J AM OPTOM ASSOC, V68, P663
   Daut PM, 2000, AM J OPHTHALMOL, V130, P519, DOI 10.1016/S0002-9394(00)00558-4
   GROVE AS, 1975, NEW ENGL J MED, V292, P1005, DOI 10.1056/NEJM197505082921905
   Hwang JM, 2009, OPHTHALMOLOGY, V116, P813, DOI 10.1016/j.ophtha.2008.12.006
   Japan Thyroid Association the Japan Endocrine Society, 2020, TREATM GUID THYR ASS, V0, P0
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kashkouli MB, 2008, OPTOMETRY VISION SCI, V85, P1012, DOI 10.1097/OPX.0b013e3181890dc7
   Kim IT, 2001, OPHTHALMOLOGICA, V215, P156, DOI 10.1159/000050850
   Lambert S LJ, 2017, TAYLOR HOYTS PEDIATRIC OPHTHALMOLOGY AND STRABISMUS, V5th editio, P0
   Lee Andrew G, 2002, CURR NEUROL NEUROSCI REP, V2, P413, DOI 10.1007/s11910-002-0067-5
   Maeda K, 2012, INTERNAL MED, V51, P989, DOI 10.2169/internalmedicine.51.7119
   Miller N, 2004, WALSH AND HOYTS CLINICAL NEURO-OPHTHALMOLOGY, V0, P0
   Nakayama T, 1992, JPN J CLIN OPHTHAL, V46, P1031
   Ortube MC, 2006, J AAPOS, V10, P414, DOI 10.1016/j.jaapos.2006.04.012
   Pitceathly RDS, 2016, EUR RADIOL, V26, P130, DOI 10.1007/s00330-015-3801-5
   Schmidt P, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0211817
   Schoser BGH, 2006, STRABISMUS, V14, P107, DOI 10.1080/09273970600701218
   Tauber J, 2019, J AAPOS, V23, P295, DOI 10.1016/j.jaapos.2019.05.005
   Torii K, 2012, JPN J CLIN OPHTHAL, V66, P1497
   Yu-Wai-Man C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075048
NR 23
TC 0
Z9 0
U1 1
U2 2
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005, JAPAN
SN 0021-5155
EI 1613-2246
J9 JPN J OPHTHALMOL
JI Jpn. J. Ophthalmol.
PD MAY 15
PY 2022
VL 66
IS 3
BP 314
EP 319
DI 10.1007/s10384-022-00920-5
EA APR 2022
PG 6
WC Ophthalmology
SC Ophthalmology
GA 0V8UO
UT WOS:000784822200003
PM 35438395
DA 2024-11-01
ER

PT J
AU Florez, I
   Pirrone, I
   Casique, L
   Domínguez, CL
   Mahfoud, A
   Rodríguez, T
   Rodríguez, D
   De Lucca, M
   Ramírez, JL
AF Florez, Ingrid
   Pirrone, Irune
   Casique, Liliana
   Luisa Dominguez, Carmen
   Mahfoud, Antonieta
   Rodriguez, Tania
   Rodriguez, Daniel
   De Lucca, Marisel
   Luis Ramirez, Jose
TI Independent origin for m.3243A&gt;G mitochondrial mutation in three Venezuelan cases of MELAS syndrome
SO CLINICAL BIOCHEMISTRY
LA English
DT Article
DE MELAS syndrome; mtDNA; Heteroplasmy; Mitochondrial haplogroup; MT-TL1 gene; Venezuelan patients
ID a3243g mutation; different tissue; dna; mtdna; prevalence; children; loads; gene
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a multisystem and progressive neurodegenerative mitochondrial disease, caused by point nucleotide changes in the mtDNA where 80 % of cases have the mutation m.3243A>G in the MT-TL1 gene. In this work, we described the clinical, biochemical and molecular analysis of three Venezuelan patients affected with MELAS syndrome. All cases showed lactic acidosis, cortical cerebral atrophy on magnetic resonance imaging and muscular system deficit, and in two of the cases alteration of urine organic acid levels was also registered. A screening for the mutation m.3243A>G in different patients' body samples confirmed the presence of this mutation with variable degrees of heteroplasmy (blood = 7-41 %, buccal mucosa = 14-53 %, urine = 58-94 %). The mitochondrial haplogroups for the three patients were different (H, C1b, and A2), indicating an independent origin for the mutation.
C1 [Florez, Ingrid; Pirrone, Irune; Casique, Liliana; Luis Ramirez, Jose] Fdn Inst Estudios Avanzados IDEA, Biotechnol Ctr, Caracas, Venezuela.
   [Luisa Dominguez, Carmen; Mahfoud, Antonieta; Rodriguez, Tania; Rodriguez, Daniel; De Lucca, Marisel] Fdn Inst Estudios Avanzados IDEA, Biosci Ctr, Inborn Errors Metab Unit, Caracas, Venezuela.
   [De Lucca, Marisel] Univ Tecn Manabi, Fac Hlth Sci, Dept Biol Sci, Portoviejo, Ecuador.
   [Pirrone, Irune; Casique, Liliana] Univ Simon Bolivar, Dept Cell Biol, Lab Human Metab, Caracas, Venezuela.
C3 Universidad Tecnica de Manabi; Simon Bolivar University
RP De Lucca, M (corresponding author), Univ Tecn Manabi, Fac Hlth Sci, Dept Biol Sci, Portoviejo, Ecuador.; Casique, L (corresponding author), Univ Simon Bolivar, Dept Biol Celular, Lab Metab Humano, Caracas 1081A, Venezuela.
EM lcasique@usb.ve; marisel.delucca@utm.edu.ec
FU FONACIT Venezuela grant [2008001053]
CR de Guerra DC, 2012, FORENSIC SCI INT-GEN, V6, PE131, DOI 10.1016/j.fsigen.2011.11.004
   Chinnery PF, 1999, J MED GENET, V36, P425
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   Delgado-Sánchez R, 2007, REV NEUROLOGIA, V44, P18, DOI 10.33588/rn.4401.2006032
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   Firestone Chaz, 1900, V136, V0, PP409, DOI 10.1016/j.foodchem.2012.08.013
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Guevara-Campos José, 2007, INVEST. CLÍN, V48, P243
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Jacobs HT, 2000, HUM MOL GENET, V9, P463, DOI 10.1093/hmg/9.4.463
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Lander N, 2008, FORENS SCI INT-GEN S, V1, P346, DOI 10.1016/j.fsigss.2007.10.113
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Martínez H, 2007, HUM BIOL, V79, P201, DOI 10.1353/hub.2007.0032
   McMillan RP, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-42262-2
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   OCallaghan MM, 2015, MITOCHONDRION, V22, P17, DOI 10.1016/j.mito.2015.03.001
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B
   Pierron D, 2008, BMC MED GENET, V9, P0, DOI 10.1186/1471-2350-9-41
   Cataldo LR, 2013, REV MED CHILE, V141, P305, DOI 10.4067/S0034-98872013000300004
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Venegas V, 2012, METHODS MOL BIOL, V837, P327, DOI 10.1007/978-1-61779-504-6_22
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
NR 33
TC 1
Z9 1
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-9120
EI 1873-2933
J9 CLIN BIOCHEM
JI Clin. Biochem.
PD NOV-DEC 15
PY 2022
VL 109
IS 
BP 98
EP 101
DI 10.1016/j.clinbiochem.2022.09.007
EA DEC 2022
PG 4
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 7B1XG
UT WOS:000898934500016
PM 36130631
DA 2024-11-01
ER

PT J
AU Lima, T
   Li, TY
   Mottis, A
   Auwerx, J
AF Lima, Tanes
   Li, Terytty Yang
   Mottis, Adrienne
   Auwerx, Johan
TI Pleiotropic effects of mitochondria in aging
SO NATURE AGING
LA English
DT Review
ID human skeletal-muscle; high-fat diet; life-span; dna mutations; nicotinamide riboside; electron-transport; stress-response; quality-control; mouse model; complex-ii
AB Aging is typified by a progressive decline in mitochondrial activity and stress resilience. Here, we review how mitochondrial stress pathways have pleiotropic effects on cellular and systemic homeostasis, which can comprise protective or detrimental responses during aging. We describe recent evidence arguing that defects in these conserved adaptive pathways contribute to aging and age-related diseases. Signaling pathways regulating the mitochondrial unfolded protein response, mitochondrial membrane dynamics, and mitophagy are discussed, emphasizing how their failure contributes to heteroplasmy and de-regulation of key metabolites. Our current understanding of how these processes are controlled and interconnected explains how mitochondria can widely impact fundamental aspects of aging.
C1 [Lima, Tanes; Li, Terytty Yang; Mottis, Adrienne; Auwerx, Johan] Ecole Polytech Fed Lausanne EPFL, Lab Integrat Syst Physiol, Lausanne, Switzerland.
C3 Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne
RP Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne EPFL, Lab Integrat Syst Physiol, Lausanne, Switzerland.
EM admin.auwerx@epfl.ch
FU EPFL; European Research Council under the European Union [ERC-AdG-787702]; Swiss National Science Foundation [SNSF 31003A_179435]; GRL grant from the National Research Foundation of Korea [NRF 2017K1A1A2013124]; Human Frontier Science Program [LT000731/2018-L]; SAo Paulo Research Foundation [FAPESP 2019/11171-7]
CR Altay O, 2021, ADV SCI, V8, P0, DOI 10.1002/advs.202101222
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   Beck JS, 2016, CURR ALZHEIMER RES, V13, P610, DOI 10.2174/1567205013666151221145445
   Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048
   Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580
   Berendzen KM, 2016, CELL, V166, P1553, DOI 10.1016/j.cell.2016.08.042
   Bernhardt D, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep07885
   Bi R, 2015, NEUROBIOL AGING, V36, P0, DOI 10.1016/j.neurobiolaging.2014.10.009
   Bohnert KA, 2017, NATURE, V551, P629, DOI 10.1038/nature24620
   Boos F, 2019, NAT CELL BIOL, V21, P442, DOI 10.1038/s41556-019-0294-5
   Bowman A, 2016, J INVEST DERMATOL, V136, P912, DOI 10.1016/j.jid.2016.01.017
   Burbulla LF, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.103
   Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   Campbell SL, 2018, MOL CELL, V71, P398, DOI 10.1016/j.molcel.2018.07.015
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chaudhari SN, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00274-4
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264
   Chini CCS, 2020, NAT METAB, V2, P0, DOI 10.1038/s42255-020-00298-z
   Chinnery PF, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2007.048876
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110
   Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616
   Conte M, 2019, J GERONTOL A-BIOL, V74, P600, DOI 10.1093/gerona/gly153
   Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016
   Covarrubias AJ, 2020, NAT METAB, V2, P0, DOI 10.1038/s42255-020-00305-3
   Cutler RG, 2014, MECH AGEING DEV, V143, P9, DOI 10.1016/j.mad.2014.11.002
   DAmico D, 2021, TRENDS MOL MED, V27, P687, DOI 10.1016/j.molmed.2021.04.009
   DAmico D, 2019, MOL CELL, V73, P775, DOI 10.1016/j.molcel.2018.11.034
   DAmico D, 2017, TRENDS BIOCHEM SCI, V42, P712, DOI 10.1016/j.tibs.2017.05.002
   Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5
   de Picciotto NE, 2016, AGING CELL, V15, P522, DOI 10.1111/acel.12461
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   DellAgnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780
   Dulac M, 2021, J PHYSIOL-LONDON, V599, P4045, DOI 10.1113/JP281752
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Edwards CB, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0058345
   Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0
   Elhassan YS, 2019, CELL REP, V28, P1717, DOI 10.1016/j.celrep.2019.07.043
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fang EF, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-13172-8
   Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9
   Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004
   Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026
   Fasolino M, 2017, EPIGENOMICS-UK, V9, P21, DOI 10.2217/epi-2016-0084
   Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Fogarty MJ, 2020, J APPL PHYSIOL, V128, P70, DOI 10.1152/japplphysiol.00644.2019
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   Frakes AE, 2017, MOL CELL, V66, P761, DOI 10.1016/j.molcel.2017.05.031
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Gallo M, 2011, MECH AGEING DEV, V132, P515, DOI 10.1016/j.mad.2011.08.004
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Guo B, 2014, EMBO REP, V15, P705, DOI 10.1002/embr.201338310
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hansen M, 2018, NAT REV MOL CELL BIO, V19, P579, DOI 10.1038/s41580-018-0033-y
   Harrison AP, 2008, J PHYSIOL PHARMACOL, V59, P91
   Harrison DE, 2021, AGING CELL, V20, P0, DOI 10.1111/acel.13328
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015
   Herbst A, 2021, AGING CLIN EXP RES, V33, P1811, DOI 10.1007/s40520-020-01698-7
   Hirose M, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-24290-6
   Hoshino A, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3308
   Hou YJ, 2018, P NATL ACAD SCI USA, V115, PE1876, DOI 10.1073/pnas.1718819115
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Huang XH, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002493
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Imai S, 2016, NPJ AGING MECH DIS, V2, P0, DOI 10.1038/npjamd.2016.17
   Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jiang HC, 2015, P NATL ACAD SCI USA, V112, P8768, DOI 10.1073/pnas.1501831112
   Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122
   Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034
   Kandul NP, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13100
   Kang SG, 2021, ISCIENCE, V24, P0, DOI 10.1016/j.isci.2021.102181
   Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kim HE, 2016, CELL, V166, P1539, DOI 10.1016/j.cell.2016.08.027
   Kleele T, 2021, NATURE, V593, P435, DOI 10.1038/s41586-021-03510-6
   Kraus F, 2021, NATURE, V590, P57, DOI 10.1038/s41586-021-03214-x
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Kuang JJ, 2012, MITOCHONDRION, V12, P280, DOI 10.1016/j.mito.2011.10.003
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004
   Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Li TY, 2021, NATURE AGING, V1, P165, DOI 10.1038/s43587-020-00025-z
   Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4
   Lima A, 2021, NAT METAB, V3, P1091, DOI 10.1038/s42255-021-00422-7
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lisci M, 2021, SCIENCE, V374, P0, DOI 10.1126/science.abe9977
   Liu J, 2013, AGING CELL, V12, P833, DOI 10.1111/acel.12107
   Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546
   Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905
   Liu YJ, 2020, J CELL BIOL, V219, P0, DOI 10.1083/jcb.201907067
   Luan PL, 2021, SCI TRANSL MED, V13, P0, DOI 10.1126/scitranslmed.abb0319
   Ma C, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0170930
   Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788
   Maksimoska J, 2014, BIOCHEMISTRY-US, V53, P3415, DOI 10.1021/bi500380f
   Mårtensson CU, 2019, NATURE, V569, P679, DOI 10.1038/s41586-019-1227-y
   Martínez-Reyes I, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13668-3
   Martínez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002
   Matheoud D, 2019, NATURE, V571, P565, DOI 10.1038/s41586-019-1405-y
   Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039
   Mehr AP, 2018, NAT MED, V24, P1351, DOI 10.1038/s41591-018-0138-z
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012
   Migliavacca E, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-13694-1
   Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704
   Minhas PS, 2019, NAT IMMUNOL, V20, P50, DOI 10.1038/s41590-018-0255-3
   Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Molenaars M, 2020, CELL METAB, V31, P549, DOI 10.1016/j.cmet.2020.01.011
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034
   Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Ng MYW, 2021, DEV CELL, V56, P881, DOI 10.1016/j.devcel.2021.02.009
   Niemiec T, 2011, J PHYSIOL PHARMACOL, V62, P37
   Nowicki S, 2015, FEBS J, V282, P2796, DOI 10.1111/febs.13295
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13
   Patoli D, 2020, J CLIN INVEST, V130, P5858, DOI 10.1172/JCI130996
   Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022
   Pichaud N, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00130
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200
   Pinós T, 2012, AGE, V34, P227, DOI 10.1007/s11357-011-9209-5
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002
   Pulliam DA, 2014, BIOCHEM J, V462, P359, DOI 10.1042/BJ20140291
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Quirós PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Rai P, 2021, NAT IMMUNOL, V22, P312, DOI 10.1038/s41590-020-00859-0
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Rana A, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00525-4
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698
   Rodríguez-Nuevo A, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201796553
   Romani M, 2021, CELL REP, V34, P0, DOI 10.1016/j.celrep.2020.108660
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Ryu D, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aaf5504
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005
   Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059
   Schieber M, 2014, CURR BIOL, V24, PR453, DOI 10.1016/j.cub.2014.03.034
   Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003
   Schwarz C, 2018, AGING-US, V10, P19, DOI 10.18632/aging.101354
   Shahmirzadi AA, 2020, CELL METAB, V32, P447, DOI 10.1016/j.cmet.2020.08.004
   Shao LW, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-18501-w
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023
   Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143
   Spinelli JB, 2021, SCIENCE, V374, P1227, DOI 10.1126/science.abi7495
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Su Y, 2019, AGING-US, V11, P4183, DOI 10.18632/aging.102045
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Suhm T, 2018, CELL METAB, V27, P1309, DOI 10.1016/j.cmet.2018.04.011
   Sujkowski A, 2019, MITOCHONDRION, V47, P188, DOI 10.1016/j.mito.2018.11.005
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   TeSlaa T, 2016, CELL METAB, V24, P485, DOI 10.1016/j.cmet.2016.07.002
   Tian QY, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13059
   Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011
   Tischler J, 2019, EMBO J, V38, P0, DOI 10.15252/embj.201899518
   Tran MT, 2016, NATURE, V531, P528, DOI 10.1038/nature17184
   Tranah GJ, 2015, NEUROLOGY, V85, P325, DOI 10.1212/WNL.0000000000001744
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trumpff C, 2021, MITOCHONDRION, V59, P225, DOI 10.1016/j.mito.2021.04.002
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Udagawa O, 2014, CURR BIOL, V24, P2451, DOI 10.1016/j.cub.2014.08.060
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103
   Walker MA, 2020, NEW ENGL J MED, V383, P1556, DOI 10.1056/NEJMoa2001265
   Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859
   Wang XY, 2014, AGING-US, V6, P690, DOI 10.18632/aging.100687
   Wang X, 2017, MOL CELL, V68, P540, DOI 10.1016/j.molcel.2017.10.006
   Wang Y, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-19360-1
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Weidberg H, 2018, SCIENCE, V360, P0, DOI 10.1126/science.aan4146
   Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024
   Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097
   Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092
   Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951
   Wu YB, 2014, CELL, V158, P1415, DOI 10.1016/j.cell.2014.07.039
   Yamamoto T, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0098972
   Yang QY, 2022, NAT CELL BIOL, V24, P181, DOI 10.1038/s41556-021-00840-5
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yuan J, 2020, NATURE, V579, P118, DOI 10.1038/s41586-020-2037-y
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zhang HB, 2018, DEVELOPMENT, V145, P0, DOI 10.1242/dev.143420
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200
   Zhang MH, 2009, PLOS BIOL, V7, P0, DOI 10.1371/journal.pbio.1000245
   Zhang Q, 2021, NAT CELL BIOL, V23, P870, DOI 10.1038/s41556-021-00724-8
   Zhang Q, 2018, CELL, V174, P870, DOI 10.1016/j.cell.2018.06.029
   Zhang RY, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-4287-0
   Zhang WL, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.21407
   Zhang Y, 2012, ELIFE, V1, P0, DOI 10.7554/eLife.00065
   Zhang ZZ, 2021, AGING CELL, V20, P0, DOI 10.1111/acel.13291
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069
   Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057
   Zhu CT, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004354
   Zhu D, 2020, SCI ADV, V6, P0, DOI 10.1126/sciadv.abb2529
NR 255
TC 91
Z9 93
U1 13
U2 34
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 
EI 2662-8465
J9 NATURE AGING
JI Nature Aging
PD MAR 15
PY 2022
VL 2
IS 3
BP 199
EP 213
DI 10.1038/s43587-022-00191-2
PG 15
WC Cell Biology; Geriatrics & Gerontology; Neurosciences
SC Cell Biology; Geriatrics & Gerontology; Neurosciences & Neurology
GA 8A9SZ
UT WOS:000916575600010
PM 37118378
DA 2024-11-01
ER

PT J
AU Kim, D
   Kim, S
   Sung, A
   Patel, N
   Wong, N
   Conboy, MJ
   Conboy, IM
AF Kim, Daehwan
   Kim, Subin
   Sung, Ashley
   Patel, Neetika
   Wong, Nathan
   Conboy, Michael J.
   Conboy, Irina M.
TI Autologous treatment for ALS with implication for broad neuroprotection
SO TRANSLATIONAL NEURODEGENERATION
LA English
DT Article
DE Neurodegeneration; Amyotrophic lateral sclerosis; SOD1 mutation; Pluripotent stem cells; Secretome
ID mesenchymal stem-cells; amyotrophic-lateral-sclerosis; motor-neuron degeneration; hesc-secreted proteins; heat-shock-protein; oxidative stress; superoxide-dismutase; mouse model; proteomic analysis; ezh2
AB Background: Amyotrophic lateral sclerosis (ALS) is characterized by a progressive loss of motor neurons (MNs), leading to paralysis, respiratory failure and death within 2-5 years of diagnosis. The exact mechanisms of sporadic ALS, which comprises 90% of all cases, remain unknown. In familial ALS, mutations in superoxide dismutase (SOD1) cause 10% of cases. Methods: ALS patient-derived human-induced pluripotent stem cells (ALS hiPSCs, harboring the SOD1(AV4) mutation), were differentiated to MNs (ALS-MNs). The neuroprotective effects of conditioned medium (CM) of hESCs (H9), wt hiPSCs (WTC-11) and the ALS iPSCs, on MN apoptosis and viability, formation and maintenance of neurites, mitochondrial activity and expression of inflammatory genes, were examined. For in vivo studies, 200 mu l of CM from the ALS iPSCs (CS07 and CS053) was injected subcutaneously into the ALS model mice (transgenic for the human SOD1(G93A) mutation). Animal agility and strength, muscle innervation and mass, neurological score, onset of paralysis and lifespan of the ALS mice were assayed. After observing significant disease-modifying effects, the CM was characterized biochemically by fractionation, comparative proteomics, and epigenetic screens for the dependence on pluripotency. CM of fibroblasts that were differentiated from the wt hiPSCs lacked any neuroprotective activity and was used as a negative control throughout the studies. Results: The secretome of PSCs including the ALS patient iPSCs was neuroprotective in the H2O2 model. In the model with pathogenic SOD1 mutation, ALS iPSC-CM attenuated all examined hallmarks of ALS pathology, rescued human ALS-MNs from denervation and death, restored mitochondrial health, and reduced the expression of inflammatory genes. The ALS iPSC-CM also improved neuro-muscular health and function, and delayed paralysis and morbidity in ALS mice. Compared side by side, cyclosporine (CsA), a mitochondrial membrane blocker that prevents the leakage of mitochondrial DNA, failed to avert the death of ALS-MNs, although CsA and ALS iPSC-CM equally stabilized MN mitochondria and attenuated inflammatory genes. Biochemical characterization, comparative proteomics, and epigenetic screen all suggested that it was the interactome of several key proteins from different fractions of PSC-CM that delivered the multifaceted neuroprotection. Conclusions: This work introduces and mechanistically characterizes a new biologic for treating ALS and other complex neurodegenerative diseases.
C1 [Conboy, Irina M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA.
C3 University of California System; University of California Berkeley; University of California System; University of California Berkeley
RP Conboy, IM (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
EM iconboy@berkeley.edu
FU NIBIB [R01 EB023776]; NIA [R01AG071787]; NHLBI [R01 HL139605]; Open Philanthropy; Silicon Valley Community Foundation; Foster Foundation; San Francisco Foundation; Georges' Harik Foundation; Donors'Trust grants; National Heart Lung and Blood Institute [R01HL139605] Funding Source: NIH RePORTER
CR Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x
   Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200
   Alves CJ, 2011, BRAIN RES, V1394, P90, DOI 10.1016/j.brainres.2011.02.060
   Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027
   Aoyama K, 2013, INT J MOL SCI, V14, P21021, DOI 10.3390/ijms141021021
   Aparicio-Erriu IM, 2012, FRONT NEUROSCI-SWITZ, V6, P0, DOI 10.3389/fnins.2012.00167
   Ari C, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0103526
   Ashutosh, 2012, CELL DEATH DIS, V3, P0, DOI 10.1038/cddis.2012.54
   Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019
   Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008
   Basu J, 2016, EXPERT OPIN BIOL TH, V16, P489, DOI 10.1517/14712598.2016.1131976
   Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086
   Boland MJ, 2014, CIRC RES, V115, P311, DOI 10.1161/CIRCRESAHA.115.301517
   Bruneteau G, 2015, ANN CLIN TRANSL NEUR, V2, P362, DOI 10.1002/acn3.179
   Cai M, 2015, TOXINS, V7, P846, DOI 10.3390/toxins7030846
   Cappello V, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18102092
   Check W A, 1979, JAMA, V242, P319, DOI 10.1001/jama.242.4.319
   Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004
   Chen YT, 2019, STEM CELL RES THER, V10, P0, DOI 10.1186/s13287-019-1491-7
   Clark JA, 2016, J CHEM NEUROANAT, V76, P35, DOI 10.1016/j.jchemneu.2016.03.003
   Collinson A, 2016, CELL REP, V17, P2700, DOI 10.1016/j.celrep.2016.11.032
   Comley L, 2015, NEUROSCIENCE, V291, P216, DOI 10.1016/j.neuroscience.2015.02.013
   Dahbour S, 2017, CNS NEUROSCI THER, V23, P866, DOI 10.1111/cns.12759
   Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230
   Douvaras P, 2014, STEM CELL REP, V3, P250, DOI 10.1016/j.stemcr.2014.06.012
   Duffy LM, 2011, NEUROPATH APPL NEURO, V37, P336, DOI 10.1111/j.1365-2990.2011.01166.x
   Fletcher L, 2013, BMC NEUROSCI, V14, P0, DOI 10.1186/1471-2202-14-158
   Fontanilla CV, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep16953
   Fujimori K, 2018, NAT MED, V24, P1579, DOI 10.1038/s41591-018-0140-5
   Fukuoka H, 2012, AM J COSMETIC SURG, V29, P273, DOI 10.5992/AJCS-D-12-00015.1
   Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c
   Gorecka J, 2019, STEM CELL RES THER, V10, P0, DOI 10.1186/s13287-019-1185-1
   Guerrero EN, 2019, HUM MOL GENET, V28, P2459, DOI 10.1093/hmg/ddz062
   Guo YL, 2010, STEM CELLS DEV, V19, P1321, DOI 10.1089/scd.2009.0313
   GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258
   Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471
   Haenggeli C, 2007, NEUROBIOL DIS, V26, P146, DOI 10.1016/j.nbd.2006.12.013
   Hatzipetros T, 2015, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/53257
   Herrera-Merchan A, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms1623
   Hilkens P, 2014, STEM CELL RES, V12, P778, DOI 10.1016/j.scr.2014.03.008
   Huang JY, 2009, J NEUROCHEM, V109, P1400, DOI 10.1111/j.1471-4159.2009.06061.x
   Huang QR, 2017, BLOOD, V129, P2737, DOI 10.1182/blood-2016-08-735886
   Huang WJ, 2016, BIOMED REP, V4, P519, DOI 10.3892/br.2016.630
   Huynh H, 2011, BLOOD, V118, P3236, DOI 10.1182/blood-2011-01-331876
   Inoue H, 2003, EMBO J, V22, P6665, DOI 10.1093/emboj/cdg634
   Jang SE, 2020, FRONT NEUROSCI-SWITZ, V14, P0, DOI 10.3389/fnins.2020.558532
   Jiang H, 2014, EXP NEUROL, V261, P245, DOI 10.1016/j.expneurol.2014.05.013
   Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997
   Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008
   Kay AG, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-18144-w
   Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008
   Kim HS, 2012, J PROTEOME RES, V11, P839, DOI 10.1021/pr200682z
   Kosacka J, 2005, CELL TISSUE RES, V320, P11, DOI 10.1007/s00441-004-1068-2
   Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559
   Lee YC, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18091986
   Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335
   Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048
   Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590
   Metsalu T, 2015, NUCLEIC ACIDS RES, V43, PW566, DOI 10.1093/nar/gkv468
   Migita T, 2010, AM J PATHOL, V176, P1756, DOI 10.2353/ajpath.2010.090500
   Moore HM, 2013, BREAST CANCER RES TR, V138, P741, DOI 10.1007/s10549-013-2498-x
   OCarroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001
   Patel P, 2014, MOL THER, V22, P498, DOI 10.1038/mt.2013.239
   Patel YJK, 2005, MOL BRAIN RES, V134, P256, DOI 10.1016/j.molbrainres.2004.10.028
   Pawitan JA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/965849
   Pedersen WA, 2000, FASEB J, V14, P913, DOI 10.1096/fasebj.14.7.913
   Pires AO, 2016, STEM CELLS DEV, V25, P1073, DOI 10.1089/scd.2016.0048
   Pizurki L, 2003, BRIT J PHARMACOL, V139, P329, DOI 10.1038/sj.bjp.0705259
   Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653
   Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110
   Qu QH, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4449
   Rabinovich-Toidman P, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0143420
   Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200
   Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, P0, DOI 10.3389/fncel.2013.00253
   Sagaradze G, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20071656
   Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x
   Sathasivam S, 2005, LANCET NEUROL, V4, P500, DOI 10.1016/S1474-4422(05)70142-3
   Sebastià J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52
   Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121
   Smith EF, 2019, NEUROSCI LETT, V710, P0, DOI 10.1016/j.neulet.2017.06.052
   Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019
   Song CG, 2018, NEURAL REGEN RES, V13, P1294, DOI 10.4103/1673-5374.235085
   Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991
   Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004
   Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290
   Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095
   Sultani Masooma, 2012, CHEMOTHER RES PRACT, V2012, P490804, DOI 10.1155/2012/490804
   Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, PH886, DOI 10.1152/ajpheart.00142.2006
   Tarng DC, 2016, CELL TRANSPLANT, V25, P517, DOI 10.3727/096368915X688542
   Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI 10.1089/neu.2009.0959
   Tóth ME, 2013, CELL STRESS CHAPERON, V18, P759, DOI 10.1007/s12192-013-0428-9
   Toth ME, 2010, CELL STRESS CHAPERON, V15, P807, DOI 10.1007/s12192-010-0188-8
   Tucker BA, 2013, ELIFE, V2, P0, DOI 10.7554/eLife.00824
   Venugopal A, 2019, EGYPTIAN J MED HUMAN, V20, P0, DOI 10.1186/s43042-019-0023-4
   Verghese PB, 2013, P NATL ACAD SCI USA, V110, PE1807, DOI 10.1073/pnas.1220484110
   Wang JM, 2019, BRAIN SCI, V9, P0, DOI 10.3390/brainsci9070165
   Wang YJ, 2015, INT J CARDIOL, V192, P61, DOI 10.1016/j.ijcard.2015.05.020
   Weeks SD, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-017-18874-x
   Xiang J, 2017, NEUROSCI LETT, V644, P62, DOI 10.1016/j.neulet.2017.02.040
   Yamashita T, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-74216-4
   Yang DY, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054495
   Yao YZ, 2016, GENES-BASEL, V7, P0, DOI 10.3390/genes7100083
   Yin J, 2019, NEUROSCIENCE, V411, P177, DOI 10.1016/j.neuroscience.2019.05.038
   Yousef H, 2014, AGING-US, V6, P602, DOI 10.18632/aging.100659
   Yousef H, 2013, AGING-US, V5, P357, DOI 10.18632/aging.100559
   Yu AL, 2008, INVEST OPHTH VIS SCI, V49, P5403, DOI 10.1167/iovs.07-1478
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zakrzewski W, 2019, STEM CELL RES THER, V10, P0, DOI 10.1186/s13287-019-1165-5
   Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401
   Zhao QC, 2015, BRAIN RES, V1624, P489, DOI 10.1016/j.brainres.2015.08.003
   Zhou BR, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/519126
   Zhou S, 2013, FEBS LETT, V587, P254, DOI 10.1016/j.febslet.2012.12.003
   Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71
NR 113
TC 2
Z9 3
U1 1
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2047-9158
EI 
J9 TRANSL NEURODEGENER
JI Transl. Neurodegener.
PD MAR 11
PY 2022
VL 11
IS 1
BP 
EP 
DI 10.1186/s40035-022-00290-5
PG 19
WC Neurosciences
SC Neurosciences & Neurology
GA ZQ6IE
UT WOS:000767205600001
PM 35272709
DA 2024-11-01
ER

PT J
AU Hedberg-Oldfors, C
   Lindgren, U
   Visuttijai, K
   Lööf, D
   Roos, S
   Thomsen, C
   Oldfors, A
AF Hedberg-Oldfors, Carola
   Lindgren, Ulrika
   Visuttijai, Kittichate
   Loof, Daniel
   Roos, Sara
   Thomsen, Christer
   Oldfors, Anders
TI Respiratory chain dysfunction in perifascicular muscle fibres in patients with dermatomyositis is associated with mitochondrial DNA depletion
SO NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
LA English
DT Article
DE dermatomyositis; inflammatory myopathy; mitochondria; mitochondrial DNA; oxidative phosphorylation; respiratory chain
ID maintenance; classification; abnormality; pathology; deletions
AB Aims Patients with dermatomyositis (DM) suffer from reduced aerobic metabolism contributing to impaired muscle function, which has been linked to cytochrome c oxidase (COX) deficiency in muscle tissue. This mitochondrial respiratory chain dysfunction is typically seen in perifascicular regions, which also show the most intense inflammatory reaction along with capillary loss and muscle fibre atrophy. The objective of this study was to investigate the pathobiology of the oxidative phosphorylation deficiency in DM. Methods Muscle biopsy specimens with perifascicular COX deficiency from five juveniles and seven adults with DM were investigated. We combined immunohistochemical analyses of subunits in the respiratory chain including complex I (subunit NDUFB8), complex II (succinate dehydrogenase, subunit SDHB) and complex IV (COX, subunit MTCO1) with in situ hybridisation, next generation deep sequencing and quantitative polymerase chain reaction (PCR). Results There was a profound deficiency of complexes I and IV in the perifascicular regions with enzyme histochemical COX deficiency, whereas succinate dehydrogenase activity and complex II were preserved. In situ hybridisation of mitochondrial RNA showed depletion of mitochondrial DNA (mtDNA) transcripts in the perifascicular regions. Analysis of mtDNA by next generation deep sequencing and quantitative PCR in affected muscle regions showed an overall reduction of mtDNA copy number particularly in the perifascicular regions. Conclusion The respiratory chain dysfunction in DM muscle is associated with mtDNA depletion causing deficiency of complexes I and IV, which are partially encoded by mtDNA, whereas complex II, which is entirely encoded by nuclear DNA, is preserved. The depletion of mtDNA indicates a perturbed replication of mtDNA explaining the muscle pathology and the disturbed aerobic metabolism.
C1 [Hedberg-Oldfors, Carola; Lindgren, Ulrika; Visuttijai, Kittichate; Loof, Daniel; Roos, Sara; Thomsen, Christer; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Lab Med, Gothenburg, Sweden.
   [Lindgren, Ulrika] Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital
RP Oldfors, A (corresponding author), Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden.
EM anders.oldfors@gu.se
FU Vetenskapsradet
CR Alhatou MI, 2004, J MOL HISTOL, V35, P615
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163
   Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225
   De Paepe B, 2017, ANN TRANSL MED, V5, P0, DOI 10.21037/atm.2016.12.68
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Dubowitz V, 2007, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, P0, DOI 10.1111/bpa.12931
   Lahoria R, 2016, BRAIN, V139, P1891, DOI 10.1093/brain/aww122
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   Lundberg IE, 2018, NAT REV RHEUMATOL, V14, P269, DOI 10.1038/nrrheum.2018.41
   Maiuri AR, 2018, CANCER METAB, V6, P0, DOI 10.1186/s40170-018-0182-7
   Mammen AL, 2020, NEUROMUSCULAR DISORD, V30, P70, DOI 10.1016/j.nmd.2019.10.005
   Mariampillai K, 2018, JAMA NEUROL, V75, P1528, DOI 10.1001/jamaneurol.2018.2598
   Meyer A, 2017, ACTA NEUROPATHOL, V134, P655, DOI 10.1007/s00401-017-1731-9
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Roos S, 2014, NEUROMUSCULAR DISORD, V24, P713, DOI 10.1016/j.nmd.2014.05.009
   Roos S, 2022, BRAIN PATHOL, V32, P0, DOI 10.1111/bpa.13038
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Varadhachary AS, 2010, CURR OPIN RHEUMATOL, V22, P651, DOI 10.1097/BOR.0b013e32833f108a
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wiesinger GF, 2000, ARCH PHYS MED REHAB, V81, P1, DOI 10.1016/S0003-9993(00)90212-0
   WOO M, 1988, J NEUROL SCI, V88, P133, DOI 10.1016/0022-510X(88)90211-0
   Zhong DL, 2020, PEERJ, V8, P0, DOI 10.7717/peerj.8611
NR 31
TC 9
Z9 9
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1846
EI 1365-2990
J9 NEUROPATH APPL NEURO
JI Neuropathol. Appl. Neurobiol.
PD DEC 15
PY 2022
VL 48
IS 7
BP 
EP 
DI 10.1111/nan.12841
EA AUG 2022
PG 10
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 5W2ED
UT WOS:000836877300001
PM 35894812
DA 2024-11-01
ER

PT J
AU Sanchez-Contreras, M
   Kennedy, SR
AF Sanchez-Contreras, Monica
   Kennedy, Scott R.
TI The Complicated Nature of Somatic mtDNA Mutations in Aging
SO FRONTIERS IN AGING
LA English
DT Review
DE mtDNA; somatic mutations; aging; mitochondria; mutagenesis; sequencing
ID mitochondrial-dna mutations; genome-wide expression; base excision-repair; aged muscle-fibers; polymerase-gamma; point mutations; skeletal-muscle; deletion mutations; oxidative damage; copy-number
AB Mitochondria are the main source of energy used to maintain cellular homeostasis. This aspect of mitochondrial biology underlies their putative role in age-associated tissue dysfunction. Proper functioning of the electron transport chain (ETC), which is partially encoded by the extra-nuclear mitochondrial genome (mtDNA), is key to maintaining this energy production. The acquisition of de novo somatic mutations that interrupt the function of the ETC have long been associated with aging and common diseases of the elderly. Yet, despite over 30 years of study, the exact role(s) mtDNA mutations play in driving aging and its associated pathologies remains under considerable debate. Furthermore, even fundamental aspects of age-related mtDNA mutagenesis, such as when mutations arise during aging, where and how often they occur across tissues, and the specific mechanisms that give rise to them, remain poorly understood. In this review, we address the current understanding of the somatic mtDNA mutations, with an emphasis of when, where, and how these mutations arise during aging. Additionally, we highlight current limitations in our knowledge and critically evaluate the controversies stemming from these limitations. Lastly, we highlight new and emerging technologies that offer potential ways forward in increasing our understanding of somatic mtDNA mutagenesis in the aging process.
C1 [Sanchez-Contreras, Monica; Kennedy, Scott R.] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA.
C3 University of Washington; University of Washington Seattle
RP Kennedy, SR (corresponding author), Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA.
EM scottrk@uw.edu
FU We would like to acknowledge the following agencies/awards for supporting this manuscript R21DK128540 to MS-C; R21HG011229, 1R21CA259780, and W81XWH-16-1-0579 to SK. [R21DK128540, R21HG011229, 1R21CA259780, W81XWH-16-1-0579]; National Cancer Institute [R21CA259780] Funding Source: NIH RePORTER
CR Abascal F, 2021, NATURE, V593, P405, DOI 10.1038/s41586-021-03477-4
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Anderson AP, 2020, NUCLEIC ACIDS RES, V48, P817, DOI 10.1093/nar/gkz1018
   Andreazza S, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-10857-y
   Arbeithuber B, 2020, PLOS BIOL, V18, P0, DOI 10.1371/journal.pbio.3000745
   Atilano SR, 2021, PLOS ONE, V16, P0, DOI 10.1371/journal.pone.0246114
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Baker KT, 2019, MOL CANCER RES, V17, P488, DOI 10.1158/1541-7786.MCR-18-0520
   Bebenek A, 2018, CURR GENET, V64, P985, DOI 10.1007/s00294-018-0820-1
   Belle EMS, 2005, GENE, V355, P58, DOI 10.1016/j.gene.2005.05.019
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751
   Bratic A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9808
   BROSSAS JY, 1994, BIOCHEM BIOPH RES CO, V202, P654, DOI 10.1006/bbrc.1994.1980
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Broz AK, 2021, GENETICS, V218, P0, DOI 10.1093/genetics/iyab039
   Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Castellani CA, 2020, MITOCHONDRION, V53, P214, DOI 10.1016/j.mito.2020.06.004
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   Chocron ES, 2019, BBA-MOL BASIS DIS, V1865, P285, DOI 10.1016/j.bbadis.2018.09.035
   Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Cocco T, 2005, FREE RADICAL BIO MED, V38, P796, DOI 10.1016/j.freeradbiomed.2004.11.034
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cottrell D A, 2000, CURR OPIN CLIN NUTR METAB CARE, V3, P473, DOI 10.1097/00075197-200011000-00009
   Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Degtyareva NP, 2019, PLOS BIOL, V17, P0, DOI 10.1371/journal.pbio.3000263
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Fazal FM, 2019, CELL, V178, P473, DOI 10.1016/j.cell.2019.05.027
   FEIG DI, 1994, P NATL ACAD SCI USA, V91, P6609, DOI 10.1073/pnas.91.14.6609
   Fellous TG, 2009, STEM CELLS, V27, P1410, DOI 10.1002/stem.67
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Foury F, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027847
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k
   Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179
   Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x
   Gray MW, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011403
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Grimm A, 2017, J NEUROCHEM, V143, P418, DOI 10.1111/jnc.14037
   Gyllborg D, 2020, NUCLEIC ACIDS RES, V48, P0, DOI 10.1093/nar/gkaa792
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Haroon S, 2018, CELL REP, V22, P3115, DOI 10.1016/j.celrep.2018.02.099
   Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6
   Hebert SL, 2010, MECH AGEING DEV, V131, P451, DOI 10.1016/j.mad.2010.03.007
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hoekstra JG, 2016, ANN NEUROL, V80, P301, DOI 10.1002/ana.24709
   Itsara LS, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1003974
   KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kauppila TES, 2018, P NATL ACAD SCI USA, V115, PE9620, DOI 10.1073/pnas.1721683115
   Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kenney MC, 2010, INVEST OPHTH VIS SCI, V51, P4289, DOI 10.1167/iovs.09-4778
   Kent JA, 2016, J APPL PHYSIOL, V121, P996, DOI 10.1152/japplphysiol.00583.2016
   Khrapko K, 2004, ANN NY ACAD SCI, V1019, P240, DOI 10.1196/annals.1297.040
   Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044
   Komakula SSB, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-33151-1
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kowaltowski AJ, 2000, BRAZ J MED BIOL RES, V33, P241, DOI 10.1590/S0100-879X2000000200014
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2009, METHODS MOL BIOL, V554, P329, DOI 10.1007/978-1-59745-521-3_21
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukreja L, 2014, MOL NEURODEGENER, V9, P0, DOI 10.1186/1750-1326-9-16
   KUNKEL TA, 1986, J BIOL CHEM, V261, P160
   Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200
   Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu Danhui, 2013, FRONT BIOSCI (ELITE ED), V5, P734
   Loh E, 2007, J BIOL CHEM, V282, P12201, DOI 10.1074/jbc.M611294200
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Lujan SA, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-02138-5
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Ma B, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep22375
   Ma H, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0201304
   Macao B, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8303
   Macken WL, 2021, NAT REV NEUROL, V17, P215, DOI 10.1038/s41582-021-00455-2
   Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002
   Maeda R, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-67686-z
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Martínez-Azorín F, 2008, J NEUROCHEM, V105, P165, DOI 10.1111/j.1471-4159.2007.05122.x
   Matam K, 2014, MOL GENET GENOMICS, V289, P533, DOI 10.1007/s00438-014-0828-2
   Matic S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03552-x
   Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067
   MIQUEL J, 1992, MUTAT RES, V275, P209, DOI 10.1016/0921-8734(92)90024-J
   Moore L, 2021, NATURE, V597, P381, DOI 10.1038/s41586-021-03822-7
   Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807
   Navin NE, 2015, GENOME RES, V25, P1499, DOI 10.1101/gr.191098.115
   Nissanka N, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04895-1
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, P0, DOI 10.1007/s11910-018-0829-3
   Payne Brendan A I, 2015, METHODS MOL BIOL, V1264, P67, DOI 10.1007/978-1-4939-2257-4_7
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231
   Pouget JP, 2002, RADIAT RES, V157, P589, DOI 10.1667/0033-7587(2002)157[0589:FOMDBI]2.0.CO;2
   Prakash A, 2015, J CELL BIOCHEM, V116, P1490, DOI 10.1002/jcb.25103
   Preissl S, 2018, NAT NEUROSCI, V21, P432, DOI 10.1038/s41593-018-0079-3
   PURMAL AA, 1994, NUCLEIC ACIDS RES, V22, P72, DOI 10.1093/nar/22.1.72
   Rinke C, 2014, NAT PROTOC, V9, P1038, DOI 10.1038/nprot.2014.067
   Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219
   Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383
   Salk JJ, 2018, NAT REV GENET, V19, P269, DOI 10.1038/nrg.2017.117
   Sampath H, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0051697
   Samstag CL, 2018, PLOS GENET, V14, P0, DOI 10.1371/journal.pgen.1007805
   Sanchez-Contreras M, 2021, NUCLEIC ACIDS RES, V49, P11103, DOI 10.1093/nar/gkab901
   Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Sevini F, 2014, EXP GERONTOL, V56, P234, DOI 10.1016/j.exger.2014.03.022
   Shah VO, 2009, GENET MED, V11, P147, DOI 10.1097/GIM.0b013e31819307a2
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Smith ALM, 2020, NAT CANCER, V1, P976, DOI 10.1038/s43018-020-00112-5
   Soltys DT, 2019, NEUROBIOL AGING, V73, P161, DOI 10.1016/j.neurobiolaging.2018.09.015
   Srivatsan SR, 2021, SCIENCE, V373, P111, DOI 10.1126/science.abb9536
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stickels RR, 2021, NAT BIOTECHNOL, V39, P313, DOI 10.1038/s41587-020-0739-1
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Szczepanowska K, 2017, ESSAYS BIOCHEM, V61, P325, DOI 10.1042/EBC20160090
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   Vecoli C, 2020, MUTAT RES-REV MUTAT, V784, P0, DOI 10.1016/j.mrrev.2020.108309
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2009, CELL METAB, V10, P437, DOI 10.1016/j.cmet.2009.11.001
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Vitak SA, 2017, NAT METHODS, V14, P302, DOI 10.1038/NMETH.4154
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang YQ, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2014610118
   Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   Williams SL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003990
   Wu ZQ, 2020, P NATL ACAD SCI USA, V117, P16448, DOI 10.1073/pnas.2001998117
   Xu J, 2019, ELIFE, V8, P0, DOI 10.7554/eLife.45105
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
   Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164
NR 170
TC 22
Z9 23
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 2673-6217
J9 FRONT AGING-LAUSANNE
JI Front. Aging
PD JAN 10
PY 2022
VL 2
IS 
BP 
EP 
DI 10.3389/fragi.2021.805126
PG 16
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA U8YD7
UT WOS:001087592200001
PM 35252966
DA 2024-11-01
ER

PT J
AU Tolomeo, M
   Chimienti, G
   Lanza, M
   Barbaro, R
   Nisco, A
   Latronico, T
   Leone, P
   Petrosillo, G
   Liuzzi, GM
   Ryder, B
   Inbar-Feigenberg, M
   Colella, M
   Lezza, AMS
   Olsen, RKJ
   Barile, M
AF Tolomeo, Maria
   Chimienti, Guglielmina
   Lanza, Martina
   Barbaro, Roberto
   Nisco, Alessia
   Latronico, Tiziana
   Leone, Piero
   Petrosillo, Giuseppe
   Liuzzi, Grazia Maria
   Ryder, Bryony
   Inbar-Feigenberg, Michal
   Colella, Matilde
   Lezza, Angela M. S.
   Olsen, Rikke K. J.
   Barile, Maria
TI Retrograde response to mitochondrial dysfunctions associated to LOF variations in <i>FLAD1</i> exon 2: unraveling the importance of RFVT2
SO FREE RADICAL RESEARCH
LA English
DT Article
DE FLAD1; LSMFLAD; MADD; RFVT2; mitochondrial myopathy
ID acyl-coa dehydrogenase; fad synthase; over-expression; riboflavin; mutations; patient; transcription; homeostasis; deficiency
AB Flavin adenine dinucleotide (FAD) synthase (EC 2.7.7.2), encoded by human flavin adenine dinucleotide synthetase 1 (FLAD1), catalyzes the last step of the pathway converting riboflavin (Rf) into FAD. FLAD1 variations were identified as a cause of LSMFLAD (lipid storage myopathy due to FAD synthase deficiency, OMIM #255100), resembling Multiple Acyl-CoA Dehydrogenase Deficiency, sometimes treatable with high doses of Rf; no alternative therapeutic strategies are available. We describe here cell morphological and mitochondrial alterations in dermal fibroblasts derived from a LSMFLAD patient carrying a homozygous truncating FLAD1 variant (c.745C > T) in exon 2. Despite a severe decrease in FAD synthesis rate, the patient had decreased cellular levels of Rf and flavin mononucleotide and responded to Rf treatment.We hypothesized that disturbed flavin homeostasis and Rf-responsiveness could be due to a secondary impairment in the expression of the Rf transporter 2 (RFVT2), encoded by SLC52A2, in the frame of an adaptive retrograde signaling to mitochondrial dysfunction. Interestingly, an antioxidant response element (ARE) is found in the region upstream of the transcriptional start site of SLC52A2. Accordingly, we found that abnormal mitochondrial morphology and impairments in bioenergetics were accompanied by increased cellular reactive oxygen species content and mtDNA oxidative damage. Concomitantly, an active response to mitochondrial stress is suggested by increased levels of PPAR gamma-co-activator-1 alpha and Peroxiredoxin III. In this scenario, the treatment with high doses of Rf might compensate for the secondary RFVT2 molecular defect, providing a molecular rationale for the Rf responsiveness in patients with loss of function variants in FLAD1 exon 2.
C1 [Tolomeo, Maria; Chimienti, Guglielmina; Lanza, Martina; Barbaro, Roberto; Nisco, Alessia; Latronico, Tiziana; Leone, Piero; Liuzzi, Grazia Maria; Colella, Matilde; Lezza, Angela M. S.; Barile, Maria] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Environm, Bari, Italy.
   [Tolomeo, Maria] Univ Calabria, Dept DiBEST Biol Ecol & Sci Terra, Arcavacata di Rende, Italy.
   [Petrosillo, Giuseppe] Natl Res Council CNR, Inst Biomembranes Bioenerget & Mol Biotechnol IBIO, Bari, Italy.
   [Ryder, Bryony] Starship Childrens Hosp, Natl Metab Serv, Auckland, New Zealand.
   [Inbar-Feigenberg, Michal] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON, Canada.
   [Olsen, Rikke K. J.] Aarhus Univ, Dept Clin Med, Res Unit Mol Med, Aarhus, Denmark.
   [Olsen, Rikke K. J.] Aarhus Univ Hosp, Aarhus, Denmark.
C3 Universita degli Studi di Bari Aldo Moro; University of Calabria; Starship Children's Hospital; University of Toronto; Hospital for Sick Children (SickKids); Aarhus University; Aarhus University
RP Barile, M (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Environm, Bari, Italy.
EM maria.barile@uniba.it
CR Barile M, 2016, J INHERIT METAB DIS, V39, P545, DOI 10.1007/s10545-016-9950-0
   Bosch AM, 2011, J INHERIT METAB DIS, V34, P159, DOI 10.1007/s10545-010-9242-z
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brizio C, 2006, BIOCHEM BIOPH RES CO, V344, P1008, DOI 10.1016/j.bbrc.2006.04.003
   Bruni F, 2012, MITOCHONDRION, V12, P492, DOI 10.1016/j.mito.2012.06.010
   Capriglia F, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11070674
   Chimienti G, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12091439
   Chimienti G, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22041665
   Chimienti G, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20133302
   Chimienti G, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20102601
   Chimienti G, 2018, FREE RADICAL BIO MED, V124, P447, DOI 10.1016/j.freeradbiomed.2018.06.041
   Coppi L, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22136913
   Cornelius N, 2012, HUM MOL GENET, V21, P3435, DOI 10.1093/hmg/dds175
   Di Bari G, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0129322
   Frerman FE, 2001, METABOLIC MOL BASIS, V0, P2357
   García-Villoria J, 2018, CLIN GENET, V94, P592, DOI 10.1111/cge.13452
   Gerbino A, 2012, CELL CALCIUM, V51, P393, DOI 10.1016/j.ceca.2012.01.002
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Giancaspero TA, 2008, FEBS J, V275, P1103, DOI 10.1111/j.1742-4658.2008.06270.x
   Giancaspero TA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/101286
   Giancaspero TA, 2013, J BIOL CHEM, V288, P29069, DOI 10.1074/jbc.M113.500066
   Green P, 2010, AM J HUM GENET, V86, P485, DOI 10.1016/j.ajhg.2010.02.006
   GREGERSEN N, 1982, PEDIATR RES, V16, P861, DOI 10.1203/00006450-198210000-00012
   Grünert SC, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0117-5
   Hellebrekers DM, 2017, EUR J HUM GENET, V25, P886, DOI 10.1038/ejhg.2017.62
   Henriques BJ, 2009, J BIOL CHEM, V284, P4222, DOI 10.1074/jbc.M805719200
   Ho G, 2011, HUM MUTAT, V32, PE1976, DOI 10.1002/humu.21399
   Horvath R, 2012, J INHERIT METAB DIS, V35, P679, DOI 10.1007/s10545-011-9434-1
   Kogot-Levin A, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0165417
   Latronico T, 2021, INFLAMMOPHARMACOLOGY, V29, P561, DOI 10.1007/s10787-020-00772-w
   Latronico T, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0153451
   Lee YJ, 2021, NEUROMUSCULAR DISORD, V31, P1194, DOI 10.1016/j.nmd.2021.07.006
   Leone P, 2022, IUBMB LIFE, V74, P672, DOI 10.1002/iub.2553
   Leone P, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20246203
   Leone P, 2019, INT J BIOL MACROMOL, V138, P986, DOI 10.1016/j.ijbiomac.2019.07.138
   Leone P, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23010116
   Liuzzi VC, 2012, BBA-GEN SUBJECTS, V1820, P521, DOI 10.1016/j.bbagen.2012.01.012
   Miccolis A, 2012, INT J MOL SCI, V13, P16880, DOI 10.3390/ijms131216880
   Mosegaard S, 2017, MOL GENET METAB, V122, P182, DOI 10.1016/j.ymgme.2017.10.014
   Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135
   Olsen RKJ, 2016, AM J HUM GENET, V98, P1130, DOI 10.1016/j.ajhg.2016.04.006
   Olsen RKJ, 2015, J INHERIT METAB DIS, V38, P703, DOI 10.1007/s10545-015-9861-5
   Pastukh VM, 2016, FREE RADICAL BIO MED, V96, P78, DOI 10.1016/j.freeradbiomed.2016.04.011
   Picca A, 2018, EUR J CLIN INVEST, V48, P0, DOI 10.1111/eci.12877
   Picca A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074644
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   Ryder B, 2019, JIMD REP, V45, P37, DOI 10.1007/8904_2018_139
   Ryoo IG, 2018, TOXICOL APPL PHARM, V359, P24, DOI 10.1016/j.taap.2018.09.014
   Schiff M, 2016, NEW ENGL J MED, V374, P795, DOI 10.1056/NEJMc1513610
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Tolomeo M, 2021, METHODS MOL BIOL, V2280, P275, DOI 10.1007/978-1-0716-1286-6_18
   Tolomeo M, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21155310
   Torchetti EM, 2011, FEBS J, V278, P4435, DOI 10.1111/j.1742-4658.2011.08368.x
   Torchetti EM, 2010, MITOCHONDRION, V10, P263, DOI 10.1016/j.mito.2009.12.149
   Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392
   Vengalil S, 2022, ANN INDIAN ACAD NEUR, V25, P106, DOI 10.4103/aian.aian_333_21
   Wen B, 2022, HUM MOL GENET, V31, P1115, DOI 10.1093/hmg/ddab308
   Yamada K, 2019, BRAIN DEV-JPN, V41, P638, DOI 10.1016/j.braindev.2019.04.002
   Zhang YR, 2020, REDOX BIOL, V28, P0, DOI 10.1016/j.redox.2019.101365
NR 59
TC 3
Z9 4
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PD AUG 3
PY 2022
VL 56
IS 7-8
BP 511
EP 525
DI 10.1080/10715762.2022.2146501
EA DEC 2022
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 8O1FQ
UT WOS:000894297000001
PM 36480241
DA 2024-11-01
ER

PT J
AU Chiaratti, MR
   Chinnery, PF
AF Chiaratti, Marcos R.
   Chinnery, Patrick F.
TI Modulating mitochondrial DNA mutations: factors shaping heteroplasmy in the germ line and somatic cells
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Mitochondria; MtDNA; Mutant; Selection; Mitophagy; Selfish
ID copy number; mtdna heteroplasmy; quality-control; sequence heterogeneity; genetic bottleneck; rapid segregation; oxidative stress; helicase twinkle; skeletal-muscle; in-vivo
AB Until recently it was thought that most humans only harbor one type of mitochondrial DNA (mtDNA), however, deep sequencing and single-cell analysis has shown the converse - that mixed populations of mtDNA (heteroplasmy) are the norm. This is important because heteroplasmy levels can change dramatically during transmission in the female germ line, leading to high levels causing severe mitochondrial diseases. There is also emerging evidence that low level mtDNA mutations contribute to common late onset diseases such as neurodegenerative disorders and cardiometabolic diseases because the inherited mutation levels can change within developing organs and non-dividing cells over time. Initial predictions suggested that the segregation of mtDNA heteroplasmy was largely stochastic, with an equal tendency for levels to increase or decrease. However, transgenic animal work and single-cell analysis have shown this not to be the case during germ-line transmission and in somatic tissues during life. Mutation levels in specific mtDNA regions can increase or decrease in different contexts and the underlying molecular mechanisms are starting to be unraveled. In this review we provide a synthesis of recent literature on the mechanisms of selection for and against mtDNA variants. We identify the most pertinent gaps in our understanding and suggest ways these could be addressed using state of the art techniques.
C1 [Chiaratti, Marcos R.] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, Sao Carlos, Brazil.
   [Chinnery, Patrick F.] Univ Cambridge, Cambridge Biomed Campus, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
   [Chinnery, Patrick F.] Univ Cambridge, Cambridge Biomed Campus, Med Res Council, Mitochondrial Biol Unit, Cambridge, England.
C3 Universidade Federal de Sao Carlos; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge
RP Chiaratti, MR (corresponding author), Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, Sao Carlos, Brazil.; Chinnery, PF (corresponding author), Univ Cambridge, Cambridge Biomed Campus, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
EM marcos.chiaratti@ufscar.br; pfc25@cam.ac.uk
FU Sao Paulo Research Foundation (FAPESP/Brazil) [2017/04372-0, 2020/15412-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil) [001]; Academy of Medical Sciences-Newton Advanced Fellowship; Wellcome Trust [212219/Z/18/Z]; Medical Research Council Mitochondrial Biology Unit [MC_UU_00028/7]; Medical Research Council (MRC) International Center for Genomic Medicine in Neuromuscular Disease [MR/S005021/1]; Leverhulme Trust [RPG2018-408]; MRC [MR/S035699/1]; Alzheimer's Society [AS-PG-18b-022]; NIHR Cambridge Biomedical Research Center [BRC-1215-20014]; EPSRC [EP/N01426X/1] Funding Source: UKRI; MRC [MR/M008886/1, MC_PC_13047, MR/S035699/1, MR/S005021/1, MC_UU_00028/7] Funding Source: UKRI; Wellcome Trust [212219/Z/18/Z] Funding Source: Wellcome Trust
CR Acton BM, 2007, BIOL REPROD, V77, P569, DOI 10.1095/biolreprod.107.060806
   Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986
   Ahier A, 2021, CELL REP, V35, P0, DOI 10.1016/j.celrep.2021.109203
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Aiken CEM, 2008, REPROD BIOMED ONLINE, V17, P806, DOI 10.1016/S1472-6483(10)60409-9
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Anderson NS, 2020, TRENDS CELL BIOL, V30, P428, DOI 10.1016/j.tcb.2020.03.001
   Arbeithuber B, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2118740119
   Arbeithuber B, 2020, PLOS BIOL, V18, P0, DOI 10.1371/journal.pbio.3000745
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barriocanal-Casado E, 2019, EBIOMEDICINE, V42, P511, DOI 10.1016/j.ebiom.2019.03.025
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blackwood JK, 2011, J PATHOL, V225, P181, DOI 10.1002/path.2965
   Boucret L, 2017, HUM REPROD, V32, P2101, DOI 10.1093/humrep/dex268
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brüser C, 2021, CELL REP, V37, P0, DOI 10.1016/j.celrep.2021.110000
   Bruni F, 2017, FEBS J, V284, P1767, DOI 10.1111/febs.13981
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burgstaller JP, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04797-2
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106
   Cai N, 2021, NAT MED, V27, P1564, DOI 10.1038/s41591-021-01441-3
   Calabrese C, 2022, PLOS GENET, V18, P0, DOI 10.1371/journal.pgen.1010068
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Carvalho KF, 2020, FASEB J, V34, P7644, DOI 10.1096/fj.201901761R
   Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen Z, 2020, J CELL BIOL, V219, P0, DOI 10.1083/jcb.201905160
   Cherezov V, 2013, SCIENCE, V342, P1524, DOI 10.1126/ science.1244360
   Chiang ACY, 2019, CURR BIOL, V29, P4330, DOI 10.1016/j.cub.2019.10.060
   Chiaratti MR, 2021, BIOPHYS REV-GER, V13, P967, DOI 10.1007/s12551-021-00891-w
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Cho SI, 2022, CELL, V185, P1764, DOI 10.1016/j.cell.2022.03.039
   Chung CY, 2022, TRENDS CELL BIOL, V32, P391, DOI 10.1016/j.tcb.2021.10.005
   Chung CY, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-26746-2
   Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Diez-Juan A, 2015, FERTIL STERIL, V104, P534, DOI 10.1016/j.fertnstert.2015.05.022
   DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Durham SE, 2006, NEUROLOGY, V67, P502, DOI 10.1212/01.wnl.0000227961.55640.2f
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fan XY, 2022, NAT BIOMED ENG, V6, P339, DOI 10.1038/s41551-022-00881-7
   Fellous TG, 2009, STEM CELLS, V27, P1410, DOI 10.1002/stem.67
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Fonseca MM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0106654
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   Fragouli E, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005241
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Granatiero V, 2016, CELL DEATH DIFFER, V23, P231, DOI 10.1038/cdd.2015.84
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920
   Hirano M, 1997, P NATL ACAD SCI USA, V94, P14894, DOI 10.1073/pnas.94.26.14894
   Holt AG, 2021, ACTA BIOTHEOR, V69, P671, DOI 10.1007/s10441-021-09417-z
   Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122
   Johnson MT, 2007, BIOL REPROD, V77, P2, DOI 10.1095/biolreprod.106.059899
   Jokinen R, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001161
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Kandul NP, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13100
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kleele T, 2021, NATURE, V593, P435, DOI 10.1038/s41586-021-03510-6
   Kowald A, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9030126
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Li J, 2020, BIOCHEM BIOPH RES CO, V521, P1024, DOI 10.1016/j.bbrc.2019.10.112
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4
   Lima A, 2021, NAT METAB, V3, P1091, DOI 10.1038/s42255-021-00422-7
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lorente L, 2016, J CRIT CARE, V33, P95, DOI 10.1016/j.jcrc.2016.02.003
   Lorente L, 2012, CRIT CARE, V16, P0, DOI 10.1186/cc11150
   Ma HS, 2016, NAT GENET, V48, P798, DOI 10.1038/ng.3587
   Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919
   Ma H, 2020, BIOL REPROD, V102, P607, DOI 10.1093/biolre/ioz202
   Ma H, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0201304
   Ma H, 2016, CELL METAB, V24, P283, DOI 10.1016/j.cmet.2016.06.012
   Machado TS, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0133650
   Malena A, 2016, AUTOPHAGY, V12, P2098, DOI 10.1080/15548627.2016.1226734
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   McLelland GL, 2016, J CELL BIOL, V214, P275, DOI 10.1083/jcb.201603105
   Meshnik L, 2022, BMC BIOL, V20, P0, DOI 10.1186/s12915-022-01241-2
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mick E, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.49178
   Miller B, 2020, EXP CELL RES, V393, P0, DOI 10.1016/j.yexcr.2020.112056
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Mueller EE, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016455
   Murakoshi Y, 2013, J ASSIST REPROD GEN, V30, P1367, DOI 10.1007/s10815-013-0062-6
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038
   Ng MYW, 2021, DEV CELL, V56, P881, DOI 10.1016/j.devcel.2021.02.009
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Nie Y, 2022, ACTA NEUROPATHOL, V143, P687, DOI 10.1007/s00401-022-02423-6
   Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Otten ABC, 2018, HUM REPROD, V33, P1331, DOI 10.1093/humrep/dey114
   Palombo F, 2021, STEM CELL REP, V16, P1953, DOI 10.1016/j.stemcr.2021.06.016
   Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pezet MG, 2021, COMMUN BIOL, V4, P0, DOI 10.1038/s42003-021-02069-2
   Phillips WS, 2015, GENOME BIOL EVOL, V7, P2023, DOI 10.1093/gbe/evv116
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2
   Pla-Martin D, 2021, BIORXIV, V0, P0, DOI DOI 10.1101/2021.08.06.455397
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Pozzi A, 2019, GENOME BIOL EVOL, V11, P1883, DOI 10.1093/gbe/evz132
   Rainbolt TK, 2013, CELL METAB, V18, P908, DOI 10.1016/j.cmet.2013.11.006
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Ramírez S, 2017, CELL METAB, V25, P1390, DOI 10.1016/j.cmet.2017.05.010
   Rand DM, 2008, PLOS BIOL, V6, P229, DOI 10.1371/journal.pbio.0060035
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Rius-Pérez S, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/1452696
   Rodríguez-Nuevo A, 2022, NATURE, V607, P756, DOI 10.1038/s41586-022-04979-5
   Rojansky R, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.17896
   Samstag CL, 2018, PLOS GENET, V14, P0, DOI 10.1371/journal.pgen.1007805
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Sanchez-Contreras M, 2021, NUCLEIC ACIDS RES, V49, P11103, DOI 10.1093/nar/gkab901
   Sato A, 2007, GENETICS, V177, P2031, DOI 10.1534/genetics.107.081026
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Shin MG, 2004, BLOOD, V103, P4466, DOI 10.1182/blood-2003-11-3949
   Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724
   Silva-Pinheiro P, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-28358-w
   Song LY, 2017, NEUROBIOL DIS, V100, P30, DOI 10.1016/j.nbd.2016.12.024
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Stewart JB, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005333
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162
   Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466
   Szczepanowska K, 2021, BBA-BIOENERGETICS, V1862, P0, DOI 10.1016/j.bbabio.2020.148365
   Tan JX, 2020, J CELL BIOL, V219, P0, DOI 10.1083/jcb.202002179
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Tostes K, 2022, AUTOPHAGY, V18, P2397, DOI 10.1080/15548627.2022.2038501
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trinh J, 2022, MEDRXIV, V0, P0, DOI DOI 10.1101/2022.05.17.22275087
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Udagawa O, 2014, CURR BIOL, V24, P2451, DOI 10.1016/j.cub.2014.08.060
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Umbria M, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-59631-x
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Lechuga-Vieco AV, 2022, CIRCULATION, V145, P1084, DOI 10.1161/CIRCULATIONAHA.121.056286
   Lechuga-Vieco AV, 2020, SCI ADV, V6, P0, DOI 10.1126/sciadv.aba5345
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wang YQ, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2014610118
   Wei W, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-25482-x
   Wei W, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15336-3
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Wei W, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1007126
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Williams SL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003990
   Wojewoda M, 2011, INT J BIOCHEM CELL B, V43, P1178, DOI 10.1016/j.biocel.2011.04.011
   Wolf DP, 2017, EMBO J, V36, P2177, DOI 10.15252/embj.201797606
   Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014
   Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001
   Yamamoto K, 2020, COMMUN BIOL, V3, P0, DOI 10.1038/s42003-020-0812-9
   Yang QY, 2022, NAT CELL BIOL, V24, P181, DOI 10.1038/s41556-021-00840-5
   Yang Y, 2008, GENET MED, V10, P187, DOI 10.1097/GIM.0b013e318163c343
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yonova-Doing E, 2021, NAT GENET, V53, P982, DOI 10.1038/s41588-021-00868-1
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zhang HX, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abi5657
   Zhang Y, 2019, MOL CELL, V73, P1127, DOI 10.1016/j.molcel.2019.01.013
   Zhang Y, 2016, EMBO J, V35, P1045, DOI 10.15252/embj.201592994
   Zheng XD, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.13378
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
   Zinovkina LA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P233, DOI 10.1134/S0006297918030045
NR 220
TC 11
Z9 14
U1 0
U2 21
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
EI 1096-1186
J9 PHARMACOL RES
JI Pharmacol. Res.
PD NOV 15
PY 2022
VL 185
IS 
BP 
EP 
DI 10.1016/j.phrs.2022.106466
PG 17
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 5N9QI
UT WOS:000872120100002
PM 36174964
DA 2024-11-01
ER

PT J
AU Zanini, G
   Selleri, V
   Nasi, M
   De Gaetano, A
   Martinelli, I
   Gianferrari, G
   Lofaro, FD
   Boraldi, F
   Mandrioli, J
   Pinti, M
AF Zanini, Giada
   Selleri, Valentina
   Nasi, Milena
   De Gaetano, Anna
   Martinelli, Ilaria
   Gianferrari, Giulia
   Lofaro, Francesco Demetrio
   Boraldi, Federica
   Mandrioli, Jessica
   Pinti, Marcello
TI Mitochondrial and Endoplasmic Reticulum Alterations in a Case of Amyotrophic Lateral Sclerosis Caused by TDP-43 A382T Mutation
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE TDP-43; amyotrophic lateral sclerosis; mitochondria; mtDNA
ID lon protease; multiple-sclerosis; gene-mutations; disease; dna
AB Amyotrophic lateral sclerosis is the most common form of motor neuron disease. Mutations in TARDBP, the gene encoding the RNA-binding protein TDP-43, are responsible for about 5% of familial ALS. Here we report the clinical and biological features of an ALS patients with pA382T mutation in TPD-43 protein. Disease began with right hand muscles weakness, and equally involved upper and lower motor neuron with a classic phenotype, without cognitive impairment. While a family history of neurological diseases was reported, there was no evidence of familial frontotemporal dementia. Cultured fibroblasts from the patient were characterized by profound alterations of cell proteome, which impacts particularly the mitochondrial metabolic pathways and the endoplasmic reticulum. TDP-43 levels were similar to control, healthy fibroblasts, but a higher fraction localized in mitochondria. Mitochondrial network appeared fragmented, and the organelles smaller and more spheric. In agreement with impaired proteome and morphology of mitochondria, basal cell respiration was reduced. Mitochondrial DNA levels appeared normal. However, a higher amount of mitochondrial DNA was present in the cytosol, suggesting a pronounced mitochondrial DNA misplacement which can promote a pro-inflammatory response mediating by cGAS/STING. Thus, this case report further expands the clinical and pathological phenotype of A382T mutation.
C1 [Zanini, Giada; Selleri, Valentina; De Gaetano, Anna; Lofaro, Francesco Demetrio; Boraldi, Federica; Pinti, Marcello] Univ Modena & Reggio Emilia, Dept Life Sci, Via G Campi 287, I-41125 Modena, Italy.
   [Selleri, Valentina; De Gaetano, Anna] Natl Inst Cardiovasc Res, Via Irnerio 28, I-40126 Bologna, Italy.
   [Nasi, Milena] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, I-41125 Modena, Italy.
   [Martinelli, Ilaria; Gianferrari, Giulia; Mandrioli, Jessica] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurosci, Via G Campi 287, I-41125 Modena, Italy.
C3 Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia
RP Pinti, M (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Via G Campi 287, I-41125 Modena, Italy.; Mandrioli, J (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurosci, Via G Campi 287, I-41125 Modena, Italy.
EM jessica.mandrioli@unimore.it; marcello.pinti@unimore.it
FU Agenzia Italiana del Farmaco [2016-02364678]
CR Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028
   Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612
   Borghero G, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.07.012
   Borghero G, 2011, NEUROBIOL AGING, V32, P0, DOI 10.1016/j.neurobiolaging.2011.06.009
   Bozzo F, 2017, NEUROSCI LETT, V636, P3, DOI 10.1016/j.neulet.2016.04.065
   Cannas A, 2013, NEUROGENETICS, V14, P161, DOI 10.1007/s10048-013-0360-2
   Chaudhry A, 2020, AM J PHYSIOL-ENDOC M, V318, PE87, DOI 10.1152/ajpendo.00457.2019
   Cheng WW, 2019, NEURON, V104, P885, DOI 10.1016/j.neuron.2019.09.003
   Chiò A, 2011, ARCH NEUROL-CHICAGO, V68, P594, DOI 10.1001/archneurol.2010.352
   Corcia P, 2012, NEUROLOGY, V78, P1519, DOI 10.1212/WNL.0b013e3182553c88
   Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950
   Cui C, 2021, AMYOTROPH LAT SCL FR, V22, P211, DOI 10.1080/21678421.2020.1861022
   DAmico E, 2013, FREE RADICAL BIO MED, V65, P509, DOI 10.1016/j.freeradbiomed.2013.06.029
   De Marco G, 2017, NEUROPATH APPL NEURO, V43, P133, DOI 10.1111/nan.12328
   Etemadifar M, 2012, MULT SCLER J, V18, P902, DOI 10.1177/1352458511427719
   François-Moutal L, 2019, FRONT MOL NEUROSCI, V12, P0, DOI 10.3389/fnmol.2019.00301
   Gianferrari G, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10040819
   Gianini M, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009260
   Gibellini L, 2018, FRONT ONCOL, V8, P0, DOI 10.3389/fonc.2018.00254
   Gibellini L, 2014, MITOCHONDRION, V18, P76, DOI 10.1016/j.mito.2014.08.001
   Gibellini L, 2014, FASEB J, V28, P5122, DOI 10.1096/fj.14-255869
   Goris A, 2014, HUM MOL GENET, V23, P1916, DOI 10.1093/hmg/ddt574
   Hemminki K, 2009, NEUROGENETICS, V10, P111, DOI 10.1007/s10048-008-0164-y
   Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534
   Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200
   Lofaro FD, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms221910564
   Lofaro FD, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.610266
   Longinetti E, 2022, AMYOTROPH LAT SCL FR, V23, P209, DOI 10.1080/21678421.2021.1946084
   Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200
   Mandrioli J, 2020, SEMIN CELL DEV BIOL, V99, P183, DOI 10.1016/j.semcdb.2019.06.003
   Mutihac R, 2015, NEUROBIOL DIS, V75, P64, DOI 10.1016/j.nbd.2014.12.010
   Nasi M, 2020, J NEUROIMMUNOL, V338, P0, DOI 10.1016/j.jneuroim.2019.577107
   Onesto E, 2016, ACTA NEUROPATHOL COM, V4, P0, DOI 10.1186/s40478-016-0316-5
   Orrù S, 2016, HUM MOL GENET, V25, P4473, DOI 10.1093/hmg/ddw276
   Pesiridis GS, 2009, HUM MOL GENET, V18, PR156, DOI 10.1093/hmg/ddp303
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Suk TR, 2020, MOL NEURODEGENER, V15, P0, DOI 10.1186/s13024-020-00397-1
   Theunissen F, 2021, TRANSL NEURODEGENER, V10, P0, DOI 10.1186/s40035-021-00272-z
   Tsai TH, 2020, MOL CELL PROTEOMICS, V19, P944, DOI 10.1074/mcp.RA119.001792
   Turner MR, 2013, NEUROLOGY, V81, P1222, DOI 10.1212/WNL.0b013e3182a6cc13
   Wang WZ, 2016, NAT MED, V22, P869, DOI 10.1038/nm.4130
   Watanabe S, 2013, J BIOL CHEM, V288, P3641, DOI 10.1074/jbc.M112.433615
   Wood A, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22094705
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zhou YY, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-09234-6
NR 46
TC 7
Z9 8
U1 1
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT 15
PY 2022
VL 23
IS 19
BP 
EP 
DI 10.3390/ijms231911881
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 5H5UG
UT WOS:000867743600001
PM 36233180
DA 2024-11-01
ER

PT J
AU van Kempen, CMA
   Beynon, AJ
   Smits, JJ
   Janssen, MCH
AF van Kempen, Carlijn M. A.
   Beynon, Andy J.
   Smits, Jeroen J.
   Janssen, Mirian C. H.
TI A retrospective cohort study exploring the association between different mitochondrial diseases and hearing loss
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondrial disease; Hearing loss; Audiological assessment; Tonal audiogram; Speech perception; Auditory brainstem responses; NMDAS
ID mutations; children
AB Some pathogenic variants in mtDNA and nuclear DNA, affecting mitochondrial function, are associated with hearing loss. Behavioral and electrophysiological auditory performance are obtained from 62 patients, clinically diagnosed with different mitochondrial diseases (MD) using tone/speech audiometry and Auditory Brainstem Responses (ABR). Audiological variables (hearing loss type, pure tone average (PTA), interaural asymmetry, speech perception and brainstem neural conductivity) were analyzed and related to Newcastle Mitochondrial Disease Scale for Adults (NMDAS). In 35% of MDs, a mild to severe symmetrical sensorineural hearing loss (SNHL) was found. Patients with Maternally Inherited Diabetes and Deafness (MIDD) show significantly higher PTAs compared to other MDs. For all MDs, speech recognition scores were in accordance with their individual age- and gender-corrected tone audiometry, but ABR peak latencies were prolonged in patients with MIDD, Mitochondrial Encephalopathy Lactate acidosis and Stroke-like episodes (MELAS), Chronic Progressive External Ophthalmoplegia (CPEO) and Subacute necrotizing encephalopathy (Leigh). Correlations between NMDAS and audiological variables were low. (C) 2022 The Authors. Published by Elsevier Inc.
C1 [van Kempen, Carlijn M. A.; Beynon, Andy J.; Smits, Jeroen J.] Radboudumc Nijmegen, Dept Otorhinolaryngol Head & Neck Surg, Nijmegen, Netherlands.
   [Janssen, Mirian C. H.] Radboudumc Nijmegen, Radboud Ctr Mitochondria Med, Dept Internal Med, Nijmegen, Netherlands.
RP Beynon, AJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Head Vestibular & Auditory Evoked Potential Lab, Dept Otorhinolaryngol Head & Neck Surg,Donders In, Philips van Leydenlaan 15, NL-6525 EX Nijmegen, Netherlands.
EM andy.beynon@radboudumc.nl
CR Ahmed H, 2017, JARO-J ASSOC RES OTO, V18, P649, DOI 10.1007/s10162-017-0634-8
   Amatuzzi MG, 2001, ARCH OTOLARYNGOL, V127, P629, DOI 10.1001/archotol.127.6.629
   Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Bosman J, 1989, SPEECH PERCEPTION HE, V0, P0
   Burkard RF, 2006, AUDITORY EVOKED POTENTIALS: BASIC PRINCIPLES AND CLINICAL APPLICATION, V1, P0
   Chennupati SK, 2011, INT J PEDIATR OTORHI, V75, P1519, DOI 10.1016/j.ijporl.2011.08.019
   Cunningham LL, 2017, NEW ENGL J MED, V377, P2465, DOI 10.1056/NEJMra1616601
   Ding Y, 2013, BIOCHEM GENET, V51, P588, DOI 10.1007/s10528-013-9589-6
   Eggermont JJ, 2019, HAND CLINIC, V160, P451, DOI 10.1016/B978-0-444-64032-1.00030-8
   Fujimoto C, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8040109
   Gerards M, 2016, MOL GENET METAB, V117, P300, DOI 10.1016/j.ymgme.2015.12.004
   Haast RAM, 2018, NEUROIMAGE-CLIN, V18, P231, DOI 10.1016/j.nicl.2018.01.017
   Hougaard DD, 2019, J INT ADV OTOL, V15, P296, DOI 10.5152/iao.2019.5913
   Hutchin TP, 2000, CELL MOL LIFE SCI, V57, P1927, DOI 10.1007/PL00000673
   Ibrahim I, 2018, MUTAT RES-FUND MOL M, V810, P39, DOI 10.1016/j.mrfmmm.2018.03.003
   Jacobs HT, 1997, ANN MED, V29, P483, DOI 10.3109/07853899709007472
   Jiang ZX, 2019, J DIABETES RES, V2019, P0, DOI 10.1155/2019/5184647
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Lee SJ, 2018, YONSEI MED J, V59, P1190
   Moassass F, 2018, INT J PEDIATR OTORHI, V113, P110, DOI 10.1016/j.ijporl.2018.07.028
   Parkkonen L, 2009, HUM BRAIN MAPP, V30, P1772, DOI 10.1002/hbm.20788
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schmand B, 1991, TIJDSCHR GERONTOL GERIATR, V22, P15
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Ulualp SO, 2004, LARYNGOSCOPE, V114, P2239, DOI 10.1097/01.mlg.0000149465.80703.8e
   van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Zheng J, 2020, MITOCHONDRION, V52, P163, DOI 10.1016/j.mito.2020.03.005
   Zwirner P, 2001, LARYNGOSCOPE, V111, P515, DOI 10.1097/00005537-200103000-00024
NR 29
TC 7
Z9 7
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD APR 15
PY 2022
VL 135
IS 4
BP 333
EP 341
DI 10.1016/j.ymgme.2022.02.003
EA MAR 2022
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA ZY1HG
UT WOS:000772339900117
PM 35190254
DA 2024-11-01
ER

PT J
AU Li, YJ
   Jin, X
   Li, D
   Lu, J
   Zhang, XN
   Yang, SJ
   Zhao, YX
   Wu, M
AF Li, Yu-juan
   Jin, Xiao
   Li, Dan
   Lu, Jing
   Zhang, Xiao-nan
   Yang, Sheng-jie
   Zhao, Yi-xi
   Wu, Min
TI New insights into vascular aging: Emerging role of mitochondria function
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Review
DE Vascular aging; Mitochondria; Endothelial cell; Vascular smooth muscle cell; Natural compounds
ID dna copy number; telomerase reverse-transcriptase; manganese superoxide-dismutase; improves endothelial function; lipoprotein-induced apoptosis; peroxide-induced apoptosis; coronary-artery-disease; smooth-muscle-cells; oxidative stress; peripheral-blood
AB Vascular aging, a major risk factor for cardiovascular disease, contributes to morbidity and mortality in older people. Mitochondria play an important role in vascular aging. In endothelial and smooth muscle cells, multiple changes in the mitochondrial structure and function contribute to aging, including the effects of mitochondrial oxidative stress, mitochondrial DNA mutations, mitochondrial dynamics, and mitophagy. Mitochondrial dysfunction also contributes to other age-related molecular and cellular mechanisms, such as crosstalk with telomeres, senescence-associated secretory phenotypes, and low-grade inflammation. Thus, enhancing mitochondrial biogenesis, reducing oxidative stress, recovering dynamics, and mitophagy have been suggested as effective interventions to delay vascular aging and age-related cardiovascular diseases. Furthermore, accumulating evidence has shown that commonly used herbs and their natural compounds have great potential to improve mitochondrial function during vascular aging. Herein, we review the cellular and molecular mechanisms of mitochondrial effects on vascular aging, emphasizing the efficacy of natural compounds in the treatment of vascular aging by improving mitochondrial structure and function. We aim to provide new insights into delaying vascular aging and preventing cardiovascular diseases.
C1 [Li, Yu-juan; Jin, Xiao; Li, Dan; Lu, Jing; Yang, Sheng-jie; Zhao, Yi-xi; Wu, Min] China Acad Chinese Med Sci, Guangan Men Hosp, Beijing 100053, Peoples R China.
   [Lu, Jing; Zhao, Yi-xi] Beijing Univ Chinese Med, Beijing 100029, Peoples R China.
   [Zhang, Xiao-nan] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing 100091, Peoples R China.
C3 China Academy of Chinese Medical Sciences; Beijing University of Chinese Medicine; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS
RP Wu, M (corresponding author), China Acad Chinese Med Sci, Guangan Men Hosp, Beijing 100053, Peoples R China.
EM wumin19762000@126.com
FU National Natural Science Foundation of China; Beijing Natural Science Foundation;  [81202805];  [82074254];  [7172185]
CR Aeby E, 2016, CELL REP, V17, P3107, DOI 10.1016/j.celrep.2016.11.071
   Ale-Agha N, 2014, EXP GERONTOL, V56, P189, DOI 10.1016/j.exger.2014.02.011
   Allen AM, 2012, LIPIDS HEALTH DIS, V11, P0, DOI 10.1186/1476-511X-11-169
   Amorim JA, 2022, NAT REV ENDOCRINOL, V18, P243, DOI 10.1038/s41574-021-00626-7
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arbeithuber B, 2020, PLOS BIOL, V18, P0, DOI 10.1371/journal.pbio.3000745
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Assis LHD, 2022, FRONT MOL BIOSCI, V9, P0, DOI 10.3389/fmolb.2022.839428
   Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182
   Bachmann JC, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11101657
   Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029
   Belser M, 2021, FRONT GENET, V12, P0, DOI 10.3389/fgene.2021.714228
   Billard P, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20194959
   Bliksoen M, 2016, BASIC RES CARDIOL, V111, P0, DOI 10.1007/s00395-016-0553-6
   Braakhuis AJ, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/8575263
   Byrne JJ, 2019, CELL MOL LIFE SCI, V76, P1967, DOI 10.1007/s00018-019-03024-5
   Campbell MD, 2019, FREE RADICAL BIO MED, V134, P268, DOI 10.1016/j.freeradbiomed.2018.12.031
   Canugovi C, 2019, REDOX BIOL, V26, P0, DOI 10.1016/j.redox.2019.101288
   Cao YL, 2017, NATURE, V542, P372, DOI 10.1038/nature21077
   Caporarello N, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-31890-4
   Caporarello N, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13196
   Chang X, 2021, THERANOSTICS, V11, P6766, DOI 10.7150/thno.60143
   Chang X, 2021, OXID MED CELL LONGEV, V2021, P0, DOI 10.1155/2021/6659240
   Chen HJ, 2021, FRONT CARDIOVASC MED, V8, P0, DOI 10.3389/fcvm.2021.664626
   Chen HC, 2015, J CELL BIOL, V211, P795, DOI 10.1083/jcb.201507035
   Chen LY, 2012, MOL CELL, V47, P839, DOI 10.1016/j.molcel.2012.07.002
   Chen SY, 2014, ATHEROSCLEROSIS, V237, P220, DOI 10.1016/j.atherosclerosis.2014.08.051
   Chen XY, 2021, EUR J PHARMACOL, V911, P0, DOI 10.1016/j.ejphar.2021.174495
   Chen XP, 2020, EUR J PHARMACOL, V868, P0, DOI 10.1016/j.ejphar.2019.172885
   Cheng Y, 2018, CELL REP, V24, P2589, DOI 10.1016/j.celrep.2018.08.003
   Chirinos JA, 2020, J AM COLL CARDIOL, V75, P72, DOI 10.1016/j.jacc.2019.11.007
   Chistiakov DA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/238463
   Chowdhury A, 2022, FRONT CELL DEV BIOL, V10, P0, DOI 10.3389/fcell.2022.796066
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Cox FF, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11030342
   Crimmins EM, 2020, AGEING RES REV, V63, P0, DOI 10.1016/j.arr.2020.101136
   Csiszar A, 2007, AGING CELL, V6, P783, DOI 10.1111/j.1474-9726.2007.00339.x
   Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, PH13, DOI 10.1152/ajpheart.00368.2009
   Cui L, 2017, VASC PHARMACOL, V88, P21, DOI 10.1016/j.vph.2016.11.006
   Dabravolski SA, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23020952
   Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR
   Dagher O, 2021, FRONT CARDIOVASC MED, V8, P0, DOI 10.3389/fcvm.2021.658400
   Dai DF, 2017, PROG MOL BIOL TRANSL, V146, P203, DOI 10.1016/bs.pmbts.2016.12.015
   Das A, 2018, CELL, V173, P74, DOI 10.1016/j.cell.2018.02.008
   Davinelli S, 2013, IMMUN AGEING, V10, P0, DOI 10.1186/1742-4933-10-28
   Deng XY, 2021, BMC CARDIOVASC DISOR, V21, P0, DOI 10.1186/s12872-021-01918-6
   Diao RY, 2022, AM J PHYSIOL-CELL PH, V322, PC218, DOI 10.1152/ajpcell.00360.2021
   Diaz-Morales N, 2017, ANTIOXID REDOX SIGN, V27, P1439, DOI 10.1089/ars.2017.7122
   Dikalova AE, 2020, CIRC RES, V126, P439, DOI 10.1161/CIRCRESAHA.119.315767
   Dikalova AE, 2017, CIRC RES, V121, P564, DOI 10.1161/CIRCRESAHA.117.310933
   Dominic A, 2020, REDOX BIOL, V37, P0, DOI 10.1016/j.redox.2020.101614
   Donato AJ, 2018, CIRC RES, V123, P825, DOI 10.1161/CIRCRESAHA.118.312563
   Doran AC, 2017, J CLIN INVEST, V127, P4075, DOI 10.1172/JCI94735
   Dorighello GG, 2022, ANTIOXIDANTS-BASEL, V11, P0, DOI 10.3390/antiox11091734
   Duan M, 2022, CELL COMMUN SIGNAL, V20, P0, DOI 10.1186/s12964-022-00858-8
   Dumont A, 2021, MOL ASPECTS MED, V77, P0, DOI 10.1016/j.mam.2020.100922
   Dunbar SB, 2018, CIRCULATION, V137, PE558, DOI 10.1161/CIR.0000000000000570
   Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884
   Fan XS, 2019, J CARDIOVASC TRANSL, V12, P591, DOI 10.1007/s12265-019-09900-6
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Foote K, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12773
   Fordjour PA, 2016, HEART FAIL REV, V21, P489, DOI 10.1007/s10741-016-9557-4
   Forte M, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-021-04188-4
   Fouquerel E, 2019, MOL CELL, V75, P117, DOI 10.1016/j.molcel.2019.04.024
   Fujimoto H, 2008, EUR HEART J, V29, P1267, DOI 10.1093/eurheartj/ehm500
   Fukai T, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9081849
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Gioscia-Ryan RA, 2021, J PHYSIOL-LONDON, V599, P911, DOI 10.1113/JP280607
   Gioscia-Ryan RA, 2018, J APPL PHYSIOL, V124, P1194, DOI 10.1152/japplphysiol.00670.2017
   Gioscia-Ryan RA, 2014, J PHYSIOL-LONDON, V592, P2549, DOI 10.1113/jphysiol.2013.268680
   Gong GH, 2010, EUR J PHARMACOL, V628, P27, DOI 10.1016/j.ejphar.2009.11.028
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Green PD, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20061509
   Guo Y, 2020, GEROSCIENCE, V42, P547, DOI 10.1007/s11357-020-00179-z
   Gupta P, 2016, INT J PHARMACEUT, V511, P1012, DOI 10.1016/j.ijpharm.2016.07.071
   Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3
   Han RH, 2017, MOL MED REP, V15, P4027, DOI 10.3892/mmr.2017.6515
   Harel S, 2017, VASC PHARMACOL, V92, P22, DOI 10.1016/j.vph.2017.03.002
   Harman D, 1973, TRIANGLE, V12, P153
   He L, 2019, J CELL PHYSIOL, V234, P8668, DOI 10.1002/jcp.27527
   He YH, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.01.015
   Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5
   Hernandez-Mijares A, 2016, ATHEROSCLEROSIS, V247, P40, DOI 10.1016/j.atherosclerosis.2016.01.044
   Ho CY, 2016, ARTERIOSCL THROM VAS, V36, P1475, DOI 10.1161/ATVBAHA.116.306717
   Hocsak E, 2017, FREE RADICAL BIO MED, V108, P770, DOI 10.1016/j.freeradbiomed.2017.04.018
   Hofmann P, 2019, CARDIOVASC RES, V115, P230, DOI 10.1093/cvr/cvy206
   Hu C, 2022, AGING DIS, V13, P103, DOI 10.14336/AD.2021.0927
   Iorio R, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11010030
   Jahn LA, 2022, AM J PHYSIOL-ENDOC M, V322, PE173, DOI 10.1152/ajpendo.00287.2021
   Jia Q, 2020, MED SCI MONITOR, V26, P0, DOI 10.12659/MSM.925401
   Jiang YH, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.00512
   Joshi MS, 2015, DIABETES VASC DIS RE, V12, P208, DOI 10.1177/1479164114565629
   Kampa RP, 2021, BIOMED PHARMACOTHER, V142, P0, DOI 10.1016/j.biopha.2021.112039
   Kang YH, 2018, CELL REP, V22, P3493, DOI 10.1016/j.celrep.2018.02.071
   Kant S, 2022, ARTERIOSCL THROM VAS, V42, P19, DOI 10.1161/ATVBAHA.121.317066
   Karunakaran D, 2015, CIRC RES, V117, P266, DOI 10.1161/CIRCRESAHA.117.305624
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Khatua Tarak Nath, 2016, BIOCHEM BIOPHYS REP, V5, P77, DOI 10.1016/j.bbrep.2015.11.008
   Kim EN, 2018, ATHEROSCLEROSIS, V270, P123, DOI 10.1016/j.atherosclerosis.2018.01.043
   Kirichenko TV, 2020, DATA BRIEF, V29, P0, DOI 10.1016/j.dib.2020.105136
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Kolijn D, 2021, CARDIOVASC RES, V117, P495, DOI 10.1093/cvr/cvaa123
   Koller A, 2020, J INTERN MED, V287, P569, DOI 10.1111/joim.13027
   Korytowski W, 2015, ARTERIOSCL THROM VAS, V35, P2104, DOI 10.1161/ATVBAHA.115.306210
   Kucharska-Newton AM, 2019, CLIN CHEM, V65, P108, DOI 10.1373/clinchem.2018.287623
   Lampert MA, 2019, AUTOPHAGY, V15, P1182, DOI 10.1080/15548627.2019.1580095
   Lezi E, 2014, NEUROBIOL AGING, V35, P2574, DOI 10.1016/j.neurobiolaging.2014.05.033
   Li C, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00796
   Li GY, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.788634
   Li HZ, 2017, BBA-MOL BASIS DIS, V1863, P2266, DOI 10.1016/j.bbadis.2017.05.022
   Li HG, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20092155
   Li JL, 2021, ARTERIOSCL THROM VAS, V41, P839, DOI 10.1161/ATVBAHA.120.315556
   Li K, 2021, BMC PULM MED, V21, P0, DOI 10.1186/s12890-021-01439-0
   Li Y, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2015666118
   Lionaki E, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-28272-1
   Liu L, 2013, EUR REV MED PHARMACO, V17, P88
   Liu LL, 2014, EUR J PHARMACOL, V725, P23, DOI 10.1016/j.ejphar.2014.01.010
   Liu LP, 2017, ATHEROSCLEROSIS, V261, P105, DOI 10.1016/j.atherosclerosis.2017.02.013
   Liu MX, 2022, FRONT CARDIOVASC MED, V9, P0, DOI 10.3389/fcvm.2022.819454
   Liu X, 2021, CELL GENOM, V1, P0, DOI 10.1016/j.xgen.2021.100006
   Liu YJ, 2017, MOL MED REP, V15, P2457, DOI 10.3892/mmr.2017.6304
   Lu Y, 2015, INT J MOL MED, V36, P1223, DOI 10.3892/ijmm.2015.2345
   Lunder M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22062796
   Ma CM, 2015, DIS MARKERS, V2015, P0, DOI 10.1155/2015/909572
   Ma D, 2020, PLOS BIOL, V18, P0, DOI 10.1371/journal.pbio.3000808
   Ma Y, 2018, FREE RADICAL BIO MED, V129, P463, DOI 10.1016/j.freeradbiomed.2018.10.412
   Madreiter-Sokolowski CT, 2019, REDOX BIOL, V20, P458, DOI 10.1016/j.redox.2018.11.003
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Markaki M, 2018, INT REV CEL MOL BIO, V340, P169, DOI 10.1016/bs.ircmb.2018.05.005
   Martínez P, 2017, J CELL BIOL, V216, P875, DOI 10.1083/jcb.201610111
   Marzetti E, 2013, AM J PHYSIOL-HEART C, V305, PH459, DOI 10.1152/ajpheart.00936.2012
   Mathew A, 2012, J ALZHEIMERS DIS, V30, P617, DOI 10.3233/JAD-2012-120145
   McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047
   McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008
   Melicher D, 2021, ARCH MED SCI, V17, P1191, DOI 10.5114/aoms.2019.83173
   Meng PP, 2021, OXID MED CELL LONGEV, V2021, P0, DOI 10.1155/2021/1481236
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012
   Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107
   Miao XY, 2022, CELL BIOCHEM BIOPHYS, V80, P341, DOI 10.1007/s12013-021-01058-w
   Miyao M, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21093112
   Mone P, 2022, HYPERTENSION, V79, P1633, DOI 10.1161/HYPERTENSIONAHA.122.19586
   Nadeem MS, 2022, ANTIOXIDANTS-BASEL, V11, P0, DOI 10.3390/antiox11010087
   Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100
   Ning RH, 2021, REDOX BIOL, V46, P0, DOI 10.1016/j.redox.2021.102113
   Oliveira HCF, 2020, MOL ASPECTS MED, V71, P0, DOI 10.1016/j.mam.2019.100840
   Osellame LD, 2016, J CELL SCI, V129, P2170, DOI 10.1242/jcs.185165
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Pang NB, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/7180943
   Pantsulaia I, 2016, AGEING RES REV, V29, P13, DOI 10.1016/j.arr.2016.05.011
   Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893
   Passos JF, 2010, MOL SYST BIOL, V6, P0, DOI 10.1038/msb.2010.5
   Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022
   Peng X, 2020, CELL BIOL INT, V44, P1481, DOI 10.1002/cbin.11343
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Picca A, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11040675
   Pieters N, 2015, MECH AGEING DEV, V145, P51, DOI 10.1016/j.mad.2015.02.003
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Pollack RM, 2017, J GERONTOL A-BIOL, V72, P1703, DOI 10.1093/gerona/glx041
   Pu YF, 2013, CELL PHYSIOL BIOCHEM, V32, P1167, DOI 10.1159/000354516
   Puhm F, 2019, CIRC RES, V125, P43, DOI 10.1161/CIRCRESAHA.118.314601
   Qi YB, 2016, J CELL BIOL, V215, P621, DOI 10.1083/jcb.201609019
   Qian W, 2019, P NATL ACAD SCI USA, V116, P18435, DOI 10.1073/pnas.1910574116
   Qiao Y, 2017, DRUG DES DEV THER, V11, P3567, DOI 10.2147/DDDT.S152489
   Qin Q, 2018, AM J PHYSIOL-HEART C, V315, PH1127, DOI 10.1152/ajpheart.00685.2017
   Rana A, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00525-4
   Redondo-Horcajo M, 2010, CARDIOVASC RES, V87, P356, DOI 10.1093/cvr/cvq028
   Ren XC, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/4175353
   Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010
   Robert P, 2021, FASEB J, V35, P0, DOI 10.1096/fj.202000238RRR
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossman MJ, 2021, HYPERTENSION, V77, P1212, DOI 10.1161/HYPERTENSIONAHA.120.16175
   Rossman MJ, 2018, HYPERTENSION, V71, P1056, DOI 10.1161/HYPERTENSIONAHA.117.10787
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Salazar G, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19051327
   Sanchez-Contreras M, 2022, FRONT AGING-LAUSANNE, V2, P0, DOI 10.3389/fragi.2021.805126
   Saretzki G, 2003, AGING CELL, V2, P141, DOI 10.1046/j.1474-9728.2003.00040.x
   Schreckenberger ZJ, 2020, AM J HYPERTENS, V33, P804, DOI 10.1093/ajh/hpaa058
   Seabright AP, 2020, FASEB J, V34, P6284, DOI 10.1096/fj.201903051R
   Sekine S, 2018, BMC BIOL, V16, P0, DOI 10.1186/s12915-017-0470-7
   Shaw RL, 2021, AM J PHYSIOL-HEART C, V320, PH1625, DOI 10.1152/ajpheart.00956.2020
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Shin J, 2022, REDOX BIOL, V50, P0, DOI 10.1016/j.redox.2022.102252
   Smiles WJ, 2018, ACTA PHYSIOL, V222, P0, DOI 10.1111/apha.13004
   Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023
   Song YJ, 2021, OXID MED CELL LONGEV, V2021, P0, DOI 10.1155/2021/3960773
   Sprenger HG, 2021, NAT METAB, V3, P636, DOI 10.1038/s42255-021-00385-9
   Springo Z, 2015, J GERONTOL A-BIOL, V70, P1355, DOI 10.1093/gerona/glu244
   Sundquist K, 2022, ATHEROSCLEROSIS, V341, P58, DOI 10.1016/j.atherosclerosis.2021.11.020
   Swiader A, 2016, ONCOTARGET, V7, P28821, DOI 10.18632/oncotarget.8936
   Tarantini S, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12731
   Triggle CR, 2022, METABOLISM, V133, P0, DOI 10.1016/j.metabol.2022.155223
   Tsai IC, 2016, J MOL CELL CARDIOL, V98, P18, DOI 10.1016/j.yjmcc.2016.07.001
   Tsamis A, 2013, J R SOC INTERFACE, V10, P0, DOI 10.1098/rsif.2012.1004
   Ungvari Z, 2020, J AM COLL CARDIOL, V75, P931, DOI 10.1016/j.jacc.2019.11.061
   Ungvari Z, 2018, CIRC RES, V123, P849, DOI 10.1161/CIRCRESAHA.118.311378
   Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, PH1876, DOI 10.1152/ajpheart.00375.2009
   Uraoka M, 2011, HYPERTENSION, V58, P254, DOI 10.1161/HYPERTENSIONAHA.111.176701
   Van der Stukken C, 2022, AGING-US, V14, P1627, DOI 10.18632/aging.203897
   van Kuijk K, 2022, CARDIOVASC RES, V118, P1232, DOI 10.1093/cvr/cvab152
   van Leeuwen N, 2014, AGE, V36, P1463, DOI 10.1007/s11357-014-9629-0
   Vaughan KL, 2018, J GERONTOL A-BIOL, V73, P48, DOI 10.1093/gerona/glx088
   Vecoli C, 2020, MUTAT RES-REV MUTAT, V784, P0, DOI 10.1016/j.mrrev.2020.108309
   Vecoli C, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20215508
   Vecoli C, 2018, ATHEROSCLEROSIS, V276, P91, DOI 10.1016/j.atherosclerosis.2018.07.015
   Vendrov AE, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.117.006775
   Vendrov AE, 2015, ANTIOXID REDOX SIGN, V23, P1389, DOI 10.1089/ars.2014.6221
   Verschoor CP, 2015, MOL IMMUNOL, V65, P148, DOI 10.1016/j.molimm.2015.01.015
   Villa E, 2018, TRENDS CELL BIOL, V28, P882, DOI 10.1016/j.tcb.2018.07.004
   Wang G, 2019, BIOMED RES INT, V2019, P0, DOI 10.1155/2019/7284767
   Wang HH, 2019, ANGIOGENESIS, V22, P569, DOI 10.1007/s10456-019-09680-2
   Wang L, 2015, CORONARY ARTERY DIS, V26, P296, DOI 10.1097/MCA.0000000000000231
   Wang LL, 2021, DIS MARKERS, V2021, P0, DOI 10.1155/2021/7157109
   Wang QL, 2017, DIABETES, V66, P193, DOI 10.2337/db16-0915
   Wang TH, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-28908-2
   Wang X, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/7151946
   Wang XB, 2019, ATHEROSCLEROSIS, V284, P165, DOI 10.1016/j.atherosclerosis.2019.03.010
   Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153
   Wang YC, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12792
   Wei T, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.117.006114
   Wei YY, 2018, CIRCULATION, V138, P2007, DOI 10.1161/CIRCULATIONAHA.117.031589
   Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Whelton PK, 2018, J AM COLL CARDIOL, V71, PE127, DOI 10.1016/j.jacc.2017.11.006
   Wu GN, 2019, J THORAC DIS, V11, P4816, DOI 10.21037/jtd.2019.10.26
   Wu HK, 2020, AUTOPHAGY, V16, P683, DOI 10.1080/15548627.2019.1635380
   Wu NN, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/9825061
   Wu WW, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0132499
   Wu YH, 2021, J DIABETES RES, V2021, P0, DOI 10.1155/2021/6626627
   Xi JX, 2021, J ETHNOPHARMACOL, V271, P0, DOI 10.1016/j.jep.2021.113855
   Xing SS, 2015, VASC PHARMACOL, V72, P141, DOI 10.1016/j.vph.2015.07.004
   Xing SS, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/904834
   Xiong SQ, 2015, CELL REP, V12, P1391, DOI 10.1016/j.celrep.2015.07.047
   Xu CL, 2022, J CELL MOL MED, V26, P1315, DOI 10.1111/jcmm.17190
   Xu M, 2016, CELL CYCLE, V15, P1331, DOI 10.1080/15384101.2016.1160985
   Xu MC, 2013, MOL MED REP, V8, P147, DOI 10.3892/mmr.2013.1468
   Yan CJ, 2020, AUTOPHAGY, V16, P419, DOI 10.1080/15548627.2019.1628520
   Yang CB, 2020, PHARMACOL THERAPEUT, V216, P0, DOI 10.1016/j.pharmthera.2020.107673
   Yang JN, 2019, NUTR METAB, V16, P0, DOI 10.1186/s12986-019-0338-7
   Yang L, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13206
   Yang MY, 2021, J PHARMACOL SCI, V145, P105, DOI 10.1016/j.jphs.2020.10.007
   Yang S, 2019, ATHEROSCLEROSIS, V285, P23, DOI 10.1016/j.atherosclerosis.2019.04.202
   Yang Z, 2021, OXID MED CELL LONGEV, V2021, P0, DOI 10.1155/2021/5546711
   Yin Z, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-20942-w
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu EPK, 2017, ARTERIOSCL THROM VAS, V37, P2322, DOI 10.1161/ATVBAHA.117.310042
   Zeisbrich M, 2018, ANN RHEUM DIS, V77, P1053, DOI 10.1136/annrheumdis-2017-212647
   Zhang J, 2017, AM J CARDIOL, V119, P473, DOI 10.1016/j.amjcard.2016.10.017
   Zhang JJ, 2017, MECH AGEING DEV, V164, P8, DOI 10.1016/j.mad.2017.03.009
   Zhang L, 2012, APOPTOSIS, V17, P25, DOI 10.1007/s10495-011-0653-6
   Zhang M, 2017, CELL PHYSIOL BIOCHEM, V41, P2255, DOI 10.1159/000475640
   Zhang P, 2016, TRANSPL P, V48, P3378, DOI 10.1016/j.transproceed.2016.10.023
   Zhang Qing, 2021, J ADV RES, V34, P43, DOI 10.1016/j.jare.2021.06.023
   Zhang RH, 2020, MECH AGEING DEV, V188, P0, DOI 10.1016/j.mad.2020.111245
   Zhang XY, 2020, NAT METAB, V2, P110, DOI 10.1038/s42255-019-0162-4
   Zhang X, 2021, FREE RADICAL BIO MED, V177, P347, DOI 10.1016/j.freeradbiomed.2021.11.002
   Zhang YK, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/2876350
   Zhao DM, 2019, INT J MOL MED, V43, P2279, DOI 10.3892/ijmm.2019.4153
   Zhao M, 2021, ACS NANO, V15, P1519, DOI 10.1021/acsnano.0c08947
   Zheng Q, 2019, PROTEIN CELL, V10, P631, DOI 10.1007/s13238-019-0612-5
   Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057
   Zhou H, 2018, REDOX BIOL, V15, P335, DOI 10.1016/j.redox.2017.12.019
   Zhou H, 2017, REDOX BIOL, V13, P498, DOI 10.1016/j.redox.2017.07.007
   Zhou Q, 2018, PHYTOMEDICINE, V51, P171, DOI 10.1016/j.phymed.2018.10.002
   Zhou Q, 2020, TOXICOL IN VITRO, V65, P0, DOI 10.1016/j.tiv.2020.104817
   Zhou X, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.530
   Zhu WZ, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-018-0861-x
   Zhuang XY, 2017, EXP THER MED, V14, P515, DOI 10.3892/etm.2017.4541
NR 273
TC 10
Z9 10
U1 4
U2 26
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD DEC 15
PY 2022
VL 156
IS 
BP 
EP 
DI 10.1016/j.biopha.2022.113954
EA NOV 2022
PG 18
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 7J2GS
UT WOS:000904403400009
PM 36411638
DA 2024-11-01
ER

PT J
AU Pérez-Hernández, M
   van Opbergen, CJM
   Bagwan, N
   Vissing, CR
   Marrón-Liñares, GM
   Zhang, ML
   Vega, ET
   Sorrentino, A
   Drici, L
   Sulek, K
   Zhai, RX
   Hansen, FB
   Christensen, AH
   Boesgaard, S
   Gustafsson, F
   Rossing, K
   Small, EM
   Davies, MJ
   Rothenberg, E
   Sato, PY
   Cerrone, M
   Jensen, THL
   Qvortrup, K
   Bundgaard, H
   Delmar, M
   Lundby, A
AF Perez-Hernandez, Marta
   van Opbergen, Chantal J. M.
   Bagwan, Navratan
   Vissing, Christoffer Rasmus
   Marron-Linares, Grecia M.
   Zhang, Mingliang
   Vega, Estefania Torres
   Sorrentino, Andrea
   Drici, Lylia
   Sulek, Karolina
   Zhai, Ruxu
   Hansen, Finn B.
   Christensen, Alex Horby
   Boesgaard, Soren
   Gustafsson, Finn
   Rossing, Kasper
   Small, Eric M.
   Davies, Michael J.
   Rothenberg, Eli
   Sato, Priscila Y.
   Cerrone, Marina
   Jensen, Thomas Hartvig Lindkaer
   Qvortrup, Klaus
   Bundgaard, Henning
   Delmar, Mario
   Lundby, Alicia
TI Loss of Nuclear Envelope Integrity and Increased Oxidant Production Cause DNA Damage in Adult Hearts Deficient in PKP2: A Molecular Substrate of ARVC
SO CIRCULATION
LA English
DT Article
DE arrhythmogenic right ventricular dysplasia; DNA damage; nuclear envelope; oxidative stress; plakophilins; sirtuin 3
ID arrhythmogenic cardiomyopathy; intermediate-filaments; gene; mutations; repair
AB Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by high propensity to life-threatening arrhythmias and progressive loss of heart muscle. More than 40% of reported genetic variants linked to ARVC reside in the PKP2 gene, which encodes the PKP2 protein (plakophilin-2). Methods: We describe a comprehensive characterization of the ARVC molecular landscape as determined by high-resolution mass spectrometry, RNA sequencing, and transmission electron microscopy of right ventricular biopsy samples obtained from patients with ARVC with PKP2 mutations and left ventricular ejection fraction >45%. Samples from healthy relatives served as controls. The observations led to experimental work using multiple imaging and biochemical techniques in mice with a cardiac-specific deletion of Pkp2 studied at a time of preserved left ventricular ejection fraction and in human induced pluripotent stem cell-derived PKP2-deficient myocytes. Results: Samples from patients with ARVC present a loss of nuclear envelope integrity, molecular signatures indicative of increased DNA damage, and a deficit in transcripts coding for proteins in the electron transport chain. Mice with a cardiac-specific deletion of Pkp2 also present a loss of nuclear envelope integrity, which leads to DNA damage and subsequent excess oxidant production (O-2(.-) and H2O2), the latter increased further under mechanical stress (isoproterenol or exercise). Increased oxidant production and DNA damage is recapitulated in human induced pluripotent stem cell-derived PKP2-deficient myocytes. Furthermore, PKP2-deficient cells release H2O2 into the extracellular environment, causing DNA damage and increased oxidant production in neighboring myocytes in a paracrine manner. Treatment with honokiol increases SIRT3 (mitochondrial nicotinamide adenine dinucleotide-dependent protein deacetylase sirtuin-3) activity, reduces oxidant levels and DNA damage in vitro and in vivo, reduces collagen abundance in the right ventricular free wall, and has a protective effect on right ventricular function. Conclusions: Loss of nuclear envelope integrity and subsequent DNA damage is a key substrate in the molecular pathology of ARVC. We show transcriptional downregulation of proteins of the electron transcript chain as an early event in the molecular pathophysiology of the disease (before loss of left ventricular ejection fraction <45%), which associates with increased oxidant production (O-2(.-) and H2O2). We propose therapies that limit oxidant formation as a possible intervention to restrict DNA damage in ARVC.
C1 [Perez-Hernandez, Marta; van Opbergen, Chantal J. M.; Marron-Linares, Grecia M.; Zhang, Mingliang; Cerrone, Marina; Delmar, Mario] NYU, Leon H Charney Div Cardiol, Grossman Sch Med, New York, NY USA.
   [Bagwan, Navratan; Vega, Estefania Torres; Sorrentino, Andrea; Hansen, Finn B.; Davies, Michael J.; Qvortrup, Klaus; Lundby, Alicia] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.
   [Drici, Lylia; Sulek, Karolina] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Copenhagen, Denmark.
   [Vissing, Christoffer Rasmus; Christensen, Alex Horby; Gustafsson, Finn; Rossing, Kasper; Jensen, Thomas Hartvig Lindkaer; Bundgaard, Henning] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.
   [Vissing, Christoffer Rasmus; Christensen, Alex Horby; Boesgaard, Soren; Gustafsson, Finn; Rossing, Kasper; Jensen, Thomas Hartvig Lindkaer; Bundgaard, Henning] Rigshosp, Heart Ctr, Dept Cardiol, Copenhagen, Denmark.
   [Zhai, Ruxu; Sato, Priscila Y.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.
   [Christensen, Alex Horby] Copenhagen Univ Hosp, Dept Cardiol, Herlev Gentofte Hosp, Copenhagen, Denmark.
   [Small, Eric M.] Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA.
   [Rothenberg, Eli] NYU, Div Pharmacol, Sch Med, New York, NY USA.
C3 New York University; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; Drexel University; University of Copenhagen; University of Rochester; New York University
RP Delmar, M (corresponding author), NYU, Leon H Chamey Div Cardiol, Sch Med, 435 East 30th St,NSB 707, New York, NY 10016 USA.; Lundby, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Norregade 10, DK-1165 Copenhagen, Denmark.
EM mario.delmar@nyulangone.org; alicia.lundby@sund.ku.dk
FU Transatlantic Network of Excellence grant from the Leducq Foundation; Heart Rhythm Society; American Heart Association; Danish Council for Independent Research [DFF-0134-00054B]; Novo Nordisk Foundation [NNF18OC0052844, NNF20OC0059767, NNF20SA0064214, NNF14CC0001]; NIH [R56HL149887, R01HL163666]; Innovation Fund Denmark; NordForsk; AP Moller Foundation; Research Foundation at Rigshospitalet; Research Foundation at Capital Region of Denmark;  [R35HL160840];  [R01HL136179]; [R01HL145911]; National Heart Lung and Blood Institute [R01HL145911] Funding Source: NIH RePORTER; National Institute of General Medical Sciences [R35GM134947] Funding Source: NIH RePORTER
CR Ahuja P, 2013, CIRCULATION, V127, P1957, DOI 10.1161/CIRCULATIONAHA.112.001219
   Akdis D, 2016, HEART RHYTHM, V13, P731, DOI 10.1016/j.hrthm.2015.11.010
   Austin KM, 2019, NAT REV CARDIOL, V16, P519, DOI 10.1038/s41569-019-0200-7
   Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033
   Cerrone M, 2022, EUR HEART J, V43, P1251, DOI 10.1093/eurheartj/ehab772
   Cerrone M, 2019, CIRCULATION, V140, P595, DOI 10.1161/CIRCULATIONAHA.118.035954
   Cerrone M, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00127-0
   Chelko SP, 2021, SCI TRANSL MED, V13, P0, DOI 10.1126/scitranslmed.abf0891
   Chelko SP, 2019, CIRCULATION, V140, P1491, DOI 10.1161/CIRCULATIONAHA.119.040676
   Chen SN, 2019, CIRC RES, V124, P856, DOI 10.1161/CIRCRESAHA.118.314238
   Cheung KG, 2015, J BIOL CHEM, V290, P10981, DOI 10.1074/jbc.M114.607960
   Chollet F, 2017, PROC CVPR IEEE, V0, PP1800, DOI 10.1109/CVPR.2017.195
   Corrado D, 2017, NEW ENGL J MED, V376, P61, DOI 10.1056/NEJMra1509267
   Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412
   Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297
   Earle AJ, 2020, NAT MATER, V19, P464, DOI 10.1038/s41563-019-0563-5
   Groeneweg JA, 2015, CIRC-CARDIOVASC GENE, V8, P437, DOI 10.1161/CIRCGENETICS.114.001003
   Haywood AFM, 2013, EUR HEART J, V34, P1002, DOI 10.1093/eurheartj/ehs383
   Heffler J, 2020, CIRC RES, V126, PE10, DOI 10.1161/CIRCRESAHA.119.315582
   KARTENBECK J, 1983, EMBO J, V2, P735, DOI 10.1002/j.1460-2075.1983.tb01493.x
   Kerr M, 2020, JCI INSIGHT, V5, P0, DOI 10.1172/jci.insight.140326
   Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799
   Kim JC, 2019, CIRCULATION, V140, P1015, DOI 10.1161/CIRCULATIONAHA.119.039710
   Li N, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30817
   Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004
   Linscheid N, 2021, PLOS BIOL, V19, P0, DOI 10.1371/journal.pbio.3001144
   Linscheid N, 2020, MOL CELL PROTEOMICS, V19, P1132, DOI 10.1074/mcp.RA119.001878
   Ljubojevic S, 2014, CIRCULATION, V130, P244, DOI 10.1161/CIRCULATIONAHA.114.008927
   Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6
   Marcus FI, 2010, EUR HEART J, V31, P806, DOI 10.1161/CIRCULATIONAHA.108.840827
   Nicolás-Avila JA, 2020, CELL, V183, P94, DOI 10.1016/j.cell.2020.08.031
   Nishikawa T, 1999, CARDIOVASC PATHOL, V8, P185, DOI 10.1016/S1054-8807(99)00007-1
   Numaga-Tomita T, 2019, PFLUG ARCH EUR J PHY, V471, P507, DOI 10.1007/s00424-018-2211-3
   Pan J, 2017, CANCER PREV RES, V10, P133, DOI 10.1158/1940-6207.capr-16-0129
   Paulo JA, 2019, ANAL CHEM, V91, P12167, DOI 10.1021/acs.analchem.9b03162
   Pérez-Hernández M, 2021, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.623190
   Pérez-Hernández M, 2021, CIRC RES, V128, P419, DOI 10.1161/CIRCRESAHA.120.318239
   Pillai VB, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7656
   Quarta G, 2012, EUR HEART J, V33, P1128, DOI 10.1093/eurheartj/ehr451
   Reid DA, 2021, SCIENCE, V372, P91, DOI 10.1126/science.abb9032
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rouhi L, 2020, CARDIOVASC RES, V117, P2377
   Sato PY, 2018, SCI SIGNAL, V11, P0, DOI 10.1126/scisignal.aau0144
   Srinivas US, 2019, REDOX BIOL, V25, P0, DOI 10.1016/j.redox.2018.101084
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162
   Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560
   Towbin JA, 2019, HEART RHYTHM, V16, PE373, DOI 10.1016/j.hrthm.2019.09.019
   Valente M, 1998, AM J PATHOL, V152, P479
   Zecha J, 2019, MOL CELL PROTEOMICS, V18, P1468, DOI 10.1074/mcp.TIR119.001385
NR 50
TC 20
Z9 20
U1 2
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD SEP 13
PY 2022
VL 146
IS 11
BP 851
EP 867
DI 10.1161/CIRCULATIONAHA.122.060454
PG 17
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 4M2ZI
UT WOS:000853194300014
PM 35959657
DA 2024-11-01
ER

PT J
AU AlMenabawy, N
   Hassaan, HM
   Ramadan, M
   Meguid, IEA
   El Gindy, HA
   Beetz, C
   Selim, L
AF AlMenabawy, Nihal
   Hassaan, Hebatallah M.
   Ramadan, Manal
   Meguid, Iman Ehsan Abdel
   El Gindy, Hala Ahmed
   Beetz, Christian
   Selim, Laila
TI Clinical and genetic spectrum of mitochondrial DNA depletion syndromes: A report of 6 cases with 4 novel variants
SO MITOCHONDRION
LA English
DT Article
ID deoxyguanosine kinase gene; hepatocerebral form; homozygous mutation; fbxl4; tk2; nephronophthisis; encephalopathy; defect
AB Mitochondrial DNA (mtDNA) depletion syndromes (MDS) are a heterogeneous group of rare autosomal recessive genetic disorders characterized by a decrease in the number of mtDNA copies inside the organ involved. There are three distinct forms of MDS including the hepatocerebral, the myopathic and the encephalomyopathic forms. The diversity in the clinical and genetic spectrum of these disorders makes the diagnosis challenging. Here, we describe the clinical phenotype and the genetic spectrum of 6 patients with MDS including 4 novel variants and compare them with previously reported cases. Subject and Methods: Six patients from six unrelated families were included in this study. All the patients were subjected to a detailed history, thorough general and neurologic examination, basic laboratory investigations including lactic acid and ammonia, amino acids, acylcarnitine profiles and brain MRI. Whole-exome sequencing was performed for all of them to confirm the suspicion of mitochondrial disorder. Results: In our series, four patients presented with the hepatocerebral form of MDS with the major presenting manifestation of progressive liver cell failure with severe hypotonia and global developmental delay. Four variants in the DGUOK gene and the MPV17 have been identified including 2 novel variants. One patient was identified in the myopathic form presenting with myopathy associated with two novel variants in the TK2 gene. One patient was diagnosed with encephalomyopathic form presenting with persistent lactic acidosis and global delay due to a homozygous variant in the FBXL4 gene. Conclusion: MDS has a wide spectrum of heterogeneous clinical presentations and about nine different genes involved. Whole exome sequencing (WES) has resulted in faster diagnosis of these challenging cases as the phenotype overlap with many other disorders. This should be considered the first-tier diagnostic test obviating the need for more invasive testing like muscle biopsies.
C1 [AlMenabawy, Nihal; Hassaan, Hebatallah M.; Meguid, Iman Ehsan Abdel; El Gindy, Hala Ahmed; Selim, Laila] Cairo Univ, Children Hosp, Genet Dept, Cairo, Egypt.
   [Ramadan, Manal] Ahmed Maher Teaching Hosp, Pediat Dept, Cairo, Egypt.
   [Beetz, Christian] Centogene, Rostock, Germany.
C3 Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); CENTOGENE AG
RP Hassaan, HM (corresponding author), Cairo Univ, Children Hosp, Genet Dept, Cairo, Egypt.
EM Hebahassaan@outlook.com
CR Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   Almannai M, 2017, GENEREVIEWS, V0, P0
   Ballout RA, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00039
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bellavia S, 2010, NEPHROL DIAL TRANSPL, V25, P4097, DOI 10.1093/ndt/gfq519
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Brahimi N, 2009, MOL GENET METAB, V97, P221, DOI 10.1016/j.ymgme.2009.03.007
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Douglas GV, 2011, J HUM GENET, V56, P834, DOI 10.1038/jhg.2011.112
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   Fang WY, 2017, ONCOTARGET, V8, P84309, DOI 10.18632/oncotarget.20905
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Jankowska I, 2021, CLIN RES HEPATOL GAS, V45, P0, DOI 10.1016/j.clinre.2020.02.018
   Mahjoub G, 2019, BMC MED GENET, V20, P0, DOI 10.1186/s12881-019-0893-9
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mazurova S, 2017, CARDIOL YOUNG, V27, P936, DOI 10.1017/S1047951116001876
   Moalem S, 2013, AM J MED GENET A, V161A, P1792, DOI 10.1002/ajmg.a.36036
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Papadimas George K, 2020, ACTA MYOL, V39, P94, DOI 10.36185/2532-1900-012
   Pyal A, 2017, MITOCHONDRION, V37, P41, DOI 10.1016/j.mito.2017.06.006
   Selim LA, 2017, ADV EXP MED BIOL, V1007, P129, DOI 10.1007/978-3-319-60733-7_8
   Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000
   Smith ED, 2019, GENET MED, V21, P2199, DOI 10.1038/s41436-019-0477-2
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   van Rij MC, 2016, CLIN CASE REP, V4, P425, DOI 10.1002/ccr3.511
   Villarroya J, 2009, EXP CELL RES, V315, P1429, DOI 10.1016/j.yexcr.2009.02.018
NR 35
TC 6
Z9 6
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2022
VL 65
IS 
BP 139
EP 144
DI 10.1016/j.mito.2022.06.004
EA JUN 2022
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 4Y8SD
UT WOS:000861791200001
PM 35750291
DA 2024-11-01
ER

PT J
AU Lam, FC
AF Lam, Fred C.
TI The DNA damage response - from cell biology to human disease
SO JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS
LA English
DT Review
DE DNA damage response; DNA damage repair; mutagenesis; cancer; neurodegeneration; neuropsychiatric disorders; premature aging; clinical outcomes
ID fanconi-anemia pathway; mismatch repair deficiency; strand break repair; transcription-coupled repair; xeroderma-pigmentosum; ataxia-telangiectasia; targeted disruption; cockayne-syndrome; mouse model; genomic instability
AB Maintenance of DNA integrity is crucial for faithful transmission of the genetic code from generation to generation. Our genetic code is constantly under attack from both endogenous and exogenous sources of DNA damage. To ensure genome stability, cells have developed elegant DNA damage repair mechanisms. Defects in DNA damage repair have been linked to several human diseases including promoting oncogenesis, heritable neurodegenerative and neuromuscular diseases caused by unstable DNA repeats, neuropathies and myopathies caused by mutations and rearrangements in mitochondrial DNA, neuropsychiatric disorders, and heritable premature aging syndromes. This review will discuss our current understanding of how these underlying errors in DNA repair contribute to the clinical outcomes of patients who present with these diseases.
C1 [Lam, Fred C.] McMaster Univ, Hamilton Gen Hosp, Fac Hlth Sci, Div Neurosurg, Hamilton, ON L8L 2X2, Canada.
C3 McMaster University
RP Lam, FC (corresponding author), McMaster Univ, Hamilton Gen Hosp, Fac Hlth Sci, Div Neurosurg, Hamilton, ON L8L 2X2, Canada.
EM lamf9@mcmaster.ca
CR Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828
   Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335
   Altmann T, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0520-1
   Andressoo JO, 2005, MUTAT RES-FUND MOL M, V577, P179, DOI 10.1016/j.mrfmmm.2005.04.004
   Anheim M, 2009, BRAIN, V132, P2688, DOI 10.1093/brain/awp211
   Assaf Y, 2008, EXP NEUROL, V209, P181, DOI 10.1016/j.expneurol.2007.09.021
   Baranes K, 2009, EXP NEUROL, V218, P24, DOI 10.1016/j.expneurol.2009.03.026
   Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001
   Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006
   Bohgaki M, 2013, P NATL ACAD SCI USA, V110, P20982, DOI 10.1073/pnas.1320302111
   Brooks PJ, 2008, DNA REPAIR, V7, P1168, DOI 10.1016/j.dnarep.2008.03.016
   Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7
   Carpenter DO, 2013, J ADOLESCENT HEALTH, V52, PS21, DOI 10.1016/j.jadohealth.2013.01.027
   Carreau M, 1998, BLOOD, V91, P2737, DOI 10.1182/blood.V91.8.2737.2737_2737_2744
   Casellas R, 2016, NAT REV IMMUNOL, V16, P164, DOI 10.1038/nri.2016.2
   Ceccaldi R, 2016, NAT REV MOL CELL BIO, V17, P337, DOI 10.1038/nrm.2016.48
   Chan SH, 2021, JNCI CANCER SPECT, V5, P0, DOI 10.1093/jncics/pkaa117
   Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389
   Chatterjee N, 2017, ENVIRON MOL MUTAGEN, V58, P235, DOI 10.1002/em.22087
   Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962
   Chen Lishan, 2002, JOURNAL OF BIOMEDICINE & BIOTECHNOLOGY, V2, P46, DOI 10.1155/S1110724302201011
   Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066
   Cheng NC, 2000, HUM MOL GENET, V9, P1805, DOI 10.1093/hmg/9.12.1805
   Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382
   Chistiakov DA, 2010, ADV EXP MED BIOL, V685, P175
   Chrzanowska KH, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-13
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Croteau DL, 2012, TRENDS GENET, V28, P624, DOI 10.1016/j.tig.2012.08.003
   Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9
   DErrico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277
   de Andrade KC, 2019, HUM MUTAT, V40, P97, DOI 10.1002/humu.23673
   de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174
   De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025
   de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005
   de Villartay JP, 2015, BRIT MED BULL, V114, P157, DOI 10.1093/bmb/ldv020
   de Villartay JP, 2003, NAT REV IMMUNOL, V3, P962, DOI 10.1038/nri1247
   de Villartay JP, 2003, CURR OPIN IMMUNOL, V15, P592, DOI 10.1016/S0952-7915(03)00101-8
   de Wind N, 1998, CANCER RES, V58, P248
   DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4
   di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504
   Divine KK, 2001, MUTAT RES-DNA REPAIR, V461, P273, DOI 10.1016/S0921-8777(00)00059-8
   Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014
   Dumitrache LC, 2017, MECH AGEING DEV, V161, P121, DOI 10.1016/j.mad.2016.04.009
   Durandy Anne, 2007, ADV IMMUNOL, V94, P275, DOI 10.1016/S0065-2776(06)94009-7
   El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314
   Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084
   Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629
   Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054
   Felgentreff K, 2015, J ALLERGY CLIN IMMUN, V136, P140, DOI 10.1016/j.jaci.2015.03.005
   FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3
   Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142
   Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228
   FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630
   Galron R, 2011, J MOL NEUROSCI, V45, P202, DOI 10.1007/s12031-011-9494-6
   Garfinkel David J, 2002, JOURNAL OF BIOMEDICINE & BIOTECHNOLOGY, V2, P55, DOI 10.1155/S1110724302201023
   Gatti RA, 2003, ATAXIA TELANGIECTASIA, V0, P600
   Gennery AR, 2000, CLIN EXP IMMUNOL, V121, P1, DOI 10.1046/j.1365-2249.2000.01257.x
   Gool AJ, 1997, EMBO J, V16, P5955
   Grover S, 2012, JAMA-J AM MED ASSOC, V308, P485, DOI 10.1001/jama.2012.8780
   Guirouilh-Barbat J, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00175
   Guo CW, 2015, J ALLERGY CLIN IMMUN, V136, P1007, DOI 10.1016/j.jaci.2015.06.007
   Haber JE, 2015, CELL, V162, P1183, DOI 10.1016/j.cell.2015.08.034
   Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1
   Hanada K, 2007, CELL MOL LIFE SCI, V64, P2306, DOI 10.1007/s00018-007-7121-z
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Harhouri K, 2018, NUCLEUS-PHILA, V9, P246, DOI 10.1080/19491034.2018.1460045
   Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015
   Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359
   Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346
   HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4
   Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089
   Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
   Ibrahim M, 2018, BMC CANCER, V18, P0, DOI 10.1186/s12885-018-4098-y
   Inlora J, 1900, V3, V0, P0
   Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467
   Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907
   Jiricny J, 2000, CURR OPIN GENET DEV, V10, P157, DOI 10.1016/S0959-437X(00)00066-6
   Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447
   Karikkineth AC, 2017, AGEING RES REV, V33, P3, DOI 10.1016/j.arr.2016.08.002
   Katsuki Y, 2016, ENDOCR-RELAT CANCER, V23, PT19, DOI 10.1530/ERC-16-0221
   Katyal S, 2008, MECH AGEING DEV, V129, P483, DOI 10.1016/j.mad.2008.03.008
   Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0
   Keim C, 2013, GENE DEV, V27, P1, DOI 10.1101/gad.200014.112
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kerzendorfer C, 2009, DNA REPAIR, V8, P1139, DOI 10.1016/j.dnarep.2009.04.018
   Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372
   Kote-Jarai Z, 2011, BRIT J CANCER, V105, P1230, DOI 10.1038/bjc.2011.383
   Kracker S, 2010, ADV EXP MED BIOL, V685, P166
   Kraemer KH, 2015, PHOTOCHEM PHOTOBIOL, V91, P452, DOI 10.1111/php.12345
   KRAEMER KH, 1984, CARCINOGENESIS, V5, P511, DOI 10.1093/carcin/5.4.511
   KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241
   Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161
   Lanz MC, 2019, EMBO J, V38, P0, DOI 10.15252/embj.2019101801
   Laugel V, 2008, J MED GENET, V45, P564, DOI 10.1136/jmg.2007.057141
   Laugel V, 2013, MECH AGEING DEV, V134, P161, DOI 10.1016/j.mad.2013.02.006
   Lavin MF, 2013, DNA REPAIR, V12, P612, DOI 10.1016/j.dnarep.2013.04.014
   Quyen PL, 2020, AM J MED GENET A, V182, P1236, DOI 10.1002/ajmg.a.61520
   Lehmann J, 2018, ANTICANCER RES, V38, P1159, DOI 10.21873/anticanres.12335
   Levy-Lahad E, 2010, NAT GENET, V42, P368, DOI 10.1038/ng0510-368
   Li JW, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-24232-3
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266
   Liu FJ, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011152
   Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104
   Livingston JH, 2016, NEUROPEDIATRICS, V47, P355, DOI 10.1055/s-0036-1592307
   Lomax ME, 2013, CLIN ONCOL-UK, V25, P578, DOI 10.1016/j.clon.2013.06.007
   Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908
   Luong TT, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12121919
   Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034
   Martin LJ, 2018, J NEUROPATH EXP NEUR, V77, P636, DOI 10.1093/jnen/nly040
   Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549
   MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6
   Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101
   Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222
   Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189
   Moreira MC, 1993, ATAXIA WITH OCULOMOTOR APRAXIA TYPE 2, V0, P0
   Morimoto M, 1993, SCHIMKE IMMUNOOSSEOUS DYSPLASIA, V0, P0
   Morio T, 2017, INT J HEMATOL, V106, P357, DOI 10.1007/s12185-017-2263-8
   Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9
   Murai M, 2001, P NATL ACAD SCI USA, V98, P13379, DOI 10.1073/pnas.231329598
   Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420
   Nalepa G, 2018, NAT REV CANCER, V18, P168, DOI 10.1038/nrc.2017.116
   Natale V, 2011, AM J MED GENET A, V155A, P1081, DOI 10.1002/ajmg.a.33933
   Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885
   Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858
   Niraj J, 2019, ANNU REV CANC BIOL, V3, P457, DOI 10.1146/annurev-cancerbio-030617-050422
   ODriscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129
   ODriscoll M, 2008, DNA REPAIR, V7, P1039, DOI 10.1016/j.dnarep.2008.03.018
   Oshima J, 2017, AGEING RES REV, V33, P105, DOI 10.1016/j.arr.2016.03.002
   Otake M, 1998, INT J RADIAT BIOL, V74, P159, DOI 10.1080/095530098141555
   Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350
   PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J
   Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2
   Perez H, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.64695
   Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2
   Pilié PG, 2019, NAT REV CLIN ONCOL, V16, P81, DOI 10.1038/s41571-018-0114-z
   Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678
   Prakash R, 2015, CSH PERSPECT BIOL, V7, P0, DOI 10.1101/cshperspect.a016600
   Qamar N, 2014, CLIN REV ALLERG IMMU, V46, P120, DOI 10.1007/s12016-013-8378-7
   Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043
   Reynolds JJ, 2013, BRAIN, V136, P14, DOI 10.1093/brain/aws310
   Reynolds JJ, 2012, NUCLEIC ACIDS RES, V40, P6608, DOI 10.1093/nar/gks318
   Richardson C, 2004, DNA REPAIR, V3, P1149, DOI 10.1016/j.dnarep.2004.05.007
   Root H, 2016, HUM MOL GENET, V25, P3255, DOI 10.1093/hmg/ddw175
   RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013
   Ryan E, 2017, CRIT REV ONCOL HEMAT, V116, P38, DOI 10.1016/j.critrevonc.2017.05.006
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Savage SA, 2009, HEMATOL ONCOL CLIN N, V23, P215, DOI 10.1016/j.hoc.2009.01.003
   Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Seidle HF, 2005, J BIOL CHEM, V280, P20927, DOI 10.1074/jbc.M502889200
   Sharma R, 2020, FRONT PEDIATR, V8, P0, DOI 10.3389/fped.2020.570084
   Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526
   Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609
   Sidorova JM, 2014, ADV GENOMICS GENET, V5, P19
   Specks Julia, 2015, METHODS MOL BIOL, V1267, P413, DOI 10.1007/978-1-4939-2297-0_21
   Spring K, 2001, CANCER RES, V61, P4561
   Spry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4191, DOI 10.2741/2380
   Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042
   Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0
   Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X
   Tai YC, 2007, J NATL CANCER I, V99, P1811, DOI 10.1093/jnci/djm203
   Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987
   Tal E, 2018, DNA REPAIR, V72, P10, DOI 10.1016/j.dnarep.2018.10.001
   Tilgner K, 2013, STEM CELLS, V31, P2015, DOI 10.1002/stem.1456
   Tiwari V, 2019, AM J HUM GENET, V105, P237, DOI 10.1016/j.ajhg.2019.06.005
   Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9
   van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002
   van Wietmarschen N, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-017-02760-1
   vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8
   Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976
   Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864
   Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010
   Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010
   Welty S, 2018, J BIOL CHEM, V293, P1353, DOI 10.1074/jbc.M117.808402
   Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287
   Whitney MA, 1996, BLOOD, V88, P49
   Wiesmueller Lisa, 2002, JOURNAL OF BIOMEDICINE & BIOTECHNOLOGY, V2, P45, DOI 10.1155/S1110724302001985
   Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002
   Wilson BT, 2016, GENET MED, V18, P483, DOI 10.1038/gim.2015.110
   Wimmer K, 2014, J MED GENET, V51, P355, DOI 10.1136/jmedgenet-2014-102284
   Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743
   Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401
   Yang YG, 2006, DNA REPAIR, V5, P885, DOI 10.1016/j.dnarep.2006.05.004
   Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7
NR 189
TC 11
Z9 11
U1 4
U2 4
PU OAE PUBLISHING INC
PI ALHAMBRA
PA 245 E MAIN ST, ST122, ALHAMBRA, CA 91801 USA
SN 
EI 2578-5281
J9 J TRANSL GENET GENOM
JI J. Transl. Genet. Genom.
PD JUN 15
PY 2022
VL 6
IS 2
BP 204
EP 222
DI 10.20517/jtgg.2021.61
PG 19
WC Genetics & Heredity
SC Genetics & Heredity
GA OO1I0
UT WOS:001208119200006
DA 2024-11-01
ER

PT J
AU Sengupta, D
   Sengupta, K
AF Sengupta, Duhita
   Sengupta, Kaushik
TI Lamin A and telomere maintenance in aging: Two to Tango
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE Lamin A; Telomere; HGPS; Aging
ID nuclear-envelope; fibroblasts; expression; chromatin; progerin; cells; progression; senescence; periphery; mutant
AB Lamin proteins which constitute the nuclear lamina in almost all higher eukaryotes, are mainly of two types A & B encoded by LMNA and LMNB1/B2 genes respectively. While lamin A remains the principal product of LMNA gene, variants like lamin C, C2 and A Delta 10 are also formed as alternate splice products. Role of lamin A in aging has been highlighted in recent times due to its association with progeroid or premature aging syndromes which is classified as a type of laminopathy. Progeria caused by accelerated accumulation of lamin A Delta 50 or progerin occurs due to a mutation in this LMNA gene leading to defects in post translational modification of lamin A. One of the most common and severe symptoms of progeroid laminopathy is accelerated cellular senescence or aging along with bone resorption, muscle weakness, lipodystrophy and cardiovascular disorders. On the other hand, progerin accumulation and telomere dysfunction merge as common traits in the process of chronological aging. Two major hallmarks of physiological aging in humans include loss of genomic integrity and telomere attrition which can result from defective laminar organization leading to deformed nuclear architecture and culminates into replicative senescence. This also adversely affects epigenetic landscape, mitochondrial dysfunction and several signalling pathways like DNA repair, mTOR, MAPK, TGF beta. In this review, we discuss the telomere-lamina interplay in the context of physiological aging and progeria.
C1 [Sengupta, Duhita; Sengupta, Kaushik] Saha Inst Nucl Phys, 1-AF Bidhannagar, Kolkata 700064, West Bengal, India.
   [Sengupta, Duhita; Sengupta, Kaushik] Homi Bhabha Natl Inst, Training Sch Complex, Mumbai 400094, India.
C3 Saha Institute of Nuclear Physics; Homi Bhabha National Institute
RP Sengupta, K (corresponding author), Saha Inst Nucl Phys, 1-AF Bidhannagar, Kolkata 700064, West Bengal, India.
EM kaushik.sengupta@saha.ac.in
CR Afilalo J, 2007, AM J PHYSIOL-HEART C, V293, PH1451, DOI 10.1152/ajpheart.01194.2006
   Ahn J, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-11684-x
   Arai Y, 2015, EBIOMEDICINE, V2, P1549, DOI 10.1016/j.ebiom.2015.07.029
   Arii J, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-75852-6
   Ashapkin VV, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00455
   Baek JH, 2015, HUM MOL GENET, V24, P1305, DOI 10.1093/hmg/ddu541
   Bajpai G, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.63976
   Bedrosian TA, 2021, EMBO J, V40, P0, DOI 10.15252/embj.2020105819
   Benson EK, 2010, J CELL SCI, V123, P2605, DOI 10.1242/jcs.067306
   Bhattacharjee P, 2017, BBA-GEN SUBJECTS, V1861, P2598, DOI 10.1016/j.bbagen.2017.08.016
   Brunet A, 2021, NUCLEUS-PHILA, V12, P6, DOI 10.1080/19491034.2020.1868105
   Burla R, 2020, NUCLEUS-PHILA, V11, P205, DOI 10.1080/19491034.2020.1806661
   Casciaro F, 2018, AGING-US, V10, P2911, DOI 10.18632/aging.101599
   Cenni V, 2020, AGEING RES REV, V62, P0, DOI 10.1016/j.arr.2020.101073
   Chen L, 2019, J GERONTOL A-BIOL, V74, P91, DOI 10.1093/gerona/gly223
   Chen RJ, 2017, CELL DEATH DIS, V8, P0, DOI 10.1038/cddis.2017.333
   Cho S, 2019, DEV CELL, V49, P920, DOI 10.1016/j.devcel.2019.04.020
   Chojnowski A, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.07759
   Cohen-Carmon D, 2020, MOL NEUROBIOL, V57, P1768, DOI 10.1007/s12035-019-01839-8
   Das A, 2013, NUCLEUS-AUSTIN, V4, P410, DOI 10.4161/nucl.26873
   De Majo F, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2022974118
   Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104
   Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297
   Erdos MR, 2021, NAT MED, V27, P536, DOI 10.1038/s41591-021-01274-0
   Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196
   Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357
   Hartmann A, 2021, FRONT GENET, V12, P0, DOI 10.3389/fgene.2021.686320
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Hilton BA, 2017, FASEB J, V31, P3882, DOI 10.1096/fj.201700014R
   Huang S, 2008, EXP CELL RES, V314, P82, DOI 10.1016/j.yexcr.2007.08.004
   Katsumata K, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1006304
   Kawamura T, 2021, OXID MED CELL LONGEV, V2021, P0, DOI 10.1155/2021/5566880
   Koblan LW, 2021, NATURE, V589, P608, DOI 10.1038/s41586-020-03086-7
   Komari CJ, 2020, DNA REPAIR, V96, P0, DOI 10.1016/j.dnarep.2020.102975
   Kronenberg-Tenga R, 2021, J CELL SCI, V134, P0, DOI 10.1242/jcs.256156
   Kychygina A, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-92631-z
   Lacavalla MA, 2021, EUR J HISTOCHEM, V65, P0, DOI 10.4081/ejh.2021.3229
   Li W, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21010062
   Li YH, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12979
   Margalef P, 2018, CELL, V172, P439, DOI 10.1016/j.cell.2017.11.047
   Martins F, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13143
   Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205
   McClintock D, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0001269
   Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898
   Misteli T, 2021, CELL, V184, P293, DOI 10.1016/j.cell.2020.12.029
   Morgan RG, 2019, J MOL CELL CARDIOL, V127, P74, DOI 10.1016/j.yjmcc.2018.11.014
   Mukherjee C, 2021, SOFT MATTER, V17, P6787, DOI 10.1039/d1sm00293g
   Naetar N, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.63476
   Ottaviani A, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000394
   Pan XM, 2020, FASEB J, V34, P7905, DOI 10.1096/fj.201903048RR
   Ranade D, 2019, BMC MOL CELL BIOL, V20, P0, DOI 10.1186/s12860-019-0192-5
   Rauschert I, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0175953
   Röhrl JM, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10010153
   Rogerson C, 2021, CELL DEATH DIFFER, V28, P1849, DOI 10.1038/s41418-020-00712-9
   Romero-Bueno R, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8070664
   Sapra KT, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-20049-8
   Skoczynska A, 2015, MENOPAUSE REV, V14, P53, DOI 10.5114/pm.2015.49532
   Srivastava LK, 2021, J CELL SCI, V134, P0, DOI 10.1242/jcs.248559
   Stroik S, 2020, NUCLEIC ACIDS RES, V48, P4960, DOI 10.1093/nar/gkaa199
   Tedone E, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12859
   Travina AO, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22073293
   Tsoukalas D, 2021, INT J MOL MED, V48, P0, DOI 10.3892/ijmm.2021.5032
   Vautrot V, 2016, HUM MUTAT, V37, P280, DOI 10.1002/humu.22945
   Wheaton K, 2017, MOL CELL BIOL, V37, P0, DOI 10.1128/MCB.00659-16
   Willaume S, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12040552
   Wood AM, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6467
   Yu KR, 2013, J CELL SCI, V126, P5422, DOI 10.1242/jcs.133314
   Zhang J, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13215
   Zorin V, 2019, AGING-US, V11, P4536, DOI 10.18632/aging.102067
   Zwerger M, 2015, J CELL SCI, V128, P3607, DOI 10.1242/jcs.171843
NR 70
TC 6
Z9 6
U1 0
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0027-5107
EI 1873-135X
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD JUL-DEC 15
PY 2022
VL 825
IS 
BP 
EP 
DI 10.1016/j.mrfmmm.2022.111788
EA JUN 2022
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 2C4RX
UT WOS:000810858700001
DA 2024-11-01
ER

PT J
AU Tajane, TD
   Waghmare, PJ
   Taksande, BA
   Ambulkar, PS
   Waghmare, JE
AF Tajane, Tejas Dilip
   Waghmare, Pranita Jwalant
   Taksande, Bharati Amar
   Ambulkar, Prafulla Shriram
   Waghmare, Jwalant Eknath
TI Role of Mitochondrial Dynamics in Type 2 Diabetes Mellitus Dysfunction
SO JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
LA English
DT Review
DE Insulin sensitivity; Oxidative markers; Oxidative stress
ID oxidative stress; insulin-resistance; dna deletions; mechanisms; muscle; repair; cells; complications; isoprostanes; antioxidants
AB Type 2 Diabetes Mellitus (T2DM) is influenced by the action of both hereditary and environmental factors. These factors are comprehended in the disease interaction with beta cells and insulin sensitivity to the receptors.The main cause of T2DM development is ageing, obesity, and oxidative stress. The dysfunction of the beta cells of the pancreas leads to insulin insensitivity in the liver, muscle and fat metabolism. These occur due to the result of oxidative stress. Lipid peroxidation is a key initiating factor in the development of oxidative stress, which results in T2DM and its related micro-and macro-vascular problems. These are initially compensated for the generation of excess insulin synthesis, thus ensuring normal glucose tolerance. When these compensatory processes are disrupted, the majority of persons develop T2DM. Although the gene is the primary cause of T2DM, the environment also plays an important role in the disease's progression. Particularly, a sedentary lifestyle characterised by excessive food consumption and physical inactivity is a known risk factor for obesity and type 2 diabetes. This review has briefly discussed the significance of numerous causal factors, and genomic and biochemical pathways which are responsible for increasing the production of oxidative stress, a crucial component for the etiology and development of T2DM. The conclusion drawn was that the analysis of oxidative stress markers may be one of the potential methods for the diagnosis and prognosis of T2DM. Furthermore, this review will be helpful to establish the broaden conceptual framework for future studies on oxidative stress with relation to etiology of type 2 diabetes and therapeutic development.
C1 [Tajane, Tejas Dilip; Waghmare, Jwalant Eknath] Mahatma Gandhi Inst Med Sci, Dept Anat, Wardha, Maharashtra, India.
   [Waghmare, Pranita Jwalant] Mahatma Gandhi Inst Med Sci, Dept Biochem, Wardha, Maharashtra, India.
   [Taksande, Bharati Amar] Mahatma Gandhi Inst Med Sci, Dept Med, Wardha, Maharashtra, India.
   [Ambulkar, Prafulla Shriram] Mahatma Gandhi Inst Med Sci, Ctr Genet & Genom, Dept Anat, Wardha, Maharashtra, India.
C3 Mahatma Gandhi Institute of Medical Sciences, Sevagram; Mahatma Gandhi Institute of Medical Sciences, Sevagram; Mahatma Gandhi Institute of Medical Sciences, Sevagram; Mahatma Gandhi Institute of Medical Sciences, Sevagram
RP Waghmare, JE (corresponding author), Mahatma Gandhi Inst Med Sci, Dept Anat, Wardha, Maharashtra, India.
EM jewaghmare@mgims.ac.in
FU Indian Council of Medical Research (ICMR), New Delhi, India [5/4/5-10/Diab./20-NCD-III]
CR Amer Diabet Assoc, 2005, DIABETES CARE, V28, P0
   [Anonymous], 2022, DIABETES, V0, P0
   Banerjee M, 2014, REDOX BIOL, V2, P170, DOI 10.4103/0971-6866.132747
   Baysal BE, 2001, J MOL MED, V79, P495, DOI 10.1007/s001090100267
   Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bigagli E, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/5953685
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Boguszewska K, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25122857
   Boldinova EO, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20133279
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Burgstaller JP, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04797-2
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Cui Hang, 2012, J SIGNAL TRANSDUCT, V2012, P646354, DOI 10.1155/2012/646354
   Czerska M, 2016, INT J OCCUP MED ENV, V29, P179, DOI 10.13075/ijomeh.1896.00596
   Daryabor G, 2020, FRONT IMMUNOL, V11, P0, DOI 10.3389/fimmu.2020.01582
   Diabetes A, 2022, FACTAND FIG, V0, P0
   Ding Y, 2022, DIABET METAB SYND OB, V15, P1687, DOI 10.2147/DMSO.S363978
   dos Santos KG, 2006, DIS MARKERS, V22, P355, DOI 10.1155/2006/983408
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Formosa LE, 2018, NAT CELL BIOL, V20, P511, DOI 10.1038/s41556-018-0098-z
   Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665
   Garcia I, 2017, FRONT BIOSCI-LANDMRK, V22, P710, DOI 10.2741/4511
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Goth Laszlo, 2004, MOL DIAGN, V8, P141
   Gryszczynska B, 2017, BIOMED RES INT, V2017, P0, DOI 10.1155/2017/4975264
   Hahn A, 2019, TRENDS CELL BIOL, V29, P227, DOI 10.1016/j.tcb.2018.11.004
   Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hotta N, 2010, J DIABETES INVEST, V1, P134, DOI 10.1111/j.2040-1124.2010.00037.x
   Kaneto H, 2012, INT J MOL SCI, V13, P13680, DOI 10.3390/ijms131013680
   Kato Y, 2009, J CLIN BIOCHEM NUTR, V44, P67, DOI 10.3164/jcbn.08-185
   Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lacolley P, 2017, PHYSIOL REV, V97, P1555, DOI 10.1152/physrev.00003.2017
   Lee JH, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20194924
   Lephart ED, 2018, COSMETICS-BASEL, V5, P0, DOI 10.3390/cosmetics5010016
   Leyane TS, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23137273
   Lönn ME, 2012, FREE RADICAL BIO MED, V53, P863, DOI 10.1016/j.freeradbiomed.2012.05.027
   Ma ZA, 2012, EXP DIABETES RES, V2012, P1
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Mandal M, 2019, CLIN DIABETOL, V8, P215, DOI 10.5603/DK.2019.0015
   Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001
   Martinez-Moral MP, 2022, ANAL BIOANAL CHEM, V414, P2103, DOI 10.1007/s00216-021-03844-0
   Montgomery MK, 2015, ENDOCR CONNECT, V4, P0, DOI 10.1530/EC-14-0092
   Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev
   Nandi A, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/9613090
   NICHOLLS DG, 1977, BIOCHEM SOC T, V5, P200, DOI 10.1042/bst0050200
   Nissanka N, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201949612
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Volpe CMO, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-017-0135-z
   Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012
   Patel DK, 2011, ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE, V1, P316, DOI 10.1016/S2221-1691(11)60051-8
   Poetsch AR, 2020, COMPUT STRUCT BIOTEC, V18, P207, DOI 10.1016/j.csbj.2019.12.013
   Prasun P, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165838
   Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012
   Ritter O, 2015, J MOL MED, V93, P831, DOI 10.1007/s00109-015-1310-2
   Robinson KN, 2020, ENDOCR PRACT, V26, P241, DOI 10.4158/EP-2019-0270
   Roger AJ, 2017, CURR BIOL, V27, PR1177, DOI 10.1016/j.cub.2017.09.015
   Rong ZY, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.669379
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013
   Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006
   Sharifi-Rad M, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00694
   Singh A, 2022, MOLECULES, V27, P0, DOI 10.3390/molecules27030950
   Singh S, 2019, ASIAN J PHARMA CLIN, V0, P204
   St John JC, 2010, HUM REPROD UPDATE, V16, P488, DOI 10.1093/humupd/dmq002
   Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015
   Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754
   Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456
   Thrash JC, 2011, SCI REP-UK, V1, P0, DOI 10.1038/srep00013
   Tiwari Brahm Kumar, 2013, J BIOMARK, V2013, P378790, DOI 10.1155/2013/378790
   Urbaniak SK, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25010202
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   Vera-Ramirez L, 2012, CANCER LETT, V327, P134, DOI 10.1016/j.canlet.2011.12.029
   Vona R, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/8267234
   Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030
   Westermann B, 2008, J BIOL CHEM, V283, P13501, DOI 10.1074/jbc.R800011200
   Westermann B, 2014, BBA-BIOENERGETICS, V1837, P1039, DOI 10.1016/j.bbabio.2013.10.005
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Yang Q, 2018, NAT REV MOL CELL BIO, V19, P654, DOI 10.1038/s41580-018-0044-8
   Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336
NR 84
TC 0
Z9 0
U1 1
U2 1
PU PREMCHAND SHANTIDEVI RESEARCH FOUNDATION
PI DELHI
PA 71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA
SN 2249-782X
EI 0973-709X
J9 J CLIN DIAGN RES
JI J. Clin. Diagn. Res.
PD NOV 15
PY 2022
VL 16
IS 11
BP GE1
EP GE7
DI 10.7860/JCDR/2022/59325.17165
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 6P4BI
UT WOS:000890875200002
DA 2024-11-01
ER

PT J
AU Lechuga-Vieco, AV
   Latorre-Pellicer, A
   Calvo, E
   Torroja, C
   Pellico, J
   Acín-Pérez, R
   García-Gil, ML
   Santos, A
   Bagwan, N
   Bonzon-Kulichenko, E
   Magni, R
   Benito, M
   Justo-Méndez, R
   Simon, AK
   Sánchez-Cabo, F
   Vázquez, J
   Ruíz-Cabello, J
   Enríquez, JA
AF Victoria Lechuga-Vieco, Ana
   Latorre-Pellicer, Ana
   Calvo, Enrique
   Torroja, Carlos
   Pellico, Juan
   Acin-Perez, Rebeca
   Luisa Garcia-Gil, Maria
   Santos, Arnoldo
   Bagwan, Navratan
   Bonzon-Kulichenko, Elena
   Magni, Ricardo
   Benito, Marina
   Justo-Mendez, Raquel
   Katharina Simon, Anna
   Sanchez-Cabo, Fatima
   Vazquez, Jesus
   Ruiz-Cabello, Jesus
   Antonio Enriquez, Jose
TI Heteroplasmy of Wild-Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty
SO CIRCULATION
LA English
DT Article
DE DNA; mitochondrial; haplotypes; heart diseases; heteroplasmy; hypertension; pulmonary; mice; oxidative phosphorylation
ID arterial-hypertension; pronuclear transfer; stromal cells; mtdna; segregation; replacement; evolution; autophagy; responses; selection
AB Background: In most eukaryotic cells, the mitochondrial DNA (mtDNA) is transmitted uniparentally and present in multiple copies derived from the clonal expansion of maternally inherited mtDNA. All copies are therefore near-identical, or homoplasmic. The presence of >1 mtDNA variant in the same cytoplasm can arise naturally or result from new medical technologies aimed at preventing mitochondrial genetic diseases and improving fertility. The latter is called divergent nonpathologic mtDNA heteroplasmy (DNPH). We hypothesized that DNPH is maladaptive and usually prevented by the cell. Methods: We engineered and characterized DNPH mice throughout their lifespan using transcriptomic, metabolomic, biochemical, physiologic, and phenotyping techniques. We focused on in vivo imaging techniques for noninvasive assessment of cardiac and pulmonary energy metabolism. Results: We show that DNPH impairs mitochondrial function, with profound consequences in critical tissues that cannot resolve heteroplasmy, particularly cardiac and skeletal muscle. Progressive metabolic stress in these tissues leads to severe pathology in adulthood, including pulmonary hypertension and heart failure, skeletal muscle wasting, frailty, and premature death. Symptom severity is strongly modulated by the nuclear context. Conclusions: Medical interventions that may generate DNPH should address potential incompatibilities between donor and recipient mtDNA.
C1 [Victoria Lechuga-Vieco, Ana; Magni, Ricardo; Benito, Marina; Justo-Mendez, Raquel; Ruiz-Cabello, Jesus] Ctr Nacl Invest Cardiovasc carlos III, Melchor Fernandez Almagro 3, Madrid 28029, Spain.
   [Victoria Lechuga-Vieco, Ana; Katharina Simon, Anna] Univ Oxford, Kennedy Inst Rheumatol, NDORMS, Oxford, England.
   [Victoria Lechuga-Vieco, Ana; Pellico, Juan; Santos, Arnoldo; Ruiz-Cabello, Jesus] Ciber Enfermedades Respiratorias CIBERES, Madrid, Spain.
   [Latorre-Pellicer, Ana] Univ Zaragoza, Dept Pharmacol Physiol, Sch Med, Unit Clin Genet & Funct Genom,IIS Aragon, Zaragoza, Spain.
   [Luisa Garcia-Gil, Maria] Univ Complutense Madrid, Ctr Nacl Microscopia Elect ICTS CNME, Madrid, Spain.
   [Santos, Arnoldo] ITC Ingenioria & Tecn Clin, Madrid, Spain.
   [Bonzon-Kulichenko, Elena; Vazquez, Jesus] Ciber Enfermedades Cardiova Dates CIBERCV, Madrid, Spain.
   [Ruiz-Cabello, Jesus] CIC biomaGUNE, Doniostia San Sebastian, Spain.
   [Ruiz-Cabello, Jesus] Basque Fdn Sci, IKE RBASOUE, Bilbao, Spain.
   [Ruiz-Cabello, Jesus] Univ Complutense Madrid, Madrid, Spain.
   [Antonio Enriquez, Jose] Ciber Fragilidad & Envejecimiento Saludable CIBER, Madrid, Spain.
   [Pellico, Juan] Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England.
C3 Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Oxford; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Zaragoza; Complutense University of Madrid; CIC biomaGUNE; Basque Foundation for Science; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERFES; University of London; King's College London
RP Enríquez, JA (corresponding author), Ctr Nacl Invest Cardiovasc carlos III, Melchor Fernandez Almagro 3, Madrid 28029, Spain.
EM jaenriquez@cnic.es
FU European Molecular Biology Organization [ALTF115-2019]; Ministerio de Ciencia e Innovacion [SAF2015-65633-R, RTI2018-099357-B-I00, PGC2018-097019-B-I00, PRB3-IPT17/0019/0003-ISCIII-SGEFI/ERDF, SVP-2013-068089]; Humand Frontier Science Program [RGP0016/2018]; Ministerio de Economia, Industria y Competitivida [SAF2017-84494-C2-R]; Programa Red Guipuzcoana de Ciencia, Tecnologia e Informacion [2018-CIEN-000058-01]; Gobierno Vasco, Dpto Industria, Innovacion, Comercio y Turismo under the ELKARTEK Program [KK-2019/bmG19]; BBVA Foundation (Ayudas a Equipos de Investigacion Cientifica Biomedicina 2018); Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency [MDM-2017-0720]; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [796721]; Fundacio MaratoTV3 [122/C/2015]; "la Caixa" Banking Foundation [HR17-00247]; Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion; Pro Centro Nacional de Investigaciones Cardiovasculares Foundation; Marie Curie Actions (MSCA) [796721] Funding Source: Marie Curie Actions (MSCA)
CR Acton BM, 2007, BIOL REPROD, V77, P569, DOI 10.1095/biolreprod.107.060806
   Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   Enríquez JA, 2019, NAT METAB, V1, P5, DOI 10.1038/s42255-018-0018-3
   Baertling F, 2017, HUM MUTAT, V38, P692, DOI 10.1002/humu.23210
   Bagwan N, 2018, CELL REP, V23, P3685, DOI 10.1016/j.celrep.2018.05.080
   Barritt JA, 2001, HUM REPROD UPDATE, V7, P428, DOI 10.1093/humupd/7.4.428
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739
   Ben Chorin A, 2020, PROTEIN SCI, V29, P258, DOI 10.1002/pro.3779
   Bray AW, 2017, CURR OPIN CARDIOL, V32, P267, DOI 10.1097/HCO.0000000000000383
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Fernández-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148
   Fragoso CAV, 2019, EXP GERONTOL, V115, P96, DOI 10.1016/j.exger.2018.11.023
   Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796
   Garcia-Alvarez A, 2013, J AM COLL CARDIOL, V62, P1621, DOI 10.1016/j.jacc.2013.07.037
   García-Marqués F, 2016, MOL CELL PROTEOMICS, V15, P1740, DOI 10.1074/mcp.M115.055905
   Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Johnston IG, 2016, AM J HUM GENET, V99, P1150, DOI 10.1016/j.ajhg.2016.09.016
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Kim SJ, 2015, INT J MOL SCI, V16, P21486, DOI 10.3390/ijms160921486
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Lane N, 2012, CELL, V151, P246, DOI 10.1016/j.cell.2012.09.028
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Martínez-Bartolomé S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200
   McCully JD, 2009, AM J PHYSIOL-HEART C, V296, PH94, DOI 10.1152/ajpheart.00567.2008
   Meirelles FV, 1997, GENETICS, V145, P445
   Navarro P, 2014, J PROTEOME RES, V13, P1234, DOI 10.1021/pr4006958
   Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h
   Plotnikov EY, 2010, EXP CELL RES, V316, P2447, DOI 10.1016/j.yexcr.2010.06.009
   Roushandeh AM, 2019, CYTOTECHNOLOGY, V71, P647, DOI 10.1007/s10616-019-00302-9
   Royrvik EC, 2016, MOL HUM REPROD, V22, P809, DOI 10.1093/molehr/gaw062
   Ryan JJ, 2015, CIRCULATION, V131, P1691, DOI 10.1161/CIRCULATIONAHA.114.006979
   Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333
   Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Spindler M, 2002, AM J PHYSIOL-HEART C, V283, PH680, DOI 10.1152/ajpheart.00800.2001
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Takeda K, 2000, GENETICS, V155, P777
   Talati M, 2015, PULM CIRC, V5, P269, DOI 10.1086/681227
   Theophilus BDM, 2002, METHODS MOL BIOL, V187, P57, DOI 10.1007/978-1-60761-947-5
   Trevisan-Herraz M, 2019, BIOINFORMATICS, V35, P1594, DOI 10.1093/bioinformatics/bty815
   TUFT SJ, 1986, INVEST OPHTH VIS SCI, V27, P1199
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   Lechuga-Vieco AV, 2021, IUBMB LIFE, V73, P511, DOI 10.1002/iub.2434
   Lechuga-Vieco AV, 2020, SCI ADV, V6, P0, DOI 10.1126/sciadv.aba5345
   Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5
   Woods DC, 2015, SEMIN REPROD MED, V33, P410, DOI 10.1055/s-0035-1567826
   Yonova-Doing E, 2021, NAT GENET, V53, P982, DOI 10.1038/s41588-021-00868-1
NR 59
TC 12
Z9 12
U1 4
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD APR 5
PY 2022
VL 145
IS 14
BP 1084
EP 1101
DI 10.1161/CIRCULATIONAHA.121.056286
PG 18
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 0C2ZS
UT WOS:000775188200009
PM 35236094
DA 2024-11-01
ER

PT J
AU Bellanti, F
   Buglio, AL
   Vendemiale, G
AF Bellanti, Francesco
   Buglio, Aurelio Lo
   Vendemiale, Gianluigi
TI Muscle Delivery of Mitochondria-Targeted Drugs for the Treatment of Sarcopenia: Rationale and Perspectives
SO PHARMACEUTICS
LA English
DT Review
DE sarcopenia; mitochondrial dysfunction; oxidative stress
ID age-related-changes; vastus lateralis muscle; dna deletion mutations; skeletal-muscle; fiber types; oxidative capacity; protein-metabolism; acute exercise; older women; young
AB An impairment in mitochondrial homeostasis plays a crucial role in the process of aging and contributes to the incidence of age-related diseases, including sarcopenia, which is defined as an age-dependent loss of muscle mass and strength. Mitochondrial dysfunction exerts a negative impact on several cellular activities, including bioenergetics, metabolism, and apoptosis. In sarcopenia, mitochondria homeostasis is disrupted because of reduced oxidative phosphorylation and ATP generation, the enhanced production of reactive species, and impaired antioxidant defense. This review re-establishes the most recent evidence on mitochondrial defects that are thought to be relevant in the pathogenesis of sarcopenia and that may represent promising therapeutic targets for its prevention/treatment. Furthermore, we describe mechanisms of action and translational potential of promising mitochondria-targeted drug delivery systems, including molecules able to boost the metabolism and bioenergetics, counteract apoptosis, antioxidants to scavenge reactive species and decrease oxidative stress, and target mitophagy. Even though these mitochondria-delivered strategies demonstrate to be promising in preclinical models, their use needs to be promoted for clinical studies. Therefore, there is a compelling demand to further understand the mechanisms modulating mitochondrial homeostasis, to characterize powerful compounds that target muscle mitochondria to prevent sarcopenia in aged people.
C1 [Bellanti, Francesco; Buglio, Aurelio Lo; Vendemiale, Gianluigi] Univ Foggia, Dept Med & Surg Sci, Viale Pinto 1, I-71122 Foggia, Italy.
C3 University of Foggia
RP Vendemiale, G (corresponding author), Univ Foggia, Dept Med & Surg Sci, Viale Pinto 1, I-71122 Foggia, Italy.
EM gianluigi.vendemiale@unifg.it
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, PE672, DOI 10.1152/ajpendo.00043.2007
   Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, P0, DOI 10.1186/1556-276X-8-102
   Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200
   Armstrong JS, 2007, BRIT J PHARMACOL, V151, P1154, DOI 10.1038/sj.bjp.0707288
   Beavers KM, 2013, AM J CLIN NUTR, V97, P552, DOI 10.3945/ajcn.112.047860
   Bellanti F, 2021, BIOLOGY-BASEL, V10, P0, DOI 10.3390/biology10010031
   BEREGI E, 1988, Z GERONTOL, V21, P83
   Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Callahan DM, 2013, CURR OPIN CLIN NUTR, V16, P66, DOI 10.1097/MCO.0b013e32835a8842
   Campbell MD, 2019, FREE RADICAL BIO MED, V134, P268, DOI 10.1016/j.freeradbiomed.2018.12.031
   Carter HN, 2018, J PHYSIOL-LONDON, V596, P3567, DOI 10.1113/JP275998
   Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014
   Cento AS, 2022, CURR OSTEOPOROS REP, V20, P249, DOI 10.1007/s11914-022-00739-6
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Chamberlain GR, 2013, ACS CHEM BIOL, V8, P1389, DOI 10.1021/cb400095v
   Chen CCW, 2018, AM J PHYSIOL-ENDOC M, V315, PE404, DOI 10.1152/ajpendo.00391.2017
   Cholok D, 2017, J TRAUMA ACUTE CARE, V82, P174, DOI 10.1097/TA.0000000000001290
   Cobley JN, 2014, FREE RADICAL BIO MED, V70, P23, DOI 10.1016/j.freeradbiomed.2014.02.004
   Cobley James N, 2013, LONGEV HEALTHSPAN, V2, P11, DOI 10.1186/2046-2395-2-11
   COGGAN AR, 1992, J GERONTOL, V47, PB71, DOI 10.1093/geronj/47.3.B71
   COGSWELL AM, 1993, AM J PHYSIOL, V264, PC383, DOI 10.1152/ajpcell.1993.264.2.C383
   Consitt LA, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11112636
   Correia-Melo C, 2017, NAT PROTOC, V12, P0, DOI 10.1038/nprot.2016.159
   Croley AN, 2005, J APPL PHYSIOL, V99, P1872, DOI 10.1152/japplphysiol.00498.2005
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P0, DOI 10.1093/ageing/afz046
   DAngelo E, 2019, J GERONTOL GERIATR, V67, P46
   DAntona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276
   Derbré F, 2012, AGE, V34, P669, DOI 10.1007/s11357-011-9264-y
   Dhillon RJS, 2017, CLIN GERIATR MED, V33, P17, DOI 10.1016/j.cger.2016.08.002
   Dodds RM, 2018, EXP GERONTOL, V113, P80, DOI 10.1016/j.exger.2018.09.020
   Drummond MJ, 2014, J GERONTOL A-BIOL, V69, P1040, DOI 10.1093/gerona/glu004
   Ebner DC, 2015, CURR PHARM DESIGN, V21, P1327, DOI 10.2174/1381612820666140929095755
   Englund DA, 2021, MECH AGEING DEV, V200, P0, DOI 10.1016/j.mad.2021.111595
   Evans WJ, 2010, AM J CLIN NUTR, V91, P1123S, DOI 10.3945/ajcn.2010.28608A
   Favaro G, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-10226-9
   Fernando R, 2019, FREE RADICAL BIO MED, V132, P58, DOI 10.1016/j.freeradbiomed.2018.08.037
   Fry Christopher S, 2011, CURR AGING SCI, V4, P260
   Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137
   Gao XJ, 2014, MOL THER, V22, P1333, DOI 10.1038/mt.2014.63
   Gaster M, 2000, AM J PHYSIOL-ENDOC M, V278, PE910, DOI 10.1152/ajpendo.2000.278.5.E910
   Gheller BJF, 2016, ANNU REV NUTR, V36, P129, DOI 10.1146/annurev-nutr-071715-050901
   Gouspillou G, 2014, FASEB J, V28, P1621, DOI 10.1096/fj.13-242750
   Guglielmi V, 2019, INT J PHARMACEUT, V560, P347, DOI 10.1016/j.ijpharm.2019.02.017
   Herbst A, 2021, AGING CLIN EXP RES, V33, P1811, DOI 10.1007/s40520-020-01698-7
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137
   Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015
   Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838
   Jang EH, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11080811
   Jativa SD, 2019, MOL PHARMACEUT, V16, P2376, DOI 10.1021/acs.molpharmaceut.8b01313
   Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003
   Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189
   Joseph AM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069327
   Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x
   Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072, DOI 10.1152/jappl.2000.89.3.1072
   Kim C, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12041079
   Köller M, 2023, WIEN MED WOCHENSCHR, V173, P97, DOI 10.1007/s10354-022-00927-0
   Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x
   Landers-Ramos RQ, 2018, EXERC SPORT SCI REV, V46, P172, DOI 10.1249/JES.0000000000000151
   Landi F, 2019, CLIN NUTR, V38, P2113, DOI 10.1016/j.clnu.2018.11.021
   Landi F, 2014, CURR OPIN CLIN NUTR, V17, P25, DOI 10.1097/MCO.0000000000000018
   Leduc-Gaudet JP, 2019, J PHYSIOL-LONDON, V597, P1975, DOI 10.1113/JP277157
   Leduc-Gaudet JP, 2015, J PHYSIOL-LONDON, V593, P2993, DOI 10.1113/JP270736
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Lezza AMS, 2001, FEBS LETT, V501, P74, DOI 10.1016/S0014-5793(01)02628-X
   Liu DM, 2013, J GERONTOL A-BIOL, V68, P1035, DOI 10.1093/gerona/glt015
   Liu YQ, 2020, INT UROL NEPHROL, V52, P1551, DOI 10.1007/s11255-020-02508-9
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu P, 2016, J CONTROL RELEASE, V240, P38, DOI 10.1016/j.jconrel.2015.10.023
   Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782
   Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2
   Maretti E, 2022, PHARMACEUTICS, V14, P0, DOI 10.3390/pharmaceutics14030648
   Martone AM, 2019, J GERONTOL GERIATR, V67, P39
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McGregor Robin A, 2014, LONGEV HEALTHSPAN, V3, P9, DOI 10.1186/2046-2395-3-9
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   McKiernan SH, 2009, EXP GERONTOL, V44, P170, DOI 10.1016/j.exger.2008.09.014
   Mitchell WK, 2012, FRONT PHYSIOL, V3, P0, DOI 10.3389/fphys.2012.00260
   Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054
   Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008
   Narici MV, 2003, J APPL PHYSIOL, V95, P2229, DOI 10.1152/japplphysiol.00433.2003
   Nawawi A, 2021, J GERONTOL GERIATR, V69, P45, DOI 10.36150/2499-6564-340
   OLeary MF, 2013, AM J PHYSIOL-CELL PH, V304, PC422, DOI 10.1152/ajpcell.00240.2012
   Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002
   Papadopoulou SK, 2020, J NUTR HEALTH AGING, V24, P83, DOI 10.1007/s12603-019-1267-x
   Pesce V, 2005, J GERONTOL A-BIOL, V60, P715, DOI 10.1093/gerona/60.6.715
   Phu S, 2015, J CLIN DENSITOM, V18, P488, DOI 10.1016/j.jocd.2015.04.011
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Picard M, 2011, AGING CELL, V10, P1047, DOI 10.1111/j.1474-9726.2011.00745.x
   Picca A, 2017, EXP GERONTOL, V96, P63, DOI 10.1016/j.exger.2017.06.005
   Pin F, 2022, FRONT CELL DEV BIOL, V10, P0, DOI 10.3389/fcell.2022.861622
   Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002
   Pollock N, 2017, FREE RADICAL BIO MED, V112, P84, DOI 10.1016/j.freeradbiomed.2017.07.017
   PROCTOR DN, 1995, J APPL PHYSIOL, V78, P2033, DOI 10.1152/jappl.1995.78.6.2033
   Raimondo TM, 2018, P NATL ACAD SCI USA, V115, P10648, DOI 10.1073/pnas.1806908115
   Rennie MJ, 2009, APPL PHYSIOL NUTR ME, V34, P377, DOI 10.1139/H09-012
   Romanello V, 2016, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00422
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Rosenberg IH, 1997, J NUTR, V127, PS990, DOI 10.1093/jn/127.5.990S
   Rygiel KA, 2014, NEUROBIOL AGING, V35, P2230, DOI 10.1016/j.neurobiolaging.2014.02.027
   Safdar A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010778
   Salucci S, 2017, MICROSC RES TECHNIQ, V80, P1174, DOI 10.1002/jemt.22914
   Samoylova TI, 1999, MUSCLE NERVE, V22, P460, DOI 10.1002/(SICI)1097-4598(199904)22:4<460::AID-MUS6>3.0.CO;2-L
   Sayed RKA, 2018, J GERONTOL A-BIOL, V73, P1330, DOI 10.1093/gerona/gly059
   Scott W, 2001, PHYS THER, V81, P1810, DOI 10.1093/ptj/81.11.1810
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Serviddio G, 2010, CURR MED CHEM, V17, P2325, DOI 10.2174/092986710791698530
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517
   Supinski GS, 2020, AM J PHYSIOL-LUNG C, V319, PL228, DOI 10.1152/ajplung.00473.2019
   Szeto HH, 2006, AAPS J, V8, PE277, DOI 10.1007/BF02854898
   Thom JM, 2007, EUR J APPL PHYSIOL, V100, P613, DOI 10.1007/s00421-007-0481-0
   Tieland M, 2018, J CACHEXIA SARCOPENI, V9, P3, DOI 10.1002/jcsm.12238
   Torchilin VP, 2001, P NATL ACAD SCI USA, V98, P8786, DOI 10.1073/pnas.151247498
   Tucker MZ, 2003, AM J PHYSIOL-ENDOC M, V285, PE827, DOI 10.1152/ajpendo.00222.2002
   Tucker MZ, 2002, AM J PHYSIOL-ENDOC M, V282, PE1102, DOI 10.1152/ajpendo.00175.2001
   van de Weijer T, 2015, DIABETES, V64, P1193, DOI 10.2337/db14-0667
   Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206
   Volpi E, 2000, DIABETES NUTR METAB, V13, P99
   Westerblad H, 2010, EXP CELL RES, V316, P3093, DOI 10.1016/j.yexcr.2010.05.019
   Wilkinson DJ, 2018, AGEING RES REV, V47, P123, DOI 10.1016/j.arr.2018.07.005
   Wongrakpanich A, 2014, NANOMEDICINE-UK, V9, P2531, DOI 10.2217/NNM.14.161
   Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016
   Yamada Y, 2012, BIOMATERIALS, V33, P1589, DOI 10.1016/j.biomaterials.2011.10.082
   Yeo D, 2019, FREE RADICAL BIO MED, V130, P361, DOI 10.1016/j.freeradbiomed.2018.10.456
   Yoo SZ, 2018, J EXERC REHABIL, V14, P551, DOI 10.12965/jer.1836268.134
NR 131
TC 15
Z9 15
U1 2
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1999-4923
J9 PHARMACEUTICS
JI Pharmaceutics
PD DEC 15
PY 2022
VL 14
IS 12
BP 
EP 
DI 10.3390/pharmaceutics14122588
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 7G8VQ
UT WOS:000902794800001
PM 36559079
DA 2024-11-01
ER

PT J
AU Percetti, M
   Franco, G
   Monfrini, E
   Caporali, L
   Minardi, R
   La Morgia, C
   Valentino, ML
   Liguori, R
   Palmieri, I
   Ottaviani, D
   Vizziello, M
   Ronchi, D
   Di Berardino, F
   Cocco, A
   Macao, B
   Falkenberg, M
   Comi, GP
   Albanese, A
   Giometto, B
   Valente, EM
   Carelli, V
   Di Fonzo, A
AF Percetti, Marco
   Franco, Giulia
   Monfrini, Edoardo
   Caporali, Leonardo
   Minardi, Raffaella
   La Morgia, Chiara
   Valentino, Maria Lucia
   Liguori, Rocco
   Palmieri, Ilaria
   Ottaviani, Donatella
   Vizziello, Maria
   Ronchi, Dario
   Di Berardino, Federica
   Cocco, Antoniangela
   Macao, Bertil
   Falkenberg, Maria
   Comi, Giacomo Pietro
   Albanese, Alberto
   Giometto, Bruno
   Valente, Enza Maria
   Carelli, Valerio
   Di Fonzo, Alessio
TI <i>TWNK</i> in Parkinson's Disease: A Movement Disorder and Mitochondrial Disease Center Perspective Study
SO MOVEMENT DISORDERS
LA English
DT Article
DE TWNK; twinkle; Parkinson's disease; parkinsonism; mitochondrial DNA
ID progressive external ophthalmoplegia; onset spinocerebellar ataxia; familial parkinsonism; dna deletions; twinkle; mutations; polg
AB Background Parkinsonian features have been described in patients harboring variants in nuclear genes encoding for proteins involved in mitochondrial DNA maintenance, such as TWNK. Objectives The aim was to screen for TWNK variants in an Italian cohort of Parkinson's disease (PD) patients and to assess the occurrence of parkinsonism in patients presenting with TWNK-related autosomal dominant progressive external ophthalmoplegia (TWNK-adPEO). Methods Genomic DNA of 263 consecutively collected PD patients who underwent diagnostic genetic testing was analyzed with a targeted custom gene panel including TWNK, as well as genes causative of monogenic PD. Genetic and clinical data of 18 TWNK-adPEO patients with parkinsonism were retrospectively analyzed. Results Six of 263 PD patients (2%), presenting either with isolated PD (n = 4) or in combination with bilateral ptosis (n = 2), carried TWNK likely pathogenic variants. Among 18 TWNK-adPEO patients, 5 (28%) had parkinsonism. Conclusions We show candidate TWNK variants occurring in PD without PEO. This finding will require further confirmatory studies. (c) 2022 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.
C1 [Percetti, Marco; Franco, Giulia; Monfrini, Edoardo; Vizziello, Maria; Ronchi, Dario; Comi, Giacomo Pietro; Di Fonzo, Alessio] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Neurosci Sect, Milan, Italy.
   [Percetti, Marco] ASST Monza, San Gerardo Hosp, Neurol Unit, Monza, Italy.
   [Franco, Giulia; Monfrini, Edoardo; Vizziello, Maria; Comi, Giacomo Pietro; Di Fonzo, Alessio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Via Francesco Sforza 35, I-20122 Milan, MI, Italy.
   [Caporali, Leonardo; Minardi, Raffaella; La Morgia, Chiara; Valentino, Maria Lucia; Liguori, Rocco; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Bologna, Italy.
   [Valentino, Maria Lucia; Liguori, Rocco; Carelli, Valerio] Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Unit Neurol, Bologna, Italy.
   [Palmieri, Ilaria; Valente, Enza Maria] IRCCS Mondino Fdn, Neurogenet Res Ctr, Pavia, Italy.
   [Ottaviani, Donatella; Giometto, Bruno] Azienda Prov & Servizi Sanitari APSS Trento, Rovereto Hosp, Neurol Unit, Trento, Italy.
   [Di Berardino, Federica] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Audiol Unit, Milan, Italy.
   [Cocco, Antoniangela] Univ Milan, Milan, Italy.
   [Cocco, Antoniangela; Albanese, Alberto] Ist Ricovero & Cura Carattere Sci Humanitas, Res Hosp, Dept Neurol, Milan, Italy.
   [Macao, Bertil; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
   [Valente, Enza Maria] Univ Pavia, Dept Mol Med, Pavia, Italy.
C3 University of Milan; San Gerardo Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; IRCCS Fondazione Casimiro Mondino; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Gothenburg; University of Pavia
RP Di Fonzo, A (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Via Francesco Sforza 35, I-20122 Milan, MI, Italy.
EM alessio.difonzo@policlinico.mi.it
FU Italian Ministry of Health; Italian region Emilia-Romagna funding (ER-MITO project-Programma di ricerca Regione-Universitaa 2010-2012) [PRUa1RI-2012-008]
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bitetto G, 2020, PARKINSONISM RELAT D, V74, P1, DOI 10.1016/j.parkreldis.2020.03.018
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Breen DP, 2020, NEUROLOGY, V95, P644, DOI 10.1212/WNL.0000000000010674
   Brichta L, 2014, FRONT NEUROANAT, V8, P0, DOI 10.3389/fnana.2014.00152
   Caporali L, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx301
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Liu ZR, 2008, MOL VIS, V14, P1995
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Manini A, 2022, AGEING RES REV, V76, P0, DOI 10.1016/j.arr.2022.101578
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Peter B, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11040408
   Rani L, 2020, MITOCHONDRION, V50, P25, DOI 10.1016/j.mito.2019.09.010
   Remtulla S, 2019, PEDIATR NEUROL, V90, P61, DOI 10.1016/j.pediatrneurol.2018.08.007
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
NR 27
TC 8
Z9 8
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD SEP 15
PY 2022
VL 37
IS 9
BP 1938
EP 1943
DI 10.1002/mds.29139
EA JUL 2022
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA 4P1ZW
UT WOS:000821119700001
PM 35792653
DA 2024-11-01
ER

PT J
AU Newstead, SM
   Finsterer, J
AF Newstead, Shaundra M.
   Finsterer, Josef
TI Leigh-Like Syndrome With a Novel, Complex Phenotype Due to m.10191T&gt;C in Mt-ND3
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE genetics; respiratory chain; mitochondrial disorder; mtdna; m .10191t > c
ID mitochondrial-dna mutations; missense mutation; chinese children; lactic-acidosis; encephalopathy; enzyme
AB Leigh-like syndrome (LLS) due to the variant m.10191T>C in ND3 with a number of new phenotypic traits has not been published. In this case report, a 32-year-old woman diagnosed with Leigh-like syndrome presented with a complex novel, progressive, multisystem phenotype, manifesting in the brain (mild cognitive impairment, seizures, choreoathetosis, pseudotumor cerebri, hypersomnia, symmetric pallidal insufficiency, renal tubular acidosis, nephrolithiasis), muscles (myopathy, exercise intolerance, easy fatigability), peripheral nerves (small fiber neuropathy, dysautonomia), connective tissue (hyperlaxity of joints, bruising), and bones (scoliosis, Chiari malformation). A genetic workup revealed the known pathogenic variant m.10191T>C in ND3, which was also carried by the patient's mother. This case demonstrates that the m.10191T>C variant in ND3 can phenotypically manifest with multisystem disease and that this disease is responsive to symptomatic treatment and application of additional compounds.
C1 [Newstead, Shaundra M.] HeatSync Biochem Lab, Biochem, Mesa, AZ USA.
   [Finsterer, Josef] Neurol & Neurophysiol Ctr, Neurol, Vienna, Austria.
RP Finsterer, J (corresponding author), Neurol & Neurophysiol Ctr, Neurol, Vienna, Austria.
EM fipaps@yahoo.de
CR Bakare AB, 2021, FRONT PHYSIOL, V12, P0, DOI 10.3389/fphys.2021.693734
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Krysko KM, 2017, NEURO-OPHTHALMOLOGY, V41, P30, DOI 10.1080/01658107.2016.1224256
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   Levy RJ, 2014, J CHILD NEUROL, V29, PNP105, DOI 10.1177/0883073813506783
   Li TR, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00347
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Ma YY, 2013, MITOCHONDR DNA, V24, P67, DOI 10.3109/19401736.2012.717932
   Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Matsui Jun, 2014, NO TO HATTATSU, V46, P363
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Na JH, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.752467
   Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Wei YP, 2018, J NEUROL, V265, P2388, DOI 10.1007/s00415-018-9014-5
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 20
TC 4
Z9 4
U1 0
U2 1
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD SEP 9
PY 2022
VL 14
IS 9
BP 
EP 
DI 10.7759/cureus.28986
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 8Z5VT
UT WOS:000933446400024
PM 36249637
DA 2024-11-01
ER

PT J
AU Ni, J
   Liu, Z
   Yuan, YC
   Li, WZ
   Hu, YT
   Liu, P
   Hou, XR
   Zhu, XY
   Tang, XX
   Liang, MY
   Zheng, SQ
   Hou, X
   Du, J
   Tang, JG
   Jiang, H
   Shen, L
   Tang, BS
   Wang, JL
AF Ni, Jie
   Liu, Zhen
   Yuan, Yanchun
   Li, Wanzhen
   Hu, Yiting
   Liu, Pan
   Hou, Xiaorong
   Zhu, Xiangyu
   Tang, Xuxiong
   Liang, Mingyu
   Zheng, Siqi
   Hou, Xuan
   Du, Juan
   Tang, Jianguang
   Jiang, Hong
   Shen, Lu
   Tang, Beisha
   Wang, Junling
TI Mitochondrial genome variations are associated with amyotrophic lateral sclerosis in patients from mainland China
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Amyotrophic lateral sclerosis; Long-range polymerase chain reaction; Mitochondrial DNA haplogroup; Mitochondrial DNA variation; Whole mitochondrial genome screening
ID dna mutations; skeletal-muscle; haplogroups; disease; revision; neurons; damage; genes; als
AB Background Amyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative disorder. Mitochondrial dysfunction is involved in the complex pathophysiology of ALS; however, the role of mitochondrial DNA (mtDNA) variants in ALS is poorly understood. We aimed to elucidate the role of mtDNA variants in the pathogenesis of ALS. Methods The mitochondrial haplogroups of 585 ALS patients and 371 healthy controls were determined; 38 ALS patients and 42 controls underwent long-range polymerase chain reaction combined with next-generation sequencing technology to analyze whole mitochondrial genome variants. Results A higher percentage of variants accumulated in ALS patients than in controls. Analysis of coding region variations that were further stratified by mtDNA genes revealed that nonsynonymous variants were more vulnerable in ALS patients than in controls, particularly in the ND4L, ND5, and ATP8 genes. Moreover, pathogenic nonsynonymous variants tended to over-represent in ALS patients. Unsurprisingly, nonsynonymous variants were not related to the phenotype. Haplogroup analysis did not found evidence of association between haplogroups with the risk of ALS, however, patients belonging to haplogroup Y and M7c were prone to develop later onset of ALS. Conclusions This is the first study to profile mtDNA variants in ALS patients from mainland China. Our results suggest that an increase in the number of nonsynonymous variants is linked to the pathogenesis of ALS. Moreover, haplogroup Y and M7c may modulate the clinical expression of ALS. Our findings provide independent, albeit limited, evidence for the role of mtDNA in the pathogenesis of ALS.
C1 [Ni, Jie; Liu, Zhen; Yuan, Yanchun; Li, Wanzhen; Hu, Yiting; Liu, Pan; Hou, Xiaorong; Zhu, Xiangyu; Tang, Xuxiong; Hou, Xuan; Du, Juan; Jiang, Hong; Shen, Lu; Tang, Beisha; Wang, Junling] Cent South Univ, Xiangya Hosp, Dept Neurol, 87 Xiangya Rd, Changsha, Hunan, Peoples R China.
   [Liang, Mingyu; Zheng, Siqi] Cent South Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China.
   [Tang, Jianguang] Cent South Univ, Xiangya Hosp 2, Dept Neurol, Changsha, Hunan, Peoples R China.
   [Jiang, Hong; Shen, Lu; Tang, Beisha; Wang, Junling] Cent South Univ, Lab Med Genet, Changsha 410008, Hunan, Peoples R China.
   [Jiang, Hong; Shen, Lu; Tang, Beisha; Wang, Junling] Cent South Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Hunan, Peoples R China.
   [Jiang, Hong; Shen, Lu; Tang, Beisha; Wang, Junling] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Dis, Changsha 410008, Hunan, Peoples R China.
C3 Central South University; Central South University; Central South University; Central South University; Central South University; Central South University
RP Wang, JL (corresponding author), Cent South Univ, Xiangya Hosp, Dept Neurol, 87 Xiangya Rd, Changsha, Hunan, Peoples R China.; Wang, JL (corresponding author), Cent South Univ, Lab Med Genet, Changsha 410008, Hunan, Peoples R China.; Wang, JL (corresponding author), Cent South Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Hunan, Peoples R China.; Wang, JL (corresponding author), Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Dis, Changsha 410008, Hunan, Peoples R China.
EM junling.wang@csu.edu.cn
FU National Key Research and Development Program of China [2018YFC1312003]; Program of National Natural Science Foundation of China [81671120, 81300981]; Natural Science Fund for Distinguished Young Scholars of Hunan province, China [2020JJ2057]; Project Program of National Clinical Research Center for Geriatric Disorders (Xiangya Hospital) [2020LNJJ13]; Degree & Postgraduate Education Reform Project of Central South University [2020JGB136]
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Artuso L, 2013, AMYOTROPH LAT SCL FR, V14, P261, DOI 10.3109/21678421.2012.735239
   Bi R, 2015, NEUROBIOL AGING, V36, P0, DOI 10.1016/j.neurobiolaging.2014.10.009
   Bris C, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00632
   Brown RH, 2017, NEW ENGL J MED, V377, P162, DOI 10.1056/NEJMra1603471
   Cha MY, 2015, EXP MOL MED, V47, P0, DOI 10.1038/emm.2014.122
   Chen YF, 2015, CHINESE MED J-PEKING, V128, P1748, DOI 10.4103/0366-6999.159348
   Chia R, 2018, LANCET NEUROL, V17, P94, DOI 10.1016/S1474-4422(17)30401-5
   Chinnery PF, 2007, NEUROGENETICS, V8, P65, DOI 10.1007/s10048-006-0066-9
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Fan L, 2013, MITOCHONDRION, V13, P360, DOI 10.1016/j.mito.2013.04.011
   Ghasemi M, 2018, CSH PERSPECT MED, V8, P0, DOI 10.1101/cshperspect.a024125
   Hoekstra JG, 2016, ANN NEUROL, V80, P301, DOI 10.1002/ana.24709
   Ingram CJE, 2012, AMYOTROPH LATERAL SC, V13, P341, DOI 10.3109/17482968.2012.654394
   Keeney PM, 2010, MOL NEURODEGENER, V5, P0, DOI 10.1186/1750-1326-5-21
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Ladd AC, 2017, BRAIN RES, V1667, P74, DOI 10.1016/j.brainres.2017.05.010
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1, DOI 10.1002/0471250953.bi0123s44
   Ludolph A, 2015, AMYOTROPH LAT SCL FR, V16, P291, DOI 10.3109/21678421.2015.1049183
   Lynch D, 2008, MITOCHONDRION, V8, P109, DOI 10.1016/j.mito.2007.09.002
   Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060
   Muratai T, 2008, FREE RADICAL RES, V42, P221, DOI 10.1080/10715760701877262
   Preste R, 2019, NUCLEIC ACIDS RES, V47, PD1202, DOI 10.1093/nar/gky1024
   Reiff DM, 2011, NEUROL SCI, V32, P883, DOI 10.1007/s10072-011-0735-9
   Ryan TE, 2014, MUSCLE NERVE, V50, P767, DOI 10.1002/mus.24223
   Siddiqui A, 2012, FREE RADICAL BIO MED, V53, P1478, DOI 10.1016/j.freeradbiomed.2012.06.008
   Stoccoro A, 2018, EPIGENOMICS-UK, V10, P1431, DOI 10.2217/epi-2018-0072
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   Yuan HY, 2020, GENE, V738, P0, DOI 10.1016/j.gene.2020.144487
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zhang W, 2014, J GENET GENOMICS, V41, P397, DOI 10.1016/j.jgg.2014.05.004
NR 33
TC 3
Z9 3
U1 0
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD FEB 15
PY 2022
VL 269
IS 2
BP 805
EP 814
DI 10.1007/s00415-021-10659-7
EA JUN 2021
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA YL5DP
UT WOS:000661792800002
PM 34129120
DA 2024-11-01
ER

PT J
AU Villa, O
   Stuhr, NL
   Yen, CA
   Crimmins, EM
   Arpawong, TE
   Curran, SP
AF Villa, Osvaldo
   Stuhr, Nicole L.
   Yen, Chia-an
   Crimmins, Eileen M.
   Arpawong, Thalida Em
   Curran, Sean P.
TI Genetic variation in <i>ALDH4A1</i> is associated with muscle health over the lifespan and across species
SO ELIFE
LA English
DT Article
DE aging; sarcopenia; HRS; muscle; genetic variation; genetics; C; elegans; Human
ID genome-wide association; population stratification; proline catabolism; sarcopenia; prevalence; skn-1; algorithm; profile
AB The influence of genetic variation on the aging process, including the incidence and severity of age-related diseases, is complex. Here, we define the evolutionarily conserved mitochondrial enzyme ALH-6/ALDH4A1 as a predictive biomarker for age-related changes in muscle health by combining Caenorhabditis elegans genetics and a gene-wide association scanning (GeneWAS) from older human participants of the US Health and Retirement Study (HRS). In a screen for mutations that activate oxidative stress responses, specifically in the muscle of C. elegans, we identified 96 independent genetic mutants harboring loss-of-function alleles of alh-6, exclusively. Each of these genetic mutations mapped to the ALH-6 polypeptide and led to the age-dependent loss of muscle health. Intriguingly, genetic variants in ALDH4A1 show associations with age-related muscle-related function in humans. Taken together, our work uncovers mitochondrial alh-6/ALDH4A1 as a critical component to impact normal muscle aging across species and a predictive biomarker for muscle health over the lifespan.
C1 [Villa, Osvaldo; Stuhr, Nicole L.; Yen, Chia-an; Crimmins, Eileen M.; Arpawong, Thalida Em; Curran, Sean P.] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA USA.
   [Stuhr, Nicole L.; Yen, Chia-an; Curran, Sean P.] Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Mol & Computat Biol, Los Angeles, CA USA.
   [Curran, Sean P.] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA.
C3 University of Southern California; University of Southern California; University of Southern California
RP Curran, SP (corresponding author), Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA USA.; Curran, SP (corresponding author), Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Mol & Computat Biol, Los Angeles, CA USA.; Curran, SP (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA.
EM spcurran@usc.edu
FU National Institute on Aging [R01 AG058610, RF1 AG063947, T32 AG052374, T32 GM118289, P30 AG068345]; National Institute on Aging [R01AG058610] Funding Source: NIH RePORTER
CR Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277
   Ahmadpanah M, 2015, INT J PSYCHIAT CLIN, V19, P168, DOI 10.3109/13651501.2015.1049277
   Batsis JA, 2016, EUR J CLIN NUTR, V70, P1168, DOI 10.1038/ejcn.2016.90
   Batsis JA, 2013, J AM GERIATR SOC, V61, P974, DOI 10.1111/jgs.12260
   BRENNER S, 1974, GENETICS, V77, P71
   Carson RG, 2018, NEUROBIOL AGING, V71, P189, DOI 10.1016/j.neurobiolaging.2018.07.023
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Dent E, 2019, J NUTR HEALTH AGING, V23, P771, DOI 10.1007/s12603-019-1273-z
   Dey R, 2017, AM J HUM GENET, V101, P37, DOI 10.1016/j.ajhg.2017.05.014
   Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297
   Fisher GG, 2018, WORK AGING RETIRE, V4, P1, DOI 10.1093/workar/wax032
   Hall MA, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004678
   Han B, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000456
   HRS Health and Retirement Study, 2021, HLTH RETIREMENT STUD, V0, P0
   Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009
   Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058
   Juster FT, 1995, J HUM RESOUR, V30, PS7, DOI 10.2307/146277
   Ke WF, 2021, PLOS GENET, V17, P0, DOI 10.1371/journal.pgen.1009736
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kim DH, 2019, J GERONTOL A-BIOL, V74, P1271, DOI 10.1093/gerona/gly197
   Laranjeiro R, 2019, P NATL ACAD SCI USA, V116, P23829, DOI 10.1073/pnas.1909210116
   Laranjeiro R, 2017, BMC BIOL, V15, P0, DOI 10.1186/s12915-017-0368-4
   Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516
   Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296
   Liu ZY, 2019, PLOS MED, V16, P0, DOI 10.1371/journal.pmed.1002827
   Lo JY, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1006762
   Lynn DA, 2015, P NATL ACAD SCI USA, V112, P15378, DOI 10.1073/pnas.1514012112
   MacEwan JP, 2018, J NUTR HEALTH AGING, V22, P1253, DOI 10.1007/s12603-018-1104-7
   Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494
   McGrath R, 2020, SAGE OPEN MED, V8, P0, DOI 10.1177/2050312120910358
   Nhan JD, 2019, P NATL ACAD SCI USA, V116, P22322, DOI 10.1073/pnas.1909666116
   North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527
   Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331
   Pahl R, 2010, BIOINFORMATICS, V26, P2093, DOI 10.1093/bioinformatics/btq399
   Pang SS, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6048
   Pang SS, 2014, CELL METAB, V19, P221, DOI 10.1016/j.cmet.2013.12.005
   Pendergrass SA, 2015, HUM HERED, V79, P111, DOI 10.1159/000381851
   Pendergrass SA, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003087
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Renteria Miguel E, 2013, METHODS MOL BIOL, V1019, P193, DOI 10.1007/978-1-62703-447-0_8
   Roussel Nicolas, 2014, WORM, V3, Pe982437, DOI 10.4161/21624054.2014.982437
   Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177
   Sayer AA, 2008, J NUTR HEALTH AGING, V12, P427, DOI 10.1007/BF02982703
   Serre D, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001382
   Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706
   Shields HJ, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.628157
   Song LJ, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.58376
   Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067
   Spatola BN, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-48286-y
   Stuhr NL, 2020, COMMUN BIOL, V3, P0, DOI 10.1038/s42003-020-01379-1
   Tam V, 2019, NAT REV GENET, V20, P467, DOI 10.1038/s41576-019-0127-1
   Tang HQ, 2016, CELL REP, V17, P2837, DOI 10.1016/j.celrep.2016.11.038
   Teumer A, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-11576-0
   Tian C, 2008, HUM MOL GENET, V17, PR143, DOI 10.1093/hmg/ddn268
   Timmers PRHJ, 2019, ELIFE, V8, P0, DOI 10.7554/eLife.39856
   Tsekoura M, 2017, ADV EXP MED BIOL, V987, P213, DOI 10.1007/978-3-319-57379-3_19
   von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P129, DOI 10.1007/s13539-010-0014-2
   Wang Y, 2015, SCIENCE, V350, P1204, DOI 10.1126/science.aac4357
   Weir DR, 2013, QUALITY CONTROL REPO, V0, P0
   Wu CK, 2017, J AM GERIATR SOC, V65, P1482, DOI 10.1111/jgs.14816
   Yen CA, 2016, EXP GERONTOL, V86, P106, DOI 10.1016/j.exger.2016.02.012
   Yen CA, 2021, AGING CELL, V20, P0, DOI 10.1111/acel.13308
   Yen CA, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.52899
   Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196
   Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210
NR 67
TC 6
Z9 6
U1 1
U2 4
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
EI 
J9 ELIFE
JI eLife
PD APR 26
PY 2022
VL 11
IS 
BP 
EP 
DI 10.7554/eLife.74308
PG 20
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 1H5QE
UT WOS:000796597600001
PM 35470798
DA 2024-11-01
ER

PT J
AU Manini, A
   Meneri, M
   Rodolico, C
   Corti, S
   Toscano, A
   Comi, GP
   Musumeci, O
   Ronchi, D
AF Manini, Arianna
   Meneri, Megi
   Rodolico, Carmelo
   Corti, Stefania
   Toscano, Antonio
   Comi, Giacomo Pietro
   Musumeci, Olimpia
   Ronchi, Dario
TI Case Report: Thymidine Kinase 2 (TK2) Deficiency: A Novel Mutation Associated With Childhood-Onset Mitochondrial Myopathy and Atypical Progression
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE thymidine kinase 2; TK2; mitochondrial DNA; mtDNA maintenance defects; myopathy; deoxynucleosides
ID external ophthalmoplegia; dna depletion; gene
AB The nuclear gene TK2 encodes the mitochondrial thymidine kinase, an enzyme involved in the phosphorylation of deoxycytidine and deoxythymidine nucleosides. Biallelic TK2 mutations are associated with a spectrum of clinical presentations mainly affecting skeletal muscle and featuring muscle mitochondrial DNA (mtDNA) instability. Current classification includes infantile- ( <= 1 year), childhood- (1-12 years), and late-onset (>= 12 years) forms. In addition to age at onset, these forms differ for progression, life expectancy, and signs of mtDNA instability (mtDNA depletion vs. accumulation of multiple mtDNA deletions). Childhood-onset TK2 deficiency typically causes a rapidly progressive proximal myopathy, which leads to wheelchair-bound status within 10 years of disease onset, and severe respiratory impairment. Muscle biopsy usually reveals a combination of mitochondrial myopathy and dystrophic features with reduced mtDNA content. Here we report the case of an Italian patient presenting childhood-onset, slowly progressive mitochondrial myopathy, ptosis, hypoacusis, dysphonia, and dysphagia, harboring the TK2 variants c.278A>G and c.543del, the latter unreported so far. Compared to other childhood-onset TK2-patients, our case displays atypical features, including slowly progressive muscle weakness and absence of respiratory failure, which are usually observed in late-onset forms. This report extends the genetic background of TK2-related myopathy, highlighting the clinical overlap among different forms.
C1 [Manini, Arianna; Meneri, Megi; Corti, Stefania; Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Neurosci Sect, Milan, Italy.
   [Meneri, Megi; Corti, Stefania] IRCCS Fdn CaGranda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Rodolico, Carmelo; Toscano, Antonio; Musumeci, Olimpia] Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular Disorders, Messina, Italy.
   [Comi, Giacomo Pietro] Fdn IRCCS CaGranda Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, Milan, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Messina; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Ronchi, D (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Neurosci Sect, Milan, Italy.; Musumeci, O (corresponding author), Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular Disorders, Messina, Italy.
EM olimpia.musumeci@unime.it; dario.ronchi@unimi.it
FU Italian Ministry Fundation IRCCS Ca Granda Ospedale Maggiore Policlinico Ricerca Corrente 2020
CR Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Fasullo M, 2015, INT J MOL SCI, V16, P9431, DOI 10.3390/ijms16059431
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ronchi D, 2019, ANN CLIN TRANSL NEUR, V6, P1893, DOI 10.1002/acn3.50888
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
NR 17
TC 0
Z9 0
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD FEB 25
PY 2022
VL 13
IS 
BP 
EP 
DI 10.3389/fneur.2022.857279
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ZV8MR
UT WOS:000770778400001
PM 35280287
DA 2024-11-01
ER

PT J
AU Korzeniewski, B
AF Korzeniewski, Bernard
TI Effect of training on skeletal muscle bioenergetic system in patients with mitochondrial myopathies: A computational study
SO RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
LA English
DT Article
DE Mitochondrial myopathies; OXPHOS deficiencies; Muscle training; V-O2 on-kinetics; Exercise duration; V(O2)max
ID each-step activation; oxidative-phosphorylation; exercise; diseases; humans; dna; metabolism; diagnosis; responses; mutation
AB A computer model of the skeletal muscle bioenergetic system, involving the "Pi double-threshold" mechanism of muscle fatigue, was used to investigate the effect of muscle training on system kinetic properties in mitochondrial myopathies (MM) patients with inborn OXPHOS deficiencies. An increase in OXPHOS activity and decrease in peak Pi can account for the training-induced increase in VO2max, acceleration of the primary phase II of the VO2 on-kinetics, delay of muscle fatigue and prolongation of exercise at a given work intensity encountered in experimental studies. Depending on the mutation load and work intensity, training can bring the muscle from severe- to very-heavy- to moderate-exercise-like behavior, thus lessening the exertional fatigue and lengthening the physical activity of a given intensity. Training significantly increases critical power (CP) and slightly decreases the curvature constant (W') of the power-duration relationship. Generally, a mechanism underlying the training-induced changes in the skeletal muscle bioenergetic system in MM patients is proposed.
C1 [Korzeniewski, Bernard] BioSimulat Ctr, Ul Filarecka 6-7, PL-30110 Krakow, Poland.
RP Korzeniewski, B (corresponding author), BioSimulat Ctr, Ul Filarecka 6-7, PL-30110 Krakow, Poland.
EM bernard.korzeniewski@gmail.com
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, PE672, DOI 10.1152/ajpendo.00043.2007
   Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007
   Burnley M, 2010, EXP PHYSIOL, V95, P798, DOI 10.1113/expphysiol.2010.052688
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Delaney NF, 2017, P NATL ACAD SCI USA, V114, P8402, DOI 10.1073/pnas.1703338114
   DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Grassi B, 2009, MED SCI SPORT EXER, V41, P2120, DOI 10.1249/MSS.0b013e3181aae96b
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jeppesen TD, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00349
   Korzeniewski B, 2004, BIOCHEM J, V379, P703, DOI 10.1042/BJ20031740
   Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189
   Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3
   Korzeniewski B, 2021, J APPL PHYSIOL, V131, P768, DOI 10.1152/japplphysiol.00196.2021
   Korzeniewski B, 2021, J APPL PHYSIOL, V130, P498, DOI 10.1152/japplphysiol.00745.2020
   Korzeniewski B, 2020, EUR J APPL PHYSIOL, V120, P1609, DOI 10.1007/s00421-020-04388-4
   Korzeniewski B, 2019, EUR J APPL PHYSIOL, V119, P2201, DOI 10.1007/s00421-019-04204-8
   Korzeniewski B, 2017, PROG BIOPHYS MOL BIO, V125, P1, DOI 10.1016/j.pbiomolbio.2016.12.001
   Korzeniewski B, 2016, J APPL PHYSIOL, V121, P424, DOI 10.1152/japplphysiol.00358.2016
   Korzeniewski B, 2015, J PHYSIOL-LONDON, V593, P5255, DOI 10.1113/JP271299
   Korzeniewski B, 2015, BBA-BIOENERGETICS, V1847, P1310, DOI 10.1016/j.bbabio.2015.07.007
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Porcelli S, 2016, J APPL PHYSIOL, V121, P699, DOI 10.1152/japplphysiol.00885.2015
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Vanhatalo A, 2010, EXP PHYSIOL, V95, P528, DOI 10.1113/expphysiol.2009.050500
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WILSON JR, 1988, J APPL PHYSIOL, V64, P2333, DOI 10.1152/jappl.1988.64.6.2333
NR 35
TC 6
Z9 6
U1 1
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1569-9048
EI 1878-1519
J9 RESP PHYSIOL NEUROBI
JI Respir. Physiol. Neuro.
PD FEB 15
PY 2022
VL 296
IS 
BP 
EP 
DI 10.1016/j.resp.2021.103799
EA OCT 2021
PG 7
WC Physiology; Respiratory System
SC Physiology; Respiratory System
GA WI0XB
UT WOS:000708089600001
PM 34624544
DA 2024-11-01
ER

PT J
AU Ng, YS
   Lax, NZ
   Blain, AP
   Erskine, D
   Baker, MR
   Polvikoski, T
   Thomas, RH
   Morris, CM
   Lai, M
   Whittaker, RG
   Gebbels, A
   Winder, A
   Hall, J
   Feeney, C
   Farrugia, ME
   Hirst, C
   Roberts, M
   Lawthom, C
   Chrysostomou, A
   Murphy, K
   Baird, T
   Maddison, P
   Duncan, C
   Poulton, J
   Nesbitt, V
   Hanna, MG
   Pitceathly, RDS
   Taylor, RW
   Blakely, EL
   Schaefer, AM
   Turnbull, DM
   McFarland, R
   Gorman, GS
AF Ng, Yi Shiau
   Lax, Nichola Z.
   Blain, Alasdair P.
   Erskine, Daniel
   Baker, Mark R.
   Polvikoski, Tuomo
   Thomas, Rhys H.
   Morris, Christopher M.
   Lai, Ming
   Whittaker, Roger G.
   Gebbels, Alasdair
   Winder, Amy
   Hall, Julie
   Feeney, Catherine
   Farrugia, Maria Elena
   Hirst, Claire
   Roberts, Mark
   Lawthom, Charlotte
   Chrysostomou, Alexia
   Murphy, Kevin
   Baird, Tracey
   Maddison, Paul
   Duncan, Callum
   Poulton, Joanna
   Nesbitt, Victoria
   Hanna, Michael G.
   Pitceathly, Robert D. S.
   Taylor, Robert W.
   Blakely, Emma L.
   Schaefer, Andrew M.
   Turnbull, Doug M.
   McFarland, Robert
   Gorman, Grainne S.
TI Forecasting stroke-like episodes and outcomes in mitochondrial disease
SO BRAIN
LA English
DT Article
DE prognostic modelling; neuropathology; MELAS; mitochondrial DNA (mtDNA); seizures
ID multivariable prediction model; clinical-features; lactic-acidosis; dna mutations; melas; encephalopathy; diagnosis; epilepsy; gene; myopathy
AB In this retrospective, multicentre, observational cohort study, we sought to determine the clinical, radiological, EEG, genetics and neuropathological characteristics of mitochondrial stroke-like episodes and to identify associated risk predictors. Between January 1998 and June 2018, we identified 111 patients with genetically determined mitochondrial disease who developed stroke-like episodes. Post-mortem cases of mitochondrial disease (n = 26) were identified from Newcastle Brain Tissue Resource. The primary outcome was to interrogate the clinico-radiopathological correlates and prognostic indicators of stroke-like episode in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome (MELAS). The secondary objective was to develop a multivariable prediction model to forecast stroke-like episode risk. The most common genetic cause of stroke-like episodes was the m.3243A>G variant in MT-TL1 (n = 66), followed by recessive pathogenic POLG variants (n = 22), and 11 other rarer pathogenic mitochondrial DNA variants (n = 23). The age of first stroke-like episode was available for 105 patients [mean (SD) age: 31.8 (16.1)]; a total of 35 patients (32%) presented with their first stroke-like episode >= 40 years of age. The median interval (interquartile range) between first and second stroke-like episodes was 1.33 (2.86) years; 43% of patients developed recurrent stroke-like episodes within 12 months. Clinico-radiological, electrophysiological and neuropathological findings of stroke-like episodes were consistent with the hallmarks of medically refractory epilepsy. Patients with POLG-related stroke-like episodes demonstrated more fulminant disease trajectories than cases of m.3243A>G and other mitochondrial DNA pathogenic variants, in terms of the frequency of refractory status epilepticus, rapidity of progression and overall mortality. In multivariate analysis, baseline factors of body mass index, age-adjusted blood m.3243A>G heteroplasmy, sensorineural hearing loss and serum lactate were significantly associated with risk of stroke-like episodes in patients with the m.3243A>G variant. These factors informed the development of a prediction model to assess the risk of developing stroke-like episodes that demonstrated good overall discrimination (area under the curve = 0.87, 95% CI 0.82-0.93; c-statistic = 0.89). Significant radiological and pathological features of neurodegeneration were more evident in patients harbouring pathogenic mtDNA variants compared with POLG: brain atrophy on cranial MRI (90% versus 44%, P < 0.001) and reduced mean brain weight (SD) [1044 g (148) versus 1304 g (142), P = 0.005]. Our findings highlight the often idiosyncratic clinical, radiological and EEG characteristics of mitochondrial stroke-like episodes. Early recognition of seizures and aggressive instigation of treatment may help circumvent or slow neuronal loss and abate increasing disease burden. The risk-prediction model for the m.3243A>G variant can help inform more tailored genetic counselling and prognostication in routine clinical practice.
C1 [Ng, Yi Shiau; Lax, Nichola Z.; Blain, Alasdair P.; Erskine, Daniel; Thomas, Rhys H.; Feeney, Catherine; Chrysostomou, Alexia; Taylor, Robert W.; Blakely, Emma L.; Schaefer, Andrew M.; Turnbull, Doug M.; McFarland, Robert; Gorman, Grainne S.] Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Ng, Yi Shiau; Lax, Nichola Z.; Blain, Alasdair P.; Erskine, Daniel; Thomas, Rhys H.; Feeney, Catherine; Chrysostomou, Alexia; Taylor, Robert W.; Blakely, Emma L.; Schaefer, Andrew M.; Turnbull, Doug M.; McFarland, Robert; Gorman, Grainne S.] Newcastle Univ, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Ng, Yi Shiau; Lax, Nichola Z.; Blain, Alasdair P.; Erskine, Daniel; Thomas, Rhys H.; Feeney, Catherine; Chrysostomou, Alexia; Taylor, Robert W.; Blakely, Emma L.; Schaefer, Andrew M.; Turnbull, Doug M.; McFarland, Robert; Gorman, Grainne S.] Newcastle Univ, Campus Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Ng, Yi Shiau; Baker, Mark R.; Thomas, Rhys H.; Lai, Ming; Whittaker, Roger G.; Gebbels, Alasdair; Winder, Amy; Hall, Julie; Feeney, Catherine; Schaefer, Andrew M.; Gorman, Grainne S.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Directorate Neurosci, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Ng, Yi Shiau; Thomas, Rhys H.; Feeney, Catherine; Taylor, Robert W.; Blakely, Emma L.; Schaefer, Andrew M.; Turnbull, Doug M.; McFarland, Robert; Gorman, Grainne S.] NHS Highly Specialised Serv Rare Mitochondrial Di, Dept Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Baker, Mark R.; Polvikoski, Tuomo; Morris, Christopher M.] Newcastle Univ, Newcastle Brain Tissue Resource, Campus Ageing & Vital, Edwardson Bldg, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Whittaker, Roger G.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Farrugia, Maria Elena; Baird, Tracey] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland.
   [Hirst, Claire] Trust Headquarters, One Talbot Gateway,Baglan Energy Pk, Baglan SA12 7BR, Port Talbot, Wales.
   [Roberts, Mark] Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Greater Manchester Neurosci Ctr, Salford M6 8HD, Lancs, England.
   [Lawthom, Charlotte] Aneurin Bevan Univ Hlth Board, Aneurin Bevan Epilepsy Specialist Team, Newport NP20 2UB, Wales.
   [Murphy, Kevin] Sligo Univ Hosp, Dept Neurol, Sligo F91 H684, Ireland.
   [Maddison, Paul] Queens Med Ctr, Dept Neurol, Nottingham NG7 2UH, England.
   [Duncan, Callum] NHS Grampian, Aberdeen Royal Infirm, Dept Neurol, Aberdeen AB25 2ZN, Scotland.
   [Poulton, Joanna] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford OX3 9DU, England.
   [Nesbitt, Victoria] Univ Oxford, Dept Paediat, Med Sci Div, Oxford OX3 9DU, England.
   [Nesbitt, Victoria] Childrens Hosp, Dept Paediat, Oxford OX3 9DU, England.
   [Hanna, Michael G.; Pitceathly, Robert D. S.] UCL, Queen Sq Inst Neurol, Dept Neuromuscular Dis, London WC1N 3BG, England.
   [Hanna, Michael G.; Pitceathly, Robert D. S.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Glasgow; Queen Elizabeth University Hospital (QEUH); Salford Royal NHS Foundation Trust; University of Nottingham; University of Aberdeen; University of Oxford; University of Oxford; University of Oxford; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust
RP Gorman, GS (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM grainne.gorman@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105]; Newcastle University Centre for Ageing and Vitality; Biotechnology and Biological Sciences Research Council; UK National Institute for Health Research (NIHR) Biomedical Research Centre for Ageing and Age-Related Disease award; Lily Foundation; UK NHS Specialist Commissioners; UK Medical Research Council; Alzheimer's Society; Alzheimer's Research UK; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; NIHR Clinical Lectureship in Neurology [CL-2016-01-003]; Medical Research Council Centre of Neuromuscular Diseases [MR/K000608/1]; Alzheimer's Research UK Fellowship [ARUK-RF2018C-005]; Medical Research Council Clinician Scientist Fellowship [MR/S002065/1]; Medical Research Council [MR/S005021/1, L016354]; Academy of Finland (AKA) [203105] Funding Source: Academy of Finland (AKA)
CR Adcock JE, 2012, J CLIN NEUROPHYSIOL, V29, P397, DOI 10.1097/WNP.0b013e31826c98fe
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012
   ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976
   Benjamin EJ, 2019, CIRCULATION, V139, PE56, DOI 10.1161/CIR.0000000000000659
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bertram EH, 2013, EXP NEUROL, V244, P67, DOI 10.1016/j.expneurol.2012.01.028
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Boal RL, 2019, J CLIN ENDOCR METAB, V104, P2057, DOI 10.1210/jc.2018-00957
   Chan F, 2019, BRAIN, V142, P391, DOI 10.1093/brain/awy320
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chrysostomou A, 2016, NEUROPATH APPL NEURO, V42, P477, DOI 10.1111/nan.12282
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Cianchetti C, 2017, SEIZURE-EUR J EPILEP, V52, P169, DOI 10.1016/j.seizure.2017.10.010
   Cianfoni A, 2013, EUR J RADIOL, V82, P1964, DOI 10.1016/j.ejrad.2013.05.020
   Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI 10.1016/j.jclinepi.2014.11.010
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Faigle R, 2013, J CLIN NEUROPHYSIOL, V30, P505, DOI 10.1097/WNP.0b013e3182a73db9
   Fernandes Peter M, 2013, PRACT NEUROL, V13, P21, DOI 10.1136/practneurol-2012-000465
   Foote C, 2017, AM J KIDNEY DIS, V69, P555, DOI 10.1053/j.ajkd.2017.02.005
   Galovic M, 2018, LANCET NEUROL, V17, P143, DOI 10.1016/S1474-4422(17)30404-0
   Gibson LM, 2013, J ROY COLL PHYS EDIN, V43, P114, DOI 10.4997/JRCPE.2013.205
   Giovannini G, 2018, EPILEPSIA, V59, P120, DOI 10.1111/epi.14493
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grier J, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000230
   Hikmat O, 2020, J INHERIT METAB DIS, V43, P726, DOI 10.1002/jimd.12211
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hocker S, 2016, JAMA NEUROL, V73, P1201, DOI 10.1001/jamaneurol.2016.1572
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kane N, 2017, CLIN NEUROPHYS PRACT, V2, P170, DOI 10.1016/j.cnp.2017.07.002
   Kaplan PW, 2004, J CLIN NEUROPHYSIOL, V21, P307
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, P0, DOI 10.1136/jnnp.2007.122648
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mendes A, 2016, SEIZURE-EUR J EPILEP, V38, P63, DOI 10.1016/j.seizure.2016.04.007
   Nakae Y, 2016, J NEUROL, V263, P127, DOI 10.1007/s00415-015-7948-4
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   Ng Yi Shiau, 2018, EPILEPSIA OPEN, V3, P103, DOI 10.1002/epi4.12094
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Samuels MA, 2006, J ROY SOC MED, V99, P219, DOI 10.1258/jrsm.99.5.219-a
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P8
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Therneau TM, 2000, STAT BIOL HEALTH, V0, P0, DOI DOI 10.1007/978-1-4757-3294-8_3
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318
   Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zacharia TT, 2019, CLIN ANAT, V32, P1053, DOI 10.1002/ca.23439
   Zerna C, 2018, LANCET, V392, P1247, DOI 10.1016/S0140-6736(18)31874-9
   Zsurka G, 2010, J BIOENERG BIOMEMBR, V42, P443, DOI 10.1007/s10863-010-9314-7
NR 72
TC 30
Z9 31
U1 1
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD APR 18
PY 2022
VL 145
IS 2
BP 542
EP 554
DI 10.1093/brain/awab353
EA MAR 2022
PG 13
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 0O1OF
UT WOS:000776236500001
PM 34927673
DA 2024-11-01
ER

PT J
AU Ricci, G
   Fontanelli, L
   Torri, F
   Schirinzi, E
   Siciliano, G
AF Ricci, Giulia
   Fontanelli, Lorenzo
   Torri, Francesca
   Schirinzi, Erika
   Siciliano, Gabriele
TI Fatigue as a common signature of inflammatory myopathies: clinical aspects and care
SO CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
LA English
DT Review
DE fatigue; idiopathic inflammatory myopathies; treatment
ID mitochondrial-dna deletions; inclusion-body myositis; skeletal-muscle; double-blind; polymyositis; depression; dermatomyositis; classification; activation; healthy
AB Fatigue is a common symptom in idiolife. Fatigue is a complex phenomenon that covers a range of dimensions from biological to behavioural, the pathophysiology of which is still poorly understood. The aim of this review is to describe the different determinants of fatigue in IIMs, discuss their clinical implications and how to evaluate and manage the condition, which are all relevant issues for the treating physicians in their everyday practice.
C1 [Ricci, Giulia; Fontanelli, Lorenzo; Torri, Francesca; Schirinzi, Erika; Siciliano, Gabriele] Univ Pisa, Dept Clin & Expt Med, Neurol Clin, Pisa, Italy.
C3 University of Pisa
RP Siciliano, G (corresponding author), Univ Pisa, Dipartimento Med Clin & Sperimentale, UO Neurol, Via Roma 67, I-56126 Pisa, Italy.
EM gabriele.siciliano@unipi.it
CR Albayda J, 2020, CURR RHEUMATOL REP, V22, P0, DOI 10.1007/s11926-020-00947-y
   Alexanderson H, 2000, SCAND J RHEUMATOL, V29, P295
   Alfano LN, 2014, NEUROMUSCULAR DISORD, V24, P222, DOI 10.1016/j.nmd.2013.11.012
   Aljabban J, 2020, HELIYON, V6, P0, DOI 10.1016/j.heliyon.2020.e04866
   Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007
   Argov Z, 1998, MUSCLE NERVE, V21, P1523, DOI 10.1002/(SICI)1097-4598(199811)21:11<1523::AID-MUS22>3.0.CO;2-#
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   Campbell R, 2014, MUSCLE NERVE, V50, P401, DOI 10.1002/mus.24148
   Campbell RC, 2011, RHEUMATOLOGY, V50, P67
   Campbell RCJ, 2011, ARTHRITIS RHEUM-US, V63, P0
   CAMPOS Y, 1995, ANN RHEUM DIS, V54, P491, DOI 10.1136/ard.54.6.491
   Capuron L, 2011, BIOL PSYCHIAT, V70, P175, DOI 10.1016/j.biopsych.2010.12.006
   Cardelli C, 2022, CLIN EXP RHEUMATOL, V40, P199, DOI 10.55563/clinexprheumatol/vskjxi
   Carroll TJ, 2017, J APPL PHYSIOL, V122, P1068, DOI 10.1152/japplphysiol.00775.2016
   CARRY MR, 1986, MUSCLE NERVE, V9, P445, DOI 10.1002/mus.880090510
   Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163
   Chariot P, 1996, ACTA NEUROPATHOL, V91, P530, DOI 10.1007/s004010050462
   Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2
   Chung YL, 2007, ARTHRIT RHEUM-ARTHR, V57, P694, DOI 10.1002/art.22687
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   Dastmalchi M, 2007, ARTHRIT RHEUM-ARTHR, V57, P1303, DOI 10.1002/art.22996
   Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4
   Doud J R, 1995, ELECTROMYOGR CLIN NEUROPHYSIOL, V35, P331
   Ernste FC, 2021, J RHEUMATOL, V48, P94, DOI 10.3899/jrheum.191374
   Findlay AR, 2015, MUSCLE NERVE, V51, P638, DOI 10.1002/mus.24566
   Finsterer J, 2014, AM J HOSP PALLIAT ME, V31, P562, DOI 10.1177/1049909113494748
   Fukunaga T, 1997, J APPL PHYSIOL, V82, P354, DOI 10.1152/jappl.1997.82.1.354
   Gao SM, 2017, AUTOIMMUN REV, V16, P1044, DOI 10.1016/j.autrev.2017.07.021
   Josefson A, 1996, J RHEUMATOL, V23, P1380
   Karshikoff B, 2017, FRONT IMMUNOL, V8, P0, DOI 10.3389/fimmu.2017.00021
   Kaya A, 2013, CLIN RHEUMATOL, V32, P1155, DOI 10.1007/s10067-013-2249-8
   Kerr CW, 2012, J PAIN SYMPTOM MANAG, V43, P68, DOI 10.1016/j.jpainsymman.2011.03.026
   Kirsh KL, 2001, J PAIN SYMPTOM MANAG, V22, P931, DOI 10.1016/S0885-3924(01)00350-5
   KRISTOFOOR E L, 2019, J RHEUM DIS TREAT, V5, P0
   Lee CH, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.01696
   Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M
   Liepert J, 1996, MUSCLE NERVE, V19, P1429, DOI 10.1002/(SICI)1097-4598(199611)19:11<1429::AID-MUS7>3.0.CO;2-E
   Loubinoux I, 2002, NEUROPSYCHOLOGIA, V40, P1815, DOI 10.1016/S0028-3932(02)00030-1
   LUERA MJ, 2018, PRELIMINARY COMP MUS, V0, P0
   Lundberg IE, 2018, NAT REV RHEUMATOL, V14, P269, DOI 10.1038/nrrheum.2018.41
   Mahdy MAA, 2019, CELL TISSUE RES, V375, P575, DOI 10.1007/s00441-018-2955-2
   Meeusen R, 2007, APPL PHYSIOL NUTR ME, V32, P857, DOI 10.1139/H07-080
   Meeusen R, 2006, SPORTS MED, V36, P881, DOI 10.2165/00007256-200636100-00006
   Miró O, 1998, BRIT J RHEUMATOL, V37, P1047
   MISSE R, 2020, OPEN J RHEUMATOL AUTOIMMUN DIS, V10, P88, DOI 10.4236/ojra.2020.102011
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Moyer AL, 2011, CURR OPIN RHEUMATOL, V23, P568, DOI 10.1097/BOR.0b013e32834bac92
   Murillo-Rodríguez E, 2018, ACS CHEM NEUROSCI, V9, P151, DOI 10.1021/acschemneuro.7b00374
   OLDROYD A, 2020, BMC RHEUMATOL, V4, P1
   Persson PB, 2016, ACTA PHYSIOL, V218, P3, DOI 10.1111/apha.12756
   Poulson MJ, 2001, J CLIN ONCOL, V19, P4180, DOI 10.1200/JCO.2001.19.21.4180
   Rider LG, 2018, NAT REV RHEUMATOL, V14, P303, DOI 10.1038/nrrheum.2018.33
   Rider LG, 2011, ARTHRIT CARE RES, V63, PS118, DOI 10.1002/acr.20532
   Ropper AH, 2019, ADAMS VICTORS PRINCI, V0, P0
   Rossi B, 1991, RIV NEUROL, V61, P23
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Sahlin K, 1998, ACTA PHYSIOL SCAND, V162, P261, DOI 10.1046/j.1365-201X.1998.0298f.x
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Savitz J, 2015, PSYCHONEUROENDOCRINO, V62, P54, DOI 10.1016/j.psyneuen.2015.07.609
   Schillings ML, 2005, J APPL PHYSIOL, V98, P2292, DOI 10.1152/japplphysiol.01342.2004
   Selva-OCallaghan A, 2018, LANCET NEUROL, V17, P816, DOI 10.1016/S1474-4422(18)30254-0
   Siciliano G, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00451
   Siciliano Gabriele, 2019, ACTA MYOL, V38, P233
   Talbot J, 2016, WIRES DEV BIOL, V5, P518, DOI 10.1002/wdev.230
   Tiffreau V, 2017, ARCH PHYS MED REHAB, V98, P227, DOI 10.1016/j.apmr.2016.09.125
   Tjärnlund A, 2018, ANN RHEUM DIS, V77, P55, DOI 10.1136/annrheumdis-2017-211751
   Vencovsky J, 2019, RHEUM DIS CLIN N AM, V45, P569, DOI 10.1016/j.rdc.2019.07.006
   Wallace A, 2019, NEUROLOGY, V92, PE1773, DOI 10.1212/WNL.0000000000007265
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Xie SS, 2018, DNA CELL BIOL, V37, P982, DOI 10.1089/dna.2018.4256
   Yadav MC, 2007, GLIA, V55, P1385, DOI 10.1002/glia.20544
   Zong M, 2014, ANN RHEUM DIS, V73, P913, DOI 10.1136/annrheumdis-2012-202857
NR 72
TC 4
Z9 4
U1 0
U2 3
PU CLINICAL & EXPER RHEUMATOLOGY
PI PISA
PA VIA SANTA MARIA 31, 56126 PISA, ITALY
SN 0392-856X
EI 1593-098X
J9 CLIN EXP RHEUMATOL
JI Clin. Exp. Rheumatol.
PD FEB 15
PY 2022
VL 40
IS 2
BP 425
EP 432
DI 
PG 8
WC Rheumatology
SC Rheumatology
GA ZK2EA
UT WOS:000762805800028
PM 35225228
DA 2024-11-01
ER

PT J
AU Sen, A
   Kallabis, S
   Gaedke, F
   Jüngst, C
   Boix, J
   Nüchel, J
   Maliphol, K
   Hofmann, J
   Schauss, AC
   Krüger, M
   Wiesner, RJ
   Pla-Martín, D
AF Sen, Ayesha
   Kallabis, Sebastian
   Gaedke, Felix
   Juengst, Christian
   Boix, Julia
   Nuechel, Julian
   Maliphol, Kanjanamas
   Hofmann, Julia
   Schauss, Astrid C.
   Krueger, Marcus
   Wiesner, Rudolf J.
   Pla-Martin, David
TI Mitochondrial membrane proteins and VPS35 orchestrate selective removal of mtDNA
SO NATURE COMMUNICATIONS
LA English
DT Article
ID quality-control; skeletal-muscle; dna; mutations; mitophagy; deletions; stability; autophagy; transport; pathway
AB Understanding the mechanisms governing selective turnover of mutation-bearing mtDNA is fundamental to design therapeutic strategies against mtDNA diseases. Here, we show that specific mtDNA damage leads to an exacerbated mtDNA turnover, independent of canonical macroautophagy, but relying on lysosomal function and ATG5. Using proximity labeling and Twinkle as a nucleoid marker, we demonstrate that mtDNA damage induces membrane remodeling and endosomal recruitment in close proximity to mitochondrial nucleoid sub-compartments. Targeting of mitochondrial nucleoids is controlled by the ATAD3-SAMM50 axis, which is disrupted upon mtDNA damage. SAMM50 acts as a gatekeeper, influencing BAK clustering, controlling nucleoid release and facilitating transfer to endosomes. Here, VPS35 mediates maturation of early endosomes to late autophagy vesicles where degradation occurs. In addition, using a mouse model where mtDNA alterations cause impairment of muscle regeneration, we show that stimulation of lysosomal activity by rapamycin, selectively removes mtDNA deletions without affecting mtDNA copy number, ameliorating mitochondrial dysfunction. Taken together, our data demonstrates that upon mtDNA damage, mitochondrial nucleoids are eliminated outside the mitochondrial network through an endosomal-mitophagy pathway. With these results, we unveil the molecular players of a complex mechanism with multiple potential benefits to understand mtDNA related diseases, inherited, acquired or due to normal ageing. Mitochondrial quality control mechanisms prevent damage accumulation, including in mitochondrial DNA (mtDNA). Here, Sen et al. show that altered mtDNA elicits local rearrangements in mitochondrial membrane potential and cristae structure, with mtDNA eliminated through VPS35 endosomes.
C1 [Sen, Ayesha; Boix, Julia; Maliphol, Kanjanamas; Hofmann, Julia; Wiesner, Rudolf J.; Pla-Martin, David] Univ Cologne, Fac Med, Ctr Physiol & Pathophysiol, Cologne, Germany.
   [Sen, Ayesha; Boix, Julia; Nuechel, Julian; Maliphol, Kanjanamas; Hofmann, Julia; Wiesner, Rudolf J.; Pla-Martin, David] Univ Cologne, Univ Hosp Cologne, Cologne, Germany.
   [Kallabis, Sebastian; Gaedke, Felix; Juengst, Christian; Schauss, Astrid C.; Krueger, Marcus; Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
   [Boix, Julia; Wiesner, Rudolf J.; Pla-Martin, David] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.
   [Nuechel, Julian] Univ Cologne, Fac Med, Ctr Biochem, Cologne, Germany.
C3 University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne
RP Pla-Martín, D (corresponding author), Univ Cologne, Fac Med, Ctr Physiol & Pathophysiol, Cologne, Germany.; Pla-Martín, D (corresponding author), Univ Cologne, Univ Hosp Cologne, Cologne, Germany.; Pla-Martín, D (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.
EM dplamart@uni-koeln.de
FU Deutsche Forschungs-gemeinschaft [PL 895/1-1]; Koln Fortune [341/2019]
CR Abudu YP, 2021, J CELL BIOL, V220, P0, DOI 10.1083/jcb.202009092
   Alsina D, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911659
   Arguello T, 2021, CELL REP, V37, P0, DOI 10.1016/j.celrep.2021.110139
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Bono K, 2020, MOL BRAIN, V13, P0, DOI 10.1186/s13041-020-00675-5
   Bové J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068
   Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066
   Cantarero L, 2020, HUM MOL GENET, V29, P3589, DOI 10.1093/hmg/ddaa243
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen L, 2022, HEPATOLOGY, V76, P1389, DOI 10.1002/hep.32471
   Civiletto G, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708799
   Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249
   Crupi AN, 2018, AGING-US, V10, P3327, DOI 10.18632/aging.101643
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Dong B, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2347
   Dossou AS, 2019, CANCERS, V11, P0, DOI 10.3390/cancers11101422
   Eleuteri S, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.01272
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hammerling BC, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms14050
   Han S, 2017, CELL CHEM BIOL, V24, P404, DOI 10.1016/j.chembiol.2017.02.002
   Hanss Z, 2021, MOVEMENT DISORD, V36, P704, DOI 10.1002/mds.28365
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   Jakubke C, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abi8886
   Jian FL, 2018, CELL REP, V23, P2989, DOI 10.1016/j.celrep.2018.05.015
   Jin GX, 2018, NAT IMMUNOL, V19, P29, DOI 10.1038/s41590-017-0002-1
   Kallabis S, 2020, SKELET MUSCLE, V10, P0, DOI 10.1186/s13395-020-00226-5
   Kandul NP, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13100
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kimoloi S, 2022, J CACHEXIA SARCOPENI, V13, P2132, DOI 10.1002/jcsm.13026
   Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280
   Kloepper JE, 2015, J INVEST DERMATOL, V135, P679, DOI 10.1038/jid.2014.475
   Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Linhart R, 2014, MOL NEURODEGENER, V9, P0, DOI 10.1186/1750-1326-9-23
   Liu S, 2016, FEBS LETT, V590, P1313, DOI 10.1002/1873-3468.12170
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma KY, 2021, TRANSL NEURODEGENER, V10, P0, DOI 10.1186/s40035-021-00243-4
   Mai S, 2012, AUTOPHAGY, V8, P47, DOI 10.4161/auto.8.1.18174
   McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   Montoro AG, 2018, DEV CELL, V45, P621, DOI 10.1016/j.devcel.2018.05.011
   Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291
   Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038
   Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217
   Ock CY, 2012, WORLD J GASTROENTERO, V18, P302, DOI 10.3748/wjg.v18.i4.302
   Oexner RR, 2020, INVEST OPHTH VIS SCI, V61, P0, DOI 10.1167/iovs.61.12.14
   Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015
   Pass T, 2021, FRONT MOL BIOSCI, V8, P0, DOI 10.3389/fmolb.2021.676187
   Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, PD442, DOI 10.1093/nar/gky1106
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Remtulla S, 2019, PEDIATR NEUROL, V90, P61, DOI 10.1016/j.pediatrneurol.2018.08.007
   Riley JS, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201899238
   Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278
   Sage-Schwaede A, 2019, ANN CLIN TRANSL NEUR, V6, P1877, DOI 10.1002/acn3.50846
   Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013
   Shu L, 2021, EMBO J, V40, P0, DOI 10.15252/embj.2020106283
   Silwal P, 2021, COMMUN BIOL, V4, P0, DOI 10.1038/s42003-021-02073-6
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Sprenger HG, 2021, NAT METAB, V3, P636, DOI 10.1038/s42255-021-00385-9
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Szczepanowska K, 2020, HUMAN MITOCHONDRIAL, V0, P221
   Tang JH, 2020, CELL DEATH DIFFER, V27, P146, DOI 10.1038/s41418-019-0345-2
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Weiland D, 2018, J INVEST DERMATOL, V138, P132, DOI 10.1016/j.jid.2017.08.019
   Williams ET, 2018, HUM MOL GENET, V27, P3189, DOI 10.1093/hmg/ddy224
   Yamano K, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.31326
   Yang X, 2019, ANNU REV NUTR, V39, P201, DOI 10.1146/annurev-nutr-082018-124643
   Zhao YY, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-09291-x
   Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11
   Zhu Shusen, 2017, BMC RES NOTES, V10, P269, DOI 10.1186/s13104-017-2593-x
NR 75
TC 32
Z9 34
U1 2
U2 18
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 7
PY 2022
VL 13
IS 1
BP 
EP 
DI 10.1038/s41467-022-34205-9
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 5Z3DW
UT WOS:000879857400001
PM 36344526
DA 2024-11-01
ER

PT J
AU Riccio, AA
   Bouvette, J
   Perera, L
   Longley, MJ
   Krahn, JM
   Williams, JG
   Dutcher, R
   Borgnia, MJ
   Copeland, WC
AF Riccio, Amanda A.
   Bouvette, Jonathan
   Perera, Lalith
   Longley, Matthew J.
   Krahn, Juno M.
   Williams, Jason G.
   Dutcher, Robert
   Borgnia, Mario J.
   Copeland, William C.
TI Structural insight and characterization of human Twinkle helicase in mitochondrial disease
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE mitochondrial DNA; Twinkle helicase; mitochondrial DNA replication; cryo-electron microscopy; progressive external ophthalmoplegia
ID stranded-dna-binding; crystal-structure; bacteriophage t7; modular architecture; primase; protein; mutations; dynamics; visualization; simulation
AB Twinkle is the mammalian helicase vital for replication and integrity of mitochondrial DNA. Over 90 Twinkle helicase disease variants have been linked to progressive external ophthalmoplegia and ataxia neuropathies among other mitochondrial diseases. Despite the biological and clinical importance, Twinkle represents the only remaining component of the human minimal mitochondrial replisome that has yet to be structurally characterized. Here, we present 3-dimensional structures of human Twinkle W315L. Employing cryo-electron microscopy (cryo-EM), we characterize the oligomeric assemblies of human full-length Twinkle W315L, define its multimeric interface, and map clinical variants associated with Twinkle in inherited mitochondrial disease. Cryo-EM, crosslinking-mass spectrometry, and molecular dynamics simulations provide insight into the dynamic movement and molecular consequences of the W315L clinical variant. Collectively, this ensemble of structures outlines a framework for studying Twinkle function in mitochondrial DNA replication and associated disease states.
C1 [Riccio, Amanda A.; Longley, Matthew J.; Copeland, William C.] NIEHS, Mitochondrial DNA Replicat Grp, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.
   [Bouvette, Jonathan; Borgnia, Mario J.] NIEHS, Mol Microscopy Consortium, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.
   [Perera, Lalith] NIEHS, Computat Chem & Mol Modeling Support Grp, NIH, Res Triangle Pk, NC 27709 USA.
   [Krahn, Juno M.] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.
   [Williams, Jason G.] NIEHS, Mass Spectrometry Res & Support Grp, Epigenet & Stem Cell Biol Lab, Genome Integr & Struct Biol Lab,NIH, Res Triangle Pk, NC 27709 USA.
   [Dutcher, Robert] NIEHS, Macromol Struct Grp, Epigenet & Stem Cell Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mitochondrial DNA Replicat Grp, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU Division of Intramural Research of the NIH, National Institute of Environmental Health Sciences (NIEHS) [Z01 ES065078, Z01 ES065080, Z01 ES043010, ZIC ES 103326]; NIH [P41-GM103311]; National Institute of Environmental Health Sciences [ZIAES065078] Funding Source: NIH RePORTER
CR [Anonymous], 2015, THE PYMOL MOLECULAR GRAPHICS SYSTEM, V0, P0
   Case DA, 2018, AMBER2018, V0, P0
   Combe CW, 2015, MOL CELL PROTEOMICS, V14, P1137, DOI 10.1074/mcp.O114.042259
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   Drulyte I, 2018, ACTA CRYSTALLOGR D, V74, P560, DOI 10.1107/S2059798318006496
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Fernández-Millán P, 2015, NUCLEIC ACIDS RES, V43, P4284, DOI 10.1093/nar/gkv189
   Gao Y, 2019, SCIENCE, V363, P835, DOI 10.1126/science.aav7003
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Jones M, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-14856-2
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kaguni LS, 2016, CRIT REV BIOCHEM MOL, V51, P53, DOI 10.3109/10409238.2015.1117056
   Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3
   Kaur P, 2020, J BIOL CHEM, V295, P5564, DOI 10.1074/jbc.RA120.012795
   Khan I, 2016, J BIOL CHEM, V291, P14324, DOI 10.1074/jbc.M115.712026
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Patel G, 2011, J BIOL CHEM, V286, P20490, DOI 10.1074/jbc.M110.201657
   Peter B, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11040408
   Peter B, 2019, HUM MOL GENET, V28, P1090, DOI 10.1093/hmg/ddy415
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pilion MC, 2019, NAT STRUCT MOL BIOL, V26, P830, DOI 10.1038/s41594-019-0289-8
   Punjani A, 2017, NAT METHODS, V14, P290, DOI 10.1038/NMETH.4169
   Riccio AA, 2021, WWPDB, V0, P0, DOI DOI 10.2210/pdb7T8C/pdb
   Riccio AA, 2021, WWPDB, V0, P0, DOI DOI 10.2210/pdb7T8B/pdb
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Sanchez-Garcia R, 2021, COMMUN BIOL, V4, P0, DOI 10.1038/s42003-021-02399-1
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7
   Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Vos SM, 2018, NATURE, V560, P607, DOI 10.1038/s41586-018-0440-4
   Wallen JR, 2017, STRUCTURE, V25, P157, DOI 10.1016/j.str.2016.11.019
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
   Zhang HD, 2012, J BIOL CHEM, V287, P34273, DOI 10.1074/jbc.M112.401158
   Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 54
TC 7
Z9 9
U1 1
U2 11
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 9
PY 2022
VL 119
IS 32
BP 
EP 
DI 10.1073/pnas.2207459119
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 8X4GV
UT WOS:000931973700072
PM 35914129
DA 2024-11-01
ER

PT J
AU Seed, LM
   Dean, A
   Krishnakumar, D
   Phyu, P
   Horvath, R
   Harijan, PD
AF Seed, Lydia M.
   Dean, Andrew
   Krishnakumar, Deepa
   Phyu, Poe
   Horvath, Rita
   Harijan, Pooja Devi
TI Molecular and neurological features of MELAS syndrome in paediatric patients: A case series and review of the literature
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Review
DE encephalopathy; genetics; lactic acidosis; m.3243A > G; MELAS syndrome; mitochondrial disease; paediatric neurology; stroke-like episodes
ID stroke-like episodes; transfer rnaleu(uur) gene; lactic-acidosis; mitochondrial-dna; mutation; encephalomyopathy; encephalopathy; myopathy; diseases; a3243g
AB Background: Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome is one of the most well-known mitochondrial diseases, with most cases attributed to m.3243A>G. MELAS syndrome patients typically present in the first two decades of life with a broad, multi-systemic phenotype that predominantly features neurological manifestations--stroke-like episodes. However, marked phenotypic variability has been observed among paediatric patients, creating a clinical challenge and delaying diagnoses. Methods: A literature review of paediatric MELAS syndrome patients and a retrospective analysis in a UK tertiary paediatric neurology centre were performed. Results: Three children were included in this case series. All patients presented with seizures and had MRI changes not confined to a single vascular territory. Blood heteroplasmy varied considerably, and one patient required a muscle biopsy. Based on a literature review of 114 patients, the mean age of presentation is 8.1 years and seizures are the most prevalent manifestation of stroke-like episodes. Heteroplasmy is higher in a tissue other than blood in most cases. Conclusion: The threshold for investigating MELAS syndrome in children with suspicious neurological symptoms should be low. If blood m.3243A>G analysis is negative, yet clinical suspicion remains high, invasive testing or further interrogation of the mitochondrial genome should be considered.
C1 [Seed, Lydia M.] Univ Cambridge, Sch Clin Med, Cambridge, England.
   [Dean, Andrew; Horvath, Rita] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
   [Dean, Andrew] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England.
   [Krishnakumar, Deepa; Harijan, Pooja Devi] Cambridge Univ Hosp NHS Fdn Trust, Dept Paediat Neurosci, Cambridge, England.
   [Phyu, Poe] Cambridge Univ Hosp NHS Fdn Trust, Dept Clin Neuroradiol, Cambridge, England.
C3 University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge
RP Harijan, PD (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Dept Paediat Neurosci, Cambridge, England.
EM pooja.harijan@addenbrookes.nhs.uk
FU Medical Research Council (UK) [109,915/Z/15/Z]; European Research Council [MR/N025431/1, MR/V009346/1]; Newton Fund (UK/Turkey) [309548]; Addenbrookes Charitable Trust [MR/N027302/1]; Evelyn Trust [G100142]; Stoneygate Trust; Lily Foundation [MR/S005021/1]; NIHR Cambridge Biomedical Research Centre; Department of Health and Social Care [BRC-1215-20,014]
CR Alcubilla-Prats P, 2017, MED CLIN-BARCELONA, V148, P357, DOI 10.1016/j.medcle.2017.04.002
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   [Anonymous], 2008, MITOMAP: A HUMAN MITOCHONDRIAL GENOME DATABASE, V0, P0
   Bhatia KD, 2020, AM J NEURORADIOL, V41, P167, DOI 10.3174/ajnr.A6325
   Brisca G, 2015, BIOCHEM BIOPH RES CO, V458, P601, DOI 10.1016/j.bbrc.2015.01.157
   Calvaruso MA, 2011, MITOCHONDRION, V11, P778, DOI 10.1016/j.mito.2011.06.004
   Chakrabarty S, 2021, J NEUROL, V1, P3
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Emmanuele V, 2013, J CHILD NEUROL, V28, P236, DOI 10.1177/0883073812445787
   FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8
   Fujii A, 2004, INTERNAL MED, V43, P1126, DOI 10.2169/internalmedicine.43.1126
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, P0, DOI 10.1186/s40478-015-0227-x
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Karvonen SL, 1999, BRIT J DERMATOL, V140, P634
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kraya T, 2019, MITOCHONDRION, V44, P53, DOI 10.1016/j.mito.2017.12.012
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, PD1062, DOI 10.1093/nar/gkx1153
   Li C, 2021, MITOCHONDRION, V58, P131, DOI 10.1016/j.mito.2021.02.015
   Longo N, 2008, AM J MED GENET A, V146A, P361, DOI 10.1002/ajmg.a.31841
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   McKusick-Nathans Institute of Genetic Medicine, 2022, ONLINE MENDELIAN INH, V0, P0
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   Muñoz MF, 2015, FRONT CELL NEUROSCI, V9, P0, DOI 10.3389/fncel.2015.00059
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Niu FN, 2017, CNS NEUROSCI THER, V23, P686, DOI 10.1111/cns.12714
   Ohno K, 1997, NEURORADIOLOGY, V39, P781, DOI 10.1007/s002340050505
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Phadke R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6070064
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   Sotiriou E, 2009, NEUROMUSCULAR DISORD, V19, P297, DOI 10.1016/j.nmd.2009.01.014
   Sproule D M, 2008, J INHERIT METAB DIS, V31 Suppl 3, P497, DOI 10.1007/s10545-007-0735-3
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Stenqvist L, 2005, PEDIATR RES, V58, P258, DOI 10.1203/01.PDR.0000169966.82325.1A
   Uittenbogaard M, 2019, MOL GENET METAB, V126, P429, DOI 10.1016/j.ymgme.2019.01.022
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yorifuji T, 1996, J MED GENET, V33, P621, DOI 10.1136/jmg.33.7.621
NR 53
TC 7
Z9 7
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
EI 
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD JUL 15
PY 2022
VL 10
IS 7
BP 
EP 
DI 10.1002/mgg3.1955
EA APR 2022
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA 2S7HT
UT WOS:000787570800001
PM 35474314
DA 2024-11-01
ER

PT J
AU Qi, M
   Liao, SM
   Wang, J
   Deng, YK
   Zha, AD
   Shao, YR
   Cui, ZJ
   Song, TX
   Tang, YL
   Tan, B
   Yin, YL
AF Qi, Ming
   Liao, Simeng
   Wang, Jing
   Deng, Yuankun
   Zha, Andong
   Shao, Yirui
   Cui, Zhijuan
   Song, Tongxing
   Tang, Yulong
   Tan, Bie
   Yin, Yulong
TI MyD88 deficiency ameliorates weight loss caused by intestinal oxidative injury in an autophagy-dependent mechanism
SO JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
LA English
DT Article
DE Intestinal epithelial cells; Cachexia; Weight loss; DNA damage repair; Mitochondria) fission; Autophagy
ID dna-damage; stress; muscle; cancer; pathogenesis; sarcopenia; protects; cachexia; insights; systems
AB Background Gut health plays a vital role in the overall health and disease control of human and animals. Intestinal oxidative stress is a critical player in the induction and progression of cachexia which is conventionally diagnosed and classified by weight loss. Therefore, reduction of intestinal oxidative injury is a common and highly effective strategy for the maintenance of human and animal health. Here we identify intestinal myeloid differentiation primary response gene 88 (MyD88) as a novel target for intestinal oxidative stress using canonical oxidative stress model induced by paraquat (PQ) in vitro and in vivo. Methods Intestinal oxidative stress was induced by administration of PQ in intestinal epithelial cells (IECs) and mouse model. Cell proliferation, apoptosis, DNA damage, mitochondrial function, oxidative status, and autophagy process were measured in wild-type and MyD88-deficient IECs during PQ exposure. Autophagy inhibitor (3-methyladenine) and activator (rapamycin) were employed to assess the role of autophagy in MyD88-deficient IECs during PQ exposure. MyD88 specific inhibitor, ST2825, was used to verify function of MyD88 during PQ exposure in mouse model. Results MyD88 protein levels and apoptotic rate of IECs are increased in response to PQ exposure (P < 0.001). Intestinal deletion of MyD88 blocks PQ-induced apoptosis (similar to 42% reduction) and DNA damage (similar to 86% reduction), and improves mitochondrial fission (similar to 37% reduction) and function including mitochondrial membrane potential (similar to 23% increment) and respiratory metabolism capacity (similar to 26% increment) (P < 0.01). Notably, there is a marked decrease in reactive oxygen species in MyD88-deficient IECs during PQ exposure (similar to 70% reduction), which are consistent with high activity of antioxidative enzymes (similar to 83% increment) (P < 0.001). Intestinal ablation of MyD88 inhibits mTOR signalling, and further phosphorylates p53 proteins during PQ exposure, which eventually promotes intestinal autophagy (similar to 74% increment) (P < 0.01). Activation of autophagy (rapamycin) promotes IECs growth as compared with 3-methyladenine-treatment during PQ exposure (similar to 173% increment), while inhibition of autophagy (3-methyladenine) exacerbates oxidative stress in MyD88-deficient IECs (P < 0.001). In mouse model, inhibition of MyD88 using specific inhibitor ST2825 followed by PQ treatment effectively ameliorates weight loss (similar to 4% increment), decreased food intake (similar to 92% increment), gastrocnemius and soleus loss (similar to 24% and similar to 20% increment, respectively), and intestinal oxidative stress in an autophagy dependent manner (P < 0.01). Conclusions MyD88 modulates intestinal oxidative stress in an autophagy-dependent mechanism, which suggests that reducing MyD88 level may constitute a putative therapeutic target for intestinal oxidative injury-induced weight loss.
C1 [Qi, Ming; Liao, Simeng; Zha, Andong; Shao, Yirui; Cui, Zhijuan; Tang, Yulong; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Natl Engn Lab Pollut Control & Waste Utilizat Liv, Lab Anim Nutr Physiol & Metab Proc,Key Lab Agroec, Changsha 410125, Hunan, Peoples R China.
   [Qi, Ming; Wang, Jing; Deng, Yuankun; Cui, Zhijuan; Tan, Bie; Yin, Yulong] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha 410000, Hunan, Peoples R China.
   [Qi, Ming; Liao, Simeng; Zha, Andong; Shao, Yirui; Yin, Yulong] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Song, Tongxing] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Peoples R China.
C3 Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Hunan Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Huazhong Agricultural University
RP Tang, YL (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Natl Engn Lab Pollut Control & Waste Utilizat Liv, Lab Anim Nutr Physiol & Metab Proc,Key Lab Agroec, Changsha 410125, Hunan, Peoples R China.; Tan, B (corresponding author), Hunan Agr Univ, Coll Anim Sci & Technol, Changsha 410000, Hunan, Peoples R China.
EM bietan@hunau.edu.cn; tangyulong@isa.ac.cn
FU National Natural Science Foundation of China [32072745, 32130099]; Innovation Province Project [2019RS3021]
CR Abrigo J, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/2063179
   Aoki H, 2002, J NUTR, V132, P2258, DOI 10.1093/jn/132.8.2258
   Argilés JM, 2011, EUR J PHARMACOL, V668, PS81, DOI 10.1016/j.ejphar.2011.07.007
   Baraldo M, 2020, J CACHEXIA SARCOPENI, V11, P208, DOI 10.1002/jcsm.12496
   Barazzoni R, 2017, J CACHEXIA SARCOPENI, V8, P991, DOI 10.1002/jcsm.12254
   Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012
   Brown JL, 2020, J CACHEXIA SARCOPENI, V11, P1688, DOI 10.1002/jcsm.12615
   Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232
   Costa RGF, 2019, J CACHEXIA SARCOPENI, V10, P1116, DOI 10.1002/jcsm.12449
   De Zio D, 2013, ANTIOXID REDOX SIGN, V19, P559, DOI 10.1089/ars.2012.4938
   González-Polo RA, 2004, BRAIN RES, V1011, P170, DOI 10.1016/j.brainres.2004.02.078
   Harberts E, 2015, J IMMUNOL, V194, P3127, DOI 10.4049/jimmunol.1402583
   He J, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24244502
   Hinch ECA, 2013, J CACHEXIA SARCOPENI, V4, P287, DOI 10.1007/s13539-013-0116-8
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Hwang J, 2020, REDOX BIOL, V37, P0, DOI 10.1016/j.redox.2020.101760
   Konstam MA, 2018, CIRCULATION, V137, PE578, DOI 10.1161/CIR.0000000000000560
   Pötgens SA, 2021, J CACHEXIA SARCOPENI, V12, P456, DOI 10.1002/jcsm.12684
   Qaisar R, 2018, J CACHEXIA SARCOPENI, V9, P1003, DOI 10.1002/jcsm.12339
   Qi M, 2019, J ANIM SCI, V97, P3795, DOI 10.1093/jas/skz205
   Reczek CR, 2017, NAT CHEM BIOL, V13, P1274, DOI 10.1038/nchembio.2499
   Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006
   Ruud J, 2010, BRAIN BEHAV IMMUN, V24, P554, DOI 10.1016/j.bbi.2010.01.006
   Shibata M, 2010, J BIOL CHEM, V285, P20915, DOI 10.1074/jbc.M110.126482
   Siegel MP, 2012, MECH AGEING DEV, V133, P620, DOI 10.1016/j.mad.2012.08.002
   Song XZ, 2017, REDOX BIOL, V11, P219, DOI 10.1016/j.redox.2016.12.015
   Takenaka A, 2003, BIOSCI BIOTECH BIOCH, V67, P278, DOI 10.1271/bbb.67.278
   Takizawa M, 2007, TOXICOL IN VITRO, V21, P355, DOI 10.1016/j.tiv.2006.09.003
   Tang YL, 2015, FREE RADICAL BIO MED, V89, P944, DOI 10.1016/j.freeradbiomed.2015.09.012
   Tao SY, 2019, CURR PROTEIN PEPT SC, V20, P713, DOI 10.2174/1389203720666190124165243
   Thiesen S, 2014, J LEUKOCYTE BIOL, V95, P531, DOI 10.1189/jlb.0113021
   Ulmer TF, 2014, INT J SURG, V12, P426, DOI 10.1016/j.ijsu.2014.03.014
   Van Krimpen SJ, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13041115
   von Haehling S, 2019, J CACHEXIA SARCOPENI, V10, P1143, DOI 10.1002/jcsm.12501
   Wen CY, 2020, J ANIM SCI BIOTECHNO, V11, P0, DOI 10.1186/s40104-020-00463-0
   Wyart E, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21228592
   Yang JH, 2020, FASEB J, V34, P12324, DOI 10.1096/fj.202001252R
   Yin JY, 2019, THERANOSTICS, V9, P4019, DOI 10.7150/thno.33000
   Zha AD, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/5363546
   Zhou MX, 2018, EBIOMEDICINE, V35, P345, DOI 10.1016/j.ebiom.2018.08.035
   Zhu XX, 2019, J CACHEXIA SARCOPENI, V10, P378, DOI 10.1002/jcsm.12377
NR 41
TC 16
Z9 16
U1 0
U2 33
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2190-5991
EI 2190-6009
J9 J CACHEXIA SARCOPENI
JI J. Cachexia Sarcopenia Muscle
PD FEB 15
PY 2022
VL 13
IS 1
BP 677
EP 695
DI 10.1002/jcsm.12858
EA NOV 2021
PG 19
WC Geriatrics & Gerontology; Medicine, General & Internal
SC Geriatrics & Gerontology; General & Internal Medicine
GA 2O3QI
UT WOS:000721429400001
PM 34811946
DA 2024-11-01
ER

PT J
AU Yalcouyé, A
   Diallo, SH
   Cissé, L
   Karembé, M
   Diallo, S
   Coulibaly, T
   Diarra, S
   Coulibaly, D
   Keita, M
   Guinto, CO
   Fischbeck, KH
   Wonkam, A
   Landouré, G
AF Yalcouye, Abdoulaye
   Diallo, Seybou H.
   Cisse, Lassana
   Karembe, Mamadou
   Diallo, Salimata
   Coulibaly, Thomas
   Diarra, Salimata
   Coulibaly, Dramane
   Keita, Mohamed
   Guinto, Cheick O.
   Fischbeck, Kenneth H.
   Wonkam, Ambroise
   Landoure, Guida
TI <i>GJB1</i> variants in Charcot-Marie-Tooth disease X-linked type 1 in Mali
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Article
DE Africa; CMTX1; GJB1; inherited neuropathies; Mali
ID connexin32; mutations; gene; neuropathy; pathogenesis; subtypes; family; cohort; motor; cell
AB X-linked Charcot-Marie-Tooth type 1 (CMTX1) disease is one of the most common subtypes of inherited neuropathies and is caused by mutations in the GJB1 gene. To date, more than 400 mutations have been reported in GJB1 worldwide but none in sub-Saharan Africa (SSA). We aimed to clinically characterize patients with CMTX1 and identify the genetic defects. All patients were examined thoroughly, and Nerve Conduction Studies (NCS) were done. EEG and pure tone audiometry (PTA) were also done in select individuals having additional symptoms. DNA was extracted for CMT gene panel testing (50 genes + mtDNA and PMP22 duplication), and putative variants were screened in available relatives. The predominant starting symptom was tingling, and the chief complaint was gait difficulty. Neurological examination found a distal muscle weakness and atrophy, and sensory loss, skeletal deformities, decreased or absent reflexes and steppage gait. The inheritance pattern was consistent with dominant X-linked. NCS showed no response in most of the tested nerves in lower limbs, and normal or reduced amplitudes in upper limbs. A severe sensorineural hearing impairment and a focal epileptic seizure were observed in one patient each. A high intra and inter-familial clinical variability was observed. Genetic testing found three pathogenic missense variants in GJB1, one in each of the families (Val91Met, Arg15Trp, and Phe235Cys). This is the first report of genetically confirmed cases of CMTX1 in SSA, and confirms its clinical and genetic heterogeneity.
C1 [Yalcouye, Abdoulaye; Wonkam, Ambroise] Univ Cape Town, Dept Pathol, Div Human Genet, Cape Town, South Africa.
   [Yalcouye, Abdoulaye; Diallo, Seybou H.; Coulibaly, Thomas; Diarra, Salimata; Keita, Mohamed; Guinto, Cheick O.; Landoure, Guida] USTTB, Fac Med & Odontostomatol, BP 1805, Bamako, Mali.
   [Diallo, Seybou H.; Diallo, Salimata] Ctr Hosp Univ Gabriel Toure, Serv Neurol, Bamako, Mali.
   [Cisse, Lassana; Karembe, Mamadou; Coulibaly, Thomas; Guinto, Cheick O.; Landoure, Guida] Ctr Hosp Univ Point G, Serv Neurol, Bamako, Mali.
   [Diarra, Salimata; Fischbeck, Kenneth H.; Landoure, Guida] NINDS, Neurogenet Branch, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Coulibaly, Dramane] Ctr Hosp Univ Mere Enfant Luxembourg, Serv Med, Bamako, Mali.
   [Keita, Mohamed] Ctr Hosp Univ Gabriel Toure, Serv ORL, Bamako, Mali.
C3 University of Cape Town; University of Science & Technology of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
RP Landouré, G (corresponding author), USTTB, Fac Med & Odontostomatol, BP 1805, Bamako, Mali.
EM guida@icermali.org
FU National Institute of Neurological Disorders and Stroke [U01HG007044]; NINDS [NS002974]; Wellcome Trust [107755Z/15/Z]; NIH, USA [U01-HG-009716]; African Academy of Science/Wellcome Trust [H3A/18/001]; National Institute on Deafness and Other Communication Disorders; NIH Office of the Director [U01HG009716] Funding Source: NIH RePORTER
CR Abrams CK, 2019, NEUROSCI LETT, V695, P91, DOI 10.1016/j.neulet.2017.05.037
   Abrams CK, 2003, J NEUROSCI, V23, P10548
   Arthur-Farraj PJ, 2012, NEUROMUSCULAR DISORD, V22, P622, DOI 10.1016/j.nmd.2012.02.008
   Bähr M, 1999, J NEUROL NEUROSUR PS, V66, P202, DOI 10.1136/jnnp.66.2.202
   BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101
   Bienfait HME, 2007, NEUROLOGY, V68, P1658, DOI 10.1212/01.wnl.0000263479.97552.94
   Bissar-Tadmouri N, 2000, CLIN GENET, V58, P396, DOI 10.1034/j.1399-0004.2000.580511.x
   Bone LJ, 1997, NEUROBIOL DIS, V4, P221, DOI 10.1006/nbdi.1997.0152
   DiVincenzo C, 2014, MOL GENET GENOM MED, V2, P522, DOI 10.1002/mgg3.106
   Dubourg O, 2001, BRAIN, V124, P1958, DOI 10.1093/brain/124.10.1958
   Fridman V, 2015, J NEUROL NEUROSUR PS, V86, P873, DOI 10.1136/jnnp-2014-308826
   Kleopa KA, 2012, BRAIN RES, V1487, P198, DOI 10.1016/j.brainres.2012.03.068
   Lee MJ, 2002, J NEUROL NEUROSUR PS, V73, P304, DOI 10.1136/jnnp.73.3.304
   Liang GSL, 2005, ANN NEUROL, V57, P749, DOI 10.1002/ana.20459
   Lu YY, 2017, CHINESE MED J-PEKING, V130, P1049, DOI 10.4103/0366-6999.204925
   Meggouh F, 1998, J MED GENET, V35, P251, DOI 10.1136/jmg.35.3.251
   Murakami T, 2019, ADV EXP MED BIOL, V1190, P301, DOI 10.1007/978-981-32-9636-7_19
   Nelis E, 1999, HUM MUTAT, V13, P11, DOI 10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A
   Panosyan FB, 2017, NEUROLOGY, V89, P927, DOI 10.1212/WNL.0000000000004296
   Pareyson D, 1999, MUSCLE NERVE, V22, P1498, DOI 10.1002/(SICI)1097-4598(199911)22:11<1498::AID-MUS4>3.0.CO;2-9
   Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166
   Scherer SS, 1998, GLIA, V24, P8, DOI 10.1002/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3
   Senderek J, 1998, ACTA NEUROPATHOL, V95, P443, DOI 10.1007/s004010050823
   Shahrizaila N, 2014, MUSCLE NERVE, V49, P198, DOI 10.1002/mus.23892
   Shy ME, 2007, NEUROLOGY, V68, P849, DOI 10.1212/01.wnl.0000256709.08271.4d
   Totland MZ, 2020, CELL MOL LIFE SCI, V77, P573, DOI 10.1007/s00018-019-03285-0
   Tsai PC, 2016, ANN CLIN TRANSL NEUR, V3, P854, DOI 10.1002/acn3.347
   VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1
   Wicklein EM, 1997, J NEUROL NEUROSUR PS, V63, P379, DOI 10.1136/jnnp.63.3.379
   Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076
   Yiu EM, 2011, NEUROLOGY, V76, P461, DOI 10.1212/WNL.0b013e31820a0ceb
NR 33
TC 1
Z9 2
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD JUN 15
PY 2022
VL 27
IS 2
BP 113
EP 119
DI 10.1111/jns.12486
EA APR 2022
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 1W1IS
UT WOS:000778176800001
PM 35383424
DA 2024-11-01
ER

PT J
AU Wang, HY
   Han, YJ
   Li, SW
   Chen, YA
   Chen, YF
   Wang, J
   Zhang, YQ
   Zhang, YW
   Wang, JS
   Xia, Y
   Yuan, JX
AF Wang, Haiying
   Han, Yijun
   Li, Shenwei
   Chen, Yunan
   Chen, Yafen
   Wang, Jing
   Zhang, Yuqing
   Zhang, Yawen
   Wang, Jingsuo
   Xia, Yong
   Yuan, Jinxiang
TI Mitochondrial DNA Depletion Syndrome and Its Associated Cardiac Disease
SO FRONTIERS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
DE mitochondrial DNA depletion syndrome; nuclear gene mutation; mtDNA; cardiac disease; ATP
ID coa ligase deficiency; skeletal-muscle; cardiovascular-disease; acylglycerol kinase; maintenance defect; oxidative stress; mtdna depletion; mutations; heart; gene
AB Mitochondria is a ubiquitous, energy-supplying (ATP-based) organelle found in nearly all eukaryotes. It acts as a "power plant" by producing ATP through oxidative phosphorylation, providing energy for the cell. The bioenergetic functions of mitochondria are regulated by nuclear genes (nDNA). Mitochondrial DNA (mtDNA) and respiratory enzymes lose normal structure and function when nuclear genes encoding the related mitochondrial factors are impaired, resulting in deficiency in energy production. Massive generation of reactive oxygen species and calcium overload are common causes of mitochondrial diseases. The mitochondrial depletion syndrome (MDS) is associated with the mutations of mitochondrial genes in the nucleus. It is a heterogeneous group of progressive disorders characterized by the low mtDNA copy number. TK2, FBXL4, TYPM, and AGK are genes known to be related to MDS. More recent studies identified new mutation loci associated with this disease. Herein, we first summarize the structure and function of mitochondria, and then discuss the characteristics of various types of MDS and its association with cardiac diseases.
C1 [Wang, Haiying] Jining Med Univ, Inst Basic Med Coll, Dept Physiol, Jining, Peoples R China.
   [Han, Yijun] Jining Med Univ, Clin Med Coll, Jining, Peoples R China.
   [Li, Shenwei; Chen, Yunan; Chen, Yafen; Zhang, Yuqing; Zhang, Yawen; Wang, Jingsuo] Jining Med Univ, Inst Basic Med Coll, Jining, Peoples R China.
   [Wang, Jing] Dongying Fifth Peoples Hosp, Dongying, Peoples R China.
   [Xia, Yong] Jining Med Univ, Inst Precis Med, Key Lab Precis Oncol Shandong Higher Educ, Jining, Peoples R China.
   [Yuan, Jinxiang] Jining Med Univ, Collaborat Innovat Ctr, Jining, Peoples R China.
C3 Jining Medical University; Jining Medical University; Jining Medical University; Jining Medical University; Jining Medical University
RP Xia, Y (corresponding author), Jining Med Univ, Inst Precis Med, Key Lab Precis Oncol Shandong Higher Educ, Jining, Peoples R China.; Yuan, JX (corresponding author), Jining Med Univ, Collaborat Innovat Ctr, Jining, Peoples R China.
EM xiayong@mail.jnmc.edu.cn; yuanjinxiang18@163.com
FU Jining Medical University [600791001]; Foundation of Medical Health Science and Technology Development Program of Shandong Province [202002061311]; Jining Medical University [JYFC2019KJ013]; Jining Medical College Student Innovation and Entrepreneurship Training Program [cx2021053]
CR Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009
   El Cadi CA, 2020, BIOMED RES INT, V2020, P0, DOI 10.1155/2020/7614634
   Alonzo JR, 2018, J BIOL CHEM, V293, P20285, DOI 10.1074/jbc.RA118.004788
   Ambrose LJA, 2014, J CARDIOVASC PHARM T, V19, P574, DOI 10.1177/1074248414524480
   AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083
   Antoun G, 2016, JIMD REP, V27, P1, DOI 10.1007/8904_2015_491
   Ballout RA, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00039
   Baroy T, 2016, EUR J MED GENET, V59, P342, DOI 10.1016/j.ejmg.2016.05.005
   Behjati M, 2021, HEART FAIL REV, V26, P391, DOI 10.1007/s10741-020-10009-1
   Benard G, 2010, BBA-BIOENERGETICS, V1797, P698, DOI 10.1016/j.bbabio.2010.02.030
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Boschetti E, 2021, AM J PHYSIOL-GASTR L, V320, PG768, DOI 10.1152/ajpgi.00047.2021
   Bouchez C, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8040287
   Bouda E, 2019, PROTEIN SCI, V28, P1594, DOI 10.1002/pro.3688
   Briston T, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-10673-8
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Chaturvedi S, 2005, MED SCI MONITOR, V11, P0
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Dai H, 2017, CLIN GENET, V91, P634, DOI 10.1111/cge.12894
   de Oliveira VC, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0235856
   Demirbas Didem, 2019, JIMD REP, V46, P63, DOI 10.1002/jmd2.12018
   Deshpande OA, 2020, BIOCH OXIDATIVE PHOS, V0, P0
   Dey S, 2018, CIRC RES, V123, P356, DOI 10.1161/CIRCRESAHA.118.312708
   Dogan SA, 2018, CELL METAB, V28, P764, DOI 10.1016/j.cmet.2018.07.012
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115
   Dunham-Snary KJ, 2013, FREE RADICAL BIO MED, V65, P1229, DOI 10.1016/j.freeradbiomed.2013.09.007
   Dziewulska A, 2010, POSTEP HIG MED DOSW, V64, P513
   El-Hattab AW, 1993, SUCLG1 RELATED MITOC, V0, P0
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Emperador S, 2020, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.01300
   Fangdai L, 2019, CHIN J PEDIAT, V57, P211, DOI 10.3760/cma.j.issn.0578-1310.2019.03.011
   Felhi R, 2019, CLIN CHIM ACTA, V488, P104, DOI 10.1016/j.cca.2018.11.003
   Fernández-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028
   Filosto M, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7110389
   Flores-Herrera O, 2015, BBA-BIOENERGETICS, V1847, P143, DOI 10.1016/j.bbabio.2014.10.002
   Fuhrmann DC, 2017, REDOX BIOL, V12, P208, DOI 10.1016/j.redox.2017.02.012
   Gao P, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.604240
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Gherardi G, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.554904
   Gherardi G, 2019, CELL DEATH DIFFER, V26, P362, DOI 10.1038/s41418-018-0191-7
   Gödiker J, 2018, J HUM GENET, V63, P707, DOI 10.1038/s10038-018-0442-y
   Gómez-Valadés AG, 2017, CURR DIABETES REV, V13, P370, DOI 10.2174/1573399812666151012115229
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Guarani V, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.17163
   Guarani V, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.06265
   Guo WJ, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-02351-0
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Hebbar M, 2017, EUR J MED GENET, V60, P533, DOI 10.1016/j.ejmg.2017.07.010
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   Hoff KE, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0203198
   Hoshino A, 2019, NATURE, V575, P375, DOI 10.1038/s41586-019-1667-4
   Hou TT, 2019, CELL RES, V29, P754, DOI 10.1038/s41422-019-0208-x
   Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Jackson TD, 2021, MOL BIOL CELL, V32, P475, DOI 10.1091/mbc.E20-06-0390
   Jamali F, 2019, ARCH IRAN MED, V22, P728
   Ji LL, 2015, ADV PHYSIOL EDUC, V39, P352, DOI 10.1152/advan.00106.2014
   Kalari S, 2009, AM J PHYSIOL-LUNG C, V296, PL328, DOI 10.1152/ajplung.90431.2008
   Kamath VG, 2015, J BIOL CHEM, V290, P2034, DOI 10.1074/jbc.M114.624213
   Kashiki T, 2022, BRAIN DEV-JPN, V44, P56, DOI 10.1016/j.braindev.2021.08.005
   Kim J, 2016, MOL GENET METAB REP, V8, P74, DOI 10.1016/j.ymgmr.2016.06.006
   Kishita Y, 2020, MOL GENET GENOM MED, V8, P0, DOI 10.1002/mgg3.1427
   Kondadi AK, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20174311
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Köse E, 2020, TURKISH J PEDIATR, V62, P652, DOI 10.24953/turkjped.2020.04.016
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Krzywanski DM, 2011, LAB INVEST, V91, P1122, DOI 10.1038/labinvest.2011.95
   Kume K, 2020, BMC MED GENET, V21, P0, DOI 10.1186/s12881-020-01002-4
   Lamperti C, 2009, ACTA MYOL, V28, P2
   Landsverk ML, 2014, MOLEC GENET METAB RE, V1, P451, DOI 10.1016/j.ymgmr.2014.09.007
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Lee CF, 2016, CIRCULATION, V134, P883, DOI 10.1161/CIRCULATIONAHA.116.022495
   Lee H, 2016, BIOCHEM SOC T, V44, P1725, DOI 10.1042/BST20160129
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Li XH, 2019, BMC MED GENET, V20, P0, DOI 10.1186/s12881-019-0875-y
   Liang K, 2014, BIOMED ENG CLIN MED, V18, P501, DOI 10.13339/j.cnki.sglc.2014.05.049
   Lin Gui-Zhi, 2020, ZHONGGUO DANG DAI ER KE ZA ZHI, V22, P274
   Liu YP, 2016, BRAIN DEV-JPN, V38, P61, DOI 10.1016/j.braindev.2015.05.002
   [陆相朋 Lu Xiangpeng], 2017, 临床儿科杂志 JOURNAL OF CHINICAL PEDIATRICS, V35, P810
   Madungwe NB, 2020, AM J TRANSL RES, V12, P3412
   Mahjoub G, 2019, BMC MED GENET, V20, P0, DOI 10.1186/s12881-019-0893-9
   Martínez-Reyes I, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13668-3
   Marzetti E, 2013, AM J PHYSIOL-HEART C, V305, PH459, DOI 10.1152/ajpheart.00936.2012
   Matic S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03552-x
   Meurs KM, 2019, GENES-BASEL, V10, P0, DOI 10.3390/genes10020168
   Meyer JN, 2017, TOXICOLOGY, V391, P42, DOI 10.1016/j.tox.2017.07.019
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060
   Neary MT, 2014, J MOL CELL CARDIOL, V74, P340, DOI 10.1016/j.yjmcc.2014.06.013
   Nemani N, 2020, SCI SIGNAL, V13, P0, DOI 10.1126/scisignal.aaz6206
   Nogueira C, 2014, ITAL J PEDIATR, V40, P0, DOI 10.1186/1824-7288-40-34
   Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002
   Papadimas George K, 2020, ACTA MYOL, V39, P94, DOI 10.36185/2532-1900-012
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Pohjoismäki JL, 2017, FREE RADICAL BIO MED, V106, P345, DOI 10.1016/j.freeradbiomed.2017.02.032
   Pohjoismäki JLO, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010426
   Prasun Pankaj, 2019, P83, V0, P0, DOI DOI 10.1016/B978-0-12-817006-9.00015-0
   Pronicki M, 2018, POL J PATHOL, V69, P292, DOI 10.5114/PJP.2018.79549
   Protasoni M, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2019102817
   Riva A, 2005, AM J PHYSIOL-HEART C, V289, PH868, DOI 10.1152/ajpheart.00866.2004
   Rivera H, 2010, MITOCHONDRION, V10, P362, DOI 10.1016/j.mito.2010.03.003
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Sabouny R, 2019, BBA-MOL BASIS DIS, V1865, P0, DOI 10.1016/j.bbadis.2019.165536
   Saki M, 2017, FREE RADICAL BIO MED, V107, P216, DOI 10.1016/j.freeradbiomed.2016.11.050
   Santorelli FM, 2002, NEUROMUSCULAR DISORD, V12, P56, DOI 10.1016/S0960-8966(01)00248-6
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Sas K, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23010191
   Scarpelli M, 2017, APPL CLIN GENET, V10, P21, DOI 10.2147/TACG.S94267
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Shvetsova AN, 2017, REDOX BIOL, V12, P1052, DOI 10.1016/j.redox.2017.05.003
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Stojanovic V, 2013, CROAT MED J, V54, P579, DOI 10.3325/cmj.2013.54.579
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Szabadosova V, 2018, J CLIN LAB ANAL, V32, P0, DOI 10.1002/jcla.22254
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Tanaka A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067642
   Tang XQ, 2020, FRONT ENDOCRINOL, V11, P0, DOI 10.3389/fendo.2020.00280
   Teodoro JS, 2018, METHODS MOL BIOL, V1782, P109, DOI 10.1007/978-1-4939-7831-1_6
   Thomas LW, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00071
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Thorburn DR, 1993, GENEREVIEWS, V0, P0
   Tian R, 2019, CIRCULATION, V140, P1205, DOI 10.1161/CIRCULATIONAHA.119.040551
   Tseng YT, 2020, MOL GENET GENOM MED, V8, P0, DOI 10.1002/mgg3.1497
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   Victor VM, 2009, CURR MED CHEM, V16, P4654, DOI 10.2174/092986709789878265
   Vukotic M, 2017, MOL CELL, V67, P471, DOI 10.1016/j.molcel.2017.06.013
   Wang BZ, 2021, FRONT PEDIATR, V9, P0, DOI 10.3389/fped.2021.639687
   Wang J, 1993, TK2-RELATED MITOCHONDRIAL DNA MAINTENANCE DEFECT, V0, P0
   Wang LY, 2020, BMC MOL CELL BIOL, V21, P0, DOI 10.1186/s12860-020-00272-3
   Wang SM, 2020, J NEUROL SCI, V416, P0, DOI 10.1016/j.jns.2020.116948
   Wang W, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aac7410
   Wei H, 2018, J PRACT DIABETOL, V14, P9
   WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3
   Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024
   Wu Y, 2018, ZHONGHUA ER KE ZA ZHI, V56, P381, DOI 10.3760/cma.j.issn.0578-1310.2018.05.016
   Yadak R, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1016-6
   Yan Y, 2018, J PRACT MED, V34, P2892, DOI 10.3969/j.issn.1006-5725.2018.17.018
   Yang C, 2018, NUCLEIC ACIDS RES, V46, P11075, DOI 10.1093/nar/gky855
   Zapico SC, 2013, AGING DIS, V4, P364, DOI 10.14336/AD.2013.0400364
   Zeharia A, 2016, EUR J HUM GENET, V24, P1778, DOI 10.1038/ejhg.2016.83
   Zerbes RM, 2016, J MOL BIOL, V428, P1485, DOI 10.1016/j.jmb.2016.02.031
   Zhang J, 2013, SLC26A4 TFAM GENE PO, V0, P0
   Zhou ZD, 2017, MOL NEUROBIOL, V54, P5534, DOI 10.1007/s12035-016-0099-5
NR 160
TC 5
Z9 5
U1 0
U2 21
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2297-055X
EI 
J9 FRONT CARDIOVASC MED
JI Front. Cardiovasc. Med.
PD FEB 14
PY 2022
VL 8
IS 
BP 
EP 
DI 10.3389/fcvm.2021.808115
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA ZI5YG
UT WOS:000761696000001
PM 35237671
DA 2024-11-01
ER

PT J
AU Mahmud, S
   Biswas, S
   Afrose, S
   Mita, MA
   Hasan, MR
   Shimu, MSS
   Paul, GK
   Chung, S
   Abu Saleh, M
   Alshehri, S
   Ghoneim, MM
   Alruwaily, M
   Kim, B
AF Mahmud, Shafi
   Biswas, Suvro
   Afrose, Shamima
   Mita, Mohasana Akter
   Hasan, Md Robiul
   Shimu, Mst Sharmin Sultana
   Paul, Gobindo Kumar
   Chung, Sanghyun
   Abu Saleh, Md
   Alshehri, Sultan
   Ghoneim, Momammed M.
   Alruwaily, Maha
   Kim, Bonglee
TI Use of Next-Generation Sequencing for Identifying Mitochondrial Disorders
SO CURRENT ISSUES IN MOLECULAR BIOLOGY
LA English
DT Article
DE mitochondrial disorder; OXPHOS; mtDNA; nDNA; NGS
ID hereditary optic neuropathy; dna mutations; whole-exome; leigh-syndrome; molecular diagnosis; disease; genome; nuclear; prevalence; genes
AB Mitochondria are major contributors to ATP synthesis, generating more than 90% of the total cellular energy production through oxidative phosphorylation (OXPHOS): metabolite oxidation, such as the beta-oxidation of fatty acids, and the Krebs's cycle. OXPHOS inadequacy due to large genetic lesions in mitochondrial as well as nuclear genes and homo- or heteroplasmic point mutations in mitochondrially encoded genes is a characteristic of heterogeneous, maternally inherited genetic disorders known as mitochondrial disorders that affect multisystemic tissues and organs with high energy requirements, resulting in various signs and symptoms. Several traditional diagnostic approaches, including magnetic resonance imaging of the brain, cardiac testing, biochemical screening, variable heteroplasmy genetic testing, identifying clinical features, and skeletal muscle biopsies, are associated with increased risks, high costs, a high degree of false-positive or false-negative results, or a lack of precision, which limits their diagnostic abilities for mitochondrial disorders. Variable heteroplasmy levels, mtDNA depletion, and the identification of pathogenic variants can be detected through genetic sequencing, including the gold standard Sanger sequencing. However, sequencing can be time consuming, and Sanger sequencing can result in the missed recognition of larger structural variations such as CNVs or copy-number variations. Although each sequencing method has its own limitations, genetic sequencing can be an alternative to traditional diagnostic methods. The ever-growing roster of possible mutations has led to the development of next-generation sequencing (NGS). The enhancement of NGS methods can offer a precise diagnosis of the mitochondrial disorder within a short period at a reasonable expense for both research and clinical applications.
C1 [Mahmud, Shafi; Biswas, Suvro; Afrose, Shamima; Mita, Mohasana Akter; Hasan, Md Robiul; Shimu, Mst Sharmin Sultana; Paul, Gobindo Kumar; Abu Saleh, Md] Univ Rajshahi, Dept Genet Engn & Biotechnol, Rajshahi 6205, Bangladesh.
   [Chung, Sanghyun; Kim, Bonglee] Kyung Hee Univ, Coll Korean Med, Dept Pathol, Seoul 02447, South Korea.
   [Alshehri, Sultan] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh 11451, Saudi Arabia.
   [Ghoneim, Momammed M.; Alruwaily, Maha] AlMaarefa Univ, Coll Pharm, Dept Pharm Practice, Ad Diriyah 13713, Saudi Arabia.
C3 University of Rajshahi; Kyung Hee University; King Saud University; Almaarefa University
RP Mahmud, S (corresponding author), Univ Rajshahi, Dept Genet Engn & Biotechnol, Rajshahi 6205, Bangladesh.; Kim, B (corresponding author), Kyung Hee Univ, Coll Korean Med, Dept Pathol, Seoul 02447, South Korea.
EM shafimahmudfz@gmail.com; suvrobiswas0@gmail.com; shamimaafrose.ru@gmail.com; mohasanamita26@gmail.com; rhonanik7@gmail.com; sharminshimu120@gmail.com; gobindokumar38@gmail.com; nukyung2@khu.ac.kr; saleh@ru.ac.bd; salshehril@ksu.edu.sa; mghoneim@mcst.edu.sa; mrowaili@mcst.edu.sa; bongleekim@khu.ac.kr
FU Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2020R1I1A2066868]; National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1A5A201941311]
CR Ahmad R, 2021, INT J HEALTH SCI-IJH, V15, P1
   Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bewicke-Copley F, 2019, COMPUT STRUCT BIOTEC, V17, P1348, DOI 10.1016/j.csbj.2019.10.004
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bick D, 2011, CURR OPIN PEDIATR, V23, P594, DOI 10.1097/MOP.0b013e32834b20ec
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Carroll CJ, 2014, BRIT J PHARMACOL, V171, P1837, DOI 10.1111/bph.12469
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z
   Chin J, 2014, MITOCHONDRION, V17, P34, DOI 10.1016/j.mito.2014.05.005
   Chinnasamy P, 2021, INT CONF COMP COMMUN, V0, P0, DOI DOI 10.1109/ICCCI50826.2021.9402681
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   Circu ML, 2009, FREE RADICAL BIO MED, V47, P1190, DOI 10.1016/j.freeradbiomed.2009.07.032
   Clark MM, 2019, SCI TRANSL MED, V11, P0, DOI 10.1126/scitranslmed.aat6177
   Clima R, 2017, NUCLEIC ACIDS RES, V45, PD698, DOI 10.1093/nar/gkw1066
   Crispatzu G, 2017, HUM MUTAT, V38, P1325, DOI 10.1002/humu.23275
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   Cummings BB, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aal5209
   Dai Y, 2018, BIOMED REP, V8, P51, DOI 10.3892/br.2017.1014
   Dames S, 2013, J MOL DIAGN, V15, P526, DOI 10.1016/j.jmoldx.2013.03.005
   DaRe JT, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-118
   Davis RL, 2018, MITOCHONDRIAL DIS, V147, P0
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717
   Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 2020, ROSENBERGS MOL GENET, V0, P0
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   Dimmock DP, 2017, PEDIATR CLIN N AM, V64, P161, DOI 10.1016/j.pcl.2016.08.011
   Dinwiddie DL, 2013, GENOMICS, V102, P148, DOI 10.1016/j.ygeno.2013.04.013
   Diroma MA, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-S3-S2
   Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI 10.1042/bse0470115
   ElBeheiry AA, 2014, EGYPT J RADIOL NUC M, V45, P523, DOI 10.1016/j.ejrnm.2013.12.012
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Escribano-Lopez I, 2016, FRONT MED CHEM, V8, P96
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Fendt L, 2009, BMC GENOMICS, V10, P0, DOI 10.1186/1471-2164-10-139
   Fernandez D, 2009, AUTOIMMUN REV, V8, P184, DOI 10.1016/j.autrev.2008.07.041
   Fresard L, 2019, NAT MED, V25, P911, DOI 10.1038/s41591-019-0457-8
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Gambin T, 2017, NUCLEIC ACIDS RES, V45, P1633, DOI 10.1093/nar/gkw1237
   Genomes Project C, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Gilissen C, 2014, NATURE, V511, P344, DOI 10.1038/nature13394
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gorski MM, 2016, BLOOD, V127, P2924, DOI 10.1182/blood-2015-12-685735
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Griffin HR, 2014, GENET MED, V16, P962, DOI 10.1038/gim.2014.66
   Hakeem KR, 2016, PLANT OMICS: TRENDS AND APPLICATIONS, V0, P0
   Hamilton A, 2016, MOL GENET GENOM MED, V4, P504, DOI 10.1002/mgg3.223
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2019, DIAGNOSIS MANAG MITO, V0, PP281, DOI 10.1007/978-3-030-05517-2
   Huang Taosheng, 2011, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1908s71
   Huoponen K, 2001, NEUROGENETICS, V3, P119, DOI 10.1007/s100480100115
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Jongbloed Jan Dh, 2011, EXPERT OPIN MED DIAGN, V5, P9, DOI 10.1517/17530059.2011.540566
   Kaneko T, 2015, METHODS MOL BIOL, V1239, P307, DOI 10.1007/978-1-4939-1862-1_18
   Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0
   Kathiresan N, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-09089-1
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kendall FD, 2012, J PEDIATR BIOCHEM, V2, P193, DOI 10.3233/JPB-120061
   Kerr M, 2020, MOL GENET METAB, V131, P66, DOI 10.1016/j.ymgme.2020.08.009
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Kisilevsley E, 2020, SURV OPHTHALMOL, V65, P294, DOI 10.1016/j.survophthal.2019.11.001
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kotrys AV, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9010017
   Kremer LS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15824
   Kulkarni P, 2017, COMPUT STRUCT BIOTEC, V15, P471, DOI 10.1016/j.csbj.2017.10.001
   Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, PD980, DOI 10.1093/nar/gkt1113
   Lee HN, 2020, GENET MED, V22, P490, DOI 10.1038/s41436-019-0672-1
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Li L, 2018, MITOCHONDRIAL DNA B, V3, P1004, DOI 10.1080/23802359.2018.1501287
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Liang P, 2012, J APPL BIOINFORM COM, V1, P1, DOI 10.4172/2329-9533.1000101
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Limongelli G, 2012, FUTUR CARDIOL, V8, P71, DOI 10.2217/fca.11.79
   Lohmann K, 2014, NEUROTHERAPEUTICS, V11, P699, DOI 10.1007/s13311-014-0288-8
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Ma ESK, 2017, CANCER GENET-NY, V218, P15, DOI 10.1016/j.cancergen.2017.09.001
   Ma M, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/1471-2164-16-S8-S3
   Macken WL, 2021, NAT REV NEUROL, V17, P215, DOI 10.1038/s41582-021-00455-2
   Magner Martin, 2015, DEV PERIOD MED, V19, P441
   Malicdan MCV, 2018, HUM MUTAT, V39, P69, DOI 10.1002/humu.23345
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1
   McCormick EM, 2018, CURR OPIN PEDIATR, V30, P714, DOI 10.1097/MOP.0000000000000686
   McDermott JH, 2022, CLIN PHARMACOL THER, V111, P366, DOI 10.1002/cpt.2309
   McMillan HJ, 2014, BMC MED GENET, V15, P0, DOI 10.1186/1471-2350-15-36
   Mejia EM, 2016, J BIOENERG BIOMEMBR, V48, P99, DOI 10.1007/s10863-015-9601-4
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Molnar MJ, 2018, MITOCHONDRIAL DIS, V145, P0
   Mori M, 2018, CELL BIOL INT, V42, P643, DOI 10.1002/cbin.10917
   Murphy E, 2009, J MOL CELL CARDIOL, V46, P765, DOI 10.1016/j.yjmcc.2009.03.004
   Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250
   Ng YS, 2019, DIAGNOSIS MANAGEMENT, V0, P1
   Nicolson GL, 2014, INTEGR MED CLIN J, V13, P35
   Nissanka N, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201949612
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Norton N, 2012, CURR OPIN CARDIOL, V27, P214, DOI 10.1097/HCO.0b013e328352207e
   Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Parikh S, 2014, MITOCHONDRION, V14, P26, DOI 10.1016/j.mito.2013.07.116
   Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9
   Pfundt R, 2017, GENET MED, V19, P667, DOI 10.1038/gim.2016.163
   Phadke R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6070064
   Picardi E, 2012, NAT METHODS, V9, P523, DOI 10.1038/nmeth.2029
   Pincus JH, 1912, DEV MED CHILD NEUROL, V14, P101, DOI 10.1111/j.1469-8749.1972.tb02563.x
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pitceathly RDS, 2020, HUMAN MITOCHONDRIAL, V0, P353
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Puusepp S, 2018, MOL GENET METAB REP, V15, P80, DOI 10.1016/j.ymgmr.2018.03.004
   Rachek LI, 2009, TOXICOL APPL PHARM, V240, P348, DOI 10.1016/j.taap.2009.07.021
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393
   Rius R, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12040607
   Rodenburg RJT, 2013, MITOCHONDRION, V13, P36, DOI 10.1016/j.mito.2012.11.004
   ROTIG A, 1989, LANCET, V1, P902
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Salomao Karina Bezerra, 2013, INDIAN J HUM GENET, V19, P54, DOI 10.4103/0971-6866.112888
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schlieben LD, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.600079
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Seneca S, 2015, EUR J HUM GENET, V23, P41, DOI 10.1038/ejhg.2014.49
   Shen L, 2020, CLIN LAB MED, V40, P149, DOI 10.1016/j.cll.2020.02.002
   Shen LS, 2018, HUM MUTAT, V39, P806, DOI 10.1002/humu.23422
   Shen LS, 2016, HUM MUTAT, V37, P540, DOI 10.1002/humu.22974
   Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325
   Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Sikkema-Raddatz B, 2013, HUM MUTAT, V34, P1035, DOI 10.1002/humu.22332
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010
   Smith RAJ, 2011, ANTIOXID REDOX SIGN, V15, P3021, DOI 10.1089/ars.2011.3969
   Solomon DA, 2018, PRACTICAL SURG NEURO, V0, P0
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Stark Z, 2019, GENET MED, V21, P173, DOI 10.1038/s41436-018-0006-8
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.E04-09-0807
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Uriho A, 2021, ADV TRADIT MED, V21, P1, DOI 10.1007/s13596-020-00492-0
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005
   VANERVEN PMM, 1987, CLIN NEUROL NEUROSUR, V89, P217, DOI 10.1016/S0303-8467(87)80020-3
   Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x
   Vasta V, 2009, GENOME MED, V1, P0, DOI 10.1186/gm100
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
   Wagner M, 2019, J INHERIT METAB DIS, V42, P909, DOI 10.1002/jimd.12109
   Wallace DC, 1987, SCIENCE, V729, P27
   Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wang Jing, 2011, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1906s68
   Wang X, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22147525
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Watson E, 2020, J. TRANSL. GENET. GENOMICS, V4, P188, DOI 10.20517/JTGG.2020.31
   WECHSLER H, 1983, NEW ENGL J MED, V308, P97, DOI 10.1056/NEJM198301133080211
   Weigl S, 2013, CURR GENOMICS, V14, P195, DOI 10.2174/1389202911314030005
   Whitaker RM, 2016, ANNU REV PHARMACOL, V56, P229, DOI 10.1146/annurev-pharmtox-010715-103155
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
   Wright CF, 2018, GENET MED, V20, P1216, DOI 10.1038/gim.2017.246
   Xie HBM, 2011, BMC BIOINFORMATICS, V12, P0, DOI 10.1186/1471-2105-12-402
   Xue W, 2011, NATURE, V473, P544, DOI 10.1038/nature09909
   Young LT, 2007, J PSYCHIATR NEUROSCI, V32, P160
   Yu JN, 2019, J CLIN ONCOL, V37, P0, DOI 10.1200/JCO.2019.37.15_suppl.e13051
   Zare F, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1705-x
   Zhang P, 2016, BRIEF BIOINFORM, V17, P224, DOI 10.1093/bib/bbv057
   Zhu ZH, 2017, ADV EXP MED BIOL, V1038, P219, DOI 10.1007/978-981-10-6674-0_15
   Zsurka G, 2010, NEUROLOGY, V74, P507, DOI 10.1212/WNL.0b013e3181cef7ab
NR 202
TC 9
Z9 11
U1 0
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1467-3037
EI 1467-3045
J9 CURR ISSUES MOL BIOL
JI Curr. Issues Mol. Biol.
PD MAR 15
PY 2022
VL 44
IS 3
BP 1127
EP 1148
DI 10.3390/cimb44030074
PG 22
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 0C8NA
UT WOS:000775562300001
PM 35723297
DA 2024-11-01
ER

PT J
AU Arena, IG
   Pugliese, A
   Volta, S
   Toscano, A
   Musumeci, O
AF Arena, Ignazio Giuseppe
   Pugliese, Alessia
   Volta, Sara
   Toscano, Antonio
   Musumeci, Olimpia
TI Molecular Genetics Overview of Primary Mitochondrial Myopathies
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE mitochondrial myopathy; exercise intolerance; ophtalmoplegia; mtDNA; nDNA; oxidative phosphorylation
ID complex i deficiency; progressive external ophthalmoplegia; cytochrome-b gene; impair mtdna replication; c-oxidase deficiency; stop-codon mutation; exercise intolerance; nonsense mutation; respiratory-chain; iii deficiency
AB Mitochondrial disorders are the most common inherited conditions, characterized by defects in oxidative phosphorylation and caused by mutations in nuclear or mitochondrial genes. Due to its high energy request, skeletal muscle is typically involved. According to the International Workshop of Experts in Mitochondrial Diseases held in Rome in 2016, the term Primary Mitochondrial Myopathy (PMM) should refer to those mitochondrial disorders affecting principally, but not exclusively, the skeletal muscle. The clinical presentation may include general isolated myopathy with muscle weakness, exercise intolerance, chronic ophthalmoplegia/ophthalmoparesis (cPEO) and eyelids ptosis, or multisystem conditions where there is a coexistence with extramuscular signs and symptoms. In recent years, new therapeutic targets have been identified leading to the launch of some promising clinical trials that have mainly focused on treating muscle symptoms and that require populations with defined genotype. Advantages in next-generation sequencing techniques have substantially improved diagnosis. So far, an increasing number of mutations have been identified as responsible for mitochondrial disorders. In this review, we focused on the principal molecular genetic alterations in PMM. Accordingly, we carried out a comprehensive review of the literature and briefly discussed the possible approaches which could guide the clinician to a genetic diagnosis.
C1 [Arena, Ignazio Giuseppe; Pugliese, Alessia; Toscano, Antonio; Musumeci, Olimpia] Univ Messina, Unit Neurol & Neuromuscular Disorders, Dept Clin & Expt Med, I-98125 Messina, Italy.
   [Volta, Sara] Univ Padua, Dept Neurosci, I-35100 Padua, Italy.
C3 University of Messina; University of Padua
RP Musumeci, O (corresponding author), Univ Messina, Unit Neurol & Neuromuscular Disorders, Dept Clin & Expt Med, I-98125 Messina, Italy.
EM igna.arena@live.it; alessiapugliese76@gmail.com; sara.volta@studenti.unipd.it; atoscano@unime.it; omusumeci@unime.it
FU European Reference Network for ERN EURO-NMD [739543]
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Alston CL, 2016, AM J HUM GENET, V99, P217, DOI 10.1016/j.ajhg.2016.05.021
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], 1993, GENEREVIEWS, V0, P0
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Ballana E, 2008, HUM MUTAT, V29, P248, DOI 10.1002/humu.20639
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Barca E, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000402
   Barca E, 2018, HUM MOL GENET, V27, P3305, DOI 10.1093/hmg/ddy231
   Besse A, 2016, MOL BRAIN, V9, P0, DOI 10.1186/s13041-016-0273-8
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Boczonadi V, 2018, ESSAYS BIOCHEM, V62, P321, DOI 10.1042/EBC20170103
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOUZIDI MF, 1993, NEUROMUSCULAR DISORD, V3, P599
   Brischigliaro M, 2021, BBA-BIOENERGETICS, V1862, P0, DOI 10.1016/j.bbabio.2020.148335
   Bruno C, 2003, MUSCLE NERVE, V28, P508, DOI 10.1002/mus.10429
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Cardaioli E, 2008, J NEUROL SCI, V272, P106, DOI 10.1016/j.jns.2008.05.005
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Darin N, 2017, EUR J NEUROL, V24, P587, DOI 10.1111/ene.13249
   DARLEYUSMAR VM, 1983, P NATL ACAD SCI-BIOL, V80, P5103, DOI 10.1073/pnas.80.16.5103
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053
   El-Hattab AW, 2017, GENEREVIEWS, V0, P0
   El-Hattab AW, 2009, GENEREVIEWS, V0, P0
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Fassone E, 2015, HUM MOL GENET, V24, P4183, DOI 10.1093/hmg/ddv164
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072
   Fernández-Vizarra E, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00134
   Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006
   Finsterer J, 2018, BIOMED REP, V9, P119, DOI 10.3892/br.2018.1115
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Franzolin E, 2015, J BIOL CHEM, V290, P25986, DOI 10.1074/jbc.M115.675082
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Gandhi VV, 2011, NUCLEOS NUCLEOT NUCL, V30, P317, DOI 10.1080/15257770.2011.586955
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Garcia I, 2017, FRONT BIOSCI-LANDMRK, V22, P710, DOI 10.2741/4511
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Ghezzi D, 2018, ESSAYS BIOCHEM, V62, P271, DOI 10.1042/EBC20170099
   Gorman GS, 2015, CLIN SCI, V128, P895, DOI 10.1042/CS20140705
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hargreaves IP, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10091970
   HAYES DJ, 1984, BRAIN, V107, P1165, DOI 10.1093/brain/107.4.1165
   Hejzlarová K, 2014, PHYSIOL RES, V63, PS57, DOI 10.33549/physiolres.932643
   Hellebrekers DMEI, 2019, NEUROMUSCULAR DISORD, V29, P693, DOI 10.1016/j.nmd.2019.08.005
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horváth R, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.015024
   Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Inoue M, 2019, ANN NEUROL, V86, P193, DOI 10.1002/ana.25517
   Jain-Ghai S, 2013, AM J MED GENET A, V161A, P285, DOI 10.1002/ajmg.a.35714
   Kara B, 2012, MOL GENET METAB, V107, P389, DOI 10.1016/j.ymgme.2012.06.013
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Keshavan N, 2020, GENET MED, V22, P199, DOI 10.1038/s41436-019-0613-z
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317
   Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   Lehmann D, 2015, EUR J HUM GENET, V23, P1735, DOI 10.1038/ejhg.2015.73
   Lenaers G, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-46
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Mahale RR, 2022, ACTA NEUROL BELG, V122, P1115, DOI 10.1007/s13760-021-01598-1
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mancuso M, 2003, J NEUROL SCI, V209, P61, DOI 10.1016/S0022-510X(02)00462-8
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   McCormick EM, 2018, CURR OPIN PEDIATR, V30, P714, DOI 10.1097/MOP.0000000000000686
   Meyer JN, 2017, TOXICOLOGY, V391, P42, DOI 10.1016/j.tox.2017.07.019
   Meyerson C, 2015, CLIN OPHTHALMOL, V9, P1165, DOI 10.2147/OPTH.S62021
   Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111
   Musumeci O, 2000, AM J HUM GENET, V66, P1900, DOI 10.1086/302927
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Ng YS, 2020, FRONT GENET, V11, P0, DOI 10.3389/fgene.2020.00024
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Ohlenbusch A, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-69
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Pagniez-Mammeri H, 2012, MOL GENET METAB, V105, P163, DOI 10.1016/j.ymgme.2011.11.188
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pitceathly RDS, 2013, JAMA NEUROL, V70, P1556, DOI 10.1001/jamaneurol.2013.3242
   Pitceathly RDS, 2013, CELL REP, V3, P1795, DOI 10.1016/j.celrep.2013.05.005
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Rafiq J, 2016, JIMD REP, V25, P65, DOI 10.1007/8904_2015_459
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Renkema GH, 2015, EUR J HUM GENET, V23, P202, DOI 10.1038/ejhg.2014.80
   Repp BM, 2018, ORPHANET J RARE DIS, V13, P0, DOI 10.1186/s13023-018-0784-8
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Roos S, 2019, EUR J HUM GENET, V27, P331, DOI 10.1038/s41431-018-0286-0
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862
   Sánchez-Caballero L, 2016, AM J HUM GENET, V99, P208, DOI 10.1016/j.ajhg.2016.05.022
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Soldath P, 2017, BMC MUSCULOSKEL DIS, V18, P0, DOI 10.1186/s12891-017-1781-0
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SPIRO AJ, 1970, ARCH NEUROL-CHICAGO, V23, P103, DOI 10.1001/archneur.1970.00480260009002
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Takata A, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-r92
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tarnopolsky M, 2019, MITOCHONDRION, V47, P139, DOI 10.1016/j.mito.2019.04.003
   Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104
   Torres-Torronteras J, 2018, HUM GENE THER, V29, P708, DOI 10.1089/hum.2017.133
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361
   van Rahden VA, 2015, AM J HUM GENET, V96, P640, DOI 10.1016/j.ajhg.2015.02.002
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Visuttijai K, 2021, ACTA NEUROL SCAND, V143, P103, DOI 10.1111/ane.13339
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wedding IM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0086340
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   Wild KT, 2020, AM J MED GENET A, V182, P365, DOI 10.1002/ajmg.a.61433
   Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Zanolini A, 2017, MOL GENET METAB REP, V10, P24, DOI 10.1016/j.ymgmr.2016.11.009
NR 156
TC 12
Z9 12
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD FEB 15
PY 2022
VL 11
IS 3
BP 
EP 
DI 10.3390/jcm11030632
PG 27
WC Medicine, General & Internal
SC General & Internal Medicine
GA YY8JN
UT WOS:000755031500001
PM 35160083
DA 2024-11-01
ER

PT J
AU Kumar, R
   Harilal, S
   Parambi, DT
   Kanthlal, SK
   Rahman, MA
   Alexiou, A
   Batiha, GE
   Mathew, B
AF Kumar, Rajesh
   Harilal, Seetha
   Thomas Parambi, Della Grace
   Kanthlal, S. K.
   Rahman, Md Atiar
   Alexiou, Athanasios
   Batiha, Gaber El-Saber
   Mathew, Bijo
TI The Role of Mitochondrial Genes in Neurodegenerative Disorders
SO CURRENT NEUROPHARMACOLOGY
LA English
DT Review
DE Alzheimer's disease; amyotrophic lateral sclerosis; mtDNA; multiple sclerosis; neurodegeneration; Parkinson's disease; stroke
ID respiratory-chain function; human skeletal-muscle; mtdna control-region; dna mutations; alzheimers-disease; parkinsons-disease; substantia-nigra; point mutations; frontotemporal dementia; cytochrome-oxidase
AB Mitochondrial disorders are clinically heterogeneous, resulting from nuclear gene and mitochondrial mutations that disturb the mitochondrial functions and dynamics. There is a lack of evidence linking mtDNA mutations to neurodegenerative disorders, mainly due to the absence of noticeable neuropathological lesions in postmortem samples. This review describes various gene mutations in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and stroke. These abnormalities, including PINK1, Parkin, and SOD1 mutations, seem to reveal mitochondrial dysfunctions due to either mtDNA mutation or deletion, the mechanism of which remains unclear in depth.
C1 [Kumar, Rajesh; Harilal, Seetha] Kerala Univ Hlth Sci, Dept Pharm, Trichur, Kerala, India.
   [Thomas Parambi, Della Grace] Jouf Univ, Coll Pharm, Dept Pharmaceut Chem, Sakaka 2014, Al Jouf, Saudi Arabia.
   [Kanthlal, S. K.] Amrita Vishwa Vidyapeetham, Amrita Sch Pharm, Dept Pharmacol, AIMS Hlth Sci Campus, Kochi 682041, Kerala, India.
   [Rahman, Md Atiar] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong, Bangladesh.
   [Alexiou, Athanasios] Novel Global Community Educ Fdn, Hebersham, Australia.
   [Alexiou, Athanasios] AFNP Med Austria, Vienna, Austria.
   [Batiha, Gaber El-Saber] Damanhour Univ, Fac Vet Med, Dept Pharmacol & Therapeut, Damanhour 22511, Albeheira, Egypt.
   [Mathew, Bijo] Amrita Vishwa Vidyapeetham, Amrita Sch Pharm, Dept Pharmaceut Chem, AIMS Hlth Sci Campus, Kochi 682041, Kerala, India.
C3 Al Jouf University; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; University of Chittagong; Egyptian Knowledge Bank (EKB); Damanhour University; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi
RP Mathew, B (corresponding author), Amrita Vishwa Vidyapeetham, Amrita Sch Pharm, Dept Pharmaceut Chem, AIMS Hlth Sci Campus, Kochi 682041, Kerala, India.
EM bijovilaventgu@gmail.com
CR Alexiou A, 2020, DIAGNOSIS AND MANAGEMENT IN DEMENTIA, V0, PP365, DOI 10.1016/B978-0-12-815854-8.00023-9
   Alexiou A, 2019, MOL NEUROBIOL, V56, P4530, DOI 10.1007/s12035-018-1397-x
   Alexiou A, 2018, CURR PROTEIN PEPT SC, V19, P850, DOI 10.2174/1389203718666170810150151
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blanch M, 2016, AM J PATHOL, V186, P385, DOI 10.1016/j.ajpath.2015.10.004
   Bobba KN, 2019, CHEM COMMUN, V55, P6429, DOI 10.1039/c9cc01483g
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bradley-Whitman MA, 2013, MECH AGEING DEV, V134, P486, DOI 10.1016/j.mad.2013.08.005
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021
   Chaudhary SS, 2020, DIAGNOSIS MANAGEMENT, V0, PP73, DOI 10.1016/B978-0-12-815946-0.00005-3
   Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011
   Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1
   Chinnery PF, 2001, AM J HUM GENET, V68, P529, DOI 10.1086/318204
   Cieslik M, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0137193
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Compagnoni GM, 2020, MOL NEUROBIOL, V57, P2959, DOI 10.1007/s12035-020-01926-1
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Coppedè F, 2019, FRONT ENDOCRINOL, V10, P0, DOI 10.3389/fendo.2019.00086
   Corona JC, 2015, NEUROCHEM RES, V40, P308, DOI 10.1007/s11064-014-1377-0
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260
   DAurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   DELEON MJ, 1983, AM J NEURORADIOL, V4, P568
   Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Grazina M, 2004, NEUROBIOL DIS, V15, P306, DOI 10.1016/j.nbd.2003.11.004
   Guan Q, 2016, EXP GERONTOL, V82, P19, DOI 10.1016/j.exger.2016.05.011
   Hamblet NS, 1997, MUTAT RES-FUND MOL M, V379, P253, DOI 10.1016/S0027-5107(97)00158-9
   Harilal S, 2020, BRAIN RES BULL, V160, P121, DOI 10.1016/j.brainresbull.2020.03.018
   Harilal S, 2019, J PHARM PHARMACOL, V71, P1370, DOI 10.1111/jphp.13132
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Hudson G, 2012, NEUROLOGY, V78, P1038, DOI 10.1212/WNL.0b013e31824e8f1d
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hwang ES, 2019, TRANSL EPIGENET SER, V10, P781, DOI 10.1016/B978-0-12-813939-4.00029-2
   Ingram CJE, 2012, AMYOTROPH LATERAL SC, V13, P341, DOI 10.3109/17482968.2012.654394
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Jesko H, 2017, NEUROCHEM RES, V42, P876, DOI 10.1007/s11064-016-2110-y
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   Kieburtz K, 2007, NEUROLOGY, V68, P20
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lakatos A, 2010, NEUROBIOL AGING, V31, P1355, DOI 10.1016/j.neurobiolaging.2010.04.031
   Latsoudis H, 2008, J HUM GENET, V53, P349, DOI 10.1007/s10038-008-0259-1
   Li HZ, 2012, ADV EXP MED BIOL, V942, P39, DOI 10.1007/978-94-007-2869-1_2
   LIAO HX, 1991, J BIOL CHEM, V266, P20714
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Mancuso M, 2007, NEUROL SCI, V28, P142, DOI 10.1007/s10072-007-0807-z
   Mapa MST, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0197946
   Mehta P, 2009, MOVEMENT DISORD, V24, P290, DOI 10.1002/mds.22389
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Müller SK, 2013, NEUROBIOL AGING, V34, P2231, DOI 10.1016/j.neurobiolaging.2013.03.016
   Müller T, 2003, NEUROSCI LETT, V341, P201, DOI 10.1016/S0304-3940(03)00185-X
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Nambiar J, 2019, MOL CELL BIOCHEM, V451, P79, DOI 10.1007/s11010-018-3395-8
   Narayanan SE, 2020, ENVIRON SCI POLLUT R, V27, P43542, DOI 10.1007/s11356-020-10477-w
   Palakkathondi A, 2020, ACS COMB SCI, V22, P592, DOI 10.1021/acscombsci.0c00136
   Parambi DT, 2020, NEUROCHEM RES, V45, P2786, DOI 10.1007/s11064-020-03130-y
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Polito L, 2017, NEUROPROTECTION IN ALZHEIMERS DISEASE, V0, PP149, DOI 10.1016/B978-0-12-803690-7.00008-9
   Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675
   Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x
   Ridge PG, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0045134
   Rorbach J, 2007, BIOCHEM SOC T, V35, P1290, DOI 10.1042/BST0351290
   Rose G, 2008, EUR J NEUROL, V15, P1006, DOI 10.1111/j.1468-1331.2008.02222.x
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   SCHWARTZBACH CJ, 1989, J BIOL CHEM, V264, P19125
   Sharma N, 2019, ENVIRON MOL MUTAGEN, V60, P668, DOI 10.1002/em.22319
   Siguroardóttir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902
   Simcox E M, 2016, MITOCHONDRIAL DYSFUNCTION IN NEURODEGENERATIVE DISORDERS, V0, P3
   Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797
   Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031
   SOONG NW, 1992, NAT GENET, V2, P318
   SPELBRINK JN, 1994, HUM MOL GENET, V3, P1989, DOI 10.1093/hmg/3.11.1989
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stoccoro A, 2017, J ALZHEIMERS DIS, V59, P559, DOI 10.3233/JAD-170139
   Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   TORRONI A, 1993, AM J HUM GENET, V53, P563
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Wright AF, 2009, TRENDS GENET, V25, P253, DOI 10.1016/j.tig.2009.04.006
   Yang WX, 2015, NEUROCHEM RES, V40, P1576, DOI 10.1007/s11064-015-1630-1
   Zoccolella S, 2012, EUR J NEUROL, V19, Pe63, DOI 10.1111/j.1468-1331.2012.03720.x
NR 123
TC 7
Z9 7
U1 1
U2 4
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1570-159X
EI 1875-6190
J9 CURR NEUROPHARMACOL
JI Curr. Neuropharmacol.
PD JUN 15
PY 2022
VL 20
IS 5
BP 824
EP 835
DI 10.2174/1570159X19666210908163839
PG 12
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 2V0QS
UT WOS:000823558300003
PM 34503413
DA 2024-11-01
ER

PT J
AU Domínguez-González, C
   Fernández-Torrón, R
   Moore, U
   de la Hoz, CPDF
   Vélez-Gómez, B
   Cabezas, JA
   Alonso-Pérez, J
   González-Mera, L
   Olivé, M
   García-García, J
   Moris, G
   Hernández, JCL
   Muelas, N
   Servian-Morilla, E
   Martin, MA
   Díaz-Manera, J
   Paradas, C
AF Dominguez-Gonzalez, Cristina
   Fernandez-Torron, Roberto
   Moore, Ursula
   de Fuenmayor-Fernandez de la Hoz, Carlos Pablo
   Velez-Gomez, Beatriz
   Antonio Cabezas, Juan
   Alonso-Perez, Jorge
   Gonzalez-Mera, Laura
   Olive, Montse
   Garcia-Garcia, Jorge
   Moris, German
   Leon Hernandez, Juan Carlos
   Muelas, Nuria
   Servian-Morilla, Emilia
   Martin, Miguel A.
   Diaz-Manera, Jordi
   Paradas, Carmen
TI Muscle MRI characteristic pattern for late-onset TK2 deficiency diagnosis
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE TK2; Mitochondrial myopathy; MRI
ID mitochondrial-dna depletion; magnetic-resonance-spectroscopy; thymidine kinase; imaging patterns; involvement
AB Background and objective TK2 deficiency (TK2d) is a rare mitochondrial disorder that manifests predominantly as a progressive myopathy with a broad spectrum of severity and age of onset. The rate of progression is variable, and the prognosis is poor due to early and severe respiratory involvement. Early and accurate diagnosis is particularly important since a specific treatment is under development. This study aims to evaluate the diagnostic value of lower limb muscle MRI in adult patients with TK2d. Methods We studied a cohort of 45 genetically confirmed patients with mitochondrial myopathy (16 with mutations in TK2, 9 with mutations in other nuclear genes involved in mitochondrial DNA [mtDNA] synthesis or maintenance, 10 with single mtDNA deletions, and 10 with point mtDNA mutations) to analyze the imaging pattern of fat replacement in lower limb muscles. We compared the identified pattern in patients with TK2d with the MRI pattern of other non-mitochondrial genetic myopathies that share similar clinical characteristics. Results We found a consistent lower limb muscle MRI pattern in patients with TK2d characterized by involvement of the gluteus maximus, gastrocnemius medialis, and sartorius muscles. The identified pattern in TK2 patients differs from the known radiological involvement of other resembling muscle dystrophies that share clinical features. Conclusions By analyzing the largest cohort of muscle MRI from patients with mitochondrial myopathies studied to date, we identified a characteristic and specific radiological pattern of muscle involvement in patients with TK2d that could be useful to speed up its diagnosis.
C1 [Dominguez-Gonzalez, Cristina; de Fuenmayor-Fernandez de la Hoz, Carlos Pablo] Hosp Univ 12 Octubre, Neurol Dept, Neuromuscular Dis Unit, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina; Martin, Miguel A.] Hosp 12 Octubre Res Inst Imas12, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina; Olive, Montse; Muelas, Nuria; Martin, Miguel A.; Diaz-Manera, Jordi] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
   [Fernandez-Torron, Roberto] Hosp Donostia, Biodonostia Hlth Res Inst, Neurol Dept, Basque Hlth Serv,Neuromuscular Area,Doctor Begiri, Donostia San Sebastian, Spain.
   [Moore, Ursula; Diaz-Manera, Jordi] Univ Newcastle, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.
   [Velez-Gomez, Beatriz; Antonio Cabezas, Juan; Servian-Morilla, Emilia; Paradas, Carmen] Hosp Univ Virgen del Rocio, Neurol Dept, Neuromuscular Dis Unit, Inst Biomed Sevilla, Seville, Spain.
   [Velez-Gomez, Beatriz; Servian-Morilla, Emilia; Paradas, Carmen] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.
   [Alonso-Perez, Jorge; Olive, Montse] Univ Autonoma Barcelona, Neurol Dept, Neuromuscular Dis Unit, Hosp Santa Creu & St Pau, Bellaterra, Spain.
   [Gonzalez-Mera, Laura] IDIBELL Hosp Univ Bellvitge, Neurol Dept, Neuromuscular Dis Unit, Barcelona, Spain.
   [Olive, Montse; Diaz-Manera, Jordi] Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona, Spain.
   [Garcia-Garcia, Jorge] Univ Albacete, Dept Neurol Hosp, Albacete, Spain.
   [Moris, German] Hosp Univ Cent Asturias, Neuromuscular Dis Unit, Neurol Dept, Asturias, Spain.
   [Leon Hernandez, Juan Carlos] Univ Nuestra Senora Candelaria, Neurol Dept Hosp, Tenerife, Spain.
   [Muelas, Nuria] Hosp Univ & Politecn La Fe, Inst Invest Sanitaria La Fe, Neurol Dept, Neuromuscular Dis Unit,Neuromuscular & Ataxias Re, Valencia, Spain.
   [Martin, Miguel A.] Hosp Univ 12 Octubre, Clin Biochem Dept, Mitochondrial Disorders Lab, Madrid, Spain.
   [Paradas, Carmen] Hosp Univ Virgen del Rocio, Unidad Enfermedades Neuromusculares CSUR EURO NMD, Inst Biomed Sevilla, Seville, Spain.
   [Diaz-Manera, Jordi] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Clin Res Inst, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Hospital Universitario 12 de Octubre; University of Barcelona; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University Hospital Donostia; Instituto de Investigacion Sanitaria Biogipuzkoa; Newcastle University - UK; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBERNED; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBERNED; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Central University Hospital Asturias; Hospital Universitari i Politecnic La Fe; Hospital Universitario 12 de Octubre; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Newcastle University - UK
RP Díaz-Manera, J (corresponding author), Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.; Díaz-Manera, J (corresponding author), Univ Newcastle, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.; Paradas, C (corresponding author), Hosp Univ Virgen del Rocio, Neurol Dept, Neuromuscular Dis Unit, Inst Biomed Sevilla, Seville, Spain.; Paradas, C (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.; Díaz-Manera, J (corresponding author), Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona, Spain.; Paradas, C (corresponding author), Hosp Univ Virgen del Rocio, Unidad Enfermedades Neuromusculares CSUR EURO NMD, Inst Biomed Sevilla, Seville, Spain.; Díaz-Manera, J (corresponding author), Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Clin Res Inst, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM cparadas@us.es
FU Instituto de Salud Carlos III; FEDER [PI18/01374, PMP15/00025]
CR Aivazoglou LU, 2021, EUR RADIOL, V31, P8498, DOI 10.1007/s00330-021-07931-9
   Alonso-Jimenez A, 2019, J NEUROL NEUROSUR PS, V90, P576, DOI 10.1136/jnnp-2018-319578
   Alonso-Pérez J, 2020, BRAIN, V143, P2696, DOI 10.1093/brain/awaa228
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Carbonell-Corvilloa P, 2018, NEUROMUSCULAR DISORD, V28, P828, DOI 10.1016/j.nmd.2018.07.006
   Castiglioni C, 2014, MUSCLE NERVE, V50, P1011, DOI 10.1002/mus.24353
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Cohen Bruce H, 2019, CONTINUUM (MINNEAP MINN), V25, P1732, DOI 10.1212/CON.0000000000000805
   Diaz-Manera J, 2018, J NEUROL NEUROSUR PS, V89, P1071, DOI 10.1136/jnnp-2017-317488
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Donkervoort S, 2019, ACTA NEUROPATHOL, V138, P1013, DOI 10.1007/s00401-019-02059-z
   Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Hankiewicz K, 2015, MUSCLE NERVE, V52, P728, DOI 10.1002/mus.24634
   Hedermann G, 2018, NEUROMUSCULAR DISORD, V28, P408, DOI 10.1016/j.nmd.2018.02.008
   Kemp GJ, 2015, ACTA PHYSIOL, V213, P107, DOI 10.1111/apha.12307
   Kornblum C, 2005, EUR J NEUROL, V12, P300, DOI 10.1111/j.1468-1331.2004.00970.x
   Leung DG, 2017, J NEUROL, V264, P1320, DOI 10.1007/s00415-016-8350-6
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   MATTHEWS PM, 1991, ANN NEUROL, V29, P435, DOI 10.1002/ana.410290416
   MATTHEWS PM, 1991, NEUROLOGY, V41, P114, DOI 10.1212/WNL.41.1.114
   Olivé M, 2011, NEUROMUSCULAR DISORD, V21, P533, DOI 10.1016/j.nmd.2011.05.002
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Peterle E, 2013, J NEUROL, V260, P2033, DOI 10.1007/s00415-013-6931-1
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Tasca G, 2017, NEUROMUSCULAR DISORD, V27, P500, DOI 10.1016/j.nmd.2017.03.001
   Tasca G, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038779
   Tordjman M, 2018, EUR RADIOL, V28, P5293, DOI 10.1007/s00330-018-5472-5
   Verdú-Díaz J, 2020, NEUROLOGY, V94, PE1094, DOI 10.1212/WNL.0000000000008902
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
NR 37
TC 6
Z9 6
U1 1
U2 8
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD JUL 15
PY 2022
VL 269
IS 7
BP 3550
EP 3562
DI 10.1007/s00415-021-10957-0
EA MAR 2022
PG 13
WC Clinical Neurology
SC Neurosciences & Neurology
GA 2I0AS
UT WOS:000768655800001
PM 35286480
DA 2024-11-01
ER

PT J
AU Chung, CY
   Valdebenito, GE
   Chacko, AR
   Duchen, MR
AF Chung, Chih-Yao
   Valdebenito, Gabriel E.
   Chacko, Anitta R.
   Duchen, Michael R.
TI Rewiring cell signalling pathways in pathogenic mtDNA mutations
SO TRENDS IN CELL BIOLOGY
LA English
DT Review
ID hereditary optic neuropathy; mitochondrial-dna mutations; quality-control; leigh-disease; atp synthesis; melas; metabolism; heteroplasmy; fibroblasts; myopathy
AB Mitochondria generate the energy to sustain cell viability and serve as a hub for cell signalling. Their own genome (mtDNA) encodes genes critical for oxidative phosphorylation. Mutations of mtDNA cause major disease and disability with a wide range of presentations and severity. We review here an emerging body of data suggesting that changes in cell metabolism and signalling pathways in response to the presence of mtDNA mutations play a key role in shaping disease presentation and progression. Understanding the impact of mtDNA mutations on cellular energy homeostasis and signalling pathways seems fundamental to identify novel therapeutic interventions with the potential to improve the prognosis for patients with primary mitochondrial disease.
C1 [Chung, Chih-Yao; Valdebenito, Gabriel E.; Chacko, Anitta R.; Duchen, Michael R.] UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.
   [Chung, Chih-Yao; Valdebenito, Gabriel E.; Chacko, Anitta R.; Duchen, Michael R.] UCL, Consortium Mitochondrial Res, Gower St, London WC1E 6BT, England.
C3 University of London; University College London; University of London; University College London
RP Duchen, MR (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.; Duchen, MR (corresponding author), UCL, Consortium Mitochondrial Res, Gower St, London WC1E 6BT, England.
EM m.duchen@ucl.ac.uk
FU National Agency for Research and Development (ANID)/Scholarship Program/DOCTORADO BECAS CHILE [72200527]; Ministry of Education, Taiwan; Medical Research Council; MRC DTP-iCASE programme [MR/RO15759/1]; Action Medical Research [GN2158]
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barriocanal-Casado E, 2019, EBIOMEDICINE, V42, P511, DOI 10.1016/j.ebiom.2019.03.025
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   Cagin U, 2015, P NATL ACAD SCI USA, V112, PE6000, DOI 10.1073/pnas.1505036112
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Chen QY, 2018, CELL METAB, V27, P1007, DOI 10.1016/j.cmet.2018.03.002
   Chen Z, 2020, J CELL BIOL, V219, P0, DOI 10.1083/jcb.201905160
   Chiang ACY, 2019, CURR BIOL, V29, P4330, DOI 10.1016/j.cub.2019.10.060
   Chou SJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep23661
   Chung CY, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-26746-2
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9
   de la Barca JMC, 2016, BRAIN, V139, P2864, DOI 10.1093/brain/aww222
   Dogan SA, 2018, CELL METAB, V28, P764, DOI 10.1016/j.cmet.2018.07.012
   Esterhuizen K, 2021, METABOLOMICS, V17, P0, DOI 10.1007/s11306-020-01769-w
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Gaude E, 2018, MOL CELL, V69, P581, DOI 10.1016/j.molcel.2018.01.034
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Granatiero V, 2016, CELL DEATH DIFFER, V23, P231, DOI 10.1038/cdd.2015.84
   Guo H, 2012, BBA-MOL BASIS DIS, V1822, P1535, DOI 10.1016/j.bbadis.2012.06.010
   Haroon S, 2018, CELL REP, V22, P3115, DOI 10.1016/j.celrep.2018.02.099
   Hathazi D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2020105364
   Hirose M, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-24290-6
   HOWELL N, 1995, GENETICS, V140, P285
   Ignatenko O, 2020, LIFE SCI ALLIANCE, V3, P0, DOI 10.26508/lsa.202000797
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Jain IH, 2020, CELL, V181, P716, DOI 10.1016/j.cell.2020.03.029
   Jain IH, 2019, CELL METAB, V30, P824, DOI 10.1016/j.cmet.2019.07.006
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Jiang PP, 2016, HUM MOL GENET, V25, P3613, DOI 10.1093/hmg/ddw199
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI 10.1042/BSE0470069
   Kandul NP, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13100
   Kang LL, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep31083
   Keshavan N, 2018, ESSAYS BIOCHEM, V62, P423, DOI 10.1042/EBC20170108
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kobayashi H, 2021, NAT CHEM BIOL, V17, P335, DOI 10.1038/s41589-020-00676-4
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Korsten A, 2010, BBA-BIOENERGETICS, V1797, P197, DOI 10.1016/j.bbabio.2009.10.003
   Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221
   Kotiadis VN, 2014, BBA-GEN SUBJECTS, V1840, P1254, DOI 10.1016/j.bbagen.2013.10.041
   Kovac S, 2019, MOL NEUROBIOL, V56, P321, DOI 10.1007/s12035-018-1078-9
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Lee P, 2020, NAT REV MOL CELL BIO, V21, P268, DOI 10.1038/s41580-020-0227-y
   Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lin DS, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8010065
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Llorente-Folch I, 2015, J PHYSIOL-LONDON, V593, P3447, DOI 10.1113/JP270254
   Lombardi AA, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12103-x
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Malena A, 2016, AUTOPHAGY, V12, P2098, DOI 10.1080/15548627.2016.1226734
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Martínez-Reyes I, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13668-3
   McMillan RP, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-42262-2
   Mick E, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.49178
   Morvan D, 2018, METABOLOMICS, V14, P0, DOI 10.1007/s11306-018-1345-9
   Mottis A, 2014, MAMM GENOME, V25, P424, DOI 10.1007/s00335-014-9525-z
   Mutai H, 2017, BMC MED GENET, V18, P0, DOI 10.1186/s12881-017-0389-4
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Ng MYW, 2021, DEV CELL, V56, P881, DOI 10.1016/j.devcel.2021.02.009
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nishioka T, 2003, J HUM GENET, V48, P385, DOI 10.1007/s10038-003-004-2
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Peng TI, 2006, BBA-MOL BASIS DIS, V1762, P241, DOI 10.1016/j.bbadis.2005.10.008
   Perry EA, 2021, NAT METAB, V3, P33, DOI 10.1038/s42255-020-00334-y
   Pezet MG, 2021, COMMUN BIOL, V4, P0, DOI 10.1038/s42003-021-02069-2
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Pitceathly RDS, 2021, J INHERIT METAB DIS, V44, P22, DOI 10.1002/jimd.12281
   Rawle MJ, 2013, CASE REP NEUROL, V5, P204, DOI 10.1159/000357518
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Sharma AK, 2016, BMJ CASE REP, V2016, P0
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   SWEENEY MG, 1993, Q J MED, V86, P709
   Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tay SKH, 2005, J CHILD NEUROL, V20, P142, DOI 10.1177/08830738050200022301
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Van Bergen NJ, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0140919
   van Gisbergen MW, 2020, FRONT ONCOL, V10, P0, DOI 10.3389/fonc.2020.00770
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wei W, 2020, J INTERN MED, V287, P634, DOI 10.1111/joim.13047
   Wiese M, 2020, MOL METAB, V38, P0, DOI 10.1016/j.molmet.2020.01.006
   Wojewoda M, 2011, INT J BIOCHEM CELL B, V43, P1178, DOI 10.1016/j.biocel.2011.04.011
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014
   Xu F, 2020, CELL BIOSCI, V10, P0, DOI 10.1186/s13578-020-00416-0
   Zhao LL, 2019, ENZYMES, V45, P311, DOI 10.1016/bs.enz.2019.08.004
   Zheng XD, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.13378
NR 118
TC 12
Z9 12
U1 1
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0962-8924
EI 1879-3088
J9 TRENDS CELL BIOL
JI Trends Cell Biol.
PD MAY 15
PY 2022
VL 32
IS 5
BP 391
EP 405
DI 10.1016/j.tcb.2021.10.005
EA APR 2022
PG 15
WC Cell Biology
SC Cell Biology
GA 1G3TR
UT WOS:000795773900006
PM 34836781
DA 2024-11-01
ER

PT J
AU Kashiki, T
   Kido, J
   Momosaki, K
   Kusunoki, S
   Ozasa, S
   Nomura, K
   Imai-Okazaki, A
   Tsuruoka, T
   Murayama, K
   Koga, Y
   Nakamura, K
AF Kashiki, Tomoko
   Kido, Jun
   Momosaki, Ken
   Kusunoki, Shouichirou
   Ozasa, Shiro
   Nomura, Keiko
   Imai-Okazaki, Atsuko
   Tsuruoka, Tomoko
   Murayama, Kei
   Koga, Yasutoshi
   Nakamura, Kimitoshi
TI Mitochondrial DNA depletion syndrome with a mutation in SLC25A4 developing epileptic encephalopathy: A case report
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE c.239G > A; Encephalopathy; Mitochondrial DNA; SLC25A4; Status epilepticus
ID adenine-nucleotide translocator
AB Introduction: Autosomal dominant mitochondrial DNA depletion syndrome (MTDPS-12A) is characterized by severe hypotonia from birth due to a mutation in the adenine nucleotide translocator 1 (ANT1). Case report: A 4-year-old female patient diagnosed with neonatal-onset mitochondrial disease, who had good cognitive function while receiving antiepileptic treatment, presented with sudden-onset status epilepticus with facial and limb myoclonus persisting for more than 30 min. Subsequently, she developed epileptic encephalopathy. Brain MRI showed progressive ventricular enlargement and marked white matter atrophy. She was unable to perform verbal communication or make eye contact and fingertip movements. She lacked any signs of cardiomyopathy. Sanger sequencing demonstrated a heterozygous de novo mutation of c.239G>A (p.Arg80His) in SLC25A4. Her right quadriceps muscle tissue showed lowered complexes I, III, and IV activities and mitochondria DNA depletion (mitochondria/nuclear DNA: 14.6 +/- 2.2%) through the quantitative polymerase chain reaction. She was definitively diagnosed with MTDPS-12A. Conclusion: Status epilepticus causes encephalopathy in patients with MTDPS-12A. Reducing the energy requirement on the cardiac muscle and brain may be a treatment strategy for patients with MTDPS-12A. Therefore, seizure management and preventive treatment of status epilepticus are considered to be important for maintaining neurodevelopmental outcomes. (C) 2021 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Kashiki, Tomoko; Kido, Jun; Kusunoki, Shouichirou; Ozasa, Shiro; Nomura, Keiko; Nakamura, Kimitoshi] Kumamoto Univ, Fac Life Sci, Dept Pediat, Kumamoto, Japan.
   [Momosaki, Ken] Kumamoto Ashikita Med Ctr Disabled Children, Kumamoto, Japan.
   [Imai-Okazaki, Atsuko] Juntendo Univ, Sch Med, Grad Sch Med,Bunkyo Ku, Intractable Dis Res Ctr,Diagnost & Therapeut Intr, Tokyo, Japan.
   [Tsuruoka, Tomoko] Chiba Childrens Hosp, Dept Neonatol, Chiba, Japan.
   [Murayama, Kei] Chiba Childrens Hosp, Ctr Med Genet, Dept Metab, Chiba, Japan.
   [Koga, Yasutoshi] Kurume Univ, Grad Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka, Japan.
C3 Kumamoto University; Juntendo University; Chiba Children's Hospital; Chiba Children's Hospital; Kurume University
RP Kido, J (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Pediat, Chuo Ku, 1-1-1 Honjo, Kumamoto, Kumamoto 8608556, Japan.
EM kidojun@kuh.kumamoto-u.ac.jp
FU Practical Research Project for Rare/Intractable Diseases [JP20ek0109468, JP19ek0109273]; Agency for Medical Research and Development (AMED), Japan; Grants-in-Aid for Scientific Research [20K08497] Funding Source: KAKEN
CR Basel D, 2020, CLIN PERINATOL, V47, P123, DOI 10.1016/j.clp.2019.10.008
   Clémençon B, 2013, MOL ASPECTS MED, V34, P485, DOI 10.1016/j.mam.2012.05.006
   El-Hattab AW, 2018, MOL GENET METAB REP, V16, P30, DOI 10.1016/j.ymgmr.2018.06.004
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Knierim E, 2015, MITOCHONDRION, V20, P1, DOI 10.1016/j.mito.2014.10.007
   Mizuguchi M, 2021, BRAIN DEV-JPN, V43, P2, DOI 10.1016/j.braindev.2020.08.001
   Murayama K, 2009, EUR J PEDIATR, V168, P297, DOI 10.1007/s00431-008-0753-7
   Palmieri F, 2020, BIOMOLECULES, V10, P0, DOI 10.3390/biom10040655
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Shimura M, 2020, ORPHANET J RARE DIS, V15, P0, DOI 10.1186/s13023-020-01441-5
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Tzoulis C, 2012, BRAIN, V135, P3627, DOI 10.1093/brain/aws223
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 14
TC 5
Z9 5
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD JAN 15
PY 2022
VL 44
IS 1
BP 56
EP 62
DI 10.1016/j.braindev.2021.08.005
EA DEC 2021
PG 7
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA XQ1EG
UT WOS:000731295700009
PM 34452803
DA 2024-11-01
ER

PT J
AU Manini, A
   Abati, E
   Comi, GP
   Corti, S
   Ronchi, D
AF Manini, Arianna
   Abati, Elena
   Comi, Giacomo Pietro
   Corti, Stefania
   Ronchi, Dario
TI Mitochondrial DNA homeostasis impairment and dopaminergic dysfunction: A trembling balance
SO AGEING RESEARCH REVIEWS
LA English
DT Review
DE MtDNA homeostasis; Parkinsonism; Parkinson's disease; POLG1; Twinkle; Mitochondrion
ID progressive external ophthalmoplegia; multiple mtdna deletions; gamma-gene polg; parkinsons-disease; polymerase-gamma; alpha-synuclein; familial parkinsonism; substantia-nigra; mouse model; copy number
AB Maintenance of mitochondrial DNA (mtDNA) homeostasis includes a variety of processes, such as mtDNA replication, repair, and nucleotides synthesis, aimed at preserving the structural and functional integrity of mtDNA molecules. Mutations in several nuclear genes (i.e., POLG, POLG2, TWNK, OPA1, DGUOK, MPV17, TYMP) impair mtDNA maintenance, leading to clinical syndromes characterized by mtDNA depletion and/or deletions in affected tissues. In the past decades, studies have demonstrated a progressive accumulation of multiple mtDNA deletions in dopaminergic neurons of the substantia nigra in elderly population and, to a greater extent, in Parkinson's disease patients. Moreover, parkinsonism has been frequently described as a prominent clinical feature in mtDNA instability syndromes. Among Parkinson's disease-related genes with a significant role in mitochondrial biology, PARK2 and LRRK2 specifically take part in mtDNA maintenance. Moreover, a variety of murine models (i.e., "Mutator", "MitoPark", "PD-mitoPstI", "Deletor", "Twinkle-dup" and "TwinkPark") provided in vivo evidence that mtDNA stability is required to preserve nigrostriatal integrity. Here, we review and discuss the clinical, genetic, and pathological background underlining the link between impaired mtDNA homeostasis and dopaminergic degeneration.
C1 [Manini, Arianna; Abati, Elena; Comi, Giacomo Pietro; Corti, Stefania; Ronchi, Dario] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Comi, Giacomo Pietro] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Corti, Stefania; Ronchi, Dario] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosci, Neurol Unit, Milan, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Ronchi, D (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Neurosci Sect, Milan, Italy.
EM dario.ronchi@unimi.it
FU Italian Ministry of Health (Ministero della Salute), Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Grant Ricerca Corrente 2020
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amboni M, 2009, MOVEMENT DISORD, V24, P303, DOI 10.1002/mds.22342
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Bai RK, 2021, GENET MED, V23, P1514, DOI 10.1038/s41436-021-01166-1
   Bakshi R, 2019, ANN NEUROL, V85, P593, DOI 10.1002/ana.25436
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Batla Amit, 2015, MOV DISORD CLIN PRACT, V2, P304, DOI 10.1002/mdc3.12164
   Bedford C, 2016, FRONT MOL NEUROSCI, V9, P0, DOI 10.3389/fnmol.2016.00035
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Billingsley KJ, 2019, NPJ PARKINSONS DIS, V5, P0, DOI 10.1038/s41531-019-0080-x
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Breen DP, 2020, NEUROLOGY, V95, P644, DOI 10.1212/WNL.0000000000010674
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Cao LQ, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000756
   Caporali L, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx301
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Chen C, 2020, NEUROBIOL DIS, V134, P0, DOI 10.1016/j.nbd.2019.104631
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Dai Y, 2014, NEUROTOXICOL TERATOL, V46, P62, DOI 10.1016/j.ntt.2014.10.004
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   di Poggio MB, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-105
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Dolhun R, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-92
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Ferreira M, 2017, ACTA NEUROL SCAND, V135, P273, DOI 10.1111/ane.12616
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Fukae J, 2007, MITOCHONDRION, V7, P58, DOI 10.1016/j.mito.2006.12.002
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gaare JJ, 2018, MOVEMENT DISORD, V33, P1591, DOI 10.1002/mds.64
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Ghaisas S, 2019, NEUROTOXICOLOGY, V75, P186, DOI 10.1016/j.neuro.2019.09.004
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gómez-Suaga P, 2014, HUM MOL GENET, V23, P6779, DOI 10.1093/hmg/ddu395
   Gómez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481
   Gonzalez-Hunt CP, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-74195-6
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Guedes LC, 2010, PARKINSONISM RELAT D, V16, P237, DOI 10.1016/j.parkreldis.2009.11.004
   Gui YX, 2015, PARKINSONISM RELAT D, V21, P282, DOI 10.1016/j.parkreldis.2014.12.030
   Gurgel-Giannetti J, 2012, MUSCLE NERVE, V45, P453, DOI 10.1002/mus.22330
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Hirano M, 2005, GENE, V354, P152, DOI 10.1016/j.gene.2005.04.041
   Howlett EH, 2017, HUM MOL GENET, V26, P4340, DOI 10.1093/hmg/ddx320
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Iannielli A, 2018, CELL REP, V22, P2066, DOI 10.1016/j.celrep.2018.01.089
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005
   Jang S, 2020, MITOCHONDRION, V51, P30, DOI 10.1016/j.mito.2019.11.006
   Jensen MB, 2008, ANN ONCOL, V19, P1910, DOI 10.1093/annonc/mdn407
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Jüllig M, 2000, EUR J BIOCHEM, V267, P5466, DOI 10.1046/j.1432-1327.2000.01607.x
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029
   Kim SJ, 2017, J PHYSIOL-LONDON, V595, P6613, DOI 10.1113/JP274472
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MANN VM, 1992, FEBS LETT, V299, P218, DOI 10.1016/0014-5793(92)80118-Z
   Martijn J, 2018, NATURE, V557, P101, DOI 10.1038/s41586-018-0059-5
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Mehta AR, 2011, MOVEMENT DISORD, V26, P753, DOI 10.1002/mds.23510
   Meira B, 2019, BMJ CASE REP, V12, P0, DOI 10.1136/bcr-2018-228482
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013
   Milone M, 2011, ARCH NEUROL-CHICAGO, V68, P806, DOI 10.1001/archneurol.2011.124
   Minnerop M, 2005, J NEUROL NEUROSUR PS, V76, P118, DOI 10.1136/jnnp.2004.040220
   MIYABAYASHI S, 1992, J INHERIT METAB DIS, V15, P797, DOI 10.1007/BF01800024
   Montassir H, 2015, BRAIN DEV-JPN, V37, P719, DOI 10.1016/j.braindev.2014.10.013
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033
   Müller-Nedebock AC, 2019, NEUROCHEM INT, V129, P0, DOI 10.1016/j.neuint.2019.104495
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   Mukai Masako, 2014, RINSHO SHINKEIGAKU, V54, P417
   Mukai M, 2013, PARKINSONISM RELAT D, V19, P821, DOI 10.1016/j.parkreldis.2013.04.011
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nissanka N, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04895-1
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Nuzhnyi E, 2021, CLIN NEUROL NEUROSUR, V201, P0, DOI 10.1016/j.clineuro.2020.106462
   Ouzren N, 2019, ANN NEUROL, V86, P324, DOI 10.1002/ana.25510
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Paisán-Ruíz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Pinto M, 2018, J NEUROSCI, V38, P1042, DOI 10.1523/JNEUROSCI.1384-17.2017
   Podlesniy P, 2019, EBIOMEDICINE, V48, P554, DOI 10.1016/j.ebiom.2019.09.015
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111
   Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shoubridge E A, 2000, HUM REPROD, V15 Suppl 2, P229
   Simon DK, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-017-0433-9
   Song LY, 2017, NEUROBIOL DIS, V100, P30, DOI 10.1016/j.nbd.2016.12.024
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Surmeier DJ, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a009290
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Tanaka K, 2020, NEUROSCI RES, V159, P9, DOI 10.1016/j.neures.2020.01.006
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2016, MITOCHONDRION, V28, P33, DOI 10.1016/j.mito.2016.03.003
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Ye F, 2014, MITOCHONDRION, V17, P157, DOI 10.1016/j.mito.2014.05.004
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yue M, 2015, NEUROBIOL DIS, V78, P172, DOI 10.1016/j.nbd.2015.02.031
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang J, 2002, PARKINSONISM RELAT D, V8, P165, DOI 10.1016/S1353-8020(01)00041-4
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 186
TC 17
Z9 19
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 1568-1637
EI 1872-9649
J9 AGEING RES REV
JI Ageing Res. Rev.
PD APR 15
PY 2022
VL 76
IS 
BP 
EP 
DI 10.1016/j.arr.2022.101578
EA FEB 2022
PG 20
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA 0I0OW
UT WOS:000779128500002
PM 35114397
DA 2024-11-01
ER

PT J
AU Bayat, A
   Krett, B
   Duno, M
   Torring, PM
   Vissing, J
AF Bayat, Allan
   Krett, Bjorg
   Duno, Morten
   Torring, Pernille Mathiesen
   Vissing, John
TI Novel truncating variants in <i>FGD1</i> detected in two Danish families with Aarskog-Scott syndrome and myopathic features
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE Aarskog-Scott syndrome; adulthood; developmental disorder; FGD1; mitochondrial myopathy
ID missense mutation; gene
AB Aarskog-Scott syndrome (AAS) is a developmental disorder, caused by disease-causing hemizygous variants in the FGD1 gene. AAS is characterized by dysmorphic features, genital malformation, skeletal anomalies, and in some cases, intellectual disability and behavioral difficulties. Myopathy has only been reported once in two affected siblings diagnosed with AAS. Only few adult cases have been reported. This article reports four adults with AAS (three male cases and one female carrier) from two unrelated Danish families, all males presented with variable features suggestive of myopathy. All four carried novel hemizygous pathogenic variants in the FGD1 gene; one family presented with the c.2266dup, p.Cys756Leufs*19 variant while the c.527dup; p.Leu177Thrfs*40 variant was detected in the second family. All males had some mild myopathic symptoms or histological abnormalities. Case 1 had the most severe myopathic phenotype with prominent proximal muscular fatigue and exercise intolerance. In addition, he had multiple deletions of mtDNA and low respiratory chain activity. His younger nephew, case 3, had difficulties doing sports in his youth and had a mildly abnormal muscle biopsy and relatively decreased mitochondrial enzyme activity. The singular case from family 2 (case 4), had a mildly myopathic muscle biopsy, but no overt myopathic symptoms. Our findings suggest that myopathic involvement should be considered in AAS.
C1 [Bayat, Allan] Danish Epilepsy Ctr, Dept Epilepsy Genet & Personalized Med, Dianalund, Denmark.
   [Bayat, Allan] Univ Southern Denmark, Inst Reg Hlth Serv, Odense, Denmark.
   [Krett, Bjorg; Vissing, John] Univ Copenhagen, Rigshosp, Copenhagen Neuromuscular Ctr, Dept Neurol, Copenhagen, Denmark.
   [Duno, Morten] Univ Hosp Copenhagen, Dept Clin Genet, Mol Genet Lab, Copenhagen, Denmark.
   [Torring, Pernille Mathiesen] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark.
C3 University of Southern Denmark; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital
RP Bayat, A (corresponding author), Danish Epilepsy Ctr, Dept Epilepsy Genet & Personalized Med, Dianalund, Denmark.
EM abaya@filadelfia.dk
CR Al-Semari A, 2013, CLIN DYSMORPHOL, V22, P13, DOI 10.1097/MCD.0b013e32835b6dc4
   Altincik A, 2013, J PEDIATR ENDOCR MET, V26, P385, DOI 10.1515/jpem-2012-0233
   Aten E, 2013, HUM MUTAT, V34, P430, DOI 10.1002/humu.22252
   Bae GY, 2020, ANN CLIN LAB SCI, V50, P691
   Bedoyan JK, 2009, EUR J MED GENET, V52, P262, DOI 10.1016/j.ejmg.2008.12.001
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bottani A, 2007, AM J MED GENET A, V143A, P2334, DOI 10.1002/ajmg.a.31733
   Ge YH, 2017, EXP THER MED, V13, P2623, DOI 10.3892/etm.2017.4301
   Janssen MCH, 2013, EUR J HUM GENET, V21, P807, DOI 10.1038/ejhg.2012.256
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Landrum MJ, 2018, HUM MUTAT, V39, P1623, DOI 10.1002/humu.23641
   Lebel RR, 2002, CLIN GENET, V61, P139, DOI 10.1034/j.1399-0004.2002.610209.x
   Orrico A, 2007, AM J MED GENET A, V143A, P58, DOI 10.1002/ajmg.a.31562
   Orrico A, 2004, EUR J HUM GENET, V12, P16, DOI 10.1038/sj.ejhg.5201081
   Orrico A, 2010, AM J MED GENET A, V152A, P313, DOI 10.1002/ajmg.a.33199
   Orrico A, 2015, EUR J HUM GENET, V23, P0, DOI 10.1038/ejhg.2014.178
   PASTERIS NG, 1994, CELL, V79, P669
   Pilozzi-Edmonds L, 2011, AM J MED GENET A, V155A, P1987, DOI 10.1002/ajmg.a.34094
   Ronce N, 2012, CLIN GENET, V82, P93, DOI 10.1111/j.1399-0004.2011.01782.x
   Schwartz CE, 2000, EUR J HUM GENET, V8, P869, DOI 10.1038/sj.ejhg.5200553
   TEEBI AS, 1993, AM J MED GENET, V46, P501, DOI 10.1002/ajmg.1320460508
   Verhoeven WMA, 2012, GENET COUNSEL, V23, P157
   Whitehead IP, 1998, MOL CELL BIOL, V18, P4689, DOI 10.1128/MCB.18.8.4689
   Drumond VZ, 2021, GENET RES, V2021, P0, DOI 10.1155/2021/6652957
NR 24
TC 2
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD JUL 15
PY 2022
VL 188
IS 7
BP 2251
EP 2257
DI 10.1002/ajmg.a.62753
EA APR 2022
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA 2B3NI
UT WOS:000779438700001
PM 35388608
DA 2024-11-01
ER

PT J
AU Bermejo-Guerrero, L
   de la Hoz, CPDF
   Serrano-Lorenzo, P
   Blazquez-Encinar, A
   Gutierrez-Gutierrez, G
   Martinez-Vicente, L
   Galan-Davila, L
   Garcia-Garcia, J
   Arenas, J
   Muelas, N
   Hernandez-Lain, A
   Dominguez-Gonzalez, C
   Martin, MA
AF Bermejo-Guerrero, Laura
   de la Hoz, Carlos Pablo de Fuenmayor-fernandez
   Serrano-Lorenzo, Pablo
   Blazquez-Encinar, Alberto
   Gutierrez-Gutierrez, Gerardo
   Martinez-Vicente, Laura
   Galan-Davila, Lucia
   Garcia-Garcia, Jorge
   Arenas, Joaquin
   Muelas, Nuria
   Hernandez-Lain, Aurelio
   Dominguez-Gonzalez, Cristina
   Martin, Miguel A.
TI Clinical, Histological, and Genetic Features of 25 Patients with Autosomal Dominant Progressive External Ophthalmoplegia (ad-PEO)/PEO-Plus Due to <i>TWNK</i> Mutations
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE TWNK gene; mitochondrial dysfunction; mtDNA maintenance defects; progressive external ophthalmoplegia
ID twinkle; diagnosis; variants; spectrum; server
AB Autosomal dominant mutations in the TWNK gene, which encodes a mitochondrial DNA helicase, cause adult-onset progressive external ophthalmoplegia (PEO) and PEO-plus presentations. In this retrospective observational study, we describe clinical and complementary data from 25 PEO patients with mutations in TWNK recruited from the Hospital 12 de Octubre Mitochondrial Disorders Laboratory Database. The mean ages of onset and diagnosis were 43 and 63 years, respectively. Family history was positive in 22 patients. Ptosis and PEO (92% and 80%) were the most common findings. Weakness was present in 48%, affecting proximal limbs, neck, and bulbar muscles. Exercise intolerance was present in 28%. Less frequent manifestations were cardiac (24%) and respiratory (4%) involvement, neuropathy (8%), ataxia (4%), and parkinsonism (4%). Only 28% had mild hyperCKemia. All 19 available muscle biopsies showed signs of mitochondrial dysfunction. Ten different TWNK mutations were identified, with c.1361T>G (p.Val454Gly) and c.1070G>C (p.Arg357Pro) being the most common. Before definitive genetic confirmation, 56% of patients were misdiagnosed (36% with myasthenia, 20% with oculopharyngeal muscle dystrophy). Accurate differential diagnosis and early confirmation with appropriately chosen complementary studies allow genetic counseling and the avoidance of unnecessary treatments. Thus, mitochondrial myopathies must be considered in PEO/PEO-plus presentations, and particularly, TWNK is an important cause when positive family history is present.
C1 [Bermejo-Guerrero, Laura; de la Hoz, Carlos Pablo de Fuenmayor-fernandez; Dominguez-Gonzalez, Cristina] Hosp Univ 12 Octubre, Dept Neurol, Neuromuscular Unit, Madrid 28041, Spain.
   [Serrano-Lorenzo, Pablo; Blazquez-Encinar, Alberto; Arenas, Joaquin; Hernandez-Lain, Aurelio; Dominguez-Gonzalez, Cristina; Martin, Miguel A.] Hosp 12 Octubre Res Inst Imas12, Madrid 28041, Spain.
   [Serrano-Lorenzo, Pablo; Blazquez-Encinar, Alberto; Arenas, Joaquin; Muelas, Nuria; Dominguez-Gonzalez, Cristina; Martin, Miguel A.] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid 28029, Spain.
   [Serrano-Lorenzo, Pablo; Blazquez-Encinar, Alberto; Arenas, Joaquin; Martin, Miguel A.] Hosp Univ 12 Octubre, Clin Biochem Dept, Mitochondrial Disorders Lab, Madrid 28041, Spain.
   [Gutierrez-Gutierrez, Gerardo] Hosp Univ Infanta Sofia, Dept Neurol, Madrid 28703, Spain.
   [Martinez-Vicente, Laura; Galan-Davila, Lucia] Hosp Univ Clin San Carlos, Dept Neurol, Madrid 28040, Spain.
   [Garcia-Garcia, Jorge] Complejo Hosp Univ Albacete, Dept Neurol, Albacete 02006, Spain.
   [Muelas, Nuria] Hosp Univ & Politecn La Fe, Dept Neurol, Neuromuscular Unit, Valencia 46026, Spain.
   [Muelas, Nuria] Inst Invest Sanitaria La Fe, Neuromuscular & Ataxias Res Grp, Valencia 46026, Spain.
   [Hernandez-Lain, Aurelio] Hosp Univ 12 Octubre, Dept Neuropathol, Madrid 28041, Spain.
C3 Hospital Universitario 12 de Octubre; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre; Hospital Universitario Infanta Sofia; Hospital Universitari i Politecnic La Fe; Hospital Universitario 12 de Octubre
RP Dominguez-Gonzalez, C (corresponding author), Hosp Univ 12 Octubre, Dept Neurol, Neuromuscular Unit, Madrid 28041, Spain.; Dominguez-Gonzalez, C (corresponding author), Hosp 12 Octubre Res Inst Imas12, Madrid 28041, Spain.; Dominguez-Gonzalez, C (corresponding author), Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid 28029, Spain.
EM laura.bermejo@salud.madrid.org; carlosdefuenmayor@hotmail.com; pabloserra.lor@gmail.com; abencinar@hotmail.com; g3.neuro@gmail.com; lmvicente@salud.madrid.org; lgaland@yahoo.com; jorgaga@sescam.jccm.es; joaquin.arenas@salud.madrid.org; muelas_nur@gva.es; aurelio.hlain@salud.madrid.org; cdgonzalez@salud.madrid.org; mamcasanueva.imas12@h12o.es
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Alonso-Jimenez A, 2019, J NEUROL NEUROSUR PS, V90, P576, DOI 10.1136/jnnp-2018-319578
   [Anonymous], 1900, NHLBI GO EXOME SEQUENCING PROJECT (ESP), V0, P0
   Brais Bernard, 2011, HANDB CLIN NEUROL, V101, P181, DOI 10.1016/B978-0-08-045031-5.00014-1
   Braz LP, 2021, NEUROL-CLIN PRACT, V11, P97, DOI 10.1212/CPJ.0000000000000795
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Ciafaloni Emma, 2019, CONTINUUM (MINNEAP MINN), V25, P1767, DOI 10.1212/CON.0000000000000800
   Clarke L, 2017, NUCLEIC ACIDS RES, V45, PD854, DOI 10.1093/nar/gkw829
   Cohen Bruce H, 2019, CONTINUUM (MINNEAP MINN), V25, P1732, DOI 10.1212/CON.0000000000000805
   Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072
   Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, PD1062, DOI 10.1093/nar/gkx1153
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Ostos Fernando, 2020, J CLIN NEUROMUSCUL DIS, V21, P222, DOI 10.1097/CND.0000000000000277
   Pasnoor M, 2018, NEUROL CLIN, V36, P261, DOI 10.1016/j.ncl.2018.01.010
   Peña-Chilet M, 2021, NUCLEIC ACIDS RES, V49, PD1130, DOI 10.1093/nar/gkaa794
   Peñas A, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22126396
   Peter B, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11040408
   Poulsen NS, 2020, MITOCHONDRION, V50, P35, DOI 10.1016/j.mito.2019.10.005
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Sim NL, 2012, NUCLEIC ACIDS RES, V40, PW452, DOI 10.1093/nar/gks539
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Wong KT, 1996, NEUROMUSCULAR DISORD, V6, P163, DOI 10.1016/0960-8966(95)00039-9
NR 38
TC 5
Z9 5
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD JAN 15
PY 2022
VL 11
IS 1
BP 
EP 
DI 10.3390/jcm11010022
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA ZE0MU
UT WOS:000758587200001
PM 35011763
DA 2024-11-01
ER

PT J
AU Asadullah
   Din, AU
   Ul Ghafoor, S
   Akbar, F
   Akhtar, N
   Khan, MF
   Ullah, Z
   Kareem, A
AF Asadullah
   Din, Aziz Ud
   Ul Ghafoor, Sajid
   Akbar, Fazal
   Akhtar, Naveed
   Khan, Muhammad Fiaz
   Ullah, Zaib
   Kareem, Abdul
TI Analysis of mutations in leu tRNA gene in patients of heart diseases
SO SAUDI JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE Leu tRNA; Gene; Mutation; CVD
ID maternally inherited myopathy; mitochondrial-dna; cardiomyopathy; burden; risk
AB Cardiovascular diseases (CVD) are the leading cause of death all over the world. Beside general risk factors, there are some genetic factors which lead to cardiovascular diseases. Various nuclear DNA mutation and also mitochondrial DNA mutations have been related with cardiovascular diseases. In the present study, a total of 21 samples were collected from different families residing in district Dir. DNA was extracted from buccal epithelial cells using saliva. The mitochondrial tRNA leu (MT TL1) gene was amplified by PCR and 10 samples of different families were sequenced. The sequence was aligned with revised Cambridge Reference Sequence (rCRS) accession # NC-012920.1. It is concluded that cardiovascular diseases in our subjects are not due to mutation in the mitochondrial leucine tRNA gene. However, a large population of subjects with cardiovascular diseases needs to be studied and whole mitochondrial DNA is needed to be sequenced in the subjects with CVD. This will give an idea about the probable DNA marker which can be used to prevent loses due to these diseases at a very early stages. (C) 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
C1 [Asadullah; Din, Aziz Ud; Ul Ghafoor, Sajid] Hazara Univ, Dept Genet, Mansehra, Pakistan.
   [Akbar, Fazal] Univ Swat, Ctr Biotechnol & Microbiol, Mingora, Pakistan.
   [Akhtar, Naveed; Ullah, Zaib] Hazara Univ, Dept Zool, Sub Campus, Battagram, Pakistan.
   [Khan, Muhammad Fiaz] Hazara Univ, Dept Zool, Mansehra, Pakistan.
   [Kareem, Abdul] Sanaa Univ, Dept Life Sci, Sanaa, Yemen.
C3 Hazara University; Hazara University
RP Asadullah (corresponding author), Hazara Univ Mansehra, Dept Genet, Mansehra, Khyber Pakhtunk, Pakistan.
EM asadgeneticist@gmail.com
CR Aidar Marisi, 2007, BRAZ. DENT. J., V18, P148
   Almahmeed Wael, 2012, THER CLIN RISK MANAG, V8, P65, DOI 10.2147/TCRM.S26414
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Auer J, 2006, INT J CARDIOL, V106, P398, DOI 10.1016/j.ijcard.2004.12.085
   Ben Romdhane H, 2004, REV EPIDEMIOL SANTE, V52, P558, DOI 10.1016/S0398-7620(04)99094-3
   EAKER ED, 1993, CIRCULATION, V88, P1999, DOI 10.1161/01.CIR.88.4.1999
   Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hadjigeorgiou GM, 1999, J NEUROL SCI, V164, P153, DOI 10.1016/S0022-510X(99)00062-3
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   Murray CJL, 1996, GLOBAL BURDEN DIS, V0, P270
   Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2
   Nan DN, 2002, POSTGRAD MED J, V78, P298, DOI 10.1136/pmj.78.919.298
   Rehan Ahmad Rehan Ahmad, 2002, PAKISTAN JOURNAL OF MEDICAL SCIENCES, V18, P95
   Sadiq M, 2001, PAK PAED J, V25, P63
   Santulli G, 2013, J CARDIOVASC DIS RES, V1, P0
   Sapa, 2006, MILLIONS DESCEND MEC, V0, P0
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423
NR 25
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-562X
EI 2213-7106
J9 SAUDI J BIOL SCI
JI Saudi J. Biol. Sci.
PD JAN 15
PY 2022
VL 29
IS 1
BP 436
EP 443
DI 10.1016/j.sjbs.2021.09.010
EA DEC 2021
PG 8
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA XV3LO
UT WOS:000734847800006
PM 35002439
DA 2024-11-01
ER

PT J
AU Tkaczyk-Wlizlo, A
   Kowal, K
   Slaska, B
AF Tkaczyk-Wlizlo, Angelika
   Kowal, Krzysztof
   Slaska, Brygida
TI Mitochondrial DNA alterations in the domestic dog<i> (Canis</i><i> lupus</i><i> familiaris)</i> and their association with development of diseases: A review
SO MITOCHONDRION
LA English
DT Review
DE mtDNA; Mutation; Canine disease; Tumour; Myopathy
ID subacute necrotizing encephalopathy; lactic-acidosis; mtdna mutation; myopathy; gene; rna; encephalomyelopathy; encephalomyopathy; expression; epilepsy
AB Currently, the issue of the aetiology of mitochondrial diseases resulting from mitochondrial DNA (mtDNA) defects is underestimated. Genetic research is mostly focused on alterations in the nuclear genome (nDNA), and its impact on disease development as well as further health consequences without considering mtDNA abnormalities. However, in the case of energy-dependent diseases, it is important to understand the bioenergetic pathophysiology and its relation with mtDNA changes.In the current animal research, there is limited data about mtDNA defects and their association with the development of bioenergetic diseases in the domestic dog (Canis lupus familiaris) in contrast to human medicine, where mitochondrial genetics research has recently increased. Molecular findings about mtDNA indicate that improper functioning of mitochondria resulting from genetic defects of mtDNA has a severe impact on cells and tissues, especially those that are heavily dependent on oxidative metabolism such as the brain, skeletal and cardiac muscles and, consequently, the whole organism.The aim of this paper is to highlight the role of defects of mitochondria and mtDNA on the development and course of different diseases in the domestic dog. The field of canine mitochondrial genetics and genomics is definitely inexhaustible and it is worth drawing attention to the importance and consequences of the mitochondrial genome alterations. This review collects scientific data on mitochondrial DNA with special regard to the structure, features of canine mtDNA, and abnormalities in the mitochondrial genome and their association with the course and development of diseases, including mitochondrial myopathies, encephalopathies, and tumours.
C1 [Tkaczyk-Wlizlo, Angelika; Kowal, Krzysztof; Slaska, Brygida] Univ Life Sci Lublin, Inst Biol Bases Anim Prod, Akad 13, PL-20950 Lublin, Poland.
C3 University of Life Sciences in Lublin
RP Slaska, B (corresponding author), Univ Life Sci Lublin, Inst Biol Bases Anim Prod, Akad 13, PL-20950 Lublin, Poland.
EM angelika.tkaczyk@up.lublin.pl; krzysztof.kowal@up.lublin.pl; brygida.slaska@up.lublin.pl
FU National Science Centre in Poland [2019/35/B/NZ5/00775]
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Appleyard GD, 2006, INVEST OPHTH VIS SCI, V47, P1810, DOI 10.1167/iovs.05-0819
   Baiker K, 2009, ACTA NEUROPATHOL, V118, P697, DOI 10.1007/s00401-009-0548-6
   Baranowska I, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000499
   Bertagnolli AC, 2009, VET J, V182, P269, DOI 10.1016/j.tvjl.2008.07.005
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   BREITSCHWERDT EB, 1992, J AM VET MED ASSOC, V201, P731
   Brenner O, 1997, ACTA NEUROPATHOL, V94, P390, DOI 10.1007/s004010050724
   Brenner O, 2000, ACTA NEUROPATHOL, V100, P50, DOI 10.1007/s004010051192
   Brenner O, 1997, ACTA NEUROPATHOL, V94, P54, DOI 10.1007/s004010050672
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Collins D, 2013, J COMP PATHOL, V148, P345, DOI 10.1016/j.jcpa.2012.08.008
   Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dobson Jane M, 2013, ISRN VET SCI, V2013, P941275, DOI 10.1155/2013/941275
   EICHMANN C, 2007, INT J LEGAL MED, V121, P411, DOI 10.1007/S00414-006-0143-5
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Gammage PA, 2019, BMC BIOL, V17, P0, DOI 10.1186/s12915-019-0668-y
   Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258
   Gruber AD, 2002, VET PATHOL, V39, P732, DOI 10.1354/vp.39-6-732
   Guo L, 2016, BIOCHEM BIOPH RES CO, V479, P800, DOI 10.1016/j.bbrc.2016.09.129
   Hardy SA, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000082
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kim KS, 1998, MOL PHYLOGENET EVOL, V10, P210, DOI 10.1006/mpev.1998.0513
   KORNEGAY JN, 1988, MUSCLE NERVE, V11, P1056, DOI 10.1002/mus.880111008
   Kowal K, 2019, ANN ANIM SCI, V19, P619, DOI 10.2478/aoas-2019-0027
   Kozakiewicz P, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22105100
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Li FY, 2006, NEUROBIOL DIS, V21, P35, DOI 10.1016/j.nbd.2005.06.009
   Lopes R, 2006, AM J VET RES, V67, P971, DOI 10.2460/ajvr.67.6.971
   MCKERRELL RE, 1986, VET PATHOL, V23, P411, DOI 10.1177/030098588602300410
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Nisztuk-Pacek S, 2019, ANN ANIM SCI, V19, P61, DOI 10.2478/aoas-2018-0049
   Olby NJ, 1997, J SMALL ANIM PRACT, V38, P213, DOI 10.1111/j.1748-5827.1997.tb03346.x
   Onishi M, 2021, EMBO J, V40, P0, DOI 10.15252/embj.2020104705
   Orsucci D, 2018, EBIOMEDICINE, V30, P3, DOI 10.1016/j.ebiom.2018.03.007
   Paciello O, 2003, VET PATHOL, V40, P507, DOI 10.1354/vp.40-5-507
   Parrella P, 2001, CANCER RES, V61, P7623
   Perli E, 2012, HUM MOL GENET, V21, P85, DOI 10.1093/hmg/ddr440
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Prochaska LJ, 2013, ENCY BIOPHYSICS, V0, P0, DOI DOI 10.1007/978-3-642-16712-6_25
   Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004
   Siegmund SE, 2017, HUM MOL GENET, V26, P4588, DOI 10.1093/hmg/ddx341
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Slaska B, 2016, POL J VET SCI, V19, P461, DOI 10.1515/pjvs-2016-0058
   Slaska B, 2020, ANN ANIM SCI, V20, P919, DOI 10.2478/aoas-2020-0027
   Slaska B, 2015, MITOCHONDR DNA, V26, P452, DOI 10.3109/19401736.2013.840594
   Slaska B, 2014, B VET I PULAWY, V58, P631, DOI 10.2478/bvip-2014-0096
   Slaska B, 2014, MITOCHONDR DNA, V25, P238, DOI 10.3109/19401736.2013.792054
   Smiech A, 2019, IN VIVO, V33, P57, DOI 10.21873/invivo.11439
   Smiech A, 2016, ACTA VET SCAND, V58, P0, DOI 10.1186/s13028-016-0210-y
   Stewart JB, 2021, J INHERIT METAB DIS, V44, P325, DOI 10.1002/jimd.12324
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003
   Tauro A, 2008, VET REC, V27, P0
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Verscheure S, 2013, ZOOKEYS, V0, PP381, DOI 10.3897/zookeys.365.5859
   VIJAYASARATHY C, 1994, COMP BIOCHEM PHYS A, V109, P887, DOI 10.1016/0300-9629(94)90236-4
   Wakshlag JJ, 1999, J SMALL ANIM PRACT, V40, P585, DOI 10.1111/j.1748-5827.1999.tb03028.x
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Zhang AM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026511
   Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011
NR 64
TC 8
Z9 8
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2022
VL 63
IS 
BP 72
EP 84
DI 10.1016/j.mito.2022.02.001
EA FEB 2022
PG 13
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 0U8BW
UT WOS:000787873200009
PM 35134592
DA 2024-11-01
ER

PT J
AU Zeviani, M
   Carelli, V
AF Zeviani, Massimo
   Carelli, Valerio
TI Mitochondrial Retinopathies
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE retina; mitochondrial disorders; mitochondrial DNA; retinitis pigmentosa; optic atrophy; mtDNA heteroplasmic deletions; Kearns-Sayre syndrome; neurogenic muscle weakness; ataxia and retinitis pigmentosa (NARP); Leber's hereditary optic neuropathy (LHON); autosomal dominant optic atrophy (ADOA)
ID hereditary-optic-neuropathy; retinal-pigment epithelium; sclerosis-like disorder; external ophthalmoplegia; dna deletions; ophthalmoscopic findings; incomplete penetrance; allotopic expression; biallelic variants; glucose-metabolism
AB The retina is an exquisite target for defects of oxidative phosphorylation (OXPHOS) associated with mitochondrial impairment. Retinal involvement occurs in two ways, retinal dystrophy (retinitis pigmentosa) and subacute or chronic optic atrophy, which are the most common clinical entities. Both can present as isolated or virtually exclusive conditions, or as part of more complex, frequently multisystem syndromes. In most cases, mutations of mtDNA have been found in association with mitochondrial retinopathy. The main genetic abnormalities of mtDNA include mutations associated with neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) sometimes with earlier onset and increased severity (maternally inherited Leigh syndrome, MILS), single large-scale deletions determining Kearns-Sayre syndrome (KSS, of which retinal dystrophy is a cardinal symptom), and mutations, particularly in mtDNA-encoded ND genes, associated with Leber hereditary optic neuropathy (LHON). However, mutations in nuclear genes can also cause mitochondrial retinopathy, including autosomal recessive phenocopies of LHON, and slowly progressive optic atrophy caused by dominant or, more rarely, recessive, mutations in the fusion/mitochondrial shaping protein OPA1, encoded by a nuclear gene on chromosome 3q29.
C1 [Zeviani, Massimo] Univ Padua, Dept Neurosci, Sch Clin, I-35128 Padua, Italy.
   [Zeviani, Massimo] Veneto Inst Mol Med, Via Orus 2, I-35128 Padua, Italy.
   [Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40139 Bologna, Italy.
   [Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Via Altura 6, I-40139 Bologna, Italy.
C3 University of Padua; Veneto Institute Molecular Medicine; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB)
RP Zeviani, M (corresponding author), Univ Padua, Dept Neurosci, Sch Clin, I-35128 Padua, Italy.; Zeviani, M (corresponding author), Veneto Inst Mol Med, Via Orus 2, I-35128 Padua, Italy.; Carelli, V (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, I-40139 Bologna, Italy.; Carelli, V (corresponding author), IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Via Altura 6, I-40139 Bologna, Italy.
EM massimo.zeviani@unipd.it; valerio.carelli@unibo.it
FU Telethon-Italy [GP19007]; Associazione Renato Comini ONLUS; Italian Ministry of Health; Italian Ministry of Research and University, Telethon-Italy; EU Horizon 2020 program; MITOCON; IFOND
CR Abrams AJ, 2018, HUM MUTAT, V39, P1995, DOI 10.1002/humu.23639
   Achilli A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042242
   Aït-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023
   Aleo SJ, 2020, HUM MOL GENET, V29, P3631, DOI 10.1093/hmg/ddaa244
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992
   ANDERSON B, 1964, ARCH OPHTHALMOL-CHIC, V72, P792
   Angebault C, 2015, AM J HUM GENET, V97, P754, DOI 10.1016/j.ajhg.2015.09.012
   [Anonymous], 1909, KLIN MON AUGENHEILKD, V0, P0
   Bacman SR, 2020, METHOD CELL BIOL, V155, P441, DOI 10.1016/bs.mcb.2019.12.004
   Balducci N, 2018, CLIN EXP OPHTHALMOL, V46, P1055, DOI 10.1111/ceo.13326
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Barboni P, 2006, INVEST OPHTH VIS SCI, V47, P5303, DOI 10.1167/iovs.06-0520
   Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026
   Bargiela D, 2019, NEUROSCI LETT, V710, P0, DOI 10.1016/j.neulet.2017.06.051
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560
   Berardo A, 2020, J NEUROL, V267, P823, DOI 10.1007/s00415-019-09619-z
   Birtel J, 2022, OPHTHALMOL RETINA, V6, P65, DOI 10.1016/j.oret.2021.02.017
   Blasiak J, 2015, BIORESEARCH OPEN ACC, V4, P334, DOI 10.1089/biores.2015.0022
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Brown EE, 2019, REDOX BIOL, V24, P0, DOI 10.1016/j.redox.2019.101201
   Bursle C, 2018, JIMD REP, V42, P53, DOI 10.1007/8904_2017_79
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Calkins DJ, 2021, MOL THER-METH CLIN D, V23, P307, DOI 10.1016/j.omtm.2021.09.013
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Caporali L, 2020, ANN NEUROL, V88, P18, DOI 10.1002/ana.25723
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2006, MITOCHONDRIAL MEDICINE, V0, P0, DOI DOI 10.1201/B14623-7
   Carelli V, 2008, NEUROLOGY, V70, P1075, DOI 10.1212/01.wnl.0000307668.75233.35
   Carelli V, 2017, J NEURO-OPHTHALMOL, V37, P371, DOI 10.1097/WNO.0000000000000570
   Carelli V, 2017, HUM MOL GENET, V26, PR139, DOI 10.1093/hmg/ddx273
   Carelli V, 2016, BRAIN, V139, P0, DOI 10.1093/brain/awv339
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awu234
   Carelli V, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awr180
   Casson RJ, 2014, OPHTHALMOLOGY, V121, P1203, DOI 10.1016/j.ophtha.2013.12.011
   Catarino CB, 2020, J NEURO-OPHTHALMOL, V40, P558, DOI 10.1097/WNO.0000000000001023
   Charif M, 2021, BRAIN COMMUN, V3, P0, DOI 10.1093/braincomms/fcab063
   Charif M, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000428
   Charif M, 2018, JAMA NEUROL, V75, P105, DOI 10.1001/jamaneurol.2017.2065
   Charlesworth G, 2016, MOVEMENT DISORD, V31, P1249, DOI 10.1002/mds.26716
   Chinchore Y, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.25946
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   Cretin E, 2021, EMBO MOL MED, V13, P0, DOI 10.15252/emmm.202013579
   Cringle SJ, 2002, INVEST OPHTH VIS SCI, V43, P1922
   DAngelo L, 2021, CELL REP, V35, P0, DOI 10.1016/j.celrep.2021.109002
   Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Del Dotto V, 2018, PHARMACOL RES, V131, P199, DOI 10.1016/j.phrs.2018.02.018
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dimitriadis K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0158-9
   Dzbek J, 2008, J BIOL CHEM, V283, P33232, DOI 10.1074/jbc.M802404200
   Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892
   ERICKSON RP, 1972, AM J HUM GENET, V24, P348
   Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012
   Fisher CR, 2018, INVEST OPHTH VIS SCI, V59, PAMD41, DOI 10.1167/iovs.18-24289
   Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x
   Formosa LE, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2019665118
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724
   Gerber S, 2017, BRAIN, V140, P2586, DOI 10.1093/brain/awx219
   Gerber S, 2017, J MED GENET, V54, P346, DOI 10.1136/jmedgenet-2016-104212
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Giordano L, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.364
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Gueven N, 2021, REDOX BIOL, V38, P0, DOI 10.1016/j.redox.2020.101812
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016
   Hanein S, 2009, AM J HUM GENET, V84, P493, DOI 10.1016/j.ajhg.2009.03.003
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Hwang TJ, 2017, OPHTHALMOLOGY, V124, P843, DOI 10.1016/j.ophtha.2017.01.002
   Invernizzi F, 2021, BRAIN, V144, P0, DOI 10.1093/brain/awab238
   Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159
   Jezek P, 2018, ANTIOXID REDOX SIGN, V29, P667, DOI 10.1089/ars.2017.7225
   Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498
   Jurkute N, 2021, INVEST OPHTH VIS SCI, V62, P0, DOI 10.1167/iovs.62.15.12
   Jurkute N, 2019, ANN NEUROL, V86, P368, DOI 10.1002/ana.25550
   Kaarniranta K, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20102374
   Kanow MA, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.28899
   Karunadharma PP, 2010, INVEST OPHTH VIS SCI, V51, P5470, DOI 10.1167/iovs.10-5429
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   KJER P, 1959, ACTA OPHTHALMOL SUPPL, V164, P1
   Kleffner I, 2015, J NEUROL SCI, V357, P115, DOI 10.1016/j.jns.2015.07.009
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0
   La Morgia Chiara, 2021, HANDB CLIN NEUROL, V179, P315, DOI 10.1016/B978-0-12-819975-6.00020-0
   La Morgia C, 2019, NEUROL-GENET, V5, P0, DOI 10.1212/NXG.0000000000000329
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lee J, 2016, MOL MED REP, V14, P33, DOI 10.3892/mmr.2016.5209
   Lenaers G, 2021, PROG RETIN EYE RES, V83, P0, DOI 10.1016/j.preteyeres.2020.100935
   Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X
   Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P3521, DOI 10.1167/iovs.10-6163
   Majander A, 2017, BRIT J OPHTHALMOL, V101, P1505, DOI 10.1136/bjophthalmol-2016-310072
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Maresca A, 2021, BIOMOLECULES, V11, P0, DOI 10.3390/biom11040496
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   Mascialino B, 2012, EUR J OPHTHALMOL, V22, P461, DOI 10.5301/ejo.5000055
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198
   Meunier I, 2021, RETINA-J RET VIT DIS, V41, P1771, DOI 10.1097/IAE.0000000000003054
   Miller NR, 2005, WALSH HOYTS CLIN NEU, V6th, P0
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   Mitchell P, 2011, BBA-BIOENERGETICS, V1807, P1507, DOI 10.1016/j.bbabio.2011.09.018
   Mnatsakanyan L, 2011, J NEURO-OPHTHALMOL, V31, P6, DOI 10.1097/WNO.0b013e3181fab1b4
   Montava-Garriga L, 2020, J MOL BIOL, V432, P206, DOI 10.1016/j.jmb.2019.06.032
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Mori M, 2014, JIMD REP, V17, P47, DOI 10.1007/8904_2014_332
   Murakami T, 1996, J NEUROL SCI, V142, P111, DOI 10.1016/0022-510X(96)00165-7
   Narayan DS, 2017, CLIN EXP OPHTHALMOL, V45, P730, DOI 10.1111/ceo.12952
   Narayan DS, 2016, ACTA OPHTHALMOL, V94, P748, DOI 10.1111/aos.13141
   Newman NJ, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.662838
   Newman NJ, 2021, OPHTHALMOLOGY, V128, P649, DOI 10.1016/j.ophtha.2020.12.012
   Newman NJ, 2020, J NEURO-OPHTHALMOL, V40, P547, DOI 10.1097/WNO.0000000000001045
   Nicholson GA, 2008, NEUROLOGY, V70, P1678, DOI 10.1212/01.wnl.0000311275.89032.22
   NIKOSKELAINEN E, 1982, ARCH OPHTHALMOL-CHIC, V100, P1597, DOI 10.1001/archopht.1982.01030040575003
   NIKOSKELAINEN E, 1983, ARCH OPHTHALMOL-CHIC, V101, P1059, DOI 10.1001/archopht.1983.01040020061011
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Niven JE, 2007, PLOS BIOL, V5, P828, DOI 10.1371/journal.pbio.0050116
   Oca-Cossio J, 2003, GENETICS, V165, P707
   Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029
   Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452
   Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001
   Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769
   Petit L, 2018, CELL REP, V23, P2629, DOI 10.1016/j.celrep.2018.04.111
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Piro-Mégy C, 2020, J CLIN INVEST, V130, P143, DOI 10.1172/JCI128513
   POULTON J, 1989, LANCET, V1, P236
   Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234
   Rajabian F, 2021, J NEURO-OPHTHALMOL, V41, PE290, DOI 10.1097/WNO.0000000000001124
   Reynier P, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.016576
   Romagnoli M, 2020, ANN CLIN TRANSL NEUR, V7, P590, DOI 10.1002/acn3.51026
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010
   Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schon Eric A, 2007, NOVARTIS FOUND SYMP, V287, P214
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Shibeeb O, 2016, CLIN EXP OPHTHALMOL, V44, P24, DOI 10.1111/ceo.12581
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Spikes TE, 2020, P NATL ACAD SCI USA, V117, P23519, DOI 10.1073/pnas.2013998117
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   STEINBERG RH, 1983, VISION RES, V23, P1315, DOI 10.1016/0042-6989(83)90107-4
   Stenton SL, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI138267
   Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004
   Terluk MR, 2015, J NEUROSCI, V35, P7304, DOI 10.1523/JNEUROSCI.0190-15.2015
   Thorburn DR, 1993, GENEREVIEWS, V0, P0
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Wallace DC, 2009, COLD SH Q B, V74, P383, DOI 10.1101/sqb.2009.74.031
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wan JJ, 2016, BRAIN, V139, P2877, DOI 10.1093/brain/aww212
   Wan X, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep21587
   Wang L, 1997, INVEST OPHTH VIS SCI, V38, P48
   Wang W, 2016, CELL REP, V15, P372, DOI 10.1016/j.celrep.2016.03.022
   WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667
   Yu JL, 2020, J CLIN INVEST, V130, P4935, DOI 10.1172/JCI134965
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2008, J NEURO-OPHTHALMOL, V28, P155, DOI 10.1097/WNO.0b013e3181772db4
   Yu-Wai-Man P, 2022, EYE, V36, P818, DOI 10.1038/s41433-021-01535-9
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.aaz7423
   Yu-Wai-Man P, 2016, ANN CLIN TRANSL NEUR, V3, P723, DOI 10.1002/acn3.323
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Zaninello M, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-17821-1
   Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zekonyte U, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-23561-7
   Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 195
TC 33
Z9 34
U1 0
U2 19
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN 15
PY 2022
VL 23
IS 1
BP 
EP 
DI 10.3390/ijms23010210
PG 33
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA YF3UT
UT WOS:000741736600001
PM 35008635
DA 2024-11-01
ER

PT J
AU Morciano, G
   Rimessi, A
   Patergnani, S
   Vitto, VAM
   Danese, A
   Kahsay, A
   Palumbo, L
   Bonora, M
   Wieckowski, MR
   Giorgi, C
   Pinton, P
AF Morciano, Giampaolo
   Rimessi, Alessandro
   Patergnani, Simone
   Vitto, Veronica A. M.
   Danese, Alberto
   Kahsay, Asrat
   Palumbo, Laura
   Bonora, Massimo
   Wieckowski, Mariusz R.
   Giorgi, Carlotta
   Pinton, Paolo
TI Calcium dysregulation in heart diseases: Targeting calcium channels to achieve a correct calcium homeostasis
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Calcium channels; Mitochondria; Sarcoplasmic reticulum; Heart disease; Therapy
ID mitochondrial permeability transition; dependent protein-kinase; polymorphic ventricular-tachycardia; sarcoplasmic-reticulum ca2+-atpase; ischemia-reperfusion injury; single-nucleotide polymorphisms; na+/ca2+ exchanger inhibitor; cardiac ryanodine receptor; genome-wide association; serca2a gene-transfer
AB Intracellular calcium signaling is a universal language source shared by the most part of biological entities inside cells that, all together, give rise to physiological and functional anatomical units, the organ. Although preferentially recognized as signaling between cell life and death processes, in the heart it assumes additional relevance considered the importance of calcium cycling coupled to ATP consumption in excitation-contraction coupling. The concerted action of a plethora of exchangers, channels and pumps inward and outward calcium fluxes where needed, to convert energy and electric impulses in muscle contraction. All this without realizing it, thousands of times, every day. An improper function of those proteins (i.e., variation in expression, mutations onset, dysregulated channeling, differential protein-protein interactions) being part of this signaling network triggers a short circuit with severe acute and chronic pathological consequences reported as arrhythmias, cardiac remodeling, heart failure, reperfusion injury and cardiomyopathies. By acting with chemical, peptide-based and pharmacological modulators of these players, a correction of calcium homeostasis can be achieved accompanied by an amelioration of clinical symptoms. This review will focus on all those defects in calcium homeostasis which occur in the most common cardiac diseases, including myocardial infarction, arrhythmia, hypertrophy, heart failure and cardiomyopathies. This part will be introduced by the state of the art on the proteins involved in calcium homeostasis in cardiomyocytes and followed by the therapeutic treatments that to date, are able to target them and to revert the pathological phenotype.
C1 [Morciano, Giampaolo; Rimessi, Alessandro; Patergnani, Simone; Vitto, Veronica A. M.; Danese, Alberto; Kahsay, Asrat; Palumbo, Laura; Bonora, Massimo; Giorgi, Carlotta; Pinton, Paolo] Univ Ferrara, Dept Med Sci, Sect Expt Med, Lab Technol Adv Therapies LTTA, I-44121 Ferrara, Italy.
   [Morciano, Giampaolo; Pinton, Paolo] Maria Cecilia Hosp, GVM Care & Res, I-48033 Cotignola, RA, Italy.
   [Wieckowski, Mariusz R.] Polish Acad Sci, Nencki Inst Expt Biol, Lab Mitochondrial Biol & Metab, PL-02093 Warsaw, Poland.
C3 University of Ferrara; Maria Cecilia Hospital; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences
RP Morciano, G; Pinton, P (corresponding author), Univ Ferrara, Dept Med Sci, Sect Expt Med, Lab Technol Adv Therapies LTTA, I-44121 Ferrara, Italy.
EM giampaolo.morciano@unife.it; paolo.pinton@unife.it
FU Italian Association for Cancer Research [IG-23670, IG-19803]; A-ROSE, Progetti di Rilevante Interesse Nazionale [PRIN2017E5L5P3, PRIN20177E9EPY]; Italian Ministry of Health [GR-2013-02356747, GR-2019-12369862]; European Research Council [853057-InflaPML]; University of Ferrara; Polish National Science Centre [UMO-2014/15/B/NZ1/00490]
CR Ablorh Naa-Adjeley D, 2015, BIOPHYS REV, V7, P63, DOI 10.1007/s12551-014-0157-z
   Acsai K, 2011, J PHYSIOL-LONDON, V589, P2569, DOI 10.1113/jphysiol.2010.202663
   Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371
   Alexandre J, 2018, PHARMACOL THERAPEUT, V189, P89, DOI 10.1016/j.pharmthera.2018.04.009
   ALTMANN P, 1977, HUM GENET, V38, P357, DOI 10.1007/BF00402165
   An DW, 2019, CLIN EXP HYPERTENS, V41, P323, DOI 10.1080/10641963.2018.1481421
   Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996
   Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014
   Andrikopoulos GK, 2015, WORLD J CARDIOL, V7, P76, DOI 10.4330/wjc.v7.i2.76
   Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5
   Arai M, 1998, J MOL CELL CARDIOL, V30, P243, DOI 10.1006/jmcc.1997.0588
   Arai M, 2000, CIRC RES, V86, P8, DOI 10.1161/01.RES.86.1.8
   Arai M, 1996, J MOL CELL CARDIOL, V28, P1583, DOI 10.1006/jmcc.1996.0149
   Arunachalam K, 2021, FLECAINIDE, V0, P0
   Asghar MY, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21051739
   Bai T, 2016, AM J PHYSIOL-HEART C, V311, PH1051, DOI 10.1152/ajpheart.00296.2016
   Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575
   Balam Ortiz Eros Osiris, 1999, ARCHIVOS DEL INSTITUTO DE CARDIOLOGIA DE MEXICO, V69, P311
   Bartok A, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-11646-3
   Bauer TM, 2020, CIRC RES, V126, P280, DOI 10.1161/CIRCRESAHA.119.316306
   Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001
   Beauverger P, 2020, CARDIOVASC RES, V116, P329, DOI 10.1093/cvr/cvz097
   Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916
   Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a
   Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455
   BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y
   Bidaud I, 2006, BBA-MOL CELL RES, V1763, P1169, DOI 10.1016/j.bbamcr.2006.08.049
   Biscaglia S, 2020, AM HEART J, V229, P100, DOI 10.1016/j.ahj.2020.08.007
   Bish LT, 2011, HUM GENE THER, V22, P969, DOI 10.1089/hum.2011.035
   Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763
   Boerries M, 2007, MOL CELL BIOL, V27, P4365, DOI 10.1128/MCB.02045-06
   Bonora M, 2022, NAT REV MOL CELL BIO, V23, P266, DOI 10.1038/s41580-021-00433-y
   Bonora M, 2020, BIOMOLECULES, V10, P0, DOI 10.3390/biom10070998
   Bonora M, 2019, NAT REV CARDIOL, V16, P33, DOI 10.1038/s41569-018-0074-0
   Bootman MD, 2017, ADV EXP MED BIOL, V993, P363, DOI 10.1007/978-3-319-57732-6_19
   Boys JA, 2010, J INVEST MED, V58, P875, DOI 10.231/JIM.0b013e3181e5d719
   BRAUN AP, 1995, J PHYSIOL-LONDON, V488, P37, DOI 10.1113/jphysiol.1995.sp020944
   Brown DA, 2008, CARDIOVASC RES, V79, P141, DOI 10.1093/cvr/cvn053
   Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026
   Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200
   Byrne MJ, 2008, GENE THER, V15, P1550, DOI 10.1038/gt.2008.120
   Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177
   CARAFOLI E, 1976, CLIN ENDOCRINOL, V5, PS49, DOI 10.1111/j.1365-2265.1976.tb03815.x
   CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7
   Carvalho BMR, 2006, AM J PHYSIOL-HEART C, V291, PH1803, DOI 10.1152/ajpheart.01345.2005
   Catterall WA, 2011, CSH PERSPECT BIOL, V3, P0, DOI 10.1101/cshperspect.a003947
   CHAFFMAN M, 1985, DRUGS, V29, P387, DOI 10.2165/00003495-198529050-00001
   Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890
   Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0
   Chen HY, 2013, J GEN PHYSIOL, V142, P127, DOI 10.1085/jgp.201311022
   Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181
   Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995
   Chiamvimonvat N, 2017, J PHYSIOL-LONDON, V595, P2229, DOI 10.1113/JP272883
   Chopra N, 2009, P NATL ACAD SCI USA, V106, P7636, DOI 10.1073/pnas.0902919106
   Chung E, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042297
   Connell P, 2020, EXPERT OPIN THER TAR, V24, P25, DOI 10.1080/14728222.2020.1708326
   Coultrap SJ, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025245
   Csordás G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016
   Dambrova M, 2021, FREE RADICAL BIO MED, V165, P24, DOI 10.1016/j.freeradbiomed.2021.01.036
   Danese A, 2023, REV PHYSIOL BIOCH P, V185, P153, DOI 10.1007/112_2020_43
   Darcy YL, 2016, MOL PHARMACOL, V90, P106, DOI 10.1124/mol.115.102277
   García-Rivas GD, 2006, BRIT J PHARMACOL, V149, P829, DOI 10.1038/sj.bjp.0706932
   De Stefani D, 2012, CELL DEATH DIFFER, V19, P267, DOI 10.1038/cdd.2011.92
   del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308
   Dhingra R, 2020, CARDIOVASC RES, V116, P1161, DOI 10.1093/cvr/cvz240
   Di Marco G, 2020, CELL REP, V30, P2321, DOI 10.1016/j.celrep.2020.01.081
   Di Virgilio F, 2015, CURR MED CHEM, V22, P866
   Dow J, 2009, J CARDIOVASC PHARM T, V14, P99, DOI 10.1177/1074248408329606
   Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342
   Elliott WJ, 2011, J CLIN HYPERTENS, V13, P687, DOI 10.1111/j.1751-7176.2011.00513.x
   Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171
   Fan MR, 2020, NATURE, V582, P129, DOI 10.1038/s41586-020-2309-6
   Fernández-Ruiz I, 2017, NAT REV CARDIOL, V14, P633, DOI 10.1038/nrcardio.2017.158
   Ferrandi M, 2013, BRIT J PHARMACOL, V169, P1849, DOI 10.1111/bph.12278
   Flesch M, 1996, CIRCULATION, V94, P992, DOI 10.1161/01.CIR.94.5.992
   Fleury S, 2003, CIRCULATION, V107, P2375, DOI 10.1161/01.CIR.0000065598.46411.EF
   Fontana V, 2014, J AM HEART ASSOC, V3, P0, DOI 10.1161/JAHA.114.001398
   Foskett JK, 2015, J MOL CELL CARDIOL, V78, P3, DOI 10.1016/j.yjmcc.2014.11.015
   Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4
   Gambardella J, 2018, ADV EXP MED BIOL, V1067, P373, DOI 10.1007/5584_2017_106
   García-Rivas GD, 2005, FEBS J, V272, P3477, DOI 10.1111/j.1742-4658.2005.04771.x
   Ghali JK, 2007, AM J CARDIOL, V99, P47A, DOI 10.1016/j.amjcard.2006.09.006
   Gheorghiade M, 2008, J AM COLL CARDIOL, V51, P2276, DOI 10.1016/j.jacc.2008.03.015
   Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983
   Godfraind T, 2017, FRONT PHARMACOL, V8, P0, DOI 10.3389/fphar.2017.00286
   Goel M, 2007, AM J PHYSIOL-HEART C, V292, PH874, DOI 10.1152/ajpheart.00785.2006
   GOLDSTEIN RE, 1991, CIRCULATION, V83, P52, DOI 10.1161/01.CIR.83.1.52
   Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227
   Gordan R, 2016, CELL CALCIUM, V60, P363, DOI 10.1016/j.ceca.2016.09.001
   Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005
   GROVER GJ, 1990, J CARDIOVASC PHARM, V16, P783, DOI 10.1097/00005344-199011000-00014
   Guan LC, 2019, INT J IMPLANT DENT, V5, P0, DOI 10.1111/jcmm.14662
   Guo XB, 2003, MOL CELL BIOCHEM, V254, P163, DOI 10.1023/A:1027321130997
   Guo YH, 2016, CARDIOVASC DRUG THER, V30, P1, DOI 10.1007/s10557-016-6644-7
   Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008
   Gurung IS, 2009, J MOL CELL CARDIOL, V47, P622, DOI 10.1016/j.yjmcc.2009.08.001
   Hadri L, 2010, MOL THER, V18, P1284, DOI 10.1038/mt.2010.77
   Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252
   Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892
   Haghighi K, 2012, J MOL CELL CARDIOL, V52, P773, DOI 10.1016/j.yjmcc.2011.11.012
   Hajjar RJ, 1997, CIRCULATION, V95, P423
   Hall AE, 2016, CELL DEATH DIS, V7, P0, DOI 10.1038/cddis.2016.91
   Hanna AD, 2014, MOL PHARMACOL, V86, P438, DOI 10.1124/mol.114.093849
   HANSEN JF, 1990, AM J CARDIOL, V66, P779
   Haq S, 2001, CIRCULATION, V103, P670
   Hay I, 2005, AM J PHYSIOL-HEART C, V288, PH1203, DOI 10.1152/ajpheart.00681.2004
   HAYAT LH, 1987, BIOCHEM J, V244, P533, DOI 10.1042/bj2440533
   Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780
   Hilliard FA, 2010, J MOL CELL CARDIOL, V48, P293, DOI 10.1016/j.yjmcc.2009.10.005
   Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361
   Hof T, 2019, NAT REV CARDIOL, V16, P344, DOI 10.1038/s41569-018-0145-2
   Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013
   HOFMANN SL, 1989, J BIOL CHEM, V264, P8260
   HOFMANN SL, 1989, J BIOL CHEM, V264, P18083
   Holmström KM, 2015, J MOL CELL CARDIOL, V85, P178, DOI 10.1016/j.yjmcc.2015.05.022
   Hu ST, 2011, J PHYSIOL SCI, V61, P363, DOI 10.1007/s12576-011-0154-y
   Hulot JS, 2017, EUR J HEART FAIL, V19, P1534, DOI 10.1002/ejhf.826
   Hulot JS, 2016, EUR HEART J, V37, P1651, DOI 10.1093/eurheartj/ehw019
   Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007
   ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040
   Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391
   Iwamoto T, 2006, MOL PHARMACOL, V70, P2075, DOI 10.1124/mol.106.028464
   Jadiya P, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-11813-6
   January CT, 2014, J AM COLL CARDIOL, V64, PE1, DOI 10.1016/j.jacc.2014.03.022
   Jaski BE, 2009, J CARD FAIL, V15, P171, DOI 10.1016/j.cardfail.2009.01.013
   Jeffs GJ, 2007, J CLIN NEUROSCI, V14, P507, DOI 10.1016/j.jocn.2006.07.013
   Jernigan NL, 2009, AM J PHYSIOL-LUNG C, V297, PL271, DOI 10.1152/ajplung.00020.2009
   Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889
   Johnson CN, 2019, CELL CALCIUM, V82, P0, DOI 10.1016/j.ceca.2019.102063
   Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013
   Joiner MLA, 2012, NATURE, V491, P269, DOI 10.1038/nature11444
   Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807
   Kamer KJ, 2017, EMBO REP, V18, P1397, DOI 10.15252/embr.201643748
   Kao YH, 2011, LAB INVEST, V91, P1291, DOI 10.1038/labinvest.2011.92
   Karagueuzian HS, 2017, FRONT PHARMACOL, V8, P0, DOI 10.3389/fphar.2017.00036
   Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014
   Kaye DM, 2007, J AM COLL CARDIOL, V50, P253, DOI 10.1016/j.jacc.2007.03.047
   Kayima J, 2017, CLIN GENET, V92, P487, DOI 10.1111/cge.12974
   Kho C, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8229
   Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407
   Kim SY, 2006, EXP MOL MED, V38, P535, DOI 10.1038/emm.2006.63
   Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246
   Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106
   Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200
   Kobayashi S, 2020, J CARDIOL, V75, P454, DOI 10.1016/j.jjcc.2019.08.020
   Kobayashi S, 2010, CIRC J, V74, P2579, DOI 10.1253/circj.CJ-10-0680
   Kobayashi S, 2009, J AM COLL CARDIOL, V53, P1993, DOI 10.1016/j.jacc.2009.01.065
   Kon N, 2017, CELL DEATH DISCOV, V3, P0, DOI 10.1038/cddiscovery.2017.45
   Kostic M, 2019, SEMIN CELL DEV BIOL, V94, P59, DOI 10.1016/j.semcdb.2019.01.009
   Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107
   Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754
   Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x
   Krebs J, 2017, ADV EXP MED BIOL, V981, P3, DOI 10.1007/978-3-319-55858-5_1
   Kujala K, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044660
   Kulkarni S, 2019, INT J APPL BASIC MED, V9, P221, DOI 10.4103/ijabmr.IJABMR_92_19
   Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001
   Ladilov Y, 1999, AM J PHYSIOL-HEART C, V276, PH1868, DOI 10.1152/ajpheart.1999.276.6.H1868
   Landstrom AP, 2017, CIRC RES, V120, P1969, DOI 10.1161/CIRCRESAHA.117.310083
   Lanner JT, 2010, CSH PERSPECT BIOL, V2, P0, DOI 10.1101/cshperspect.a003996
   Lattanzio FA, 2005, CARDIOVASC TOXICOL, V5, P377, DOI 10.1385/CT:5:4:377
   Le Page S, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0164066
   Lebek S, 2018, J MOL CELL CARDIOL, V118, P159, DOI 10.1016/j.yjmcc.2018.03.020
   Lee HJ, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0146841
   Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346
   Lei M, 2018, CIRCULATION, V138, P1879, DOI 10.1161/CIRCULATIONAHA.118.035455
   Leite-Moreira AF, 2006, HEART, V92, P712, DOI 10.1136/hrt.2005.062950
   Leonardi S, 2020, OPEN HEART, V7, P0, DOI 10.1136/openhrt-2020-001415
   Leptidis S, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057800
   Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384
   Lewis R, 2020, IJC HEART VASC, V26, P0, DOI 10.1016/j.ijcha.2019.100449
   Leychenko A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0029055
   Li J, 2013, BIOMED ENVIRON SCI, V26, P577, DOI 10.3967/0895-3988.2013.07.009
   Li J, 2015, AM J HYPERTENS, V28, P1031, DOI 10.1093/ajh/hpu263
   Li N, 2017, INT J CARDIOL, V227, P668, DOI 10.1016/j.ijcard.2016.10.078
   LI WH, 1992, J BIOL CHEM, V267, P17983
   LIGETI E, 1981, BIOCHIM BIOPHYS ACTA, V656, P177
   Lipskaia L, 2013, CURR VASC PHARMACOL, V11, P465
   Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462
   Little R, 2017, AGING CELL, V16, P1104, DOI 10.1111/acel.12637
   Liu LJ, 2016, FRONT PHYSIOL, V7, P0, DOI 10.3389/fphys.2016.00382
   LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5
   Liu R, 2020, ALCOHOL CLIN EXP RES, V44, P2187, DOI 10.1111/acer.14471
   Liu XP, 2012, CELL, V150, P1055, DOI 10.1016/j.cell.2012.06.052
   Liu XY, 2020, FRONT CELL NEUROSCI, V14, P0, DOI 10.3389/fncel.2020.00205
   Liu X, 2016, J GERIATR CARDIOL, V13, P138, DOI 10.11909/j.issn.1671-5411.2016.02.008
   Lu XY, 2016, CIRC RES, V118, P834, DOI 10.1161/CIRCRESAHA.115.308093
   LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302
   LUKACS GL, 1986, BIOCHIM BIOPHYS ACTA, V858, P125, DOI 10.1016/0005-2736(86)90298-1
   LULE SA, 2019, MOL GENETICS GENOMIC, V0007, P0
   Luongo TS, 2017, NATURE, V545, P93, DOI 10.1038/nature22082
   Ma WZ, 2020, BASIC CLIN PHARMACOL, V126, P166, DOI 10.1111/bcpt.13318
   MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151
   Magi S, 2020, CELL CALCIUM, V86, P0, DOI 10.1016/j.ceca.2020.102162
   Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49
   Marchi S, 2020, MOL CELL, V78, P1055, DOI 10.1016/j.molcel.2020.04.017
   Márta K, 2021, J MOL CELL CARDIOL, V151, P135, DOI 10.1016/j.yjmcc.2020.09.014
   Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223
   Matteo RG, 2000, CARDIOVASC RES, V45, P961, DOI 10.1016/S0008-6363(99)00409-5
   Mattera GG, 2007, AM J CARDIOL, V99, P33A, DOI 10.1016/j.amjcard.2006.09.004
   McCauley MD, 2011, ACTA PHARMACOL SIN, V32, P749, DOI 10.1038/aps.2011.44
   MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170
   McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x
   Mei QB, 2001, AM J PHYSIOL-HEART C, V281, PH334, DOI 10.1152/ajpheart.2001.281.1.H334
   Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005
   Micheletti R, 2007, AM J CARDIOL, V99, P24A, DOI 10.1016/j.amjcard.2006.09.003
   Minelli A, 2007, CELL CALCIUM, V41, P221, DOI 10.1016/j.ceca.2006.06.004
   Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319
   Mohamed TMA, 2011, J BIOL CHEM, V286, P41520, DOI 10.1074/jbc.M111.290411
   Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1
   MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1
   Morciano G, 2022, CARDIOVASC RES, V118, P2548, DOI 10.1093/cvr/cvab267
   Morciano G, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11050436
   Morciano G, 2021, CELL REP, V35, P0, DOI 10.1016/j.celrep.2021.108983
   Morciano G, 2017, ADV EXP MED BIOL, V982, P169, DOI 10.1007/978-3-319-55330-6_9
   Morciano G, 2015, J MOL CELL CARDIOL, V78, P142, DOI 10.1016/j.yjmcc.2014.08.015
   MORENOSANCHEZ R, 1990, BIOCHEM J, V268, P421, DOI 10.1042/bj2680421
   Mori Y, 1996, JPN J PHARMACOL, V72, P83, DOI 10.1254/jjp.72.83
   MOSCHELLA MC, 1993, J CELL BIOL, V120, P1137, DOI 10.1083/jcb.120.5.1137
   Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454
   Most P, 2007, FUTUR CARDIOL, V3, P5, DOI 10.2217/14796678.3.1.5
   Motloch LJ, 2018, J AM HEART ASSOC, V7, P0, DOI 10.1161/JAHA.118.009598
   Nakamura Aki, 1998, FOLIA PHARMACOLOGICA JAPONICA, V111, P105, DOI 10.1254/fpj.111.105
   Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263
   Neef S, 2018, J MOL CELL CARDIOL, V115, P73, DOI 10.1016/j.yjmcc.2017.12.015
   Nichols M, 2017, J CEREBR BLOOD F MET, V37, P3027, DOI 10.1177/0271678X16682250
   Nie JL, 2019, J CELL PHYSIOL, V234, P11587, DOI 10.1002/jcp.27791
   Niwano K, 2008, MOL THER, V16, P1026, DOI 10.1038/mt.2008.61
   Norby FL, 2002, AM J PHYSIOL-ENDOC M, V283, PE658, DOI 10.1152/ajpendo.00003.2002
   Nurnberg ST, 2016, CIRC RES, V118, P586, DOI 10.1161/CIRCRESAHA.115.306464
   Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015
   Oguri G, 2014, AM J PHYSIOL-HEART C, V307, PH1339, DOI 10.1152/ajpheart.01021.2013
   Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020
   Okuyama Y, 2018, HYPERTENS RES, V41, P80, DOI 10.1038/hr.2017.92
   Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107
   Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868
   Park CS, 2013, BASIC RES CARDIOL, V108, P344, DOI 10.1007/s00395-013-0344-2
   Pavasini R, 2020, EUR HEART J, V41, P2225, DOI 10.1093/eurheartj/ehaa351
   Pavlov E, 2005, BBA-BIOENERGETICS, V1710, P96, DOI 10.1016/j.bbabio.2005.09.006
   Pearl JM, 2011, J SURG RES, V167, P279, DOI 10.1016/j.jss.2009.05.001
   Peng W, 2020, P NATL ACAD SCI USA, V117, P19266, DOI 10.1073/pnas.2003236117
   Penttinen K, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0125366
   Piquereau J, 2010, J PHYSIOL-LONDON, V588, P2443, DOI 10.1113/jphysiol.2010.189670
   Pleger ST, 2007, CIRCULATION, V115, P2506, DOI 10.1161/CIRCULATIONAHA.106.671701
   Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014
   Priori SG, 2001, CIRCULATION, V103, P196
   Prunier F, 2008, CIRCULATION, V118, P614, DOI 10.1161/CIRCULATIONAHA.108.770883
   Qi XY, 2014, CIRCULATION, V129, P430, DOI 10.1161/CIRCULATIONAHA.113.003019
   Ramaccini D, 2021, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.624216
   Ramachandra CJA, 2020, EBIOMEDICINE, V57, P0, DOI 10.1016/j.ebiom.2020.102884
   Rasmussen TP, 2015, P NATL ACAD SCI USA, V112, P9129, DOI 10.1073/pnas.1504705112
   Redd MA, 2021, CIRCULATION, V144, P947, DOI 10.1161/CIRCULATIONAHA.121.054360
   Reilly L, 2015, FASEB J, V29, P4532, DOI 10.1096/fj.15-276493
   Ren XY, 2008, BIOCHEMISTRY-US, V47, P6081, DOI 10.1021/bi800177t
   Rimessi A, 2020, SEMIN CELL DEV BIOL, V98, P167, DOI 10.1016/j.semcdb.2019.05.015
   Rincon MY, 2015, CARDIOVASC RES, V108, P4, DOI 10.1093/cvr/cvv205
   RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Robert V, 2001, EMBO J, V20, P4998, DOI 10.1093/emboj/20.17.4998
   Rosenberg P, 2021, PFLUG ARCH EUR J PHY, V473, P417, DOI 10.1007/s00424-021-02540-3
   Rosencrans WM, 2021, CELL CALCIUM, V95, P0, DOI 10.1016/j.ceca.2021.102355
   Rossato LG, 2013, CARDIOVASC TOXICOL, V13, P413, DOI 10.1007/s12012-013-9224-0
   ROSSI CS, 1973, BIOCHEM BIOPH RES CO, V50, P846, DOI 10.1016/0006-291X(73)91322-3
   Rosso R, 2007, HEART RHYTHM, V4, P1149, DOI 10.1016/j.hrthm.2007.05.017
   Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006
   Roy S, 2017, BBA-MOL CELL RES, V1864, P997, DOI 10.1016/j.bbamcr.2017.01.011
   Rubaiy HN, 2017, J BIOL CHEM, V292, P8158, DOI 10.1074/jbc.M116.773556
   Sabbah HN, 2007, AM J CARDIOL, V99, P41A, DOI 10.1016/j.amjcard.2006.09.005
   Sacherer M, 2012, BRIT J PHARMACOL, V167, P493, DOI 10.1111/j.1476-5381.2012.01995.x
   Sadi A, 2018, CLIN SCI, V132, P641, DOI 10.1042/CS20171337
   Sakai H, 2014, J MOL CELL CARDIOL, V76, P177, DOI 10.1016/j.yjmcc.2014.09.006
   Sakata S, 2007, J MOL CELL CARDIOL, V42, P852, DOI 10.1016/j.yjmcc.2007.01.003
   Sakata S, 2006, MOL THER, V13, P987, DOI 10.1016/j.ymthe.2006.01.002
   Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015
   Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23
   Salimi A, 2019, DRUG RES, V69, P598, DOI 10.1055/a-0866-9356
   Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200
   Samuel TJ, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19041086
   Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993
   Santo-Domingo J, 2007, BRIT J PHARMACOL, V151, P647, DOI 10.1038/sj.bjp.0707260
   Santulli G, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.679725
   Sasaki K, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0164795
   Schmidt U, 1999, AM J PHYSIOL-HEART C, V277, PH474, DOI 10.1152/ajpheart.1999.277.2.H474
   Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578
   Schotten U, 2003, CIRCULATION, V107, P1433, DOI 10.1161/01.CIR.0000055314.10801.4F
   Schwinger RHG, 1999, J MOL CELL CARDIOL, V31, P479, DOI 10.1006/jmcc.1998.0897
   Schwinger RHG, 1999, CIRCULATION, V99, P2105, DOI 10.1161/01.CIR.99.16.2105
   Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111
   Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581
   Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649
   Sharov VG, 2005, HEART FAIL REV, V10, P305, DOI 10.1007/s10741-005-7545-1
   Sharov VG, 2007, J MOL CELL CARDIOL, V42, P150, DOI 10.1016/j.yjmcc.2006.09.013
   Shenouda SK, 2008, CARDIOVASC RES, V79, P662, DOI 10.1093/cvr/cvn129
   Shi G, 2011, GENET EPIDEMIOL, V35, P111, DOI 10.1002/gepi.20556
   Smyth JT, 2002, J BIOL CHEM, V277, P35061, DOI 10.1074/jbc.M202928200
   Solem LE, 1996, J MOL CELL CARDIOL, V28, P1023, DOI 10.1006/jmcc.1996.0095
   Sombié HK, 2019, BMC CARDIOVASC DISOR, V19, P0, DOI 10.1186/s12872-019-1136-x
   Stoica R, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4996
   Striessnig J, 1998, TRENDS PHARMACOL SCI, V19, P108, DOI 10.1016/S0165-6147(98)01171-7
   Stüdeli R, 2006, AM J TRANSPLANT, V6, P775, DOI 10.1111/j.1600-6143.2006.01241.x
   Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852
   Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, PH833, DOI 10.1152/ajpheart.00418.2009
   SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E
   Sun XM, 2019, EUR REV MED PHARMACO, V23, P10609, DOI 10.26355/eurrev_201912_19756
   Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833
   Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073
   Tabara Y, 2010, HYPERTENSION, V56, P973, DOI 10.1161/HYPERTENSIONAHA.110.153429
   Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952
   Takahashi K, 2003, EUR J PHARMACOL, V458, P155, DOI 10.1016/S0014-2999(02)02732-2
   Tang L, 2016, NATURE, V537, P117, DOI 10.1038/nature19102
   Terentyev D, 2014, AM J PHYSIOL-HEART C, V306, PH738, DOI 10.1152/ajpheart.00621.2013
   Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, PC423, DOI 10.1152/ajpcell.2000.278.2.C423
   Tester David J, 2014, METHODIST DEBAKEY CARDIOVASC J, V10, P29
   Tikhonov DB, 2009, J BIOL CHEM, V284, P19006, DOI 10.1074/jbc.M109.011296
   Tonet E, 2018, POSTEP KARDIOL INTER, V14, P5, DOI 10.5114/aic.2018.74349
   Traaseth N, 2004, BBA-BIOENERGETICS, V1658, P64, DOI 10.1016/j.bbabio.2004.04.015
   Tsutsui Hiroyuki, 2008, CIRC J, V72 Suppl A, PA31, DOI 10.1253/circj.CJ-08-0014
   Vais H, 2020, P NATL ACAD SCI USA, V117, P21731, DOI 10.1073/pnas.2005976117
   Vargas JD, 2016, DATA BRIEF, V7, P229, DOI 10.1016/j.dib.2016.01.048
   VASINGTON FD, 1972, BIOCHIM BIOPHYS ACTA, V256, P43, DOI 10.1016/0005-2728(72)90161-2
   Waddell HMM, 2016, BIOPHYS J, V110, P2386, DOI 10.1016/j.bpj.2016.04.036
   Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073
   Wallace KB, 2020, CIRC RES, V126, P926, DOI 10.1161/CIRCRESAHA.119.314681
   Wang Y, 2013, MOL BIOL REP, V40, P1867, DOI 10.1007/s11033-012-2242-3
   Wang YW, 2017, J PHYSIOL-LONDON, V595, P7383, DOI 10.1113/JP274110
   Wang YJ, 2012, J R STAT SOC C-APPL, V61, P1, DOI 10.1111/j.1467-9876.2011.01016.x
   Washburn DG, 2013, BIOORG MED CHEM LETT, V23, P4979, DOI 10.1016/j.bmcl.2013.06.047
   Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942
   Watanabe Y, 2006, J PHARMACOL SCI, V102, P7, DOI 10.1254/jphs.FMJ06002X2
   Watanabe Y, 2019, J PHYSIOL SCI, V69, P837, DOI 10.1007/s12576-019-00721-5
   Weber CR, 2002, CIRC RES, V90, P182, DOI 10.1161/hh0202.103940
   Weber CR, 2001, J GEN PHYSIOL, V117, P119, DOI 10.1085/jgp.117.2.119
   Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301
   Weinreuter M, 2014, EMBO MOL MED, V6, P1231, DOI 10.15252/emmm.201403848
   Weiss JN, 2015, J MOL CELL CARDIOL, V82, P136, DOI 10.1016/j.yjmcc.2015.02.017
   Wescott AP, 2019, NAT METAB, V1, P975, DOI 10.1038/s42255-019-0126-8
   Wiczer BM, 2014, BIOCHEM BIOPH RES CO, V444, P44, DOI 10.1016/j.bbrc.2014.01.009
   Woods JJ, 2019, ACS CENTRAL SCI, V5, P153, DOI 10.1021/acscentsci.8b00773
   Word TA, 2021, J CELL MOL MED, V25, P6115, DOI 10.1111/jcmm.16521
   Wu X, 2009, J CLIN INVEST, V119, P976, DOI 10.1172/JCI36693
   Wu YJ, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7081
   Xiao X, 2014, AM J PHYSIOL-RENAL, V306, PF1318, DOI 10.1152/ajprenal.00036.2014
   Xin W, 2011, MOL MED, V17, P201, DOI 10.2119/molmed.2010.00197
   Xu J, 2016, BIOMED RES INT, V2016, P0, DOI 10.1155/2016/1910565
   Yamashita K, 2016, N-S ARCH PHARMACOL, V389, P1205, DOI 10.1007/s00210-016-1282-y
   Yan Y, 2008, CARDIOVASC RES, V77, P432, DOI 10.1093/cvr/cvm047
   Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE
   Yaradanakul A, 2007, J PHYSIOL-LONDON, V582, P991, DOI 10.1113/jphysiol.2007.132712
   Yoshiyama M, 2004, J PHARMACOL SCI, V95, P196, DOI 10.1254/jphs.FPJ03101X
   Yu ZQ, 2018, INT J CARDIOL, V271, P161, DOI 10.1016/j.ijcard.2018.05.054
   Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654
   Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215
   Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5
   Zhang XH, 2019, STEM CELLS DEV, V28, P920, DOI 10.1089/scd.2018.0234
   Zhang YH, 2013, PFLUG ARCH EUR J PHY, V465, P1439, DOI 10.1007/s00424-013-1291-3
   Zhang YH, 2012, BASIC RES CARDIOL, V107, P0, DOI 10.1007/s00395-012-0282-4
   Zhao XY, 2008, BASIC CLIN PHARMACOL, V102, P419, DOI 10.1111/j.1742-7843.2007.00150.x
   ZIZI M, 1994, J BIOL CHEM, V269, P1614
NR 357
TC 29
Z9 29
U1 3
U2 28
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
EI 1096-1186
J9 PHARMACOL RES
JI Pharmacol. Res.
PD MAR 15
PY 2022
VL 177
IS 
BP 
EP 
DI 10.1016/j.phrs.2022.106119
EA FEB 2022
PG 23
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 0I8XM
UT WOS:000779696800001
PM 35131483
DA 2024-11-01
ER

PT J
AU Burr, SP
   Chinnery, PF
AF Burr, Stephen P.
   Chinnery, Patrick F.
TI Measuring Single-Cell Mitochondrial DNA Copy Number and Heteroplasmy using Digital Droplet Polymerase Chain Reaction
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
ID pcr; deletions; transcription; mutation; muscle
AB The mammalian mitochondrial (mt)DNA is a small, circular, double-stranded, intra-mitochondrial DNA molecule, encoding 13 subunits of the electron transport chain. Unlike the diploid nuclear genome, most cells contain many more copies of mtDNA, ranging from less than 100 to over 200,000 copies depending on cell type. MtDNA copy number is increasingly used as a biomarker for a number of age-related degenerative conditions and diseases, and thus, accurate measurement of the mtDNA copy number is becoming a key tool in both research and diagnostic settings. Mutations in the mtDNA, often occurring as single nucleotide polymorphisms (SNPs) or deletions, can either exist in all copies of the mtDNA within the cell (termed homoplasmy) or as a mixture of mutated and WT mtDNA copies (termed heteroplasmy). Heteroplasmic mtDNA mutations are a major cause of clinical mitochondrial pathology, either in rare diseases or in a growing number of common late-onset diseases such as Parkinson's disease. Determining the level of heteroplasmy present in cells is a critical step in the diagnosis of rare mitochondrial diseases and in research aimed at understanding common late-onset disorders where mitochondria may play a role. MtDNA copy number and heteroplasmy have traditionally been measured by quantitative (q)PCR-based assays or deep sequencing. However, the recent introduction of ddPCR technology has provided an alternative method for measuring both parameters. It offers several advantages over existing methods, including the ability to measure absolute mtDNA copy number and sufficient sensitivity to make accurate measurements from single cells even at low copy numbers. Presented here is a detailed protocol describing the measurement of mtDNA copy number in single cells using ddPCR, referred to as droplet generation PCR henceforth, with the option for simultaneous measurement of heteroplasmy in cells with mtDNA deletions. The possibility of expanding this method to measure heteroplasmy in cells with mtDNA SNPs is also discussed.
C1 [Burr, Stephen P.; Chinnery, Patrick F.] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England.
   [Burr, Stephen P.; Chinnery, Patrick F.] Univ Cambridge, MRC, Mitochondria Biol Unit, Cambridge Biomed Campus, Cambridge, England.
C3 University of Cambridge; University of Cambridge
RP Burr, SP (corresponding author), Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England.; Burr, SP (corresponding author), Univ Cambridge, MRC, Mitochondria Biol Unit, Cambridge Biomed Campus, Cambridge, England.
EM spb54@cam.ac.uk
FU SPB at the Medical Research Council Mitochondrial Biology Unit, University of Cambridge [MC_UU_00015/9]; Wellcome Trust [212219/Z/18/Z]; Wellcome Trust [212219/Z/18/Z] Funding Source: Wellcome Trust
CR Belmonte FR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25186
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633
   Kamitaki N, 2018, METHODS MOL BIOL, V1768, P401, DOI 10.1007/978-1-4939-7778-9_23
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lee J, 2020, EXP MOL MED, V52, P1428, DOI 10.1038/s12276-020-0420-2
   Li ZD, 2021, BIOSENS BIOELECTRON, V177, P0, DOI 10.1016/j.bios.2020.112952
   Lin XY, 2019, ACS SENSORS, V4, P242, DOI 10.1021/acssensors.8b01419
   Liu H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067146
   Lowes H, 2019, MITOCHONDRION, V46, P307, DOI 10.1016/j.mito.2018.07.008
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Macaulay IC, 2016, NAT PROTOC, V11, P36, DOI 10.1038/nprot.2016.138
   Maeda R, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-67686-z
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   OHara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Quan PL, 2018, SENSORS-BASEL, V18, P0, DOI 10.3390/s18041271
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Taylor SC, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-02217-x
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wang Y, 2005, GYNECOL ONCOL, V98, P104, DOI 10.1016/j.ygyno.2005.04.015
NR 32
TC 9
Z9 9
U1 4
U2 6
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
EI 
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JUL 15
PY 2022
VL 0
IS 185
BP 
EP 
DI 10.3791/63870
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 3Q4YP
UT WOS:000838239000027
PM 35913155
DA 2024-11-01
ER

PT J
AU Sakata, A
   Kashio, A
   Koyama, H
   Uranaka, T
   Iwasaki, S
   Fujimoto, C
   Kinoshita, M
   Yamasoba, T
AF Sakata, Aki
   Kashio, Akinori
   Koyama, Hajime
   Uranaka, Tsukasa
   Iwasaki, Shinichi
   Fujimoto, Chisato
   Kinoshita, Makoto
   Yamasoba, Tatsuya
TI Long-Term Progression and Rapid Decline in Hearing Loss in Patients with a Point Mutation at Nucleotide 3243 of the Mitochondrial DNA
SO LIFE-BASEL
LA English
DT Article
DE hearing loss; dizziness; disequilibrium; diabetes; mitochondrial gene mutations
ID evoked myogenic potentials; transfer rna(leu(uur)) gene; a3243g mutation; diabetes-mellitus; lactic-acidosis; melas; myopathy; inheritance; dysfunction; features
AB Patients with m.3243A>G mutation of mitochondrial DNA develop bilaterally symmetric sensorineural hearing loss. However, it is unclear how fast their hearing loss progresses over time, and whether they experience rapid progression of hearing loss. In the present study, we conducted a long-term hearing evaluation in patients with MELAS or MIDD who harbored the m.3243A>G mutation of mitochondrial DNA. A retrospective chart review was performed on 15 patients with this mutation who underwent pure-tone audiometry at least once a year for more than two years. The mean follow-up period was 12.8 years. The mean progression rate of hearing loss was 5.5 dB per year. Hearing loss progressed rapidly to be profoundly deaf in seven patients during the observation period. Heteroplasmy and age-corrected heteroplasmy levels correlated with the age of onset of hearing loss. These results indicate that patients with m.3243A>G mutation have a gradual progression of hearing loss in the early stages and rapid decline in hearing to be profoundly deaf in approximately half of the patients. Although it is possible to predict the age of onset of hearing loss from heteroplasmy and age-corrected heteroplasmy levels, it is difficult to predict whether and when the rapid hearing loss will occur.
C1 [Sakata, Aki; Kashio, Akinori; Koyama, Hajime; Uranaka, Tsukasa; Iwasaki, Shinichi; Fujimoto, Chisato; Kinoshita, Makoto; Yamasoba, Tatsuya] Univ Tokyo, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Tokyo 1138654, Japan.
   [Iwasaki, Shinichi] Nagoya City Univ, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Nagoya, Aichi 4678601, Japan.
C3 University of Tokyo; Nagoya City University
RP Yamasoba, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Tokyo 1138654, Japan.
EM harvest-tky@umin.ac.jp; kashioa-tky@umin.ac.jp; hakoyama-tky@umin.ac.jp; uranakat-oto@h.u-tokyo.ac.jp; iwashin@med.nagoya-cu.ac.jp; cfujimoto-tky@umin.ac.jp; kinoshitam-zao@umin.ac.jp; tyamasoba-tky@umin.ac.jp
FU Health and Labor Sciences Research Grant for Research on Rare and Intractable Diseases and Comprehensive Research on Disability Health and Welfare from Ministry of Health, Labor and Welfare of Japan [201324019B]; Ministry of Health, Labor, and Welfare Japan [20FC1019]
CR Asano T, 1999, DIABETOLOGIA, V42, P1439
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   Ciodaro F, 2020, INT ARCH OTORHINOLAR, V24, PE5, DOI 10.1055/s-0039-1697988
   Ciuman RR, 2009, J LARYNGOL OTOL, V123, P151, DOI 10.1017/S0022215108002624
   de Laat P, 2021, J MED GENET, V58, P48, DOI 10.1136/jmedgenet-2019-106800
   de Wit HM, 2012, NETH J MED, V70, P460
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Durand-Dubief F, 2004, REV NEUROL-FRANCE, V160, P824, DOI 10.1016/S0035-3787(04)71038-3
   Freni F, 2020, INT J ENV RES PUB HE, V17, P0, DOI 10.3390/ijerph17124187
   Fujimoto C, 2009, J NEUROL, V256, P1488, DOI 10.1007/s00415-009-5147-x
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   HIGUCHI I, 1989, ACTA NEUROPATHOL, V79, P300, DOI 10.1007/BF00294665
   HIGUCHI I, 1991, ACTA NEUROPATHOL, V82, P55, DOI 10.1007/BF00310923
   Inoue A, 2019, OTOL NEUROTOL, V40, P359, DOI 10.1097/MAO.0000000000002091
   Iwasaki S, 2005, OTOL NEUROTOL, V26, P1196, DOI 10.1097/01.mao.0000194890.44023.e6
   Iwasaki S, 2011, LARYNGOSCOPE, V121, P1821, DOI 10.1002/lary.21879
   Kanemoto K, 2022, LIFE, V12, P0, DOI 10.3390/life12040482
   LINDSAY JR, 1976, ARCH OTOLARYNGOL, V102, P747
   Liu CH, 2012, J FORMOS MED ASSOC, V111, P489, DOI 10.1016/j.jfma.2011.06.014
   Murofushi T, 1999, ARCH OTOLARYNGOL, V125, P660, DOI 10.1001/archotol.125.6.660
   Oshima T, 1996, LARYNGOSCOPE, V106, P43, DOI 10.1097/00005537-199601000-00009
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   SANAI T, 1990, NEPHRON, V54, P53, DOI 10.1159/000185810
   Scarpelli M, 2012, GENET RES INT, V2012, P0, DOI 10.1155/2012/287432
   Schmäl F, 2005, J VESTIBUL RES-EQUIL, V15, P215
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Takahashi K, 2003, LARYNGOSCOPE, V113, P1362, DOI 10.1097/00005537-200308000-00018
   Tamagawa Y, 1997, ANN OTO RHINOL LARYN, V106, P338
   Tsunenori Shimizu T, 2007, OTOL JPN, V17, P691
   Usami S, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031276
   Vandana VP, 2016, CLIN NEUROL NEUROSUR, V148, P17, DOI 10.1016/j.clineuro.2016.04.024
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WU CM, 1992, MUSCLE NERVE, V15, P1258, DOI 10.1002/mus.880151107
   Yamasoba T, 2006, NEUROSCI LETT, V395, P18, DOI 10.1016/j.neulet.2005.10.045
   Yamasoba T, 1996, LARYNGOSCOPE, V106, P49, DOI 10.1097/00005537-199601000-00010
   Yamasoba T, 1999, NEUROLOGY, V52, P1705, DOI 10.1212/WNL.52.8.1705
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
   Yano T, 2014, J HUM GENET, V59, P100, DOI 10.1038/jhg.2013.128
NR 41
TC 4
Z9 4
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD APR 15
PY 2022
VL 12
IS 4
BP 
EP 
DI 10.3390/life12040543
PG 13
WC Biology; Microbiology
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA 0T3BJ
UT WOS:000786845100001
PM 35455034
DA 2024-11-01
ER

PT J
AU Berio, A
   Mariottini, GL
   Frascio, M
   Piazzi, A
AF Berio, Agostino
   Mariottini, Gian Luigi
   Frascio, Marco
   Piazzi, Attilia
TI Kearns-Sayre syndrome with optic nerve atrophy phenotype: A possible biological and clinical concurrence of two mutations?
SO JOURNAL OF BIOLOGICAL RESEARCH-BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE
LA English
DT Article
DE Chronic progressive external ophthalmoplegia; Kearns-Sayre syndrome; Coenzyme Q10 therapy; optic nerve atrophy; OPA 1 mutation; coenzyme Q10
ID progressive external ophthalmoplegia; mitochondrial-dna deletions; respiratory-chain disorders; neurodegenerative disorders; dysfunction; improvement; depletion; muscle; plus; gene
AB The authors report about the association of progressive external ophthalmoplegia, atypical pigmentary retinopathy, ataxia phenotype with onset in first months of life (Kearns-Sayre syndrome) and with optic nerve atrophy and deafness. The localization of retinal lesions was coincident with that reported by multifunctional electroretinogram (mfERG) in OPA 1 mutation. The authors hypothesize that Kearns-Sayre mitochondrial mutation may be associated with OPA 1 missense mutation, with worsening of symptomatology, as occurs in the reported case. The prolonged rehabilitation and treatment with coenzyme Q10 for many years gave positive results, with amelioration of ophthalmoplegia, stopping of aggravation of retinal damage and optic nerve atrophy, maintaining of vision some meters away, possibility of socialization and proprioceptive ability amelioration.
C1 [Berio, Agostino; Piazzi, Attilia] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mother C, Genoa, Italy.
   [Mariottini, Gian Luigi] Univ Genoa, Dept Earth Environm & Life Sci DISTAV, Genoa, Italy.
   [Frascio, Marco] Univ Genoa, Dept Surg Sci & Integrated Diagnost DISC, Genoa, Italy.
C3 University of Genoa; University of Genoa; University of Genoa
RP Berio, A (corresponding author), Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mother C, Genoa, Italy.; Mariottini, GL (corresponding author), Univ Genoa, Dept Earth Environm & Life Sci DISTAV, Genoa, Italy.
EM Agostinoberio@ospedale-gaslini.ge.it; Gian.Luigi.Mariottini@unige.it
CR Barbet F, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.025502
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   BERIO A, 1994, OPHTHALMOLOGICA, V208, P342, DOI 10.1159/000310536
   Berio A, 2011, J BIOL RES-BOLL SOC, V84, P73, DOI 10.4081/jbr.2011.4496
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Cascavilla ML, 2018, ACTA OPHTHALMOL, V96, Pe156, DOI 10.1111/aos.13557
   Cerri C, 1983, MITOCHONDRIAL PATHOL, V0, P141
   Chertkof J, 2020, OPHTHALMIC GENET, V41, P497, DOI 10.1080/13816810.2020.1799416
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   EAGLE RC, 1982, OPHTHALMOLOGY, V89, P1433
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   HORWITZ SJ, 1978, ANN NEUROL, V3, P513, DOI 10.1002/ana.410030611
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805
   Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5
   Luca P, 2020, NEURORADIOLOGY, V62, P1315, DOI 10.1007/s00234-020-02501-0
   Melberg A, 1996, MUSCLE NERVE, V19, P751
   Mishra R, 2020, J MED RES, V6, P271
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   OGASAHARA S, 1985, NEUROLOGY, V35, P372, DOI 10.1212/WNL.35.3.372
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P161, DOI 10.1007/978-3-319-95046-4_30
   Willett W, 2002, AM J CLIN NUTR, V76, P274S, DOI 10.1093/ajcn/76.1.274S
   ZIERZ S, 1989, J NEUROL, V236, P97, DOI 10.1007/BF00314404
NR 33
TC 0
Z9 0
U1 1
U2 1
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 1826-8838
EI 2284-0230
J9 J BIOL RES-BOLL SOC
JI J. Biol. Res.-Boll. Soc. Biol. Sper.
PD JUN 15
PY 2022
VL 95
IS 1
BP 
EP 
DI 10.4081/jbr.2022.10308
PG 7
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 2K0CY
UT WOS:000816014500012
DA 2024-11-01
ER

PT J
AU Capiau, S
   Smet, J
   De Paepe, B
   Yildiz, Y
   Arslan, M
   Stevens, O
   Verschoore, M
   Stepman, H
   Seneca, S
   Vanlander, A
AF Capiau, Sara
   Smet, Joel
   De Paepe, Boel
   Yildiz, Yilmaz
   Arslan, Mutluay
   Stevens, Olivier
   Verschoore, Maxime
   Stepman, Hedwig
   Seneca, Sara
   Vanlander, Arnaud
TI Clinical Heterogeneity in <i>MT-ATP6</i> Pathogenic Variants: Same Genotype-Different Onset
SO CELLS
LA English
DT Article
DE ATP-synthase; complex V deficiency; MT-ATP6; NC_012920.1(MT-ATP6):m.9035T > C; p.L170P; genotype-phenotype correlation; mitochondrial disorder
ID cytochrome-c-oxidase; mitochondrial-dna; respiratory-chain; atp synthase; mutations; electrophoresis; identification; organization; deficiency; phenotype
AB Human mitochondrial disease exhibits large variation of clinical phenotypes, even in patients with the same causative gene defect. We illustrate this heterogeneity by confronting clinical and biochemical data of two patients with the uncommon pathogenic homoplasmic NC_012920.1(MT-ATP6):m.9035T > C variant in MT-ATP6. Patient 1 presented as a toddler with severe motor and speech delay and spastic ataxia without extra-neurologic involvement. Patient 2 presented in adolescence with ataxia and ophthalmoplegia without cognitive or motor impairment. Respiratory chain complex activities were normal in cultured skin fibroblasts from both patients when calculated as ratios over citrate synthase activity. Native gels found presence of subcomplexes of complex V in fibroblast and/or skeletal muscle. Bioenergetic measurements in fibroblasts from both patients detected reduced spare respiratory capacities and altered extracellular acidification rates, revealing a switch from mitochondrial respiration to glycolysis to uphold ATP production. Thus, in contrast to the differing disease presentation, biochemical evidence of mitochondrial deficiency turned out quite similar. We conclude that biochemical analysis remains a valuable tool to confirm the genetic diagnosis of mitochondrial disease, especially in patients with new gene variants or atypical clinical presentation.
C1 [Capiau, Sara] Ghent Univ Hosp, Dept Lab Med, B-9000 Ghent, Belgium.
   [Smet, Joel; De Paepe, Boel; Verschoore, Maxime; Vanlander, Arnaud] Ghent Univ Hosp, Dept Child Neurol & Metab, B-9000 Ghent, Belgium.
   [Smet, Joel; De Paepe, Boel; Verschoore, Maxime; Vanlander, Arnaud] Univ Ghent, Lab Mitochondrial Invest, B-9000 Ghent, Belgium.
   [Yildiz, Yilmaz] Hacettepe Univ, Dept Pediat Metab, Ihsan Dogramaci Childrens Hosp, TR-06230 Ankara, Turkey.
   [Yildiz, Yilmaz] Univ Hlth Sci, Pediat Metab Dis Unit, Gulhane Training & Res Hosp, TR-06010 Gulhane, Turkey.
   [Arslan, Mutluay] Univ Hlth Sci, Gulhane Training & Res Hosp, Dept Pediat Neurol, TR-06010 Gulhane, Turkey.
   [Stevens, Olivier] Maria Middelares Gen Hosp, Dept Neurol, B-9000 Ghent, Belgium.
   [Seneca, Sara] Free Univ Brussels VUB, Res Grp Reprod & Genet REGE, B-1090 Brussels, Belgium.
   [Seneca, Sara] Free Univ Brussels VUB, Univ Hosp Brussels, Ctr Med Genet, B-1090 Brussels, Belgium.
C3 Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Hacettepe University; Gulhane Training & Research Hospital; Gulhane Training & Research Hospital; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel
RP Capiau, S (corresponding author), Ghent Univ Hosp, Dept Lab Med, B-9000 Ghent, Belgium.; Vanlander, A (corresponding author), Ghent Univ Hosp, Dept Child Neurol & Metab, B-9000 Ghent, Belgium.; Vanlander, A (corresponding author), Univ Ghent, Lab Mitochondrial Invest, B-9000 Ghent, Belgium.
EM sara.capiau@uzgent.be; joel.smet@ugent.be; boel.depaepe@ugent.be; yilmaz.yildiz@hacettepe.edu.tr; mutluayarslan@yahoo.com; olivier.stevens@azmmsj.be; maxime.verschoore@ugent.be; hedwig.stepman@uzgent.be; sara.seneca@uzbrussel.be; arnaud.vanlander@ugent.be
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dautant A, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.00329
   De A, 2007, BIOCHEM J, V402, P175, DOI 10.1042/BJ20061004
   De Paepe B, 2012, PEDIATR RES, V72, P232, DOI 10.1038/pr.2012.84
   Devreese B, 2002, ELECTROPHORESIS, V23, P2525, DOI 10.1002/1522-2683(200208)23:15<2525::AID-ELPS2525>3.0.CO;2-I
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Garret P, 2019, HUM MUTAT, V40, P2430, DOI 10.1002/humu.23885
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Haraux F, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0221886
   Hatefi Y, 1978, METHODS ENZYMOL, V53, P21
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lombès A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Nolte D, 2021, J NEUROL, V268, P4866, DOI 10.1007/s00415-021-10607-5
   Panneman DM, 2020, CLIN GENET, V97, P556, DOI 10.1111/cge.13706
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Rucheton B, 2020, MITOCHONDRION, V55, P64, DOI 10.1016/j.mito.2020.08.004
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Sikorska M, 2009, MUSCLE NERVE, V40, P381, DOI 10.1002/mus.21355
   Smet J, 2011, J INHERIT METAB DIS, V34, P741, DOI 10.1007/s10545-011-9315-7
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Srere PA, 1969, METHOD ENZYMOL, V13, P3, DOI 10.1016/0076-6879(69)13005-0
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van der Westhuizen FH, 2010, J INHERIT METAB DIS, V33, PS55, DOI 10.1007/s10545-009-9020-y
   Vantroys E, 2017, MOL GENET METAB, V122, P172, DOI 10.1016/j.ymgme.2017.10.004
   Villanueva-Paz M, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165726
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
NR 43
TC 8
Z9 8
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD FEB 15
PY 2022
VL 11
IS 3
BP 
EP 
DI 10.3390/cells11030489
PG 18
WC Cell Biology
SC Cell Biology
GA YZ2XX
UT WOS:000755345100001
PM 35159298
DA 2024-11-01
ER

PT J
AU Yoshimi, A
   Ishikawa, K
   Niemeyer, C
   Grünert, SC
AF Yoshimi, Ayami
   Ishikawa, Kaori
   Niemeyer, Charlotte
   Gruenert, Sarah C.
TI Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Review
DE Pearson syndrome; Natural history; Mitochondrial DNA deletion
ID pancreas syndrome; dna deletion; 3-methylglutaconic aciduria; clinical-manifestations; sideroblastic anemia; molecular diagnosis; mtdna; vacuolization; generation; phenotypes
AB Pearson syndrome (PS) is a rare fatal mitochondrial disorder caused by single large-scale mitochondrial DNA deletions (SLSMDs). Most patients present with anemia in infancy. Bone marrow cytology with vacuolization in erythroid and myeloid precursors and ring-sideroblasts guides to the correct diagnosis, which is established by detection of SLSMDs. Non hematological symptoms suggesting a mitochondrial disease are often lacking at initial presentation, thus PS is an important differential diagnosis in isolated hypogenerative anemia in infancy. Spontaneous resolution of anemia occurs in two-third of patients at the age of 1-3 years, while multisystem non-hematological complications such as failure to thrive, muscle hypotonia, exocrine pancreas insufficiency, renal tubulopathy and cardiac dysfunction develop during the clinical course. Some patients with PS experience a phenotypical change to Kearns-Sayre syndrome. In the absence of curative therapy, the prognosis of patients with PS is dismal. Most patients die of acute lactic acidosis and multi-organ failure in early childhood. There is a great need for the development of novel therapies to alter the natural history of patients with PS.
C1 [Yoshimi, Ayami; Niemeyer, Charlotte] Univ Freiburg, Fac Med, Med Ctr, Dept Pediat Hematol & Oncol, Freiburg, Germany.
   [Gruenert, Sarah C.] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan.
   [Ishikawa, Kaori] Univ Freiburg, Univ Med Ctr, Fac Med, Dept Gen Pediat Adolescent Med & Neonatol, Freiburg, Germany.
C3 University of Freiburg; University of Tsukuba; University of Freiburg
RP Yoshimi, A (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Pediat Hematol & Oncol, Freiburg, Germany.
EM ayami.yoshimi@uniklinik-freiburg.de
FU FZSE (Freiburg Zentrum fur Seltene Erkrankungen/Freiburg Center for Rare Diseases) in University of Freiburg; German Federal Ministry of Education and Research (BMBF) [01GM1911A]; European Reference Network for Paediatric Oncology (ERN PaedCan); European Reference Network for Hereditary Metabolic Disorders (MetabERN)
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bader-Meunier B, 1999, PEDIATR RES, V46, P158, DOI 10.1203/00006450-199908000-00005
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   Bernstein WB, 2003, ANN PHARMACOTHER, V37, P517, DOI 10.1345/aph.1C361
   Bezzerri V, 2019, MOL DIAGN THER, V23, P281, DOI 10.1007/s40291-018-0368-2
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   CORMIER V, 1990, J PEDIATR-US, V117, P599, DOI 10.1016/S0022-3476(05)80698-5
   Crippa BL, 2015, AM J MED GENET A, V167, P621, DOI 10.1002/ajmg.a.36939
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   DEVRIES DD, 1992, NEUROMUSCULAR DISORD, V2, P185, DOI 10.1016/0960-8966(92)90005-Q
   Farruggia P, 2018, EXPERT REV HEMATOL, V11, P239, DOI 10.1080/17474086.2018.1426454
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Fraczkiewicz J, 2020, J PEDIAT HEMATOL ONC, V42, P113, DOI 10.1097/MPH.0000000000001528
   Gagne KE, 2014, BLOOD, V124, P437, DOI 10.1182/blood-2014-01-545830
   GIBSON KM, 1992, J PEDIATR-US, V121, P940, DOI 10.1016/S0022-3476(05)80348-8
   Golan K, 2020, BLOOD, V136, P2607, DOI 10.1182/blood.2020005399
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Hasegawa DH S, 2017, INT M CHILDHOOD MDS, V0, P0
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Hoyoux C, 2008, PEDIATR BLOOD CANCER, V51, P566, DOI 10.1002/pbc.21615
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Inoue SI, 2006, HUM MOL GENET, V15, P1801, DOI 10.1093/hmg/ddl102
   Jacoby E, 2021, NPJ REGEN MED, V6, P0, DOI 10.1038/s41536-021-00167-7
   Jacoby E, 2018, BLOOD, V132, P0, DOI 10.1182/blood-2018-99-113773
   Jennifer MS, 2020, ANN NONINVAS ELECTRO, V25, P0, DOI 10.1111/anec.12681
   Katada S, 2013, G3-GENES GENOM GENET, V3, P1545, DOI 10.1534/g3.113.007245
   LANE M, 1965, BLOOD-J HEMATOL, V25, P432, DOI 10.1182/blood.V25.4.432.432
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Lazarchick J, 2012, CURR OPIN HEMATOL, V19, P58, DOI 10.1097/MOH.0b013e32834da9d2
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Lightowlers RN, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.202050964
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Muraki K, 1997, J INHERIT METAB DIS, V20, P697, DOI 10.1023/A:1005378527077
   Nishimura A, 2021, PEDIATR BLOOD CANCER, V68, P0, DOI 10.1002/pbc.28799
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pillai NR, 2020, AM J MED GENET A, V182, P2781, DOI 10.1002/ajmg.a.61851
   Pronman L, 2019, CLIN PEDIATR, V58, P819, DOI 10.1177/0009922819834285
   Qin YM, 2021, FRONT ONCOL, V11, P0, DOI 10.3389/fonc.2021.672781
   Reynolds E, 2021, MOL GENET METAB, V134, P301, DOI 10.1016/j.ymgme.2021.11.004
   Riley LG, 2018, HAEMATOLOGICA, V103, P2008, DOI 10.3324/haematol.2017.182659
   ROSENBACH LM, 1960, NEW ENGL J MED, V263, P724, DOI 10.1056/NEJM196010132631503
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROTIG A, 1988, LANCET, V2, P567
   SANO T, 1993, PEDIATR RES, V34, P105, DOI 10.1203/00006450-199307000-00024
   Santorelli FM, 1996, NEUROLOGY, V47, P1320, DOI 10.1212/WNL.47.5.1320
   Sato T, 2015, EUR J PEDIATR, V174, P1593, DOI 10.1007/s00431-015-2576-7
   Seneca S, 1997, CLIN GENET, V51, P338
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Sheqwara J, 2013, BLOOD, V122, P311, DOI 10.1182/blood-2012-12-469239
   SHERMAN JD, 1964, NEW ENGL J MED, V270, P810, DOI 10.1056/NEJM196404162701602
   Son JS, 2022, MEDICINE, V101, P0, DOI 10.1097/MD.0000000000028793
   SUPERTIFURGA A, 1993, EUR J PEDIATR, V152, P44, DOI 10.1007/BF02072515
   Tadiotto E, 2018, PEDIATR BLOOD CANCER, V65, P0, DOI 10.1002/pbc.26939
   Tinker RJ, 2021, MOL DIAGN THER, V25, P181, DOI 10.1007/s40291-020-00510-6
   Tumino M, 2011, AM J MED GENET A, V155A, P3063, DOI 10.1002/ajmg.a.34288
   Valenti D, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22158312
   Williams TB, 2012, MOL GENET METAB, V106, P104, DOI 10.1016/j.ymgme.2012.01.018
   Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001
   YAMADORI I, 1992, ACTA NEUROPATHOL, V84, P337
   Yanagihara I, 2001, J PEDIATR-US, V139, P452, DOI 10.1067/mpd.2001.116296
   YEUNG KY, 1988, BLOOD CELLS, V13, P487
   Ying YQ, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.802402
   Ayami Y, 2021, BRIT J HAEMATOL, V193, P1283, DOI 10.1111/bjh.17434
NR 69
TC 19
Z9 19
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD OCT 17
PY 2022
VL 17
IS 1
BP 
EP 
DI 10.1186/s13023-022-02538-9
PG 11
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA 5J8BF
UT WOS:000869261900003
PM 36253820
DA 2024-11-01
ER

PT J
AU Di Toro, A
   Urtis, M
   Narula, N
   Giuliani, L
   Grasso, M
   Pasotti, M
   Pellegrini, C
   Serio, A
   Pilotto, A
   Antoniazzi, E
   Rampino, T
   Magrassi, L
   Valentini, A
   Cavallini, A
   Scelsi, L
   Ghio, S
   Abelli, M
   Olivotto, I
   Porcu, M
   Gavazzi, A
   Kodama, T
   Arbustini, E
AF Di Toro, Alessandro
   Urtis, Mario
   Narula, Nupoor
   Giuliani, Lorenzo
   Grasso, Maurizia
   Pasotti, Michele
   Pellegrini, Carlo
   Serio, Alessandra
   Pilotto, Andrea
   Antoniazzi, Elena
   Rampino, Teresa
   Magrassi, Lorenzo
   Valentini, Adele
   Cavallini, Anna
   Scelsi, Laura
   Ghio, Stefano
   Abelli, Massimo
   Olivotto, Iacopo
   Porcu, Maurizio
   Gavazzi, Antonello
   Kodama, Takahide
   Arbustini, Eloisa
TI Impediments to Heart Transplantation in Adults With MELAS<SUP><i>MT-TL1:</i>m.3243A&gt;G</SUP> Cardiomyopathy
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE heart transplantation; MELAS; mitochondrial cardiomyopathy; MT-TL1:m.3243A > G
ID stroke-like episodes; lactic-acidosis; mitochondrial; encephalopathy; mutations; risk
AB BACKGROUND The heart is commonly involved in maternally inherited mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome caused by the MT-TL1m.3243A>G mutation of the mitochondrial DNA. Heart transplantation (HTx) is controversial and has rarely been performed with conflicting results. OBJECTIVES We analyzed factors preventing HTx in consecutive adult patients with MELAS(MT-TL1:m.3243A>G) cardiomyopathy diagnosed and followed during the last 23 years in our HTx referral center. METHODS The series consists of 14 unrelated adult probands who were referred for evaluation of cardiomyopathy from 1998 to 2021. None had a suspected diagnosis of MELAS before referral. All patients underwent clinical and genetic visit and counseling, mitochondrial DNA sequencing, cardiovascular investigation (including right heart catheterization and endo-myocardial biopsy in 10), multidisciplinary assessment, and biochemical tests. Family screening identified 2 affected relatives. RESULTS The cardiac phenotype was characterized by hypertrophic, concentric, nonobstructive cardiomyopathy that often evolved into a dilated cardiomyopathy-like phenotype. Of the 14 probands, 7 were potential candidates for HTx, 2 for heart and kidney Tx, and 1 was on the active HTx list for 3 years. None of the 10 probands underwent HTx. One is currently being evaluated for HTx. All had diabetes, hearing loss, and myopathy, and 10 had chronic kidney disease and progressive encephalomyopathy. During follow-up, 10 died from heart failure associated with multiorgan failure within 5 years of the genetic diagnosis. CONCLUSIONS High risk of stroke-like episodes, chronic kidney disease, and wasting myopathy in MELAS(MT-TL1:m.3243A>G) patients prevents activation of plans for HTx. As a result, the management of their cardiomyopathy in this syndromic context remains an unmet clinical need. (C) 2022 by the American College of Cardiology Foundation.
C1 [Di Toro, Alessandro; Urtis, Mario; Narula, Nupoor; Giuliani, Lorenzo; Grasso, Maurizia; Serio, Alessandra; Pilotto, Andrea; Arbustini, Eloisa] Fdn IRCCS Policlin San Matteo, Transplant Res Area, Pavia, Italy.
   [Di Toro, Alessandro; Urtis, Mario; Narula, Nupoor; Giuliani, Lorenzo; Grasso, Maurizia; Serio, Alessandra; Pilotto, Andrea; Arbustini, Eloisa] Dept Med Sci & Infect Dis, Ctr Inherited Cardiovascular Dis, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
   [Narula, Nupoor] Univ Pavia, Dept Elect Comp & Biomed Engn, Pavia, Italy.
   [Pasotti, Michele] Weill Cornell Med, Div Cardiol, Dept Med, New York, NY USA.
   [Pellegrini, Carlo] Osped Civile Voghera, Dept Cardiol, Voghera, Italy.
   [Pellegrini, Carlo] Fdn IRCCS Policlin San Matteo, Cardiac Surg Div, Dept Intens Med, Pavia, Italy.
   [Antoniazzi, Elena] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.
   [Rampino, Teresa] Fdn IRCCS Policlin San Matteo, Ophthalmol Div, Pavia, Italy.
   [Magrassi, Lorenzo] Fdn IRCCS Policlin San Matteo, Unit Nephrol Dialysis & Transplantat, Pavia, Italy.
   [Valentini, Adele] Univ Pavia, Neurosurg Div, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.
   [Valentini, Adele] Fdn IRCCS Policlini San Matteo, Radiol Dept, Pavia, Italy.
   [Cavallini, Anna] Fdn IRCCS Policlin San Matteo, Stroke Unit, Pavia, Italy.
   [Scelsi, Laura] Fdn IRCCS Policlin San Matteo, Div Cardiol, Pavia, Italy.
   [Abelli, Massimo] Univ Pavia, Renal Transplantat Div, Dept Surg, Pavia, Italy.
   [Abelli, Massimo] Fdn IRCCS Policlin San Matteo, Pavia, Italy.
   [Olivotto, Iacopo] Univ Florence, Cardiomyopathy Unit, Florence, Italy.
   [Porcu, Maurizio] Mater Olbia Hosp, Cardiol Serv, Olbia, Italy.
   [Gavazzi, Antonello] Res Fdn, Bergamo, Italy.
   [Kodama, Takahide] Toranomon Gen Hosp, Dept Cardiovasc Ctr, Tokyo, Japan.
C3 IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia; Cornell University; Weill Cornell Medicine; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; University of Florence; Toranomon Hospital
RP Arbustini, E (corresponding author), Fdn IRCCS Policlin San Matteo, Dept Med Sci & Infect Dis, Transplant Res Area & Ctr Inherited Cardiovasc, Piazzale Camillo Golgi 19, I-27100 Pavia, Italy.
EM e.arbustini@smatteo.pv.it
FU Ministry of Health [888-rcr2017i-71, RCR-2019-23669116_001 CV-PREVITAL]
CR Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Bhati RS, 2005, J HEART LUNG TRANSPL, V24, P2286, DOI 10.1016/j.healun.2005.05.012
   Bonnet D, 2001, HEART, V86, P570, DOI 10.1136/heart.86.5.570
   Brambilla A, 2019, INT J CARDIOL, V276, P14, DOI 10.1016/j.ijcard.2018.10.051
   Chen T, 2021, CAN J NEUROL SCI, V48, P715, DOI 10.1017/cjn.2020.282
   de Laat P, 2019, CLIN KIDNEY J, V12, P840, DOI 10.1093/ckj/sfz020
   DeFronzo R, 2016, METABOLISM, V65, P20, DOI 10.1016/j.metabol.2015.10.014
   El-Hattab AW, 1993, GENEREVIEWS, V0, P0
   Finsterer J, 2021, CAN J NEUROL SCI, V48, P744, DOI 10.1017/cjn.2021.25
   Finsterer J, 2020, J NEUROL SCI, V412, P0, DOI 10.1016/j.jns.2020.116726
   Ganetzky RD, 2018, MOL GENET METAB, V123, P301, DOI 10.1016/j.ymgme.2018.01.010
   Heindryckx B, 2014, MITOCHONDRION, V18, P12, DOI 10.1016/j.mito.2014.08.005
   Hsu YHR, 2016, HEART FAIL REV, V21, P103, DOI 10.1007/s10741-015-9524-5
   Kim Sang Hun, 2019, ANESTH PAIN MED (SEOUL), V14, P416, DOI 10.17085/apm.2019.14.4.416
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   McCormick EM, 2020, HUM MUTAT, V41, P2028, DOI 10.1002/humu.24107
   McMillan RP, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-42262-2
   Murakami Hidetomo, 2017, BRAIN NERVE, V69, P111, DOI 10.11477/mf.1416200650
   Niedermayr K, 2018, CONGENIT HEART DIS, V13, P671, DOI 10.1111/chd.12634
   OHTANI Y, 1985, BRAIN DEV-JPN, V7, P249
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Tranah GJ, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30255-6
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Xu P, 2022, AM J CLIN PATHOL, V157, P664, DOI 10.1093/ajcp/aqab174
   Zaragoza MV, 2011, EUR J HUM GENET, V19, P200, DOI 10.1038/ejhg.2010.169
   Zaragoza MV, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012295
NR 30
TC 4
Z9 4
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD OCT 11
PY 2022
VL 80
IS 15
BP 1431
EP 1443
DI 10.1016/j.jacc.2022.04.067
EA OCT 2022
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 6C9CT
UT WOS:000882303300002
PM 36202533
DA 2024-11-01
ER

PT J
AU Zorov, DB
   Zorova, LD
   Andrianova, NV
   Babenko, VA
   Zorov, SD
   Pevzner, IB
   Sukhikh, GT
   Silachev, DN
AF Zorov, Dmitry B.
   Zorova, Ljubava D.
   Andrianova, Nadezda V.
   Babenko, Valentina A.
   Zorov, Savva D.
   Pevzner, Irina B.
   Sukhikh, Gennady T.
   Silachev, Denis N.
TI Isn't It Time for Establishing Mitochondrial Nomenclature Breaking Mitochondrial Paradigm?
SO BIOCHEMISTRY-MOSCOW
LA English
DT Review
DE mitochondria; bacteria; structure; heterogeneity; mitochondrial DNA; heteroplasmy; diseases; phenotype; taxonomy
ID progressive external ophthalmoplegia; linked mechanical-activity; multipotent stromal cells; red-blood-cells; ultrastructural bases; cardiac myocytes; dna deletions; in-vivo; origin; genome
AB In this work, we decided to initiate a discussion concerning heterogeneity of mitochondria, suggesting that it is time to build classification of mitochondria, like the one that exists for their progenitors, alpha-proteobacteria, proposing possible separation of mitochondrial strains and maybe species. We continue to adhere to the general line that mitochondria are friends and foes: on the one hand, they provide the cell and organism with the necessary energy and signaling molecules, and, on the other hand, participate in destruction of the cell and the organism. Current understanding that the activity of mitochondria is not only limited to energy production, but also that these alternative non-energetic functions are unique and irreplaceable in the cell, allowed us to speak about the strong subordination of the entire cellular metabolism to characteristic functional manifestations of mitochondria. Mitochondria are capable of producing not only ATP, but also iron-sulfur clusters, steroid hormones, heme, reactive oxygen and nitrogen species, participate in thermogenesis, regulate cell death, proliferation and differentiation, participate in detoxification, etc. They are a mandatory attribute of eukaryotic cells, and, so far, no eukaryotic cells performing a non-parasitic or non-symbiotic life style have been found that lack mitochondria. We believe that the structural-functional intracellular, intercellular, inter-organ, and interspecific diversity of mitochondria is large enough to provide grounds for creating a mitochondrial nomenclature. The arguments for this are given in this analytical work.
C1 [Zorov, Dmitry B.; Zorova, Ljubava D.; Andrianova, Nadezda V.; Babenko, Valentina A.; Zorov, Savva D.; Pevzner, Irina B.; Silachev, Denis N.] Lomonosov Moscow State Univ, Belozersky Inst Physico Chem Biol, Moscow 119991, Russia.
   [Zorov, Dmitry B.; Zorova, Ljubava D.; Babenko, Valentina A.; Pevzner, Irina B.; Sukhikh, Gennady T.; Silachev, Denis N.] Kulakov Natl Med Res Ctr Obstet Gynecol & Perinato, Moscow 117997, Russia.
   [Zorov, Savva D.] Lomonosov Moscow State Univ, Fac Bioengn & Bioinformat, Moscow 119991, Russia.
C3 Lomonosov Moscow State University; Lomonosov Moscow State University
RP Zorov, DB (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physico Chem Biol, Moscow 119991, Russia.; Zorov, DB (corresponding author), Kulakov Natl Med Res Ctr Obstet Gynecol & Perinato, Moscow 117997, Russia.
EM zorov@belozersky.msu.ru
FU Russian Science Foundation [19-14-00173-P]
CR Abele D, 2002, NATURE, V420, P27, DOI 10.1038/420027a
   AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995
   AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094
   Anusha-Kiran Y, 2022, FREE RADICAL BIO MED, V193, P34, DOI 10.1016/j.freeradbiomed.2022.09.027
   Aryaman J, 2019, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00718
   Babenko VA, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23030687
   Babenko VA, 2015, STEM CELL TRANSL MED, V4, P1011, DOI 10.5966/sctm.2015-0010
   BAKEEVA LE, 1981, EUR J CELL BIOL, V25, P175
   BAKEEVA LE, 1978, BIOCHIM BIOPHYS ACTA, V501, P349, DOI 10.1016/0005-2728(78)90104-4
   BAKEEVA LE, 1970, BIOCHIM BIOPHYS ACTA, V216, P13, DOI 10.1016/0005-2728(70)90154-4
   Beck EA, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.925786
   Burki F, 2016, CURR BIOL, V26, PR410, DOI 10.1016/j.cub.2016.04.032
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   DEMPSEY ME, 1974, ANNU REV BIOCHEM, V43, P967, DOI 10.1146/annurev.bi.43.070174.004535
   DILISA F, 1995, J PHYSIOL-LONDON, V486, P1
   DRACHEV VA, 1986, DOKL AKAD NAUK SSSR+, V287, P1237
   Driscoll TP, 2017, MBIO, V8, P0, DOI 10.1128/mBio.00859-17
   DUBIEL W, 1989, RBC-CELL BIOL REV, V21, P505
   Dzierzak E, 2013, CSH PERSPECT MED, V3, P0, DOI 10.1101/cshperspect.a011601
   Eldarov CM, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9030712
   Emelyanov VV, 2003, EUR J BIOCHEM, V270, P1599, DOI 10.1046/j.1432-1033.2003.03499.x
   Emelyanov VV, 2001, FEBS LETT, V501, P11, DOI 10.1016/S0014-5793(01)02618-7
   Famintzin AS, 1907, ZAP IMP AKAD NAUK F, V20, P1
   Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009
   Frankenberg G, 2022, AM J RESP CELL MOL, V67, P471, DOI 10.1165/rcmb.2022-0041OC
   GAEHTGENS P, 1981, PFLUG ARCH EUR J PHY, V390, P278, DOI 10.1007/BF00658276
   Géminard C, 2002, BIOCELL, V26, P205
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   GRAY MW, 1983, BIOSCIENCE, V33, P693, DOI 10.2307/1309349
   Gureev AP, 2022, FEBS J, V289, P5697, DOI 10.1111/febs.16451
   HACKENBRCR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598
   HACKENBROCK CR, 1968, J CELL BIOL, V37, P345, DOI 10.1083/jcb.37.2.345
   HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269
   HACKENBROCK CR, 1972, ANN NY ACAD SCI, V195, P492, DOI 10.1111/j.1749-6632.1972.tb54831.x
   He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Jazwinski SM, 2002, ANNU REV MICROBIOL, V56, P769, DOI 10.1146/annurev.micro.56.012302.160830
   John U, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav1110
   JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105
   Karnkowska A, 2016, CURR BIOL, V26, P1274, DOI 10.1016/j.cub.2016.03.053
   Kayal E, 2021, MOL BIOL EVOL, V38, P2493, DOI 10.1093/molbev/msab041
   Khryapenkova TG, 2008, B EXP BIOL MED+, V146, P506, DOI 10.1007/s10517-009-0327-3
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Kopinski PK, 2021, NAT REV CANCER, V21, P431, DOI 10.1038/s41568-021-00358-w
   Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038
   Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c
   Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000
   Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911
   MARGULIS L, 1985, SYMBIOSIS, V1, P101
   Margulis L, 1981, P1, V0, P0
   Martin W, 2010, NAT ED, V3, P0
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, PH966, DOI 10.1152/ajpheart.00883.2012
   McLean JS, 2020, CELL REP, V32, P0, DOI 10.1016/j.celrep.2020.107939
   Mereschkowsky C, 1905, BIOL. CENT., V25, P593, DOI 10.1017/S0967026299002231
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Ngo J, 2021, BIOLOGY-BASEL, V10, P0, DOI 10.3390/biology10090927
   Pallen MJ, 2011, TRENDS MICROBIOL, V19, P58, DOI 10.1016/j.tim.2010.11.001
   Plotnikov EY, 2008, J CELL MOL MED, V12, P1622, DOI 10.1111/j.1582-4934.2007.00205.x
   Plotnikov EY, 2008, FEBS LETT, V582, P3117, DOI 10.1016/j.febslet.2008.08.002
   Plotnikov EY, 2015, BIOCHEMISTRY-MOSCOW+, V80, P542, DOI 10.1134/S0006297915050041
   Plotnikov EY, 2017, HEART LUNG CIRC, V26, P648, DOI 10.1016/j.hlc.2016.12.002
   Plotnikov EY, 2010, EXP CELL RES, V316, P2447, DOI 10.1016/j.yexcr.2010.06.009
   Popkov VA, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1549, DOI 10.1134/S0006297917120148
   Popkov VA, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1480, DOI 10.1134/S0006297916120099
   Popkov VA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P532, DOI 10.1134/S000629791505003X
   Portier PJ, 1918, LES SYMBIOTES, V0, P1
   POULTON J, 1989, LANCET, V1, P236
   Roger AJ, 2017, CURR BIOL, V27, PR1177, DOI 10.1016/j.cub.2017.09.015
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Sakai C, 2012, BBA-GEN SUBJECTS, V1820, P643, DOI 10.1016/j.bbagen.2011.12.013
   Salinas G, 2020, BBA-BIOENERGETICS, V1861, P0, DOI 10.1016/j.bbabio.2020.148278
   Santamaria M, 2007, BIOL CHEM, V388, P943, DOI 10.1515/BC.2007.121
   Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163
   Sinha P, 2016, CURR OPIN GENET DEV, V38, P97, DOI 10.1016/j.gde.2016.05.002
   Skulachev VP, 2004, MOL CELL BIOCHEM, V256, P341, DOI 10.1023/B:MCBI.0000009880.94044.49
   Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7
   SMITH RA, 1983, INT REV CYTOL, V83, P63, DOI 10.1016/S0074-7696(08)61686-1
   Snyder GK, 1999, AM ZOOL, V39, P189
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Torroni A, 1996, GENETICS, V144, P1835
   Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x
   VIALE AM, 1994, FEBS LETT, V341, P146, DOI 10.1016/0014-5793(94)80446-X
   VOROBJEV IA, 1983, FEBS LETT, V163, P311, DOI 10.1016/0014-5793(83)80842-4
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wallin IE, 1925, AM J ANAT, V36, P131, DOI 10.1002/aja.1000360106
   Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757
   Wikstrom JD, 2009, INT J BIOCHEM CELL B, V41, P1914, DOI 10.1016/j.biocel.2009.06.006
   Willingham TB, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.757305
   Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6
   Yang C, 2021, BRIT J HAEMATOL, V193, P1260, DOI 10.1111/bjh.17531
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zorov DB, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1115, DOI 10.1134/S0006297907100094
   Zorov DB, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1017, DOI 10.1134/S0006297914100046
   Zorov DB, 2013, BIOCHEMISTRY-MOSCOW+, V78, P979, DOI 10.1134/S0006297913090034
   Zorov DB, 2012, BIOCHEMISTRY-MOSCOW+, V77, P742, DOI 10.1134/S0006297912070073
   Zorov DB, 1997, BIOSCIENCE REP, V17, P507, DOI 10.1023/A:1027304122259
   Zorov DB, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8020175
   Zorov DB, 2017, J GERONTOL A-BIOL, V72, P1171, DOI 10.1093/gerona/glw184
   Zorova LD, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23010482
   Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009
NR 108
TC 0
Z9 0
U1 0
U2 1
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0006-2979
EI 1608-3040
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD DEC 15
PY 2022
VL 87
IS 12-13
BP 1487
EP 1497
DI 10.1134/S0006297922120069
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 7Z9BQ
UT WOS:000915846700006
PM 36717442
DA 2024-11-01
ER

PT J
AU Schaefer, PM
   Rathi, K
   Butic, A
   Tan, W
   Mitchell, K
   Wallace, DC
AF Schaefer, Patrick M.
   Rathi, Komal
   Butic, Arrienne
   Tan, Wendy
   Mitchell, Katherine
   Wallace, Douglas C.
TI Mitochondrial mutations alter endurance exercise response and determinants in mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE mitochondrial disease; endurance exercise; skeletal muscle adaption
ID elite athletic status; skeletal-muscle; dilated cardiomyopathy; cardiac adaptation; dna variation; mouse model; deficiency; haplogroups; performance; capacity
AB Primary mitochondrial diseases (PMDs) are a heterogeneous group of metabolic disorders that can be caused by hundreds of mutations in both mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) genes. Current therapeutic approaches are limited, although one approach has been exercise training. Endurance exercise is known to improve mitochondrial function in heathy subjects and reduce risk for secondary metabolic disorders such as diabetes or neurodegenerative disorders. However, in PMDs the benefit of endurance exercise is unclear, and exercise might be beneficial for some mitochondrial disorders but contraindicated in others. Here we investigate the effect of an endurance exercise regimen in mouse models for PMDs harboring distinct mitochondrial mutations. We show that while an mtDNA ND6 mutation in complex I demonstrated improvement in response to exercise, mice with a CO1 mutation affecting complex IV showed significantly fewer positive effects, and mice with an ND5 complex I mutation did not respond to exercise at all. For mice deficient in the nDNA adenine nucleotide translocase 1 (Ant1), endurance exercise actually worsened the dilated cardiomyopathy. Correlating the gene expression profile of skeletal muscle and heart with the physiologic exercise response identified oxidative phosphorylation, amino acid metabolism, matrisome (extracellular matrix [ECM]) structure, and cell cycle regulation as key pathways in the exercise response. This emphasizes the crucial role of mitochondria in determining the exercise capacity and exercise response. Consequently, the benefit of endurance exercise in PMDs strongly depends on the underlying mutation, although our results suggest a general beneficial effect.
C1 [Schaefer, Patrick M.; Butic, Arrienne; Tan, Wendy; Mitchell, Katherine; Wallace, Douglas C.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.
   [Rathi, Komal] Childrens Hosp Philadelphia, Dept Biomed Informat, Philadelphia, PA 19104 USA.
   [Wallace, Douglas C.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania
RP Wallace, DC (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.; Wallace, DC (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.
EM wallaced1@email.chop.edu
FU German Research Foundation [SCHA 2182/1-1]; NIH [NS021328, MH108592, OD010944]; US Department of Defense [W81XWH-16-1-0401, W81XWH-21-1-0128 (PR202887.e002)]
CR Abulí M, 2020, J CARDIOVASC TRANSL, V13, P265, DOI 10.1007/s12265-020-10021-8
   Andersen K, 2013, EUR HEART J, V34, P3624, DOI 10.1093/eurheartj/eht188
   Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018
   Barbieri E, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/917085
   Basu J, 2020, CLIN CARDIOL, V43, P889, DOI 10.1002/clc.23343
   Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282
   Bernardo BC, 2016, CARDIOL CLIN, V34, P515, DOI 10.1016/j.ccl.2016.06.002
   Bertholet AM, 2019, NATURE, V571, P515, DOI 10.1038/s41586-019-1400-3
   Bertram S, 2016, ENDOCRINE, V53, P350, DOI 10.1007/s12020-016-0976-8
   Bouchard C, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0037887
   Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010
   Brosnan M, 2018, HEART LUNG CIRC, V27, P1052, DOI 10.1016/j.hlc.2018.04.297
   Cantó C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006
   Deason M, 2012, SCAND J MED SCI SPOR, V22, P217, DOI 10.1111/j.1600-0838.2010.01289.x
   DIONNE FT, 1991, MED SCI SPORT EXER, V23, P177
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fiuza-Luces C, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00790
   Fiuza-Luces C, 2018, MED SCI SPORT EXER, V50, P1142, DOI 10.1249/MSS.0000000000001546
   Gabriel BM, 2017, CELL METAB, V25, P1000, DOI 10.1016/j.cmet.2017.04.018
   Gardner JL, 2007, BIOSCIENCE REP, V27, P139, DOI 10.1007/s10540-007-9042-3
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   He Z, 2008, BRIT J SPORT MED, V42, P0, DOI 10.1136/bjsm.2007.042945
   Hoshino A, 2019, NATURE, V575, P375, DOI 10.1038/s41586-019-1667-4
   Irving BA, 2015, J CLIN ENDOCR METAB, V100, P1654, DOI 10.1210/jc.2014-3081
   Jacobs RA, 2013, EXP PHYSIOL, V98, P908, DOI 10.1113/expphysiol.2012.070037
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Karch J, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aaw4597
   Kim KC, 2012, INT J SPORTS MED, V33, P76, DOI 10.1055/s-0031-1285866
   Kjær M, 2006, J ANAT, V208, P445, DOI 10.1111/j.1469-7580.2006.00549.x
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Komlódi T, 2018, METHODS MOL BIOL, V1782, P137, DOI 10.1007/978-1-4939-7831-1_8
   La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Luijkx T, 2012, BRIT J SPORT MED, V46, P1119, DOI 10.1136/bjsports-2011-090520
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mann TN, 2014, SPORTS MED, V44, P1113, DOI 10.1007/s40279-014-0197-3
   Martinez-Huenchullan S, 2017, OBES REV, V18, P776, DOI 10.1111/obr.12548
   Maruszak A, 2014, SCAND J MED SCI SPOR, V24, P311, DOI 10.1111/sms.12012
   McKenzie JA, 2011, EXP PHYSIOL, V96, P338, DOI 10.1113/expphysiol.2010.055400
   Mikami E, 2013, J HUM GENET, V58, P780, DOI 10.1038/jhg.2013.102
   Montero D, 2015, J PHYSIOL-LONDON, V593, P4677, DOI 10.1113/JP270250
   Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114
   Murakami H, 2002, JPN J PHYSIOL, V52, P247, DOI 10.2170/jjphysiol.52.247
   Narula N, 2011, JACC-CARDIOVASC IMAG, V4, P1, DOI 10.1016/j.jcmg.2010.06.018
   Niemi AK, 2005, EUR J HUM GENET, V13, P965, DOI 10.1038/sj.ejhg.5201438
   Nogales-Gadea G, 2011, MITOCHONDRION, V11, P905, DOI 10.1016/j.mito.2011.08.002
   Onkelinx S, 2011, ACTA CARDIOL, V66, P407, DOI 10.1080/AC.66.4.2126586
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pérusse L, 2001, MED SCI SPORT EXER, V33, P597
   Rankinen T, 2000, J APPL PHYSIOL, V88, P346, DOI 10.1152/jappl.2000.88.1.346
   Reichard A, 2019, MOL BIOL REP, V46, P1393, DOI 10.1007/s11033-018-4488-x
   Robbins JM, 2021, NAT METAB, V3, P786, DOI 10.1038/s42255-021-00400-z
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sanford JA, 2020, CELL, V181, P1464, DOI 10.1016/j.cell.2020.06.004
   Scott RA, 2009, MED SCI SPORT EXER, V41, P123, DOI 10.1249/MSS.0b013e31818313a2
   Seo YG, 2019, J CARDIOPULM REHABIL, V39, P235, DOI 10.1097/HCR.0000000000000382
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Thirupathi A, 2017, J PHYSIOL BIOCHEM, V73, P487, DOI 10.1007/s13105-017-0576-y
   Timmons JA, 2005, BMC BIOL, V3, P0, DOI 10.1186/1741-7007-3-19
   Vega RB, 2017, CELL METAB, V25, P1012, DOI 10.1016/j.cmet.2017.04.025
   Wallace DC, 2016, NATURE, V535, P498, DOI 10.1038/nature18902
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   White AT, 2012, AM J PHYSIOL-ENDOC M, V303, PE308, DOI 10.1152/ajpendo.00054.2012
   Williams CJ, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-4192-6
   Yardeni T, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2021429118
   Zarebska A, 2014, BIOL SPORT, V31, P261, DOI 10.5604/20831862.1120932
   Zhang WY, 2021, CELL BIOSCI, V11, P0, DOI 10.1186/s13578-021-00579-4
   Zhou YY, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-09234-6
NR 74
TC 6
Z9 6
U1 2
U2 13
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 3
PY 2022
VL 119
IS 18
BP 
EP 
DI 10.1073/pnas.2200549119
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 1V6OW
UT WOS:000806207700005
PM 35482926
DA 2024-11-01
ER

PT J
AU Russo, SN
   Shah, EG
   Copeland, WC
   Koenig, MK
AF Russo, S. Nicholas
   Shah, Ekta G.
   Copeland, William C.
   Koenig, Mary Kay
TI A new pathogenic POLG variant
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE Mitochondria; Mitochondrial depletion; Alpers-Huttenlocher syndrome; DNA polymerase gamma; POLG syndrome
ID mitochondrial-dna polymerase; progressive external ophthalmoplegia; ataxic neuropathy; mutations; parkinsonism; dominant; spectrum; patient; family; a467t
AB POLG gene mutations are the most common causes of inherited mitochondrial disorders. The enzyme produced by this gene is responsible for the replication and repair of mitochondrial DNA. To date, around 300 pathogenic variants have been described in this gene. The resulting clinical outcomes of POLG mutations are widely variable in both phenotype and severity. There is considerable overlap in the phenotype of the so-called POLG syndromes with no clear genotype-phenotype correlation. Here we describe a newly discovered pathogenic variant in the POLG gene in a 7-year-old male that died of uncontrollable refractory status epilepticus. Genetic epilepsy panel sequencing identified two variants in the POLG gene, the common p.A467T pathological mutation and a novel p. S809R POLG variant found in trans with the p.A467T POLG that accompanied a severely reduced mitochondrial DNA level in the patient's tissues.
C1 [Russo, S. Nicholas; Shah, Ekta G.; Koenig, Mary Kay] Univ Texas McGovern Med Sch, Dept Pediat, Div Child & Adolescent Neurol, Houston, TX USA.
   [Copeland, William C.] Natl Inst Hlth, Genome Integr & Struct Biol Lab, Mitochondrial DNA Replicat Grp, Durham, NC USA.
   [Russo, S. Nicholas; Koenig, Mary Kay] Univ Texas McGovern Med Sch, Ctr Treatment Pediat Neurodegenerat Dis, Houston, TX USA.
   [Russo, S. Nicholas] Univ Texas McGovern Med Sch, 6410 Fannin St, Suite 1535, Houston, TX 77030 USA.
C3 National Institutes of Health (NIH) - USA
RP Russo, SN (corresponding author), Univ Texas McGovern Med Sch, Dept Pediat, Div Child & Adolescent Neurol, Houston, TX USA.; Russo, SN (corresponding author), Univ Texas McGovern Med Sch, Ctr Treatment Pediat Neurodegenerat Dis, Houston, TX USA.; Russo, SN (corresponding author), Univ Texas McGovern Med Sch, 6410 Fannin St, Suite 1535, Houston, TX 77030 USA.
EM sam.n.russo@uth.tmc.edu
FU National Institute of Environmental Health Sciences [ES065078]; National Institute of Environmental Health Sciences [ZIAES065078] Funding Source: NIH RePORTER
CR Barca E, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000402
   Bekheirnia MR, 2012, GENE, V499, P209, DOI 10.1016/j.gene.2012.02.034
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Cohen BH, 2018, POLG RELATED DISORDE, V0, P0
   Copeland WC, 2020, HUMAN DNA POLYMERASE, V0, P0
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horvath R, 2008, NEUROTHERAPEUTICS, V5, P558, DOI 10.1016/j.nurt.2008.07.002
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Specchio N, 2020, BRAIN SCI, V10, P0, DOI 10.3390/brainsci10110768
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
NR 36
TC 4
Z9 4
U1 0
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 
EI 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD SEP 15
PY 2022
VL 32
IS 
BP 
EP 
DI 10.1016/j.ymgmr.2022.100890
EA JUL 2022
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA 3Q2HW
UT WOS:000838055000004
PM 35860755
DA 2024-11-01
ER

PT J
AU Hou, Y
   Zhao, XT
   Xie, ZY
   Yu, M
   Lv, H
   Zhang, W
   Yuan, Y
   Wang, ZX
AF Hou, Yue
   Zhao, Xutong
   Xie, Zhiying
   Yu, Meng
   Lv, He
   Zhang, Wei
   Yuan, Yun
   Wang, Zhaoxia
TI Novel and recurrent nuclear gene variations in a cohort of Chinese progressive external ophthalmoplegia patients with multiple mtDNA deletions
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE progressive external ophthalmoplegia; mtDNA maintenance defect; multiple mtDNA deletion; POLG; POLG2; RRM2B; TK2; TWNK
ID dna-polymerase; mitochondrial disorder; sensory neuropathy; spacer-region; mutations; ataxia; polg; disease; spectrum; peo1
AB Objectives: This study aimed to investigate the clinical and genetic spectrum in Chinese patients with multiple mtDNA deletions presenting with autosomal-inherited mitochondrial progressive external ophthalmoplegia (PEO). Methods: Long-range polymerase chain reaction and massively parallel sequencing of the mitochondrial genome were performed to detect deletions in muscle mtDNA of 274 unrelated families. Then, targeted next generation sequencing was used to detect nuclear gene variations in patients with multiple mtDNA deletions. Results: A total of 40 Chinese PEO patients (10 males and 30 females) from 20 families were found to have multiple mtDNA deletions in this study, and the median age at onset was 35 (1-70) years. PEO and positive family history were the two prominent features of these patients, and ataxia, neuropathy, and hypogonadism were also present as onset symptoms in some patients. Fifteen of 20 probands with multiple mtDNA deletions were identified to carry nuclear gene variants; eight (40.0%) probands had variants within POLG, two (10.0%) within TWNK, two (10.0%) within RRM2B, two (10.0%) within TK2, and one (5.0%) within POLG2. A total of 24 variants were found in these five nuclear genes, of which 19 were novel. The causal nuclear genetic factors in five pedigrees remain undetermined. Conclusions: The POLG gene is the most common disease-causing gene in this group of PEO patients with multiple mtDNA deletions. While inherited PEO is the most prominent symptoms in these patients, genotypic and phenotypic heterogeneity still exist, for example in onset age, initial symptoms, and accompanying manifestations.
C1 [Hou, Yue; Zhao, Xutong; Xie, Zhiying; Yu, Meng; Lv, He; Zhang, Wei; Yuan, Yun; Wang, Zhaoxia] Peking Univ, Dept Neurol, Hosp 1, Beijing 100034, Peoples R China.
   [Hou, Yue] Peking Univ, Dept Geriatr, Hosp 1, Beijing, Peoples R China.
   [Wang, Zhaoxia] Beijing Key Lab Neurovasc Dis Discovery, Beijing, Peoples R China.
C3 Peking University; Peking University
RP Wang, ZX (corresponding author), Peking Univ, Dept Neurol, Hosp 1, Beijing 100034, Peoples R China.
EM drwangzx@163.com
FU Ministry of Science and Technology of China [2011ZX09307-001-07]; Beijing Municipal Science and Technology Commission [Z151100003915126]
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Birtel J, 2022, OPHTHALMOL RETINA, V6, P65, DOI 10.1016/j.oret.2021.02.017
   Bostan A, 2012, AUTON NEUROSCI-BASIC, V170, P70, DOI 10.1016/j.autneu.2012.06.002
   Brandt T, 2020, GENET MED, V22, P336, DOI 10.1038/s41436-019-0655-2
   Bugiardini E, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000149
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Finsterer J, 2018, NEUROPEDIATRICS, V49, P231, DOI 10.1055/s-0037-1609039
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI 10.1093/bioinformatics/btp100
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Qian YF, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00135
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Savard M, 2013, NEUROLOGY, V81, P770, DOI 10.1212/WNL.0b013e3182a1aa78
   Schicks J, 2010, MOVEMENT DISORD, V25, P2678, DOI 10.1002/mds.23286
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Siibak T, 2017, HUM MOL GENET, V26, P2515, DOI 10.1093/hmg/ddx146
   Sohl CD, 2013, HUM MOL GENET, V22, P1074, DOI 10.1093/hmg/dds509
   Sommerville Ewen W, 2014, J NEUROMUSCUL DIS, V1, P119
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361
   Varma H, 2016, EUR J MED GENET, V59, P540, DOI 10.1016/j.ejmg.2016.08.012
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Vogel AP, 2017, MITOCHONDRION, V37, P1, DOI 10.1016/j.mito.2017.06.002
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
   Xie ZY, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1021-9
   Zhu CC, 2017, OPHTHALMIC GENET, V38, P67, DOI 10.3109/13816810.2015.1130153
NR 43
TC 5
Z9 6
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
EI 
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD MAY 15
PY 2022
VL 10
IS 5
BP 
EP 
DI 10.1002/mgg3.1921
EA MAR 2022
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA 0R7SW
UT WOS:000768646600001
PM 35289132
DA 2024-11-01
ER

PT J
AU Sathyabhama, M
   Dharshini, LCP
   Karthikeyan, A
   Kalaiselvi, S
   Min, TS
AF Sathyabhama, Muthuswamy
   Dharshini, Loganathan Chandramani Priya
   Karthikeyan, Adhimoolam
   Kalaiselvi, Senthil
   Min, Taesun
TI The Credible Role of Curcumin in Oxidative Stress-Mediated Mitochondrial Dysfunction in Mammals
SO BIOMOLECULES
LA English
DT Review
DE curcumin; mammals; mitochondrial dysfunction; oxidative stress; antioxidant; anti-inflammatory; anticancer; antimicrobial
ID factor-kappa-b; endothelial-cells; skeletal-muscle; atp synthesis; antioxidant; liver; hydrogen; calcium; beta; nephrotoxicity
AB Oxidative stress and mitochondrial dysfunction are associated with the pathogenesis of several human diseases. The excessive generation of reactive oxygen species (ROS) and/or lack of adequate antioxidant defenses causes DNA mutations in mitochondria, damages the mitochondrial respiratory chain, and alters membrane permeability and mitochondrial defense mechanisms. All these alterations are linked to the development of numerous diseases. Curcumin, an active ingredient of turmeric plant rhizomes, exhibits numerous biological activities (i.e., antioxidant, anti-inflammatory, anticancer, and antimicrobial). In recent years, many researchers have shown evidence that curcumin has the ability to reduce the oxidative stress- and mitochondrial dysfunction-associated diseases. In this review, we discuss curcumin's antioxidant mechanism and significance in oxidative stress reduction and suppression of mitochondrial dysfunction in mammals. We also discuss the research gaps and give our opinion on how curcumin research in mammals should proceed moving forward.
C1 [Sathyabhama, Muthuswamy; Dharshini, Loganathan Chandramani Priya] PSG Coll Arts & Sci, Dept Biotechnol, Coimbatore 641014, Tamil Nadu, India.
   [Karthikeyan, Adhimoolam] Jeju Natl Univ, Subtrop Hort Res Inst, Jeju 63243, South Korea.
   [Kalaiselvi, Senthil] Avinashilingam Inst Home Sci & Higher Educ Women, Dept Biochem Biotechnol & Bioinformat, Coimbatore 641043, Tamil Nadu, India.
   [Min, Taesun] Jeju Natl Univ, Jeju Natl Anim Res Ctr JIA, Dept Anim Biotechnol, Jeju 63243, India.
   [Min, Taesun] Jeju Natl Univ, Sustainable Agr Res Inst SARI, Jeju 63243, India.
C3 PSG College of Arts & Science; Jeju National University; Avinashilingam University for Women
RP Min, TS (corresponding author), Jeju Natl Univ, Jeju Natl Anim Res Ctr JIA, Dept Anim Biotechnol, Jeju 63243, India.; Min, TS (corresponding author), Jeju Natl Univ, Sustainable Agr Res Inst SARI, Jeju 63243, India.
EM tsmin@jejunu.ac.kr
FU Creative Challenge Program through the National Research Foundation of Korea (NRF), Ministry of Science and ICT [2020R1\1A1A01060923]; Basic Science Research Program through the National Research Foundation of Korea (NRF), Ministry of Science and ICT [2019R1A6A1A11052070, 2022R1A2B5B02001711]
CR Abo-Salem OM, 2014, J BIOCHEM MOL TOXIC, V28, P263, DOI 10.1002/jbt.21562
   Abrigo J, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/2063179
   Alex AF, 2010, CURR EYE RES, V35, P1021, DOI 10.3109/02713683.2010.506970
   Ali BH, 2005, FUND CLIN PHARMACOL, V19, P473, DOI 10.1111/j.1472-8206.2005.00343.x
   Andersen JK, 2004, NAT MED, V10, PS18, DOI 10.1038/nrn1434
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964
   Aparicio-Trejo OE, 2017, BIOFACTORS, V43, P293, DOI 10.1002/biof.1338
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Banach M, 2014, INT UROL NEPHROL, V46, P947, DOI 10.1007/s11255-014-0657-6
   Bhattacharyya S, 2010, CELL MOL IMMUNOL, V7, P306, DOI 10.1038/cmi.2010.11
   Bimonte S, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/878134
   Bonora M, 2012, PURINERG SIGNAL, V8, P343, DOI 10.1007/s11302-012-9305-8
   Chanséaume E, 2009, INT J MOL SCI, V10, P306, DOI 10.3390/ijms10010306
   Chen JH, 2014, J FUNCT FOODS, V7, P330, DOI 10.1016/j.jff.2014.01.027
   Chen TK, 2019, JAMA-J AM MED ASSOC, V322, P1294, DOI 10.1001/jama.2019.14745
   Cloonan SM, 2020, EUR RESPIR REV, V29, P0, DOI 10.1183/16000617.0165-2020
   Correa F, 2013, FREE RADICAL BIO MED, V61, P119, DOI 10.1016/j.freeradbiomed.2013.03.017
   Da W, 2019, INT J IMMUNOPATH PH, V33, P0, DOI 10.1177/2058738419861600
   Daverey A, 2016, NEUROSCIENCE, V333, P92, DOI 10.1016/j.neuroscience.2016.07.012
   Del Prado-Audelo ML, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9020056
   Domazetovic V, 2017, CLIN CASES MINER BON, V14, P209, DOI 10.11138/ccmbm/2017.14.1.209
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Dugger BN, 2017, CSH PERSPECT BIOL, V9, P0, DOI 10.1101/cshperspect.a028035
   Dumont M, 2009, FREE RADICAL BIO MED, V47, P1019, DOI 10.1016/j.freeradbiomed.2009.07.008
   Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4
   Ferreiro E, 2012, INT J CELL BIOL, V2012, P735206, DOI 10.1155/2012/735206
   Ferrer MD, 2010, CELL PHYSIOL BIOCHEM, V25, P241, DOI 10.1159/000276558
   FLYNN DL, 1986, PROSTAG LEUKOTR ESS, V22, P357, DOI 10.1016/0262-1746(86)90146-0
   Gao XH, 2005, J EXP THER ONCOL, V5, P39
   Gemmell E, 2012, STROKE, V43, P808, DOI 10.1161/STROKEAHA.111.636498
   Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, PF1146, DOI 10.1152/ajprenal.90732.2008
   Giasson BI, 2002, FREE RADICAL BIO MED, V32, P1264, DOI 10.1016/S0891-5849(02)00804-3
   González-Salazar A, 2011, CARDIOVASC TOXICOL, V11, P357, DOI 10.1007/s12012-011-9128-9
   Gouspillou G, 2016, FRONT PHYSIOL, V7, P0, DOI 10.3389/fphys.2016.00446
   Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8
   Guzik TJ, 2002, HYPERTENSION, V39, P1088, DOI 10.1161/01.HYP.0000018041.48432.B5
   Halliwell B, 1995, BIOCHEM SOC SYMP, V0, PP73, DOI 10.1042/bss0610073
   Huang M-T, 1997, FOOD FACTORS CANC PR, V0, PP249, DOI 10.1007/978-4-431-67017-9_50
   Jagetia GC, 2007, J CLIN IMMUNOL, V27, P19, DOI 10.1007/s10875-006-9066-7
   Jakubczyk K, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9111092
   JENSEN PK, 1966, BIOCHIM BIOPHYS ACTA, V122, P157, DOI 10.1016/0926-6593(66)90057-9
   Karthikeyan A, 2021, PHARMACEUTICS, V13, P0, DOI 10.3390/pharmaceutics13040484
   Karthikeyan A, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.00487
   Kasote DM, 2013, BIOFACTORS, V39, P392, DOI 10.1002/biof.1093
   Kowluru RA, 2007, NUTR METAB, V4, P0, DOI 10.1186/1743-7075-4-8
   Kuo JJ, 2012, INT J MOL MED, V30, P643, DOI 10.3892/ijmm.2012.1020
   Lakshman R, 2015, CLIN RES HEPATOL GAS, V39, PS29, DOI 10.1016/j.clinre.2015.05.007
   Lefkowitch Jay H, 2005, CLIN LIVER DIS, V9, P37, DOI 10.1016/j.cld.2004.11.001
   Leitner LM, 2017, ANTIOXID REDOX SIGN, V26, P700, DOI 10.1089/ars.2016.6942
   Lestari Maria L A D, 2014, PROFILES DRUG SUBST EXCIP RELAT METHODOL, V39, P113, DOI 10.1016/B978-0-12-800173-8.00003-9
   Levine M, 1999, JAMA-J AM MED ASSOC, V281, P1415, DOI 10.1001/jama.281.15.1415
   Li L, 2021, J CELL MOL MED, V25, P9863, DOI 10.1111/jcmm.16934
   Lin XY, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0216711
   Lin YG, 2007, CLIN CANCER RES, V13, P3423, DOI 10.1158/1078-0432.CCR-06-3072
   LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Malik SM, 2009, AM J TRANSPLANT, V9, P782, DOI 10.1111/j.1600-6143.2009.02590.x
   Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006
   Manikandan R, 2011, EUR J PHARMACOL, V670, P578, DOI 10.1016/j.ejphar.2011.08.037
   Mansouri A, 2018, GASTROENTEROLOGY, V155, P629, DOI 10.1053/j.gastro.2018.06.083
   Marchiani A, 2014, CURR MED CHEM, V21, P204
   MaresPerlman JA, 1996, ARCH OPHTHALMOL-CHIC, V114, P991, DOI 10.1001/archopht.1996.01100140199014
   Martínez-Morúa A, 2013, J ASIAN NAT PROD RES, V15, P905, DOI 10.1080/10286020.2013.802687
   Menon VP, 2007, ADV EXP MED BIOL, V595, P105
   Molina-Jijón E, 2011, FREE RADICAL BIO MED, V51, P1543, DOI 10.1016/j.freeradbiomed.2011.07.018
   Moorthi RN, 2017, CURR OPIN NEPHROL HY, V26, P219, DOI 10.1097/MNH.0000000000000318
   Navarro-Yepes J, 2014, PHARMACOL THERAPEUT, V142, P206, DOI 10.1016/j.pharmthera.2013.12.007
   Negrette-Guzmán M, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/135314
   Norat P, 2020, NPJ REGEN MED, V5, P0, DOI 10.1038/s41536-020-00107-x
   OConnell MA, 2008, BRIT J PHARMACOL, V153, P403, DOI 10.1038/sj.bjp.0707580
   Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018
   Oyetayo BO, 2020, J FUNCT FOODS, V71, P0, DOI 10.1016/j.jff.2020.104035
   Peddada KV, 2015, ORTHOP SURG, V7, P222, DOI 10.1111/os.12183
   Pinlaor S, 2009, MOL NUTR FOOD RES, V53, P1316, DOI 10.1002/mnfr.200800567
   Premanand C, 2006, INVEST OPHTH VIS SCI, V47, P2179, DOI 10.1167/iovs.05-0580
   Priyadarsini KI, 2014, MOLECULES, V19, P20091, DOI 10.3390/molecules191220091
   Priyadarsini KI, 2003, FREE RADICAL BIO MED, V35, P475, DOI 10.1016/S0891-5849(03)00325-3
   Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267
   Rafiee P, 2010, AM J PHYSIOL-GASTR L, V298, PG865, DOI 10.1152/ajpgi.00339.2009
   Rao MS, 2004, HEPATOLOGY, V40, P783, DOI 10.1002/hep.20453
   Razmaria Aria A, 2016, JAMA, V315, P2248, DOI 10.1001/jama.2016.1426
   Reddy PH, 2016, J INVEST MED, V64, P1220, DOI 10.1136/jim-2016-000240
   Reddy RC, 2005, BIOCHEM BIOPH RES CO, V326, P472, DOI 10.1016/j.bbrc.2004.11.051
   Rohanizadeh R, 2016, BONEKEY REP, V5, P0, DOI 10.1038/bonekey.2016.20
   Roth F, 2004, GRAEF ARCH CLIN EXP, V242, P710, DOI 10.1007/s00417-004-0976-x
   Saavedra-Molina A, 2003, AMINO ACIDS, V24, P95, DOI 10.1007/s00726-002-0331-7
   Sabet NS, 2020, N-S ARCH PHARMACOL, V393, P1447, DOI 10.1007/s00210-020-01853-x
   Sahebkar A, 2015, J FUNCT FOODS, V18, P898, DOI 10.1016/j.jff.2015.01.005
   Salehi B, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9020430
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Sato H, 2013, NEUROSCIENCE, V248, P345, DOI 10.1016/j.neuroscience.2013.06.010
   Schrier SA, 2011, CURR OPIN OPHTHALMOL, V22, P325, DOI 10.1097/ICU.0b013e328349419d
   Shen L, 2012, TRENDS MOL MED, V18, P138, DOI 10.1016/j.molmed.2012.01.004
   Shi HL, 1999, FREE RADICAL BIO MED, V27, P334, DOI 10.1016/S0891-5849(99)00053-2
   Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Sivertsen H, 2015, DEMENT GERIATR COGN, V40, P311, DOI 10.1159/000437299
   Soto-Urquieta MG, 2014, BIOL RES, V47, P0, DOI 10.1186/0717-6287-47-74
   Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004
   Swerdlow RH, 2011, BBA-MOL BASIS DIS, V1812, P1630, DOI 10.1016/j.bbadis.2011.08.012
   Tapia E, 2012, OXID MED CELL LONGEV, V2012, P0, DOI 10.1155/2012/269039
   Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003
   Terruzzi I, 2019, BIOMED RES INT, V2019, P0, DOI 10.1155/2019/5678548
   Trujillo J, 2014, ARCH PHARM, V347, P873, DOI 10.1002/ardp.201400266
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Vasireddy V, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021193
   Vera-Ramirez L, 2013, BIOFACTORS, V39, P88, DOI 10.1002/biof.1057
   Walker MA, 2014, J IMMUNOL RES, V2014, P0, DOI 10.1155/2014/164309
   Wang DT, 2020, J NUTR BIOCHEM, V83, P0, DOI 10.1016/j.jnutbio.2020.108404
   Wang DT, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-10027-4
   Waseem M, 2016, PROTOPLASMA, V253, P417, DOI 10.1007/s00709-015-0821-6
   Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5
   Weisberg SP, 2008, ENDOCRINOLOGY, V149, P3549, DOI 10.1210/en.2008-0262
   WEISIGER RA, 1973, J BIOL CHEM, V248, P3582
   Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91
   Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163
   Wu JQ, 2013, PROG NEURO-PSYCHOPH, V46, P200, DOI 10.1016/j.pnpbp.2013.02.015
   Zhang YF, 2020, BASIC CLIN PHARMACOL, V127, P243, DOI 10.1111/bcpt.13455
NR 121
TC 22
Z9 22
U1 2
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD OCT 15
PY 2022
VL 12
IS 10
BP 
EP 
DI 10.3390/biom12101405
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 5O1UX
UT WOS:000872268000001
PM 36291614
DA 2024-11-01
ER

PT J
AU Zhang, J
   Shi, YG
AF Zhang, Jun
   Shi, Yuguang
TI In Search of the Holy Grail: Toward a Unified Hypothesis on Mitochondrial Dysfunction in Age-Related Diseases
SO CELLS
LA English
DT Review
DE ALCAT1; cardiolipin; mitochondrial dysfunction; aging; age-related diseases
ID electron-transport chain; acetyl-l-carnitine; increased oxidative stress; complex-i activity; c-oxidase activity; cytochrome-c; rat-heart; skeletal-muscle; tetralinoleoyl-cardiolipin; docosahexaenoic acid
AB Cardiolipin (CL) is a mitochondrial signature phospholipid that plays a pivotal role in mitochondrial dynamics, membrane structure, oxidative phosphorylation, mtDNA bioenergetics, and mitophagy. The depletion or abnormal acyl composition of CL causes mitochondrial dysfunction, which is implicated in the pathogenesis of aging and age-related disorders. However, the molecular mechanisms by which mitochondrial dysfunction causes age-related diseases remain poorly understood. Recent development in the field has identified acyl-CoA:lysocardiolipin acyltransferase 1 (ALCAT1), an acyltransferase upregulated by oxidative stress, as a key enzyme that promotes mitochondrial dysfunction in age-related diseases. ALCAT1 catalyzes CL remodeling with very-long-chain polyunsaturated fatty acids, such as docosahexaenoic acid (DHA). Enrichment of DHA renders CL highly sensitive to oxidative damage by reactive oxygen species (ROS). Oxidized CL becomes a new source of ROS in the form of lipid peroxides, leading to a vicious cycle of oxidative stress, CL depletion, and mitochondrial dysfunction. Consequently, ablation or the pharmacological inhibition of ALCAT1 have been shown to mitigate obesity, type 2 diabetes, heart failure, cardiomyopathy, fatty liver diseases, neurodegenerative diseases, and cancer. The findings suggest that age-related disorders are one disease (aging) manifested by different mitochondrion-sensitive tissues, and therefore should be treated as one disease. This review will discuss a unified hypothesis on CL remodeling by ALCAT1 as the common denominator of mitochondrial dysfunction, linking mitochondrial dysfunction to the development of age-related diseases.
C1 [Zhang, Jun; Shi, Yuguang] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, Dept Pharmacol, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at San Antonio
RP Shi, YG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, Dept Pharmacol, San Antonio, TX 78229 USA.
EM zhangj7@uthscsa.edu; shiy4@uthscsa.edu
FU National Institute on Aging [R01AG055747, P30AG013319]; American Diabetes Association [1-18 IBS-329]; Barth Syndrome Foundation; National Institute on Aging [R01AG055747] Funding Source: NIH RePORTER
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Agrawal I, 2020, FRONT AGING NEUROSCI, V12, P0, DOI 10.3389/fnagi.2020.00252
   Ahmadpour ST, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21218031
   Anderson EJ, 2009, J AM COLL CARDIOL, V54, P1891, DOI 10.1016/j.jacc.2009.07.031
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168
   Beltrán-Heredia E, 2019, COMMUN BIOL, V2, P0, DOI 10.1038/s42003-019-0471-x
   Bissler JJ, 2002, LAB INVEST, V82, P335, DOI 10.1038/labinvest.3780427
   Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601
   Cao JS, 2009, AM J PHYSIOL-ENDOC M, V296, PE647, DOI 10.1152/ajpendo.90761.2008
   Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200
   Chen DH, 2006, BIOCHEM J, V398, P169, DOI 10.1042/BJ20060303
   Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x
   Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, PC33, DOI 10.1152/ajpcell.00243.2006
   Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003
   DeBerardinis RJ, 2020, NAT METAB, V2, P127, DOI 10.1038/s42255-020-0172-2
   Desai R, 2020, SCI ADV, V6, P0, DOI 10.1126/sciadv.abc9955
   Deus CM, 2020, TRENDS MOL MED, V26, P71, DOI 10.1016/j.molmed.2019.10.009
   Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376
   Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005
   Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039
   Fane M, 2020, NAT REV CANCER, V20, P89, DOI 10.1038/s41568-019-0222-9
   Feng HM, 2018, ONCOL LETT, V15, P2661, DOI 10.3892/ol.2017.7591
   Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015
   Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379
   HOSTETLER KY, 1975, BIOCHIM BIOPHYS ACTA, V380, P382, DOI 10.1016/0005-2760(75)90106-X
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054
   Hsu P, 2017, BBA-MOL CELL BIOL L, V1862, P114, DOI 10.1016/j.bbalip.2016.08.003
   Huang LS, 2020, J BIOL CHEM, V295, P13393, DOI 10.1074/jbc.RA120.012680
   Hulbert AJ, 2008, COMP BIOCHEM PHYS A, V150, P196, DOI 10.1016/j.cbpa.2006.05.014
   Jia DD, 2021, MOL THER, V29, P3498, DOI 10.1016/j.ymthe.2021.06.007
   Joubert F, 2021, MEMBRANES-BASEL, V11, P0, DOI 10.3390/membranes11070465
   Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727
   Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011
   Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200
   Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636
   Lee HJ, 2006, LIPIDS HEALTH DIS, V5, P0, DOI 10.1186/1476-511X-5-2
   Li J, 2012, P NATL ACAD SCI USA, V109, P6975, DOI 10.1073/pnas.1120043109
   Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003
   Li XB, 2019, J CELL PHYSIOL, V234, P16238, DOI 10.1002/jcp.28287
   Liu XL, 2012, MOL CELL BIOL, V32, P4493, DOI 10.1128/MCB.01092-12
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu B, 2006, J LIPID RES, V47, P1140, DOI 10.1194/jlr.C600004-JLR200
   Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003
   Mejia EM, 2016, J BIOENERG BIOMEMBR, V48, P99, DOI 10.1007/s10863-015-9601-4
   Menshikova EV, 2007, J APPL PHYSIOL, V103, P21, DOI 10.1152/japplphysiol.01228.2006
   Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781
   Neuwald AF, 1997, CURR BIOL, V7, P0
   Ng Y, 2005, CARCINOGENESIS, V26, P1914, DOI 10.1093/carcin/bgi163
   Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183
   Pamplona R, 1998, J LIPID RES, V39, P1989
   Pangborn MC, 1942, J BIOL CHEM, V143, P247
   Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9
   PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2
   Paradies G, 1999, FEBS LETT, V454, P207, DOI 10.1016/S0014-5793(99)00809-1
   Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64
   PARADIES G, 1992, BIOCHIM BIOPHYS ACTA, V1103, P324, DOI 10.1016/0005-2736(92)90103-S
   Paradies G, 1997, FEBS LETT, V406, P136, DOI 10.1016/S0014-5793(97)00264-0
   PARADIES G, 1994, FEBS LETT, V350, P213, DOI 10.1016/0014-5793(94)00763-2
   Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6
   Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020
   Paradies G, 2009, CELL CALCIUM, V45, P643, DOI 10.1016/j.ceca.2009.03.012
   Pathak S, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0098317
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108
   RUSTOW B, 1989, BIOCHIM BIOPHYS ACTA, V1002, P261, DOI 10.1016/0005-2760(89)90296-8
   Ryan T, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03241-9
   Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9
   SCHLAME M, 1986, BIOCHEM J, V240, P247, DOI 10.1042/bj2400247
   SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079
   Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176
   Schlame M, 2021, BBA-BIOENERGETICS, V1862, P0, DOI 10.1016/j.bbabio.2020.148305
   Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506
   Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6
   Song CJ, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12941
   Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200
   Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461
   Taylor WA, 2003, J BIOL CHEM, V278, P12716, DOI 10.1074/jbc.M210329200
   Taylor WA, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0048628
   Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322
   Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang L, 2015, HEPATOLOGY, V61, P486, DOI 10.1002/hep.27420
   Wang WD, 2010, DEV DYNAM, V239, P1827, DOI 10.1002/dvdy.22300
   Wang WZ, 2020, MOL NEURODEGENER, V15, P0, DOI 10.1186/s13024-020-00376-6
   Watkins SM, 1998, J LIPID RES, V39, P1583
   Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448
   Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907
   Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200
   YAMAOKAKOSEKI S, 1991, J NUTR, V121, P956, DOI 10.1093/jn/121.7.956
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
   Zhang J, 2022, AUTOPHAGY, V18, P2134, DOI 10.1080/15548627.2021.2020979
   Zhong HQ, 2017, FREE RADICAL BIO MED, V102, P67, DOI 10.1016/j.freeradbiomed.2016.10.494
   Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25
NR 103
TC 12
Z9 13
U1 4
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD JUN 15
PY 2022
VL 11
IS 12
BP 
EP 
DI 10.3390/cells11121906
PG 14
WC Cell Biology
SC Cell Biology
GA 2M1PE
UT WOS:000817479700001
PM 35741033
DA 2024-11-01
ER

PT J
AU Jurecka, A
   Tylki-Szymanska, A
AF Jurecka, Agnieszka
   Tylki-Szymanska, Anna
TI Inborn errors of purine and pyrimidine metabolism: A guide to diagnosis
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Review
DE Encephalopathy; Hypotonia; Myopathy; Purines; Pyrimidines; Seizures
ID adenylosuccinate lyase deficiency; mitochondrial-dna depletion; beta-ureidopropionase deficiency; dominant retinitis-pigmentosa; dihydropyrimidine dehydrogenase; thymidine kinase; hprt deficiency; disorders; degradation; mutations
AB Inborn errors of purine and pyrimidine (P/P) metabolism are under-reported and rarely mentioned in the general literature or in clinical practice, as well as in reviews dedicated to other inborn errors of metabolism (IEMs). However, their diagnosis is important because genetic counseling can be provided and, in some cases, specific treatment exists that may slow or even reverse clinical signs. The purpose of this review is to provide a practical guideline on the suspicion and investigation of inborn errors of P/P metabolism. Failure of a physician to recognize the presence of these disorders may be devastating for affected infants and children because of its permanent effects in the patient, and for their parents because of implications for future offspring. Diagnosis is crucial because genetic counseling can be provided and, in some cases, specific treatment can be offered that may slow or even reverse clinical symptoms. This review highlights the risk factors in the history, the important examination findings, and the appropriate biochemical investigation of the child. Herein we describe the approach to the diagnosis of P/P disorders and emphasize clinical situations in which physicians should consider these diseases as diagnostic possibilities.
C1 [Jurecka, Agnieszka] CoA Therapeut, Palo Alto, CA USA.
   [Tylki-Szymanska, Anna] Childrens Mem Hlth Inst, Warsaw, Poland.
   [Jurecka, Agnieszka] 1800 Owens St,Suite C-1200, San Francisco, CA 94158 USA.
C3 Children's Memorial Health Institute
RP Jurecka, A (corresponding author), 1800 Owens St,Suite C-1200, San Francisco, CA 94158 USA.
EM ajurecka@gmail.com
CR Almannai M, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.640371
   [Anonymous], 2005, CLIN GUIDE INHERITED, V0, P0
   Asadov Chingiz, 2017, CARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY, V15, P23, DOI 10.2174/1871525715666170529091921
   Assmann BE, 2006, EPILEPSIA, V47, P215, DOI 10.1111/j.1528-1167.2006.00391.x
   Balasubramaniam S, 2014, J INHERIT METAB DIS, V37, P687, DOI 10.1007/s10545-014-9742-3
   Bierau J, 2014, PHYS GUIDE DIAGNOSIS, V0, P0
   Blau N, 2003, PHYSICIANS GUIDE TO THE LABORATORY DIAGNOSIS OF METABOLIC DISEASES, V0, P0, DOI DOI 10.1007/978-3-642-55878-8
   Burton BK, 1998, PEDIATRICS, V102, P0, DOI 10.1542/peds.102.6.e69
   CAMERON JS, 1993, PEDIATR NEPHROL, V7, P105, DOI 10.1007/BF00861588
   Caudle KE, 2013, CLIN PHARMACOL THER, V94, P640, DOI 10.1038/clpt.2013.172
   Christodoulou John, 2004, SEMIN NEONATOL, V9, P275, DOI 10.1016/j.siny.2003.10.004
   Curto R, 1998, BIOCHEM J, V329, P477, DOI 10.1042/bj3290477
   de Goede C, 2016, EUR J PAEDIATR NEURO, V20, P286, DOI 10.1016/j.ejpn.2015.11.012
   De Vivo DC, 1999, J CHILD NEUROL, V14, PS1, DOI 10.1177/0883073899014001011
   del Caño-Ochoa F, 2020, GENET MED, V22, P1598, DOI 10.1038/s41436-020-0833-2
   Fernandes J, 2006, INBORN METABOLIC DIS, VFourth, P0
   Ghosh A, 2017, ARCH DIS CHILD, V102, P1019, DOI 10.1136/archdischild-2017-312738
   GIBLETT ER, 1972, LANCET, V2, P1067
   Gitiaux C, 2009, EUR J HUM GENET, V17, P133, DOI 10.1038/ejhg.2008.174
   Hartmann S, 2006, CLIN CHEM, V52, P1127, DOI 10.1373/clinchem.2005.058842
   Hershfield MS, 1997, J INHERIT METAB DIS, V20, P179, DOI 10.1023/A:1005300621350
   Hoffmann GF, 2017, INHERITED METABOLIC, V2th, P0
   Holder-Espinasse M, 2002, J MED GENET, V39, P440, DOI 10.1136/jmg.39.6.440
   Jinnah HA, 2013, HAND CLINIC, V113, P1827, DOI 10.1016/B978-0-444-59565-2.00052-6
   Jinnah HA, 2006, BRAIN, V129, P1201, DOI 10.1093/brain/awl056
   Jurecka A, 2009, J INHERIT METAB DIS, V32, P247, DOI 10.1007/s10545-009-1094-z
   Jurecka A, 2008, MOL GENET METAB, V94, P435, DOI 10.1016/j.ymgme.2008.04.013
   Jurecka A, 2015, J INHERIT METAB DIS, V38, P231, DOI 10.1007/s10545-014-9755-y
   Jurecka A, 2014, NEUROPEDIATRICS, V45, P50, DOI 10.1055/s-0033-1337335
   Jurecka A, 2010, J INHERIT METAB DIS, V33, PS21, DOI 10.1007/s10545-009-9011-z
   Jurecka A, 2012, J CHILD NEUROL, V27, P645, DOI 10.1177/0883073811424465
   Jurecka A, 2012, EUR J PEDIATR, V171, P131, DOI 10.1007/s00431-011-1503-9
   Kamatani N, 1998, INTERNAL MED, V37, P905, DOI 10.2169/internalmedicine.37.905
   Kassimatis TI, 2005, J NEPHROL, V18, P447
   Kiss A, 1999, UROL INT, V63, P242, DOI 10.1159/000030458
   Kozma P, 2005, AM J OPHTHALMOL, V140, P858, DOI 10.1016/j.ajo.2005.05.027
   Leonard JV, 2006, ACTA PAEDIATR, V95, P6, DOI 10.1080/08035250500349413
   Löffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003
   Lundy CT, 2010, PEDIATR NEUROL, V43, P351, DOI 10.1016/j.pediatrneurol.2010.06.007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Maring JG, 2002, BRIT J CANCER, V86, P1028, DOI 10.1038/sj/bjc/6600208
   McBride MB, 1998, PEDIATR NEPHROL, V12, P357, DOI 10.1007/s004670050466
   MITCHELL G, 1984, CAN MED ASSOC J, V130, P1323
   Mouchegh K, 2007, J PEDIATR-US, V150, P57, DOI 10.1016/j.jpeds.2006.09.027
   Najarian T, 2000, NEUROREHAB NEURAL RE, V14, P237, DOI 10.1177/154596830001400310
   Ng BG, 2015, HUM MOL GENET, V24, P3050, DOI 10.1093/hmg/ddv057
   Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Puig JG, 2001, MEDICINE, V80, P102, DOI 10.1097/00005792-200103000-00003
   Ramond F, 2020, J INHERIT METAB DIS, V43, P1254, DOI 10.1002/jimd.12274
   Rymen D, 2020, GENET MED, V22, P1589, DOI 10.1038/s41436-020-0933-z
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schatz Patrik, 2005, OPHTHALMIC GENET, V26, P119, DOI 10.1080/13816810500229090
   Schretlen DJ, 2005, DEV MED CHILD NEUROL, V47, P673, DOI 10.1017/S0012162205001374
   Scriver CR, 2001, METABOLIC MOL BASES, V0, P2512
   Simmonds HA, 1991, TECHNIQUES DIAGNOSTI, V0, P397
   Simmonds HA, 2000, INHERITED METABOLIC, V0, P215
   SIMMONDS HA, 1994, PHARM WORLD SCI, V16, P139, DOI 10.1007/BF01880664
   Simmonds HA, 1997, J INHERIT METAB DIS, V20, P214, DOI 10.1023/A:1005308923168
   Torres RJ, 2007, ORPHANET J RARE DIS, V2, P0, DOI 10.1186/1750-1172-2-48
   VALENTINE WN, 1980, HEMOGLOBIN, V4, P669, DOI 10.3109/03630268008997736
   Valik D, 1997, MAYO CLIN PROC, V72, P719
   Van Gennip AH, 2000, ADV EXP MED BIOL, V486, P233
   Van Gennip AH, 1999, NED TIJDSH KLIN CHEM, V24, P171
   van Kuilenburg ABP, 2008, LAB GUIDE METHODS BI, V0, P0
   Van Kuilenburg ABP, 2002, INT J CANCER, V101, P253, DOI 10.1002/ijc.10599
   van Kuilenburg ABP, 2004, NUCLEOS NUCLEOT NUCL, V23, P1371, DOI 10.1081/NCN-200027624
   van Kuilenburg ABP, 2004, HUM MOL GENET, V13, P2793, DOI 10.1093/hmg/ddh303
   van Kuilenburg ABP, 2004, EUR J CANCER, V40, P939, DOI 10.1016/j.ejca.2003.12.004
   van Kuilenburg ABP, 2003, CLIN CANCER RES, V9, P4363
   Van Kuilenburg ABP, 1999, HUM GENET, V104, P1, DOI 10.1007/PL00008711
   van Kuilenburg ABP, 2000, CLIN CANCER RES, V6, P4705
   vanGennip AH, 1997, J INHERIT METAB DIS, V20, P203, DOI 10.1023/A:1005356806329
   Wada Y, 2005, INVEST OPHTH VIS SCI, V46, P1735, DOI 10.1167/iovs.04-1197
   Zhou L, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.00064
NR 75
TC 9
Z9 9
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JUL 15
PY 2022
VL 136
IS 3
BP 164
EP 176
DI 10.1016/j.ymgme.2022.02.007
EA JUN 2022
PG 13
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA 2J9ZF
UT WOS:000816004700002
PM 35216884
DA 2024-11-01
ER

PT J
AU Ji, KQ
   Lin, Y
   Xu, XB
   Wang, W
   Wang, DD
   Zhang, C
   Li, W
   Zhao, YY
   Yan, CZ
AF Ji, Kunqian
   Lin, Yan
   Xu, Xuebi
   Wang, Wei
   Wang, Dongdong
   Zhang, Chen
   Li, Wei
   Zhao, Yuying
   Yan, Chuanzhu
TI MELAS-associated m.5541C&gt;T mutation caused instability of mitochondrial tRNA<SUP>Trp</SUP> and remarkable mitochondrial dysfunction
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE neuromuscular diseases; neurology; molecular medicine
ID transfer-rna modification; optimization; deficiency
AB Background Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episode (MELAS) is a group of genetic diseases caused by mutations in mitochondrial DNA and nuclear DNA. The causative mutations of MELAS have drawn much attention, among them, mutations in mitochondrial tRNA genes possessing prominent status. However, the detailed molecular pathogenesis of these tRNA gene mutations remains unclear and there are very few effective therapies available to date. Methods We performed muscle histochemistry, genetic analysis, molecular dynamic stimulation and measurement of oxygen consumption rate and respiratory chain complex activities to demonstrate the molecular pathomechanisms of m.5541C>T mutation. Moreover, we use cybrid cells to investigate the potential of taurine to rescue mitochondrial dysfunction caused by this mutation. Results We found a pathogenic m.5541C>T mutation in the tRNA(Trp) gene in a large MELAS family. This mutation first affected the maturation and stability of tRNA(Trp) and impaired mitochondrial respiratory chain complex activities, followed by remarkable mitochondrial dysfunction. Surprisingly, we identified that the supplementation of taurine almost completely restored mitochondrial tRNA(Trp) levels and mitochondrial respiration deficiency at the in vitro cell level. Conclusion The m.5541C>T mutation disturbed the translation machinery of mitochondrial tRNA(Trp) and taurine supplementation may be a potential treatment for patients with m.5541C>T mutation. Further studies are needed to explore the full potential of taurine supplementation as therapy for patients with this mutation.
C1 [Ji, Kunqian; Lin, Yan; Wang, Wei; Wang, Dongdong; Li, Wei; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Dept Neurol, Qilu Hosp, Jinan, Shandong, Peoples R China.
   [Ji, Kunqian; Yan, Chuanzhu] Shandong Univ, Dept Neurol, Res Inst Neuromuscular & Neurodegenerat Dis, Jinan, Peoples R China.
   [Xu, Xuebi] Wenzhou Med Univ, Dept Neurol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China.
   [Zhang, Chen] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan, Peoples R China.
C3 Shandong University; Shandong University; Wenzhou Medical University; Shandong University; Shandong University
RP Yan, CZ (corresponding author), Shandong Univ, Dept Neurol, Qilu Hosp, Jinan, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Dept Neurol, Res Inst Neuromuscular & Neurodegenerat Dis, Jinan, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Brain Sci Res Inst, Jinan, Peoples R China.
EM czyan@sdu.edu.cn
FU National Natural Science Foundation of China [81701237, 81671235]; People's Benefit Project of Science and Technology in Qingdao [16-6-2-1-nsh]; Taishan Scholars Programme of Shandong Province
CR Bacman SR, 2007, METHOD CELL BIOL, V80, P503, DOI 10.1016/S0091-679X(06)80025-7
   BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Götz A, 2012, PEDIATR RES, V72, P90, DOI 10.1038/pr.2012.43
   Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872
   Grosjean H, 2016, NUCLEIC ACIDS RES, V44, P8020, DOI 10.1093/nar/gkw608
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, P0, DOI 10.1186/s40478-015-0227-x
   Ji KQ, 2014, NEUROMOL MED, V16, P119, DOI 10.1007/s12017-013-8264-8
   Jia ZD, 2019, NUCLEIC ACIDS RES, V47, P2056, DOI 10.1093/nar/gky1241
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Malfatti E, 2010, J NEUROL SCI, V297, P105, DOI 10.1016/j.jns.2010.06.009
   Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pon LA, 2011, MITOCHONDRIA, V0, P0
   Ra SG, 2016, APPL PHYSIOL NUTR ME, V41, P618, DOI 10.1139/apnm-2015-0560
   Rikimaru M, 2012, INTERNAL MED, V51, P3351, DOI 10.2169/internalmedicine.51.7529
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743
   TRAUTWEIN EA, 1990, AM J CLIN NUTR, V52, P758, DOI 10.1093/ajcn/52.4.758
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   Wang J, 2017, NUCLEIC ACIDS RES, V45, P6299, DOI 10.1093/nar/gkx386
   Yan JB, 2014, J MOL DIAGN, V16, P431, DOI 10.1016/j.jmoldx.2014.03.005
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Yasukawa T, 2000, NUCLEIC ACIDS RES, V28, P3779, DOI 10.1093/nar/28.19.3779
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107
NR 37
TC 4
Z9 4
U1 1
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD JAN 15
PY 2022
VL 59
IS 1
BP 79
EP 87
DI 10.1136/jmedgenet-2020-107323
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA XR0XZ
UT WOS:000731964400011
PM 33208382
DA 2024-11-01
ER

PT J
AU Roos, S
   Hedberg-Oldfors, C
   Visuttijai, K
   Stein, M
   Kollberg, G
   Elíasdóttir, O
   Lindberg, C
   Darin, N
   Oldfors, A
AF Roos, Sara
   Hedberg-Oldfors, Carola
   Visuttijai, Kittichate
   Stein, My
   Kollberg, Gittan
   Eliasdottir, Olof
   Lindberg, Christopher
   Darin, Niklas
   Oldfors, Anders
TI Expression pattern of mitochondrial respiratory chain enzymes in skeletal muscle of patients with mitochondrial myopathy associated with the homoplasmic m.14674T>C variant
SO BRAIN PATHOLOGY
LA English
DT Article
DE homoplasmic mt-tRNA(Glu) variant; mitochondrial myopathy; mtDNA; reversible infantile respiratory chain deficiency; whole genome sequencing
ID c-oxidase deficiency; mutation; arthrogryposis; genes
AB Two homoplasmic variants in tRNA(Glu) (m.14674T>C/G) are associated with reversible infantile respiratory chain deficiency. This study sought to further characterize the expression of the individual mitochondrial respiratory chain complexes and to describe the natural history of the disease. Seven patients from four families with mitochondrial myopathy associated with the homoplasmic m.14674T>C variant were investigated. All patients underwent skeletal muscle biopsy and mtDNA sequencing. Whole-genome sequencing was performed in one family. Western blot and immunohistochemical analyses were used to characterize the expression of the individual respiratory chain complexes. Patients presented with hypotonia and feeding difficulties within the first weeks or months of life, except for one patient who first showed symptoms at 4 years of age. Histopathological findings in muscle included lipid accumulation, numerous COX-deficient fibers, and mitochondrial proliferation. Ultrastructural abnormalities included enlarged mitochondria with concentric cristae and dense mitochondrial matrix. The m.14674T>C variant in MT-TE was identified in all patients. Immunohistochemistry and immunoblotting demonstrated pronounced deficiency of the complex I subunit NDUFB8. The expression of MTCO1, a complex IV subunit, was also decreased, but not to the same extent as NDUFB8. Longitudinal follow-up data demonstrated that not all features of the disorder are entirely transient, that the disease may be progressive, and that signs and symptoms of myopathy may develop during childhood. This study sheds new light on the involvement of complex I in reversible infantile respiratory chain deficiency, it shows that the disorder may be progressive, and that myopathy can develop without an infantile episode.
C1 [Roos, Sara; Hedberg-Oldfors, Carola; Visuttijai, Kittichate; Kollberg, Gittan; Oldfors, Anders] Univ Gothenburg, Inst Biomed, Dept Lab Med, Gothenburg, Sweden.
   [Stein, My] Helsingborg Hosp, Dept Pediat, Helsingborg, Sweden.
   [Eliasdottir, Olof; Lindberg, Christopher] Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
   [Darin, Niklas] Univ Gothenburg, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
C3 University of Gothenburg; Helsingborgs Hospital; Sahlgrenska University Hospital; University of Gothenburg
RP Roos, S (corresponding author), Univ Gothenburg, Inst Biomed, Dept Lab Med, Gothenburg, Sweden.
EM sara.m.roos@vgregion.se
FU Swedish Research Council [2018-02821]; ALF agreement grants [ALFGBG-716821, ALFGBG-718681]; Swedish Research Council [2018-02821] Funding Source: Swedish Research Council; Vinnova [2018-02821] Funding Source: Vinnova
CR Attali R, 2009, HUM MOL GENET, V18, P3462, DOI 10.1093/hmg/ddp290
   Baumann M, 2017, EUR J HUM GENET, V25, P262, DOI 10.1038/ejhg.2016.144
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   DIMAURO S, 1981, T AM NEUROL ASSOC, V106, P205
   Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P1, DOI 10.1177/000271623618500112
   Gurgel-Giannetti J, 2018, BRAIN, V141, P2289, DOI 10.1093/brain/awy172
   Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577
   Hathazi D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2020105364
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, P0, DOI 10.1111/bpa.12931
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2
   Jennions E, 2019, J INHERIT METAB DIS, V42, P898, DOI 10.1002/jimd.12149
   Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048
   Laquérriere A, 2014, HUM MOL GENET, V23, P2279, DOI 10.1093/hmg/ddt618
   Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111
   OLDFORS A, 1989, ACTA NEUROPATHOL, V77, P267, DOI 10.1007/BF00687578
   Schuelke M, 2017, NEUROPATH APPL NEURO, V43, P44, DOI 10.1111/nan.12374
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300
   Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995
   Visuttijai K, 2021, ACTA NEUROL SCAND, V143, P103, DOI 10.1111/ane.13339
   Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002
   Zhang JL, 2010, HUM MOL GENET, V19, P329, DOI 10.1093/hmg/ddp499
NR 24
TC 4
Z9 4
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD JUL 15
PY 2022
VL 32
IS 4
BP 
EP 
DI 10.1111/bpa.13038
EA NOV 2021
PG 16
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 2J7FM
UT WOS:000720790300001
PM 34806237
DA 2024-11-01
ER

PT J
AU Lima, ML
   Abengozar, MA
   Torres-Santos, EC
   Borborema, SET
   Godzien, J
   Lopez-Gonzalvezd, A
   Barbas, C
   Rivas, L
   Tempone, AG
AF Lima, Marta Lopes
   Abengozar, Maria A.
   Torres-Santos, Eduardo Caio
   Borborema, Samanta Etel Treiger
   Godzien, Joanna
   Lopez-Gonzalvezd, Angeles
   Barbas, Coral
   Rivas, Luis
   Tempone, Andre Gustavo
TI Energy metabolism as a target for cyclobenzaprine: A drug candidate against Visceral Leishmaniasis
SO BIOORGANIC CHEMISTRY
LA English
DT Article
DE Leishmania; Cyclobenzaprine; Drug repurposing; Mechanism of action; Leishmaniasis; Neglected diseases
ID programmed cell-death; trypanosoma-cruzi; donovani promastigotes; antidepressants; inhibition; induction; infantum
AB Leishmaniases have a broad spectrum of clinical manifestations, ranging from a cutaneous to a progressive and fatal visceral disease. Chemotherapy is nowadays the almost exclusive way to fight the disease but limited by its scarce therapeutic arsenal, on its own compromised by adverse side effects and clinical resistance. Cyclobenzaprine (CBP), an FDA-approved oral muscle relaxant drug has previously demonstrated in vitro and in vivo activity against Leishmania sp., but its targets were not fully unveiled. This study aimed to define the role of energy metabolism as a target for the leishmanicidal mechanisms of CBP. Methodology to assess CBP leishmanicidal mechanism variation of intracellular ATP levels using living Leishmania transfected with a cytoplasmic luciferase. Induction of plasma membrane permeability by assessing depolarization with DiSBAC(2)3 and entrance of the vital dye SYTOX (R) Green. Mitochondrial depolarization by rhodamine 123 accumulation. Mapping target site within the respiratory chain by oxygen consumption rate. Reactive oxygen species (ROS) production using MitoSOX. Morphological changes by transmission electron microscopy. CBP caused on L. infantum promastigotes a decrease of intracellular ATP levels, with irreversible depolarization of plasma membrane, the collapse of the mitochondrial electrochemical potential, mild uncoupling of the respiratory chain, and ROS production, with ensuing intracellular Ca2+ imbalance and DNA fragmentation. Electron microscopy supported autophagic features but not a massive plasma membrane disruption. The severe and irreversible mitochondrial damage induced by CBP endorsed the bioenergetics metabolism as a relevant target within the lethal programme induced by CBP in Leishmania. This, together with the mild-side effects of this oral drug, endorses CBP as an appealing novel candidate as a leishmanicidal drug under a drug repurposing strategy.
C1 [Lima, Marta Lopes; Borborema, Samanta Etel Treiger; Tempone, Andre Gustavo] Adolfo Lutz Inst, Ctr Parasitol & Mycol, Sao Paulo, SP, Brazil.
   [Abengozar, Maria A.; Rivas, Luis] Ctr Invest Biol Margarita Salas CSIC, Madrid, Spain.
   [Torres-Santos, Eduardo Caio] Fiocruz MS, Inst Oswaldo Cruz, Lab Bioquim Tripanosomatideos, Rio De Janeiro, Brazil.
   [Godzien, Joanna; Lopez-Gonzalvezd, Angeles; Barbas, Coral] Univ CEU San Pablo, Fac Pharm, Ctr Metabol & Bioanal CEMBIO, Madrid, Spain.
C3 Instituto Adolfo Lutz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Fundacao Oswaldo Cruz; San Pablo CEU University
RP Tempone, AG (corresponding author), Adolfo Lutz Inst, Ctr Parasitol & Mycol, Sao Paulo, SP, Brazil.; Rivas, L (corresponding author), Ctr Invest Biol Margarita Salas CSIC, Madrid, Spain.; Barbas, C (corresponding author), Univ CEU San Pablo, Fac Pharm, Ctr Metabol & Bioanal CEMBIO, Madrid, Spain.
EM cbarbas@ceu.es; luis.rivas@cib.csic.es; andre.tempone@ial.sp.gov.br
FU Sao Paulo State Research Foundation [FAPESP 2019/10434-4, 2021/04464-8, 2017/50333-7]; Subdireccion General de Redes y Centros de Investigacion Cooperativa -FEDER [RICET RD16/0027/0010]; Ministerio de Ciencia e Innovacion Espana. Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion 2017-2020-FEDER [PID2019108166GB-100/AEI/10.13039/501100011033]; EADS-CASA/Brazilian Air Force (FAB) mobility program; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Swedish Research Council [2021-04464] Funding Source: Swedish Research Council
CR ABOOD LG, 1955, P SOC EXP BIOL MED, V88, P688
   Alvar J, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035671
   Andrade-Neto VV, 2018, FRONT BIOSCI-LANDMRK, V23, P967, DOI 10.2741/4629
   Abengózar MA, 2017, ANTIMICROB AGENTS CH, V61, P0, DOI 10.1128/AAC.02288-16
   Abengózar MA, 2015, ANTIMICROB AGENTS CH, V59, P1211, DOI 10.1128/AAC.04003-14
   Basmaciyan L, 2018, MICROB CELL, V5, P404, DOI 10.15698/mic2018.09.646
   Benaim G, 2020, FRONT CELL INFECT MI, V10, P0, DOI 10.3389/fcimb.2020.00046
   Bera A, 2003, MOL BIOCHEM PARASIT, V127, P23, DOI 10.1016/S0166-6851(02)00300-6
   Carvalho L, 2010, ANTIMICROB AGENTS CH, V54, P5344, DOI 10.1128/AAC.00790-10
   Cha Y, 2018, BRIT J PHARMACOL, V175, P168, DOI 10.1111/bph.13798
   Cimolai Nevio, 2009, EXPERT REV CLIN PHARMACOL, V2, P255, DOI 10.1586/ecp.09.5
   Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x
   Cunha EF, 2017, PLOS NEGLECT TROP D, V11, P0, DOI 10.1371/journal.pntd.0005281
   Docampo R, 2022, J EUKARYOT MICROBIOL, V69, P0, DOI 10.1111/jeu.12899
   El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631
   EVANS AT, 1994, BIOCHEM PHARMACOL, V48, P613, DOI 10.1016/0006-2952(94)90293-3
   Field MC, 2017, NAT REV MICROBIOL, V15, P447, DOI 10.1038/nrmicro.2017.69
   Fisar Z, 2005, GEN PHYSIOL BIOPHYS, V24, P161
   Gillespie PM, 2016, VACCINE, V34, P2992, DOI 10.1016/j.vaccine.2015.12.071
   GLASER TA, 1992, MOL BIOCHEM PARASIT, V51, P1, DOI 10.1016/0166-6851(92)90194-O
   Goldshmidt H, 2010, PLOS PATHOG, V6, P0, DOI 10.1371/journal.ppat.1000731
   Hannaert Veronique, 2003, KINETOPLASTID BIOLOGY AND DISEASE, V2, P0
   Honda M, 2003, EUR J PHARMACOL, V458, P91, DOI 10.1016/S0014-2999(02)02735-8
   Jones DC, 2010, MOL BIOCHEM PARASIT, V169, P12, DOI 10.1016/j.molbiopara.2009.09.002
   Kaiser A, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20010138
   Kapoor R, 2019, J GEN PHYSIOL, V151, P342, DOI 10.1085/jgp.201812263
   Kathuria M, 2014, ANTIMICROB AGENTS CH, V58, P5916, DOI 10.1128/AAC.02459-14
   Leroux AE, 2016, MOL BIOCHEM PARASIT, V206, P67, DOI 10.1016/j.molbiopara.2015.11.003
   Luque-Ortega JR, 2003, BIOCHEM J, V375, P221, DOI 10.1042/BJ20030544
   Luque-Ortega JR, 2001, ANTIMICROB AGENTS CH, V45, P1121, DOI 10.1128/AAC.45.4.1121-1125.2001
   Maarouf M, 1997, EXP CELL RES, V232, P339, DOI 10.1006/excr.1997.3500
   Mallick K, 2022, INT J APPL PHARM, V14, P1
   Manglik A, 2017, BIOCHEMISTRY-US, V56, P5628, DOI 10.1021/acs.biochem.7b00747
   McConville Malcolm J, 2015, F1000RES, V4, P938, DOI 10.12688/f1000research.6724.1
   Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200
   Opperdoes FR, 2008, TRENDS PARASITOL, V24, P310, DOI 10.1016/j.pt.2008.03.013
   Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004
   Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004
   Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281
   Luque-Ortega JR, 2010, J MED CHEM, V53, P1788, DOI 10.1021/jm901677h
   Luque-Ortega JR, 2007, ANTIMICROB AGENTS CH, V51, P1327, DOI 10.1128/AAC.01415-06
   Luque-Ortega JR, 2010, METHODS MOL BIOL, V618, P393, DOI 10.1007/978-1-60761-594-1_25
   Menna-Barreto RFS, 2014, BIOMED RES INT-UK, V2014, P0, DOI 10.1155/2014/614014
   Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553
   Sen N, 2004, J BIOL CHEM, V279, P52366, DOI 10.1074/jbc.M406705200
   Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305
   Shrestha R, 2021, MOL METAB, V51, P0, DOI 10.1016/j.molmet.2021.101222
   Tempone AG, 2017, EUR J MED CHEM, V139, P947, DOI 10.1016/j.ejmech.2017.08.055
   Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007
   VanHellemond JJ, 1997, PARASITOLOGY, V114, P351, DOI 10.1017/S0031182096008591
   VERCESI AE, 1991, J BIOL CHEM, V266, P14431
   Verma NK, 2004, ANTIMICROB AGENTS CH, V48, P3010, DOI 10.1128/AAC.48.8.3010-3015.2004
   Vieira LL, 1995, MOL BIOCHEM PARASIT, V75, P15, DOI 10.1016/0166-6851(95)02505-7
   Villanueva-Paz Marina, 2016, GENES CANCER, V7, P260
   WEINBACH EC, 1986, BIOCHEM PHARMACOL, V35, P1445, DOI 10.1016/0006-2952(86)90108-5
   ZILBERSTEIN D, 1984, SCIENCE, V226, P977, DOI 10.1126/science.6505677
NR 56
TC 1
Z9 1
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0045-2068
EI 1090-2120
J9 BIOORG CHEM
JI Bioorganic Chem.
PD OCT 15
PY 2022
VL 127
IS 
BP 
EP 
DI 10.1016/j.bioorg.2022.106009
EA JUL 2022
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 3G1CS
UT WOS:000831094000005
PM 35841672
DA 2024-11-01
ER

PT J
AU Chen, J
   Xiao, JF
   Chen, G
   Xu, Q
   Wu, XW
   Tian, LF
   Huang, ZH
   Xin, CL
   Zhao, Y
   Guo, Z
   Zou, Y
   Wu, QF
AF Chen, Jia
   Xiao, Junfang
   Chen, Ge
   Xu, Qiang
   Wu, Xingwu
   Tian, Lifeng
   Huang, Zhihui
   Xin, Cailin
   Zhao, Yan
   Guo, Zhen
   Zou, Yang
   Wu, Qiongfang
TI Indentification of novel <i>MSTO1</i> compound heterozygous mutations in a Chinese family with recessive cerebellar atrophy and ataxia
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE MSTO1; myopathy and ataxia; mitochondrial disorders; whole exome sequencing; missense variant
ID mitochondrial; saccharomyces; drosophila; myopathy; protein; misato; gene
AB Misato mitochondrial distribution and morphology regulator 1 (MSTO1) is a nuclear-encoded cytoplasmic protein involved in mitochondrial fusion and distribution. Its disruption causes an extremely rare mitochondrial disorder characterized by early-onset myopathy and cerebellar ataxia. The genotype-phenotype correlation in the MSTO1 gene is rarely studied before 2017, and only 25 mutations have been described in the patients. Here, we reported two siblings with progressive cerebellar atrophy and ataxia in a Chinese family. Two compound heterozygous mutations in the MSTO1 gene, a novel missense mutation c.571C>T (p.Arg191Trp), and a reported frameshift mutation c.1259delG (p.Gly420ValfsTer2) were identified in the patients by whole exome sequencing. in vitro experiments found both of the mutations lead to reduced protein abundance and link to decreased mtDNA content. Except for ataxia and delayed motor, both of the siblings also have low birth weights, learning difficulties, and dysarthria. Our report enriched the genotype and phenotype spectrums of the MSTO1-related disorder and supported the recessive inheritance of the disease.
C1 [Chen, Jia; Xu, Qiang; Wu, Xingwu; Tian, Lifeng; Huang, Zhihui; Xin, Cailin; Zhao, Yan; Wu, Qiongfang] Jiangxi Prov Maternal & Child Hlth Hosp, Reprod Med Ctr, Nanchang, Peoples R China.
   [Xiao, Junfang] Jiangxi Prov Maternal & Child Hlth Hosp, Med Genet Ctr, Nanchang, Peoples R China.
   [Xiao, Junfang] Jiangxi Prov Key Lab Birth Defect Prevent & Contro, Nanchang, Peoples R China.
   [Chen, Ge; Zou, Yang] Jiangxi Prov Maxternal & Child Hlth Hosp, Cent Lab, Nanchang, Peoples R China.
   [Guo, Zhen] Jiangxi Prov Maternal & Child Hlth Hosp, Med Imaging Ctr, Nanchang, Peoples R China.
RP Wu, QF (corresponding author), Jiangxi Prov Maternal & Child Hlth Hosp, Reprod Med Ctr, Nanchang, Peoples R China.; Zou, Y (corresponding author), Jiangxi Prov Maxternal & Child Hlth Hosp, Cent Lab, Nanchang, Peoples R China.
EM zouyang81@163.com; wuqiongfang898@sina.com
CR Ardicli D, 2019, NEUROMUSCULAR DISORD, V29, P448, DOI 10.1016/j.nmd.2019.03.011
   Chen J, 2020, BMC CARDIOVASC DISOR, V20, P0, DOI 10.1186/s12872-019-01322-1
   Donkervoort S, 2019, ACTA NEUROPATHOL, V138, P1013, DOI 10.1007/s00401-019-02059-z
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   Gal A, 2017, EMBO MOL MED, V9, P967, DOI 10.15252/emmm.201607058
   Gurvitz A, 2002, FEMS YEAST RES, V2, P123, DOI 10.1111/j.1567-1364.2002.tb00077.x
   Iwama K, 2018, J HUM GENET, V63, P263, DOI 10.1038/s10038-017-0405-8
   Jiao YQ, 2021, ACTA NEUROL BELG, V121, P795, DOI 10.1007/s13760-020-01544-7
   Kimura M, 2007, EXP CELL RES, V313, P1393, DOI 10.1016/j.yexcr.2007.02.004
   Li K, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2019.01.013
   Liu LQ, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.947886
   Miklos GLG, 1997, P NATL ACAD SCI USA, V94, P5189, DOI 10.1073/pnas.94.10.5189
   Mottier-Pavie V, 2011, J CELL SCI, V124, P706, DOI 10.1242/jcs.072348
   Nasca A, 2021, J HUM GENET, V66, P835, DOI 10.1038/s10038-020-00897-4
   Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Schultz-Rogers L, 2019, CSH MOL CASE STUD, V5, P0, DOI 10.1101/mcs.a004309
   Tian Yang, 2022, ZHONGHUA YIXUE YICHUANXUE ZAZHI, V39, P417, DOI 10.3760/cma.j.cn511374-20210319-00249
NR 19
TC 0
Z9 0
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD NOV 17
PY 2022
VL 13
IS 
BP 
EP 
DI 10.3389/fneur.2022.988519
PG 12
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 7S0RR
UT WOS:000910470800001
PM 36468072
DA 2024-11-01
ER

PT J
AU Solomon, CU
   McVey, DG
   Andreadi, C
   Gong, P
   Turner, L
   Stanczyk, PJ
   Khemiri, S
   Chamberlain, JC
   Yang, W
   Webb, TR
   Nelson, CP
   Samani, NJ
   Ye, S
AF Solomon, Charles U.
   McVey, David G.
   Andreadi, Catherine
   Gong, Peng
   Turner, Lenka
   Stanczyk, Paulina J.
   Khemiri, Sonja
   Chamberlain, Julie C.
   Yang, Wei
   Webb, Tom R.
   Nelson, Christopher P.
   Samani, Nilesh J.
   Ye, Shu
TI Effects of Coronary Artery Disease-Associated Variants on Vascular Smooth Muscle Cells
SO CIRCULATION
LA English
DT Article
DE coronary artery disease; genetics; muscle; smooth; vascular; transcriptomes
ID mitochondrial-function; loci; generation; signals; yipf6; golgi; gwas; eqtl
AB Background: Genome-wide association studies have identified many genetic loci that are robustly associated with coronary artery disease (CAD). However, the underlying biological mechanisms are still unknown for most of these loci, hindering the progress to medical translation. Evidence suggests that the genetic influence on CAD susceptibility may act partly through vascular smooth muscle cells (VSMCs). Methods: We undertook genotyping, RNA sequencing, and cell behavior assays on a large bank of VSMCs (n>1499). Expression quantitative trait locus and splicing quantitative trait locus analyses were performed to identify genes with an expression that was influenced by CAD-associated variants. To identify candidate causal genes for CAD, we ascertained colocalizations of VSMC expression quantitative trait locus signals with CAD association signals by performing causal variants identification in associated regions analysis and the summary data-based mendelian randomization test. Druggability analysis was then performed on the candidate causal genes. CAD risk variants were tested for associations with VSMC proliferation, migration, and apoptosis. Collective effects of multiple CAD-associated variants on VSMC behavior were estimated by polygenic scores. Results: Approximately 60% of the known CAD-associated variants showed statistically significant expression quantitative trait locus or splicing quantitative trait locus effects in VSMCs. Colocalization analyses identified 84 genes with expression quantitative trait locus signals that significantly colocalized with CAD association signals, identifying them as candidate causal genes. Druggability analysis indicated that 38 of the candidate causal genes were druggable, and 13 had evidence of drug-gene interactions. Of the CAD-associated variants tested, 139 showed suggestive associations with VSMC proliferation, migration, or apoptosis. A polygenic score model explained up to 5.94% of variation in several VSMC behavior parameters, consistent with polygenic influences on VSMC behavior. Conclusions: This comprehensive analysis shows that a large percentage of CAD loci can modulate gene expression in VSMCs and influence VSMC behavior. Several candidate causal genes identified are likely to be druggable and thus represent potential therapeutic targets.
C1 [Solomon, Charles U.; McVey, David G.; Andreadi, Catherine; Gong, Peng; Turner, Lenka; Stanczyk, Paulina J.; Khemiri, Sonja; Chamberlain, Julie C.; Webb, Tom R.; Nelson, Christopher P.; Samani, Nilesh J.; Ye, Shu] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.
   [Solomon, Charles U.; McVey, David G.; Andreadi, Catherine; Gong, Peng; Turner, Lenka; Stanczyk, Paulina J.; Khemiri, Sonja; Chamberlain, Julie C.; Webb, Tom R.; Nelson, Christopher P.; Samani, Nilesh J.; Ye, Shu] Natl Inst Hlth Res Leicester Biomed Res Ctr, Leicester, Leics, England.
   [Yang, Wei; Ye, Shu] Shantou Univ, Med Coll, Shantou, Peoples R China.
   [Ye, Shu] Natl Univ Singapore, Dept Med, Cardiovasc Dis Translat Res Programme, Singapore, Singapore.
C3 University of Leicester; Shantou University; National University of Singapore
RP Ye, S (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Cardiovasc Dis Translat Res Programme, Dept Med,Ctr Translat Med, Block MD 6,14 Med Dr, Singapore 117599, Singapore.
EM sy127@leicester.ac.uk
FU British Heart Foundation [RG/16/13/32609, RG/19/9/34655, PG/16/9/31995, PG/18/73/34059, SP/19/2/344612]; National University of Singapore [NUHSRO/2022/004/Startup/01]; National University Health System Internal Grant Funding [NUHSRO/2022/004/Startup/01]; National Natural Science Foundation of China [81370202, 82070466, 82000341]
CR Aherrahrou R, 2020, CIRC RES, V127, P1552, DOI 10.1161/CIRCRESAHA.120.317415
   Almontashiri NAM, 2015, CIRCULATION, V132, P1969, DOI 10.1161/CIRCULATIONAHA.114.015023
   Angelakopoulou A, 2012, EUR HEART J, V33, P393, DOI 10.1093/eurheartj/ehr225
   Aragam KG, 2021, MEDRXIV, V0, P0, DOI DOI 10.1101/2021.05.24.21257377
   Basatemur GL, 2019, NAT REV CARDIOL, V16, P727, DOI 10.1161/CIRCRESAHA.115.306361
   Buniello A, 2019, NUCLEIC ACIDS RES, V47, PD1005, DOI 10.1093/nar/gky1120
   Chang CC, 2015, GIGASCIENCE, V4, P0, DOI 10.1186/s13742-015-0047-8
   Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214
   Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656
   Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480
   Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808
   Dituri F, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8101130
   Djusberg E, 2017, PROSTATE, V77, P625, DOI 10.1002/pros.23307
   Dobin Alexander, 2015, CURR PROTOC BIOINFORMATICS, V51, P0, DOI 10.1002/0471250953.bi1114s51
   Erdmann J, 2018, CARDIOVASC RES, V114, P1241, DOI 10.1093/cvr/cvy084
   Finan C, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aag1166
   Freshour SL, 2021, NUCLEIC ACIDS RES, V49, PD1144, DOI 10.1093/nar/gkaa1084
   Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003
   Howson JMM, 2017, NAT GENET, V49, P1113, DOI 10.1038/ng.3874
   Huang CK, 2020, CIRC RES, V126, P663, DOI 10.1161/CIRCRESAHA.119.315856
   Huang QQ, 2018, NUCLEIC ACIDS RES, V46, P0, DOI 10.1093/nar/gky780
   Iyer D, 2018, PLOS GENET, V14, P0, DOI 10.1371/journal.pgen.1007681
   Kessler T, 2017, CIRCULATION, V136, P476, DOI 10.1161/CIRCULATIONAHA.116.024152
   Khera AV, 2017, NAT REV GENET, V18, P0, DOI 10.1038/nrg.2016.160
   Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, P0, DOI 10.1186/1471-2105-9-559
   Leik CE, 2004, HYPERTENSION, V43, P837, DOI 10.1161/01.HYP.0000119191.33112.9c
   Liu BX, 2018, AM J HUM GENET, V103, P377, DOI 10.1016/j.ajhg.2018.08.001
   Love MI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/s13059-014-0550-8
   Low EL, 2019, CELL SIGNAL, V53, P90, DOI 10.1016/j.cellsig.2018.09.004
   Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794
   Morrell NW, 2016, NAT REV CARDIOL, V13, P106, DOI 10.1038/nrcardio.2015.156
   Motterle A, 2012, HUM MOL GENET, V21, P4021, DOI 10.1093/hmg/dds224
   Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266
   Nanda V, 2018, PLOS GENET, V14, P0, DOI 10.1371/journal.pgen.1007755
   National Center for Biotechnology Information (NCBI), 2002, GEO, V0, P0
   Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913
   Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314
   Nurnberg ST, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005155
   Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051
   Pu XY, 2013, AM J HUM GENET, V92, P366, DOI 10.1016/j.ajhg.2013.01.012
   Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6
   Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089
   Soonthornsit J, 2017, EXP CELL RES, V353, P100, DOI 10.1016/j.yexcr.2017.03.011
   Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521
   van der Harst P, 2018, CIRC RES, V122, P433, DOI 10.1161/CIRCRESAHA.117.312086
   Webb TR, 2017, J AM COLL CARDIOL, V69, P823, DOI 10.1016/j.jacc.2016.11.056
   Wirka RC, 2019, NAT MED, V25, P1280, DOI 10.1038/s41591-019-0512-5
   Xin YL, 2019, BIOCHEM J, V476, P1585, DOI 10.1042/BCJ20190057
   Yang W, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1006127
   Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538
NR 52
TC 14
Z9 14
U1 2
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD SEP 20
PY 2022
VL 146
IS 12
BP 917
EP 929
DI 10.1161/CIRCULATIONAHA.121.058389
PG 13
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 4N6ZD
UT WOS:000854165700008
PM 35735005
DA 2024-11-01
ER

PT J
AU Zeviani, M
   Viscomi, C
AF Zeviani, Massimo
   Viscomi, Carlo
TI Mitochondrial Neurodegeneration
SO CELLS
LA English
DT Review
DE mitochondrial disease; mitochondrial respiratory chain; OXPHOS; Leigh syndrome; MELAS; MERRF; POLG
ID cytochrome-c-oxidase; complex-iii deficiency; progressive external ophthalmoplegia; ragged-red fibers; spinal-cord involvement; onset spinocerebellar ataxia; autosomal recessive ataxia; transfer-rna synthetases; bcs1l gene; oxidative-phosphorylation
AB Mitochondria are cytoplasmic organelles, which generate energy as heat and ATP, the universal energy currency of the cell. This process is carried out by coupling electron stripping through oxidation of nutrient substrates with the formation of a proton-based electrochemical gradient across the inner mitochondrial membrane. Controlled dissipation of the gradient can lead to production of heat as well as ATP, via ADP phosphorylation. This process is known as oxidative phosphorylation, and is carried out by four multiheteromeric complexes (from I to IV) of the mitochondrial respiratory chain, carrying out the electron flow whose energy is stored as a proton-based electrochemical gradient. This gradient sustains a second reaction, operated by the mitochondrial ATP synthase, or complex V, which condensates ADP and Pi into ATP. Four complexes (CI, CIII, CIV, and CV) are composed of proteins encoded by genes present in two separate compartments: the nuclear genome and a small circular DNA found in mitochondria themselves, and are termed mitochondrial DNA (mtDNA). Mutations striking either genome can lead to mitochondrial impairment, determining infantile, childhood or adult neurodegeneration. Mitochondrial disorders are complex neurological syndromes, and are often part of a multisystem disorder. In this paper, we divide the diseases into those caused by mtDNA defects and those that are due to mutations involving nuclear genes; from a clinical point of view, we discuss pediatric disorders in comparison to juvenile or adult-onset conditions. The complementary genetic contributions controlling organellar function and the complexity of the biochemical pathways present in the mitochondria justify the extreme genetic and phenotypic heterogeneity of this new area of inborn errors of metabolism known as 'mitochondrial medicine'.
C1 [Zeviani, Massimo] Univ Padua, Dept Neurosci, Via Giustiniani 2, I-35128 Padua, Italy.
   [Zeviani, Massimo] Veneto Inst Mol Med, Lab Mitochondrial Med, Via Orus 2, I-35128 Padua, Italy.
   [Viscomi, Carlo] Univ Padua, Dept Bomed Sci, Via Ugo Bassi 58b, I-35128 Padua, Italy.
C3 University of Padua; Veneto Institute Molecular Medicine; University of Padua
RP Zeviani, M (corresponding author), Univ Padua, Dept Neurosci, Via Giustiniani 2, I-35128 Padua, Italy.; Zeviani, M (corresponding author), Veneto Inst Mol Med, Lab Mitochondrial Med, Via Orus 2, I-35128 Padua, Italy.; Viscomi, C (corresponding author), Univ Padua, Dept Bomed Sci, Via Ugo Bassi 58b, I-35128 Padua, Italy.
EM carlo.viscomi@unipd.it; carlo.viscomi@unipd.it
FU Telethon Foundation [GGP19007, 20013]; Fondation NRJ pour les Neurosciences, Institute de France Grant; Associazione Luigi Comini Onlus; AFM-Telethon [23706]
CR Al-Owain M, 2013, J INHERIT METAB DIS, V36, P813, DOI 10.1007/s10545-012-9536-4
   Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Alsina D, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911659
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Angerer H, 2013, BIOCHEM SOC T, V41, P1335, DOI 10.1042/BST20130116
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Atwal PS, 2014, JIMD REP, V14, P43, DOI 10.1007/8904_2013_282
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Bano D, 2018, EBIOMEDICINE, V30, P29, DOI 10.1016/j.ebiom.2018.03.016
   BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   BERKOVIC SF, 1993, EPILEPSIA, V34, P0
   BINDOFF LA, 1989, J NEUROL SCI, V93, P311, DOI 10.1016/0022-510X(89)90200-1
   Blázques A, 2009, NEUROMUSCULAR DISORD, V19, P143, DOI 10.1016/j.nmd.2008.11.016
   Boczonadi V, 2018, ESSAYS BIOCHEM, V62, P321, DOI 10.1042/EBC20170103
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Bonekamp NA, 2018, CELL, V172, P388, DOI 10.1016/j.cell.2017.12.039
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Bottani E, 2017, MOL CELL, V67, P96, DOI 10.1016/j.molcel.2017.06.001
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L
   Brischigliaro M, 2021, BBA-BIOENERGETICS, V1862, P0, DOI 10.1016/j.bbabio.2020.148335
   BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101
   Brunetti D, 2016, EMBO MOL MED, V8, P176, DOI 10.15252/emmm.201505894
   Bugiani M, 2005, J MED GENET, V42, P0, DOI 10.1136/jmg.2004.029926
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Gil-Borlado MC, 2009, MITOCHONDRION, V9, P299, DOI 10.1016/j.mito.2009.04.001
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Chinnery PF, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00682
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Claerhout H, 2018, J INHERIT METAB DIS, V41, P101, DOI 10.1007/s10545-017-0089-4
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Craig K, 2007, J MED GENET, V44, P797, DOI 10.1136/jmg.2007.052902
   Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433
   Di Nottia M, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12020247
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   Dionisi-Vici C, 1998, J INHERIT METAB DIS, V21, P2, DOI 10.1023/A:1005397227996
   Dionisi-Vici C, 2016, BRAIN, V139, P1045, DOI 10.1093/brain/aww013
   Echaniz-Laguna A, 2013, NEUROLOGY, V81, P1523, DOI 10.1212/WNL.0b013e3182a4a518
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Ezgu F, 2013, GENE, V528, P364, DOI 10.1016/j.gene.2013.07.007
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072
   Fernandez-Vizarra E, 2021, FEBS LETT, V595, P1062, DOI 10.1002/1873-3468.13995
   Fernández-Vizarra E, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00134
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   FRANCESCHETTI S, 1993, ACTA NEUROL SCAND, V87, P219
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Fujii T, 1998, PEDIATR NEUROL, V18, P275, DOI 10.1016/S0887-8994(97)00187-2
   FUKUHARA N, 1991, REV NEUROL, V147, P476
   Galber C, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11040325
   Garcia-Diaz B, 2015, HUM MOL GENET, V24, P4516, DOI 10.1093/hmg/ddv183
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   González-Serrano LE, 2019, J BIOL CHEM, V294, P5309, DOI 10.1074/jbc.REV118.002953
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gusic M, 2021, FEBS LETT, V595, P1132, DOI 10.1002/1873-3468.14068
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2005, GENE, V354, P152, DOI 10.1016/j.gene.2005.04.041
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hoefs SJG, 2012, MITOCHONDRION, V12, P520, DOI 10.1016/j.mito.2012.07.106
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Indrieri A, 2013, EMBO MOL MED, V5, P280, DOI 10.1002/emmm.201201739
   Jankovic M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22189832
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   Joseph JT, 2014, J NEUROPATH EXP NEUR, V73, P1009, DOI 10.1097/NEN.0000000000000123
   Jurkute N, 2019, ANN NEUROL, V86, P368, DOI 10.1002/ana.25550
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kasapkara ÇS, 2014, RENAL FAILURE, V36, P953, DOI 10.3109/0886022X.2014.900422
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kunii M, 2015, J HUM GENET, V60, P187, DOI 10.1038/jhg.2015.7
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Langer Y, 2018, J MED GENET, V55, P599, DOI 10.1136/jmedgenet-2018-105330
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Levitas A, 2010, EUR J HUM GENET, V18, P1160, DOI 10.1038/ejhg.2010.83
   Lill R, 2020, ANNU REV BIOCHEM, V89, P471, DOI 10.1146/annurev-biochem-013118-111540
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   López-Martín JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058
   Lynn AM, 2012, ANN CLIN BIOCHEM, V49, P201, DOI 10.1258/acb.2011.011180
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   MATTHEWS PM, 1993, ANN NEUROL, V33, P652, DOI 10.1002/ana.410330616
   Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788
   MCKELVIE PA, 1991, J NEUROL SCI, V102, P51, DOI 10.1016/0022-510X(91)90093-M
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Melchionda L, 2014, AM J HUM GENET, V95, P315, DOI 10.1016/j.ajhg.2014.08.003
   Meunier I, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-98150-1
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   MIZUKAMI K, 1992, ACTA NEUROPATHOL, V83, P449, DOI 10.1007/BF00713541
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Morino H, 2014, BMC NEUROL, V14, P0, DOI 10.1186/1471-2377-14-5
   Moulinier L, 2017, HUM MUTAT, V38, P1316, DOI 10.1002/humu.23277
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x
   Nogueira C, 2013, NEUROGENETICS, V14, P153, DOI 10.1007/s10048-013-0361-1
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Ognjenovic J, 2018, RNA BIOL, V15, P623, DOI 10.1080/15476286.2017.1330245
   OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328
   OLDFORS A, 1990, ACTA NEUROPATHOL, V80, P541, DOI 10.1007/BF00294616
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Pérez MJ, 2021, MOL PSYCHIATR, V26, P5733, DOI 10.1038/s41380-020-0807-4
   Piro-Mégy C, 2020, J CLIN INVEST, V130, P143, DOI 10.1172/JCI128513
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   Rahman S, 2001, ANN NEUROL, V49, P797, DOI 10.1002/ana.1060
   Ramos-Arroyo MA, 2009, CLIN GENET, V75, P585, DOI 10.1111/j.1399-0004.2009.01160.x
   Randle SJ, 2017, CURR PROTEIN PEPT SC, V18, P715, DOI 10.2174/1389203717666160311121433
   Rantamäki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043
   Reyes A, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708698
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Riley LG, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-193
   Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008
   ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303
   Rustin P, 2002, BBA-BIOENERGETICS, V1553, P117, DOI 10.1016/S0005-2728(01)00228-6
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sanchez MIGL, 2021, AM J HUM GENET, V108, P2159, DOI 10.1016/j.ajhg.2021.09.015
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Savoiardo M, 1999, RIV NEURORADIOL, V12, P73, DOI 10.1177/19714009990120S311
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Schwenzer H, 2014, TOP CURR CHEM, V344, P247, DOI 10.1007/128_2013_457
   Sciacco M, 2003, J NEUROL, V250, P1498, DOI 10.1007/s00415-003-0246-6
   Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027
   Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shokolenko IN, 2013, J BIOL CHEM, V288, P26594, DOI 10.1074/jbc.M113.472977
   Siddiqi S, 2013, J HUM GENET, V58, P819, DOI 10.1038/jhg.2013.101
   Signes A, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201809582
   Silva-Pinheiro P, 2021, NUCLEIC ACIDS RES, V49, P5230, DOI 10.1093/nar/gkab282
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Simonati A, 2003, ACTA NEUROPATHOL, V106, P57, DOI 10.1007/s00401-003-0698-x
   Singh LN, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10123460
   Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Smeitink JAM, 1998, HUM MOL GENET, V7, P1573, DOI 10.1093/hmg/7.10.1573
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Stenton SL, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI138267
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SWEENEY MG, 1994, J NEUROL SCI, V121, P57, DOI 10.1016/0022-510X(94)90157-0
   Tanji K, 1999, ANN NEUROL, V45, P377, DOI 10.1002/1531-8249(199903)45:3<377::AID-ANA14>3.0.CO;2-M
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104
   Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsuchiya K, 1999, ACTA NEUROPATHOL, V97, P520, DOI 10.1007/s004010051023
   Tuppen HAL, 2010, MOL GENET METAB, V100, P345, DOI 10.1016/j.ymgme.2010.04.010
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Uziel G, 2011, SEMIN FETAL NEONAT M, V16, P205, DOI 10.1016/j.siny.2011.04.003
   Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   van Berge L, 2014, BRAIN, V137, P1019, DOI 10.1093/brain/awu026
   van der Knaap MS, 2003, ANN NEUROL, V53, P252, DOI 10.1002/ana.10456
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vázquez-Vélez GE, 2021, ANNU REV NEUROSCI, V44, P87, DOI 10.1146/annurev-neuro-100720-034518
   Verrigni D, 2017, CLIN GENET, V91, P918, DOI 10.1111/cge.12931
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wegener N, 2011, MOL CELL, V44, P191, DOI 10.1016/j.molcel.2011.07.036
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wiggs JL, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI147734
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   ZEVIANI M, 1995, BBA-MOL BASIS DIS, V1271, P153, DOI 10.1016/0925-4439(95)00022-V
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani Massimo, 2012, HANDB CLIN NEUROL, V103, P359, DOI 10.1016/B978-0-444-51892-7.00022-X
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
NR 241
TC 31
Z9 31
U1 0
U2 21
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD FEB 15
PY 2022
VL 11
IS 4
BP 
EP 
DI 10.3390/cells11040637
PG 45
WC Cell Biology
SC Cell Biology
GA ZV9QF
UT WOS:000770857600001
PM 35203288
DA 2024-11-01
ER

PT J
AU Nasca, A
   Legati, A
   Meneri, M
   Ermert, ME
   Frascarelli, C
   Zanetti, N
   Garbellini, M
   Comi, GP
   Catania, A
   Lamperti, C
   Ronchi, D
   Ghezzi, D
AF Nasca, Alessia
   Legati, Andrea
   Meneri, Megi
   Ermert, Melisa Emel
   Frascarelli, Chiara
   Zanetti, Nadia
   Garbellini, Manuela
   Comi, Giacomo Pietro
   Catania, Alessia
   Lamperti, Costanza
   Ronchi, Dario
   Ghezzi, Daniele
TI Biallelic Variants in <i>ENDOG</i> Associated with Mitochondrial Myopathy and Multiple mtDNA Deletions
SO CELLS
LA English
DT Article
DE endonuclease G; ENDOG; mitochondrial DNA; mitochondrial myopathy; multiple mtDNA deletions
ID endonuclease-g; dna deletions; mutations; replication; generation; mechanisms
AB Endonuclease G (ENDOG) is a nuclear-encoded mitochondrial-localized nuclease. Although its precise biological function remains unclear, its proximity to mitochondrial DNA (mtDNA) makes it an excellent candidate to participate in mtDNA replication, metabolism and maintenance. Indeed, several roles for ENDOG have been hypothesized, including maturation of RNA primers during mtDNA replication, splicing of polycistronic transcripts and mtDNA repair. To date, ENDOG has been deemed as a determinant of cardiac hypertrophy, but no pathogenic variants or genetically defined patients linked to this gene have been described. Here, we report biallelic ENDOG variants identified by NGS in a patient with progressive external ophthalmoplegia, mitochondrial myopathy and multiple mtDNA deletions in muscle. The absence of the ENDOG protein in the patient's muscle and fibroblasts indicates that the identified variants are pathogenic. The presence of multiple mtDNA deletions supports the role of ENDOG in mtDNA maintenance; moreover, the patient's clinical presentation is very similar to mitochondrial diseases caused by mutations in other genes involved in mtDNA homeostasis. Although the patient's fibroblasts did not present multiple mtDNA deletions or delay in the replication process, interestingly, we detected an accumulation of low-level heteroplasmy mtDNA point mutations compared with age-matched controls. This may indicate a possible role of ENDOG in mtDNA replication or repair. Our report provides evidence of the association of ENDOG variants with mitochondrial myopathy.
C1 [Nasca, Alessia; Legati, Andrea; Ermert, Melisa Emel; Frascarelli, Chiara; Zanetti, Nadia; Catania, Alessia; Lamperti, Costanza; Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, I-20126 Milan, Italy.
   [Meneri, Megi; Garbellini, Manuela; Ronchi, Dario] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, I-20122 Milan, Italy.
   [Meneri, Megi; Ermert, Melisa Emel; Comi, Giacomo Pietro; Ronchi, Dario; Ghezzi, Daniele] Univ Milan, Dept Pathophysiol & Transplantat DEPT, I-20122 Milan, Italy.
   [Comi, Giacomo Pietro] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuromuscular & Rare Dis Unit, I-20122 Milan, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Ghezzi, D (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, I-20126 Milan, Italy.; Ghezzi, D (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat DEPT, I-20122 Milan, Italy.
EM alessia.nasca@istituto-besta.it; andrea.legati@istituto-besta.it; megimeneri@gmail.com; melisaemel.ermert@studenti.unimi.it; chiara.frascarelli@istituto-besta.it; nadia.zanetti@istituto-besta.it; manuela.garbellini@polidinico.mi.it; giacomo.comi@unimi.it; alessia.catania@istituto-besta.it; costanza.lamperti@istituto-besta.it; dario.ronchi@unimi.it; daniele.ghezzi@unimi.it
FU ERA PerMed project PerMiM [J49C2000019000-RE15]; European Joint Programme on Rare Diseases [J42F19000030006-RE17]; Italian Ministry Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Ricerca Corrente 2020 - Mariani Foundation; Dino Ferrari Center at the University of Milan
CR Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   da Costa CK, 2007, J NEUROL SCI, V263, P139, DOI 10.1016/j.jns.2007.07.006
   Diener T, 2010, EXP GERONTOL, V45, P638, DOI 10.1016/j.exger.2010.03.002
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Irvine RA, 2005, MOL CELL BIOL, V25, P294, DOI 10.1128/MCB.25.1.294-302.2005
   Itsara LS, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1003974
   Jang DS, 2015, DNA CELL BIOL, V34, P92, DOI 10.1089/dna.2014.2530
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Legati A, 2021, J MOL DIAGN, V23, P732, DOI 10.1016/j.jmoldx.2021.03.002
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620
   Marchet S, 2020, HUM MUTAT, V41, P1745, DOI 10.1002/humu.24081
   McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rong ZY, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.669379
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Sharma P, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8020100
   Wiehe Rahel Stefanie, 2018, ONCOTARGET, V9, P18309, DOI 10.18632/oncotarget.24822
   Wu SL, 2009, J BIOMED SCI, V16, P0, DOI 10.1186/1423-0127-16-6
   Yan CJ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8040379
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   ZASSENHAUS HP, 1994, CURR GENET, V25, P142, DOI 10.1007/BF00309540
NR 29
TC 6
Z9 6
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAR 15
PY 2022
VL 11
IS 6
BP 
EP 
DI 10.3390/cells11060974
PG 10
WC Cell Biology
SC Cell Biology
GA 0D0NB
UT WOS:000775699200001
PM 35326425
DA 2024-11-01
ER

PT J
AU Liu, H
   Liu, X
   Zhou, JX
   Li, T
AF Liu, Hui
   Liu, Xin
   Zhou, Jingxin
   Li, Tao
TI Mitochondrial DNA Is a Vital Driving Force in Ischemia-Reperfusion Injury in Cardiovascular Diseases
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Review
ID coronary-heart-disease; nlrp3 inflammasome activation; preserved ejection fraction; acute myocardial-infarction; life-span; sterile inflammation; aim2 inflammasome; oxidative stress; skeletal-muscle; copy number
AB According to the latest Global Burden of Disease Study, cardiovascular disease (CVD) is the leading cause of death, and ischemic heart disease and stroke are the cause of death in approximately half of CVD patients. In CVD, mitochondrial dysfunction following ischemia-reperfusion (I/R) injury results in heart failure. The proper functioning of oxidative phosphorylation (OXPHOS) and the mitochondrial life cycle in cardiac mitochondria are closely related to mitochondrial DNA (mtDNA). Following myocardial I/R injury, mitochondria activate multiple repair and clearance mechanisms to repair damaged mtDNA. When these repair mechanisms are insufficient to restore the structure and function of mtDNA, irreversible mtDNA damage occurs, leading to mtDNA mutations. Since mtDNA mutations aggravate OXPHOS dysfunction and affect mitophagy, mtDNA mutation accumulation leads to leakage of mtDNA and proteins outside the mitochondria, inducing an innate immune response, aggravating cardiovascular injury, and leading to the need for external interventions to stop or slow the disease course. On the other hand, mtDNA released into the circulation after cardiac injury can serve as a biomarker for CVD diagnosis and prognosis. This article reviews the pathogenic basis and related research findings of mtDNA oxidative damage and mtDNA leak-triggered innate immune response associated with I/R injury in CVD and summarizes therapeutic options that target mtDNA.
C1 [Liu, Hui; Liu, Xin; Li, Tao] Natl Local Joint Engn Res Ctr Translat Med Anesthe, Dept Anesthesiol, Lab Mitochondria & Metab, Chengdu 610041, Peoples R China.
   [Liu, Hui; Zhou, Jingxin] Sichuan Univ, West China Second Univ Hosp, Dept Anesthesiol, Key Lab Birth Defects & Related Dis Women & Childr, Chengdu 610041, Peoples R China.
C3 Sichuan University
RP Li, T (corresponding author), Natl Local Joint Engn Res Ctr Translat Med Anesthe, Dept Anesthesiol, Lab Mitochondria & Metab, Chengdu 610041, Peoples R China.
EM liuhui_scu@163.com; liuxin.1113@163.com; 403030869@qq.com; scutaoli1981@scu.edu.cn
FU National Natural Science Foundation of China [81970715]; Key Research and Development Program of Sichuan Province [22ZDYF2138]; Innovation Spark Project of Sichuan University [2018SCUH0065]
CR Abbafati C, 2020, LANCET, V396, P1204
   Abu-Amero KK, 2010, GENET TEST MOL BIOMA, V14, P43, DOI 10.1089/gtmb.2009.0095
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andres AM, 2017, JCI INSIGHT, V2, P0, DOI 10.1172/jci.insight.89303
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], 2008, RTI PRESS RES REPORT, V0, P0
   Antozzi C, 1997, CARDIOVASC RES, V35, P184, DOI 10.1016/S0008-6363(97)00141-7
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Atar D, 2012, CARDIOLOGY, V123, P201, DOI 10.1159/000342981
   Bai J, 2021, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.623450
   Bai JL, 2019, DIABETES, V68, P1099, DOI 10.2337/dbi18-0052
   Barisic N, 2002, CROAT MED J, V43, P37
   Bliksoen M, 2012, INT J CARDIOL, V158, P132, DOI 10.1016/j.ijcard.2012.04.047
   Blitzer D, 2020, ANN THORAC SURG, V109, P711, DOI 10.1016/j.athoracsur.2019.06.075
   Bray AW, 2017, CURR OPIN CARDIOL, V32, P267, DOI 10.1097/HCO.0000000000000383
   Buford TW, 2018, J AM HEART ASSOC, V7, P0, DOI 10.1161/JAHA.118.010009
   Butterick TA, 2016, BASIC RES CARDIOL, V111, P0, DOI 10.1007/s00395-016-0555-4
   Calabrese C, 2022, PLOS GENET, V18, P0, DOI 10.1371/journal.pgen.1010068
   Chao W, 2009, AM J PHYSIOL-HEART C, V296, PH1, DOI 10.1152/ajpheart.00995.2008
   Chapman J, 2020, LIFE-BASEL, V10, P0, DOI 10.3390/life10090164
   Chen SY, 2014, ATHEROSCLEROSIS, V237, P220, DOI 10.1016/j.atherosclerosis.2014.08.051
   Chen X, 2018, EUR REV MED PHARMACO, V22, P5248, DOI 10.26355/eurrev_201808_15723
   Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585
   Chernyak BV, 2020, BIOCHEMISTRY-MOSCOW+, V85, P636, DOI 10.1134/S0006297920050132
   Cho Y, 2021, J BIOL CHEM, V297, P0, DOI 10.1016/j.jbc.2021.100825
   Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   Crewe C, 2021, CELL METAB, V33, P1853, DOI 10.1016/j.cmet.2021.08.002
   Dabravolski SA, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22168770
   Decout A, 2021, NAT REV IMMUNOL, V21, P548, DOI 10.1038/s41577-021-00524-z
   Deng Y, 2021, CIRC RES, V128, P232, DOI 10.1161/CIRCRESAHA.120.317933
   Dhondup Y, 2016, J CARD FAIL, V22, P823, DOI 10.1016/j.cardfail.2016.06.013
   Ding Y, 2013, INT J MOL MED, V32, P768, DOI 10.3892/ijmm.2013.1459
   Donnino MW, 2017, RESUSCITATION, V113, P56, DOI 10.1016/j.resuscitation.2016.12.029
   Dorn GW, 2015, EMBO MOL MED, V7, P865, DOI 10.15252/emmm.201404575
   Du Y, 2019, J ATHEROSCLER THROMB, V26, P868, DOI 10.5551/jat.47019
   Dunlay SM, 2017, NAT REV CARDIOL, V14, P0, DOI 10.1038/nrcardio.2017.65
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Fernández-Ruiz I, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0095073
   Fox BM, 2019, KIDNEY INT, V95, P590, DOI 10.1016/j.kint.2018.10.020
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28
   Fu MH, 2019, J NEUROINFLAMM, V16, P0, DOI 10.1186/s12974-019-1623-0
   Gabaldón T, 2005, BIOINFORMATICS, V21, P144, DOI 10.1093/bioinformatics/bti1124
   Galera-Monge T, 2019, J CELL PHYSIOL, V234, P19511, DOI 10.1002/jcp.28549
   Gallucci S, 2017, TRENDS IMMUNOL, V38, P719, DOI 10.1016/j.it.2017.07.012
   Gan WQ, 2018, BBA-MOL BASIS DIS, V1864, P1, DOI 10.1016/j.bbadis.2017.10.001
   Gentili M, 2019, CELL REP, V26, P2377, DOI 10.1016/j.celrep.2019.01.105
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720
   Guo H, 2022, AM J HYPERTENS, V35, P96, DOI 10.1093/ajh/hpab123
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hassanpour SH, 2018, J CARDIOVASC THORAC, V10, P1, DOI 10.15171/jcvtr.2018.01
   He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002
   Hotz MJ, 2018, AM J RESP CRIT CARE, V197, P470, DOI 10.1164/rccm.201706-1161OC
   Hu D, 2020, AM J PHYSIOL-HEART C, V318, PH1525, DOI 10.1152/ajpheart.00097.2020
   Hu HC, 2020, EXP MOL PATHOL, V114, P0, DOI 10.1016/j.yexmp.2020.104412
   Hu QY, 2019, SHOCK, V51, P52, DOI 10.1097/SHK.0000000000001190
   Huang LS, 2020, IMMUNITY, V52, P475, DOI 10.1016/j.immuni.2020.02.002
   Huang X, 2021, FRONT CARDIOVASC MED, V8, P0, DOI 10.3389/fcvm.2021.682409
   Ikeda G, 2021, J AM COLL CARDIOL, V77, P1073, DOI 10.1016/j.jacc.2020.12.060
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346
   Jabir MS, 2015, AUTOPHAGY, V11, P166, DOI 10.4161/15548627.2014.981915
   Ji QW, 2014, MEDIAT INFLAMM, V2014, P0, DOI 10.1155/2014/165742
   Jiang K, 2022, J CLIN INVEST, V132, P0, DOI 10.1172/JCI151268
   Jiao HF, 2021, CELL, V184, P2896, DOI 10.1016/j.cell.2021.04.027
   Jo A, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/305716
   Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813
   Khwaja B, 2021, MOL CELL BIOCHEM, V476, P1915, DOI 10.1007/s11010-021-04061-0
   Kitazume-Taneike R, 2019, BIOCHEM BIOPH RES CO, V515, P442, DOI 10.1016/j.bbrc.2019.05.150
   Komada T, 2018, J AM SOC NEPHROL, V29, P1165, DOI 10.1681/ASN.2017080863
   Konerman MC, 2018, J CARD FAIL, V24, P90, DOI 10.1016/j.cardfail.2017.10.010
   Kowalska M, 2020, DNA CELL BIOL, V39, P1410, DOI 10.1089/dna.2019.5347
   Krychtiuk KA, 2020, EUR HEART J-ACUTE CA, V9, P419, DOI 10.1177/2048872618823405
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lakshmanan LN, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12814
   Lam LKM, 2021, SCI TRANSL MED, V13, P0, DOI 10.1126/scitranslmed.abj1008
   Lampert MA, 2019, AUTOPHAGY, V15, P1182, DOI 10.1080/15548627.2019.1580095
   Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028
   Lauritzen KH, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.59828
   Lee CF, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-39419-4
   LEE WJ, 1995, GENETICS, V139, P873
   Li SC, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/6914849
   Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005
   Li X, 2021, ADV MATER, V33, P0, DOI 10.1002/adma.202105348
   Liang WJJ, 2020, FRONT CARDIOVASC MED, V7, P0, DOI 10.3389/fcvm.2020.00018
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Liu CY, 2018, HUM GENET, V137, P203, DOI 10.1007/s00439-018-1873-4
   Liu JK, 2009, ADV DRUG DELIVER REV, V61, P1343, DOI 10.1016/j.addr.2009.06.007
   Liu J, 2016, J DIABETES INVEST, V7, P109, DOI 10.1111/jdi.12366
   Liu J, 2015, CLIN LAB, V61, P661, DOI 10.7754/Clin.Lab.2014.141132
   Liu L, 2004, CHINESE J CLIN REHAB, V8, P2271
   Liu L, 2019, CELL PROLIFERAT, V52, P0, DOI 10.1111/cpr.12579
   Liu XQ, 2017, NAT GENET, V49, P1152, DOI 10.1038/ng.3870
   Liu X, 2022, J MOL CELL CARDIOL, V165, P76, DOI 10.1016/j.yjmcc.2021.12.015
   Liu YJ, 2019, INT J EPIDEMIOL, V48, P455, DOI 10.1093/ije/dyz009
   Liu YQ, 2021, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.634137
   Maeda H, 2020, J CELL MOL MED, V24, P5007, DOI 10.1111/jcmm.15120
   Man SM, 2016, EUR J IMMUNOL, V46, P269, DOI 10.1002/eji.201545839
   Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936
   Mann Douglas L, 2010, TRANS AM CLIN CLIMATOL ASSOC, V121, P34
   Marin-Garcia J, 1999, PEDIATRICS, V103, P456, DOI 10.1542/peds.103.2.456
   Marín-García J, 2016, HEART FAIL REV, V21, P475, DOI 10.1007/s10741-016-9543-x
   MarinGarcia J, 1996, CARDIOVASC RES, V31, P306
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039
   McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047
   McElroy GS, 2020, CELL METAB, V32, P301, DOI 10.1016/j.cmet.2020.06.003
   McIlroy DJ, 2014, J CRIT CARE, V29, P0, DOI 10.1016/j.jcrc.2014.07.013
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mesquita T, 2021, AGING CELL, V20, P0, DOI 10.1111/acel.13453
   Mezzaroma E, 2021, MOLECULES, V26, P0, DOI 10.3390/molecules26040976
   Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Morton AC, 2015, EUR HEART J, V36, P377, DOI 10.1093/eurheartj/ehu272
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nakayama H, 2018, BIOCHEM J, V475, P839, DOI 10.1042/BCJ20170714
   Nicolás-Avila JA, 2020, CELL, V183, P94, DOI 10.1016/j.cell.2020.08.031
   Nishida K, 2017, CIRC J, V81, P622, DOI 10.1253/circj.CJ-17-0261
   ONeill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Onódi Z, 2021, CARDIOVASC RES, V117, P2639, DOI 10.1093/cvr/cvab202
   Orekhov AN, 2021, CURR PHARM DESIGN, V27, P276, DOI 10.2174/1381612826666201012164330
   Ou W, 2021, REDOX BIOL, V43, P0, DOI 10.1016/j.redox.2021.101994
   Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10
   Pazmandi K, 2014, FREE RADICAL BIO MED, V77, P281, DOI 10.1016/j.freeradbiomed.2014.09.028
   Picca A, 2020, FRONT IMMUNOL, V11, P0, DOI 10.3389/fimmu.2020.601740
   Pisano A, 2016, CARDIOVASC PATHOL, V25, P103, DOI 10.1016/j.carpath.2015.09.009
   Protasoni M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22020586
   Qiao L, 2021, AM J HUM GENET, V108, P1964, DOI 10.1016/j.ajhg.2021.08.011
   Qin CY, 2017, ANATOL J CARDIOL, V17, P224, DOI 10.14744/AnatolJCardiol.2016.7209
   Qin CY, 2016, J CARDIOTHORAC SURG, V11, P0, DOI 10.1186/s13019-016-0481-4
   Qin CY, 2015, J CARDIOTHORAC SURG, V10, P0, DOI 10.1186/s13019-015-0298-6
   Quan Y, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/9423593
   Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864
   Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009
   Riley JS, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201899238
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010
   Ryan FP, 2009, J ROY SOC MED, V102, P272, DOI 10.1258/jrsm.2009.080372
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106
   Sandler N, 2018, HEART LUNG CIRC, V27, P122, DOI 10.1016/j.hlc.2017.02.014
   Santulli G, 2015, P NATL ACAD SCI USA, V112, P11389, DOI 10.1073/pnas.1513047112
   Sazonova MA, 2018, DIS MARKERS, V2018, P0, DOI 10.1155/2018/9749457
   Severino P, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21093167
   Shah SJ, 2016, CIRCULATION, V134, P73, DOI 10.1161/CIRCULATIONAHA.116.021884
   Sharma A, 2016, CIRC-HEART FAIL, V9, P0, DOI 10.1161/CIRCHEARTFAILURE.115.002639
   Sharma BR, 2019, EUR J IMMUNOL, V49, P1998, DOI 10.1002/eji.201848070
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Shin B, 2019, JACC-BASIC TRANSL SC, V4, P871, DOI 10.1016/j.jacbts.2019.08.007
   Sobenin IA, 2015, CURR PHARM DESIGN, V21, P1158, DOI 10.2174/1381612820666141013133000
   Srivaratharajah K, 2016, CIRC-HEART FAIL, V9, P0, DOI 10.1161/CIRCHEARTFAILURE.115.002562
   Steenman Marja, 2017, BIOPHYS REV, V9, P131, DOI 10.1007/s12551-017-0255-9
   Sudakov NP, 2017, EUR J MED RES, V22, P0, DOI 10.1186/s40001-016-0241-x
   Suetomi T, 2018, CIRCULATION, V138, P2530, DOI 10.1161/CIRCULATIONAHA.118.034621
   Takeda N, 1996, ANN NY ACAD SCI, V793, P282, DOI 10.1111/j.1749-6632.1996.tb33521.x
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tansel T, 2014, CARDIOL YOUNG, V24, P531, DOI 10.1017/S1047951113000668
   Tian R, 2019, CIRCULATION, V140, P1205, DOI 10.1161/CIRCULATIONAHA.119.040551
   Tian XC, 2017, J BIOMED SCI, V24, P1, DOI 10.1186/s12929-017-0345-9
   Tian YK, 2019, J THORAC CARDIOV SUR, V157, P2256, DOI 10.1016/j.jtcvs.2018.09.043
   Todkar K, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-21984-w
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00107
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Umbria M, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-59631-x
   van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025
   Vásquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301
   Vezza T, 2022, WORLD J MENS HEALTH, V40, P399, DOI 10.5534/wjmh.210146
   Volt H, 2016, J PINEAL RES, V60, P193, DOI 10.1111/jpi.12303
   Walensky LD, 2019, NAT CHEM BIOL, V15, P657, DOI 10.1038/s41589-019-0306-6
   Wang L, 2015, CORONARY ARTERY DIS, V26, P296, DOI 10.1097/MCA.0000000000000231
   Wang LL, 2021, DIS MARKERS, V2021, P0, DOI 10.1155/2021/7157109
   Wang SY, 2020, SIGNAL TRANSDUCT TAR, V5, P0, DOI 10.1038/s41392-020-0171-5
   Wang XW, 2020, BASIC RES CARDIOL, V115, P0, DOI 10.1007/s00395-020-00832-w
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Willcox JAL, 2022, AM J HUM GENET, V109, P961, DOI 10.1016/j.ajhg.2022.03.011
   Willeford A, 2018, JCI INSIGHT, V3, P0, DOI 10.1172/jci.insight.97054
   Wu XQ, 2020, FOOD FUNCT, V11, P5621, DOI 10.1039/d0fo00694g
   Xia N, 2017, BRIT J PHARMACOL, V174, P1633, DOI 10.1111/bph.13492
   Xie L, 2017, REGUL TOXICOL PHARM, V89, P148, DOI 10.1016/j.yrtph.2017.07.028
   Xu F, 2017, INDIAN HEART J, V69, P797, DOI 10.1016/j.ihj.2017.03.009
   Xue L, 2016, MITOCHONDRION, V30, P208, DOI 10.1016/j.mito.2016.08.008
   Xue RQ, 2017, J CELL MOL MED, V21, P58, DOI 10.1111/jcmm.12938
   Yamazoe M, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-85204-7
   Yang J, 2019, J MOL CELL CARDIOL, V130, P36, DOI 10.1016/j.yjmcc.2019.03.008
   Yang XM, 2015, BASIC RES CARDIOL, V110, P0, DOI 10.1007/s00395-014-0459-0
   Yang YW, 2012, NUCLEIC ACIDS RES, V40, P0, DOI 10.1093/nar/gks639
   Ye W, 2017, MOL IMMUNOL, V87, P114, DOI 10.1016/j.molimm.2017.03.011
   Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yue P, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0206003
   Zeng L, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aan5689
   Zhang HL, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.60827
   Zhang ZX, 2019, BMC CARDIOVASC DISOR, V19, P0, DOI 10.1186/s12872-019-01284-4
   Zhao Y, 2018, MITOCHONDRIAL DNA A, V29, P1090, DOI 10.1080/24701394.2017.1407762
   Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z
   Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057
   Zhou H, 2020, BASIC RES CARDIOL, V115, P0, DOI 10.1007/s00395-019-0773-7
   Zhou H, 2017, J PINEAL RES, V63, P0, DOI 10.1111/jpi.12413
   Zhou ZL, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/1209307
   Zhou ZX, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17122064
   Zhu Y, 2020, BMC MED GENET, V21, P0, DOI 10.1186/s12881-020-01045-7
   Zhuge Ruiqi, 2017, ZHONGGUO YI XUE KE XUE YUAN XUE BAO, V39, P438, DOI 10.3881/j.issn.1000-503X.2017.03.024
NR 212
TC 16
Z9 20
U1 8
U2 26
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD MAY 17
PY 2022
VL 2022
IS 
BP 
EP 
DI 10.1155/2022/6235747
PG 19
WC Cell Biology
SC Cell Biology
GA 1W9YW
UT WOS:000807123100007
PM 35620580
DA 2024-11-01
ER

PT J
AU Hanaford, AR
   Cho, YJ
   Nakai, H
AF Hanaford, Allison R.
   Cho, Yoon-Jae
   Nakai, Hiroyuki
TI AAV-vector based gene therapy for mitochondrial disease: progress and future perspectives
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Review
DE Gene therapy; Mitochondrial disease; AAV
ID thymidine kinase 2; mouse model; neurogastrointestinal encephalomyopathy; ethylmalonic encephalopathy; replacement therapy; optic atrophy; deoxynucleotide pools; liver-transplantation; dna mutations; murine model
AB Mitochondrial diseases are a group of rare, heterogeneous diseases caused by gene mutations in both nuclear and mitochondrial genomes that result in defects in mitochondrial function. They are responsible for significant morbidity and mortality as they affect multiple organ systems and particularly those with high energy-utilizing tissues, such as the nervous system, skeletal muscle, and cardiac muscle. Virtually no effective treatments exist for these patients, despite the urgent need. As the majority of these conditions are monogenic and caused by mutations in nuclear genes, gene replacement is a highly attractive therapeutic strategy. Adeno-associated virus (AAV) is a well-characterized gene replacement vector, and its safety profile and ability to transduce quiescent cells nominates it as a potential gene therapy vehicle for several mitochondrial diseases. Indeed, AAV vector-based gene replacement is currently being explored in clinical trials for one mitochondrial disease (Leber hereditary optic neuropathy) and preclinical studies have been published investigating this strategy in other mitochondrial diseases. This review summarizes the preclinical findings of AAV vector-based gene replacement therapy for mitochondrial diseases including Leigh syndrome, Barth syndrome, ethylmalonic encephalopathy, and others.
C1 [Hanaford, Allison R.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA.
   [Hanaford, Allison R.; Cho, Yoon-Jae] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97239 USA.
   [Cho, Yoon-Jae] Oregon Hlth & Sci Univ, Div Pediat Neurol, Doernbecher Childrens Hosp, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Nakai, Hiroyuki] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA.
   [Nakai, Hiroyuki] Oregon Hlth & Sci Univ, Dept Mol Immunol & Microbiol, Portland, OR 97239 USA.
   [Nakai, Hiroyuki] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA.
   [Cho, Yoon-Jae] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA.
C3 Seattle Children's Hospital; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University
RP Hanaford, AR (corresponding author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA.; Hanaford, AR (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97239 USA.
EM allison.hanaford@seattlechildrens.org
FU Macklin Fund at the Oregon Health & Science University
CR Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   [Anonymous], 2021, NAT MED, V27, P1311, DOI 10.1038/s41591-021-01481-9
   [Anonymous], 2020, NAT BIOTECHNOL, V38, P910, DOI 10.1038/s41587-020-0642-9
   [Anonymous], 2019, NAT BIOTECHNOL, V37, P204, DOI 10.1038/s41587-019-0062-x
   Aschauer DF, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0076310
   Bahr T, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165743
   Batista AR, 2020, HUM GENE THER, V31, P90, DOI 10.1089/hum.2019.186
   Bax BE, 2013, NEUROLOGY, V81, P1269, DOI 10.1212/WNL.0b013e3182a6cb4b
   Belbellaa B, 2020, MOL THER-METH CLIN D, V19, P120, DOI 10.1016/j.omtm.2020.08.018
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Berns KI, 2017, HUM GENE THER, V28, P308, DOI 10.1089/hum.2017.048
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Boyer M, 2018, MOL GENET METAB, V124, P57, DOI 10.1016/j.ymgme.2018.02.008
   Cabrera-Pérez R, 2019, HUM GENE THER, V30, P985, DOI 10.1089/hum.2018.217
   Chai Z, 2019, HUM GENE THER, V30, P829, DOI 10.1089/hum.2018.233
   Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593
   Chandran V, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30054
   Charlesworth G, 2016, MOVEMENT DISORD, V31, P1249, DOI 10.1002/mds.26716
   Chen L, 2018, CLIN GENET, V93, P1131, DOI 10.1111/cge.13139
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-23
   Clay A, 2019, EXPERT OPIN PHARMACO, V20, P1855, DOI 10.1080/14656566.2019.1639671
   Cole LW, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00085
   Cook A, 2017, BRIT MED BULL, V124, P19, DOI 10.1093/bmb/ldx034
   Cossée M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   Delatycki MB, 2019, NEUROBIOL DIS, V132, P0, DOI 10.1016/j.nbd.2019.104606
   DellAgnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440
   Di Meo I, 2017, GENE THER, V24, P661, DOI 10.1038/gt.2017.53
   Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433
   Di Meo I, 2011, ANTIOXID REDOX SIGN, V15, P353, DOI 10.1089/ars.2010.3520
   Dionisi-Vici C, 2016, BRAIN, V139, P1045, DOI 10.1093/brain/aww013
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71
   Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Garcia-Diaz B, 2014, BRAIN, V137, P1337, DOI 10.1093/brain/awu068
   GarciaSilva MT, 1997, PEDIATR NEUROL, V17, P165, DOI 10.1016/S0887-8994(97)00048-9
   Garlid AO, 2020, GENE, V726, P0, DOI 10.1016/j.gene.2019.144148
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Gérard C, 2014, MOL THER-METH CLIN D, V1, P0, DOI 10.1038/mtm.2014.44
   Gerards M, 2016, MOL GENET METAB, V117, P300, DOI 10.1016/j.ymgme.2015.12.004
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Giordano C, 2012, J INHERIT METAB DIS, V35, P451, DOI 10.1007/s10545-011-9408-3
   González-Vioque E, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002035
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grier J, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000230
   Grosso S, 2004, J NEUROL, V251, P755, DOI 10.1007/s00415-004-0426-z
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hammer MB, 2017, NEURODEGENER DIS, V17, P208, DOI 10.1159/000464445
   Hannappel A, 2012, BBA-BIOENERGETICS, V1817, P928, DOI 10.1016/j.bbabio.2011.09.007
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Hordeaux J, 2019, MOL THER, V27, P912, DOI 10.1016/j.ymthe.2019.02.013
   Hordeaux J, 2018, MOL THER, V26, P664, DOI 10.1016/j.ymthe.2018.01.018
   Huang Q, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0225206
   Hussain SRA, 2021, FRONT GENET, V12, P0, DOI 10.3389/fgene.2021.627050
   Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Karaarslan C, 2019, ADV THER, V36, P3299, DOI 10.1007/s12325-019-01113-2
   Katsouri L, 2016, P NATL ACAD SCI USA, V113, P12292, DOI 10.1073/pnas.1606171113
   Kiliç M, 2017, METAB BRAIN DIS, V32, P293, DOI 10.1007/s11011-016-9928-5
   Korneyenkov MA, 2021, PHARMACEUTICS, V13, P0, DOI 10.3390/pharmaceutics13050750
   Kripps KA, 2020, MOL GENET METAB, V130, P58, DOI 10.1016/j.ymgme.2020.03.001
   Kumar N, 2018, FRONT MOL NEUROSCI, V11, P0, DOI 10.3389/fnmol.2018.00413
   Kuzmin DA, 2021, NAT REV DRUG DISCOV, V20, P173, DOI 10.1038/d41573-021-00017-7
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Leborgne C, 2020, NAT MED, V26, P1096, DOI 10.1038/s41591-020-0911-7
   Li CW, 2020, NAT REV GENET, V21, P255, DOI 10.1038/s41576-019-0205-4
   Li LD, 2018, NUCLEIC ACID THER, V28, P23, DOI 10.1089/nat.2017.0703
   Ling QL, 2021, MOL THER-METH CLIN D, V23, P158, DOI 10.1016/j.omtm.2021.09.001
   Liu MM, 2011, BRIT J OPHTHALMOL, V95, P604, DOI 10.1136/bjo.2009.174912
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Lopez-Gomez C, 2021, ANN NEUROL, V90, P640, DOI 10.1002/ana.26185
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Lou XT, 2018, J HUM GENET, V63, P1269, DOI 10.1038/s10038-018-0505-0
   Lynch DR, 2021, ANN NEUROL, V89, P212, DOI 10.1002/ana.25934
   Lyseng-Williamson KA, 2016, DRUGS, V76, P805, DOI 10.1007/s40265-016-0574-3
   Madsen KL, 2020, NEUROLOGY, V94, PE687, DOI 10.1212/WNL.0000000000008861
   Maeder ML, 2019, NAT MED, V25, P229, DOI 10.1038/s41591-018-0327-9
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Matsuzaki Y, 2018, NEUROSCI LETT, V665, P182, DOI 10.1016/j.neulet.2017.11.049
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514
   Mick DU, 2012, CELL, V151, P1528, DOI 10.1016/j.cell.2012.11.053
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Monteilhet V, 2011, MOL THER, V19, P2084, DOI 10.1038/mt.2011.108
   Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001
   Newman NJ, 2021, OPHTHALMOLOGY, V128, P649, DOI 10.1016/j.ophtha.2020.12.012
   Nguyen GN, 2021, NAT BIOTECHNOL, V39, P47, DOI 10.1038/s41587-020-0741-7
   Nonnenmacher M, 2021, MOL THER-METH CLIN D, V20, P366, DOI 10.1016/j.omtm.2020.12.006
   Pacitti D, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00669
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Pavlou M, 2021, EMBO MOL MED, V13, P0, DOI 10.15252/emmm.202013392
   Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510
   Pereira CV, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201910674
   Philippidis A, 2020, HUM GENE THER, V31, P908, DOI 10.1089/hum.2020.29133.bfs
   Piguet F, 2018, MOL THER, V26, P1940, DOI 10.1016/j.ymthe.2018.05.006
   Pitceathly RDS, 2021, J INHERIT METAB DIS, V44, P22, DOI 10.1002/jimd.12281
   Pompei M, 2019, J ASSIST REPROD GEN, V36, P383, DOI 10.1007/s10815-018-1370-7
   Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818
   Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P1, DOI 10.1167/iovs.06-0789
   Quinn J, 2021, HUM GENE THER, V32, P247, DOI 10.1089/hum.2020.231
   Reynaud-Dulaurier R, 2020, BRAIN, V143, P1686, DOI 10.1093/brain/awaa105
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8
   Sage-Schwaede A, 2019, ANN CLIN TRANSL NEUR, V6, P1877, DOI 10.1002/acn3.50846
   Sands MS, 2011, METHODS MOL BIOL, V807, P141, DOI 10.1007/978-1-61779-370-7_6
   Schnepp BC, 2009, J VIROL, V83, P1456, DOI 10.1128/JVI.01686-08
   Schon KR, 2021, BMJ-BRIT MED J, V375, P0, DOI 10.1136/bmj-2021-066288
   Silva-Pinheiro P, 2020, MOL THER-METH CLIN D, V17, P1071, DOI 10.1016/j.omtm.2020.04.026
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sofou K, 2017, J INHERIT METAB DIS, V40, P237, DOI 10.1007/s10545-016-0011-5
   Soragni E, 2016, EXPERT OPIN ORPHAN D, V4, P961, DOI 10.1080/21678707.2016.1215910
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Suzuki-Hatano S, 2019, HUM GENE THER, V30, P139, DOI 10.1089/hum.2018.020
   Suzuki-Hatano S, 2019, MOL THER-METH CLIN D, V13, P167, DOI 10.1016/j.omtm.2019.01.007
   Tann A, 2019, AM J MED GENET A, V179, P1015, DOI 10.1002/ajmg.a.61104
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Terzenidou ME, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1006656
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653
   Tiranti V, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011437
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Tornabene P, 2020, HUM GENE THER, V31, P47, DOI 10.1089/hum.2019.220
   Torres-Torronteras J, 2011, GENE THER, V18, P795, DOI 10.1038/gt.2011.24
   Torres-Torronteras J, 2018, HUM GENE THER, V29, P708, DOI 10.1089/hum.2017.133
   Torres-Torronteras J, 2016, HUM GENE THER, V27, P656, DOI 10.1089/hum.2015.160
   Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023
   Vila-Julià F, 2020, EBIOMEDICINE, V62, P0, DOI 10.1016/j.ebiom.2020.103133
   Viscomi C, 2010, NAT MED, V16, P869, DOI 10.1038/nm.2188
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Vyas PM, 2012, HUM MOL GENET, V21, P1230, DOI 10.1093/hmg/ddr554
   Wan JJ, 2016, BRAIN, V139, P2877, DOI 10.1093/brain/aww212
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang SY, 2020, CIRC RES, V126, P1024, DOI 10.1161/CIRCRESAHA.119.315956
   Ward PGD, 2019, MOVEMENT DISORD, V34, P335, DOI 10.1002/mds.27606
   Yadak R, 2018, MOL THER-METH CLIN D, V8, P152, DOI 10.1016/j.omtm.2018.01.001
   Yang L, 2020, HUM MOL GENET, V29, P649, DOI 10.1093/hmg/ddz277
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Yu H, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-23836-y
   Yu H, 2015, P NATL ACAD SCI USA, V112, PE5689, DOI 10.1073/pnas.1506129112
   Yu H, 2012, MOL VIS, V18, P1668
   Yu H, 2012, P NATL ACAD SCI USA, V109, PE1238, DOI 10.1073/pnas.1119577109
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.aaz7423
   Zong L, 2015, J MED GENET, V52, P523, DOI 10.1136/jmedgenet-2014-102961
NR 149
TC 10
Z9 12
U1 0
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD JUN 6
PY 2022
VL 17
IS 1
BP 
EP 
DI 10.1186/s13023-022-02324-7
PG 21
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA 1W4PP
UT WOS:000806757400004
PM 35668433
DA 2024-11-01
ER

PT J
AU Diao, SP
   Chen, SF
   Liu, AQ
   Zhou, ZH
   Peng, ZX
   Hong, MF
AF Diao, Sheng-Peng
   Chen, Song-Fa
   Liu, Ai-Qun
   Zhou, Zhi-Hua
   Peng, Zhong-Xing
   Hong, Ming-Fan
TI Elderly onset of MELAS in a male: A case report
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE MELAS; stroke-like episodes; magnetic resonance angiography (MRA); migraine; magnetic resonance imaging (MRI)
ID stroke-like-episodes; lactic-acidosis; mitochondrial-myopathy; muscle biopsy; encephalopathy; mutation
AB BackgroundMitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) is one of the most common maternally inherited mitochondrial diseases which rarely affects elderly people. Case presentationWe reported the case of a 61-year-old male patient with MELAS. He was experiencing acute migraine-like headaches as the first symptoms. Laboratory data showed elevated lactate and creatine kinase levels. Brain magnetic resonance imaging (MRI) found a high signal intensity lesion in the left occipital-temporal-parietal lobe on diffusion-weighted imaging (DWI). Magnetic resonance angiography (MRA) revealed reversible vasoconstriction of the middle cerebral arteries and superficial temporal arteries. A muscle biopsy suggested minor muscle damage. A genetic study revealed a mitochondrial DNA A3243G mutation. ConclusionElderly onset of MELAS is rare and easily misdiagnosed as an ischemic stroke. MELAS with the onset of stroke-like episodes should be considered in adult or elderly patients with imaging findings that are atypical for cerebral infarction. The use of multimodal MRI in the clinical diagnosis of MELAS could be extremely beneficial.
C1 [Diao, Sheng-Peng; Chen, Song-Fa; Liu, Ai-Qun; Zhou, Zhi-Hua; Peng, Zhong-Xing; Hong, Ming-Fan] Guangdong Pharmaceut Univ, Affiliated Hosp 1, Coll Clin Med, Dept Neurol, Guangzhou, Peoples R China.
C3 Guangdong Pharmaceutical University
RP Hong, MF (corresponding author), Guangdong Pharmaceut Univ, Affiliated Hosp 1, Coll Clin Med, Dept Neurol, Guangzhou, Peoples R China.
EM hmf9001@163.com
CR Aurangzeb Sidra, 2014, PRACT NEUROL, V14, P432, DOI 10.1136/practneurol-2014-000853
   Baek MS, 2019, YONSEI MED J, V60, P98, DOI 10.3349/ymj.2019.60.1.98
   Cutrer FM, 2010, SEMIN NEUROL, V30, P120, DOI 10.1055/s-0030-1249222
   Dong X, 2017, NEUROSCI LETT, V636, P127, DOI 10.1016/j.neulet.2016.10.054
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 2019, YONSEI MED J, V60, P399, DOI 10.3349/ymj.2019.60.4.399
   Goldstein A, 2019, DIAGNOSIS MANAGEMENT, V0, P0, DOI DOI 10.1007/978-3-030-05517-2_5
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ikawa M, 2013, MITOCHONDRION, V13, P676, DOI 10.1016/j.mito.2013.09.007
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Maeda K, 2016, JAMA NEUROL, V73, P990, DOI 10.1001/jamaneurol.2016.0886
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mukai M, 2017, INTERNAL MED, V56, P95, DOI 10.2169/internalmedicine.56.7301
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Sinnecker T, 2019, BMC NEUROL, V19, P0, DOI 10.1186/s12883-019-1306-6
   van Adel Brian A, 2009, J CLIN NEUROMUSCUL DIS, V10, P97, DOI 10.1097/CND.0b013e3181903126
   Yu Q, 2007, MITOCHONDRION, V7, P147, DOI 10.1016/j.mito.2006.11.019
NR 21
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD DEC 1
PY 2022
VL 13
IS 
BP 
EP 
DI 10.3389/fneur.2022.1018529
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 6Y6CY
UT WOS:000897182100001
PM 36530638
DA 2024-11-01
ER

PT J
AU Sun, JY
   Su, WW
   Deng, JW
   Qin, Y
   Wang, ZX
   Liu, YH
AF Sun, Jiayu
   Su, Wenwen
   Deng, Jianwen
   Qin, Yao
   Wang, Zhaoxia
   Liu, Yuhe
TI DNA2 mutation causing multisystemic disorder with impaired mitochondrial DNA maintenance
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID replication; myopathy; reveals; disease; variant; repair
AB Purpose To describe a novel DNA2 variant contributing to defects in mtDNA maintenance and mtDNA depletion syndrome (MDS), and the clinical and histological findings associated with this variation. Methods Herein, we describe the case of a patient who presented with hearing loss and myopathy, given the family history of similar findings in the father, was evaluated by sequencing of the deafness gene panel, mitochondrial genome, and the exome. Furthermore, tissue staining, mtDNA copy number detection, mtDNA sequencing, and long-range polymerase chain reaction tests were also conducted on the muscle biopsy specimen. In vitro experiments, including analyses of the mtDNA copy number; levels of ATP, ATPase, and reactive oxygen species (ROS); and the membrane potential, were performed. Results The DNA2 heterozygous truncating variant c. 2368C > T (p.Q790X) was identified and verified as the cause of an mtDNA copy number decrement in both functional experiments and muscle tissue analyses. These changes were accompanied by reductions in ATP, ATPase, and ROS levels. Conclusion The DNA2 variant was a likely cause of MDS in this patient. These findings expand the mutational spectrum of MDS and improve our understanding of the functions of DNA2 by revealing its novel role in mtDNA maintenance.
C1 [Sun, Jiayu; Su, Wenwen; Qin, Yao; Liu, Yuhe] Peking Univ, Dept Otolaryngol Head & Neck Surg, Hosp 1, Beijing, Peoples R China.
   [Sun, Jiayu; Liu, Yuhe] Capital Med Univ, Beijing Friendship Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.
   [Sun, Jiayu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Otolaryngol Head & Neck Surg, Sch Med, Shanghai, Peoples R China.
   [Deng, Jianwen; Wang, Zhaoxia] Peking Univ, Dept Neurol, Hosp 1, Beijing, Peoples R China.
C3 Peking University; Capital Medical University; Shanghai Jiao Tong University; Peking University
RP Liu, YH (corresponding author), Peking Univ, Dept Otolaryngol Head & Neck Surg, Hosp 1, Beijing, Peoples R China.; Liu, YH (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.
EM liuyuhefeng@163.com
FU National Natural Science Foundation of China [82071070]; Beijing Municipal Science& Technology Commission [Z191100006619027]
CR Almannai M, 2018, ESSAYS BIOCHEM, V62, P297, DOI 10.1042/EBC20170101
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Chae JH, 2015, J MED GENET, V52, P208, DOI 10.1136/jmedgenet-2014-102819
   Chazotte Brad, 2011, COLD SPRING HARB PROTOC, V2011, P0, DOI 10.1101/pdb.prot065490
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Duxin JP, 2012, J BIOL CHEM, V287, P21980, DOI 10.1074/jbc.M112.359018
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   González-del Angel A, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.01049
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030
   Karanja KK, 2012, CELL CYCLE, V11, P3983, DOI 10.4161/cc.22215
   Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112
   Li ZK, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201796729
   Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88
   Markiewicz-Potoczny M, 2018, GENETICS, V209, P129, DOI 10.1534/genetics.118.300809
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Phowthongkum P, 2017, NEUROMUSCULAR DISORD, V27, P616, DOI 10.1016/j.nmd.2017.03.013
   Pinto M, 2014, BBA-MOL BASIS DIS, V1842, P1198, DOI 10.1016/j.bbadis.2013.11.012
   Ronchi D, 2019, ANN CLIN TRANSL NEUR, V6, P1893, DOI 10.1002/acn3.50888
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113
   Tarnauskaite Z, 2019, HUM MUTAT, V40, P1063, DOI 10.1002/humu.23776
   Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443
   van Gisbergen MW, 2015, MUTAT RES-REV MUTAT, V764, P16, DOI 10.1016/j.mrrev.2015.01.001
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zhong L, 2014, CURR MOL MED, V14, P1273, DOI 10.2174/1566524014666141202161326
NR 28
TC 3
Z9 3
U1 0
U2 5
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD DEC 15
PY 2022
VL 67
IS 12
BP 691
EP 699
DI 10.1038/s10038-022-01075-4
EA SEP 2022
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 6L0YV
UT WOS:000850047900001
PM 36064591
DA 2024-11-01
ER

PT J
AU Yang, X
   Fu, LJ
AF Yang, Xiao
   Fu, Le-Jun
TI Familial mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episode syndrome: Three case reports
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Article
DE Mitochondrial encephalomyopathy; Magnetic resonance imaging; Genetic testing; Pathological results; Case report
AB BACKGROUND Mitochondrial encephalomyopathy (ME) is a multisystem metabolic disease that primarily affects the central nervous system and skeletal muscle. It is caused by mutations in mitochondrial or nuclear DNA, resulting in abnormal mitochondrial structure and function and insufficient ATP synthesis. The most common subtype is mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episode (MELAS) syndrome. In recent years, reports of MELAS syndrome have increased but familial cases are rare. CASE SUMMARY We report a case of familial MELAS syndrome. Cases 2 and 3 are sisters and case 1 is their nephew. All are short in stature and showed stroke-like episodes with rapid onset and no obvious symptoms such as paroxysmal headache, aphasia, or blurred vision. After admission, blood lactate levels were significantly higher than normal. The patients underwent magnetic resonance imaging of the head. Cases 1 and 2 were considered to have ME, whereas case 3 was considered to have a space-occupying lesion in the left temporal lobe. Pathological evaluation showed no obvious tumor cells in the brain lesions of case 3. Muscle biopsy or genetic test results were consistent with ME. The patients were diagnosed with MELAS syndrome and their symptoms improved with intravenous infusions of coenzyme Q10, coenzyme A, vitamin B, and vitamin C. At the 6 mo follow-up, there was no recurrence or progression. CONCLUSION When a patient has MELAS syndrome, familial MELAS syndrome should be considered if related family members have similar symptoms.
C1 [Yang, Xiao; Fu, Le-Jun] Tianjin Huanhu Hosp, Dept Med Imaging, Tianjin 300350, Peoples R China.
RP Fu, LJ (corresponding author), Tianjin Huanhu Hosp, Dept Med Imaging, 6 Jizhao Rd, Tianjin 300350, Peoples R China.
EM doctorfu20220505@163.com
CR Chen H, 2020, SOMATOSENS MOT RES, V37, P45, DOI 10.1080/08990220.2020.1720636
   Cheng WQ, 2022, FRONT NEUROL, V13, P0, DOI 10.3389/fneur.2022.843386
   Dawod PGA, 2021, DIAGNOSTICS, V11, P0, DOI 10.3390/diagnostics11111969
   Dias SP, 2018, J NEUROL SCI, V385, P144, DOI 10.1016/j.jns.2017.12.036
   Gagliardi D, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00038
   Gramegna LL, 2021, ANN CLIN TRANSL NEUR, V8, P1200, DOI 10.1002/acn3.51329
   Hou Y, 2020, BEIJING DA XUE XUE BAO YI XUE BAN, V52, P851
   Lahiri D, 2019, J MED CASE REP, V13, P0, DOI 10.1186/s13256-018-1936-0
   Licchetta L, 2021, ANN CLIN TRANSL NEUR, V8, P704, DOI 10.1002/acn3.51259
   Liu KM, 2021, CNS NEUROSCI THER, V27, P733, DOI 10.1111/cns.13618
   Tragni V, 2022, MOLECULES, V27, P0, DOI 10.3390/molecules27113494
   Wang R, 2021, MITOCHONDRION, V59, P276, DOI 10.1016/j.mito.2021.06.012
   Wang S, 2020, MEDICINE, V99, P0, DOI 10.1097/MD.0000000000020310
   Zhang Q, 2019, ZHONGHUA BING LI XUE ZA ZHI, V48, P298, DOI 10.3760/cma.j.issn.0529-5807.2019.04.007
NR 14
TC 0
Z9 0
U1 0
U2 1
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 2307-8960
EI 
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD SEP 26
PY 2022
VL 10
IS 27
BP 9945
EP 9953
DI 10.12998/wjcc.v10.i27.9945
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA 6R2JS
UT WOS:000892134800045
PM 36186180
DA 2024-11-01
ER

PT J
AU Ehrlich, KC
   Deng, HW
   Ehrlich, M
AF Ehrlich, Kenneth C.
   Deng, Hong-Wen
   Ehrlich, Melanie
TI Epigenetics of Mitochondria-Associated Genes in Striated Muscle
SO EPIGENOMES
LA English
DT Article
DE skeletal muscle; heart; enhancer; epigenetics; DNA methylation; mitochondria; mitophagy; Parkinson's disease; PGC-1 alpha/PPARGC1A; PRKN/PARK2
ID skeletal-muscle; pgc-1-alpha isoforms; heart-failure; expression; mutations; disease; deficiency; methylation; metabolism; mitophagy
AB Striated muscle has especially large energy demands. We identified 97 genes preferentially expressed in skeletal muscle and heart, but not in aorta, and found significant enrichment for mitochondrial associations among them. We compared the epigenomic and transcriptomic profiles of the 27 genes associated with striated muscle and mitochondria. Many showed strong correlations between their tissue-specific transcription levels, and their tissue-specific promoter, enhancer, or open chromatin as well as their DNA hypomethylation. Their striated muscle-specific enhancer chromatin was inside, upstream, or downstream of the gene, throughout much of the gene as a super-enhancer (CKMT2, SLC25A4, and ACO2), or even overlapping a neighboring gene (COX6A2, COX7A1, and C0010A). Surprisingly, the 3' end of the 1.38 Mb PRKN (PARK2) gene (involved in mitophagy and linked to juvenile Parkinson's disease) displayed skeletal muscle/myoblast-specific enhancer chromatin, a myoblast-specific antisense RNA, as well as brain-specific enhancer chromatin. We also found novel tissue-specific RNAs in brain and embryonic stem cells within PPARGC1A (PGC-1 alpha), which encodes a master transcriptional coregulator for mitochondrial formation and metabolism. The tissue specificity of this gene's four alternative promoters, including a muscle-associated promoter, correlated with nearby enhancer chromatin and open chromatin. Our in-depth epigenetic examination of these genes revealed previously undescribed tissue-specific enhancer chromatin, intragenic promoters, regions of DNA hypomethylation, and intragenic noncoding RNAs that give new insights into transcription control for this medically important set of genes.
C1 [Ehrlich, Kenneth C.; Deng, Hong-Wen; Ehrlich, Melanie] Tulane Univ, Ctr Bioinformat & Genom, Hlth Sci Ctr, New Orleans, LA 70112 USA.
   [Ehrlich, Melanie] Tulane Univ, Tulane Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA.
   [Ehrlich, Melanie] Tulane Univ, Hayward Genet Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA.
C3 Tulane University; Tulane University; Tulane University
RP Ehrlich, M (corresponding author), Tulane Univ, Ctr Bioinformat & Genom, Hlth Sci Ctr, New Orleans, LA 70112 USA.; Ehrlich, M (corresponding author), Tulane Univ, Tulane Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA.; Ehrlich, M (corresponding author), Tulane Univ, Hayward Genet Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA.
EM kehrlich@tulane.edu; hcleng2@tulane.edu; ehrlich@tulane.edu
FU National Institutes of Health [NS04885, U19AG05537301, R01AR069055]; National Institutes of Health (National Center for Advancing Translational Sciences) [UL1TR001417]; Louisiana Cancer Center
CR Allan R, 2020, EUR J APPL PHYSIOL, V120, P2487, DOI 10.1007/s00421-020-04467-6
   Ang YS, 2016, CELL, V167, P1734, DOI 10.1016/j.cell.2016.11.033
   Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Banerji CRS, 2019, HUM MOL GENET, V28, P1244, DOI 10.1093/hmg/ddy405
   Benhar H, 2020, COMPUT METH PROG BIO, V195, P0, DOI 10.1016/j.cmpb.2020.105635
   Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026
   Bhattacharya D, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00480
   Boczonadi V, 2015, INT J BIOCHEM CELL B, V63, P32, DOI 10.1016/j.biocel.2015.01.025
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731
   Breckenridge RA, 2009, J MOL CELL CARDIOL, V47, P133, DOI 10.1016/j.yjmcc.2009.04.007
   Chambers JM, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9102234
   Cordeiro AV, 2020, J GERONTOL A-BIOL, V75, P2258, DOI 10.1093/gerona/glaa059
   Dagher R, 2021, MOL GENET METAB, V133, P1, DOI 10.1016/j.ymgme.2021.03.010
   Doblado L, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22083903
   Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115
   Ehrlich KC, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21218394
   Ehrlich KC, 2020, EPIGENOMES, V4, P0, DOI 10.3390/epigenomes4010001
   Eryilmaz IE, 2017, NEUROL RES, V39, P965, DOI 10.1080/01616412.2017.1368141
   Garry GA, 2022, SEMIN CELL DEV BIOL, V122, P3, DOI 10.1016/j.semcdb.2021.05.019
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gladyck S, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10020197
   Glancy B, 2021, PHYSIOL REV, V101, P1561, DOI 10.1152/physrev.00040.2020
   Gouspillou G, 2018, J PHYSIOL-LONDON, V596, P2565, DOI 10.1113/JP275604
   Gumeni S, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-021-03952-w
   Haeussler M, 2019, NUCLEIC ACIDS RES, V47, PD853, DOI 10.1093/nar/gky1095
   Ji S, 2008, MOL GENET METAB, V93, P314, DOI 10.1016/j.ymgme.2007.10.006
   Kadenbach B, 2021, MITOCHONDRION, V58, P296, DOI 10.1016/j.mito.2020.10.004
   Khan A, 2016, NUCLEIC ACIDS RES, V44, PD164, DOI 10.1093/nar/gkv1002
   Krämer AI, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20215449
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Kwik M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22073296
   Lacey M, 2019, DATA BRIEF, V23, P0, DOI 10.1016/j.dib.2019.103812
   Lampert MA, 2019, AUTOPHAGY, V15, P1182, DOI 10.1080/15548627.2019.1580095
   Larson C, 2020, INT J ENV RES PUB HE, V17, P0, DOI 10.3390/ijerph17165740
   Leach JP, 2017, NATURE, V550, P260, DOI 10.1038/nature24045
   Leduc-Gaudet JP, 2019, J PHYSIOL-LONDON, V597, P1975, DOI 10.1113/JP277157
   Léveillé M, 2020, MOL METAB, V34, P72, DOI 10.1016/j.molmet.2020.01.004
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lindskog C, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/s12864-015-1686-y
   Liu L, 2020, J CLIN INVEST, V130, P4710, DOI 10.1172/JCI136155
   Lochmann TL, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0129647
   Mackey AL, 2017, J PHYSIOL-LONDON, V595, P5115, DOI 10.1113/JP273997
   Marshall LL, 2020, NAT NEUROSCI, V23, P1203, DOI 10.1038/s41593-020-0690-y
   Martinez-Redondo V, 2016, J BIOL CHEM, V291, P15169, DOI 10.1074/jbc.M115.705822
   Martínez-Redondo V, 2015, DIABETOLOGIA, V58, P1969, DOI 10.1007/s00125-015-3671-z
   Miquerol L, 2013, WIRES DEV BIOL, V2, P17, DOI 10.1002/wdev.68
   Mizuno Y, 2020, NEUROSCI RES, V159, P3, DOI 10.1016/j.neures.2020.02.002
   Moore-Morris T, 2018, PHYSIOL REV, V98, P2453, DOI 10.1152/physrev.00048.2017
   Murillo-González FE, 2021, BIOCHEM PHARMACOL, V190, P0, DOI 10.1016/j.bcp.2021.114650
   Myers RM, 2011, PLOS BIOL, V9, P0, DOI 10.1371/journal.pbio.1001046
   Napoli C, 2020, AM HEART J, V224, P113, DOI 10.1016/j.ahj.2020.03.007
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Padmanabhan A, 2020, CIRCULATION, V142, P2338, DOI 10.1161/CIRCULATIONAHA.120.047753
   Park HD, 2009, ANN CLIN LAB SCI, V39, P399
   Patel BV, 2020, J MOL BIOL, V432, P6127, DOI 10.1016/j.jmb.2020.09.022
   Popov DV, 2015, ACTA NATURAE, V7, P48, DOI 10.32607/20758251-2015-7-1-48-59
   Puig RR, 2021, BMC GENOMICS, V22, P0, DOI 10.1186/s12864-021-07760-6
   Rönn T, 2008, DIABETOLOGIA, V51, P1159, DOI 10.1007/s00125-008-1018-8
   Roudbar MA, 2021, G3-GENES GENOM GENET, V11, P0, DOI 10.1093/g3journal/jkab112
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   Sartorelli V, 2020, NAT STRUCT MOL BIOL, V27, P521, DOI 10.1038/s41594-020-0446-0
   Schiaffino S, 2021, J NEUROMUSCULAR DIS, V8, P169, DOI 10.3233/JND-200568
   Schiaffino S, 2020, HISTOL HISTOPATHOL, V35, P239, DOI 10.14670/HH-18-170
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Shintaku J, 2016, CELL REP, V17, P514, DOI 10.1016/j.celrep.2016.09.010
   Shouman S, 2021, ADV EXP MED BIOL, V1312, P51, DOI 10.1007/5584_2020_594
   Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172
   Sondheimer N, 2017, MOL GENET METAB REP, V12, P23, DOI 10.1016/j.ymgmr.2017.05.001
   Song HX, 2021, AUTOPHAGY, V17, P4102, DOI 10.1080/15548627.2021.1904488
   Song Q, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0081148
   Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6
   Soyal SM, 2020, MOL NEUROBIOL, V57, P752, DOI 10.1007/s12035-019-01731-5
   Soyal SM, 2019, NEUROBIOL DIS, V121, P34, DOI 10.1016/j.nbd.2018.09.016
   Soyal SM, 2012, HUM MOL GENET, V21, P3461, DOI 10.1093/hmg/dds177
   Steimle JD, 2017, CURR TOP DEV BIOL, V122, P195, DOI 10.1016/bs.ctdb.2016.08.008
   Stelzer Gil, 2016, CURR PROTOC BIOINFORMATICS, V54, P0, DOI 10.1002/cpbi.5
   Swedlund B, 2020, CSH PERSPECT BIOL, V12, P0, DOI 10.1101/cshperspect.a036731
   Sweeney HL, 2018, CSH PERSPECT BIOL, V10, P0, DOI 10.1101/cshperspect.a023200
   Taylor-Weiner H, 2020, P NATL ACAD SCI USA, V117, P2978, DOI 10.1073/pnas.1919600117
   Terragni J, 2014, EPIGENETICS-US, V9, P842, DOI 10.4161/epi.28597
   Terry EE, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.34613
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Timón-Gómez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wagner AE, 2012, OXID MED CELL LONGEV, V2012, P0, DOI 10.1155/2012/835970
   Wardle FC, 2019, J MUSCLE RES CELL M, V40, P211, DOI 10.1007/s10974-019-09538-6
   Whittington HJ, 2018, CARDIOVASC RES, V114, P858, DOI 10.1093/cvr/cvy054
   Zhang RH, 2020, MECH AGEING DEV, V188, P0, DOI 10.1016/j.mad.2020.111245
NR 89
TC 3
Z9 3
U1 2
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-4655
J9 EPIGENOMES
JI Epigenomes
PD MAR 15
PY 2022
VL 6
IS 1
BP 
EP 
DI 10.3390/epigenomes6010001
PG 23
WC Genetics & Heredity
SC Genetics & Heredity
GA 0C6JY
UT WOS:000775418300001
PM 35076500
DA 2024-11-01
ER

PT J
AU Mito, T
   Vincent, AE
   Faitg, J
   Taylor, RW
   Khan, NA
   McWilliams, TG
   Suomalainen, A
AF Mito, Takayuki
   Vincent, Amy E.
   Faitg, Julie
   Taylor, Robert W.
   Khan, Nahid A.
   McWilliams, Thomas G.
   Suomalainen, Anu
TI Mosaic dysfunction of mitophagy in mitochondrial muscle disease
SO CELL METABOLISM
LA English
DT Article
ID autophagy; ubiquitin; parkin; pink1; dna; degradation; biomarker; delivery; deletion; tissue
AB Mitophagy is a quality control mechanism that eliminates damaged mitochondria, yet its significance in mammalian pathophysiology and aging has remained unclear. Here, we report that mitophagy contributes to mitochondrial dysfunction in skeletal muscle of aged mice and human patients. The early disease stage is characterized by muscle fibers with central nuclei, with enhanced mitophagy around these nuclei. However, progressive mitochondrial dysfunction halts mitophagy and disrupts lysosomal homeostasis. Interestingly, activated or halted mitophagy occur in a mosaic manner even in adjacent muscle fibers, indicating cell-autonomous regulation. Rapamycin restores mitochondrial turnover, indicating mTOR-dependence of mitochondrial recycling in advanced disease stage. Our evidence suggests that (1) mitophagy is a hallmark of age-related mitochondrial pathology in mammalian muscle, (2) mosaic halting of mitophagy is a mechanism explaining mosaic respiratory chain deficiency and accumulation of pathogenic mtDNA variants in adult-onset mitochondrial diseases and normal aging, and (3) augmenting mitophagy is a promising therapeutic approach for muscle mitochondrial dysfunction.
C1 [Mito, Takayuki; Khan, Nahid A.; McWilliams, Thomas G.; Suomalainen, Anu] Univ Helsinki, Fac Med, Biomed Helsinki, Res Program Stem Cells & Metab, Helsinki 00290, Finland.
   [Vincent, Amy E.; Faitg, Julie; Taylor, Robert W.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondria Dis, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [McWilliams, Thomas G.] Univ Helsinki, Fac Med, Dept Anat, Helsinki 00290, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, HUSlab, Helsinki 00290, Finland.
C3 University of Helsinki; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Helsinki; University of Helsinki; Helsinki University Central Hospital
RP Suomalainen, A (corresponding author), Univ Helsinki, Fac Med, Biomed Helsinki, Res Program Stem Cells & Metab, Helsinki 00290, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, HUSlab, Helsinki 00290, Finland.
EM anu.wartiovaara@helsinki.fi
FU Academy of Finland; Helsinki University; Sigrid Juselius Foundation; Helsinki University AAV-core; Laboratory Animal Centre; Biomedicum Imaging Unit; Newcastle University Electron Microscopy Research Services; BBSRC [BB/M012093/1]; Novo Nordisk Foundation; Finnish Foundation for Cardiovascular Research; University of Helsinki; Sir Henry Wellcome Fellowship [215888/Z/19/Z]; short-term EMBO fellowship [8436]; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders; Wellcome Trust [215888/Z/19/Z] Funding Source: Wellcome Trust; BBSRC [BB/M012093/1] Funding Source: UKRI
CR Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168
   Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   Belevich I, 2016, PLOS BIOL, V14, P0, DOI 10.1371/journal.pbio.1002340
   Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9
   Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111
   Deshwal S, 2020, ANNU REV BIOCHEM, V89, P501, DOI 10.1146/annurev-biochem-062917-012739
   Dubowitz V, 2007, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   Faitg J, 2020, J MICROSC-OXFORD, V278, P89, DOI 10.1111/jmi.12891
   Federici T, 2012, GENE THER, V19, P852, DOI 10.1038/gt.2011.130
   Fernandez-Mosquera L, 2019, AUTOPHAGY, V15, P1572, DOI 10.1080/15548627.2019.1586256
   Folker ES, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00363
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   Hoshino A, 2019, NATURE, V575, P375, DOI 10.1038/s41586-019-1667-4
   Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104
   Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540
   Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Killackey SA, 2020, J CELL BIOL, V219, P0, DOI 10.1083/jcb.202004029
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Kühl I, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30952
   Kuma A, 2017, AUTOPHAGY, V13, P1619, DOI 10.1080/15548627.2017.1343770
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   McQuin C, 2018, PLOS BIOL, V16, P0, DOI 10.1371/journal.pbio.2005970
   McWilliams TG, 2019, AUTOPHAGY, V15, P1296, DOI 10.1080/15548627.2019.1580509
   McWilliams TG, 2018, OPEN BIOL, V8, P0, DOI 10.1098/rsob.180108
   McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008
   McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039
   Montava-Garriga L, 2020, J MOL BIOL, V432, P206, DOI 10.1016/j.jmb.2019.06.032
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Singh F, 2020, BIORXIV, V0, P0, DOI DOI 10.1101/2020.12.07.414359
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomi Fumi, 2019, NEURONAL SIGNAL, V3, PNS20180134, DOI 10.1042/NS20180134
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Vannini N, 2019, CELL STEM CELL, V24, P405, DOI 10.1016/j.stem.2019.02.012
   Wilke SA, 2013, J NEUROSCI, V33, P507, DOI 10.1523/JNEUROSCI.1600-12.2013
   Yamada T, 2018, CELL METAB, V28, P588, DOI 10.1016/j.cmet.2018.06.014
   Yamashita SI, 2021, J CELL PHYSIOL, V236, P7612, DOI 10.1002/jcp.30404
   Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200
   Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76
NR 54
TC 38
Z9 40
U1 3
U2 41
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD FEB 1
PY 2022
VL 34
IS 2
BP 197
EP +
DI 10.1016/j.cmet.2021.12.017
EA FEB 2022
PG 17
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 2A8FX
UT WOS:000809732500005
PM 35030325
DA 2024-11-01
ER

PT J
AU Dahal, S
   Siddiqua, H
   Sharma, S
   Babu, RK
   Rathore, D
   Sharma, S
   Raghavan, SC
AF Dahal, Sumedha
   Siddiqua, Humaira
   Sharma, Shivangi
   Babu, Ravi K.
   Rathore, Diksha
   Sharma, Sheetal
   Raghavan, Sathees C.
TI Unleashing a novel function of Endonuclease G in mitochondrial genome instability
SO ELIFE
LA English
DT Article
DE tetraplexes; mitochondrial fragility; Endo G; double-strand breaks; MMEJ; mitochondrial deletion; G4 DNA; E; coli; Human; Rat
ID non-b-dna; major breakpoint region; g-quadruplex structures; base excision-repair; mtdna control-region; 9-bp deletion; evolutionary history; protein-a; end; nuclease
AB Having its genome makes the mitochondrion a unique and semiautonomous organelle within cells. Mammalian mitochondrial DNA (mtDNA) is a double-stranded closed circular molecule of about 16 kb coding for 37 genes. Mutations, including deletions in the mitochondrial genome, can culminate in different human diseases. Mapping the deletion junctions suggests that the breakpoints are generally seen at hotspots. '9 bp deletion' (8271-8281), seen in the intergenic region of cytochrome c oxidase II/tRNA(Lys), is the most common mitochondrial deletion. While it is associated with several diseases like myopathy, dystonia, and hepatocellular carcinoma, it has also been used as an evolutionary marker. However, the mechanism responsible for its fragility is unclear. In the current study, we show that Endonuclease G, a mitochondrial nuclease responsible for nonspecific cleavage of nuclear DNA during apoptosis, can induce breaks at sequences associated with '9 bp deletion' when it is present on a plasmid or in the mitochondrial genome. Through a series of in vitro and intracellular studies, we show that Endonuclease G binds to G-quadruplex structures formed at the hotspot and induces DNA breaks. Therefore, we uncover a new role for Endonuclease G in generating mtDNA deletions, which depends on the formation of G4 DNA within the mitochondrial genome. In summary, we identify a novel property of Endonuclease G, besides its role in apoptosis and the recently described 'elimination of paternal mitochondria during fertilisation.
C1 [Dahal, Sumedha; Siddiqua, Humaira; Sharma, Shivangi; Babu, Ravi K.; Rathore, Diksha; Raghavan, Sathees C.] Indian Inst Sci Bangalore, Dept Biochem, Bangalore, India.
   [Sharma, Sheetal] Post Grad Inst Med Educ & Res, Dept Expt Med & Biotechnol, Chandigarh, India.
C3 Indian Institute of Science (IISC) - Bangalore; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh
RP Raghavan, SC (corresponding author), Indian Inst Sci Bangalore, Dept Biochem, Bangalore, India.
EM sathees@iisc.ac.in
FU Council of Scientific and Industrial Research, India [37(1692)/17/EMR-11]; Department of Atomic Energy, Government of India [21/01/2016-BRNS/35074]; Department of Biotechnology, Ministry of Science and Technology, India [BT/PR/3458/COE/34/33/2015]; IISc-DBT partnership programme [BT/PR27952-INF/22/212/2018]; Indian Institute of Science
CR Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073
   Bianchi NO, 2001, MUTAT RES-REV MUTAT, V488, P9, DOI 10.1016/S1383-5742(00)00063-6
   Biffi G, 2013, NAT CHEM, V5, P182, DOI 10.1038/nchem.1548
   Butler TJ, 2020, HUM MOL GENET, V29, P1292, DOI 10.1093/hmg/ddaa043
   Carew Jennifer S, 2002, MOL CANCER, V1, P9, DOI 10.1186/1476-4598-1-9
   Carey Michael F, 2009, COLD SPRING HARB PROTOC, V2009, P0, DOI 10.1101/pdb.prot5279
   Cer RZ, 2013, NUCLEIC ACIDS RES, V41, PD94, DOI 10.1093/nar/gks955
   Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Chiruvella KK, 2012, J MOL BIOL, V417, P197, DOI 10.1016/j.jmb.2012.01.029
   Chiruvella KK, 2008, FEBS LETT, V582, P4066, DOI 10.1016/j.febslet.2008.11.001
   Chu IT, 2019, BBA-GEN SUBJECTS, V1863, P418, DOI 10.1016/j.bbagen.2018.11.009
   CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573
   COTE J, 1989, J BIOL CHEM, V264, P3301
   Dahal S, 2022, FEBS J, V289, P163, DOI 10.1111/febs.16113
   Dahal S, 2018, CELL MOL LIFE SCI, V75, P1641, DOI 10.1007/s00018-017-2702-y
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   Das K, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0158794
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   Dillon LW, 2010, CURR GENOMICS, V11, P326, DOI 10.2174/138920210791616699
   Dong DW, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-677
   Dong LF, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.22187
   Dornberger U, 1999, J BIOL CHEM, V274, P6957, DOI 10.1074/jbc.274.11.6957
   Duguay BA, 2013, J VIROL, V87, P11787, DOI 10.1128/JVI.02306-13
   Falabella M, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-41464-y
   Falabella M, 2019, CURR MED CHEM, V26, P2918, DOI 10.2174/0929867325666180228165527
   Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050
   Ghosh D, 2022, J MOL BIOL, V434, P0, DOI 10.1016/j.jmb.2022.167617
   Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234
   Greene AL, 1999, HUM MOL GENET, V8, P2263, DOI 10.1093/hmg/8.12.2263
   Holthöfer H, 1999, FASEB J, V13, P523, DOI 10.1096/fasebj.13.3.523
   Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611
   Javadekar SM, 2020, DNA RES, V27, P0, DOI 10.1093/dnares/dsaa024
   Jin YQ, 2012, GENET TEST MOL BIOMA, V16, P330, DOI 10.1089/gtmb.2011.0208
   Jose D, 2009, P NATL ACAD SCI USA, V106, P4231, DOI 10.1073/pnas.0900803106
   Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008
   Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341
   Komandur S, 2011, GENET TEST MOL BIOMA, V15, P361, DOI 10.1089/gtmb.2010.0205
   Krishnan KJ, 2010, ESSAYS BIOCHEM, V47, P139, DOI 10.1042/BSE0470139
   Kumar TS, 2010, J BIOL CHEM, V285, P32657, DOI 10.1074/jbc.M110.140350
   Kumari N, 2019, ISCIENCE, V21, P288, DOI 10.1016/j.isci.2019.10.033
   Kumari R, 2021, CELL REP, V36, P0, DOI 10.1016/j.celrep.2021.109390
   Kumari R, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0119722
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620
   Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Lombardi EP, 2020, NUCLEIC ACIDS RES, V48, P1, DOI 10.1093/nar/gkz1097
   Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5
   Marni G, 2003, MITOCHONDRIAL DNA DE, V0, P0
   Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200
   McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Misic V, 2016, BIOCHEMISTRY-MOSCOW+, V81, P163, DOI 10.1134/S0006297916020103
   Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495
   Naik AK, 2010, J BIOL CHEM, V285, P7587, DOI 10.1074/jbc.M109.089631
   Nambiar M, 2013, MOL CELL BIOL, V33, P4266, DOI 10.1128/MCB.00540-13
   Nambiar M, 2012, J BIOL CHEM, V287, P8688, DOI 10.1074/jbc.M111.307363
   Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824
   Nishana M, 2012, BIOCHEM J, V448, P115, DOI 10.1042/BJ20121031
   Ohsato T, 2002, EUR J BIOCHEM, V269, P5765, DOI 10.1046/j.1432-1033.2002.03238.x
   Oliveira PH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059907
   Omar Garcia-lepe U, 2019, MITOCHONDRIAL GENOME MAINTENANCE: DAMAGE AND REPAIR PATHWAYS, V0, P0
   Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608
   Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Raghavan SC, 2006, METHOD ENZYMOL, V409, P301, DOI 10.1016/S0076-6879(05)09017-8
   Raghavan SC, 2005, MOL CELL BIOL, V25, P6475, DOI 10.1128/MCB.25.15.6475-6484.2005
   Raghavan SC, 2005, J BIOL CHEM, V280, P22749, DOI 10.1074/jbc.M502952200
   Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005
   Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355
   Ray U, 2020, MOL CARCINOGEN, V59, P618, DOI 10.1002/mc.23186
   Raymond C, 2011, METHODS, V55, P44, DOI 10.1016/j.ymeth.2011.04.002
   REDD AJ, 1995, MOL BIOL EVOL, V12, P604
   Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615
   RUIZCARRILLO A, 1987, EMBO J, V6, P401, DOI 10.1002/j.1460-2075.1987.tb04769.x
   Sambrook J, 1989, MOLECULAR CLONING: A LABORATORY MANUAL, V0, P0
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060
   Schäfer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069
   Sharma S, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.58
   Sharma S, 2011, CELL MOL LIFE SCI, V68, P661, DOI 10.1007/s00018-010-0472-x
   Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002
   Soodyall H, 1996, AM J HUM GENET, V58, P595
   Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Sun H, 2001, P NATL ACAD SCI USA, V98, P12444, DOI 10.1073/pnas.231479198
   Suzuki H, 2002, J CELL SCI, V115, P1895
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thomas E, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep34653
   Thomas MG, 1998, PHILOS T R SOC B, V353, P955, DOI 10.1098/rstb.1998.0260
   Totaro A, 2011, NUCLEIC ACIDS RES, V39, P635, DOI 10.1093/nar/gkq797
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944
   Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105
   Wells RD, 2009, J BIOL CHEM, V284, P8997, DOI 10.1074/jbc.X800010200
   Wiehe Rahel Stefanie, 2018, ONCOTARGET, V9, P18309, DOI 10.18632/oncotarget.24822
   Wisnovsky S, 2018, ACS CHEM BIOL, V13, P900, DOI 10.1021/acschembio.8b00072
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yang C, 2018, NUCLEIC ACIDS RES, V46, P11075, DOI 10.1093/nar/gky855
   YANG JH, 1994, ARCH DERMATOL RES, V286, P386, DOI 10.1007/BF00371798
   Yao YG, 2000, HUM GENET, V107, P504, DOI 10.1007/s004390000403
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982
   Yu X, 2000, J BIOL CHEM, V275, P18541, DOI 10.1074/jbc.M909494199
   Yusoff AAM, 2019, ONCOL REV, V13, P54, DOI 10.4081/oncol.2019.409
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
   Zhuo GC, 2010, BIOCHEM GENET, V48, P157, DOI 10.1007/s10528-009-9308-5
NR 115
TC 9
Z9 9
U1 1
U2 14
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
EI 
J9 ELIFE
JI eLife
PD NOV 17
PY 2022
VL 11
IS 
BP 
EP 
DI 10.7554/eLife.69916
PG 35
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 6S5IB
UT WOS:000893019500001
PM 36394256
DA 2024-11-01
ER

PT J
AU Vandiver, AR
   Pielstick, B
   Gilpatrick, T
   Hoang, AN
   Vernon, HJ
   Wanagat, J
   Timp, W
AF Vandiver, Amy R.
   Pielstick, Brittany
   Gilpatrick, Timothy
   Hoang, Austin N.
   Vernon, Hillary J.
   Wanagat, Jonathan
   Timp, Winston
TI Long read mitochondrial genome sequencing using Cas9-guided adaptor ligation
SO MITOCHONDRION
LA English
DT Article
DE mtDNA; Sequencing; mtDNA deletions; SNPs; Aging
ID human skeletal-muscle; point mutations; mtdna mutations; dna deletions; melas; gene
AB The mitochondrial genome (mtDNA) is an important source of disease-causing genetic variability, but existing sequencing methods limit understanding, precluding phased measurement of mutations and clear detection of large sporadic deletions. We adapted a method for amplification-free sequence enrichment using Cas9 cleavage to obtain full length nanopore reads of mtDNA. We then utilized the long reads to phase mutations in a patient with an mtDNA-linked syndrome and demonstrated that this method can map age-induced mtDNA deletions. We believe this method will offer deeper insight into our understanding of mtDNA variation.
C1 [Vandiver, Amy R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA.
   [Pielstick, Brittany; Timp, Winston] Johns Hopkins Univ, Dept Mol Biol & Genet, Sch Med, Baltimore, MD 21218 USA.
   [Gilpatrick, Timothy; Timp, Winston] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
   [Hoang, Austin N.; Wanagat, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
   [Vernon, Hillary J.; Timp, Winston] Johns Hopkins Univ, Dept Genet Med, Sch Med, Baltimore, MD 21218 USA.
   [Wanagat, Jonathan] Vet Adm Greater Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
   [Timp, Winston] Johns Hopkins Univ, 3400 N Charles St,Clark 102A, Baltimore, MD 21218 USA.
C3 University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Johns Hopkins University
RP Vandiver, AR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA.; Timp, W (corresponding author), Johns Hopkins Univ, 3400 N Charles St,Clark 102A, Baltimore, MD 21218 USA.
EM avandiver@mednet.ucla.edu; wtimp@jhu.edu
FU NIH/NIAMS [T32 AR071307]; Dermatology Foundation; NIH [R01HG009190, U01CA253481, T32 GM007445, T32 GM136577, R56AG060880, R01AG055518, K02AG059847]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [T32AR071307] Funding Source: NIH RePORTER; National Institute of General Medical Sciences [T32GM136577, T32GM007445] Funding Source: NIH RePORTER; National Institute on Aging [R01AG055518, K02AG059847] Funding Source: NIH RePORTER
CR Aganezov S, 2020, GENOME RES, V30, P1258, DOI 10.1101/gr.260497.119
   Albayrak L, 2016, BMC GENOMICS, V17, P0, DOI 10.1186/s12864-016-3375-x
   Alkanaq AN, 2019, J HUM GENET, V64, P1107, DOI 10.1038/s10038-019-0654-9
   Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Berneburg M, 1998, J INVEST DERMATOL, V111, P709, DOI 10.1046/j.1523-1747.1998.00337.x
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1821-7
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chakrabarty RP, 2021, CELL STEM CELL, V28, P394, DOI 10.1016/j.stem.2021.02.011
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   de Coo IFM, 1998, NEUROLOGY, V50, P293, DOI 10.1212/WNL.50.1.293
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Gilpatrick T, 2020, NAT BIOTECHNOL, V38, P433, DOI 10.1038/s41587-020-0407-5
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Gould MP, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0139253
   HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561
   Herbst A, 2021, AGING CLIN EXP RES, V33, P1811, DOI 10.1007/s40520-020-01698-7
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Hopkins JF, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00377-y
   KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Lujan SA, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-02138-5
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Palculict ME, 2016, METHODS MOL BIOL, V1351, P3, DOI 10.1007/978-1-4939-3040-1_1
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Sato A, 2005, P NATL ACAD SCI USA, V102, P6057, DOI 10.1073/pnas.0408666102
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sedlazeck FJ, 2018, NAT METHODS, V15, P461, DOI 10.1038/s41592-018-0001-7
   Sevini F, 2014, EXP GERONTOL, V56, P234, DOI 10.1016/j.exger.2014.03.022
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Stewart JB, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005333
   Sun CB, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.601307
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Taylor RW, 1996, ANN NEUROL, V40, P459, DOI 10.1002/ana.410400318
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Wallace AD, 2021, PLOS ONE, V16, P0, DOI 10.1371/journal.pone.0241253
   Yao Y, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-53449-y
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Yusoff AAM, 2019, ONCOL REV, V13, P54, DOI 10.4081/oncol.2019.409
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
   Zook JM, 2016, SCI DATA, V3, P0, DOI 10.1038/sdata.2016.25
NR 51
TC 7
Z9 8
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2022
VL 65
IS 
BP 176
EP 183
DI 10.1016/j.mito.2022.06.003
EA JUL 2022
PG 8
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 3E8RH
UT WOS:000830245400002
PM 35787470
DA 2024-11-01
ER

PT J
AU Ansari, F
   Yoval, B
   Niatsetskaya, Z
   Ten, V
   Wittig, I
   Galkin, A
AF Ansari, Fariha
   Yoval, Belem
   Niatsetskaya, Zoya
   Ten, Vadim
   Wittig, Ilka
   Galkin, Alexander
TI How many molecules of mitochondrial complex I are in a cell?
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE Mitochondrial complex I; Flavin mononucleotide; Fluorescence; Respiratory chain; Astrocytes
ID nadh-ubiquinone oxidoreductase; respiratory-chain; fluorescent flavoproteins; native electrophoresis; dysfunction; enzymes; protein; muscle; liver; subunits
AB Mitochondrial complex I is the only enzyme responsible for oxidation of matrix NADH and regeneration of NAD+ for catabolism. Nuclear and mtDNA mutations, assembly impairments, and enzyme damage are implicated in inherited diseases, ischemia-reperfusion injury, neurodegeneration, and tumorogenesis. Here we introduce a novel method to measure the absolute content of complex I. The method is based on flavin fluorescence scanning of a polyacrylamide gel after separation of complexes by Clear Native electrophoresis. Using mouse primary astrocytes as an example, we calculated an average value of 2.2 x 10(5) complex I molecules/cell. Our method can be used for accurate quantification of complex I content.
C1 [Ansari, Fariha; Yoval, Belem; Galkin, Alexander] Feil Family Brain & Mind Res Inst, Weill Cornell Med, New York, NY 10021 USA.
   [Niatsetskaya, Zoya; Ten, Vadim] Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA.
   [Niatsetskaya, Zoya; Ten, Vadim] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA.
   [Wittig, Ilka] Goethe Univ, Inst Cardiovasc Physiol, Funct Prote, D-60590 Frankfurt, Germany.
   [Wittig, Ilka] German Ctr Cardiovasc Res DZHK, Partner site RheinMain, Frankfurt, Germany.
C3 Cornell University; Weill Cornell Medicine; Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences; Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences; Goethe University Frankfurt; German Centre for Cardiovascular Research
RP Galkin, A (corresponding author), Feil Family Brain & Mind Res Inst, Weill Cornell Med, New York, NY 10021 USA.
EM alg2057@med.cornell.edu
FU NIH [RO1NS112381, NS100850]; BMBF mitoNET-German Network for Mitochondrial Disorders [01GM1906D]
CR ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8
   Almeida A, 2002, J NEUROCHEM, V81, P207, DOI 10.1046/j.1471-4159.2002.00827.x
   Ansari F, 2021, J BIOL CHEM, V297, P0, DOI 10.1016/j.jbc.2021.101204
   Baracca A, 2010, BBA-BIOENERGETICS, V1797, P314, DOI 10.1016/j.bbabio.2009.11.006
   BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018
   Beutner G, 2021, METHODS MOL BIOL, V2276, P103, DOI 10.1007/978-1-0716-1266-8_7
   Blinova K, 2008, BIOCHEMISTRY-US, V47, P9636, DOI 10.1021/bi800307y
   Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128
   Fernández-Vizarra E, 2021, BBA-BIOENERGETICS, V1862, P0, DOI 10.1016/j.bbabio.2021.148414
   Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006
   Formosa LE, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107541
   Grosche A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069143
   Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002
   Hassinen IE, 2014, J INNOV OPT HEAL SCI, V7, P0, DOI 10.1142/S1793545813500582
   Hatefi Y, 1967, METHODS ENZYMOL, V10, P235
   He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361
   Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006
   KUNZ WS, 1986, FEBS LETT, V195, P92, DOI 10.1016/0014-5793(86)80137-5
   KUNZ WS, 1993, BIOCHEM MED METAB B, V50, P103, DOI 10.1006/bmmb.1993.1051
   KUNZ WS, 1985, BIOCHIM BIOPHYS ACTA, V841, P237, DOI 10.1016/0304-4165(85)90064-9
   Maughan DW, 2005, MOL CELL PROTEOMICS, V4, P1541, DOI 10.1074/mcp.M500053-MCP200
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   Nadtochiy SM, 2021, METHODS MOL BIOL, V2276, P227, DOI 10.1007/978-1-0716-1266-8_17
   OMeara RW, 2011, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3324
   Parey K, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abj3221
   Pereira B, 2013, MOL CELL BIOL, V33, P2623, DOI 10.1128/MCB.01476-12
   Pérez-Pérez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081
   RAGAN CI, 1976, BIOCHEM J, V154, P295, DOI 10.1042/bj1540295
   Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829
   Rao N, 1967, METHODS ENZYMOL, V0, P494
   Salehi MH, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0094069
   Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   SLED VD, 1993, BIOCHIM BIOPHYS ACTA, V1141, P262, DOI 10.1016/0005-2728(93)90051-G
   Smeitink JAM, 2004, CURR NEUROVASC RES, V1, P29, DOI 10.2174/1567202043480224
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754
   THOMPSON ST, 1975, P NATL ACAD SCI USA, V72, P669, DOI 10.1073/pnas.72.2.669
   Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Urra FA, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00118
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200
   VOLTTI H, 1979, J BIOENERG BIOMEMBR, V10, P45
   Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013
   Wisniewski JR, 2015, J PROTEOME RES, V14, P3263, DOI 10.1021/acs.jproteome.5b00276
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 51
TC 3
Z9 3
U1 1
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
EI 1096-0309
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD JUN 1
PY 2022
VL 646
IS 
BP 
EP 
DI 10.1016/j.ab.2022.114646
EA APR 2022
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 1K6TA
UT WOS:000798729400007
PM 35259403
DA 2024-11-01
ER

PT J
AU Berardo, A
   Domínguez-González, C
   Engelstad, K
   Hirano, M
AF Berardo, Andres
   Dominguez-Gonzalez, Cristina
   Engelstad, Kristin
   Hirano, Michio
TI Advances in Thymidine Kinase 2 Deficiency: Clinical Aspects, Translational Progress, and Emerging Therapies
SO JOURNAL OF NEUROMUSCULAR DISEASES
LA English
DT Review
DE Mitochondrial myopathies; deoxycytidine; thymidine; DNA; mitochondrial; mitochondrial diseases
ID mitochondrial-dna depletion; impair mtdna replication; mutations; myopathy; gene; biomarker; specificity; deletions; defects; rrm2b
AB Defects in the replication, maintenance, and repair of mitochondrial DNA (mtDNA) constitute a growing and genetically heterogeneous group of mitochondrial disorders. Multiple genes participate in these processes, including thymidine kinase 2 (TK2) encoding the mitochondrial matrix protein TK2, a critical component of the mitochondrial nucleotide salvage pathway. TK2 deficiency (TK2d) causes mtDNA depletion, multiple deletions, or both, which manifest predominantly as mitochondrial myopathy. A wide clinical spectrum phenotype includes a severe, rapidly progressive, early onset form (median survival: < 2 years); a less severe childhood-onset form; and a late-onset form with a variably slower rate of progression. Clinical presentation typically includes progressive weakness of limb, neck, facial, oropharyngeal, and respiratory muscle, whereas limb myopathy with ptosis, ophthalmoparesis, and respiratory involvement is more common in the late-onset form. Deoxynucleoside monophosphates and deoxynucleosides that can bypass the TK2 enzyme defect have been assessed in a mouse model, as well as under open-label compassionate use (expanded access) in TK2d patients, indicating clinical efficacy with a favorable side-effect profile. This treatment is currently undergoing testing in clinical trials intended to support approval in the US and European Union (EU). In the early expanded access program, growth differentiation factor 15 (GDF-15) appears to be a useful biomarker that correlates with therapeutic response. With the advent of a specific treatment and given the high morbidity and mortality associated with TK2d, clinicians need to know how to recognize and diagnose this disorder. Here, we summarize translational research about this rare condition emphasizing clinical aspects.
C1 [Berardo, Andres; Engelstad, Kristin; Hirano, Michio] Columbia Univ, Dept Neurol, Irving Med Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
   [Dominguez-Gonzalez, Cristina] Univ Hosp 12 Octubre, Res Inst Imas12, Neurol Dept, Neuromuscular Unit,Spanish Network Biomed Res Rar, Madrid, Spain.
C3 Columbia University; NewYork-Presbyterian Hospital; Hospital Universitario 12 de Octubre
RP Hirano, M (corresponding author), Columbia Univ, Dept Neurol, Irving Med Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
EM mh29@cumc.columbia.edu
FU National Institutes of Health [P01 HD32062]; Department of Defense [W81XWH2010807]; Muscular Dystrophy Association [577392]; Arturo Estopinan TK2 Research Fund; Nicholas Nunno Foundation; JDM Fund for Mitochondrial Research; Shuman Mitochondrial Disease Fund; Marriott Mitochondrial Disease Clinic Research Fund (MMDCRF) from the J. Willard and Alice S. Marriott Foundation; NIH from NINDS [U54 NS078059]; NICHD; U.S. Department of Defense (DOD) [W81XWH2010807] Funding Source: U.S. Department of Defense (DOD)
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Carrozzo R, 2003, HUM MUTAT, V21, P0, DOI 10.1002/humu.9135
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   ERIKSSON S, 1991, ADV EXP MED BIOL, V309, P239
   Finsterer J, 2018, NEUROPEDIATRICS, V49, P231, DOI 10.1055/s-0037-1609039
   Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Jurkute N, 2019, ANN NEUROL, V86, P368, DOI 10.1002/ana.25550
   Koga Y, 2021, J INHERIT METAB DIS, V44, P358, DOI 10.1002/jimd.12317
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kumar D, 2014, GENOMIC MED, V0, P131
   Lehtonen JM, 2021, J INHERIT METAB DIS, V44, P469, DOI 10.1002/jimd.12307
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lopez-Gomez C, 2021, ANN NEUROL, V90, P640, DOI 10.1002/ana.26185
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Macmillan CJ, 1996, PEDIATR NEUROL, V14, P203, DOI 10.1016/0887-8994(96)00018-5
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mayo Clinic Laboratories, 2021, ROCH 2021 INT HDB 20, V0, P0
   Mazurova S, 2017, CARDIOL YOUNG, V27, P936, DOI 10.1017/S1047951116001876
   Munch-Petersen B, 2010, NUCLEOS NUCLEOT NUCL, V29, P363, DOI 10.1080/15257771003729591
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005
   Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tsygankova PG, 2019, J INHERIT METAB DIS, V42, P918, DOI 10.1002/jimd.12142
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 54
TC 9
Z9 9
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 2214-3599
EI 2214-3602
J9 J NEUROMUSCULAR DIS
JI J. Neuromusc. Dis.
PD JUN 15
PY 2022
VL 9
IS 2
BP 225
EP 235
DI 10.3233/JND-210786
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ZM0BX
UT WOS:000764033400001
PM 35094997
DA 2024-11-01
ER

PT J
AU Bhatti, GK
   Gupta, A
   Pahwa, P
   Khullar, N
   Singh, S
   Navik, U
   Kumar, S
   Mastana, SS
   Reddy, AP
   Reddy, PH
   Bhatti, JS
AF Bhatti, Gurjit Kaur
   Gupta, Anshika
   Pahwa, Paras
   Khullar, Naina
   Singh, Satwinder
   Navik, Umashanker
   Kumar, Shashank
   Mastana, Sarabjit Singh
   Reddy, Arubala P.
   Reddy, P. Hemachandra
   Bhatti, Jasvinder Singh
TI Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases
SO BIOMEDICAL JOURNAL
LA English
DT Review
DE Bioenergetics; Mitochondrial dysfunction; Oxidative stress; Electron transport chain; Antioxidants
ID cytochrome-c-oxidase; electron-transport chain; oxidative stress; huntingtons-disease; amyloid-beta; parkinsons-disease; mouse model; life-span; a-beta; dysfunction
AB Mitochondria are the organelles that generate energy for the cells and act as biosynthetic and bioenergetic factories, vital for normal cell functioning and human health. Mitochondrial bioenergetics is considered an important measure to assess the pathogenesis of various diseases. Dysfunctional mitochondria affect or cause several conditions involving the most energy-intensive organs, including the brain, muscles, heart, and liver. This dysfunction may be attributed to an alteration in mitochondrial enzymes, increased oxidative stress, impairment of electron transport chain and oxidative phosphorylation, or mutations in mitochondrial DNA that leads to the pathophysiology of various pathological conditions, including neurological and metabolic disorders. The drugs or compounds targeting mitochondria are considered more effective and safer for treating these diseases. In this review, we make an effort to concise the available literature on mitochondrial bioenergetics in various conditions and the therapeutic potential of various drugs/compounds targeting mitochondrial bioenergetics in metabolic and neurodegenerative diseases.
C1 [Bhatti, Gurjit Kaur] Chandigarh Univ, Univ Inst Appl Hlth Sci, Dept Med Lab Technol, Mohali, Punjab, India.
   [Gupta, Anshika; Pahwa, Paras] Sri Guru Gobind Singh Coll, Dept Biotechnol, Chandigarh, India.
   [Khullar, Naina] Mata Gujri Coll, Dept Zool, Fatehgarh Sahib, Punjab, India.
   [Singh, Satwinder] Cent Univ Punjab, Dept Comp Sci & Technol, Bathinda, India.
   [Navik, Umashanker] Cent Univ Punjab, Dept Pharmacol, Bathinda, India.
   [Kumar, Shashank] Cent Univ Punjab, Sch Basic Sci, Dept Biochem, Bathinda, India.
   [Mastana, Sarabjit Singh] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England.
   [Reddy, Arubala P.] Texas Tech Univ, Dept Nutr Sci, Lubbock, TX 79430 USA.
   [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA.
   [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA.
   [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Publ Hlth, Lubbock, TX 79430 USA.
   [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Dept Neurol, Lubbock, TX 79430 USA.
   [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Dept Speech Language & Hearing Sci, Lubbock, TX 79430 USA.
   [Bhatti, Jasvinder Singh] Cent Univ Punjab, Sch Hlth Sci, Dept Human Genet & Mol Med, Bathinda, India.
C3 Chandigarh University; Central University of Punjab; Central University of Punjab; Central University of Punjab; Loughborough University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center; Central University of Punjab
RP Bhatti, JS (corresponding author), Cent Univ Punjab, Sch Hlth Sci, Dept Human Genet & Mol Med, Bathinda, India.; Reddy, PH (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Cell Biol & Biochem, Neurosci & Pharmacol,Neurol,Publ Hlth, 3601 4th St, Lubbock, TX 79430 USA.; Reddy, PH (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Hlth Profess, 3601 4th St, Lubbock, TX 79430 USA.
EM hemachandra.reddy@ttuhsc.edu; jasvinder.bhatti@cup.edu.in
FU Science and Engineering Research Board, a statutory body of the Department of Science and Technology, Government of India [TAR/2020/000430, EEQ/2020/000188]; National Institutes of Health, USA [R01AG042178, R01AG47812, R01NS105473, AG060767, AG069333, AG066347]
CR Al Maruf A, 2014, COMPREHENSIVE TOXICO, V0, P0
   Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Annesley SJ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8070680
   [Anonymous], 2021, NATURE, V54, P11
   ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0
   ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007
   Atamna H, 2012, BIOFACTORS, V38, P158, DOI 10.1002/biof.197
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014
   Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   Bhatti JS, 2022, FREE RADICAL BIO MED, V184, P114, DOI 10.1016/j.freeradbiomed.2022.03.019
   Bhatti JS, 2021, MITOCHONDRION, V58, P49, DOI 10.1016/j.mito.2021.02.007
   Bhatti JS, 2021, MOL NEUROBIOL, V58, P795, DOI 10.1007/s12035-020-02142-7
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103
   Brenza TM, 2017, NANOMED-NANOTECHNOL, V13, P809, DOI 10.1016/j.nano.2016.10.004
   Brice A, 2005, BRAIN, V128, P2760, DOI 10.1093/brain/awh676
   Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514
   Byun HO, 2008, J CELL BIOCHEM, V104, P1747, DOI 10.1002/jcb.21741
   Cerrato CP, 2015, FASEB J, V29, P4589, DOI 10.1096/fj.14-269225
   CHANCE B, 1961, J BIOL CHEM, V236, P1544
   Chinopoulos C, 2018, CELL METAB, V27, P1165, DOI 10.1016/j.cmet.2018.05.010
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Cocheme HM, 2007, MITOCHONDRION, V7, PS94, DOI 10.1016/j.mito.2007.02.007
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cottrell DA, 2002, NEUROPATH APPL NEURO, V28, P390, DOI 10.1046/j.1365-2990.2002.00414.x
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Dikalov SI, 2019, ANTIOXID REDOX SIGN, V31, P710, DOI 10.1089/ars.2018.7632
   Ding XW, 2021, PHARMACOL RES, V171, P0, DOI 10.1016/j.phrs.2021.105783
   Durán-Prado M, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0109223
   Eirin A, 2015, HYPERTENSION, V65, P264, DOI 10.1161/HYPERTENSIONAHA.114.04598
   El-Hafidi M, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165744
   Elipenahli C, 2012, J ALZHEIMERS DIS, V28, P173, DOI 10.3233/JAD-2011-111190
   Escribano-Lopez I, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-34251-8
   Esteves AR, 2010, NEUROBIOL DIS, V37, P723, DOI 10.1016/j.nbd.2009.12.011
   Farshbaf MJ, 2017, NEUROTOX RES, V32, P518, DOI 10.1007/s12640-017-9766-1
   Feillet-Coudray C, 2014, FREE RADICAL RES, V48, P1232, DOI 10.3109/10715762.2014.945079
   Fernandez-Vizarra E, 2021, FEBS LETT, V595, P1062, DOI 10.1002/1873-3468.13995
   Foo ASC, 2020, FRONT AGING NEUROSCI, V12, P0, DOI 10.3389/fnagi.2020.00089
   Fukui H, 2007, HUM MOL GENET, V16, P783, DOI 10.1093/hmg/ddm023
   Gao J, 2017, ANTIOXIDANTS-BASEL, V6, P0, DOI 10.3390/antiox6020025
   Ghanizadeh A, 2013, MITOCHONDRION, V13, P515, DOI 10.1016/j.mito.2012.10.001
   Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028
   Graham D, 2009, HYPERTENSION, V54, P322, DOI 10.1161/HYPERTENSIONAHA.109.130351
   Grasso D, 2020, CELL STRESS, V0, P0
   Guo RY, 2018, BIOMED J, V41, P9, DOI 10.1016/j.bj.2017.12.001
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002
   Han YC, 2018, REDOX BIOL, V16, P32, DOI 10.1016/j.redox.2018.02.013
   Harrison DG, 2009, MED CLIN N AM, V93, P621, DOI 10.1016/j.mcna.2009.02.015
   He Z, 2020, FREE RADICAL BIO MED, V146, P45, DOI 10.1016/j.freeradbiomed.2019.11.005
   Heinz S, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep45465
   Hu HT, 2016, BIOCHEM BIOPH RES CO, V478, P174, DOI 10.1016/j.bbrc.2016.07.071
   Huang WY, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0081546
   Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje
   Kiyuna LA, 2018, FREE RADICAL BIO MED, V129, P155, DOI 10.1016/j.freeradbiomed.2018.09.019
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Lahera V, 2017, CURR HYPERTENS REP, V19, P0, DOI 10.1007/s11906-017-0710-9
   Lewis MR, 1914, SCIENCE, V39, P330, DOI 10.1126/science.39.1000.330
   Li M, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.01039
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Lobo-Jarne T, 2018, SEMIN CELL DEV BIOL, V76, P179, DOI 10.1016/j.semcdb.2017.07.021
   Long AN, 2015, BMC NEUROL, V15, P0, DOI 10.1186/s12883-015-0272-x
   Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066
   Mao PZ, 2012, HUM MOL GENET, V21, P2973, DOI 10.1093/hmg/dds128
   Marshall JD, 2018, AM J PHYSIOL-LUNG C, V314, PL782, DOI 10.1152/ajplung.00331.2017
   Martínez-Reyes I, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13668-3
   Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3
   Miki Toshiaki, 2002, NIHON RINSHO, V60 Suppl 4, P154
   Miki Toshiaki, 2002, NIHON RINSHO, V60 Suppl 4, P149
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Mitchell W, 2020, J BIOL CHEM, V295, P7452, DOI 10.1074/jbc.RA119.012094
   Mukherjee D, 2012, J PINEAL RES, V53, P166, DOI 10.1111/j.1600-079X.2012.00984.x
   Navik U, 2019, MOL NUTR FOOD RES, V63, P0, DOI 10.1002/mnfr.201801401
   Ng LF, 2014, FREE RADICAL BIO MED, V71, P390, DOI 10.1016/j.freeradbiomed.2014.03.003
   Oliver DMA, 2019, MOL CELL NEUROSCI, V96, P47, DOI 10.1016/j.mcn.2019.03.001
   Onyango IG, 2018, NEURAL REGEN RES, V13, P19, DOI 10.4103/1673-5374.224362
   Parganlija D, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0095288
   Parker WD, 2008, BRAIN RESEARCH, V0, P0
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Pearson ER, 2019, DIABETOLOGIA, V62, P1107, DOI 10.1007/s00125-019-4909-y
   Peoples JN, 2019, EXP MOL MED, V51, P0, DOI 10.1038/s12276-019-0355-7
   Petri S, 2006, J NEUROCHEM, V98, P1141, DOI 10.1111/j.1471-4159.2006.04018.x
   Petrosillo G, 2006, FASEB J, V20, P269, DOI 10.1096/fj.05-4692com
   phytochemicals, 2000, BRIT J PHARMACOL, V130, P1115
   Poewe W, 2017, NAT REV DIS PRIMERS, V3, P0, DOI 10.1038/nrdp.2017.13
   Pugazhenthi S, 2017, BBA-MOL BASIS DIS, V1863, P1037, DOI 10.1016/j.bbadis.2016.04.017
   Ravindran S, 2017, J CELL PHYSIOL, V232, P731, DOI 10.1002/jcp.25598
   Reddy PH, 2017, HUM MOL GENET, V26, P1483, DOI 10.1093/hmg/ddx052
   Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042
   Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z
   Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001
   Rocha M, 2010, CURR PHARM DESIGN, V16, P3124, DOI 10.2174/138161210793292519
   Rojas-Charry L, 2014, NEUROTOXICOLOGY, V44, P140, DOI 10.1016/j.neuro.2014.04.007
   Rossman MJ, 2018, HYPERTENSION, V71, P1056, DOI 10.1161/HYPERTENSIONAHA.117.10787
   Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013
   Russo E, 2018, BRAIN CIRC, V4, P84, DOI 10.4103/bc.bc_14_18
   Sadli N, 2013, CELL PHYSIOL BIOCHEM, V32, P243, DOI 10.1159/000354433
   Sanchez-Rangel E, 2017, DIABETOLOGIA, V60, P1586, DOI 10.1007/s00125-017-4336-x
   Sas K, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23010191
   Schloesser A, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/789710
   Scialò F, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00428
   Scialò F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009
   Selvaraju TR, 2014, BOSNIAN J BASIC MED, V14, P195, DOI 10.17305/bjbms.2014.4.91
   Szeto HH, 2006, AAPS J, V8, PE277, DOI 10.1007/BF02854898
   Szeto HH, 2008, ANN NY ACAD SCI, V1147, P112, DOI 10.1196/annals.1427.013
   Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E
   Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456
   TETRUD JW, 1989, ACTA NEUROL SCAND, V80, P35, DOI 10.1111/j.1600-0404.1989.tb01780.x
   Veloso CD, 2019, CURR PHARM DESIGN, V25, P3175, DOI 10.2174/1389203720666190830163735
   Torres-Ortega PV, 2019, J CONTROL RELEASE, V295, P201, DOI 10.1016/j.jconrel.2018.12.036
   Voigt A, 2016, J NEUROCHEM, V139, P232, DOI 10.1111/jnc.13655
   Wang CF, 2019, EUR REV MED PHARMACO, V23, P3542, DOI 10.26355/eurrev_201904_17723
   Wang XN, 2016, BRAIN RES, V1643, P1, DOI 10.1016/j.brainres.2016.04.060
   Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105
   Yang JL, 2018, REDOX BIOL, V16, P263, DOI 10.1016/j.redox.2018.03.002
   Yang LC, 2009, ANTIOXID REDOX SIGN, V11, P2095, DOI 10.1089/ars.2009.2445
   Yang X, 2019, MITOCHONDRION, V49, P89, DOI 10.1016/j.mito.2018.11.008
   Yaribeygi H, 2019, J CELL PHYSIOL, V234, P8152, DOI 10.1002/jcp.27603
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   Young ML, 2019, MOL CELL NEUROSCI, V101, P0, DOI 10.1016/j.mcn.2019.103409
   Zhou J, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19102863
NR 135
TC 19
Z9 19
U1 1
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2319-4170
EI 2320-2890
J9 BIOMED J
JI Biomed. J.
PD OCT 15
PY 2022
VL 45
IS 5
BP 733
EP 748
DI 10.1016/j.bj.2022.05.002
PG 16
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA 8V3TH
UT WOS:000930556200002
PM 35568318
DA 2024-11-01
ER

PT J
AU Montano, V
   Mancuso, M
   Simoncini, C
   Torri, F
   Chico, L
   Ali, G
   Rocchi, A
   Baldinotti, F
   Caligo, MA
   Lattanzi, G
   Mattioli, E
   Cenacchi, G
   Barison, A
   Siciliano, G
   Ricci, G
AF Montano, Vincenzo
   Mancuso, Michelangelo
   Simoncini, Costanza
   Torri, Francesca
   Chico, Lucia
   Ali, Greta
   Rocchi, Anna
   Baldinotti, Fulvia
   Caligo, Maria Adelaide
   Lattanzi, Giovanna
   Mattioli, Elisabetta
   Cenacchi, Giovanna
   Barison, Andrea
   Siciliano, Gabriele
   Ricci, Giulia
TI A Single mtDNA Deletion in Association with a <i>LMNA</i> Gene New Frameshift Variant: A Case Report
SO JOURNAL OF NEUROMUSCULAR DISEASES
LA English
DT Article
DE Muscle disorders; myopathies; LMNA-associated diseases; mitochondria
ID mitochondrial; accumulation; cells
AB Background: Proximal muscle weakness may be the presenting clinical feature of different types of myopathies, including limb girdle muscular dystrophy and primary mitochondrial myopathy. LGMD1B is caused by LMNA mutation. It is characterized by progressive weakness and wasting leading to proximal weakness, cardiomyopathy, and hearth conduction block. Objective: In this article, we describe the case of a patient who presented with limb-girdle weakness and a double trouble scenario - mitochondrial DNA single deletion and a new LMNA mutation. Methods: Pathophysiological aspects were investigated with muscle biopsy, Western Blot analysis, NGS nuclear and mtDNA analysis and neuromuscular imaging (muscle and cardiac MRI). Results: Although secondary mitochondrial involvement is possible, a "double trouble" syndrome can not be excluded. Conclusions: Implication deriving from hypothetical coexistence of two different pathological conditions or the possible secondary mitochondrial involvement are discussed.
C1 [Montano, Vincenzo; Mancuso, Michelangelo; Simoncini, Costanza; Torri, Francesca; Chico, Lucia; Rocchi, Anna; Siciliano, Gabriele; Ricci, Giulia] Univ Pisa, Dept Clin & Expt Med, Neurol Clin, Pisa, Italy.
   [Ali, Greta] Univ Pisa, Dept Surg Pathol Med Mol & Crit Area, Pisa, Italy.
   [Baldinotti, Fulvia; Caligo, Maria Adelaide] Azienda Osped Univ Pisana, Mol Genet, Pisa, Italy.
   [Lattanzi, Giovanna; Mattioli, Elisabetta] CNR, Inst Mol Genet Luigi Luca Cavalli Sforza, Unit Bologna, Bologna, Italy.
   [Lattanzi, Giovanna; Mattioli, Elisabetta] IRCCS Ist Ortoped Rizzoli, Bologna, Italy.
   [Cenacchi, Giovanna] Univ Bologna, Dept Biomed & Neuromotor Sci, Alma Mater, Italy.
   [Barison, Andrea] UOC Fdn G Monasterio CNR Reg Toscana, Pisa, Italy.
C3 University of Pisa; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Consiglio Nazionale delle Ricerche (CNR); University of Bologna
RP Ricci, G (corresponding author), Univ Pisa, Neurol Inst, Dept Clin & Expt Med, Pisa, Italy.
EM giulia.ricci@unipi.it
FU Telethon-MITOCON grant [GSP16001]; EJPRD2019 project GENOMIT; European Reference Network for Neuromuscular Diseases (ERN EURO-NMD); AIFA (TREAT LMNA project);  [RF-2016-02361495]
CR DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   Fontana M, 2013, JACC-CARDIOVASC IMAG, V6, P124, DOI 10.1016/j.jcmg.2012.06.013
   Ghaoui R, 2015, JAMA NEUROL, V72, P1424, DOI 10.1001/jamaneurol.2015.2274
   Jungbluth H, 2017, NEUROPATH APPL NEURO, V43, P24, DOI 10.1111/nan.12385
   Li YH, 2016, CURR BIOL, V26, P2052, DOI 10.1016/j.cub.2016.06.007
   Lu D, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015167
   Maggi L, 2016, CELLS-BASEL, V5, P0, DOI 10.3390/cells5030033
   Maggi L, 2014, NEUROLOGY, V83, P1634, DOI 10.1212/WNL.0000000000000934
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Sieprath T, 2015, NUCLEUS-PHILA, V6, P236, DOI 10.1080/19491034.2015.1050568
   Straub V, 2018, NEUROMUSCULAR DISORD, V28, P702, DOI 10.1016/j.nmd.2018.05.007
   Suresh E, 2013, POSTGRAD MED J, V89, P470, DOI 10.1136/postgradmedj-2013-131752
   Xu XL, 2019, THERANOSTICS, V9, P2252, DOI 10.7150/thno.30658
NR 13
TC 1
Z9 1
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 2214-3599
EI 2214-3602
J9 J NEUROMUSCULAR DIS
JI J. Neuromusc. Dis.
PD JUN 15
PY 2022
VL 9
IS 3
BP 457
EP 462
DI 10.3233/JND-220802
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 1H3JG
UT WOS:000796440600010
PM 35466949
DA 2024-11-01
ER

PT J
AU Zia, A
   Farkhondeh, T
   Pourbagher-Shahri, AM
   Samarghandian, S
AF Zia, Aliabbas
   Farkhondeh, Tahereh
   Pourbagher-Shahri, Ali Mohammad
   Samarghandian, Saeed
TI The Roles of Mitochondrial Dysfunction and Reactive Oxygen Species in Aging and Senescence
SO CURRENT MOLECULAR MEDICINE
LA English
DT Review
DE Mitochondrial dysfunction; reactive oxygen species; aging; senescente; oxidation stress; apoptosis
ID oxidative posttranslational modifications; stem-cell; life-span; dna-damage; replicative senescence; premature senescence; point mutations; quality-control; self-renewal; nuclear-dna
AB The aging process deteriorates organs' function at different levels, causing its progressive decline to resist stress, damage, and disease. In addition to alterations in metabolic control and gene expression, the rate of aging has been connected with the generation of high amounts of Reactive Oxygen Species (ROS). The essential perspective in free radical biology is that reactive oxygen species (ROS) and free radicals are toxic, mostly cause direct biological damage to targets, and are thus a major cause of oxidative stress. Different enzymatic and non-enzymatic compounds in the cells have roles in neutralizing this toxicity. Oxidative damage in aging is mostly high in particular molecular targets, such as mitochondrial DNA and aconitase, and oxidative stress in mitochondria can cause tissue aging across intrinsic apoptosis. Mitochondria's function and morphology are impaired through aging, following a decrease in the membrane potential by an increase in peroxide generation and size of the organelles. Telomeres may be the significant trigger of replicative senescence. Oxidative stress accelerates telomere loss, whereas antioxidants slow it down. Oxidative stress is a crucial modulator of telomere shortening, and that telomere-driven replicative senescence is mainly a stress response. The age-linked mitochondrial DNA mutation and protein dysfunction aggregate in some organs like the brain and skeletal muscle, thus contributing considerably to these post-mitotic tissues' aging. The aging process is mostly due to accumulated damage done by harmful species in some macromolecules such proteins, DNA, and lipids. The degradation of non-functional, oxidized proteins is a crucial part of the antioxidant defenses of cells, in which the clearance of these proteins occurs through autophagy in the cells, which is known as mitophagy for mitochondria.
C1 [Zia, Aliabbas] Univ Tehran, Inst Biochem & Biophys IBB, Dept Biochem, Tehran, Iran.
   [Farkhondeh, Tahereh; Pourbagher-Shahri, Ali Mohammad] Birjand Univ Med Sci, Med Toxicol & Drug Abuse Res Ctr MTDRC, Birjand, Iran.
   [Farkhondeh, Tahereh] Birjand Univ Med Sci, Fac Pharm, Birjand, Iran.
   [Samarghandian, Saeed] Neyshabur Univ Med Sci, Noncommunicable Dis Res Ctr, Neyshabur, Iran.
C3 University of Tehran
RP Samarghandian, S (corresponding author), Neyshabur Univ Med Sci, Noncommunicable Dis Res Ctr, Neyshabur, Iran.
EM samarghandians1@nums.ac.ir
CR Aguiar PHN, 2013, PLOS NEGLECT TROP D, V7, P0, DOI 10.1371/journal.pntd.0002279
   Ahlqvist KJ, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7494
   Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004
   Ahmed Samrein B M, 2017, J MOL SIGNAL, V12, P2, DOI 10.5334/1750-2187-12-2
   Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372
   Akasaki Y, 2014, ARTHRITIS RHEUMATOL, V66, P3349, DOI 10.1002/art.38868
   Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/360438
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barnes RP, 2019, MECH AGEING DEV, V177, P37, DOI 10.1016/j.mad.2018.03.013
   Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003
   Betts DH, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0086978
   Bhat SS, 2015, MOL CANCER, V14, P0, DOI 10.1186/s12943-015-0354-9
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Borodkina A, 2014, AGING-US, V6, P481, DOI 10.18632/aging.100673
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Bullone M, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18122612
   Bulteau AL, 2006, EXP GERONTOL, V41, P653, DOI 10.1016/j.exger.2006.03.013
   Callahan A, 2015, BMC BIOINFORMATICS, V16, P0, DOI 10.1186/s12859-015-0469-4
   Cenini G, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/2105607
   Chen HQ, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00103
   Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Coluzzi E, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8010019
   Coluzzi E, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0110963
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Dai XZ, 2020, TRENDS MOL MED, V26, P185, DOI 10.1016/j.molmed.2019.09.007
   Davis T, 2005, BIOGERONTOLOGY, V6, P371, DOI 10.1007/s10522-005-4901-4
   De la Fuente M, 2009, CURR PHARM DESIGN, V15, P3003, DOI 10.2174/138161209789058110
   Di Meo S, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/1245049
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Dunn RM, 2018, ALLERGY, V73, P284, DOI 10.1111/all.13258
   Elokil AA, 2019, POULTRY SCI, V98, P4172, DOI 10.3382/ps/pez201
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   FLEMING JE, 1986, SCIENCE, V231, P1157, DOI 10.1126/science.3080809
   Forster MJ, 2000, J GERONTOL A-BIOL, V55, PB522, DOI 10.1093/gerona/55.11.B522
   Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D
   Fujimaki S, 2015, HISTOL HISTOPATHOL, V30, P1411, DOI 10.14670/HH-11-657
   Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200
   Georgakopoulou EA, 2013, AGING-US, V5, P37
   Ghatreh-Samani M, 2016, CENT EUR J IMMUNOL, V41, P116, DOI 10.5114/ceji.2015.56973
   Gonzalez-Hunt Claudia P, 2018, CURRENT OPINION IN TOXICOLOGY, V7, P87, DOI 10.1016/j.cotox.2017.11.001
   Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hayakawa T, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0116480
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Herrero A, 1999, AGING-CLIN EXP RES, V11, P294, DOI 10.1007/BF03339803
   Himmelfarb J, 2000, KIDNEY INT, V58, P2571, DOI 10.1046/j.1523-1755.2000.00443.x
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Ho JH, 2011, CELL TRANSPLANT, V20, P1209, DOI 10.3727/096368910X546562
   Hoffmann G, 2014, J BIOL CHEM, V289, P5208, DOI 10.1074/jbc.M113.487736
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Itahana Koji, 2013, METHODS MOL BIOL, V965, P143, DOI 10.1007/978-1-62703-239-1_8
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Jung JW, 2010, CELL MOL LIFE SCI, V67, P1165, DOI 10.1007/s00018-009-0242-9
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200
   Kanki T, 2009, AUTOPHAGY, V5, P1201, DOI 10.4161/auto.5.8.9747
   Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014
   Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kim SH, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/2860642
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097
   Lee HT, 2017, NUCLEIC ACIDS RES, V45, P11752, DOI 10.1093/nar/gkx789
   Lee S, 2019, BMB REP, V52, P35, DOI 10.5483/BMBRep.2019.52.1.294
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Leon J, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep22086
   Liu H, 2013, INVEST OPHTH VIS SCI, V54, P5236, DOI 10.1167/iovs.13-11664
   Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Lu WS, 2013, EXP CELL RES, V319, P133, DOI 10.1016/j.yexcr.2012.09.005
   Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893
   Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6
   Marcotte R, 2002, J GERONTOL A-BIOL, V57, PB257, DOI 10.1093/gerona/57.7.B257
   Martinez M, 2013, FREE RADICAL BIO MED, V65, P411, DOI 10.1016/j.freeradbiomed.2013.06.039
   Matsumoto R, 2016, TELOMERE - A COMPLEX END OF A CHROMOSOME, V0, PP143, DOI 10.5772/64759
   Meshorer E, 2008, J CELL BIOL, V181, P9, DOI 10.1083/jcb.200802155
   Naudi A, 2011, FREE RADICALS ANTIOXIDANTS, V1, P3, DOI 10.5530/ax.2011.3.2
   Naudí A, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00372
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, PR1244, DOI 10.1152/ajpregu.00226.2004
   Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758
   Ngo JK, 2007, ANN NY ACAD SCI, V1119, P78, DOI 10.1196/annals.1404.015
   Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032
   Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017
   North BJ, 2004, GENOME BIOL, V5, P0, DOI 10.1186/gb-2004-5-5-224
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167
   Nyström T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599
   Okamoto K, 2009, AUTOPHAGY, V5, P1203, DOI 10.4161/auto.5.8.9830
   Onodera Y, 2017, AGING CELL, V16, P1369, DOI 10.1111/acel.12680
   Ott C, 2018, MECH AGEING DEV, V170, P72, DOI 10.1016/j.mad.2017.07.007
   Ozcan A, 2015, BASIC PRINCIPLES AND CLINICAL SIGNIFICANCE OF OXIDATIVE STRESS, V0, P0, DOI DOI 10.5772/61193
   Page MM, 2010, MECH AGEING DEV, V131, P242, DOI 10.1016/j.mad.2010.02.005
   Park HS, 2009, RESPIROLOGY, V14, P27, DOI 10.1111/j.1440-1843.2008.01447.x
   Parkinson Gemma M, 2014, CURR AGING SCI, V7, P155
   Paul MK, 2014, CELL STEM CELL, V15, P199, DOI 10.1016/j.stem.2014.05.009
   Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971
   Peroni LA, 2007, GENET MOL BIOL, V30, P872, DOI 10.1590/S1415-47572007000500016
   Phaniendra A, 2015, INDIAN J CLIN BIOCHE, V30, P11, DOI 10.1007/s12291-014-0446-0
   Pizzino G, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/8416763
   Plataki M, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-018-37438-1
   Prieur A, 2011, NAT COMMUN, V2, P0, DOI 10.1038/ncomms1473
   Raghuram GV, 2014, INDIAN J MED RES, V140, P120
   Ramsey JJ, 2014, J GERONTOL A-BIOL, V69, P1177, DOI 10.1093/gerona/glt198
   Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rohrbach S, 2006, AM J PHYSIOL-REG I, V291, PR927, DOI 10.1152/ajpregu.00890.2005
   Ryan BJ, 2014, REDOX BIOL, V2, P715, DOI 10.1016/j.redox.2014.05.004
   Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002
   Samarghandian S, 2017, INDIAN HEART J, V69, P151, DOI 10.1016/j.ihj.2016.09.008
   Samarghandian S, 2017, DOSE-RESPONSE, V15, P0, DOI 10.1177/1559325817711782
   Schiavi A, 2013, EXP GERONTOL, V48, P191, DOI 10.1016/j.exger.2012.12.002
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Scialò F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009
   Senchuk MM, 2018, PLOS GENET, V14, P0, DOI 10.1371/journal.pgen.1007268
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001
   Smith JT, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0200275
   Sonani RR, 2017, PROTOPLASMA, V254, P849, DOI 10.1007/s00709-016-0996-5
   Stauch KL, 2014, J PROTEOME RES, V13, P2620, DOI 10.1021/pr500295n
   Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902
   Svensson MJ, 2007, HEREDITAS, V144, P25, DOI 10.1111/j.2007.0018-0661.01990.x
   Tian XP, 2010, APPL BIOCHEM BIOTECH, V160, P1460, DOI 10.1007/s12010-009-8633-9
   Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50
   Toscano A, 2014, CURR MOL MED, V14, P1001, DOI 10.2174/1566524014666141010152340
   Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Uno M, 2016, NPJ AGING MECH DIS, V2, P0, DOI 10.1038/npjamd.2016.10
   Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823
   Van Houten Bennett, 2018, CURRENT OPINION IN TOXICOLOGY, V7, P9, DOI 10.1016/j.cotox.2017.10.009
   Vergel Mar, 2010, J AGING RES, V2011, P725365, DOI 10.4061/2011/725365
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vomhof-DeKrey EE, 2012, J NUTR BIOCHEM, V23, P1201, DOI 10.1016/j.jnutbio.2012.03.005
   Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
   WALFORD RL, 1964, GERONTOLOGIST, V4, P195, DOI 10.1093/geront/4.4.195
   Wang AL, 2010, NEUROBIOL AGING, V31, P2002, DOI 10.1016/j.neurobiolaging.2008.10.019
   Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018
   Whitaker AM, 2017, FRONT BIOSCI-LANDMRK, V22, P1493, DOI 10.2741/4555
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Xu Y, 2018, TOXICOL LETT, V289, P99, DOI 10.1016/j.toxlet.2018.02.001
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yen K, 2011, ANTIOXID REDOX SIGN, V14, P623, DOI 10.1089/ars.2010.3490
   Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z
   Yu KR, 2013, STEM CELL RES, V10, P156, DOI 10.1016/j.scr.2012.11.002
   Yu Y, 2018, J NUTR HEALTH AGING, V22, P710, DOI 10.1007/s12603-018-1015-7
   Yuan HF, 2012, J MOL MED, V90, P389, DOI 10.1007/s00109-011-0825-4
   Yuan ZN, 2017, BIOCHEM BIOPH RES CO, V491, P228, DOI 10.1016/j.bbrc.2017.07.083
   Zhang DY, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021397
   Zhang SW, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0080342
   Zhao L, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-07974-3
   ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0
NR 163
TC 22
Z9 23
U1 1
U2 41
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PD JUN 15
PY 2022
VL 22
IS 1
BP 37
EP 49
DI 10.2174/1566524021666210218112616
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA YD9TR
UT WOS:000740776400004
PM 33602082
DA 2024-11-01
ER

PT J
AU Stufková, H
   Kolárová, H
   Lokvencová, K
   Honzík, T
   Zeman, J
   Hansíková, H
   Tesarová, M
AF Stufkova, Hana
   Kolarova, Hana
   Lokvencova, Katerina
   Honzik, Tomas
   Zeman, Jiri
   Hansikova, Hana
   Tesarova, Marketa
TI A Novel <i>MTTK</i> Gene Variant m.8315A&gt;C as a Cause of MERRF Syndrome
SO GENES
LA English
DT Article
DE mtDNA; MTTK gene; OXPHOS; heteroplasmy; m.8315A > C
ID transfer-rna; atp synthase; mutations
AB In this study, we report on a novel heteroplasmic pathogenic variant in mitochondrial DNA (mtDNA). The studied patient had myoclonus, epilepsy, muscle weakness, and hearing impairment and harbored a heteroplasmic m.8315A>C variant in the MTTK gene with a mutation load ranging from 71% to >96% in tested tissues. In muscle mitochondria, markedly decreased activities of respiratory chain complex I + III and complex IV were observed together with mildly reduced amounts of complex I and complex V (with the detection of V*- and free F1-subcomplexes) and a diminished level of complex IV holoenzyme. This pattern was previously seen in other MTTK pathogenic variants. The novel variant was not present in internal and publicly available control databases. Our report further expands the spectrum of MTTK variants associated with mitochondrial encephalopathies in adults.
C1 [Tesarova, Marketa] Charles Univ Prague, Fac Med 1, Dept Pediat & Inherited Metab Disorders, Prague 12808, Czech Republic.
   Gen Univ Hosp Prague, Prague 12808, Czech Republic.
C3 General University Hospital Prague; Charles University Prague; General University Hospital Prague
RP Tesarová, M (corresponding author), Charles Univ Prague, Fac Med 1, Dept Pediat & Inherited Metab Disorders, Prague 12808, Czech Republic.
EM hana.stufkova@lf1.cuni.cz; hana.kolarova@vfn.cz; katerina.lokvencova@vfn.cz; tomas.honzik@vfn.cz; jzem@lf1.cuni.cz; hana.hansikova@lf1.cuni.cz; marketa.tesarova@lf1.cuni.cz
FU Ministry of Health of the Czech Republic [AZV 17-30965A]
CR Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Bolze A, 2020, BIORXIV, V0, P0, DOI DOI 10.1101/798264
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Laricchia KM, 2022, GENOME RES, V32, P569, DOI 10.1101/gr.276013.121
   MAKINE MW, 1968, NEUROLOGY, V18, P299
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   McCormick EM, 2020, HUM MUTAT, V41, P2028, DOI 10.1002/humu.24107
   MITOMAP, 2019, HUM MIT GEN DAT, V0, P0
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Richter U, 2021, FEBS LETT, V595, P1003, DOI 10.1002/1873-3468.14049
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Srere PA, 1969, METHODS IN ENZYMOLOGY, V13, P3
NR 19
TC 2
Z9 2
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD JUL 15
PY 2022
VL 13
IS 7
BP 
EP 
DI 10.3390/genes13071245
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA 3J2NA
UT WOS:000833235900001
PM 35886028
DA 2024-11-01
ER

PT J
AU Chen, TH
   Koh, KY
   Lin, KMC
   Chou, CK
AF Chen, Tsung-Hsien
   Koh, Kok-Yean
   Lin, Kurt Ming-Chao
   Chou, Chu-Kuang
TI Mitochondrial Dysfunction as an Underlying Cause of Skeletal Muscle Disorders
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mitochondrial dysfunction; skeletal muscle disorders; OXPHOS; mtDNA mutation; mitochondrial dynamics; mitophagy; mitochondrial chaperone protein
ID oxidative stress; gene-expression; dna-deletion; exercise; autophagy; phosphorylation; transcription; calcium; atrophy; activation
AB Mitochondria are an important energy source in skeletal muscle. A main function of mitochondria is the generation of ATP for energy through oxidative phosphorylation (OXPHOS). Mitochondrial defects or abnormalities can lead to muscle disease or multisystem disease. Mitochondrial dysfunction can be caused by defective mitochondrial OXPHOS, mtDNA mutations, Ca2+ imbalances, mitochondrial-related proteins, mitochondrial chaperone proteins, and ultrastructural defects. In addition, an imbalance between mitochondrial fusion and fission, lysosomal dysfunction due to insufficient biosynthesis, and/or defects in mitophagy can result in mitochondrial damage. In this review, we explore the association between impaired mitochondrial function and skeletal muscle disorders. Furthermore, we emphasize the need for more research to determine the specific clinical benefits of mitochondrial therapy in the treatment of skeletal muscle disorders.
C1 [Chen, Tsung-Hsien] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi 60002, Taiwan.
   [Koh, Kok-Yean; Chou, Chu-Kuang] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Div Gastroenterol & Hepatol, Chiayi 60002, Taiwan.
   [Lin, Kurt Ming-Chao] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Zhunan 35053, Taiwan.
   [Chou, Chu-Kuang] Chia Yi Christian Hosp, Ditmanson Med Fdn, Obes Ctr, Chiayi 60002, Taiwan.
C3 National Health Research Institutes - Taiwan
RP Chou, CK (corresponding author), Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Div Gastroenterol & Hepatol, Chiayi 60002, Taiwan.; Lin, KMC (corresponding author), Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Zhunan 35053, Taiwan.; Chou, CK (corresponding author), Chia Yi Christian Hosp, Ditmanson Med Fdn, Obes Ctr, Chiayi 60002, Taiwan.
EM klin@nhri.edu.tw; vacinu@gmail.com
CR Agrawal A, 2017, CELL STRESS CHAPERON, V22, P429, DOI 10.1007/s12192-017-0795-8
   Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200
   Al-Mehdi AB, 2012, SCI SIGNAL, V5, P0, DOI 10.1126/scisignal.2002712
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   Baker N, 2019, MITOCHONDRION, V49, P259, DOI 10.1016/j.mito.2019.06.003
   Balakrishnan R, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23094636
   Ballarò R, 2021, CANCERS, V13, P0, DOI 10.3390/cancers13040850
   Ballarò R, 2019, CANCERS, V11, P0, DOI 10.3390/cancers11030285
   Ballarò R, 2019, FASEB J, V33, P5482, DOI 10.1096/fj.201801862R
   Baracos VE, 2018, NAT REV DIS PRIMERS, V4, P0, DOI 10.1038/nrdp.2017.105
   Barone R, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep19781
   Barreto R, 2016, FRONT PHYSIOL, V7, P0, DOI 10.3389/fphys.2016.00472
   Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Bertero E, 2018, J CLIN INVEST, V128, P5191, DOI 10.1172/JCI124944
   Beyfuss K, 2018, REDOX REP, V23, P100, DOI 10.1080/13510002.2017.1416773
   Bock FJ, 2020, NAT REV MOL CELL BIO, V21, P85, DOI 10.1038/s41580-019-0173-8
   Boonyarom O, 2006, ACTA PHYSIOL, V188, P77, DOI 10.1111/j.1748-1716.2006.01613.x
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Brioche T, 2016, CURR PHARM DESIGN, V22, P2664, DOI 10.2174/1381612822666160219120531
   Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007
   Carson JA, 2016, SEMIN CELL DEV BIOL, V54, P53, DOI 10.1016/j.semcdb.2015.11.005
   Carson JA, 2010, EXERC SPORT SCI REV, V38, P168, DOI 10.1097/JES.0b013e3181f44f11
   Castellanos E, 2019, YALE J BIOL MED, V92, P523
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Challa S, 2004, NEUROL INDIA, V52, P353
   Chen TH, 2016, ONCOTARGET, V7, P54274, DOI 10.18632/oncotarget.11026
   Chen TH, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/539805
   Choi MH, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/6842568
   Conley KE, 2007, EXERC SPORT SCI REV, V35, P43
   Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005
   Correia-Melo C, 2017, NAT PROTOC, V12, P0, DOI 10.1038/nprot.2016.159
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67
   De Mario A, 2021, CELL CALCIUM, V94, P0, DOI 10.1016/j.ceca.2021.102357
   De Paepe Boel, 2009, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1902s63
   Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016
   Diaz Francisca, 2009, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1904s63
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019
   Favaro G, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-10226-9
   Fernando R, 2019, FREE RADICAL BIO MED, V132, P58, DOI 10.1016/j.freeradbiomed.2018.08.037
   Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Fry Christopher S, 2011, CURR AGING SCI, V4, P260
   Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96
   Galluzzi L, 2011, CURR BIOL, V21, PR478, DOI 10.1016/j.cub.2011.05.002
   Gammazza AM, 2018, CELLS-BASEL, V7, P0, DOI 10.3390/cells7120224
   Gehrig SM, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0488-x
   Gherardi G, 2019, CELL DEATH DIFFER, V26, P362, DOI 10.1038/s41418-018-0191-7
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a
   Houzelle A, 2021, DIABETOLOGIA, V64, P424, DOI 10.1007/s00125-020-05335-w
   Hung CHL, 2018, REDOX BIOL, V14, P7, DOI 10.1016/j.redox.2017.08.010
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   Jackson MJ, 2016, J PHYSIOL-LONDON, V594, P1979, DOI 10.1113/JP270564
   Jeppesen TD, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10081796
   Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807
   Mateos-Aierdi AJ, 2015, FRONT AGING NEUROSCI, V7, P0, DOI 10.3389/fnagi.2015.00125
   Kaludercic N, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/3869610
   Knuth ST, 2000, THESIS MARQUETTE U M, V0, P0
   Komulainen T, 2015, JIMD REP, V23, P91, DOI 10.1007/8904_2015_438
   Kozakowska M, 2015, J MUSCLE RES CELL M, V36, P377, DOI 10.1007/s10974-015-9438-9
   Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005
   Kumaran S, 2005, MOL CELL BIOCHEM, V280, P83, DOI 10.1007/s11010-005-8234-z
   Kunz WS, 2001, BBA-BIOENERGETICS, V1504, P12, DOI 10.1016/S0005-2728(00)00235-8
   Lalia AZ, 2016, J CLIN ENDOCR METAB, V101, P626, DOI 10.1210/jc.2015-2892
   Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Li B, 2022, PHARMACOL THERAPEUT, V232, P0, DOI 10.1016/j.pharmthera.2021.107995
   Luo Xiaoting, 2017, CURR PROTOC PROTEIN SCI, V87, P0, DOI 10.1002/cpps.21
   Mammucari C, 2015, CELL REP, V10, P1269, DOI 10.1016/j.celrep.2015.01.056
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782
   Mareedu S, 2021, FRONT PHYSIOL, V12, P0, DOI 10.3389/fphys.2021.647010
   Marzetti E, 2017, EXP GERONTOL, V87, P92, DOI 10.1016/j.exger.2016.10.003
   Mason S, 2007, ADV EXP MED BIOL, V618, P229
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736
   Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704
   Mingrone G, 2005, DIABETOLOGIA, V48, P2108, DOI 10.1007/s00125-005-1918-9
   Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823
   Molinari F, 2017, J CACHEXIA SARCOPENI, V8, P954, DOI 10.1002/jcsm.12226
   Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471
   Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178
   Najbauer EE, 2021, EUR BIOPHYS J BIOPHY, V50, P159, DOI 10.1007/s00249-021-01515-7
   Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0
   Naresh NU, 2019, CSH PERSPECT BIOL, V11, P0, DOI 10.1101/cshperspect.a033944
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Neupane N, 2022, COMMUN BIOL, V5, P0, DOI 10.1038/s42003-022-04034-z
   OLeary MF, 2013, AM J PHYSIOL-CELL PH, V304, PC422, DOI 10.1152/ajpcell.00240.2012
   Onesti JK, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/168407
   Onopiuk M, 2009, BIOCHEM BIOPH RES CO, V386, P463, DOI 10.1016/j.bbrc.2009.06.053
   Ophuis RJAO, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0008024
   Orfany A, 2020, J VASC SURG, V71, P1014, DOI 10.1016/j.jvs.2019.03.079
   Padilha CS, 2017, APPL PHYSIOL NUTR ME, V42, P916, DOI 10.1139/apnm-2016-0436
   Padrao AI, 2013, INT J BIOCHEM CELL B, V45, P1399, DOI 10.1016/j.biocel.2013.04.014
   Pala F, 2018, J CELL SCI, V131, P0, DOI 10.1242/jcs.212977
   Pant M, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0123875
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Penna F, 2020, ANTIOXID REDOX SIGN, V33, P542, DOI 10.1089/ars.2020.8041
   Penna F, 2019, J MOL BIOL, V431, P2674, DOI 10.1016/j.jmb.2019.05.032
   Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011
   Pigna E, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep26991
   Pin F, 2019, J CACHEXIA SARCOPENI, V10, P140, DOI 10.1002/jcsm.12360
   Pin F, 2018, CURR OPIN SUPPORT PA, V12, P420, DOI 10.1097/SPC.0000000000000382
   Pin F, 2015, ONCOTARGET, V6, P43202, DOI 10.18632/oncotarget.6439
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054
   Powers SK, 2012, CURR OPIN CLIN NUTR, V15, P240, DOI 10.1097/MCO.0b013e328352b4c2
   Primeau AJ, 2002, CAN J APPL PHYSIOL, V27, P349, DOI 10.1139/h02-020
   Puppa MJ, 2012, J CACHEXIA SARCOPENI, V3, P117, DOI 10.1007/s13539-011-0047-1
   Ranjbar K, 2019, MED SCI SPORT EXER, V51, P1387, DOI 10.1249/MSS.0000000000001916
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102
   Rybalka E, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0115763
   Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3
   Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177
   Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Shanina E, 2022, ELECTRODIAGNOSTIC EV, V0, P0
   Sharma S, 2006, FREE RADICAL BIO MED, V40, P2223, DOI 10.1016/j.freeradbiomed.2006.02.019
   Shin B, 2017, ADV EXP MED BIOL, V982, P595, DOI 10.1007/978-3-319-55330-6_31
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Singh M, 2007, MITOCHONDRION, V7, P367, DOI 10.1016/j.mito.2007.07.003
   Smith ME, 2013, BIOCHEM J, V456, P427, DOI 10.1042/BJ20130807
   Stehling O, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011312
   Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Tagliavini Francesca, 2013, MUSCLES LIGAMENTS TENDONS J, V3, P281
   Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952
   Talbert EE, 2016, SEMIN CELL DEV BIOL, V54, P82, DOI 10.1016/j.semcdb.2015.09.009
   Tan PL, 2015, INT J BIOCHEM CELL B, V62, P72, DOI 10.1016/j.biocel.2015.02.015
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970
   VanderVeen BN, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.01037
   Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, PE151, DOI 10.1152/ajpendo.00278.2006
   Vincent AE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30610
   Wang YF, 2011, SCI SIGNAL, V4, P0, DOI 10.1126/scisignal.2000902
   Wang YF, 2009, J NEUROCHEM, V110, P687, DOI 10.1111/j.1471-4159.2009.06167.x
   White JP, 2011, AM J PHYSIOL-REG I, V300, PR201, DOI 10.1152/ajpregu.00300.2010
   Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015
   Wu WX, 2016, EMBO J, V35, P1368, DOI 10.15252/embj.201593102
   Xia QH, 2021, FRONT PHYSIOL, V12, P0, DOI 10.3389/fphys.2021.638983
   Xiao T, 2020, J MOL ENDOCRINOL, V64, P67, DOI 10.1530/JME-19-0207
   Yan Y, 2017, FREE RADICAL BIO MED, V109, P108, DOI 10.1016/j.freeradbiomed.2016.12.003
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zarse K, 2021, NAT METAB, V3, P588, DOI 10.1038/s42255-021-00387-7
   Zielonka D, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00380
NR 175
TC 25
Z9 26
U1 8
U2 34
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV 15
PY 2022
VL 23
IS 21
BP 
EP 
DI 10.3390/ijms232112926
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 6B3JU
UT WOS:000881234300001
PM 36361713
DA 2024-11-01
ER

PT J
AU Rahman, MM
   Young, CKJ
   Goffart, S
   Pohjoismäki, JLO
   Young, MJ
AF Rahman, Md Mostafijur
   Young, Carolyn K. J.
   Goffart, Steffi
   Pohjoismaki, Jaakko L. O.
   Young, Matthew J.
TI Heterozygous p.Y955C mutation in DNA polymerase γ leads to alterations in bioenergetics, complex I subunit expression, and mtDNA replication
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID human mitochondrial-dna; progressive external ophthalmoplegia; transcription-factor-a; saccharomyces-cerevisiae; nucleoside analogs; helicase twinkle; disease variant; toxicity; cells; polg
AB In human cells, ATP is generated using oxidative phosphorylation machinery, which is inoperable without proteins encoded by mitochondrial DNA (mtDNA). The DNA polymerase gamma (Pol gamma) repairs and replicates the multicopy mtDNA genome in concert with additional factors. The Pol gamma catalytic subunit is encoded by the POLG gene, and mutations in this gene cause mtDNA genome instability and disease. Barriers to studying the molecular effects of disease mutations include scarcity of patient samples and a lack of available mutant models; therefore, we developed a human SJCRH30 myoblast cell line model with the most common autosomal dominant POLG mutation, c.2864A>G/p.Y955C, as individuals with this mutation can present with progressive skeletal muscle weakness. Using on-target sequencing, we detected a 50% conversion frequency of the mutation, confirming heterozygous Y955C substitution. We found mutated cells grew slowly in a glucose-containing medium and had reduced mitochondrial bioenergetics compared with the parental cell line. Furthermore, growing Y955C cells in a galactose-containing medium to obligate mitochondrial function enhanced these bioenergetic deficits. Also, we show complex I NDUFB8 and ND3 protein levels were decreased in the mutant cell line, and the maintenance of mtDNA was severely impaired (i.e., lower copy number, fewer nucleoids, and an accumulation of Y955C-specific replication intermediates). Finally, we show the mutant cells have increased sensitivity to the mitochondrial toxicant 2'-3'-dideoxycytidine. We expect this POLG Y955C cell line to be a robust system to identify new mitochondrial toxicants and therapeutics to treat mitochondrial dysfunction.
C1 [Rahman, Md Mostafijur; Young, Carolyn K. J.; Young, Matthew J.] Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA.
   [Goffart, Steffi; Pohjoismaki, Jaakko L. O.] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland.
C3 Southern Illinois University System; Southern Illinois University; University of Eastern Finland
RP Young, MJ (corresponding author), Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA.
EM matthew.young@siu.edu
FU National Institute of Environmental Health Sciences (NIEHS, National Institutes of Health) Pathway to Independence Award [5R00ES022638-04]; NIEHS, National Institutes of Health [1R15ES033394-01]; SIU School of Medicine; SIU Carbondale Doctoral Research Fellowship
CR Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Belmonte FR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25186
   Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002
   Bjork JA, 2021, TOXICOL APPL PHARM, V433, P0, DOI 10.1016/j.taap.2021.115783
   Chaudhry A, 2020, AM J PHYSIOL-ENDOC M, V318, PE87, DOI 10.1152/ajpendo.00457.2019
   Chen C, 2020, NEUROBIOL DIS, V134, P0, DOI 10.1016/j.nbd.2019.104631
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   Ciesielska EJ, 2021, MITOCHONDRION, V61, P147, DOI 10.1016/j.mito.2021.09.010
   Civitarese AE, 2010, CELL METAB, V11, P412, DOI 10.1016/j.cmet.2010.04.004
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Clayton David A, 2014, COLD SPRING HARB PROTOC, V2014, P0, DOI 10.1101/pdb.prot080002
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3
   Dong DW, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-677
   Duong VN, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-66153-z
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r
   Falabella M, 2019, CURR MED CHEM, V26, P2918, DOI 10.2174/0929867325666180228165527
   Falkenberg M, 2020, CRIT REV BIOCHEM MOL, V55, P509, DOI 10.1080/10409238.2020.1818684
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Green MR, 2012, MOL CLONING LAB MANU, V0, P0
   Gustafson MA, 2020, DNA REPAIR, V93, P0, DOI 10.1016/j.dnarep.2020.102916
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Jha Pooja, 2016, CURR PROTOC MOUSE BIOL, V6, P1, DOI 10.1002/9780470942390.mo150182
   Khurana L, 2019, METHOD ENZYMOL, V629, P307, DOI 10.1016/bs.mie.2019.05.053
   Kikin O, 2006, NUCLEIC ACIDS RES, V34, PW676, DOI 10.1093/nar/gkl253
   Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, P0, DOI 10.1093/nar/gks1324
   Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li CF, 2021, AUTOPHAGY, V17, P948, DOI 10.1080/15548627.2020.1739447
   Li M, 2016, ANTIMICROB AGENTS CH, V60, P5608, DOI 10.1128/AAC.00976-16
   Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011
   Lobo-Jarne T, 2018, SEMIN CELL DEV BIOL, V76, P179, DOI 10.1016/j.semcdb.2017.07.021
   Lujan SA, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-02138-5
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052
   MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743
   Matic S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03552-x
   MEDINA DJ, 1994, ANTIMICROB AGENTS CH, V38, P1824, DOI 10.1128/AAC.38.8.1824
   Melkonian EA, 2022, BIOCHEMISTRY, V0, P0
   Mello DF, 2022, ENVIRON SCI TECHNOL, V56, P1113, DOI 10.1021/acs.est.1c05915
   Morino K, 2012, DIABETES, V61, P877, DOI 10.2337/db11-1391
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Ohnstad HO, 2011, BMC CANCER, V11, P0, DOI 10.1186/1471-2407-11-211
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Peeva V, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04131-w
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Pohjoismäki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   Pohjoismäki JLO, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010426
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Prasad R, 2017, DNA REPAIR, V60, P77, DOI 10.1016/j.dnarep.2017.10.011
   Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2
   ROBERTS WM, 1989, CANCER RES, V49, P5407
   Rocher C, 2008, J BIOENERG BIOMEMBR, V40, P59, DOI 10.1007/s10863-008-9130-5
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Schlieben LD, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.600079
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Setzer B, 2005, ANTIVIR THER, V10, P327
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Siibak T, 2017, HUM MOL GENET, V26, P2515, DOI 10.1093/hmg/ddx146
   Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177
   Singh B, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0140409
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Sufit A, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0165107
   Sykora P, 2017, MOL CELL BIOL, V37, P0, DOI 10.1128/MCB.00237-17
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Torregrosa-Muñumer R, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-45244-6
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wallace KB, 2022, TOXICOL APPL PHARM, V442, P0, DOI 10.1016/j.taap.2022.116003
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wheeler Joel H, 2019, CURR PROTOC TOXICOL, V80, Pe75, DOI 10.1002/cptx.75
   Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI 10.1038/nchembio.2102
   Xu YL, 2021, ANTIMICROB AGENTS CH, V65, P0, DOI 10.1128/AAC.02237-20
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   Young CKJ, 2019, CELL CYCLE, V18, P476, DOI 10.1080/15384101.2019.1578133
   Young CKJ, 2021, J BIOL CHEM, V296, P0, DOI 10.1074/jbc.RA120.014885
   Young MJ, 2017, FRONT MOL BIOSCI, V4, P0, DOI 10.3389/fmolb.2017.00074
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
NR 101
TC 1
Z9 1
U1 2
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 15
PY 2022
VL 298
IS 8
BP 
EP 
DI 10.1016/j.jbc.2022.102196
EA JUL 2022
PG 29
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 3S2WH
UT WOS:000839461200010
PM 35760101
DA 2024-11-01
ER

PT J
AU Jha, R
   Patel, H
   Dubey, R
   Goswami, JN
   Bhagwat, C
   Saini, L
   Manokaran, RK
   John, BM
   Kovilapu, UB
   Mohimen, A
   Saxena, A
   Sondhi, V
AF Jha, Ruchika
   Patel, Harshkumar
   Dubey, Rachana
   Goswami, Jyotindra N.
   Bhagwat, Chandana
   Saini, Lokesh
   Manokaran, Ranjith K.
   John, Biju M.
   Kovilapu, Uday B.
   Mohimen, Aneesh
   Saxena, Apoorv
   Sondhi, Vishal
TI Clinical and molecular spectrum associated with Polymerase-gamma related disorders
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mtDNA depletion; mitochondrial disease; Leigh; Alpers; ophthalmoplegia
ID disease mutations; mitochondrial; polg; defects; a467t; mtdna
AB Background POLG pathogenic variants are the commonest single-gene cause of inherited mitochondrial disease. However, the data on clinicogenetic associations in POLG-related disorders are sparse. This study maps the clinicogenetic spectrum of POLG-related disorders in the pediatric population. Methods Individuals were recruited across 6 centers in India. Children diagnosed between January 2015 and August 2020 with pathogenic or likely pathogenic POLG variants and age of onset <15 years were eligible. Phenotypically, patients were categorized into Alpers-Huttenlocher syndrome; myocerebrohepatopathy syndrome; myoclonic epilepsy, myopathy, and sensory ataxia; ataxia-neuropathy spectrum; Leigh disease; and autosomal dominant / recessive progressive external ophthalmoplegia. Results A total of 3729 genetic reports and 4256 hospital records were screened. Twenty-two patients with pathogenic variants were included. Phenotypically, patients were classifiable into Alpers-Huttenlocher syndrome (8/22; 36.4%), progressive external ophthalmoplegia (8/22; 36.4%), Leigh disease (2/22; 9.1%), ataxia-neuropathy spectrum (2/22; 9.1%), and unclassified (2/22; 9.1%). The prominent clinical manifestations included developmental delay (n = 14; 63.7%), neuroregression (n = 14; 63.7%), encephalopathy (n = 11; 50%), epilepsy (n = 11; 50%), ophthalmoplegia (n = 8; 36.4%), and liver dysfunction (n = 8; 36.4%). Forty-four pathogenic variants were identified at 13 loci, and these were clustered at exonuclease (18/44; 40.9%), linker (13/44; 29.5%), polymerase (10/44; 22.7%), and N-terminal domains (3/44; 6.8%). Genotype-phenotype analysis suggested that serious outcomes including neuroregression (odds ratio [OR] 11, 95% CI 2.5, 41), epilepsy (OR 9, 95% CI 2.4, 39), encephalopathy (OR 5.7, 95% CI 1.4, 19), and hepatic dysfunction (OR 4.6, 95% CI 21.3, 15) were associated with at least 1 variant involving linker or polymerase domain. Conclusions We describe the clinical subgroups and their associations with different POLG domains. These can aid in the development of follow-up and management strategies of presymptomatic individuals.
C1 [Jha, Ruchika; John, Biju M.; Saxena, Apoorv; Sondhi, Vishal] Armed Forces Med Coll, Dept Pediat, Pune 40, Maharashtra, India.
   [Patel, Harshkumar] Zydus Hosp, Dept Pediat Neurol, Ahmadabad, Gujarat, India.
   [Dubey, Rachana] Medanta Hosp, Dept Pediat Neurol, Indore, Madhya Pradesh, India.
   [Goswami, Jyotindra N.] Army Hosp Res & Referral, Dept Pediat, New Delhi, India.
   [Bhagwat, Chandana; Saini, Lokesh] Postgrad Inst Med Educ & Res, Dept Pediat, Pediat Neurol Unit, Chandigarh, India.
   [Manokaran, Ranjith K.] Sri Ramachandra Inst Higher Educ, Dept Neurol, Div Pediat Neurol, Chennai, Tamil Nadu, India.
   [Kovilapu, Uday B.] Armed Forces Med Coll, Dept Radiodiag, Pune, Maharashtra, India.
   [Mohimen, Aneesh] Command Hosp Cent Command, Dept Radiodiag, Lucknow, Uttar Pradesh, India.
C3 Armed Forces Medical College; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Sri Ramachandra Institute of Higher Education & Research; Armed Forces Medical College
RP Sondhi, V (corresponding author), Armed Forces Med Coll, Dept Pediat, Pune 40, Maharashtra, India.
EM vishalsondhi@gmail.com
CR Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Cohen BH, 1993, GENEREVIEWS((R)), V0, P0
   Copeland William C, 2003, SCIENTIFICWORLDJOURNAL, V3, P34
   DeLano WL, 2002, THE PYMOL MOLECULAR GRAPHICS SYSTEM, V0, P0
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   McLaren W, 2016, GENOME BIOL, V17, P0, DOI 10.1186/s13059-016-0974-4
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 21
TC 8
Z9 8
U1 0
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAR 15
PY 2022
VL 37
IS 4
BP 246
EP 255
DI 10.1177/08830738211067065
EA JAN 2022
PG 10
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 0W4QW
UT WOS:000743606700001
PM 34986040
DA 2024-11-01
ER

PT J
AU Lang-Orsini, M
   Gonzalez-Perez, P
AF Lang-Orsini, Melanie
   Gonzalez-Perez, Paloma
TI Neuropathic Pain as Main Manifestation of <i>POLG</i>-Related Disease: A Case Report
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE CPEO; polyneuropathy; neuropathic pain; POLG; mitochondrial disease
ID progressive external ophthalmoplegia; mitochondrial; mutations
AB Mutations in nuclear-encoded genes that are involved in mitochondrial DNA replication and maintenance (e.g., POLG) have been associated with chronic progressive external ophthalmoplegia (CPEO) phenotype. These nuclear genome mutations may lead to multiple mitochondrial DNA deletions or mitochondrial DNA depletion. On the other hand, primary genetic defects of mitochondrial DNA (such as single large-scale deletion or point mutations) have also been associated with the CPEO phenotype. Chronic progressive external ophthalmoplegia (CPEO) may be a manifestation of specific syndromes that, when clinically recognized, prompt clinicians to investigate specific genetic defects. Thus, CPEO, as part of Kearns Sayre syndrome, suggests the presence of a large-scale deletion of mitochondrial DNA. However, in pure CPEO or CPEO plus phenotypes, it is more difficult to know whether causative genetic defects affect the nuclear or mitochondrial DNA. Here, we present a patient with a long-standing history of CPEO plus phenotype, in whom the sequencing of mitochondrial DNA from skeletal muscle was normal, and no other genetic defect was suspected at first. At the time of our evaluation, the presence of polyneuropathy and neuropathic pain prompted us to investigate nuclear genetic defects and, specifically, mutations in the POLG gene. Thus, the sequencing of the POLG gene revealed p.Thr251Ile and p.Pro587Leu mutations in one allele, and p.Ala467Thr mutation in another allele. Although one would expect that mutations in POLG lead to multiple mitochondrial DNA deletions or depletion (loss of copies), the absence of mitochondrial DNA abnormalities in tissue may be explained by heteroplasmy, a lack or no significant involvement of biopsied tissue, or a sampling bias. So, the absence of secondary mitochondrial DNA alterations should not discourage clinicians from further investigating mutations in nuclear-encoded genes. Lastly, mitochondrial point mutations and single mitochondrial DNA deletions very rarely cause CPEO associated with polyneuropathy and neuropathic pain, and POLG-related disease should be considered in this scenario, instead.
C1 [Lang-Orsini, Melanie] Massachusetts Gen Hosp, Harvard Med Sch, Dept Pathol, Boston, MA USA.
   [Gonzalez-Perez, Paloma] Massachusetts Gen Hosp, Harvard Med Sch, Dept Neurol, Boston, MA 02114 USA.
C3 Harvard University; Massachusetts General Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard Medical School
RP Gonzalez-Perez, P (corresponding author), Massachusetts Gen Hosp, Harvard Med Sch, Dept Neurol, Boston, MA 02114 USA.
EM pgonzalezperez@partners.org
FU Muscle Study Group; American Academy of Neurology; American Brain Foundation
CR Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   Lehmann D, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000113
   Maghbooli M, 2020, NEUROL INDIA, V68, P760, DOI 10.4103/0028-3886.293454
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 13
TC 0
Z9 0
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD MAR 8
PY 2022
VL 13
IS 
BP 
EP 
DI 10.3389/fneur.2022.846110
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 0F3QW
UT WOS:000777278600001
PM 35350396
DA 2024-11-01
ER

PT J
AU Capristo, M
   Del Dotto, V
   Tropeano, CV
   Fiorini, C
   Caporali, L
   La Morgia, C
   Valentino, ML
   Montopoli, M
   Carelli, V
   Maresca, A
AF Capristo, Mariantonietta
   Del Dotto, Valentina
   Tropeano, Concetta Valentina
   Fiorini, Claudio
   Caporali, Leonardo
   La Morgia, Chiara
   Valentino, Maria Lucia
   Montopoli, Monica
   Carelli, Valerio
   Maresca, Alessandra
TI Rapamycin rescues mitochondrial dysfunction in cells carrying the m.8344A &gt; G mutation in the mitochondrial tRNA<SUP>Lys</SUP>
SO MOLECULAR MEDICINE
LA English
DT Article
DE MERRF; Mitochondrial DNA; Niacin; PGC-1 alpha; Rapamycin; mTORC1; Mitochondrial dysfunction; Mitochondrial biogenesis
ID ragged-red fibers; myoclonic epilepsy; protein-synthesis; point mutations; mtdna mutation; mouse model; merrf; dna; disease; mtor
AB Background: Myoclonus, Epilepsy and Ragged-Red-Fibers (MERRF) is a mitochondrial encephalomyopathy due to heteroplasmic mutations in mitochondrial DNA (mtDNA) most frequently affecting the tRNA(Lys) gene at position m.8344A > G. Defective tRNA(Lys) severely impairs mitochondrial protein synthesis and respiratory chain when a high percentage of mutant heteroplasmy crosses the threshold for full-blown clinical phenotype. Therapy is currently limited to symptomatic management of myoclonic epilepsy, and supportive measures to counteract muscle weakness with co-factors/supplements. Methods: We tested two therapeutic strategies to rescue mitochondrial function in cybrids and fibroblasts carrying different loads of the m.8344A > G mutation. The first strategy was aimed at inducing mitochondrial biogenesis directly, over-expressing the master regulator PGC-1 alpha, or indirectly, through the treatment with nicotinic acid, a NAD(+) precursor. The second was aimed at stimulating the removal of damaged mitochondria through prolonged rapamycin treatment. Results: The first approach slightly increased mitochondrial protein expression and respiration in the wild type and intermediate-mutation load cells, but was ineffective in high-mutation load cell lines. This suggests that induction of mitochondrial biogenesis may not be sufficient to rescue mitochondrial dysfunction in MERRF cells with high-mutation load. The second approach, when administered chronically (4 weeks), induced a slight increase of mitochondrial respiration in fibroblasts with high-mutation load, and a significant improvement in fibroblasts with intermediate-mutation load, rescuing completely the bioenergetics defect. This effect was mediated by increased mitochondrial biogenesis, possibly related to the rapamycin-induced inhibition of the Mechanistic Target of Rapamycin Complex 1 (mTORC1) and the consequent activation of the Transcription Factor EB (TFEB). Conclusions: Overall, our results point to rapamycin-based therapy as a promising therapeutic option for MERRF.
C1 [Capristo, Mariantonietta; Del Dotto, Valentina; Tropeano, Concetta Valentina; Fiorini, Claudio; Caporali, Leonardo; La Morgia, Chiara; Valentino, Maria Lucia; Carelli, Valerio; Maresca, Alessandra] IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Via Altura 3, I-40139 Bologna, Italy.
   [Valentino, Maria Lucia; Carelli, Valerio] Univ Bologna, Dept Biomed & NeuroMotor Sci, Via Altura 3, I-40139 Bologna, Italy.
   [Montopoli, Monica] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Via Largo Meneghetti 2, I-3513 Padua, Italy.
C3 IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Padua
RP Carelli, V; Maresca, A (corresponding author), IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Via Altura 3, I-40139 Bologna, Italy.
EM valerio.carelli@unibo.it; alessandra.maresca@isnb.it
FU Italian Ministry of Health; Telethon Foundation [GGP20115]
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Antonická H, 1999, BIOCHEM J, V342, P537, DOI 10.1042/0264-6021:3420537
   ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brantová O, 2006, ULTRASTRUCT PATHOL, V30, P239, DOI 10.1080/01913120600820112
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Carelli V, 2018, ESSAYS BIOCHEM, V62, P235, DOI 10.1042/EBC20170097
   Cassandrini D, 2006, BIOCHEM BIOPH RES CO, V342, P387, DOI 10.1016/j.bbrc.2006.01.152
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003
   Cheema NJ, 2021, AM J PHYSIOL-CELL PH, V321, PC176, DOI 10.1152/ajpcell.00471.2020
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   Chomyn A, 1998, AM J HUM GENET, V62, P745, DOI 10.1086/301813
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Chung CY, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-26746-2
   Civiletto G, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708799
   Cogliati S, 2021, BIOCHEM SOC T, V49, P2655, DOI 10.1042/BST20210460
   COQUET M, 1993, NEUROMUSCULAR DISORD, V3, P593, DOI 10.1016/0960-8966(93)90122-Z
   Crowley CL, 2000, CELL DEATH DIFFER, V7, P314, DOI 10.1038/sj.cdd.4400658
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fakruddin M, 2018, CELL REP, V22, P482, DOI 10.1016/j.celrep.2017.12.051
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gammage PA, 2016, METHODS MOL BIOL, V1351, P145, DOI 10.1007/978-1-4939-3040-1_11
   Gureev AP, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00435
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   HOLME E, 1993, AM J HUM GENET, V52, P551
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Ignatenko O, 2020, LIFE SCI ALLIANCE, V3, P0, DOI 10.26508/lsa.202000797
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kim DS, 2002, J KOREAN MED SCI, V17, P103, DOI 10.3346/jkms.2002.17.1.103
   King M P, 1996, METHODS ENZYMOL, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Koh JH, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22094558
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y
   Mahalakshmi R, 2022, MOL BIOL REP, V49, P463, DOI 10.1007/s11033-021-06898-6
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Maresca A, 2020, HUM MOL GENET, V29, P1864, DOI 10.1093/hmg/ddaa014
   Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653
   Monden Y, 2013, BRAIN DEV-JPN, V35, P582, DOI 10.1016/j.braindev.2012.08.006
   Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572
   Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Perli E, 2020, FASEB J, V34, P7675, DOI 10.1096/fj.201903270R
   Perli E, 2016, HUM MOL GENET, V25, P903, DOI 10.1093/hmg/ddv619
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Richter U, 2021, FEBS LETT, V595, P1003, DOI 10.1002/1873-3468.14049
   Richter U, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06471-z
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718
   Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32
   Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wang A, 2016, ONCOTARGET, V7, P80131, DOI 10.18632/oncotarget.12560
   Wang SJ, 2020, BIOMED PHARMACOTHER, V128, P0, DOI 10.1016/j.biopha.2020.110272
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Zheng XD, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.13378
   Zhou L, 1997, J NEUROSCI, V17, P7746
NR 75
TC 3
Z9 3
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1076-1551
EI 1528-3658
J9 MOL MED
JI Mol. Med.
PD DEC 15
PY 2022
VL 28
IS 1
BP 
EP 
DI 10.1186/s10020-022-00519-z
PG 18
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine
GA 3M8PG
UT WOS:000835718100005
PM 35922766
DA 2024-11-01
ER

